


  2  1
$MOL
(4-Bromophenyl)acetic acid
C8H7BrO2
1878-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 C 6.9302 1.3337 0.0 0
M  V30 3 O 6.1601 0.0000 0.0 0
M  V30 4 O 8.4702 1.3337 0.0 0
M  V30 5 Br 0.0000 2.6673 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzeneacetamide
C9H10BrNO
7713-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1878-68-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7713-76-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6517224
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM After optimization, compound 2 was suspended in two volumes of toluene
and 10 mol % of DMF and treated under dose-controlled condition with 1.2
equiv of thionyl chloride at 40°C to ensure complete reaction. The
resulting solution was cooled to ambient temperature and transferred to
an aqueous solution of methylamine at 0-25°C. The resulting suspension
was filtered to afford the desired amide 3. Yield 94%. HPLC purity (96.4
to >99%).8,9
$DTYPE RXN:VAR(1):NOTES
$DATUM literature prepn.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Initial Process Development and Scale-Up of the Synthesis of a Triple
Reuptake Inhibitor ALB 109780
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Qiang; Ulysse, Luckner G.; McLaws, Mark D.; Keefe, Daniel K.;
Haney, Brian P.; Zha, Congxiang; Guzzo, Peter R.; Liu, Shuang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2012), 16(3), 499-506

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-5-nitropyrimidine
C4HCl2N3O2
49845-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 N 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-5-nitro-4-pyrimidinamine
C5H5ClN4O2
89283-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 N 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49845-33-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89283-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5342820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The development of novel C-2, C-8, and N-9 trisubstituted purines as
inhibitors of TNF-α production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sabat, Mark; VanRens, John C.; Clark, Michael P.; Brugel, Todd A.; Maier,
Jennifer; Bookland, Roger G.; Laufersweiler, Matthew J.; Laughlin, Steven
K.; Golebiowski, Adam; De, Biswanath; Hsieh, Lily C.; Walter, Richard L.;
Mekel, Marlene J.; Janusz, Michael J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2006), 16(16), 4360-4365

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16671453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydropyrimidopyrimidines and use as protein kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ren, Ruibao; Deng, Xianming; Liu, Ping; Jiao, Bo; Huang, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016168992 A1 2016-10-27

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
3-Bromo-5-nitrobenzoic acid
C7H4BrNO4
6307-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 5 O 6.6685 6.1600 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 Br 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-5-nitrobenzamide
C8H7BrN2O3
90050-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 Br 4.0011 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6307-83-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90050-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1079337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part B: Preparation of N-methyl-3-bromo-5-nitrobenzamide A suspension of
3-bromo-5-nitrobenzoic acid (7.10 g, 28.9 mmol) in dichloromethane (50
mL) was treated with oxalyl chloride (5.04 mL, 57.7 mmol) and a few drops
of N,N-dimethylformamide, producing gas evolution. After 2 hours, the
mixture was concentrated to give an oil, which was dissolved in
tetrahydrofuran and added dropwise to a stirred solution of methylamine
in tetrahydrofuran (2.0 M, 28.9 mL, 57.7 mmol) at 0° C. After stirring
overnight, the mixture was treated with water, ethyl acetate and 0.2 N
aqueous hydrochloric acid. The layers were separated after mixing, and
the organic phase was washed with 0.2 N aqueous hydrochloric acid, then
with saturated aqueous sodium chloride. The solution was dried over
sodium sulfate and concentrated under vacuum to provide a yellow solid
(7.0 g, 94%). 1H NMR (300 MHz, DMSO-d6) δ 9.92 (m, 1H), 8.64 (s, 1H),
8.53 (s, 1H), 8.43 (s, 1H), 2.81 (d, J=7 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclopenta[c]pyrrole and isoquinoline amines amines as
modulators of chemokine receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Batt, Douglas G.; Carter, Percy H.; Wacker, Dean A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005079497 A2 2005-09-01

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
3-Bromo-5-nitrobenzoic acid
C7H4BrNO4
6307-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 O 0.0000 3.8500 0.0 0
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 5 O 6.6685 6.1600 0.0 0
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 Br 4.0011 0.0000 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-methyl-5-nitrobenzamide
C8H7BrN2O3
90050-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 O 0.0000 3.8500 0.0 0
M  V30 8 Br 4.0011 0.0000 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6307-83-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90050-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12407480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidine- and tetrazolyl-containing ureas and related
compounds as modulators of chemokine receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Batt, Douglas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004028530 A1 2004-04-08

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, 1,1-dimethylethyl ester
C11H22N2O2
147539-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 N 10.0100 2.8736 0.0 0
M  V30 9 C 10.7800 4.2073 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 147539-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10654871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of (1-tert-Butoxycarbonylpiperidin-4-yl)methylamine
1-tert-Butoxycarbonylpiperid-4-one (6.18 g, 31 mmol) was dissolved in a
2.0 M solution of methylamine in methanol (56 mL, 112 mmol). This
solution was added to 10% palladium on carbon (wet, 1.3 g) and the
mixture placed under an atmosphere of hydrogen for 72 h. The reaction
mixture was then purged with nitrogen and filtered through a pad of
Celite, which was then washed with methanol. The resulting hazy filtrate
was filtered through a 0.2 μm filter and then concentrated in vacuo to
afford the title intermediate (6.16 g, 29 mmol, 93.5% yield). Analytical
Data: 1Η ΝMR (CDCl3): δ 2.7 (2H, m), 2.5 (IH, bm); 2.4, (3H, s, ΝHCH3),
2.2 (2H, bm), 1.8 (2H, bd), 1.4 (9H, s, (CH3)3C), 1.25 (2H, dq).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 4-amino-1-benzylpiperidines as muscarinic M2
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mammen, Mathai; Wilson, Richard; Dunham, Sarah; Hughes, Adam; Husfeld,
Craig; Ji, Yu-Hua; Li, Li; Mischki, Trevor; Stergiades, Ioanna; Oare,
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005007645 A1 2005-01-27

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenesulfonyl chloride
C6H4BrClO2S
98-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzenesulfonamide
C7H8BrNO2S
703-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 Br 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 703-12-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-14676686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of naphthyridine and isoquinoline derivatives as
metalloenzyme inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoekstra, William J.; Yates, Christopher M.; Rafferty, Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014117090 A1 2014-07-31

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15602473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel
1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid
CYP3A4 time-dependent inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Igawa, Hideyuki; Takahashi, Masashi; Shirasaki, Mikio; Kakegawa, Keiko;
Kina, Asato; Ikoma, Minoru; Aida, Jumpei; Yasuma, Tsuneo; Okuda, Shoki;
Kawata, Yayoi; Noguchi, Toshihiro; Yamamoto, Syunsuke; Fujioka, Yasushi;
Kundu, Mrinalkanti; Khamrai, Uttam; Nakayama, Masaharu; Nagisa, Yasutaka;
Kasai, Shizuo; Maekawa, Tsuyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(11), 2486-2503

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40664208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional MDM2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moore, Keith P.; Rodriguez-Rivera, Frances Paola; Kurukulasuriya, Ravi;
Imbriglio, Jason Eugene; Partridge, Anthony William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024097948 A1 2024-05-10

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21571210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel bifunctional compounds as MerTK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Mainolfi, Nello; Weiss, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020010210 A1 2020-01-09

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
4-Bromo-2-methylbenzoic acid
C8H7BrO2
68837-59-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2-dimethylbenzamide
C9H10BrNO
893420-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 C 3.8501 0.0000 0.0 0
M  V30 6 Br 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 68837-59-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 893420-18-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-12286108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Bromo-2-methyl-N-methyl-benzamide 4-Bromo-2-methylbenzoic acid (1.0g,
4.65 mmol) was added to DCM (50 ml), to this was added oxalyl chloride
(0.61 ml, 6.97 mmol) and 4 drops of DMF, the reaction was stirred until
no gas was liberated (approx 30 mins). To the reaction was added
methylamine (30 ml, 2N in THF) and the reaction was stirred for a further
10 minutes before being quenched with saturated sodium bicarbonate (60
ml), extracted with ether (2 x 100 ml), dried and the solvent was removed
in vacuo to yield a white solid. The solid was dissolved in a minimum
amount of DCM, to this was added ether and isohexane until a white solid
precipitated. The solid was filtered and dried, yield 1 .0g, 94%. NMR
(299.954 MHz, CDCl3) 7.37 (s, 1H), 7.32 (d, 1H), 7.20 (d, 1H), 5.76 (brs,
1H), 2.98 (d, 3H), 2.41 (s, 3H); m/z 229.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 4-(4-(imidazol-4-yl)-pyrimidin-2-ylamino)benzamides as CDK
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006064251 A1 2006-06-22

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23281263
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM carius tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tuning spin-crossover transition temperatures in non-symmetrical
homoleptic meridional/facial [Fe(didentate)3]2+ complexes: what for and
who cares about it?
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deorukhkar, Neel; Besnard, Celine; Guenee, Laure; Piguet, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2021), 50(4), 1206-1223

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzenesulfonamide
C7H8FNO2S
433-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 3.0800 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 F 8.4700 1.5400 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6200 0.2064 0.0 0
M  V30 9 C 4.6200 2.8736 0.0 0
M  V30 10 C 6.1600 0.2064 0.0 0
M  V30 11 C 6.1600 2.8736 0.0 0
M  V30 12 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 433-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-13109711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1. 4-fluoro-N-methylbenzenesulfonamide A round bottom flask was
charged with methylamine solution 40% (0.88 ml, 26 mmol) in ethanol (10
ml, 171 mmol). The mixture was chilled to 0° C in an ice bath, with
stirring under inert atmosphere. Then 4-fluorobenzenesulfonyl chloride
(1.00 g, 5.1 mmol) was added into the mixture. The resulting mixture was
allowed to stir at 0° C, while under inert atmosphere for 30 minutes. The
progress of the reaction was monitored by LC/MS, which showed mostly
desired product peak. The mixture was diluted with DCM and saturated
sodium bicarbonate solution, then extracted the organic layer with DCM (3
x 25 ml). The organics were combined, dried over sodium sulfate, filtered
and concentrated in vacuo. This gave 4-fluoro-N-methylbenzenesulfonamide
(0.918 g, 94% yield) as an off-white crystalline solid. MS (ESI pos. ion)
m/z: 190 (MH+). Calc'd exact mass for C7H8FNO2S: 189. 1H NMR (400 MHz,
chloroform-d): 2.64-2.71 (m, 3H), 4.63 (s, 1H), 7.18-7.28 (m, 2H),
7.88-7.93 (m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aminobenzothiazole derivatives as phosphoinositide
3-kinase (PI3 kinase) modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Booker, Shon; D'Angelo, Noel; D'Amico, Derin C.; Kim, Tae-Seong; Liu,
Longbin; Meagher, Kristin; Norman, Mark H.; Panter, Kathleen; Schenkel,
Laurie B.; Smith, Adrian L.; Tamayo, Nuria A.; Whittington, Douglas A.;
Xi, Ning; Yang, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009017822 A2 2009-02-05

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-15309123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 1-A: 4-Fluoro-N-methyl-benzamide To a solution of 30 mL MeNH2
(40% wt in H2O) was added 139 mL of 1N NaOH. To this was added 130 mL of
CH2Cl2 followed by 4-fluorobenzoyl chloride (22 grams, 139 mmol) while
the mixture was rapidly stirred. After 1 hour the organic layer was
separated, washed with H2O, dried over Na2SO4 and solvent removed under
vacuum to yield solid. Yield 20 grams, 94% 1H NMR (500 MHz, DMSO) δ: 2.78
(d, 3, J= 5), 7.28 (t, 2, J= 9), 7.91 (m, 2), 8.46 (br s, 1). 13C NMR
(125 MHz, DMSO) δ: 26.13, 114.95, 115.13, 129.49, 129.56, 130.87, 130.90,
162.67, 164.64, 165.46.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrrolecarboxamides as HIV integrase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Walker, Michael A.; Ma, Zhuping; Naidu, B. Narasimhulu; Sorenson,
Margaret E.; Pendri, Annapurna; Banville, Jacques; Plamondon, Serge;
Remillard, Roger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004004657 A2 2004-01-15

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
4-Bromobenzoic acid
C7H5BrO2
586-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 586-76-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34334178
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM SOCl2 also acts as a solvent in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide
(AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2
and Other PARPs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johannes, Jeffrey W.; Balazs, Amber; Barratt, Derek; Bista, Michal;
Chuba, Matthew D.; Cosulich, Sabina; Critchlow, Susan E.; Degorce,
Sebastien L.; Di Fruscia, Paolo; Edmondson, Scott D.; Embrey, Kevin;
Fawell, Stephen; Ghosh, Avipsa; Gill, Sonja J.; Gunnarsson, Anders;
Hande, Sudhir M.; Heightman, Tom D.; Hemsley, Paul; Illuzzi, Giuditta;
Lane, Jordan; Larner, Carrie; Leo, Elisabetta; Liu, Lina; Madin, Andrew;
Martin, Scott; McWilliams, Lisa; O'Connor, Mark J.; Orme, Jonathan P.;
Pachl, Fiona; Packer, Martin J.; Pei, Xiaohui; Pike, Andrew; Schimpl,
Marianne; She, Hongyao; Staniszewska, Anna D.; Talbot, Verity; Underwood,
Elizabeth; Varnes, Jeffrey G.; Xue, Lin; Yao, Tieguang; Zhang, Ke; Zhang,
Andrew X.; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14498-14512

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromopropoxy)benzene
C9H11BrO
588-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 Br 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-phenoxy-1-propanamine
C10H15NO
132424-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 588-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132424-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1405042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 3 A solution of 3-phenoxy-1-propyl bromide (25.25 g, 0.117
mol) in dry EtOH (100 ml.) was added over 20 min via a dropping funnel to
a cooled (0 °C) 33 wt. % solution of methylamine in absolute EtOH (250
mL, 2.0 mol, 17 equiv.) and slowly allowed to warm to RT overnight. The
RM was concentrated to dryness to afford a white solid that was
partitioned between sat. sodium carbonate solution (aq.) and DCM with
vigorous stirring. After separating the organic layer the water layer was
extracted with DCM (2x). The combined organic layers were washed with
brine, dried (Na2SO4), and concentrated to dryness to afford a light
brown oil. Yield: 18.3 g (94%). LC-MS (Method 1): Rt 1.86 min, m/z 166
[MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 7-aminobicyclo[2.2.1]heptan-2-ols muscarinic receptor
antagonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ray, Nicholas Charles; Van Neil, Monique Bodil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010071581 A1 2010-06-24

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromopropoxy)benzene
C9H11BrO
588-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 Br 9.3360 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-phenoxy-1-propanamine
C10H15NO
132424-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 N 9.3360 3.0801 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 588-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132424-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7748515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 3 A solution of 3-phenoxy-1-propyl bromide (25.25 g, 0.1 17
mol) in dry EtOH (100 ml.) was added over 20 min via a dropping funnel to
a cooled (0 °C) 33 wt. % solution of methylamine in absolute EtOH (250
mL, 2.0 mol, 17 equiv.) and slowly allowed to warm to RT overnight. The
RM was concentrated to dryness to afford a white solid that was
partitioned between sat. sodium carbonate solution (aq.) and DCM with
vigorous stirring. After separating the organic layer the water layer was
extracted with DCM (2x). The combined organic layers were washed with
brine, dried (Na2SO4), and concentrated to dryness to afford a light
brown oil. Yield: 18.3 g (94%). LC-MS (Method 1 ): Rt 1.86 min, m/z 166
[MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pharmaceutical product comprising muscarinic receptor antagonist and
second active ingredient
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ray, Nicholas Charles; Van Neil, Monique Bodil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010071582 A1 2010-06-24

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chlorophenyl)cyclopropanecarboxylic acid
C10H9ClO2
72934-37-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4471 0.9899 0.0 0
M  V30 2 O 0.0000 0.4632 0.0 0
M  V30 3 O 2.6269 0.0000 0.0 0
M  V30 4 Cl 7.8746 2.5065 0.0 0
M  V30 5 C 1.7146 2.5065 0.0 0
M  V30 6 C 0.2675 3.0332 0.0 0
M  V30 7 C 1.4471 4.0231 0.0 0
M  V30 8 C 3.2546 2.5065 0.0 0
M  V30 9 C 4.0246 3.8401 0.0 0
M  V30 10 C 4.0246 1.1729 0.0 0
M  V30 11 C 5.5646 3.8401 0.0 0
M  V30 12 C 5.5646 1.1729 0.0 0
M  V30 13 C 6.3346 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxylic acid, 1-(4-chlorophenyl)-, methyl ester
C11H11ClO2
117252-05-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3246 2.6268 0.0 0
M  V30 2 O 7.8413 2.3593 0.0 0
M  V30 3 O 5.7979 4.0740 0.0 0
M  V30 4 C 8.8311 3.5391 0.0 0
M  V30 5 Cl 0.0000 4.5271 0.0 0
M  V30 6 C 5.3348 1.4470 0.0 0
M  V30 7 C 6.3246 0.2673 0.0 0
M  V30 8 C 4.8080 0.0000 0.0 0
M  V30 9 C 4.0010 2.2170 0.0 0
M  V30 10 C 2.6673 1.4470 0.0 0
M  V30 11 C 4.0010 3.7570 0.0 0
M  V30 12 C 1.3337 2.2170 0.0 0
M  V30 13 C 2.6673 4.5271 0.0 0
M  V30 14 C 1.3337 3.7570 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 72934-37-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117252-05-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24444097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 762-98-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Protecting-group-free synthesis of hydroxyesters from amino alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reynard, Guillaume; Joseph-Valcin, Eve-Marline; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2020), 56(74),
10938-10941

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-(3-methoxy-3-oxopropyl)-N-methyl-, methyl ester
C9H17NO4
105-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 O 1.3337 1.5400 0.0 0
M  V30 10 O 2.6673 3.8501 0.0 0
M  V30 11 O 12.0033 1.5400 0.0 0
M  V30 12 O 10.6697 3.8501 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 105-71-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10327472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new stepwise synthesis of a family of propylamines derived from diatom
silaffins and their activity in silicification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annenkov, Vadim V.; Patwardhan, Siddharth V.; Belton, David;
Danilovtseva, Elena N.; Perry, Carole C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2006), (14),
1521-1523

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl glycolate
C4H8O3
623-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methylacetamide
C3H7NO2
5415-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 N 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5415-94-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-207781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Hydroxy-N-methylacetamide (Species F). A 15 mL schlenk flask was
charged with a 40% aqueous solution of methylamine (4.33 mL, 50 mmol) and
ethyl glycolate (0.95 mL, 10 mmol). The reaction was stirred at room
temperature for 3.5 hrs and then nitrogen gas was bubbled through the
solution for 1 hr. The remaining solution was then concentrated under
high vacuum. Species F as a white solid (0.84 g, 94%). 1H NMR (500 MHz,
CDCl3) δ 4.05 (s, 2H), 2.85 (d, J = 5 Hz, 3H). 13C NMR (500 MHz, CHCl3) δ
173.38, 62.10, 25.76. MS (ESI): Calcd for C3H7NO2: 89.09; observed: 90.06
(MH+), 112.04 (MNa+).
$DTYPE RXN:VAR(1):NOTES
$DATUM N2 gas was bubble through the reaction in the last hour
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanistic Rationalization of Unusual Sigmoidal Kinetic Profiles in the
Machetti-De Sarlo Cycloaddition Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mower, Matthew P.; Blackmond, Donna G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2015), 137(6), 2386-2391

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-19413192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic compound and organic light-emitting device including the
same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Sehun; Park, Sooyoung; Kwon, Jieon; Kim, Dawoon; Ryoo, Chihyun;
Jeong, Hyein
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180233675 A1 2018-08-16

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23120905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocycles as TYK2 inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Bohan; Dong, Qing; Hung, Gene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020185755 A1 2020-09-17

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-[[1-[(1,1-dimethylethoxy)carbonyl]-3-azetidinyl]...
C15H21N3O4
2868276-78-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5547 4.6201 0.0 0
M  V30 2 C 4.0012 1.9911 0.0 0
M  V30 3 O 2.6673 2.7611 0.0 0
M  V30 4 O 4.0012 0.4511 0.0 0
M  V30 5 C 1.3337 1.9911 0.0 0
M  V30 6 C 0.5637 3.3248 0.0 0
M  V30 7 C 0.0000 1.2211 0.0 0
M  V30 8 C 2.1037 0.6574 0.0 0
M  V30 9 C 13.8896 1.5400 0.0 0
M  V30 10 O 15.2232 2.3101 0.0 0
M  V30 11 O 13.8896 0.0000 0.0 0
M  V30 12 C 16.5569 1.5400 0.0 0
M  V30 13 C 7.2209 3.8501 0.0 0
M  V30 14 C 6.8224 2.3626 0.0 0
M  V30 15 C 5.7334 4.2486 0.0 0
M  V30 16 N 5.3348 2.7611 0.0 0
M  V30 17 C 9.8884 3.8501 0.0 0
M  V30 18 C 11.2221 4.6201 0.0 0
M  V30 19 C 9.8884 2.3101 0.0 0
M  V30 20 C 12.5557 3.8501 0.0 0
M  V30 21 N 11.2221 1.5400 0.0 0
M  V30 22 C 12.5557 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[[6-[(methylamino)carbonyl]-3-pyridinyl]amino]-1-azetidin...
C15H22N4O3
2868276-77-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5547 4.6201 0.0 0
M  V30 2 C 4.0012 1.9911 0.0 0
M  V30 3 O 2.6673 2.7611 0.0 0
M  V30 4 O 4.0012 0.4511 0.0 0
M  V30 5 C 1.3337 1.9911 0.0 0
M  V30 6 C 0.5637 3.3248 0.0 0
M  V30 7 C 0.0000 1.2211 0.0 0
M  V30 8 C 2.1037 0.6574 0.0 0
M  V30 9 C 13.8896 1.5400 0.0 0
M  V30 10 N 15.2232 2.3101 0.0 0
M  V30 11 O 13.8896 0.0000 0.0 0
M  V30 12 C 16.5569 1.5400 0.0 0
M  V30 13 C 7.2209 3.8501 0.0 0
M  V30 14 C 6.8224 2.3626 0.0 0
M  V30 15 C 5.7334 4.2486 0.0 0
M  V30 16 N 5.3348 2.7611 0.0 0
M  V30 17 C 9.8884 3.8501 0.0 0
M  V30 18 C 9.8884 2.3101 0.0 0
M  V30 19 C 11.2221 4.6201 0.0 0
M  V30 20 C 11.2221 1.5400 0.0 0
M  V30 21 N 12.5557 3.8501 0.0 0
M  V30 22 C 12.5557 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2868276-78-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2868276-77-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36115919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine for treating cancer and pharmaceutical composition thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Dong, Qing; Trzoss, Lynnie; Va, Porino Jinjo; Kaldor,
Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023056039 A1 2023-04-06

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenemethanamine
C8H10N2O2
19499-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3087481
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-methyl(4-nitrophenyl)methanamine p-Nitrobenzaldehyde (15.0 g, 99.3
mmol) and 40% aqueous methylamine (17 mL) were combined in MeOH (250 mL)
for 15 min at 0 °C for 15 min and then treated with sodium borohydride
(3.77 g, 99.3 mmol). The mixture was stirred at RT for 2 h and
concentrated. Water (50 mL) was added to the residue which was then
extracted with DCM (3 x 250 mL). The extracts were dried and concentrated
giving the title substance. Yield 15. 4 g, 94%. 1H NMR (CDCl3) δ 8.10 (m,
2H), 7.43 (m, 2H), 3.79 (s, 2H), 2.39 (s, 3H). MS (AP+) m/e 167 (MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic compounds as PDE10a inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of central nervous
system diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoover, Dennis Jay; Witter, Kevin G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008004117 A1 2008-01-10

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,8-Dibromoimidazo[1,2-a]pyrazine
C6H3Br2N3
63744-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.7036 0.0000 0.0 0
M  V30 2 Br 6.3710 4.6200 0.0 0
M  V30 3 N 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 3.7036 4.6200 0.0 0
M  V30 6 C 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
PAB 13
C7H7BrN4
117718-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Br 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 N 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 C 1.1444 2.3101 0.0 0
M  V30 9 C 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63744-22-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 117718-85-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4485252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(3-Bromo-imidazo[1,2-a]pyrazin-8-yl)-methyl-amine
3,5-Dibromo-imidazo[1,2-a]pyrazine (D) (2.0 g, 7 mol) was added to 2M
methylamine in THF (tetrahydrofuran) (100 ml, 30 eq.). The mixture was
heated at 70°C. in sealed tube for 3hr. The mixture was then cooled to
rt, diluted with DCM (200 ml) and water (100 ml). The organic layer was
washed with brine, dried and concentrated. The residue was purified on a
silica gel column to give
(3-bromoimidazo[1,2-a]pyrazin-8-yl)-methyl-amine. Step 3: Synthesis of
(6-Bromo-imidazo[1,2-a]pyrazin-8-yl)-methyl-amine (Intermediate S) Using
procedure for Example 1, the title compound was obtained in 94% yield
from 6,8-dibromo-imidazo[1,2-a]pyrazine (Intermediate R) and methylamine.
1H NMR (400 MHz, DMSO-d6) δ 7.98 (s, 1H), 7.95 (d, 1H), 7.79 (d, 1H),
7.47 (d, 1H), 2.89 (d, 3H). MS m/z 228 [M++1].
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-substituted 8-aminoarylimidazo[1,2-a]pyrazines as
kinase inhibitors for treatment of cancer and other conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Connie Li; Liang, Congxin; Huang, Ping; Harris, G. Davis; Guan,
Huiping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040220189 A1 2004-11-04

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8968159
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 4-amino-2-cyclohexylaminoquinazolines as metabolically
stable melanin-concentrating hormone receptor 1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kanuma, Kosuke; Omodera, Katsunori; Nishiguchi, Mariko; Funakoshi, Takeo;
Chaki, Shigeyuki; Nagase, Yasuko; Iida, Izumi; Yamaguchi, Jun-ichi;
Semple, Graeme; Tran, Thuy-Anh; Sekiguchi, Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2006), 14(10), 3307-3319

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-fluoro-3-nitro-, methyl ester
C8H6FNO4
946126-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 F 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946126-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40576785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of
Overcoming a Variety of FLT3 Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhijie; Cai, Jiongheng; Ren, Jiwei; Chen, Yun; Wu, Yingli; Cheng,
Jie; Jia, Kun; Huang, Fei; Cheng, Zitian; Sheng, Tiancheng; Song, Shiyu;
Heng, Hao; Zhu, Yifan; Tang, Weifang; Li, Hongmei; Lu, Tao; Chen, Yadong;
Lu, Shuai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14664-14701

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,5S,6S)-5-(5-Bromo-2-fluorophenyl)-3-[[(1,1-dimethylethoxy)carbonyl][[2-(t...
C24H34BrFN2O5SSi
1874240-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6534 9.8036 0.0 0
M  V30 2 O 8.1934 9.8036 0.0 0
M  V30 3 O 5.8834 11.1373 0.0 0
M  V30 4 C 4.0231 4.7129 0.0 0
M  V30 5 N 8.5509 5.3900 0.0 0
M  V30 6 C 8.5509 3.8500 0.0 0
M  V30 7 C 9.8845 6.1600 0.0 0
M  V30 8 O 9.8845 3.0800 0.0 0
M  V30 9 O 7.2171 3.0800 0.0 0
M  V30 10 O 11.2181 5.3900 0.0 0
M  V30 11 C 9.8845 1.5400 0.0 0
M  V30 12 C 12.5518 6.1600 0.0 0
M  V30 13 C 8.3445 1.5400 0.0 0
M  V30 14 C 9.8845 0.0000 0.0 0
M  V30 15 C 11.4245 1.5400 0.0 0
M  V30 16 C 13.8856 5.3900 0.0 0
M  V30 17 Si 15.2192 6.1600 0.0 0
M  V30 18 C 16.5528 6.9300 0.0 0
M  V30 19 C 14.4492 7.4936 0.0 0
M  V30 20 C 15.9892 4.8262 0.0 0
M  V30 21 F 2.5700 3.8006 0.0 0
M  V30 22 Br 0.4631 9.5891 0.0 0
M  V30 23 C 5.8834 8.4700 0.0 0 CFG=2
M  V30 24 C 4.5498 7.7000 0.0 0 CFG=2
M  V30 25 C 4.5498 9.2400 0.0 0
M  V30 26 S 7.2171 7.7000 0.0 0
M  V30 27 C 4.5498 6.1600 0.0 0 CFG=2
M  V30 28 C 7.2171 6.1600 0.0 0
M  V30 29 N 5.8834 5.3900 0.0 0
M  V30 30 C 3.0332 6.4273 0.0 0
M  V30 31 C 2.0433 5.2477 0.0 0
M  V30 32 C 2.5065 7.8745 0.0 0
M  V30 33 C 0.5267 5.5150 0.0 0
M  V30 34 C 0.9899 8.1420 0.0 0
M  V30 35 C 0.0000 6.9622 0.0 0
M  V30 36 H 3.0098 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 27 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 28
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 31
M  V30 22 1 22 34
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 24 25
M  V30 27 1 24 27
M  V30 28 1 24 36 CFG=1
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30 CFG=3
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,5S,6S)-5-(5-bromo-2-fluorophenyl)-5-methyl-1-[(methy...
C25H37BrFN3O4SSi
2079949-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6534 2.6673 0.0 0
M  V30 2 N 5.8834 1.3336 0.0 0
M  V30 3 O 8.1934 2.6673 0.0 0
M  V30 4 C 6.6534 0.0000 0.0 0
M  V30 5 C 4.0231 7.7581 0.0 0
M  V30 6 N 8.5509 7.0809 0.0 0
M  V30 7 C 8.5509 8.6209 0.0 0
M  V30 8 C 9.8845 6.3109 0.0 0
M  V30 9 O 9.8845 9.3909 0.0 0
M  V30 10 O 7.2171 9.3909 0.0 0
M  V30 11 O 11.2181 7.0809 0.0 0
M  V30 12 C 9.8845 10.9309 0.0 0
M  V30 13 C 12.5518 6.3109 0.0 0
M  V30 14 C 8.3445 10.9309 0.0 0
M  V30 15 C 9.8845 12.4709 0.0 0
M  V30 16 C 11.4245 10.9309 0.0 0
M  V30 17 C 13.8856 7.0809 0.0 0
M  V30 18 Si 15.2192 6.3109 0.0 0
M  V30 19 C 16.5528 5.5409 0.0 0
M  V30 20 C 15.9892 7.6447 0.0 0
M  V30 21 C 14.4492 4.9773 0.0 0
M  V30 22 F 2.5700 8.6704 0.0 0
M  V30 23 Br 0.4631 2.8820 0.0 0
M  V30 24 C 5.8834 4.0009 0.0 0 CFG=2
M  V30 25 C 4.5498 4.7709 0.0 0 CFG=2
M  V30 26 C 4.5498 3.2309 0.0 0
M  V30 27 S 7.2171 4.7709 0.0 0
M  V30 28 C 4.5498 6.3109 0.0 0 CFG=2
M  V30 29 C 7.2171 6.3109 0.0 0
M  V30 30 N 5.8834 7.0809 0.0 0
M  V30 31 C 3.0332 6.0436 0.0 0
M  V30 32 C 2.0433 7.2232 0.0 0
M  V30 33 C 2.5065 4.5964 0.0 0
M  V30 34 C 0.5267 6.9559 0.0 0
M  V30 35 C 0.9899 4.3289 0.0 0
M  V30 36 C 0.0000 5.5087 0.0 0
M  V30 37 H 3.0098 4.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 24 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 28 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 29
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 32
M  V30 23 1 23 35
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 25 26
M  V30 28 1 25 28
M  V30 29 1 25 37 CFG=3
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31 CFG=1
M  V30 33 2 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 24 25 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1874240-83-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2079949-14-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17502179
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of vinyl fluoride cyclopropyl fused thiazin-2-amine compounds
as beta-secretase inhibitors and methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Jennifer R.; Amegadzie, Albert; Bourbeau, Matthew P.; Brown, James
A.; Chen, Ning; Frohn, Michael J.; Liu, Longbin; Liu, Qingyian; Pettus,
Liping H.; Qian, Wenyuan; Reeves, Corey M.; Siegmund, Aaron C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017024180 A1 2017-02-09

$RFMT $RIREG SCHEME25 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[[(2E)-3-Methoxy-1-methylene-2-propen-1-yl]oxy]trimethylsilane
C8H16O2Si
54125-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 Si 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 2.1037 0.2064 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 O 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 2 4 9
M  V30 9 1 9 10
M  V30 10 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodo-1-[(4-methylphenyl)sulfonyl]-1H-indole-3-carboxaldehyde
C16H12INO3S
187655-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.5188 3.2068 0.0 0 VAL=6
M  V30 2 O 6.5188 4.7468 0.0 0
M  V30 3 O 6.5188 1.6667 0.0 0
M  V30 4 C 1.3632 1.5315 0.0 0
M  V30 5 O 1.5241 0.0000 0.0 0
M  V30 6 I 0.0000 4.5313 0.0 0
M  V30 7 C 12.6789 3.2068 0.0 0
M  V30 8 N 4.9788 3.2068 0.0 0
M  V30 9 C 4.0736 4.4526 0.0 0
M  V30 10 C 4.0736 1.9609 0.0 0
M  V30 11 C 2.6091 3.9768 0.0 0
M  V30 12 C 4.3938 5.9590 0.0 0
M  V30 13 C 2.6091 2.4367 0.0 0
M  V30 14 C 1.4645 5.0072 0.0 0
M  V30 15 C 3.2494 6.9895 0.0 0
M  V30 16 C 1.7847 6.5136 0.0 0
M  V30 17 C 8.0588 3.2068 0.0 0
M  V30 18 C 8.8288 1.8731 0.0 0
M  V30 19 C 8.8288 4.5404 0.0 0
M  V30 20 C 10.3688 1.8731 0.0 0
M  V30 21 C 10.3688 4.5404 0.0 0
M  V30 22 C 11.1388 3.2068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 17
M  V30 5 2 4 5
M  V30 6 1 4 13
M  V30 7 1 6 14
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-[4-iodo-1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl]-1-methyl-4(...
C21H19IN2O3S
187655-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 2.6964 2.4581 0.0 0
M  V30 2 C 5.6275 7.6158 0.0 0
M  V30 3 S 9.2154 3.7827 0.0 0 VAL=6
M  V30 4 O 9.2154 2.2427 0.0 0
M  V30 5 O 9.2154 5.3227 0.0 0
M  V30 6 O 0.0000 5.1103 0.0 0
M  V30 7 C 15.3754 3.7827 0.0 0
M  V30 8 C 5.3055 4.5527 0.0 0
M  V30 9 C 5.3055 3.0127 0.0 0
M  V30 10 C 6.7701 5.0286 0.0 0
M  V30 11 C 6.7701 2.5368 0.0 0
M  V30 12 C 4.1611 1.9823 0.0 0
M  V30 13 N 7.6754 3.7827 0.0 0
M  V30 14 C 7.0903 1.0304 0.0 0
M  V30 15 C 4.4812 0.4759 0.0 0
M  V30 16 C 5.9459 0.0000 0.0 0
M  V30 17 C 4.0596 5.4579 0.0 0
M  V30 18 N 4.2207 6.9894 0.0 0
M  V30 19 C 2.6528 4.8314 0.0 0
M  V30 20 C 2.9747 7.8947 0.0 0
M  V30 21 C 1.4069 5.7367 0.0 0
M  V30 22 C 1.5679 7.2683 0.0 0
M  V30 23 C 10.7554 3.7827 0.0 0
M  V30 24 C 11.5254 2.4491 0.0 0
M  V30 25 C 11.5254 5.1163 0.0 0
M  V30 26 C 13.0654 2.4491 0.0 0
M  V30 27 C 13.0654 5.1163 0.0 0
M  V30 28 C 13.8354 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 18
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 3 23
M  V30 7 2 6 21
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 17
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54125-02-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 187655-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 187655-84-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-290-CAS-16788250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 54010-75-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zinc trifluoromethanesulfonate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ham, Peter; Deng, Jun; Selvakumar, Sermadurai; Sibi, Mukund P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2011), 1-11

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Ethyl-1,3-benzodioxole-5-acetic acid
C11H12O4
18798-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 3.0800 0.0 0
M  V30 3 C 2.6674 0.7700 0.0 0
M  V30 4 O 1.3336 4.6200 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 4.0011 3.0800 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 6.6684 3.0800 0.0 0
M  V30 11 C 5.3347 5.3900 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 O 8.1331 2.6041 0.0 0
M  V30 14 O 8.1331 5.0959 0.0 0
M  V30 15 C 9.0383 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 2 11 12
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-acetamide, α-ethyl-N-methyl-
C12H15NO3
3047050-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 2.3100 0.0 0
M  V30 2 C 7.7045 3.0800 0.0 0
M  V30 3 C 6.3709 0.7700 0.0 0
M  V30 4 N 9.0383 2.3100 0.0 0
M  V30 5 O 7.7045 4.6200 0.0 0
M  V30 6 C 7.7045 0.0000 0.0 0
M  V30 7 C 10.3720 3.0800 0.0 0
M  V30 8 C 5.0372 3.0800 0.0 0
M  V30 9 C 3.7036 2.3100 0.0 0
M  V30 10 C 5.0372 4.6200 0.0 0
M  V30 11 C 2.3698 3.0800 0.0 0
M  V30 12 C 3.7036 5.3900 0.0 0
M  V30 13 C 2.3698 4.6200 0.0 0
M  V30 14 O 0.9052 2.6042 0.0 0
M  V30 15 O 0.9052 5.0959 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 2 12 13
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18798-93-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047050-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41911199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of substituted ethylamine fused heterocyclic mescaline
derivatives for pharmaceutical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matinkhoo, Kaveh; Press, David James; Lee, Jessica Bik-Jing; Cai, Ye;
Hagel, Jillian M.; Facchini, Peter J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024124353 A1 2024-06-20

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Pentanedione, 5-(2-bromophenyl)-1-(3,4-dimethoxyphenyl)-
C19H19BrO4
1879947-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 9.3358 3.8501 0.0 0
M  V30 6 O 8.0022 6.1601 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 O 0.0000 1.5400 0.0 0
M  V30 11 C 0.0000 0.0000 0.0 0
M  V30 12 Br 13.3370 6.1601 0.0 0
M  V30 13 C 4.0010 3.8501 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 20 C 13.3370 4.6201 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 14.6707 3.8501 0.0 0
M  V30 23 C 13.3370 1.5400 0.0 0
M  V30 24 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 8 16
M  V30 11 1 10 11
M  V30 12 1 10 18
M  V30 13 1 12 20
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H22BrNO3
2173253-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 O 5.3348 6.1601 0.0 0
M  V30 4 C 8.0022 4.6201 0.0 0
M  V30 5 C 9.3358 3.8501 0.0 0
M  V30 6 N 8.0022 6.1601 0.0 0
M  V30 7 C 10.6697 4.6201 0.0 0
M  V30 8 C 9.3358 6.9302 0.0 0
M  V30 9 O 0.0000 4.6201 0.0 0
M  V30 10 C 0.0000 6.1601 0.0 0
M  V30 11 O 0.0000 1.5400 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 Br 13.3370 6.1601 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 2.6673 4.6201 0.0 0
M  V30 16 C 4.0010 2.3101 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 20 C 12.0033 3.8501 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 12.0033 2.3101 0.0 0
M  V30 23 C 14.6707 3.8501 0.0 0
M  V30 24 C 13.3370 1.5400 0.0 0
M  V30 25 C 14.6707 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 17
M  V30 12 1 11 12
M  V30 13 1 11 19
M  V30 14 1 13 21
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1879947-74-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173253-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18703492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-Substituted Condensed Tetrahydropyridine-Based Enaminones
via Palladium-Catalyzed Intramolecular C-N Cross-coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dousova, Hana; Ruzickova, Zdenka; Simunek, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2018), 55(3), 670-684

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,3-dihydro-5-nitro-3-oxo-2-(phenylmethyl)-1H-indazole-1-butanoate
C20H21N3O5
1894197-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 8.0410 0.0 0
M  V30 2 C 9.4586 7.7208 0.0 0
M  V30 3 C 10.4890 8.8652 0.0 0
M  V30 4 C 11.9953 8.5450 0.0 0
M  V30 5 O 13.0259 9.6896 0.0 0
M  V30 6 O 12.4713 7.0805 0.0 0
M  V30 7 C 14.5322 9.3694 0.0 0
M  V30 8 C 15.5627 10.5138 0.0 0
M  V30 9 C 4.6201 8.3912 0.0 0
M  V30 10 O 3.2573 5.3304 0.0 0
M  V30 11 N 7.2419 0.7700 0.0 0 VAL=5
M  V30 12 O 8.5755 0.0000 0.0 0
M  V30 13 O 5.9082 0.0000 0.0 0
M  V30 14 C 7.2419 5.3901 0.0 0
M  V30 15 N 6.9217 6.8966 0.0 0
M  V30 16 C 5.9082 4.6201 0.0 0
M  V30 17 C 8.5755 4.6201 0.0 0
M  V30 18 N 5.3901 7.0575 0.0 0
M  V30 19 C 4.7636 5.6505 0.0 0
M  V30 20 C 5.9082 3.0801 0.0 0
M  V30 21 C 8.5755 3.0801 0.0 0
M  V30 22 C 7.2419 2.3101 0.0 0
M  V30 23 C 3.0801 8.3912 0.0 0
M  V30 24 C 2.3101 7.0575 0.0 0
M  V30 25 C 2.3101 9.7249 0.0 0
M  V30 26 C 0.7700 7.0575 0.0 0
M  V30 27 C 0.7700 9.7249 0.0 0
M  V30 28 C 0.0000 8.3912 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 18
M  V30 10 1 9 23
M  V30 11 2 10 19
M  V30 12 2 11 12
M  V30 13 2 11 13
M  V30 14 1 11 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-N-methyl-5-nitro-3-oxo-2-(phenylmethyl)-1H-indazole-1-butanamide
C19H20N4O4
1894197-26-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9521 8.0408 0.0 0
M  V30 2 C 9.4584 7.7206 0.0 0
M  V30 3 C 10.4889 8.8652 0.0 0
M  V30 4 C 11.9952 8.5448 0.0 0
M  V30 5 N 13.0256 9.6894 0.0 0
M  V30 6 O 12.4711 7.0803 0.0 0
M  V30 7 C 14.5321 9.3692 0.0 0
M  V30 8 C 4.6200 8.3910 0.0 0
M  V30 9 O 3.2573 5.3304 0.0 0
M  V30 10 N 7.2419 0.7700 0.0 0 VAL=5
M  V30 11 O 8.5755 0.0000 0.0 0
M  V30 12 O 5.9081 0.0000 0.0 0
M  V30 13 C 7.2419 5.3900 0.0 0
M  V30 14 N 6.9215 6.8964 0.0 0
M  V30 15 C 5.9081 4.6200 0.0 0
M  V30 16 C 8.5755 4.6200 0.0 0
M  V30 17 N 5.3900 7.0574 0.0 0
M  V30 18 C 4.7637 5.6506 0.0 0
M  V30 19 C 5.9081 3.0800 0.0 0
M  V30 20 C 8.5755 3.0800 0.0 0
M  V30 21 C 7.2419 2.3100 0.0 0
M  V30 22 C 3.0800 8.3910 0.0 0
M  V30 23 C 2.3100 7.0574 0.0 0
M  V30 24 C 2.3100 9.7248 0.0 0
M  V30 25 C 0.7700 7.0574 0.0 0
M  V30 26 C 0.7700 9.7248 0.0 0
M  V30 27 C 0.0000 8.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 17
M  V30 9 1 8 22
M  V30 10 2 9 18
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 21
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1894197-23-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1894197-26-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10898554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Antichagasic and trichomonacidal activity of 1-substituted
2-benzyl-5-nitroindazolin-3-ones and
3-alkoxy-2-benzyl-5-nitro-2H-indazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fonseca-Berzal, Cristina; Ibanez-Escribano, Alexandra; Reviriego, Felipe;
Cumella, Jose; Morales, Paula; Jagerovic, Nadine; Nogal-Ruiz, Juan Jose;
Escario, Jose Antonio; Bernardino da Silva, Patricia; Soeiro, Maria de
Nazare C.; Gomez-Barrio, Alicia; Aran, Vicente J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 115295-310

$RFMT $RIREG SCHEME29 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylbenzenesulfonyl chloride
C7H7ClO2S
1899-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-[(3-methylphenyl)sulfonyl]-2-propenamide
C12H15NO3S
1456707-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 C 6.6685 5.3901 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 5.3901 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1899-93-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-40-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(17β)-17-[3-[2,2,2-trifluoro-1,1-bis(trifluoromethyl)ethoxy]propox...
C28H33F9O5
1916503-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.4978 7.6915 0.0 0
M  V30 2 O 15.2774 8.1004 0.0 0
M  V30 3 C 14.2469 9.2449 0.0 0
M  V30 4 C 14.7227 10.7095 0.0 0
M  V30 5 C 16.2292 11.0298 0.0 0
M  V30 6 O 16.7050 12.4943 0.0 0
M  V30 7 C 18.2115 12.8145 0.0 0
M  V30 8 C 19.6096 10.0702 0.0 0
M  V30 9 C 20.9557 14.2128 0.0 0
M  V30 10 C 16.4635 16.2449 0.0 0
M  V30 11 F 18.2375 9.3711 0.0 0
M  V30 12 F 20.3088 8.6981 0.0 0
M  V30 13 F 20.9818 10.7694 0.0 0
M  V30 14 F 20.2566 15.5850 0.0 0
M  V30 15 F 21.6549 12.8407 0.0 0
M  V30 16 F 22.3279 14.9120 0.0 0
M  V30 17 F 15.0914 15.5457 0.0 0
M  V30 18 F 17.8357 16.9440 0.0 0
M  V30 19 F 15.7644 17.6170 0.0 0
M  V30 20 O 5.3347 1.5400 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 2.6674 1.5400 0.0 0
M  V30 23 O 1.3338 2.3100 0.0 0
M  V30 24 O 2.6674 0.0000 0.0 0
M  V30 25 C 0.0000 1.5400 0.0 0
M  V30 26 C 12.0032 3.8500 0.0 0 CFG=2
M  V30 27 C 13.3369 4.6200 0.0 0 CFG=2
M  V30 28 C 10.6694 4.6200 0.0 0 CFG=2
M  V30 29 C 12.0032 2.3100 0.0 0
M  V30 30 C 13.3369 6.1600 0.0 0 CFG=1
M  V30 31 C 14.8014 4.1440 0.0 0
M  V30 32 C 9.3358 3.8500 0.0 0
M  V30 33 C 10.6694 6.1600 0.0 0
M  V30 34 C 10.6694 1.5400 0.0 0
M  V30 35 C 14.8014 6.6359 0.0 0 CFG=1
M  V30 36 C 12.0032 6.9300 0.0 0
M  V30 37 C 15.7066 5.3900 0.0 0
M  V30 38 C 9.3358 2.3100 0.0 0
M  V30 39 C 8.0022 4.6200 0.0 0
M  V30 40 C 8.0022 1.5400 0.0 0
M  V30 41 C 6.6685 3.8500 0.0 0
M  V30 42 C 6.6685 2.3100 0.0 0
M  V30 43 H 14.0037 2.6950 0.0 0
M  V30 44 H 14.1300 3.2999 0.0 0
M  V30 45 H 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 30 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 35 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 9 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 10 19
M  V30 20 1 20 21
M  V30 21 1 20 42
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 26 43 CFG=1
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 27 44 CFG=3
M  V30 33 1 28 32
M  V30 34 1 28 33
M  V30 35 1 28 45 CFG=3
M  V30 36 1 29 34
M  V30 37 1 30 35
M  V30 38 1 30 36
M  V30 39 1 31 37
M  V30 40 1 32 38
M  V30 41 2 32 39
M  V30 42 1 33 36
M  V30 43 1 34 38
M  V30 44 1 35 37
M  V30 45 2 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 26 27 28 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[[(17β)-17-[3-[2,2,2-trifluoro-1,1-bis(trifluoromethyl)ethoxy]prop...
C28H34F9NO4
2233564-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.4978 7.6915 0.0 0
M  V30 2 O 15.2774 8.1004 0.0 0
M  V30 3 C 14.2469 9.2449 0.0 0
M  V30 4 C 14.7227 10.7095 0.0 0
M  V30 5 C 16.2292 11.0298 0.0 0
M  V30 6 O 16.7050 12.4943 0.0 0
M  V30 7 C 18.2115 12.8145 0.0 0
M  V30 8 C 19.6096 10.0702 0.0 0
M  V30 9 C 20.9557 14.2128 0.0 0
M  V30 10 C 16.4635 16.2449 0.0 0
M  V30 11 F 18.2375 9.3711 0.0 0
M  V30 12 F 20.3088 8.6981 0.0 0
M  V30 13 F 20.9818 10.7694 0.0 0
M  V30 14 F 20.2566 15.5850 0.0 0
M  V30 15 F 21.6549 12.8407 0.0 0
M  V30 16 F 22.3279 14.9120 0.0 0
M  V30 17 F 15.0914 15.5457 0.0 0
M  V30 18 F 17.8357 16.9440 0.0 0
M  V30 19 F 15.7644 17.6170 0.0 0
M  V30 20 O 5.3347 1.5400 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 2.6674 1.5400 0.0 0
M  V30 23 N 1.3338 2.3100 0.0 0
M  V30 24 O 2.6674 0.0000 0.0 0
M  V30 25 C 0.0000 1.5400 0.0 0
M  V30 26 C 12.0032 3.8500 0.0 0 CFG=2
M  V30 27 C 13.3369 4.6200 0.0 0 CFG=2
M  V30 28 C 10.6694 4.6200 0.0 0 CFG=2
M  V30 29 C 12.0032 2.3100 0.0 0
M  V30 30 C 13.3369 6.1600 0.0 0 CFG=1
M  V30 31 C 14.8014 4.1440 0.0 0
M  V30 32 C 9.3358 3.8500 0.0 0
M  V30 33 C 10.6694 6.1600 0.0 0
M  V30 34 C 10.6694 1.5400 0.0 0
M  V30 35 C 14.8014 6.6359 0.0 0 CFG=1
M  V30 36 C 12.0032 6.9300 0.0 0
M  V30 37 C 15.7066 5.3900 0.0 0
M  V30 38 C 9.3358 2.3100 0.0 0
M  V30 39 C 8.0022 4.6200 0.0 0
M  V30 40 C 8.0022 1.5400 0.0 0
M  V30 41 C 6.6685 3.8500 0.0 0
M  V30 42 C 6.6685 2.3100 0.0 0
M  V30 43 H 14.0037 2.6950 0.0 0
M  V30 44 H 14.1300 3.2999 0.0 0
M  V30 45 H 9.3358 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 30 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 35 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 9 16
M  V30 17 1 10 17
M  V30 18 1 10 18
M  V30 19 1 10 19
M  V30 20 1 20 21
M  V30 21 1 20 42
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 29
M  V30 29 1 26 43 CFG=1
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 27 44 CFG=3
M  V30 33 1 28 32
M  V30 34 1 28 33
M  V30 35 1 28 45 CFG=3
M  V30 36 1 29 34
M  V30 37 1 30 35
M  V30 38 1 30 36
M  V30 39 1 31 37
M  V30 40 1 32 38
M  V30 41 2 32 39
M  V30 42 1 33 36
M  V30 43 1 34 38
M  V30 44 1 35 37
M  V30 45 2 38 40
M  V30 46 1 39 41
M  V30 47 1 40 42
M  V30 48 2 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 26 27 28 30 35)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1916503-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2233564-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19325268
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM conversion = 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compounds and methods for trans-membrane delivery of molecules,
especially genetic drugs such as siRNA or antisense oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ziv, Ilan; Dubrovsky, Joseph; Grimberg, Hagit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018127927 A1 2018-07-12

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-bromo-4-chlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]...
C19H16BrClN2O2
1918182-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Br 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Bromo-4-chlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-...
C19H17BrClN3O
1918182-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Br 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19106435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biological Studies and Target Engagement of the 2-C-Methyl-D-Erythritol
4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent
(1R,3S)-MMV008138 and Analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghavami, Maryam; Merino, Emilio F.; Yao, Zhong-Ke; Elahi, Rubayet;
Simpson, Morgan E.; Fernandez-Murga, Maria L.; Butler, Joshua H.;
Casasanta, Michael A.; Krai, Priscilla M.; Totrov, Maxim M.; Slade,
Daniel J.; Carlier, Paul R.; Cassera, Maria Belen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2018), 4(4), 549-559

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-bromo-4-chlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]...
C19H16BrClN2O2
1918182-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Br 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Bromo-4-chlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-...
C19H17BrClN3O
1918182-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Br 5.3348 9.7102 0.0 0
M  V30 6 Cl 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15895152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-bromo-4-fluoro-5-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyr...
C20H18BrFN2O3
1918182-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 7.4002 0.0 0
M  V30 2 O 12.0033 6.6302 0.0 0
M  V30 3 O 10.6697 8.9402 0.0 0
M  V30 4 C 13.3370 7.4002 0.0 0
M  V30 5 Br 6.6685 9.7102 0.0 0
M  V30 6 O 1.3337 6.6302 0.0 0
M  V30 7 C 0.0000 7.4002 0.0 0
M  V30 8 F 1.3337 9.7102 0.0 0
M  V30 9 C 6.6685 5.0901 0.0 0
M  V30 10 C 8.0022 4.3201 0.0 0
M  V30 11 C 6.6685 6.6302 0.0 0 CFG=1
M  V30 12 N 5.5241 4.0597 0.0 0
M  V30 13 C 7.6820 2.8138 0.0 0
M  V30 14 C 9.3360 5.0901 0.0 0
M  V30 15 N 8.0022 7.4002 0.0 0
M  V30 16 C 6.1504 2.6527 0.0 0
M  V30 17 C 8.5872 1.5679 0.0 0
M  V30 18 C 9.3360 6.6302 0.0 0 CFG=1
M  V30 19 C 5.5241 1.2459 0.0 0
M  V30 20 C 7.9609 0.1609 0.0 0
M  V30 21 C 6.4292 0.0000 0.0 0
M  V30 22 C 5.3348 7.4002 0.0 0
M  V30 23 C 4.0010 6.6302 0.0 0
M  V30 24 C 5.3348 8.9402 0.0 0
M  V30 25 C 2.6673 7.4002 0.0 0
M  V30 26 C 4.0010 9.7102 0.0 0
M  V30 27 C 2.6673 8.9402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 22 CFG=1
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Bromo-4-fluoro-5-methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-p...
C20H19BrFN3O2
1918182-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 7.4002 0.0 0
M  V30 2 N 12.0033 6.6302 0.0 0
M  V30 3 O 10.6697 8.9402 0.0 0
M  V30 4 C 13.3370 7.4002 0.0 0
M  V30 5 Br 6.6685 9.7102 0.0 0
M  V30 6 O 1.3337 6.6302 0.0 0
M  V30 7 C 0.0000 7.4002 0.0 0
M  V30 8 F 1.3337 9.7102 0.0 0
M  V30 9 C 6.6685 5.0901 0.0 0
M  V30 10 C 8.0022 4.3201 0.0 0
M  V30 11 C 6.6685 6.6302 0.0 0 CFG=1
M  V30 12 N 5.5241 4.0597 0.0 0
M  V30 13 C 7.6820 2.8138 0.0 0
M  V30 14 C 9.3360 5.0901 0.0 0
M  V30 15 N 8.0022 7.4002 0.0 0
M  V30 16 C 6.1504 2.6527 0.0 0
M  V30 17 C 8.5872 1.5679 0.0 0
M  V30 18 C 9.3360 6.6302 0.0 0 CFG=1
M  V30 19 C 5.5241 1.2459 0.0 0
M  V30 20 C 7.9609 0.1609 0.0 0
M  V30 21 C 6.4292 0.0000 0.0 0
M  V30 22 C 5.3348 7.4002 0.0 0
M  V30 23 C 4.0010 6.6302 0.0 0
M  V30 24 C 5.3348 8.9402 0.0 0
M  V30 25 C 2.6673 7.4002 0.0 0
M  V30 26 C 4.0010 9.7102 0.0 0
M  V30 27 C 2.6673 8.9402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 22 CFG=1
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-49-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15865003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[6-(4-bromo-2-chlorophenyl)-2-(methylsulfinyl)-7-oxopy...
C22H24BrClN4O4S
1926205-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 C 7.7000 8.0020 0.0 0
M  V30 3 C 9.2400 8.0020 0.0 0
M  V30 4 N 10.0100 9.3358 0.0 0
M  V30 5 C 11.5500 9.3356 0.0 0
M  V30 6 O 12.3200 10.6694 0.0 0
M  V30 7 O 12.3200 8.0020 0.0 0
M  V30 8 C 13.8600 10.6694 0.0 0
M  V30 9 C 13.8600 9.1294 0.0 0
M  V30 10 C 15.4000 10.6694 0.0 0
M  V30 11 C 13.8600 12.2094 0.0 0
M  V30 12 O 5.3900 9.3358 0.0 0
M  V30 13 S 5.3900 1.3336 0.0 0 VAL=4
M  V30 14 C 6.9300 1.3336 0.0 0
M  V30 15 O 4.6200 0.0000 0.0 0
M  V30 16 Cl 0.0000 8.0020 0.0 0
M  V30 17 Br 0.0000 13.3367 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 N 5.3900 6.6684 0.0 0
M  V30 21 N 5.3900 4.0009 0.0 0
M  V30 22 C 2.3100 6.6684 0.0 0
M  V30 23 C 2.3100 4.0009 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 4.6200 2.6673 0.0 0
M  V30 26 C 3.0800 8.0020 0.0 0
M  V30 27 N 3.0800 2.6673 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 0.7700 9.3358 0.0 0
M  V30 30 C 3.0800 10.6694 0.0 0
M  V30 31 C 0.0000 10.6694 0.0 0
M  V30 32 C 2.3100 12.0031 0.0 0
M  V30 33 C 0.7700 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 24
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 25
M  V30 16 1 16 29
M  V30 17 1 17 33
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 23 27
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[6-(4-bromo-2-chlorophenyl)-2-(methylamino)-7-oxopyrid...
C22H25BrClN5O3
1926205-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0
M  V30 2 C 7.7000 8.0020 0.0 0
M  V30 3 C 9.2400 8.0020 0.0 0
M  V30 4 N 10.0100 9.3358 0.0 0
M  V30 5 C 11.5500 9.3356 0.0 0
M  V30 6 O 12.3200 10.6694 0.0 0
M  V30 7 O 12.3200 8.0020 0.0 0
M  V30 8 C 13.8600 10.6694 0.0 0
M  V30 9 C 13.8600 9.1294 0.0 0
M  V30 10 C 15.4000 10.6694 0.0 0
M  V30 11 C 13.8600 12.2094 0.0 0
M  V30 12 O 5.3900 9.3358 0.0 0
M  V30 13 N 5.3900 1.3336 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 15 Cl 0.0000 8.0020 0.0 0
M  V30 16 Br 0.0000 13.3367 0.0 0
M  V30 17 C 4.6200 5.3347 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 N 5.3900 6.6684 0.0 0
M  V30 20 N 5.3900 4.0009 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 2.3100 4.0009 0.0 0
M  V30 23 C 4.6200 8.0020 0.0 0
M  V30 24 C 4.6200 2.6673 0.0 0
M  V30 25 C 3.0800 8.0020 0.0 0
M  V30 26 N 3.0800 2.6673 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 0.7700 9.3358 0.0 0
M  V30 29 C 3.0800 10.6694 0.0 0
M  V30 30 C 0.0000 10.6694 0.0 0
M  V30 31 C 2.3100 12.0031 0.0 0
M  V30 32 C 0.7700 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 23
M  V30 13 1 13 14
M  V30 14 1 13 24
M  V30 15 1 15 28
M  V30 16 1 16 32
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 1 22 26
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1926205-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1926205-16-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30353165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart
Acute Cardiovascular Toxicity with a Narrow Therapeutic Window
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudolph, Joachim; Murray, Lesley J.; Ndubaku, Chudi O.; O'Brien, Thomas;
Blackwood, Elizabeth; Wang, Weiru; Aliagas, Ignacio; Gazzard, Lewis;
Crawford, James J.; Drobnick, Joy; Lee, Wendy; Zhao, Xianrui; Hoeflich,
Klaus P.; Favor, David A.; Dong, Ping; Zhang, Haiming; Heise, Christopher
E.; Oh, Angela; Ong, Christy C.; La, Hank; Chakravarty, Paroma; Chan,
Connie; Jakubiak, Diana; Epler, Jennifer; Ramaswamy, Sreemathy; Vega,
Roxanne; Cain, Gary; Diaz, Dolores; Zhong, Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(11), 5520-5541

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S,5S)-4,5-Bis(isothiocyanatodiphenylmethyl)-2,2-dimethyl-1,3-dioxolane
C33H28N2O2S2
193892-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1043 4.6200 0.0 0
M  V30 2 N 5.5643 4.6200 0.0 0
M  V30 3 C 4.7943 3.2864 0.0 0
M  V30 4 S 4.0243 1.9527 0.0 0
M  V30 5 C 4.3938 6.5894 0.0 0
M  V30 6 N 4.8698 5.1247 0.0 0
M  V30 7 C 3.8392 3.9803 0.0 0
M  V30 8 S 2.8088 2.8359 0.0 0
M  V30 9 C 9.3808 8.8501 0.0 0
M  V30 10 C 7.7134 10.0614 0.0 0
M  V30 11 C 7.1043 6.1600 0.0 0 CFG=2
M  V30 12 C 5.8585 7.0652 0.0 0 CFG=2
M  V30 13 O 8.3502 7.0652 0.0 0
M  V30 14 O 6.3343 8.5299 0.0 0
M  V30 15 C 7.8743 8.5299 0.0 0
M  V30 16 C 8.6443 4.6200 0.0 0
M  V30 17 C 9.4143 3.2864 0.0 0
M  V30 18 C 9.4143 5.9538 0.0 0
M  V30 19 C 10.9543 3.2864 0.0 0
M  V30 20 C 10.9543 5.9538 0.0 0
M  V30 21 C 11.7243 4.6200 0.0 0
M  V30 22 C 7.1043 3.0800 0.0 0
M  V30 23 C 5.7707 2.3100 0.0 0
M  V30 24 C 8.4380 2.3100 0.0 0
M  V30 25 C 5.7707 0.7700 0.0 0
M  V30 26 C 8.4380 0.7700 0.0 0
M  V30 27 C 7.1043 0.0000 0.0 0
M  V30 28 C 2.9292 6.1135 0.0 0
M  V30 29 C 2.6091 4.6071 0.0 0
M  V30 30 C 1.7847 7.1439 0.0 0
M  V30 31 C 1.1444 4.1312 0.0 0
M  V30 32 C 0.3202 6.6680 0.0 0
M  V30 33 C 0.0000 5.1616 0.0 0
M  V30 34 C 3.9179 8.0540 0.0 0
M  V30 35 C 2.4116 8.3742 0.0 0
M  V30 36 C 4.9485 9.1984 0.0 0
M  V30 37 C 1.9358 9.8388 0.0 0
M  V30 38 C 4.4725 10.6631 0.0 0
M  V30 39 C 2.9662 10.9833 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 1 16
M  V30 4 1 1 22
M  V30 5 2 2 3
M  V30 6 2 3 4
M  V30 7 1 5 6
M  V30 8 1 12 5 CFG=3
M  V30 9 1 5 28
M  V30 10 1 5 34
M  V30 11 2 6 7
M  V30 12 2 7 8
M  V30 13 1 9 15
M  V30 14 1 10 15
M  V30 15 1 11 12
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N,N′′-[[(4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl]bis(diphenylmethylene)]bi...
C35H38N4O2S2
1394855-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.3397 5.4340 0.0 0
M  V30 2 N 7.5697 4.1004 0.0 0
M  V30 3 C 8.3397 2.7666 0.0 0
M  V30 4 N 7.5697 1.4330 0.0 0
M  V30 5 S 9.8797 2.7666 0.0 0
M  V30 6 C 8.3397 0.0993 0.0 0
M  V30 7 C 4.2527 5.2828 0.0 0
M  V30 8 N 5.2009 4.0693 0.0 0
M  V30 9 C 4.6240 2.6414 0.0 0
M  V30 10 N 5.5720 1.4279 0.0 0
M  V30 11 S 3.0989 2.4270 0.0 0
M  V30 12 C 4.9951 0.0000 0.0 0
M  V30 13 C 7.3278 9.7132 0.0 0
M  V30 14 C 5.2673 9.7491 0.0 0
M  V30 15 C 7.0061 6.2040 0.0 0 CFG=2
M  V30 16 C 5.4662 6.2308 0.0 0 CFG=2
M  V30 17 O 7.5075 7.6601 0.0 0
M  V30 18 O 5.0161 7.7035 0.0 0
M  V30 19 C 6.2775 8.5869 0.0 0
M  V30 20 C 9.8272 5.0355 0.0 0
M  V30 21 C 10.9161 6.1244 0.0 0
M  V30 22 C 10.2259 3.5479 0.0 0
M  V30 23 C 12.4038 5.7257 0.0 0
M  V30 24 C 11.7134 3.1493 0.0 0
M  V30 25 C 12.8023 4.2382 0.0 0
M  V30 26 C 9.1097 6.7677 0.0 0
M  V30 27 C 10.6497 6.7677 0.0 0
M  V30 28 C 8.3397 8.1013 0.0 0
M  V30 29 C 11.4197 8.1013 0.0 0
M  V30 30 C 9.1097 9.4351 0.0 0
M  V30 31 C 10.6497 9.4351 0.0 0
M  V30 32 C 2.8351 4.6810 0.0 0
M  V30 33 C 1.6053 5.6079 0.0 0
M  V30 34 C 2.6476 3.1525 0.0 0
M  V30 35 C 0.1877 5.0061 0.0 0
M  V30 36 C 1.2298 2.5509 0.0 0
M  V30 37 C 0.0000 3.4776 0.0 0
M  V30 38 C 3.3047 6.4963 0.0 0
M  V30 39 C 3.8816 7.9242 0.0 0
M  V30 40 C 1.7796 6.2820 0.0 0
M  V30 41 C 2.9334 9.1377 0.0 0
M  V30 42 C 0.8314 7.4955 0.0 0
M  V30 43 C 1.4083 8.9234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 1 20
M  V30 4 1 1 26
M  V30 5 1 2 3
M  V30 6 1 3 4
M  V30 7 2 3 5
M  V30 8 1 4 6
M  V30 9 1 7 8
M  V30 10 1 16 7 CFG=3
M  V30 11 1 7 32
M  V30 12 1 7 38
M  V30 13 1 8 9
M  V30 14 1 9 10
M  V30 15 2 9 11
M  V30 16 1 10 12
M  V30 17 1 13 19
M  V30 18 1 14 19
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 193892-63-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1394855-16-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-1475745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of bis-(thio)ureas, general procedure GP-1: to a stirred
suspension of isothiocyanate 3a or solution of isocyanate 3b (0.5 mmol)
in diethyl ether (10 mL) was added the corresponding amine (1 mmol). A
white precipitate was formed soon after the addition of the amine. The
reaction was monitored by TLC and stopped after 3 hours. The product was
filtered, washed with diethyl ether and dried under vacuum.
1,1'-((4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-diyl) bis(diphenylmethylene)
bis(3-methylthiourea) (H1): following the general procedure GP-1 with the
mention that instead of the pure amine, a 33% (w/w) methyl amine solution
in ethanol (150 mL, 1.2 mmol) is used, the bis-thiourea H1 (286 mg, 94%)
was obtained as a colourless solid. Mp 200 - 201 °C; Rf= 0.42 (1%
MeOH/CH2Cl2); [α]D 25= - 162.3 (c 1.00; CHCl3); 1H NMR (400 MHz, CDCl3) δ
7.34 (d, J = 8Hz, 4H, Harom) 7.22 (t, J = 8Hz, 4H, Harom), 7.14-7.04 (m,
12H, Harom), 6.64 (cv, J = 4Hz, 2H, NHCH3), 6.50 (s, 2H, NH), 5.62 (s,
2H, CH), 2.96 (d, J = 4 Hz, 6H, CH3), 1.54 (s, 6H, CH3); 13C NMR (101
MHz, CDCl3) δ 181.92 (C=S), 141.22, 140.61, 130.16, 128.82, 127.45,
127.22, 126.66, 123.28, 106.89, 82.63, 66.52, 32.45, 26.49 . HRMS
calculated for C35H38N4O2S2 [M+H]+ 611.2509, found 611.2510.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral enantiopure bis(thio)ureas derived from TADDOL and their
carboxylate complexation capacity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gherase, Dragos; Roussel, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Central European Journal of Chemistry (2012), 10(4), 1066-1072

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-1-naphthalenecarboxaldehyde
C13H12O2
19523-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N-methyl-1-naphthalenemethanamine
C14H17NO
709649-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 2.6675 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19523-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15003673
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine Preparation 96 Preparation
of (2-Ethoxy-naphthalen-1-ylmethyl)methylamine [0851]According to the
procedure of Preparation 67, except substituting
2-ethoxy-naphthalene-1-carbaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (2.02 g, 94%) was
prepared as a yellow-orange oil. 1H NMR (300 MHz, DMSO-d6) δ 8.08 (d,
J=8.4 Hz, 1H), 7.85-7.82 (d, J=8.8 Hz, 2H), 7.74-7.33 (m, 3H), 4.18 (q,
J=6.9 Hz, 2H), 4.06 (s, 2H), 2.31 (s, 3H), 1.62 (br s, 1H), 1.37 (t,
J=6.9 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-1-naphthalenecarboxaldehyde
C13H12O2
19523-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N-methyl-1-naphthalenemethanamine
C14H17NO
709649-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 2.6675 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19523-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13880037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-1-naphthalenecarboxaldehyde
C13H12O2
19523-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.7700 0.0 0
M  V30 2 O 2.6675 0.0000 0.0 0
M  V30 3 O 6.6685 2.3101 0.0 0
M  V30 4 C 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 2.6675 3.0801 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N-methyl-1-naphthalenemethanamine
C14H17NO
709649-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 2.6675 1.5400 0.0 0
M  V30 3 C 2.6675 0.0000 0.0 0
M  V30 4 O 6.6685 3.8501 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 2.6675 4.6201 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 2.6675 6.1601 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 C 5.3348 6.1601 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19523-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5890898
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. Preparation of
(2-Ethoxy-naphthalen-1-ylmethyl)methylamine According to the procedure of
Preparation 1, except substituting 2-ethoxy-naphthalene-1-carbaldehyde
for 1-propyl-naphthalene-2-carbaldehyde, the title compound (2.02 g, 94%)
was prepared as a yellow-orange oil. 1H NMR (300 MHz, DMSO-d6) δ 8.08 (d,
J = 8.4 Hz, 1H), 7.85-7.82 (d, J = 8.8 Hz, 2H), 7.74-7.33 (m, 3H), 4.18
(q, J = 6.9 Hz, 2H), 4.06 (s, 2H), 2.31 (s, 3H), 1.62 (br s, 1H), 1.37
(t, J = 6.9 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Uridine, 3′-C-(2-amino-2-oxoethyl)-2′,5′-bis-O-[(1,1-dimethylethyl)dimethylsi...
C23H43N3O7Si2
195391-13-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.8575 0.0 0
M  V30 2 Si 2.6673 4.6275 0.0 0
M  V30 3 C 1.3337 5.3975 0.0 0
M  V30 4 C 3.4374 5.9612 0.0 0
M  V30 5 C 1.8973 3.2938 0.0 0
M  V30 6 C 0.5637 4.0638 0.0 0
M  V30 7 C 0.0000 6.1675 0.0 0
M  V30 8 C 2.1037 6.7312 0.0 0
M  V30 9 C 5.9716 2.6673 0.0 0
M  V30 10 C 6.7417 1.3337 0.0 0
M  V30 11 N 5.9716 0.0000 0.0 0
M  V30 12 O 8.2817 1.3337 0.0 0
M  V30 13 O 7.9875 3.0959 0.0 0
M  V30 14 C 9.3038 4.9846 0.0 0
M  V30 15 O 10.2090 6.2305 0.0 0
M  V30 16 Si 11.7406 6.0696 0.0 0
M  V30 17 C 13.2722 5.9085 0.0 0
M  V30 18 C 11.5797 4.5379 0.0 0
M  V30 19 C 11.9015 7.6011 0.0 0
M  V30 20 C 13.4331 7.4401 0.0 0
M  V30 21 C 14.8037 5.7476 0.0 0
M  V30 22 C 13.1112 4.3769 0.0 0
M  V30 23 O 6.1361 9.1718 0.0 0
M  V30 24 O 0.9179 10.2810 0.0 0
M  V30 25 C 5.3348 4.6275 0.0 0 CFG=2
M  V30 26 C 5.4958 6.1591 0.0 0 CFG=2
M  V30 27 C 6.7417 4.0010 0.0 0 CFG=1
M  V30 28 O 7.0022 6.4792 0.0 0
M  V30 29 C 7.7722 5.1456 0.0 0 CFG=1
M  V30 30 N 4.3514 7.1895 0.0 0
M  V30 31 C 4.6715 8.6960 0.0 0
M  V30 32 C 2.8866 6.7136 0.0 0
M  V30 33 N 3.5270 9.7264 0.0 0
M  V30 34 C 1.7422 7.7442 0.0 0
M  V30 35 C 2.0624 9.2505 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 25 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 27 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 27 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 29 14 CFG=3
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 2 23 31
M  V30 24 2 24 35
M  V30 25 1 25 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 26 30 CFG=3
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 31 1 30 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 2 32 34
M  V30 35 1 33 35
M  V30 36 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 25 26 27 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cytidine, 3′-C-(2-amino-2-oxoethyl)-2′,5′-bis-O-[(1,1-dimethylethyl)dimethyls...
C24H46N4O6Si2
195391-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.3576 7.8186 0.0 0
M  V30 2 Si 4.8176 7.8186 0.0 0
M  V30 3 C 3.2776 7.8186 0.0 0
M  V30 4 C 4.8176 9.3586 0.0 0
M  V30 5 C 4.8176 6.2786 0.0 0
M  V30 6 C 3.2776 9.3586 0.0 0
M  V30 7 C 1.7376 7.8186 0.0 0
M  V30 8 C 3.2776 6.2786 0.0 0
M  V30 9 C 8.6591 7.8639 0.0 0
M  V30 10 C 9.9928 8.6339 0.0 0
M  V30 11 N 9.9928 10.1739 0.0 0
M  V30 12 O 11.3265 7.8639 0.0 0
M  V30 13 O 10.1906 6.4848 0.0 0
M  V30 14 O 5.5494 2.1488 0.0 0
M  V30 15 C 10.3862 4.1911 0.0 0
M  V30 16 O 10.5472 2.6596 0.0 0
M  V30 17 Si 11.9541 2.0333 0.0 0
M  V30 18 C 13.3609 1.4068 0.0 0
M  V30 19 C 12.5804 3.4401 0.0 0
M  V30 20 C 11.3276 0.6263 0.0 0
M  V30 21 C 12.7346 0.0000 0.0 0
M  V30 22 C 14.7677 0.7805 0.0 0
M  V30 23 C 13.9872 2.8137 0.0 0
M  V30 24 N 0.4759 3.7972 0.0 0
M  V30 25 C 0.0000 2.3326 0.0 0
M  V30 26 C 6.5013 5.0780 0.0 0 CFG=2
M  V30 27 C 7.1276 6.4848 0.0 0 CFG=2
M  V30 28 O 7.6456 4.0476 0.0 0
M  V30 29 C 8.6591 6.3239 0.0 0 CFG=1
M  V30 30 C 8.9793 4.8176 0.0 0 CFG=2
M  V30 31 N 4.9948 4.7578 0.0 0
M  V30 32 C 4.5190 3.2931 0.0 0
M  V30 33 C 3.9644 5.9022 0.0 0
M  V30 34 N 3.0127 2.9730 0.0 0
M  V30 35 C 2.4580 5.5820 0.0 0
M  V30 36 C 1.9821 4.1175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 29 9 CFG=1
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 29 13 CFG=3
M  V30 14 2 14 32
M  V30 15 1 15 16
M  V30 16 1 30 15 CFG=1
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 24 25
M  V30 25 1 24 36
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 1 26 31 CFG=1
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 26 27 29 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 195391-13-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195391-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1895217
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 6553-96-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3'-β-carbamoylmethylcytidine (CAMC) and its derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ichikawa, Satoshi; Minakawa, Noriaki; Shuto, Satoshi; Tanaka, Motohiro;
Sasaki, Takuma; Matsuda, Akira
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2006), 4(7), 1284-1296

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
N-[(1,2-Dihydro-4-hydroxy-2-oxo-6-quinolinyl)carbonyl]-L-phenylalanine
C19H16N2O5
1958052-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.5501 8.0022 0.0 0
M  V30 2 O 16.1702 5.3348 0.0 0
M  V30 3 C 7.7001 4.0011 0.0 0
M  V30 4 N 6.9301 2.6675 0.0 0
M  V30 5 O 6.9301 5.3348 0.0 0
M  V30 6 C 5.3901 2.6675 0.0 0 CFG=2
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 O 3.0800 1.3337 0.0 0
M  V30 10 O 5.3901 0.0000 0.0 0
M  V30 11 C 12.3201 4.0011 0.0 0
M  V30 12 C 11.5501 5.3348 0.0 0
M  V30 13 C 11.5501 2.6675 0.0 0
M  V30 14 N 13.8602 4.0011 0.0 0
M  V30 15 C 10.0101 5.3348 0.0 0
M  V30 16 C 12.3201 6.6686 0.0 0
M  V30 17 C 10.0101 2.6675 0.0 0
M  V30 18 C 14.6302 5.3348 0.0 0
M  V30 19 C 9.2401 4.0011 0.0 0
M  V30 20 C 13.8602 6.6686 0.0 0
M  V30 21 C 3.0800 4.0011 0.0 0
M  V30 22 C 2.3100 5.3348 0.0 0
M  V30 23 C 2.3100 2.6675 0.0 0
M  V30 24 C 0.7700 5.3348 0.0 0
M  V30 25 C 0.7700 2.6675 0.0 0
M  V30 26 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 18
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 19
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 21
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-4-hydroxy-N-[(1R)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-...
C20H19N3O4
1957178-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.5503 9.3360 0.0 0
M  V30 2 O 16.1704 6.6685 0.0 0
M  V30 3 C 7.7002 5.3348 0.0 0
M  V30 4 N 6.9302 4.0012 0.0 0
M  V30 5 O 6.9302 6.6685 0.0 0
M  V30 6 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 N 5.3901 1.3337 0.0 0
M  V30 10 O 3.0801 2.6675 0.0 0
M  V30 11 C 4.6201 0.0000 0.0 0
M  V30 12 C 12.3203 5.3348 0.0 0
M  V30 13 C 11.5503 6.6685 0.0 0
M  V30 14 C 11.5503 4.0012 0.0 0
M  V30 15 N 13.8603 5.3348 0.0 0
M  V30 16 C 10.0102 6.6685 0.0 0
M  V30 17 C 12.3203 8.0023 0.0 0
M  V30 18 C 10.0102 4.0012 0.0 0
M  V30 19 C 14.6303 6.6685 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 13.8603 8.0023 0.0 0
M  V30 22 C 3.0801 5.3348 0.0 0
M  V30 23 C 2.3101 6.6685 0.0 0
M  V30 24 C 2.3101 4.0012 0.0 0
M  V30 25 C 0.7700 6.6685 0.0 0
M  V30 26 C 0.7700 4.0012 0.0 0
M  V30 27 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 2 2 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 20
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=1
M  V30 8 1 6 8
M  V30 9 1 7 22
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1958052-49-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1957178-56-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16851443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Creating novel activated factor XI inhibitors through fragment based lead
generation and structure aided drug design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fjellstroem, Ola; Akkaya, Sibel; Beisel, Hans-Georg; Eriksson, Per-Olof;
Erixon, Karl; Gustafsson, David; Jurva, Ulrik; Kang, Daiwu; Karis, David;
Knecht, Wolfgang; Nerme, Viveca; Nilsson, Ingemar; Olsson, Thomas;
Redzic, Alma; Roth, Robert; Sandmark, Jenny; Tigerstroem, Anna; Oester,
Linda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM PLoS One (2015), 10(1), 1-42

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-chloro-α,α-dimethyl-4-pyrimidineacetate
C10H13ClN2O2
1980821-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 5.3348 4.6201 0.0 0
M  V30 5 O 8.0023 3.0801 0.0 0
M  V30 6 O 6.6685 0.7700 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 10.6697 3.0801 0.0 0
M  V30 9 Cl 0.0000 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 N 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 N 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 13
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α,α-dimethyl-6-(methylamino)-4-pyrimidineacetate
C11H17N3O2
1980821-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 O 8.0022 0.7700 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 12.0033 3.0801 0.0 0
M  V30 9 N 1.3337 3.0801 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 N 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 N 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1980821-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1980821-76-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17015905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of derivatives based on pyrimidine
scaffold as potent Pan-Raf inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhang, Qing; Zhu, Gaoyuan; Zhang, Zhimin; Zhi, Yanle; Zhang,
Li; Mao, Tianxiao; Zhou, Xiang; Chen, Yadong; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2017), 13086-106

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-chloropurine riboside
C10H12ClN5O4
2004-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 10.5369 4.6201 0.0 0
M  V30 2 N 7.8695 0.0000 0.0 0
M  V30 3 O 2.9016 7.1223 0.0 0
M  V30 4 C 0.6966 2.1699 0.0 0
M  V30 5 O 1.1724 0.7053 0.0 0
M  V30 6 O 0.0000 5.4472 0.0 0
M  V30 7 C 6.5359 3.8501 0.0 0
M  V30 8 N 5.3913 4.8805 0.0 0
M  V30 9 C 7.8695 4.6201 0.0 0
M  V30 10 N 6.5359 2.3100 0.0 0
M  V30 11 C 6.0178 6.2873 0.0 0
M  V30 12 N 7.5494 6.1264 0.0 0
M  V30 13 C 9.2032 3.8501 0.0 0
M  V30 14 C 7.8695 1.5400 0.0 0
M  V30 15 N 9.2032 2.3100 0.0 0
M  V30 16 C 3.8850 4.5603 0.0 0 CFG=1
M  V30 17 O 3.2585 3.1534 0.0 0
M  V30 18 C 2.7405 5.5908 0.0 0 CFG=2
M  V30 19 C 1.7270 3.3145 0.0 0 CFG=2
M  V30 20 C 1.4068 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 18 3 CFG=1
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 16 8 CFG=3
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyladenosine
C11H16N6O4
5059-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 7.1223 0.0 0
M  V30 2 N 10.5371 4.6201 0.0 0
M  V30 3 C 11.8709 3.8501 0.0 0
M  V30 4 N 7.8697 0.0000 0.0 0
M  V30 5 C 0.6967 2.1699 0.0 0
M  V30 6 O 1.1726 0.7053 0.0 0
M  V30 7 O 0.0000 5.4473 0.0 0
M  V30 8 N 5.3915 4.8805 0.0 0
M  V30 9 C 6.5361 3.8501 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 7.8697 4.6201 0.0 0
M  V30 12 N 6.5361 2.3101 0.0 0
M  V30 13 N 7.5496 6.1264 0.0 0
M  V30 14 C 9.2034 3.8501 0.0 0
M  V30 15 C 7.8697 1.5400 0.0 0
M  V30 16 N 9.2034 2.3101 0.0 0
M  V30 17 C 3.8852 4.5603 0.0 0 CFG=1
M  V30 18 O 3.2587 3.1534 0.0 0
M  V30 19 C 2.7406 5.5908 0.0 0 CFG=2
M  V30 20 C 1.7271 3.3145 0.0 0 CFG=2
M  V30 21 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2004-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5059-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12557106
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modulation of adenosine receptor affinity and intrinsic efficacy in
adenine nucleosides substituted at the 2-position
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohno, Michihiro; Gao, Zhan-Guo; Van Rompaey, Philippe; Tchilibon,
Susanna; Kim, Soo-Kyung; Harris, Brian A.; Gross, Ariel S.; Duong, Heng
T.; Van Calenbergh, Serge; Jacobson, Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(11), 2995-3007

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bromoacetaldehyde diethyl acetal
C6H13BrO2
2032-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 O 4.6200 2.6674 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 Br 3.0800 0.0000 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 0.0000 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Diethoxy-N-methylethanamine
C7H17NO2
20677-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 O 4.6200 4.0011 0.0 0
M  V30 4 O 2.3100 2.6674 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2032-35-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20677-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34415545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward the Total Synthesis of Alpkinidine: Synthesis of Haloquinone CE
Ring System Synthons and Attempted Nucleophilic Bisannulation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buccini, Marco; Tham, Louisa; Dhoro, Francis; Skelton, Brian W.;
Williams, Craig M.; Piggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2022), 7(23), 19080-19092

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanol, 2-bromo-5-methoxy-, 1-methanesulfonate
C9H11BrO4S
203380-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6673 0.0 0
M  V30 2 O 6.9300 4.0009 0.0 0
M  V30 3 S 8.4700 4.0009 0.0 0 VAL=6
M  V30 4 C 8.4700 5.5409 0.0 0
M  V30 5 O 10.0100 4.0009 0.0 0
M  V30 6 O 8.4700 2.4609 0.0 0
M  V30 7 Br 4.6200 0.0000 0.0 0
M  V30 8 O 1.5400 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 4.6200 2.6673 0.0 0
M  V30 11 C 3.8500 4.0009 0.0 0
M  V30 12 C 3.8500 1.3336 0.0 0
M  V30 13 C 2.3100 4.0009 0.0 0
M  V30 14 C 2.3100 1.3336 0.0 0
M  V30 15 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-methoxy-N-methylbenzenemethanamine
C9H12BrNO
767289-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 Br 4.6200 0.0000 0.0 0
M  V30 5 O 1.5400 5.3349 0.0 0
M  V30 6 C 0.0000 5.3349 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 203380-42-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 767289-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3004687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Homolytic Substitution of Sulfinates and Sulfinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coulomb, Julien; Certal, Victor; Larraufie, Marie-Helene; Ollivier,
Cyril; Corbet, Jean-Pierre; Mignani, Gerard; Fensterbank, Louis; Lacote,
Emmanuel; Malacria, Max
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2009), 15(39), 10225-10232,
S10225/1-S10225/62

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichlorobenzyl bromide
C7H5BrCl2
20443-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 Br 5.3901 4.0011 0.0 0
M  V30 3 Cl 3.0800 5.3349 0.0 0
M  V30 4 Cl 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6675 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-methylbenzenemethanamine
C8H9Cl2N
15205-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 Cl 3.0800 5.3349 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20443-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15205-19-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5371294
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (2,6-Dichloro-benzyl)-methyl-amine 17.5 ml (128 mmol) of a 33 % w/v
solution of methylamine in ethanol is added dropwise into a stirred
solution of 3.0 g (15.7 mmol) of 2,6-dichlorobenzyl bromide in 10 ml of
ethanol. The whole is refluxed smoothly in a closed atmosphere for 4 hr.
After concentrating, the residue is partitioned between ethyl
ether/water. The organic layer is successively extracted with 2N
hydrochloric acid, washed with ethyl ether, basified with 2N NaOH and
extracted with dichloromethane. After drying and concentrating 2.2 g
(94%) of the title compound (92% HPLC purity) is obtained as a colourless
oil. (2,6-Dichloro-benzyl)-methyl-amine, yield 2.2 g (94%) 92% HPLC
purity
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(2-Amino-1-hydroxyethyl)phenol derivatives as agonists of the β2
adrenergic receptor, their preparation, pharmaceutical compositions, and
use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Puig Duran, Carlos; Prat Quinones, Maria; Perez Crespo, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007124898 A1 2007-11-08

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
(βR)-β-Amino-4-chloro-3-(2-phenylethyl)benzenebutanoic acid
C18H20ClNO2
2056238-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 4.6201 0.0 0
M  V30 2 C 10.6697 5.3901 0.0 0 CFG=1
M  V30 3 C 12.0033 4.6201 0.0 0
M  V30 4 N 10.6697 6.9302 0.0 0
M  V30 5 C 13.3370 5.3901 0.0 0
M  V30 6 O 14.6707 4.6201 0.0 0
M  V30 7 O 13.3370 6.9302 0.0 0
M  V30 8 C 4.0010 4.6201 0.0 0
M  V30 9 C 4.0010 3.0801 0.0 0
M  V30 10 Cl 4.0010 7.7002 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 8.0022 6.9302 0.0 0
M  V30 14 C 5.3348 5.3901 0.0 0
M  V30 15 C 6.6685 7.7002 0.0 0
M  V30 16 C 5.3348 6.9302 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 C 1.3337 3.0801 0.0 0
M  V30 20 C 1.3337 0.0000 0.0 0
M  V30 21 C 0.0000 2.3101 0.0 0
M  V30 22 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 9 17
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(βR)-β-Amino-4-chloro-N-methyl-3-(2-phenylethyl)benzenebutanamide
C19H23ClN2O
2056238-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0 CFG=1
M  V30 6 C 12.3200 6.6685 0.0 0
M  V30 7 N 12.3200 4.0011 0.0 0
M  V30 8 C 13.8600 6.6685 0.0 0
M  V30 9 N 14.6300 8.0021 0.0 0
M  V30 10 O 14.6300 5.3347 0.0 0
M  V30 11 C 16.1700 8.0021 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 7.7000 1.3336 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 9.2400 1.3336 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 2.6674 0.0 0
M  V30 21 C 0.7700 5.3347 0.0 0
M  V30 22 C 0.7700 2.6674 0.0 0
M  V30 23 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 5 6
M  V30 8 1 5 7 CFG=3
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2056238-45-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2056238-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16874914
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure based design of non-natural peptidic macrocyclic Mcl-1
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johannes, Jeffrey W.; Bates, Stephanie; Beigie, Carl; Belmonte, Matt;
Breen, John; Cao, Shenggen; Centrella, Paolo A.; Clark, Matthew A.;
Cuozzo, John W.; Dumelin, Christoph E.; Ferguson, Andrew D.; Habeshian,
Sevan; Hargreaves, David; Joubran, Camil; Kazmirski, Steven; Keefe,
Anthony D.; Lamb, Michelle L.; Lan, Haiye; Li, Yunxia; Ma, Hao;
Mlynarski, Scott; Packer, Martin J.; Rawlins, Philip B.; Robbins, Daniel
W.; Shen, Haidong; Sigel, Eric A.; Soutter, Holly H.; Su, Nancy; Troast,
Dawn M.; Wang, Haiyun; Wickson, Kate F.; Wu, Chengyan; Zhang, Ying; Zhao,
Qiuying; Zheng, Xiaolan; Hird, Alexander W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2017), 8(2), 239-244

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-5-(bromomethyl)-3-methoxyisoxazole
C5H5Br2NO2
205645-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2079 1.3628 0.0 0
M  V30 2 C 7.5415 2.1328 0.0 0
M  V30 3 Br 3.1470 0.0000 0.0 0
M  V30 4 C 0.9052 2.4899 0.0 0
M  V30 5 Br 0.0000 3.7358 0.0 0
M  V30 6 C 4.8742 2.1328 0.0 0
M  V30 7 C 3.4672 1.5065 0.0 0
M  V30 8 N 4.7131 3.6643 0.0 0
M  V30 9 C 2.4368 2.6509 0.0 0
M  V30 10 O 3.2068 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3-methoxy-N-methyl-5-isoxazolemethanamine
C6H9BrN2O2
1454849-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 1.3628 0.0 0
M  V30 2 N 7.5415 2.1328 0.0 0
M  V30 3 C 8.8752 1.3628 0.0 0
M  V30 4 Br 3.1471 0.0000 0.0 0
M  V30 5 O 0.9052 2.4899 0.0 0
M  V30 6 C 0.0000 3.7358 0.0 0
M  V30 7 C 4.8742 2.1328 0.0 0
M  V30 8 C 3.4672 1.5065 0.0 0
M  V30 9 O 4.7131 3.6644 0.0 0
M  V30 10 C 2.4368 2.6509 0.0 0
M  V30 11 N 3.2068 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 205645-05-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1454849-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11047894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 4: To a solution of methylamine 33% in ethanol (77ml, 653 mmol) at 0
°C under nitrogen, was added dropwise over 10 minutes a solution of
compound 297 in ethanol (20ml), and the mixture was allowed to warm to
room temperature overnight. The mixture was concentrated by the removal
of solvent under vacuum, then saturated aqueous sodium hydrogen carbonate
was added (20 ml), then the mixture extracted with EtOAc (100ml), dried
over Na2SO4, filtered and the solvent removed under vacuum. Compound 298
as pale yellow oil 4.5g (93.5%). 1H NMR (400 MHz, d6-DMSO): δ 3.956 (s,
3H), 3.686 (s, 2H), 2.287 (br.s, 1 H), 2.234 (s, 3H), [M+H 220.95 and
222.95].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic derivatives for the treatment of proliferative diseases and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bailey, Simon; Burke, Benjamin Joseph; Collins, Michael Raymond; Cui,
Jingrong Jean; Deal, Judith Gail; Hoffman, Robert Louis; Huang, Qinhua;
Johnson, Ted William; Kania, Robert Steven; Kath, John Charles; Le,
Phuong Thi Quy; McTigue, Michele Ann; Palmer, Cynthia Louise; Richardson,
Paul Francis; Sach, Neal William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013132376 A1 2013-09-12

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-chloro-α-(diethoxyphosphinyl)-1,4-dihydro-1,4-dioxo-2-naphthaleneacetate
C18H20ClO7P
2070840-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7710 5.3348 0.0 0
M  V30 2 P 4.0010 4.0012 0.0 0 VAL=5
M  V30 3 C 4.0010 6.6687 0.0 0
M  V30 4 O 3.2310 2.6675 0.0 0
M  V30 5 O 2.6673 4.7712 0.0 0
M  V30 6 O 5.3348 3.2311 0.0 0
M  V30 7 O 2.4610 6.6687 0.0 0
M  V30 8 O 4.7710 8.0023 0.0 0
M  V30 9 C 4.0010 1.3337 0.0 0
M  V30 10 C 1.3337 4.0012 0.0 0
M  V30 11 C 1.6910 8.0023 0.0 0
M  V30 12 C 3.2310 0.0000 0.0 0
M  V30 13 C 0.0000 4.7712 0.0 0
M  V30 14 C 0.1509 8.0023 0.0 0
M  V30 15 O 6.3111 8.0023 0.0 0
M  V30 16 Cl 6.3111 2.6675 0.0 0
M  V30 17 O 9.3911 2.6675 0.0 0
M  V30 18 C 6.3111 5.3348 0.0 0
M  V30 19 C 7.0811 6.6687 0.0 0
M  V30 20 C 7.0811 4.0012 0.0 0
M  V30 21 C 8.6211 6.6687 0.0 0
M  V30 22 C 8.6211 4.0012 0.0 0
M  V30 23 C 9.3911 5.3348 0.0 0
M  V30 24 C 9.3911 8.0023 0.0 0
M  V30 25 C 10.9312 5.3348 0.0 0
M  V30 26 C 10.9312 8.0023 0.0 0
M  V30 27 C 11.7012 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 1 4 9
M  V30 10 1 5 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 15 19
M  V30 16 1 16 20
M  V30 17 2 17 22
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 21 24
M  V30 24 1 22 23
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-(4,9-dihydro-2-hydroxy-1-methyl-4,9-dioxo-1H-benz[f]indol-3-yl)phos...
C17H18NO6P
2070840-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 8.0407 4.6948 0.0 0 VAL=5
M  V30 2 O 9.1852 5.7252 0.0 0
M  V30 3 O 9.0713 3.5503 0.0 0
M  V30 4 O 7.0103 5.8391 0.0 0
M  V30 5 C 8.8650 7.2314 0.0 0
M  V30 6 C 10.5775 3.8704 0.0 0
M  V30 7 C 10.0094 8.2620 0.0 0
M  V30 8 C 11.6081 2.7261 0.0 0
M  V30 9 O 5.3901 6.6518 0.0 0
M  V30 10 O 8.3910 1.3627 0.0 0
M  V30 11 O 2.3100 1.3171 0.0 0
M  V30 12 C 5.3303 0.0000 0.0 0
M  V30 13 C 5.3899 3.9844 0.0 0
M  V30 14 C 6.8963 3.6642 0.0 0
M  V30 15 C 4.6199 2.6508 0.0 0
M  V30 16 C 4.6201 5.3182 0.0 0
M  V30 17 C 7.0573 2.1327 0.0 0
M  V30 18 C 3.0800 2.6508 0.0 0
M  V30 19 N 5.6505 1.5064 0.0 0
M  V30 20 C 3.0800 5.3182 0.0 0
M  V30 21 C 2.3100 3.9844 0.0 0
M  V30 22 C 2.3101 6.6518 0.0 0
M  V30 23 C 0.7700 3.9844 0.0 0
M  V30 24 C 0.7701 6.6518 0.0 0
M  V30 25 C 0.0000 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 9 16
M  V30 10 1 10 17
M  V30 11 2 11 18
M  V30 12 1 12 19
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 1 18 21
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2070840-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2070840-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26875281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anticancer properties of new synthetic hybrid molecules combining
naphtho[2,3-b]furan-4,9-dione or benzo[f]indole-4,9-dione motif with
phosphonate subunit
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gach, Katarzyna; Modranka, Jakub; Szymanski, Jacek; Pomorska, Dorota;
Krajewska, Urszula; Mirowski, Marek; Janecki, Tomasz; Janecka, Anna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 12051-63

$RFMT $RIREG SCHEME46 STEP1
$RXN



  3  1
$MOL
2-Amino-5-chloro-3-methylbenzoic acid
C8H8ClNO2
20776-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 N 2.6674 6.1600 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid
C9H5BrClN3O2
500011-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0492 1.1444 0.0 0
M  V30 2 O 6.0798 0.0000 0.0 0
M  V30 3 O 3.5429 0.8242 0.0 0
M  V30 4 Cl 3.0800 6.5222 0.0 0
M  V30 5 Br 8.2357 5.5302 0.0 0
M  V30 6 N 4.6200 3.8549 0.0 0
M  V30 7 C 5.5252 2.6091 0.0 0
M  V30 8 N 5.5252 5.1008 0.0 0
M  V30 9 C 6.9898 3.0849 0.0 0
M  V30 10 C 6.9898 4.6250 0.0 0
M  V30 11 C 3.0800 3.8549 0.0 0
M  V30 12 C 2.3100 5.1886 0.0 0
M  V30 13 N 2.3100 2.5213 0.0 0
M  V30 14 C 0.7700 5.1886 0.0 0
M  V30 15 C 0.7700 2.5213 0.0 0
M  V30 16 C 0.0000 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 12
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorantraniliprole
C18H14BrCl2N5O2
500008-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 5.3027 0.0 0
M  V30 2 N 7.4090 5.3027 0.0 0
M  V30 3 O 5.0990 6.6364 0.0 0
M  V30 4 Cl 0.5546 3.1677 0.0 0
M  V30 5 Br 4.7419 0.0000 0.0 0
M  V30 6 C 10.4891 5.3027 0.0 0
M  V30 7 N 12.0291 5.3027 0.0 0
M  V30 8 O 9.7190 3.9689 0.0 0
M  V30 9 C 12.7991 3.9689 0.0 0
M  V30 10 C 5.8690 7.9701 0.0 0
M  V30 11 Cl 10.4891 10.6375 0.0 0
M  V30 12 N 3.5673 3.8080 0.0 0
M  V30 13 C 5.0990 3.9689 0.0 0
M  V30 14 N 3.2471 2.3017 0.0 0
M  V30 15 C 5.7253 2.5621 0.0 0
M  V30 16 C 4.5809 1.5317 0.0 0
M  V30 17 C 2.5369 4.9525 0.0 0
M  V30 18 C 1.0306 4.6322 0.0 0
M  V30 19 N 3.0127 6.4171 0.0 0
M  V30 20 C 0.0000 5.7768 0.0 0
M  V30 21 C 1.9823 7.5616 0.0 0
M  V30 22 C 0.4760 7.2413 0.0 0
M  V30 23 C 8.1790 6.6364 0.0 0
M  V30 24 C 9.7190 6.6364 0.0 0
M  V30 25 C 7.4090 7.9701 0.0 0
M  V30 26 C 10.4891 7.9701 0.0 0
M  V30 27 C 8.1790 9.3037 0.0 0
M  V30 28 C 9.7190 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 23
M  V30 5 1 4 18
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20776-67-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500011-86-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500008-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33469544
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-99-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on reactant stoichiometry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for preparation of anthranilamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mane, Avinash Sheshrao; Jani, Nilesh N.; Shah, Kenal V.; Shah, Bhavesh
V.; Servaiya, Nikulsinh; Patel, Ritesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022136931 A1 2022-06-30

$RFMT $RIREG SCHEME46 STEP1
$RXN



  3  1
$MOL
2-Amino-5-chloro-3-methylbenzoic acid
C8H8ClNO2
20776-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 N 2.6674 6.1600 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3338 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxylic acid
C9H5BrClN3O2
500011-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0492 1.1444 0.0 0
M  V30 2 O 6.0798 0.0000 0.0 0
M  V30 3 O 3.5429 0.8242 0.0 0
M  V30 4 Cl 3.0800 6.5222 0.0 0
M  V30 5 Br 8.2357 5.5302 0.0 0
M  V30 6 N 4.6200 3.8549 0.0 0
M  V30 7 C 5.5252 2.6091 0.0 0
M  V30 8 N 5.5252 5.1008 0.0 0
M  V30 9 C 6.9898 3.0849 0.0 0
M  V30 10 C 6.9898 4.6250 0.0 0
M  V30 11 C 3.0800 3.8549 0.0 0
M  V30 12 C 2.3100 5.1886 0.0 0
M  V30 13 N 2.3100 2.5213 0.0 0
M  V30 14 C 0.7700 5.1886 0.0 0
M  V30 15 C 0.7700 2.5213 0.0 0
M  V30 16 C 0.0000 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 12
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorantraniliprole
C18H14BrCl2N5O2
500008-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 5.3027 0.0 0
M  V30 2 N 7.4090 5.3027 0.0 0
M  V30 3 O 5.0990 6.6364 0.0 0
M  V30 4 Cl 0.5546 3.1677 0.0 0
M  V30 5 Br 4.7419 0.0000 0.0 0
M  V30 6 C 10.4891 5.3027 0.0 0
M  V30 7 N 12.0291 5.3027 0.0 0
M  V30 8 O 9.7190 3.9689 0.0 0
M  V30 9 C 12.7991 3.9689 0.0 0
M  V30 10 C 5.8690 7.9701 0.0 0
M  V30 11 Cl 10.4891 10.6375 0.0 0
M  V30 12 N 3.5673 3.8080 0.0 0
M  V30 13 C 5.0990 3.9689 0.0 0
M  V30 14 N 3.2471 2.3017 0.0 0
M  V30 15 C 5.7253 2.5621 0.0 0
M  V30 16 C 4.5809 1.5317 0.0 0
M  V30 17 C 2.5369 4.9525 0.0 0
M  V30 18 C 1.0306 4.6322 0.0 0
M  V30 19 N 3.0127 6.4171 0.0 0
M  V30 20 C 0.0000 5.7768 0.0 0
M  V30 21 C 1.9823 7.5616 0.0 0
M  V30 22 C 0.4760 7.2413 0.0 0
M  V30 23 C 8.1790 6.6364 0.0 0
M  V30 24 C 9.7190 6.6364 0.0 0
M  V30 25 C 7.4090 7.9701 0.0 0
M  V30 26 C 10.4891 7.9701 0.0 0
M  V30 27 C 8.1790 9.3037 0.0 0
M  V30 28 C 9.7190 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 23
M  V30 5 1 4 18
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 20776-67-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500011-86-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500008-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39229884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 98-59-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 108-99-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, optimization study, optimized on various reaction
condition, alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for preparation of anthranilamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mane, Avinash Sheshrao; Jani, Nilesh N.; Shah, Kenal V.; Shah, Bhavesh
V.; Servaiya, Nikulsinh; Patel, Ritesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202021056370 A 2021-01-22

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-N-[(4-methoxyphenyl)methyl]-2-quinolinamine
C17H15BrN2O
2086768-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 O 14.6708 5.3901 0.0 0
M  V30 5 C 16.0046 4.6201 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 N 5.3348 3.0801 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 6.6687 2.3101 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 6.6687 0.7700 0.0 0
M  V30 15 C 1.3338 0.7700 0.0 0
M  V30 16 C 10.6698 3.0801 0.0 0
M  V30 17 C 12.0035 2.3101 0.0 0
M  V30 18 C 10.6698 4.6201 0.0 0
M  V30 19 C 13.3372 3.0801 0.0 0
M  V30 20 C 12.0035 5.3901 0.0 0
M  V30 21 C 13.3372 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 16
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2-[(4-Methoxyphenyl)methyl]-N7-methyl-2,7-quinolinediamine
C18H19N3O
2354421-97-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.3360 2.3101 0.0 0
M  V30 2 C 10.6697 3.0801 0.0 0
M  V30 3 N 1.3338 2.3101 0.0 0
M  V30 4 C 0.0000 3.0801 0.0 0
M  V30 5 O 16.0045 0.0000 0.0 0
M  V30 6 C 17.3383 0.7700 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 6.6687 2.3101 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 6.6687 5.3901 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 2.6675 3.0801 0.0 0
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 12.0035 2.3101 0.0 0
M  V30 18 C 12.0035 0.7700 0.0 0
M  V30 19 C 13.3372 3.0801 0.0 0
M  V30 20 C 13.3372 0.0000 0.0 0
M  V30 21 C 14.6708 2.3101 0.0 0
M  V30 22 C 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 22
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2086768-31-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2354421-97-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20897285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted bicyclic heterocyclic compounds as PRMT5
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nair, Prathap Sreedharan; Gudade, Ganesh Bhausaheb; Sethi, Sachin; Lagad,
Dipak Raychand; Pawar, Chetan Sanjay; Tryambake, Mahadeo Bhaskar;
Kulkarni, Chaitanya Prabhakar; Hajare, Anil Kashiram; Gore, Balasaheb
Arjun; Kulkarni, Sanjeev Anant; Sindkhedkar, Milind Dattatraya; Palle,
Venkata P.; Kamboj, Rajender Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019116302 A1 2019-06-20

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(1S)-1-[(Dimethylamino)methyl]-2-methylpropyl]amino]-4-ethoxy-3-cyclobute...
C13H22N2O3
2115059-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0 CFG=1
M  V30 3 C 2.3101 4.0012 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 0.7700 4.0012 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 0.0000 5.3348 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 O 8.2115 3.6297 0.0 0
M  V30 11 C 9.5451 4.3997 0.0 0
M  V30 12 C 10.8788 3.6297 0.0 0
M  V30 13 O 3.6579 6.2587 0.0 0
M  V30 14 O 7.2491 7.2209 0.0 0
M  V30 15 C 5.3901 4.0012 0.0 0
M  V30 16 C 6.8776 4.3997 0.0 0
M  V30 17 C 4.9916 5.4887 0.0 0
M  V30 18 C 6.4791 5.8872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 2 13 17
M  V30 14 2 14 18
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-[[(1S)-1-[(Dimethylamino)methyl]-2-methylpropyl]amino]-4-(methylamino)-3-cy...
C12H21N3O2
2115059-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 2.6673 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0 CFG=1
M  V30 3 C 2.3101 4.0012 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 0.7700 4.0012 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 0.0000 5.3348 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 N 8.2115 3.6297 0.0 0
M  V30 11 C 9.5451 4.3997 0.0 0
M  V30 12 O 3.6579 6.2587 0.0 0
M  V30 13 O 7.2491 7.2209 0.0 0
M  V30 14 C 5.3901 4.0012 0.0 0
M  V30 15 C 6.8776 4.3997 0.0 0
M  V30 16 C 4.9916 5.4887 0.0 0
M  V30 17 C 6.4791 5.8872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 1 10 15
M  V30 12 2 12 16
M  V30 13 2 13 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2115059-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2115059-60-2
$DTYPE RXN:PRO(1):AMD
$DATUM polystyrene bound
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17725436
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, polystyrene bound methylamine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Supported and Unsupported Chiral Squaramides as Organocatalysts for
Stereoselective Michael Additions: Synthesis of Enantiopure Chromenes and
Spirochromanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andres, Jose M.; Losada, Jorge; Maestro, Alicia; Rodriguez-Ferrer,
Patricia; Pedrosa, Rafael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(16), 8444-8454

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-4-nitrobenzenesulfonyl chloride
C7H6ClNO5S
21320-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 1.3336 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 4 Cl 8.4700 4.0009 0.0 0
M  V30 5 O 6.9300 5.5409 0.0 0
M  V30 6 O 6.9300 2.4609 0.0 0
M  V30 7 N 0.7700 4.0009 0.0 0 VAL=5
M  V30 8 O 0.0000 5.3347 0.0 0
M  V30 9 O 0.0000 2.6673 0.0 0
M  V30 10 C 4.6200 2.6673 0.0 0
M  V30 11 C 5.3900 4.0009 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 2.3100 4.0009 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-4-nitrobenzenesulfonamide
C8H10N2O5S
1098373-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 6.1601 0.0 0
M  V30 2 C 2.6675 6.9302 0.0 0
M  V30 3 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 4 N 8.0023 5.3901 0.0 0
M  V30 5 O 5.8985 5.9538 0.0 0
M  V30 6 O 7.4385 3.2864 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 12
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21320-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1098373-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-22071899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Arylation and alkenylation of activated alkyl halides using sulfonamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Stuart; Kovacs, Ervin; Greaney, Michael F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2020), 56(21),
3222-3224

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(3,4-dimethoxyphenyl)-4-oxo-2-cyclohexene-1-acetate
C18H22O5
2194555-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5698 5.6786 0.0 0
M  V30 2 C 8.0170 6.2053 0.0 0
M  V30 3 O 9.1966 5.2154 0.0 0
M  V30 4 O 8.2843 7.7219 0.0 0
M  V30 5 C 10.6438 5.7421 0.0 0
M  V30 6 C 11.8236 4.7522 0.0 0
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3348 0.0 0
M  V30 9 O 4.5878 11.2184 0.0 0
M  V30 10 O 2.3100 1.3338 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 5.3900 6.6686 0.0 0
M  V30 13 C 3.9429 7.1952 0.0 0
M  V30 14 C 6.5698 7.6583 0.0 0
M  V30 15 C 3.6755 8.7118 0.0 0
M  V30 16 C 6.3023 9.1749 0.0 0
M  V30 17 C 4.8552 9.7018 0.0 0
M  V30 18 C 4.6200 5.3348 0.0 0
M  V30 19 C 3.0800 5.3348 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 4.6200 2.6675 0.0 0
M  V30 23 C 3.0800 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 21
M  V30 9 2 9 17
M  V30 10 1 10 11
M  V30 11 1 10 23
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7aR)-3a-(3,4-Dimethoxyphenyl)hexahydro-1-methyl-1H-indole-2,6-dione
C17H21NO4
21104-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5455 9.0058 0.0 0
M  V30 2 O 5.8959 9.0058 0.0 0
M  V30 3 O 6.8881 0.7700 0.0 0
M  V30 4 C 5.5544 0.0000 0.0 0
M  V30 5 O 0.0000 3.5110 0.0 0
M  V30 6 O 9.5556 2.3101 0.0 0
M  V30 7 C 10.8893 3.0801 0.0 0
M  V30 8 C 4.2208 5.3901 0.0 0 CFG=2
M  V30 9 C 2.9747 6.2954 0.0 0 CFG=1
M  V30 10 C 5.4667 6.2954 0.0 0
M  V30 11 C 4.0597 3.8584 0.0 0
M  V30 12 N 3.4508 7.7599 0.0 0
M  V30 13 C 1.5679 5.6689 0.0 0
M  V30 14 C 4.9908 7.7599 0.0 0
M  V30 15 C 2.6529 3.2321 0.0 0
M  V30 16 C 1.4070 4.1373 0.0 0
M  V30 17 C 5.5544 4.6201 0.0 0
M  V30 18 C 5.5544 3.0801 0.0 0
M  V30 19 C 6.8881 5.3901 0.0 0
M  V30 20 C 6.8881 2.3101 0.0 0
M  V30 21 C 8.2218 4.6201 0.0 0
M  V30 22 C 8.2218 3.0801 0.0 0
M  V30 23 H 1.8303 7.3258 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 2 2 14
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 2 5 16
M  V30 6 1 6 7
M  V30 7 1 6 22
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 17 CFG=3
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 9 23 CFG=3
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 12 14
M  V30 18 1 13 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2194555-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21104-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-19063168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Concise Total Synthesis of (±)-Mesembrine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Hyoungsu; Choi, Hosam; Lee, Kiyoun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2018), 29(9), 1203-1206

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(4-bromophenyl)-2-[(dimethylamino)methylene]-3-oxo-
C13H15BrN2O2
2197964-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 Br 11.5500 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3349 0.0 0
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 9.2400 5.3349 0.0 0
M  V30 18 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 13
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(4-bromophenyl)-2-[(methylamino)methylene]-3-oxo-
C12H13BrN2O2
2197964-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 4.0011 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 Br 11.5500 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 7.7000 2.6674 0.0 0
M  V30 14 C 7.7000 5.3349 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 9.2400 5.3349 0.0 0
M  V30 17 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2197964-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(4-bromobutyl)-N-[[4-(1,1-dimethylethyl)phenyl]methyl]car...
C20H32BrNO2
2202723-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6685 0.0 0
M  V30 2 N 8.4700 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 O 8.4700 2.6674 0.0 0
M  V30 6 O 6.1600 4.0011 0.0 0
M  V30 7 C 10.7800 6.6685 0.0 0
M  V30 8 C 7.7000 1.3336 0.0 0
M  V30 9 C 12.3200 6.6685 0.0 0
M  V30 10 C 6.3664 2.1036 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 9.0336 0.5636 0.0 0
M  V30 13 C 13.0900 8.0021 0.0 0
M  V30 14 Br 14.6300 8.0021 0.0 0
M  V30 15 C 1.5400 6.6685 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 19 C 6.1600 6.6685 0.0 0
M  V30 20 C 5.3900 5.3347 0.0 0
M  V30 21 C 5.3900 8.0021 0.0 0
M  V30 22 C 3.8500 5.3347 0.0 0
M  V30 23 C 3.8500 8.0021 0.0 0
M  V30 24 C 3.0800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-[4-(methylamino)b...
C21H36N2O2
2202723-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 9.3358 0.0 0
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 3.8500 8.0021 0.0 0
M  V30 4 C 6.1600 6.6684 0.0 0
M  V30 5 O 3.0800 9.3358 0.0 0
M  V30 6 O 3.0800 6.6684 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 1.5400 9.3358 0.0 0
M  V30 9 C 6.1600 4.0011 0.0 0
M  V30 10 C 1.5400 10.8758 0.0 0
M  V30 11 C 0.0000 9.3358 0.0 0
M  V30 12 C 1.5400 7.7958 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 N 6.1600 1.3336 0.0 0
M  V30 15 C 5.3900 0.0000 0.0 0
M  V30 16 C 12.3200 9.3358 0.0 0
M  V30 17 C 13.0900 8.0021 0.0 0
M  V30 18 C 13.8600 9.3358 0.0 0
M  V30 19 C 13.0900 10.6694 0.0 0
M  V30 20 C 7.7000 9.3358 0.0 0
M  V30 21 C 8.4700 8.0021 0.0 0
M  V30 22 C 8.4700 10.6694 0.0 0
M  V30 23 C 10.0100 8.0021 0.0 0
M  V30 24 C 10.0100 10.6694 0.0 0
M  V30 25 C 10.7800 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2202723-80-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2202723-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18545524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The relationship between the conformational degree of freedom of
template-containing threads and slippage in the formation of [2]rotaxane
building blocks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riss-Yaw, B.; Clavel, C.; Laurent, Ph.; Coutrot, F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2017), 53(79),
10874-10877

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine
C24H20BrNO4
220497-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 5.7533 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0810 0.0 0
M  V30 5 O 8.4208 6.7709 0.0 0
M  V30 6 C 8.4208 9.8510 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0810 0.0 0
M  V30 8 C 8.4208 11.3910 0.0 0
M  V30 9 O 9.7544 12.1610 0.0 0
M  V30 10 O 7.0871 12.1610 0.0 0
M  V30 11 Br 15.0893 9.0810 0.0 0
M  V30 12 C 4.4196 4.4609 0.0 0
M  V30 13 C 3.0128 5.0873 0.0 0
M  V30 14 C 4.2587 2.9293 0.0 0
M  V30 15 C 1.9822 3.9428 0.0 0
M  V30 16 C 2.5369 6.5519 0.0 0
M  V30 17 C 2.7522 2.6091 0.0 0
M  V30 18 C 5.2891 1.7849 0.0 0
M  V30 19 C 0.4759 4.2630 0.0 0
M  V30 20 C 1.0304 6.8721 0.0 0
M  V30 21 C 2.2763 1.1444 0.0 0
M  V30 22 C 4.8132 0.3202 0.0 0
M  V30 23 C 0.0000 5.7277 0.0 0
M  V30 24 C 3.3069 0.0000 0.0 0
M  V30 25 C 11.0881 9.8510 0.0 0
M  V30 26 C 12.4219 9.0810 0.0 0
M  V30 27 C 11.0881 11.3910 0.0 0
M  V30 28 C 13.7556 9.8510 0.0 0
M  V30 29 C 12.4219 12.1610 0.0 0
M  V30 30 C 13.7556 11.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 23
M  V30 26 1 21 24
M  V30 27 2 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9H-Fluoren-9-ylmethyl N-[(1S)-1-[(3-bromophenyl)methyl]-2-(methylamino)-2-oxo...
C25H23BrN2O3
2088113-08-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 5.2309 0.0 0
M  V30 2 O 5.7532 6.7709 0.0 0
M  V30 3 C 7.0871 7.5409 0.0 0
M  V30 4 N 7.0871 9.0809 0.0 0
M  V30 5 O 8.4207 6.7709 0.0 0
M  V30 6 C 8.4207 9.8509 0.0 0 CFG=2
M  V30 7 C 9.7544 9.0809 0.0 0
M  V30 8 C 8.4207 11.3910 0.0 0
M  V30 9 N 7.0871 12.1610 0.0 0
M  V30 10 O 9.7544 12.1610 0.0 0
M  V30 11 C 7.0871 13.7010 0.0 0
M  V30 12 Br 15.0892 9.0809 0.0 0
M  V30 13 C 4.4196 4.4608 0.0 0
M  V30 14 C 3.0128 5.0873 0.0 0
M  V30 15 C 4.2586 2.9293 0.0 0
M  V30 16 C 1.9822 3.9428 0.0 0
M  V30 17 C 2.5369 6.5519 0.0 0
M  V30 18 C 2.7522 2.6091 0.0 0
M  V30 19 C 5.2891 1.7849 0.0 0
M  V30 20 C 0.4759 4.2630 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 2.2763 1.1444 0.0 0
M  V30 23 C 4.8132 0.3202 0.0 0
M  V30 24 C 0.0000 5.7277 0.0 0
M  V30 25 C 3.3069 0.0000 0.0 0
M  V30 26 C 11.0881 9.8509 0.0 0
M  V30 27 C 12.4219 9.0809 0.0 0
M  V30 28 C 11.0881 11.3910 0.0 0
M  V30 29 C 13.7555 9.8509 0.0 0
M  V30 30 C 12.4219 12.1610 0.0 0
M  V30 31 C 13.7555 11.3910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7 CFG=3
M  V30 8 1 6 8
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 12 29
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 18
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 2 23 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 220497-48-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088113-08-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19079770
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and functional assessment of Cmpd-15 derivatives as
negative allosteric modulators for the β2-adrenergic receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meng, Kaicheng; Shim, Paul; Wang, Qingtin; Zhao, Shuai; Gu, Ting; Kahsai,
Alem W.; Ahn, Seungkirl; Chen, Xin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2018), 26(9), 2320-2330

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-4-(2-propyn-1-ylamino)benzoic acid
C11H11NO3
2228938-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 7.7000 5.3349 0.0 0
M  V30 3 C 9.2400 5.3349 0.0 0
M  V30 4 C 10.7800 5.3349 0.0 0
M  V30 5 O 5.3900 1.3338 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 0.0000 5.3349 0.0 0
M  V30 9 O 0.0000 2.6674 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-4-(2-propyn-1-ylamino)benzamide
C12H14N2O2
2637450-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 4.0011 0.0 0
M  V30 2 C 9.2400 5.3349 0.0 0
M  V30 3 C 10.7800 5.3349 0.0 0
M  V30 4 C 12.3200 5.3349 0.0 0
M  V30 5 O 6.9300 1.3338 0.0 0
M  V30 6 C 6.1600 0.0000 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 1.5400 5.3349 0.0 0
M  V30 9 O 1.5400 2.6674 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 6.1600 5.3349 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 4.6200 5.3349 0.0 0
M  V30 16 C 3.8500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2228938-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2637450-00-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36043549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylalkyne compounds for targeting mutant of p53 and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Sujing; Li, Amin; Zheng, Qian; Dang, Chaojie; Fan, Xinrui; Long, Wei;
Wang, Yanping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023016434 A1 2023-02-16

$RFMT $RIREG SCHEME55 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, N-[(3R)-2,3,4,5-tetrahydro-4-(2-hydroxyacetyl)-3-methylpyrido[...
C16H23N3O5
2230885-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5228 2.6376 0.0 0
M  V30 2 C 2.0854 1.2040 0.0 0
M  V30 3 O 0.0000 2.8672 0.0 0
M  V30 4 O 1.1253 0.0000 0.0 0
M  V30 5 N 9.1895 3.6892 0.0 0
M  V30 6 C 10.5234 4.4592 0.0 0
M  V30 7 O 11.8570 3.6892 0.0 0
M  V30 8 O 10.5234 5.9992 0.0 0
M  V30 9 C 13.1907 4.4592 0.0 0
M  V30 10 C 12.4207 5.7928 0.0 0
M  V30 11 C 14.5244 5.2292 0.0 0
M  V30 12 C 13.9607 3.1255 0.0 0
M  V30 13 C 0.2747 5.2292 0.0 0
M  V30 14 C 5.1885 4.4592 0.0 0
M  V30 15 C 5.1885 5.9992 0.0 0
M  V30 16 C 3.9844 3.4990 0.0 0
M  V30 17 C 6.5222 3.6892 0.0 0
M  V30 18 O 3.9844 6.9594 0.0 0
M  V30 19 N 6.5222 6.7692 0.0 0
M  V30 20 N 2.4830 3.8416 0.0 0
M  V30 21 C 7.8559 4.4592 0.0 0
M  V30 22 C 2.4830 6.6168 0.0 0
M  V30 23 C 7.8559 5.9992 0.0 0
M  V30 24 C 1.8148 5.2292 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 24 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-2,3,4,5-tetrahydro-3-methyl-4-[2-[[(methylamino)car...
C18H26N4O6
2230885-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.0017 1.9489 0.0 0
M  V30 2 C 14.5245 2.1785 0.0 0
M  V30 3 O 12.4390 0.5154 0.0 0
M  V30 4 O 15.4847 0.9745 0.0 0
M  V30 5 C 17.0075 1.2040 0.0 0
M  V30 6 N 17.9677 0.0000 0.0 0
M  V30 7 O 17.5702 2.6376 0.0 0
M  V30 8 C 19.4906 0.2295 0.0 0
M  V30 9 N 5.3350 3.0004 0.0 0
M  V30 10 C 4.0011 3.7705 0.0 0
M  V30 11 O 2.6675 3.0004 0.0 0
M  V30 12 O 4.0011 5.3105 0.0 0
M  V30 13 C 1.3338 3.7705 0.0 0
M  V30 14 C 2.1038 5.1043 0.0 0
M  V30 15 C 0.0000 4.5405 0.0 0
M  V30 16 C 0.5638 2.4368 0.0 0
M  V30 17 C 14.2497 4.5405 0.0 0
M  V30 18 C 9.3360 3.7705 0.0 0
M  V30 19 C 9.3360 5.3105 0.0 0
M  V30 20 C 10.5401 2.8104 0.0 0
M  V30 21 C 8.0023 3.0004 0.0 0
M  V30 22 N 8.0023 6.0805 0.0 0
M  V30 23 O 10.5401 6.2707 0.0 0
M  V30 24 N 12.0415 3.1531 0.0 0
M  V30 25 C 6.6686 3.7705 0.0 0
M  V30 26 C 6.6686 5.3105 0.0 0
M  V30 27 C 12.0415 5.9280 0.0 0
M  V30 28 C 12.7097 4.5405 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 25
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 28 17 CFG=1
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 2 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230885-22-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230885-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-22143345
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxazepine derivatives having TNAP inhibitory activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miyazaki, Shojiro; Kurosaki, Yasunobu; Inui, Masaharu; Kishida,
Masamichi; Suzuki, Keisuke; Izumi, Masanori; Soma, Kaori; Pinkerton,
Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018119449 A1 2018-06-28

$RFMT $RIREG SCHEME56 STEP1
$RXN



  3  1
$MOL

C44H44N2O10
2241963-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0023 9.7881 0.0 0
M  V30 2 C 6.6685 9.0181 0.0 0
M  V30 3 O 5.3348 9.7881 0.0 0
M  V30 4 O 6.6685 7.4781 0.0 0
M  V30 5 C 4.0011 9.0181 0.0 0
M  V30 6 C 7.2862 8.8026 0.0 0
M  V30 7 C 7.6065 10.3091 0.0 0
M  V30 8 O 6.4619 11.3395 0.0 0
M  V30 9 O 9.0711 10.7849 0.0 0
M  V30 10 C 6.7821 12.8460 0.0 0
M  V30 11 O 10.3194 6.4561 0.0 0
M  V30 12 O 5.7799 7.0619 0.0 0
M  V30 13 C 13.2210 8.1313 0.0 0
M  V30 14 O 14.4668 9.0364 0.0 0
M  V30 15 O 13.3819 6.5996 0.0 0
M  V30 16 C 15.8738 8.4101 0.0 0
M  V30 17 C 15.2473 7.0033 0.0 0
M  V30 18 C 17.2806 7.7837 0.0 0
M  V30 19 C 16.5001 9.8169 0.0 0
M  V30 20 C 7.1426 4.0011 0.0 0
M  V30 21 O 7.9126 2.6675 0.0 0
M  V30 22 O 5.6026 4.0011 0.0 0
M  V30 23 C 7.1426 1.3338 0.0 0
M  V30 24 C 8.4763 0.5638 0.0 0
M  V30 25 C 6.3726 0.0000 0.0 0
M  V30 26 C 5.8090 2.1038 0.0 0
M  V30 27 C 9.3359 9.0181 0.0 0 CFG=2
M  V30 28 C 9.9623 10.4250 0.0 0
M  V30 29 C 10.4803 7.9876 0.0 0
M  V30 30 C 11.4938 10.2640 0.0 0
M  V30 31 C 9.3359 11.8319 0.0 0
M  V30 32 N 11.8140 8.7577 0.0 0
M  V30 33 C 12.3990 11.5100 0.0 0
M  V30 34 C 10.2412 13.0777 0.0 0
M  V30 35 C 11.7727 12.9168 0.0 0
M  V30 36 C 8.4307 7.7722 0.0 0 CFG=2
M  V30 37 C 9.7644 7.0022 0.0 0
M  V30 38 C 7.2862 6.7418 0.0 0
M  V30 39 C 9.4442 5.4959 0.0 0
M  V30 40 C 11.2291 7.4781 0.0 0
M  V30 41 N 7.9126 5.3348 0.0 0
M  V30 42 C 10.5886 4.4653 0.0 0
M  V30 43 C 12.3735 6.4476 0.0 0
M  V30 44 C 12.0533 4.9412 0.0 0
M  V30 45 C 2.6675 9.7881 0.0 0
M  V30 46 C 1.3337 9.0181 0.0 0
M  V30 47 C 2.6675 11.3281 0.0 0
M  V30 48 C 0.0000 9.7881 0.0 0
M  V30 49 C 1.3337 12.0981 0.0 0
M  V30 50 C 0.0000 11.3281 0.0 0
M  V30 51 C 5.6377 13.8764 0.0 0
M  V30 52 C 5.9579 15.3827 0.0 0
M  V30 53 C 4.1730 13.4005 0.0 0
M  V30 54 C 4.8133 16.4133 0.0 0
M  V30 55 C 3.0286 14.4310 0.0 0
M  V30 56 C 3.3488 15.9374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 45
M  V30 7 1 6 7
M  V30 8 1 36 6 CFG=1
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 51
M  V30 13 2 11 29
M  V30 14 2 12 38
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 13 32
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 1 20 41
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 23 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 27 36
M  V30 32 1 28 30
M  V30 33 2 28 31
M  V30 34 1 29 32
M  V30 35 1 30 32
M  V30 36 2 30 33
M  V30 37 1 31 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 37 40
M  V30 44 1 38 41
M  V30 45 1 39 41
M  V30 46 2 39 42
M  V30 47 1 40 43
M  V30 48 1 42 44
M  V30 49 2 43 44
M  V30 50 2 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 49
M  V30 54 2 48 50
M  V30 55 1 49 50
M  V30 56 2 51 52
M  V30 57 1 51 53
M  V30 58 1 52 54
M  V30 59 2 53 55
M  V30 60 2 54 56
M  V30 61 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 27 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl iodide
CH3I
74-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 I 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[3,3′-Bi-3H-indole]-3,3′-diacetamide, 1,1′,2,2′-tetrahydro-N3,N3′,1,1′-tetram...
C24H26N4O4
2241963-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.6054 3.0010 0.0 0
M  V30 2 C 7.4792 1.9507 0.0 0
M  V30 3 N 7.8255 0.4501 0.0 0
M  V30 4 O 6.0065 2.4010 0.0 0
M  V30 5 C 9.2982 0.0000 0.0 0
M  V30 6 C 3.6643 3.4445 0.0 0
M  V30 7 C 4.9981 2.6745 0.0 0
M  V30 8 N 4.9981 1.1345 0.0 0
M  V30 9 O 6.3317 3.4445 0.0 0
M  V30 10 C 3.6643 0.3645 0.0 0
M  V30 11 O 6.0964 6.1911 0.0 0
M  V30 12 O 1.3627 3.4898 0.0 0
M  V30 13 C 8.5468 8.4760 0.0 0
M  V30 14 C 0.0000 6.5505 0.0 0
M  V30 15 C 8.2590 4.5016 0.0 0 CFG=2
M  V30 16 C 9.7875 4.6893 0.0 0
M  V30 17 C 7.6082 5.8973 0.0 0
M  V30 18 C 10.0813 6.2010 0.0 0
M  V30 19 C 10.9497 3.6789 0.0 0
M  V30 20 N 8.7344 6.9476 0.0 0
M  V30 21 C 11.5375 6.7024 0.0 0
M  V30 22 C 12.4059 4.1803 0.0 0
M  V30 23 C 12.6998 5.6920 0.0 0
M  V30 24 C 3.6643 4.9845 0.0 0 CFG=2
M  V30 25 C 3.9844 6.4908 0.0 0
M  V30 26 C 2.1327 4.8234 0.0 0
M  V30 27 C 2.6508 7.2608 0.0 0
M  V30 28 C 5.3182 7.2608 0.0 0
M  V30 29 N 1.5064 6.2304 0.0 0
M  V30 30 C 2.6508 8.8008 0.0 0
M  V30 31 C 5.3182 8.8008 0.0 0
M  V30 32 C 3.9844 9.5708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 24 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 17
M  V30 12 2 12 26
M  V30 13 1 13 20
M  V30 14 1 14 29
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=3
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 25 28
M  V30 30 1 26 29
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 1 28 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2241963-12-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-88-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241963-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25992743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organo-Cation Catalyzed Asymmetric Homo/Heterodialkylation of
Bisoxindoles: Construction of Vicinal All-Carbon Quaternary Stereocenters
and Total Synthesis of (-)-Chimonanthidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Si-Kai; Ma, Wen-Qiang; Yan, Zhi-Bo; Zhang, Fu-Min; Wang, Shao-Hua;
Tu, Yong-Qiang; Zhang, Xiao-Ming; Tian, Jin-Miao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2018), 140(32), 10099-10103

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6S)-6-(3,4-Dimethoxyphenyl)-5,6,7,8-tetrahydro-5-oxo-6-quinolineacetaldehyde
C19H19NO4
2244060-65-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.8616 2.6270 0.0 0
M  V30 2 C 4.8717 1.4471 0.0 0
M  V30 3 O 5.3984 0.0000 0.0 0
M  V30 4 O 4.0011 1.7641 0.0 0
M  V30 5 O 9.4215 7.5031 0.0 0
M  V30 6 C 8.4316 8.6829 0.0 0
M  V30 7 O 11.4013 5.1436 0.0 0
M  V30 8 C 12.3912 3.9640 0.0 0
M  V30 9 C 5.3348 4.0741 0.0 0 CFG=2
M  V30 10 C 4.0011 3.3041 0.0 0
M  V30 11 C 5.3348 5.6141 0.0 0
M  V30 12 C 2.6675 4.0741 0.0 0
M  V30 13 C 4.0011 6.3841 0.0 0
M  V30 14 C 2.6675 5.6141 0.0 0
M  V30 15 C 1.3338 3.3041 0.0 0
M  V30 16 N 1.3338 6.3841 0.0 0
M  V30 17 C 0.0000 4.0741 0.0 0
M  V30 18 C 0.0000 5.6141 0.0 0
M  V30 19 C 6.8514 4.3414 0.0 0
M  V30 20 C 7.3782 5.7886 0.0 0
M  V30 21 C 7.8413 3.1618 0.0 0
M  V30 22 C 8.8948 6.0559 0.0 0
M  V30 23 C 9.3579 3.4291 0.0 0
M  V30 24 C 9.8847 4.8763 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 14
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aS,9bR)-3a-(3,4-Dimethoxyphenyl)-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrol...
C20H24N2O2
35135-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.6149 1.7074 0.0 0
M  V30 2 O 9.4935 1.3338 0.0 0
M  V30 3 C 8.7235 0.0000 0.0 0
M  V30 4 O 11.0335 4.0011 0.0 0
M  V30 5 C 11.8035 5.3347 0.0 0
M  V30 6 C 4.8735 4.0011 0.0 0 CFG=2
M  V30 7 C 3.3420 3.8402 0.0 0 CFG=1
M  V30 8 C 5.4998 5.4080 0.0 0
M  V30 9 C 5.4998 2.5943 0.0 0
M  V30 10 C 2.4368 5.0860 0.0 0
M  V30 11 N 3.0218 2.3337 0.0 0
M  V30 12 C 4.5948 6.6539 0.0 0
M  V30 13 C 4.3554 1.5637 0.0 0
M  V30 14 C 3.0631 6.4928 0.0 0
M  V30 15 C 0.9052 4.9251 0.0 0
M  V30 16 N 2.1580 7.7388 0.0 0
M  V30 17 C 0.0000 6.1710 0.0 0
M  V30 18 C 0.6263 7.5778 0.0 0
M  V30 19 C 6.4135 4.0011 0.0 0
M  V30 20 C 7.1835 2.6674 0.0 0
M  V30 21 C 7.1835 5.3347 0.0 0
M  V30 22 C 8.7235 2.6674 0.0 0
M  V30 23 C 8.7235 5.3347 0.0 0
M  V30 24 C 9.4935 4.0011 0.0 0
M  V30 25 H 1.8355 3.5200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 22
M  V30 4 1 4 5
M  V30 5 1 4 24
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 19 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 25 CFG=3
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 1 11 13
M  V30 18 1 12 14
M  V30 19 2 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244060-65-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35135-35-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19277319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Synthesis of (-)-Corynoline by Enantioselective
Palladium-Catalyzed α-Arylation with Sterically Hindered Substrates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Xiaofeng; Li, Naikai; Bai, Heng; Dai, Chaodi; Wang, Zheng; Tang,
Wenjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(38), 12328-12332

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Ethoxy-3-(trifluoromethyl)-1(3H)-isobenzofuranone
C11H9F3O3
2254545-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.7474 2.4368 0.0 0
M  V30 2 C 3.5015 1.5315 0.0 0
M  V30 3 C 3.6625 0.0000 0.0 0
M  V30 4 C 6.1265 3.9683 0.0 0
M  V30 5 F 6.1265 2.4283 0.0 0
M  V30 6 F 7.6665 3.9683 0.0 0
M  V30 7 F 6.1265 5.5083 0.0 0
M  V30 8 O 3.0203 7.6326 0.0 0
M  V30 9 C 4.5865 3.9683 0.0 0
M  V30 10 C 3.0800 3.6481 0.0 0
M  V30 11 O 4.7474 5.4999 0.0 0
M  V30 12 C 2.3100 4.9818 0.0 0
M  V30 13 C 2.3100 2.3145 0.0 0
M  V30 14 C 3.3406 6.1263 0.0 0
M  V30 15 C 0.7700 4.9818 0.0 0
M  V30 16 C 0.7700 2.3145 0.0 0
M  V30 17 C 0.0000 3.6481 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 9
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-hydroxy-2-methyl-3-(trifluoromethyl)-1H-isoindol-1-one
C10H8F3NO2
2259648-13-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 3.6643 0.0 0
M  V30 2 F 1.5400 2.1243 0.0 0
M  V30 3 F 0.0000 3.6643 0.0 0
M  V30 4 F 1.5400 5.2043 0.0 0
M  V30 5 O 2.9191 5.1960 0.0 0
M  V30 6 C 1.5854 1.3627 0.0 0
M  V30 7 O 4.6462 0.0000 0.0 0
M  V30 8 C 4.5864 3.9844 0.0 0
M  V30 9 C 3.0800 3.6643 0.0 0
M  V30 10 C 5.3564 2.6508 0.0 0
M  V30 11 C 5.3564 5.3182 0.0 0
M  V30 12 N 2.9191 2.1327 0.0 0
M  V30 13 C 4.3259 1.5064 0.0 0
M  V30 14 C 6.8964 2.6508 0.0 0
M  V30 15 C 6.8964 5.3182 0.0 0
M  V30 16 C 7.6664 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2254545-23-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2259648-13-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30894451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Divergent pathways for reactions of CF3-containing Isobenzofuran-1-ones
and amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mitobe, Kana; Kawasaki-Takasuka, Tomoko; Agou, Tomohiro; Kubota, Toshio;
Yamazaki, Takashi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2019), 21836-41

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Phenylmethyl 4-(acetylthio)cyclohexanecarboxylate
C16H20O3S
2260787-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 S 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 14.6707 4.6201 0.0 0
M  V30 8 O 13.3370 2.3101 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0
M  V30 10 C 8.0022 3.8501 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 10.6697 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 C 1.3337 1.5400 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 0.0000 2.3101 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[(methylamino)sulfonyl]cyclohexanecarboxylate
C15H21NO4S
2260787-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0010 1.5400 0.0 0
M  V30 5 S 12.0033 4.6201 0.0 0 VAL=6
M  V30 6 N 13.3370 5.3901 0.0 0
M  V30 7 O 11.2333 5.9538 0.0 0
M  V30 8 O 12.7733 3.2864 0.0 0
M  V30 9 C 14.6707 4.6201 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 10.6697 2.3101 0.0 0
M  V30 14 C 9.3358 4.6201 0.0 0
M  V30 15 C 10.6697 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 0.0000 2.3101 0.0 0
M  V30 21 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 5 15
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2260787-68-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2260787-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27210039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128-09-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryldihydropyrimidine derivatives and methods of
treating hepatitis B infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wan, Zhao-Kui; Jiang, Yimin; Dai, Xuedong; Liu, Qian; Cheung, Wing Shun;
Deng, Gang; Fu, Liqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019001420 A1 2019-01-03

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-5-(4-morpholinyl)-2-nitrobenzenamine
C10H12FN3O3
2306425-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.3101 0.0000 0.0 0
M  V30 2 N 2.3101 5.3350 0.0 0
M  V30 3 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 4 O 0.0000 4.0012 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 5.3901 2.6675 0.0 0
M  V30 7 C 4.6201 1.3338 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 3.0801 1.3338 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 7.7002 1.3338 0.0 0
M  V30 15 C 9.2402 4.0012 0.0 0
M  V30 16 C 9.2402 1.3338 0.0 0
M  V30 17 O 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-Methyl-5-(4-morpholinyl)-2-nitro-1,3-benzenediamine
C11H16N4O3
2306425-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 N 2.3101 6.6687 0.0 0
M  V30 4 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 O 0.0000 2.6675 0.0 0
M  V30 7 C 5.3901 4.0012 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 3.0801 2.6675 0.0 0
M  V30 11 C 3.0801 5.3348 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 N 6.9302 4.0012 0.0 0
M  V30 14 C 7.7002 2.6675 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 9.2402 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 O 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2306425-43-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2306425-54-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20254760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Structural Investigation of Some Electron-Rich
Nitroaromatics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM White, Jonathan M.; Skene, Colin E.; Deadman, John; Epa, Ruwan;
Foenander, Sarah; Hamer, Kyle; Fellowes, Thomas; Lim, Shea Fern;
Marcuccio, Sebastian M.; Martin, Roger F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2019), 72(4), 311-327

$RFMT $RIREG SCHEME61 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-butynoate
C5H6O2
23326-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 3.8500 1.3336 0.0 0
M  V30 3 O 1.5400 2.6673 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 5.3900 1.3336 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3,6-dimethyl-2-thioxo-4H-1,3-thiazin-4-one
C6H7NOS2
2200249-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6674 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 S 1.5400 5.3349 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 N 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 S 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 6
M  V30 3 2 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 23326-27-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2200249-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18520260
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-mediated three-component reaction "on-water" protocol for the
synthesis of novel mono- and bis-1,3-thiazin-4-one derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arafa, Wael A. A.; Mohamed, Ashraf M.; Abdel-Magied, Ahmed F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2017), 94(8), 1439-1455

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylbenzenecarbothioamide
C8H9NS
2362-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 0.0000 0.0 0
M  V30 3 S 0.0000 2.6673 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,4-Dimethylbenzenecarbothioamide
C9H11NS
62926-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 S 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2362-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 62926-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-8759029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
N-methylthioamide 6. Primary thioamide 5 (0.005 mol) was dissolved in 33%
methylamine in absolute ethanol (10 mL) and the solution allowed to stand
for three days at room temperature until the substrate was consumed, as
followed by TLC, and then the solution was concentrated in vacuo. The
oily residue was solidified upon treatment of ice-water or keeping the
flask in the refrigerator until encrustation occurred to give pure sample
6. It can be also purified by column chromatography on silica gel
(100-200 mesh, 18:1 chloroform-methanol) and recrystallized from aqueous
isopropanol. Considerable recovery of starting material 5a was observed
when the reaction was carried out in 33% dimethylamine in absolute
ethanol under conditions analogous to those used above.
(N-Methyl(thio-p-toluamide) (6b). 94%. mp 53-55 °C (lit. [26] 55 °C); IR
v (cm-1): 3309, 2952, 2924, 2855, 1608, 1540, 1506, 1443, 1406, 1377,
1355, 1349, 1315, 1286,1242; 1H NMR δ (ppm): 2.33 (s, 3H, CH3), 3.14 (d,
3H, J = 4.7 Hz, NCH3), 7.22 (d, 2H, J = 8.2 Hz),7.72 (d, 2H, J = 8.2 Hz),
10.19(brs, 1H, NH), 13C NMR δ (ppm): 20.8, 33.4, 127.1, 128.5, 138.0,
140.6, 197.1; LRMS (EI): 165 (100), 164 (61), 150 (14), 135 (62), 132
(20); HRMS (EI): M+•, found 165.0625. C9H11NS requires 165.0612.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient syntheses of N-methylthioamides: a migration of the H2S
molecule in the thioamide-nitrile system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spychala, Jaroslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Sulfur Chemistry (2006), 27(3), 203-212

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Chloro-3-nitrophenyl)cyclopropanecarboxylic acid
C10H8ClNO4
236418-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6585 2.7197 0.0 0
M  V30 2 O 9.1752 2.4523 0.0 0
M  V30 3 O 7.1317 4.1668 0.0 0
M  V30 4 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 Cl 1.3338 4.6201 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 7.6585 0.3604 0.0 0
M  V30 10 C 6.1418 0.0929 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 15 C 4.0011 4.6201 0.0 0
M  V30 16 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(Methylamino)-3-nitrophenyl]cyclopropanecarboxylic acid
C11H12N2O4
236418-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6585 3.4404 0.0 0
M  V30 2 O 7.1316 1.9932 0.0 0
M  V30 3 O 9.1751 3.7077 0.0 0
M  V30 4 N 1.3338 4.6200 0.0 0 VAL=5
M  V30 5 O 1.3338 6.1600 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 N 1.3338 1.5400 0.0 0
M  V30 8 C 1.3338 0.0000 0.0 0
M  V30 9 C 6.6686 4.6200 0.0 0
M  V30 10 C 7.6585 5.7997 0.0 0
M  V30 11 C 6.1417 6.0672 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3348 2.3100 0.0 0
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 17 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 236418-11-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 236418-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14533917
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as
novel, potent antithrombotic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ries, Uwe J.; Priepke, Henning W. M.; Hauel, Norbert H.; Handschuh,
Sandra; Mihm, Gerhard; Stassen, Jean M.; Wienen, Wolfgang; Nar, Herbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(14), 2297-2302

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5:4,6-bis-O-[(3,4-dimethylphenyl)methylene]-L-gulonate
C25H30O7
2376619-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 O 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,5:4,6-Bis-O-[(3,4-dimethylphenyl)methylene]-N-methyl-L-gulonamide
C25H31NO6
2376620-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 N 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21725668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nucleating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179773 A1 2019-09-26

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5:4,6-bis-O-[(3,4-dimethylphenyl)methylene]-L-gulonate
C25H30O7
2376619-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 O 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,5:4,6-Bis-O-[(3,4-dimethylphenyl)methylene]-N-methyl-L-gulonamide
C25H31NO6
2376620-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 N 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21780030
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179774 A1 2019-09-26

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5:4,6-bis-O-[(3,4-dimethylphenyl)methylene]-L-gulonate
C25H30O7
2376619-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 O 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,5:4,6-Bis-O-[(3,4-dimethylphenyl)methylene]-N-methyl-L-gulonamide
C25H31NO6
2376620-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 N 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21938142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543286 A1 2019-09-25

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5:4,6-bis-O-[(3,4-dimethylphenyl)methylene]-L-gulonate
C25H30O7
2376619-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 O 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3,5:4,6-Bis-O-[(3,4-dimethylphenyl)methylene]-N-methyl-L-gulonamide
C25H31NO6
2376620-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5073 3.4963 0.0 0 CFG=2
M  V30 2 C 8.3277 2.5064 0.0 0
M  V30 3 O 10.9545 2.9696 0.0 0
M  V30 4 N 8.5952 0.9898 0.0 0
M  V30 5 O 6.8806 3.0332 0.0 0
M  V30 6 C 7.4154 0.0000 0.0 0
M  V30 7 C 1.5400 10.3476 0.0 0
M  V30 8 C 16.1700 9.0139 0.0 0
M  V30 9 C 0.0000 7.6803 0.0 0
M  V30 10 C 17.7100 6.3466 0.0 0
M  V30 11 C 8.4700 6.3466 0.0 0 CFG=1
M  V30 12 C 9.2400 7.6803 0.0 0 CFG=2
M  V30 13 C 9.2400 5.0129 0.0 0 CFG=1
M  V30 14 O 6.9300 6.3466 0.0 0
M  V30 15 O 10.7800 7.6803 0.0 0
M  V30 16 C 8.4700 9.0139 0.0 0
M  V30 17 O 10.7800 5.0129 0.0 0
M  V30 18 C 6.1600 7.6803 0.0 0 CFG=3
M  V30 19 C 11.5500 6.3466 0.0 0 CFG=3
M  V30 20 O 6.9300 9.0139 0.0 0
M  V30 21 C 4.6200 7.6803 0.0 0
M  V30 22 C 3.8500 9.0139 0.0 0
M  V30 23 C 3.8500 6.3466 0.0 0
M  V30 24 C 2.3100 9.0139 0.0 0
M  V30 25 C 2.3100 6.3466 0.0 0
M  V30 26 C 1.5400 7.6803 0.0 0
M  V30 27 C 13.0900 6.3466 0.0 0
M  V30 28 C 13.8600 7.6803 0.0 0
M  V30 29 C 13.8600 5.0129 0.0 0
M  V30 30 C 15.4000 7.6803 0.0 0
M  V30 31 C 15.4000 5.0129 0.0 0
M  V30 32 C 16.1700 6.3466 0.0 0
M  V30 33 H 7.7000 5.0129 0.0 0
M  V30 34 H 10.0100 9.0139 0.0 0
M  V30 35 H 7.7929 4.4862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 24
M  V30 8 1 8 30
M  V30 9 1 9 26
M  V30 10 1 10 32
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 33 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 34 CFG=1
M  V30 18 1 13 17
M  V30 19 1 13 35 CFG=1
M  V30 20 1 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 27
M  V30 27 2 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 2 23 25
M  V30 31 2 24 26
M  V30 32 1 25 26
M  V30 33 2 27 28
M  V30 34 1 27 29
M  V30 35 1 28 30
M  V30 36 2 29 31
M  V30 37 2 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 11 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21831749
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nuclating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543244 A1 2019-09-25

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-[(2-Methoxy-1,3-phenylene)dicarbonyl]bis[2-thiazolidinethione]
C15H14N2O3S4
247039-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.4385 0.7700 0.0 0
M  V30 2 C 5.1048 0.0000 0.0 0
M  V30 3 C 3.7710 2.3100 0.0 0
M  V30 4 O 3.7710 0.7700 0.0 0
M  V30 5 C 9.1060 2.3100 0.0 0
M  V30 6 O 9.1060 0.7700 0.0 0
M  V30 7 S 0.7104 0.9473 0.0 0
M  V30 8 S 12.1666 0.9473 0.0 0
M  V30 9 C 6.4385 2.3100 0.0 0
M  V30 10 C 5.1048 3.0800 0.0 0
M  V30 11 C 7.7722 3.0800 0.0 0
M  V30 12 C 5.1048 4.6201 0.0 0
M  V30 13 C 7.7722 4.6201 0.0 0
M  V30 14 C 6.4385 5.3901 0.0 0
M  V30 15 N 2.4374 3.0800 0.0 0
M  V30 16 C 1.0306 2.4537 0.0 0
M  V30 17 C 2.2765 4.6116 0.0 0
M  V30 18 S 0.0000 3.5981 0.0 0
M  V30 19 C 0.7700 4.9318 0.0 0
M  V30 20 N 10.4396 3.0800 0.0 0
M  V30 21 C 11.8464 2.4537 0.0 0
M  V30 22 C 10.6006 4.6116 0.0 0
M  V30 23 S 12.8770 3.5981 0.0 0
M  V30 24 C 12.1070 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 1 3 15
M  V30 6 2 5 6
M  V30 7 1 5 11
M  V30 8 1 5 20
M  V30 9 2 7 16
M  V30 10 2 8 21
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-3-[(2-thioxo-3-thiazolidinyl)carbonyl]benzamide
C13H14N2O3S2
288099-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 O 3.7711 0.7700 0.0 0
M  V30 3 O 6.4384 0.7700 0.0 0
M  V30 4 C 7.7722 0.0000 0.0 0
M  V30 5 C 9.1059 2.3101 0.0 0
M  V30 6 N 10.4396 3.0801 0.0 0
M  V30 7 O 9.1059 0.7700 0.0 0
M  V30 8 C 11.7732 2.3101 0.0 0
M  V30 9 S 0.7103 0.9473 0.0 0
M  V30 10 C 5.1047 3.0801 0.0 0
M  V30 11 C 6.4384 2.3101 0.0 0
M  V30 12 C 5.1047 4.6201 0.0 0
M  V30 13 C 7.7722 3.0801 0.0 0
M  V30 14 C 6.4384 5.3901 0.0 0
M  V30 15 C 7.7722 4.6201 0.0 0
M  V30 16 N 2.4373 3.0801 0.0 0
M  V30 17 C 1.0304 2.4537 0.0 0
M  V30 18 C 2.2763 4.6116 0.0 0
M  V30 19 S 0.0000 3.5981 0.0 0
M  V30 20 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 6 8
M  V30 10 2 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 247039-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 288099-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-8223883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and photophysical characterization of highly luminescent silica
films doped with substituted 2-hydroxyphthalamide (IAM) terbium complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Armelao, Lidia; Bottaro, Gregorio; Quici, Silvio; Cavazzini, Marco;
Scalera, Chiara; Accorsi, Gianluca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2011), 40(43), 11530-11538

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acridinium, 9-[[(3-carboxypropyl)[(4-methylphenyl)sulfonyl]amino]carbonyl]-10...
C28H27FN2O7S2
2488743-08-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5739 8.0022 0.0 0
M  V30 2 N 11.3439 6.6685 0.0 0
M  V30 3 O 11.3439 9.3360 0.0 0
M  V30 4 S 12.8839 6.6685 0.0 0 VAL=6
M  V30 5 C 10.5739 5.3348 0.0 0
M  V30 6 O 12.8839 8.2085 0.0 0
M  V30 7 O 12.8839 5.1285 0.0 0
M  V30 8 C 11.3439 4.0012 0.0 0
M  V30 9 C 10.5739 2.6673 0.0 0
M  V30 10 C 11.3439 1.3337 0.0 0
M  V30 11 O 10.5739 0.0000 0.0 0 CHG=-1
M  V30 12 O 12.8839 1.3337 0.0 0
M  V30 13 C 4.4137 8.0022 0.0 0
M  V30 14 C 3.6437 9.3360 0.0 0
M  V30 15 C 2.1037 9.3360 0.0 0
M  V30 16 S 1.3337 10.6697 0.0 0 VAL=6
M  V30 17 F 0.5637 12.0033 0.0 0
M  V30 18 O 0.0000 9.8996 0.0 0
M  V30 19 O 2.6673 11.4397 0.0 0
M  V30 20 C 19.0441 6.6685 0.0 0
M  V30 21 C 9.0338 8.0022 0.0 0
M  V30 22 C 8.2638 6.6685 0.0 0
M  V30 23 C 8.2638 9.3360 0.0 0
M  V30 24 C 6.7238 6.6685 0.0 0
M  V30 25 C 9.0338 5.3348 0.0 0
M  V30 26 C 6.7238 9.3360 0.0 0
M  V30 27 C 9.0338 10.6697 0.0 0
M  V30 28 N 5.9538 8.0022 0.0 0 CHG=1 VAL=4
M  V30 29 C 5.9538 5.3348 0.0 0
M  V30 30 C 8.2638 4.0012 0.0 0
M  V30 31 C 5.9538 10.6697 0.0 0
M  V30 32 C 8.2638 12.0033 0.0 0
M  V30 33 C 6.7238 4.0012 0.0 0
M  V30 34 C 6.7238 12.0033 0.0 0
M  V30 35 C 14.4240 6.6685 0.0 0
M  V30 36 C 15.1940 5.3348 0.0 0
M  V30 37 C 15.1940 8.0022 0.0 0
M  V30 38 C 16.7340 5.3348 0.0 0
M  V30 39 C 16.7340 8.0022 0.0 0
M  V30 40 C 17.5040 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 35
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 15 1 13 28
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 16 19
M  V30 21 1 20 40
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 22 25
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 2 25 30
M  V30 31 2 26 28
M  V30 32 1 26 31
M  V30 33 2 27 32
M  V30 34 2 29 33
M  V30 35 1 30 33
M  V30 36 2 31 34
M  V30 37 1 32 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acridinium, 9-[[(3-carboxypropyl)[(4-methylphenyl)sulfonyl]amino]carbonyl]-10...
C29H31N3O7S2
2488743-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4702 8.0022 0.0 0
M  V30 2 N 7.7002 6.6685 0.0 0
M  V30 3 O 7.7002 9.3360 0.0 0
M  V30 4 S 6.1601 6.6685 0.0 0 VAL=6
M  V30 5 C 8.4702 5.3348 0.0 0
M  V30 6 O 6.1601 8.2085 0.0 0
M  V30 7 O 6.1601 5.1285 0.0 0
M  V30 8 C 7.7002 4.0012 0.0 0
M  V30 9 C 8.4702 2.6673 0.0 0
M  V30 10 C 7.7002 1.3337 0.0 0
M  V30 11 O 8.4702 0.0000 0.0 0 CHG=-1
M  V30 12 O 6.1601 1.3337 0.0 0
M  V30 13 C 14.6303 8.0022 0.0 0
M  V30 14 C 15.4003 9.3360 0.0 0
M  V30 15 C 16.9404 9.3360 0.0 0
M  V30 16 S 17.7104 10.6697 0.0 0 VAL=6
M  V30 17 N 18.4804 12.0033 0.0 0
M  V30 18 O 19.0441 9.8996 0.0 0
M  V30 19 O 16.3767 11.4397 0.0 0
M  V30 20 C 20.0204 12.0033 0.0 0
M  V30 21 C 0.0000 6.6685 0.0 0
M  V30 22 C 10.0102 8.0022 0.0 0
M  V30 23 C 10.7802 9.3360 0.0 0
M  V30 24 C 10.7802 6.6685 0.0 0
M  V30 25 C 12.3203 9.3360 0.0 0
M  V30 26 C 10.0102 10.6697 0.0 0
M  V30 27 C 12.3203 6.6685 0.0 0
M  V30 28 C 10.0102 5.3348 0.0 0
M  V30 29 N 13.0903 8.0022 0.0 0 CHG=1 VAL=4
M  V30 30 C 13.0903 10.6697 0.0 0
M  V30 31 C 10.7802 12.0033 0.0 0
M  V30 32 C 13.0903 5.3348 0.0 0
M  V30 33 C 10.7802 4.0012 0.0 0
M  V30 34 C 12.3203 12.0033 0.0 0
M  V30 35 C 12.3203 4.0012 0.0 0
M  V30 36 C 4.6201 6.6685 0.0 0
M  V30 37 C 3.8501 5.3348 0.0 0
M  V30 38 C 3.8501 8.0022 0.0 0
M  V30 39 C 2.3101 5.3348 0.0 0
M  V30 40 C 2.3101 8.0022 0.0 0
M  V30 41 C 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 36
M  V30 9 1 5 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 15 1 13 29
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 21 41
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 23 26
M  V30 27 1 24 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 25 30
M  V30 31 2 26 31
M  V30 32 2 27 29
M  V30 33 1 27 32
M  V30 34 2 28 33
M  V30 35 2 30 34
M  V30 36 1 31 34
M  V30 37 2 32 35
M  V30 38 1 33 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2488743-08-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2488743-14-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24314904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective reaction of bifunctional carboxysulfonic acid systems:
preparation of useful intermediates for chemiluminescent, fluorescent and
UV absorbing bifunctional linkers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haack, Richard A.; Hershberger, Stefan J.; Best, Quinn A.; Swift, Kerry
M.; Tetin, Sergey Y.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2020), 61(40), 152332

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-5-[3-bromo-1-(trifluoromethyl)propyl]pyridine
C9H8Br2F3N
2565623-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1037 4.0012 0.0 0
M  V30 2 C 1.3337 2.6675 0.0 0
M  V30 3 C 1.3337 5.3348 0.0 0
M  V30 4 C 2.1037 1.3338 0.0 0
M  V30 5 F 0.5637 6.6687 0.0 0
M  V30 6 F 0.0000 4.5648 0.0 0
M  V30 7 F 2.6673 6.1048 0.0 0
M  V30 8 Br 1.3337 0.0000 0.0 0
M  V30 9 Br 8.2638 4.0012 0.0 0
M  V30 10 C 3.6437 4.0012 0.0 0
M  V30 11 C 4.4137 2.6675 0.0 0
M  V30 12 C 4.4137 5.3348 0.0 0
M  V30 13 C 5.9538 2.6675 0.0 0
M  V30 14 N 5.9538 5.3348 0.0 0
M  V30 15 C 6.7238 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-γ-(trifluoromethyl)-3-pyridinepropanamine
C10H12BrF3N2
2613239-96-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1037 5.3348 0.0 0
M  V30 2 C 1.3337 4.0011 0.0 0
M  V30 3 C 1.3337 6.6686 0.0 0
M  V30 4 C 2.1037 2.6675 0.0 0
M  V30 5 F 0.5636 8.0022 0.0 0
M  V30 6 F 0.0000 5.8986 0.0 0
M  V30 7 F 2.6673 7.4386 0.0 0
M  V30 8 N 1.3337 1.3337 0.0 0
M  V30 9 C 2.1037 0.0000 0.0 0
M  V30 10 Br 8.2637 5.3348 0.0 0
M  V30 11 C 3.6437 5.3348 0.0 0
M  V30 12 C 4.4137 4.0011 0.0 0
M  V30 13 C 4.4137 6.6686 0.0 0
M  V30 14 C 5.9537 4.0011 0.0 0
M  V30 15 N 5.9537 6.6686 0.0 0
M  V30 16 C 6.7237 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 8 9
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2565623-54-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2613239-96-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23316925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1H-imidazo[4,5-b]pyridin-2(3H)-one derivatives useful as
JAK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rai, Santosh Kumar; Bandgar, Mahadev; Ali, Sazid; Rai, Himanshu; Gunjal,
Amol Pandurang; Patil, Rakesh Iswar; Bapuram, Srinivasa Reddy; Kumar,
Anil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020240586 A1 2020-12-03

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Gemfibrozil
C15H22O3
25812-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 3.8500 0.0 0
M  V30 3 C 6.6684 4.6201 0.0 0
M  V30 4 C 8.0022 3.8500 0.0 0
M  V30 5 C 9.3359 4.6201 0.0 0
M  V30 6 C 10.1059 3.2864 0.0 0
M  V30 7 C 8.5659 5.9537 0.0 0
M  V30 8 C 10.6695 5.3901 0.0 0
M  V30 9 O 11.6459 3.2864 0.0 0
M  V30 10 O 9.3359 1.9526 0.0 0
M  V30 11 C 1.3337 6.1601 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 2.6675 3.8500 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 1.3337 1.5400 0.0 0
M  V30 18 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 11 14
M  V30 12 1 12 17
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,5-Dimethylphenoxy)-N,2,2-trimethylpentanamide
C16H25NO2
1354149-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 C 6.6684 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 C 10.1058 3.2864 0.0 0
M  V30 7 C 8.5658 5.9536 0.0 0
M  V30 8 C 10.6694 5.3900 0.0 0
M  V30 9 N 11.6458 3.2864 0.0 0
M  V30 10 O 9.3358 1.9526 0.0 0
M  V30 11 C 12.4158 1.9526 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 1.3336 4.6200 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3336 1.5400 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 12 15
M  V30 13 1 13 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25812-30-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1354149-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31987986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gemfibrozil derivatives as activators of soluble guanylyl cyclase - A
structure-activity study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gayler, Kevin M.; Quintana, Jeremy M.; Mattke, Jordan; Plunk, Michael A.;
Kostyo, Jessica H.; Karunananthan, Johann W.; Nguyen, Harold; Shuda,
Mina; Ferreira, Liam D.; Baker, Hannah; Stinchcomb, Alexandra L.;
Sharina, Iraida; Kane, Robert R.; Martin, Emil
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2021), 224113729

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (1R,5R,6S)-5-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]...
C18H21FN4O3
2736414-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 2.6674 0.0 0
M  V30 2 O 2.1037 2.6674 0.0 0
M  V30 3 O 4.4137 1.3336 0.0 0
M  V30 4 C 1.3336 1.3336 0.0 0
M  V30 5 C 2.6674 0.5636 0.0 0
M  V30 6 C 0.5636 0.0000 0.0 0
M  V30 7 C 0.0000 2.1037 0.0 0
M  V30 8 F 15.9391 4.0071 0.0 0
M  V30 9 C 5.9537 6.6685 0.0 0 CFG=1
M  V30 10 C 6.7237 5.3347 0.0 0 CFG=1
M  V30 11 C 4.4137 6.6685 0.0 0 CFG=2
M  V30 12 O 5.1837 8.0022 0.0 0
M  V30 13 C 5.9537 4.0011 0.0 0
M  V30 14 C 3.6437 5.3347 0.0 0
M  V30 15 N 4.4137 4.0011 0.0 0
M  V30 16 N 8.2637 5.3347 0.0 0
M  V30 17 C 9.1689 4.0889 0.0 0
M  V30 18 N 9.1689 6.5806 0.0 0
M  V30 19 C 10.6336 4.5647 0.0 0
M  V30 20 N 10.6336 6.1047 0.0 0
M  V30 21 C 11.8795 3.6595 0.0 0
M  V30 22 C 13.2863 4.2860 0.0 0
M  V30 23 C 11.7185 2.1280 0.0 0
M  V30 24 C 14.5323 3.3808 0.0 0
M  V30 25 C 12.9644 1.2228 0.0 0
M  V30 26 C 14.3712 1.8492 0.0 0
M  V30 27 H 7.2875 7.4385 0.0 0
M  V30 28 H 3.0800 7.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 24
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 27 CFG=1
M  V30 13 1 10 13
M  V30 14 1 10 16 CFG=1
M  V30 15 1 11 12
M  V30 16 1 11 14
M  V30 17 1 11 28 CFG=1
M  V30 18 1 13 15
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 1 19 21
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3R,4R,5S)-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]...
C19H26FN5O3
2736414-78-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.3110 2.3101 0.0 0
M  V30 2 C 12.6458 5.3901 0.0 0
M  V30 3 O 13.9795 4.6201 0.0 0
M  V30 4 O 12.6458 6.9302 0.0 0
M  V30 5 C 15.3132 5.3901 0.0 0
M  V30 6 C 16.0832 4.0564 0.0 0
M  V30 7 C 16.6468 6.1601 0.0 0
M  V30 8 C 14.5432 6.7238 0.0 0
M  V30 9 N 9.9783 0.7700 0.0 0
M  V30 10 C 11.3120 0.0000 0.0 0
M  V30 11 F 0.0000 8.0781 0.0 0
M  V30 12 C 8.6447 4.6201 0.0 0 CFG=2
M  V30 13 C 9.9783 5.3901 0.0 0
M  V30 14 C 8.6447 3.0801 0.0 0 CFG=1
M  V30 15 N 11.3120 4.6201 0.0 0
M  V30 16 C 9.9783 2.3101 0.0 0 CFG=2
M  V30 17 C 11.3120 3.0801 0.0 0
M  V30 18 N 7.3110 5.3901 0.0 0
M  V30 19 C 5.9040 4.7638 0.0 0
M  V30 20 N 7.1499 6.9217 0.0 0
M  V30 21 C 4.8736 5.9082 0.0 0
M  V30 22 N 5.6436 7.2419 0.0 0
M  V30 23 C 3.3420 5.7473 0.0 0
M  V30 24 C 2.4368 6.9931 0.0 0
M  V30 25 C 2.7155 4.3403 0.0 0
M  V30 26 C 0.9052 6.8322 0.0 0
M  V30 27 C 1.1840 4.1793 0.0 0
M  V30 28 C 0.2787 5.4252 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 16 9 CFG=1
M  V30 11 1 11 26
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18 CFG=1
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2736414-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2736414-78-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24850456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolyl-aminoglycoside carboxamides as small molecule
inhibitors of Galectin-3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jalagam, Prasada Rao; Nair, Satheesh Kesavan; Nara, Susheel Jethanand;
Panda, Manoranjan; Devasthale, Pratik; Regueiro-Ren, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021226002 A1 2021-11-11

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(OC-6-21)-Pentacarbonyl[methoxy(2-methoxyphenyl)methylene]chromium
C14H10CrO7
27436-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6255 2.8449 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1733 4.8159 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4704 2.8449 0.0 0
M  V30 4 C 4.7846 2.8449 0.0 0
M  V30 5 C 7.6255 0.0000 0.0 0
M  V30 6 C 10.0864 1.4224 0.0 0
M  V30 7 C 7.6255 5.6859 0.0 0
M  V30 8 O 4.1733 6.2345 0.0 0
M  V30 9 O 11.8890 2.8449 0.0 0 VAL=3
M  V30 10 O 3.3621 2.8449 0.0 0 VAL=3
M  V30 11 O 9.0480 0.0000 0.0 0 VAL=3
M  V30 12 O 11.5089 1.4224 0.0 0 VAL=3
M  V30 13 O 9.0480 5.6859 0.0 0 VAL=3
M  V30 14 C 2.5157 7.1945 0.0 0
M  V30 15 O 1.6105 6.2972 0.0 0
M  V30 16 C 0.0000 7.2259 0.0 0
M  V30 17 C 2.9428 4.1027 0.0 0
M  V30 18 C 1.6105 4.8747 0.0 0
M  V30 19 C 2.9428 2.5627 0.0 0
M  V30 20 C 0.2704 4.1027 0.0 0
M  V30 21 C 1.6105 1.7908 0.0 0
M  V30 22 C 0.2704 2.5627 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 17
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 18
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[(2-methoxyphenyl)(methylamino)methylene]-, (OC-6-21)-
C14H11CrNO6
332847-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6255 2.8449 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1733 4.8159 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4704 2.8449 0.0 0
M  V30 4 C 4.7846 2.8449 0.0 0
M  V30 5 C 7.6255 0.0000 0.0 0
M  V30 6 C 10.0864 1.4224 0.0 0
M  V30 7 C 7.6255 5.6859 0.0 0
M  V30 8 N 4.1733 6.2345 0.0 0
M  V30 9 O 11.8890 2.8449 0.0 0 VAL=3
M  V30 10 O 3.3621 2.8449 0.0 0 VAL=3
M  V30 11 O 9.0480 0.0000 0.0 0 VAL=3
M  V30 12 O 11.5089 1.4224 0.0 0 VAL=3
M  V30 13 O 9.0480 5.6859 0.0 0 VAL=3
M  V30 14 C 2.5157 7.1945 0.0 0
M  V30 15 O 1.6105 6.2972 0.0 0
M  V30 16 C 0.0000 7.2259 0.0 0
M  V30 17 C 2.9428 4.1027 0.0 0
M  V30 18 C 1.6105 4.8747 0.0 0
M  V30 19 C 2.9428 2.5627 0.0 0
M  V30 20 C 0.2704 4.1027 0.0 0
M  V30 21 C 1.6105 1.7908 0.0 0
M  V30 22 C 0.2704 2.5627 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 17
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 18
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27436-99-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-73-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-3427483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chromium aminocarbene complexes of diterpenoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Woodgate, P. D.; Sutherland, H. S.; Rickard, C. E. F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 626(1-2), 199-220

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(2-Bromo-4,5-dimethoxyphenyl)ethenyl]-4-methoxy-3-(methoxymethoxy)b...
C20H21BrO6
2762491-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 O 4.0010 6.1601 0.0 0
M  V30 4 C 2.6673 6.9301 0.0 0
M  V30 5 O 2.6673 8.4701 0.0 0
M  V30 6 C 1.3337 9.2401 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 O 6.6684 0.0000 0.0 0
M  V30 9 O 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8500 0.0 0
M  V30 11 Br 10.6695 2.3100 0.0 0
M  V30 12 O 10.6695 8.4701 0.0 0
M  V30 13 C 9.3357 9.2401 0.0 0
M  V30 14 O 13.3369 6.9301 0.0 0
M  V30 15 C 14.6705 6.1601 0.0 0
M  V30 16 C 5.3348 3.8500 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 5.3348 2.3100 0.0 0
M  V30 19 C 2.6673 3.8500 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 2.3100 0.0 0
M  V30 22 C 9.3357 4.6201 0.0 0
M  V30 23 C 9.3357 6.1601 0.0 0
M  V30 24 C 10.6695 3.8500 0.0 0
M  V30 25 C 10.6695 6.9301 0.0 0
M  V30 26 C 12.0032 4.6201 0.0 0
M  V30 27 C 12.0032 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 18
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 11 24
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(2-Bromo-4,5-dimethoxyphenyl)ethenyl]-4-methoxy-3-(methoxymethoxy)-...
C21H26BrNO5
2762490-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 O 4.0010 6.9302 0.0 0
M  V30 4 C 2.6673 7.7002 0.0 0
M  V30 5 O 2.6673 9.2402 0.0 0
M  V30 6 C 1.3337 10.0102 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 N 6.6685 0.7700 0.0 0
M  V30 9 C 8.0022 0.0000 0.0 0
M  V30 10 O 1.3337 5.3901 0.0 0
M  V30 11 C 0.0000 4.6201 0.0 0
M  V30 12 Br 10.6697 3.0801 0.0 0
M  V30 13 O 10.6697 9.2402 0.0 0
M  V30 14 C 9.3358 10.0102 0.0 0
M  V30 15 O 13.3370 7.7002 0.0 0
M  V30 16 C 14.6707 6.9302 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0010 5.3901 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 2.3101 0.0 0
M  V30 22 C 2.6673 3.0801 0.0 0
M  V30 23 C 9.3358 5.3901 0.0 0
M  V30 24 C 9.3358 6.9302 0.0 0
M  V30 25 C 10.6697 4.6201 0.0 0
M  V30 26 C 10.6697 7.7002 0.0 0
M  V30 27 C 12.0033 5.3901 0.0 0
M  V30 28 C 12.0033 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 17
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 18
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 19
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 20
M  V30 13 1 12 25
M  V30 14 1 13 14
M  V30 15 1 13 26
M  V30 16 1 15 16
M  V30 17 1 15 28
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2762491-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2762490-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31982440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphazene base-catalyzed hydroamination of aminoalkenes for the
construction of isoindoline scaffolds: Application to the total synthesis
of aristocularine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matsuoka, Junpei; Terashita, Maki; Miyawaki, Akari; Tomioka, Kiyoshi;
Yamamoto, Yasutomo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2022), 89153599

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H20BrDO3
2764777-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 C 9.2400 2.6674 0.0 0
M  V30 4 C 6.9300 1.3338 0.0 0
M  V30 5 O 7.7000 5.3349 0.0 0
M  V30 6 C 10.0100 4.0011 0.0 0
M  V30 7 C 5.5964 2.1038 0.0 0
M  V30 8 C 6.1600 0.0000 0.0 0
M  V30 9 C 8.2636 0.5638 0.0 0
M  V30 10 O 9.2400 5.3349 0.0 0
M  V30 11 O 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 Br 16.1700 4.0011 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 4.6200 2.6674 0.0 0
M  V30 16 C 4.6200 5.3349 0.0 0
M  V30 17 C 3.0800 2.6674 0.0 0
M  V30 18 C 3.0800 5.3349 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 12.3200 5.3349 0.0 0
M  V30 22 C 12.3200 2.6674 0.0 0
M  V30 23 C 13.8600 5.3349 0.0 0
M  V30 24 C 13.8600 2.6674 0.0 0
M  V30 25 C 14.6300 4.0011 0.0 0
M  V30 26 H 10.0100 1.3338 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 14
M  V30 6 1 3 6
M  V30 7 1 3 26
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 4 9
M  V30 11 2 6 10
M  V30 12 1 6 20
M  V30 13 1 11 12
M  V30 14 1 11 19
M  V30 15 1 13 25
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H23BrDNO
2764777-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9242 1.4645 0.0 0
M  V30 2 C 5.8938 0.3202 0.0 0
M  V30 3 C 7.4000 0.0000 0.0 0
M  V30 4 C 8.4305 1.1444 0.0 0
M  V30 5 C 6.9242 6.8857 0.0 0
M  V30 6 O 13.5136 4.1751 0.0 0
M  V30 7 C 14.2836 5.5088 0.0 0
M  V30 8 Br 0.0000 8.5658 0.0 0
M  V30 9 C 7.3535 4.1751 0.0 0
M  V30 10 C 6.4483 2.9292 0.0 0
M  V30 11 N 6.4483 5.4210 0.0 0
M  V30 12 C 4.9836 3.4051 0.0 0
M  V30 13 C 4.9836 4.9451 0.0 0
M  V30 14 C 8.8935 4.1751 0.0 0
M  V30 15 C 9.6635 5.5088 0.0 0
M  V30 16 C 9.6635 2.8415 0.0 0
M  V30 17 C 11.2036 5.5088 0.0 0
M  V30 18 C 11.2036 2.8415 0.0 0
M  V30 19 C 11.9736 4.1751 0.0 0
M  V30 20 C 3.7378 5.8503 0.0 0
M  V30 21 C 2.3310 5.2239 0.0 0
M  V30 22 C 3.8987 7.3819 0.0 0
M  V30 23 C 1.0849 6.1291 0.0 0
M  V30 24 C 2.6528 8.2871 0.0 0
M  V30 25 C 1.2460 7.6608 0.0 0
M  V30 26 H 3.7378 2.4999 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 8 25
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 12 26
M  V30 16 1 13 20
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2764777-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764777-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31588980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convergent Synthesis of 1,4-Dicarbonyl Z-Alkenes through Three-Component
Coupling of Alkynes, α-Diazo Sulfonium Triflate, and Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xuyong; Tong, Wen-Yan; Huang, Bing; Cao, Si; Li, Yunlong; Jiao,
Jingchao; Huang, Hang; Yi, Qiu; Qu, Shuanglin; Wang, Xi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2022), 144(11), 4952-4965

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-7-chloro-N-methylpyrido[2,3-d]pyrimidin-2-amine
C8H6BrClN4
2772658-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 Br 0.0000 0.0000 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 N 5.3348 3.0801 0.0 0
M  V30 8 N 2.6675 3.0801 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 N 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 12
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N2,N7-dimethylpyrido[2,3-d]pyrimidine-2,7-diamine
C9H10BrN5
2772658-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.5400 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 N 8.0023 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 Br 0.0000 4.6201 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 4.0012 3.8501 0.0 0
M  V30 8 N 2.6675 1.5400 0.0 0
M  V30 9 N 5.3348 1.5400 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 N 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2772658-95-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2772658-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32684036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic sulfonamide derivatives as GCN2 and PERK kinase
inhibitors and their preparation, pharmaceutical compositions and use in
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kearney, Patrick; Zwicker, Jeffery; Al-Ani, Gada;
Javed, Salim; Ahn, Yu Mi; Stoltz, Kristen; Lebourdonnec, Bertrand
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022109001 A1 2022-05-27

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2-dihydro-2-oxo-3-pyridinecarboxylate
C8H9NO3
27805-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 N 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 8
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-N-methyl-2-oxo-3-pyridinecarboxamide
C7H8N2O2
7208-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 O 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 N 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 5 7
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27805-12-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 7208-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37547050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel
1-((1-Phenyl-1H-1,2,3-triazol-4-yl)methyl)pyridin-2(1H)-one Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keskin, Selbi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(32), e202302133

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromohexyl 4,4-bis[(5Z)-5-octen-1-yloxy]butanoate
C26H47BrO4
2795395-35-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 10.6694 0.0 0
M  V30 2 C 11.5500 12.0032 0.0 0
M  V30 3 O 11.5500 9.3358 0.0 0
M  V30 4 O 13.8600 10.6694 0.0 0
M  V30 5 C 10.0100 12.0032 0.0 0
M  V30 6 C 12.3200 8.0021 0.0 0
M  V30 7 C 14.6300 12.0032 0.0 0
M  V30 8 C 9.2400 13.3369 0.0 0
M  V30 9 C 11.5500 6.6684 0.0 0
M  V30 10 C 16.1700 12.0032 0.0 0
M  V30 11 O 7.7000 13.3369 0.0 0
M  V30 12 O 10.0100 14.6705 0.0 0
M  V30 13 C 12.3200 5.3347 0.0 0
M  V30 14 C 16.9400 13.3369 0.0 0
M  V30 15 C 6.9300 14.6705 0.0 0
M  V30 16 C 11.5500 4.0011 0.0 0
M  V30 17 C 18.4800 13.3369 0.0 0
M  V30 18 C 5.3900 14.6705 0.0 0
M  V30 19 C 12.3200 2.6674 0.0 0
M  V30 20 C 19.2500 14.6705 0.0 0
M  V30 21 C 4.6200 16.0041 0.0 0
M  V30 22 C 11.5500 1.3336 0.0 0
M  V30 23 C 20.7900 14.6705 0.0 0
M  V30 24 C 3.0800 16.0041 0.0 0
M  V30 25 C 10.0100 1.3336 0.0 0
M  V30 26 C 21.5600 13.3369 0.0 0
M  V30 27 C 2.3100 17.3379 0.0 0
M  V30 28 C 9.2400 0.0000 0.0 0
M  V30 29 C 23.1000 13.3369 0.0 0
M  V30 30 C 0.7700 17.3379 0.0 0
M  V30 31 Br 0.0000 18.6716 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 19 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 24 27
M  V30 27 1 25 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)hexyl 4,4-bis[(5Z)-5-octen-1-yloxy]butanoate
C27H51NO4
2795397-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 10.6694 0.0 0
M  V30 2 C 11.5500 12.0032 0.0 0
M  V30 3 O 11.5500 9.3358 0.0 0
M  V30 4 O 9.2400 10.6694 0.0 0
M  V30 5 C 13.0900 12.0032 0.0 0
M  V30 6 C 10.7800 8.0021 0.0 0
M  V30 7 C 8.4700 12.0032 0.0 0
M  V30 8 C 13.8600 13.3369 0.0 0
M  V30 9 C 11.5500 6.6685 0.0 0
M  V30 10 C 6.9300 12.0032 0.0 0
M  V30 11 O 15.4000 13.3369 0.0 0
M  V30 12 O 13.0900 14.6705 0.0 0
M  V30 13 C 10.7800 5.3347 0.0 0
M  V30 14 C 6.1600 13.3369 0.0 0
M  V30 15 C 16.1700 14.6705 0.0 0
M  V30 16 C 11.5500 4.0011 0.0 0
M  V30 17 C 4.6200 13.3369 0.0 0
M  V30 18 C 17.7100 14.6705 0.0 0
M  V30 19 C 10.7800 2.6674 0.0 0
M  V30 20 C 3.8500 14.6705 0.0 0
M  V30 21 C 18.4800 16.0041 0.0 0
M  V30 22 C 11.5500 1.3336 0.0 0
M  V30 23 C 2.3100 14.6705 0.0 0
M  V30 24 C 20.0200 16.0041 0.0 0
M  V30 25 C 13.0900 1.3338 0.0 0
M  V30 26 C 1.5400 13.3369 0.0 0
M  V30 27 C 20.7900 17.3379 0.0 0
M  V30 28 C 13.8600 0.0000 0.0 0
M  V30 29 C 0.0000 13.3369 0.0 0
M  V30 30 C 22.3300 17.3379 0.0 0
M  V30 31 N 23.1000 18.6716 0.0 0
M  V30 32 C 24.6400 18.6716 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 19 22
M  V30 22 2 20 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 1 24 27
M  V30 27 1 25 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 30 31
M  V30 31 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2795395-35-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2795397-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33485140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ester-linked acetals and nanomaterials, especially lipid
nanoparticles, containing them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Patwardhan, Neeraj Narendra; Hamilton, Gregory Lawrence; Sago, Cory Dane;
Shehata, Mina Fawzy; Chhabra, Milloni Balwantkumar; Campbell, Elizabeth
Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022140252 A1 2022-06-30

$RFMT $RIREG SCHEME76 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-(didecylamino)-3-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethy...
C43H76N4O6
2826939-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 18.6784 0.0 0
M  V30 2 N 8.4700 18.6784 0.0 0
M  V30 3 C 13.7944 16.0285 0.0 0
M  V30 4 C 10.7800 20.0120 0.0 0
M  V30 5 C 7.7000 20.0120 0.0 0
M  V30 6 C 7.7000 17.3447 0.0 0
M  V30 7 N 14.8479 13.1342 0.0 0
M  V30 8 O 15.1901 16.6793 0.0 0
M  V30 9 C 12.3200 20.0120 0.0 0
M  V30 10 C 6.1600 20.0120 0.0 0
M  V30 11 N 8.4700 16.0111 0.0 0
M  V30 12 O 6.1600 17.3447 0.0 0
M  V30 13 C 16.3645 12.8669 0.0 0
M  V30 14 C 13.8580 11.9546 0.0 0
M  V30 15 O 13.0900 21.3458 0.0 0
M  V30 16 O 13.0900 18.6784 0.0 0
M  V30 17 N 5.3900 21.3458 0.0 0
M  V30 18 C 7.7000 14.6773 0.0 0
M  V30 19 C 17.3544 14.0465 0.0 0
M  V30 20 C 14.3847 10.5074 0.0 0
M  V30 21 C 12.3200 22.6794 0.0 0
M  V30 22 C 3.8500 21.3458 0.0 0
M  V30 23 C 9.0336 13.9073 0.0 0
M  V30 24 C 6.9300 13.3436 0.0 0
M  V30 25 C 6.3662 15.4473 0.0 0
M  V30 26 C 18.8710 13.7792 0.0 0
M  V30 27 C 13.3948 9.3276 0.0 0
M  V30 28 O 3.0800 22.6794 0.0 0
M  V30 29 O 3.0800 20.0122 0.0 0
M  V30 30 C 19.8609 14.9588 0.0 0
M  V30 31 C 13.9214 7.8805 0.0 0
M  V30 32 C 1.5400 22.6794 0.0 0
M  V30 33 C 21.3775 14.6915 0.0 0
M  V30 34 C 12.9315 6.7009 0.0 0
M  V30 35 C 1.5400 24.2194 0.0 0
M  V30 36 C 0.0000 22.6794 0.0 0
M  V30 37 C 1.5400 21.1394 0.0 0
M  V30 38 C 22.3673 15.8711 0.0 0
M  V30 39 C 13.4584 5.2537 0.0 0
M  V30 40 C 23.8840 15.6037 0.0 0
M  V30 41 C 12.4685 4.0741 0.0 0
M  V30 42 C 24.8738 16.7834 0.0 0
M  V30 43 C 12.9951 2.6269 0.0 0
M  V30 44 C 26.3904 16.5160 0.0 0
M  V30 45 C 12.0052 1.4471 0.0 0
M  V30 46 C 27.3803 17.6957 0.0 0
M  V30 47 C 12.5319 0.0000 0.0 0
M  V30 48 C 13.0900 24.0131 0.0 0
M  V30 49 C 14.6300 24.0131 0.0 0
M  V30 50 C 12.3200 25.3469 0.0 0
M  V30 51 C 15.4000 25.3469 0.0 0
M  V30 52 C 13.0900 26.6805 0.0 0
M  V30 53 C 14.6300 26.6805 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 1 10 17
M  V30 17 1 11 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 17 22
M  V30 22 1 18 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 19 26
M  V30 26 1 20 27
M  V30 27 1 21 48
M  V30 28 1 22 28
M  V30 29 2 22 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 1 32 35
M  V30 36 1 32 36
M  V30 37 1 32 37
M  V30 38 1 33 38
M  V30 39 1 34 39
M  V30 40 1 38 40
M  V30 41 1 39 41
M  V30 42 1 40 42
M  V30 43 1 41 43
M  V30 44 1 42 44
M  V30 45 1 43 45
M  V30 46 1 44 46
M  V30 47 1 45 47
M  V30 48 2 48 49
M  V30 49 1 48 50
M  V30 50 1 49 51
M  V30 51 2 50 52
M  V30 52 2 51 53
M  V30 53 1 52 53
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanediamide, 2-[(2-aminoethyl)[[(1,1-dimethylethyl)amino]carbonyl]amino]-N1...
C32H65N5O3.C2HF3O2
2826939-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 19.0440 0.0 0
M  V30 2 N 5.3348 18.2740 0.0 0
M  V30 3 C 8.0023 18.2740 0.0 0
M  V30 4 C 6.6685 20.5841 0.0 0
M  V30 5 C 4.0012 19.0440 0.0 0
M  V30 6 C 5.3348 16.7340 0.0 0
M  V30 7 N 8.0023 16.7340 0.0 0
M  V30 8 O 9.3360 19.0440 0.0 0
M  V30 9 C 8.0023 21.3541 0.0 0
M  V30 10 N 2.6675 18.2740 0.0 0
M  V30 11 O 4.0012 20.5841 0.0 0
M  V30 12 C 4.0012 15.9640 0.0 0
M  V30 13 C 6.6685 15.9640 0.0 0
M  V30 14 C 9.3360 15.9640 0.0 0
M  V30 15 N 8.0023 22.8941 0.0 0
M  V30 16 O 9.3360 20.5841 0.0 0
M  V30 17 C 1.3337 19.0440 0.0 0
M  V30 18 N 4.0012 14.4239 0.0 0
M  V30 19 C 6.6685 14.4239 0.0 0
M  V30 20 C 10.6697 16.7340 0.0 0
M  V30 21 C 9.3360 23.6641 0.0 0
M  V30 22 C 0.5637 17.7104 0.0 0
M  V30 23 C 0.0000 19.8140 0.0 0
M  V30 24 C 2.1037 20.3777 0.0 0
M  V30 25 C 8.0023 13.6539 0.0 0
M  V30 26 C 12.0033 15.9640 0.0 0
M  V30 27 C 8.0023 12.1139 0.0 0
M  V30 28 C 13.3372 16.7340 0.0 0
M  V30 29 C 9.3360 11.3439 0.0 0
M  V30 30 C 14.6708 15.9640 0.0 0
M  V30 31 C 9.3360 9.8038 0.0 0
M  V30 32 C 16.0045 16.7340 0.0 0
M  V30 33 C 10.6697 9.0338 0.0 0
M  V30 34 C 17.3382 15.9640 0.0 0
M  V30 35 C 10.6697 7.4938 0.0 0
M  V30 36 C 18.6720 16.7340 0.0 0
M  V30 37 C 12.0033 6.7238 0.0 0
M  V30 38 C 20.0057 15.9640 0.0 0
M  V30 39 C 12.0033 5.1837 0.0 0
M  V30 40 C 21.3393 16.7340 0.0 0
M  V30 41 C 10.0028 2.3101 0.0 0
M  V30 42 C 11.3365 1.5400 0.0 0
M  V30 43 F 10.7728 3.6437 0.0 0
M  V30 44 F 8.6692 3.0801 0.0 0
M  V30 45 F 9.2328 0.9764 0.0 0
M  V30 46 O 12.6702 2.3101 0.0 0
M  V30 47 O 11.3365 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 1 10 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 17 24
M  V30 24 1 19 25
M  V30 25 1 20 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 1 37 39
M  V30 39 1 38 40
M  V30 40 1 41 42
M  V30 41 1 41 43
M  V30 42 1 41 44
M  V30 43 1 41 45
M  V30 44 1 42 46
M  V30 45 2 42 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2826939-54-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2826939-57-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33904158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multi-Component Sequential Synthesis of Dihydroorotic Acid-Based
Amphiphilic Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sani, Monica; Bellucci, Maria Cristina; Volonterio, Alessandro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2022), 54(23), 5311-5323

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenylbenzaldehyde
C9H8O
28272-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenyl-N-methylbenzenemethanamine
C10H13N
111783-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28272-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 111783-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2373072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The 2-vinylbenzaldehyde (2.0 g, 15 mmol) was charged to a 100 mL round
bottom flask containing a magnetic stir bar and methanol (15 mL). The
reaction vessel was sealed with a rubber septum and methylamine (11 mL of
a 2.0 M solution in methanol, 22 mmol) was added at room temperature via
syringe. The reaction was stirred for one hour after which it was cooled
to 0°Cand NaBH4 (1.1 g, 29 mmol) was slowly added over ten minutes. The
reaction was allowed to come to room temperature over two hours and water
(50 mL) and CH2Cl2 (50 mL) were added. The organic layer was separated
and the aqueous layer was extracted with CH2 Cl2(2 × 30 mL). The combined
organics were washed with brine (50 mL), dried over MgSO4, filtered, and
concentrated via rotary evaporation. The residue was dried in vacuo to
yield 2.09 g (94%) of a light yellow liquid . 1H NMR (400 MHz, C6D6) δ
7.49- 7.45 (m, 1H, ArH), 7.25- 7.18 (m, 1H, ArH), 7.17- 7.15 (m, 1H,
ArH), 7.14- 7.07 (m, 2H, ArH and CH═CH2), 5.59 (dd, J= 17.5, 1.5, 1H,
CH═CH2), 5.18 (dd, J= 11.0, 1.5, 1H, CH═CH2), 3.55 (s, 2H, ArCH2), 2.21
(s, 3H, NHCH3), 0.56 (s, 1H, NHCH3). 13C{1H} NMR (125 MHz, C6D6) δ
138.38,137.78,135.48,129.86,128.18,127.83, 126.35, 115.62,54.47,36.69.
MS-EI (m/z): 147.1 (M+). HRMS-EI (m/z): calcd for C10H13N, 147.1048;
found, 147.1049.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Group IV olefin polymerization catalysts and polymerization methods
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coates, Geoffrey W.; Edson, Joseph B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010148381 A2 2010-12-23

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenylbenzaldehyde
C9H8O
28272-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethenyl-N-methylbenzenemethanamine
C10H13N
111783-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 1.5400 4.0011 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28272-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 111783-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8992204
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used in first stage
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkene polymerization catalysts bearing tridentate phenoxyamine ligands
with sp3 C donors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Edson, Joseph B.; Keresztes, Ivan; Lobkovsky, Emil B.; Coates, Geoffrey
W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2009), 1(1), 122-130

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphthalic anhydride
C9H6O4
28281-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 O 7.2706 3.9844 0.0 0
M  V30 4 C 8.0406 5.3182 0.0 0
M  V30 5 C 3.4206 2.6508 0.0 0
M  V30 6 C 2.6506 3.9844 0.0 0
M  V30 7 C 2.3902 1.5064 0.0 0
M  V30 8 C 4.9606 2.6508 0.0 0
M  V30 9 C 1.1444 3.6643 0.0 0
M  V30 10 C 3.4206 5.3182 0.0 0
M  V30 11 O 0.9834 2.1327 0.0 0
M  V30 12 C 5.7306 3.9844 0.0 0
M  V30 13 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-2-methyl-1H-isoindole-1,3(2H)-dione
C10H9NO3
63196-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 O 7.9108 4.2506 0.0 0
M  V30 5 C 9.2446 3.4806 0.0 0
M  V30 6 C 3.9099 3.4806 0.0 0
M  V30 7 C 3.9099 1.9406 0.0 0
M  V30 8 C 2.4452 3.9564 0.0 0
M  V30 9 C 5.2435 4.2506 0.0 0
M  V30 10 C 2.4452 1.4647 0.0 0
M  V30 11 C 5.2435 1.1706 0.0 0
M  V30 12 N 1.5400 2.7106 0.0 0
M  V30 13 C 6.5772 3.4806 0.0 0
M  V30 14 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 28281-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63196-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42639428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Building lactams by a driven highly selective and general deoxygenative
hydrogenation of cyclic imides using an alumina-supported AgRe bimetallic
nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lluna-Galan, Carles; Arango-Daza, Juan Camilo; Gomez, Daviel; Concepcion,
Patricia; Sun, Rong; Calvino, Jose J.; Simonelli, Laura; Adam, Rosa;
Cabrero-Antonino, Jose R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2024), 1-48

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4(1H,3H)-Pyrimidinedione, 6-[(3-azidopropyl)amino]-5-bromo-1-(phenylmethyl)-
C14H15BrN6O2
2866140-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 N 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 C 10.0100 6.6685 0.0 0
M  V30 5 C 11.5500 6.6685 0.0 0
M  V30 6 N 12.3200 8.0021 0.0 0
M  V30 7 N 13.8600 8.0021 0.0 0 CHG=1 VAL=4
M  V30 8 N 15.4000 8.0021 0.0 0 CHG=-1
M  V30 9 O 3.0800 2.6674 0.0 0
M  V30 10 Br 9.2400 2.6674 0.0 0
M  V30 11 O 7.7000 0.0000 0.0 0
M  V30 12 N 5.3900 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 4.6200 2.6674 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 N 5.3900 1.3336 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 6.6685 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.7700 6.6685 0.0 0
M  V30 23 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 6 7
M  V30 9 2 7 8
M  V30 10 2 9 14
M  V30 11 1 10 15
M  V30 12 2 11 17
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4(1H,3H)-Pyrimidinedione, 6-[(3-azidopropyl)amino]-5-(methylamino)-1-(pheny...
C15H19N7O2
2866140-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 5.3347 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 10.0100 6.6685 0.0 0
M  V30 4 C 11.5500 6.6685 0.0 0
M  V30 5 N 12.3200 8.0021 0.0 0
M  V30 6 N 13.8600 8.0021 0.0 0 CHG=1 VAL=4
M  V30 7 N 15.4000 8.0021 0.0 0 CHG=-1
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 N 9.2400 2.6674 0.0 0
M  V30 10 C 10.0100 1.3336 0.0 0
M  V30 11 O 3.0800 2.6674 0.0 0
M  V30 12 O 7.7000 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 N 5.3900 4.0011 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 4.6200 2.6674 0.0 0
M  V30 17 C 6.9300 1.3336 0.0 0
M  V30 18 N 5.3900 1.3336 0.0 0
M  V30 19 C 3.0800 5.3347 0.0 0
M  V30 20 C 2.3100 6.6685 0.0 0
M  V30 21 C 2.3100 4.0011 0.0 0
M  V30 22 C 0.7700 6.6685 0.0 0
M  V30 23 C 0.7700 4.0011 0.0 0
M  V30 24 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 6 7
M  V30 8 1 8 14
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 15
M  V30 12 2 11 16
M  V30 13 2 12 17
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2866140-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2866140-35-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32656683
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Next generation Glucose-1-phosphate thymidylyltransferase (RmlA)
inhibitors: An extended SAR study to direct future design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Ganyuan; Alphey, Magnus S.; Tran, Fanny; Pirrie, Lisa; Milbeo,
Pierre; Zhou, Yi; Bickel, Jasmine K.; Kempf, Oxana; Kempf, Karl;
Naismith, James H.; Westwood, Nicholas J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2021), 50116477

$RFMT $RIREG SCHEME80 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
2905-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-[(2-fluorophenyl)sulfonyl]-N,2-dimethyl-
C11H12FNO3S
3056449-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 3.0800 0.0 0 VAL=6
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 O 4.7711 1.7464 0.0 0
M  V30 4 O 3.2311 4.4136 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 5.3347 5.3900 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 1.5400 0.0 0
M  V30 9 C 8.0021 5.3900 0.0 0
M  V30 10 C 9.3358 3.0800 0.0 0
M  V30 11 F 1.3336 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 1.3336 3.0800 0.0 0
M  V30 14 C 2.6674 0.7700 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3336 0.0000 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 13
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-21-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056449-98-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 2-[[(2,3-dihydro-2,2-dimethyl-6-nitro-7-benzofuranyl)oxy]...
C21H22N2O7
2925227-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.9837 0.0 0
M  V30 2 C 6.1600 5.9837 0.0 0
M  V30 3 N 1.5400 5.9837 0.0 0 VAL=5
M  V30 4 O 2.3100 7.3175 0.0 0
M  V30 5 O 0.0000 5.9837 0.0 0
M  V30 6 C 6.7632 0.0000 0.0 0
M  V30 7 C 7.7936 1.7849 0.0 0
M  V30 8 C 9.2400 5.9837 0.0 0
M  V30 9 C 8.4700 4.6500 0.0 0
M  V30 10 N 10.7800 5.9837 0.0 0
M  V30 11 O 9.2400 3.3164 0.0 0
M  V30 12 O 6.9300 4.6500 0.0 0
M  V30 13 O 11.5500 7.3175 0.0 0
M  V30 14 C 10.7800 3.3164 0.0 0
M  V30 15 C 13.0900 7.3175 0.0 0
M  V30 16 C 4.6200 3.3164 0.0 0
M  V30 17 C 3.8500 4.6500 0.0 0
M  V30 18 C 3.8500 1.9828 0.0 0
M  V30 19 O 6.1263 2.9962 0.0 0
M  V30 20 C 2.3100 4.6500 0.0 0
M  V30 21 C 2.3100 1.9828 0.0 0
M  V30 22 C 4.8804 0.8382 0.0 0
M  V30 23 C 6.2874 1.4645 0.0 0
M  V30 24 C 1.5400 3.3164 0.0 0
M  V30 25 C 6.9300 7.3175 0.0 0
M  V30 26 C 8.4700 7.3175 0.0 0
M  V30 27 C 6.1600 8.6511 0.0 0
M  V30 28 C 9.2400 8.6511 0.0 0
M  V30 29 C 6.9300 9.9847 0.0 0
M  V30 30 C 8.4700 9.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 25
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 20
M  V30 7 1 6 23
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 2-[[(2,3-dihydro-2,2-dimethyl-6-nitro-7-benzofuranyl)oxy]me...
C21H23N3O6
2925227-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 5.9837 0.0 0
M  V30 2 C 6.1600 5.9837 0.0 0
M  V30 3 N 1.5400 5.9837 0.0 0 VAL=5
M  V30 4 O 2.3100 7.3175 0.0 0
M  V30 5 O 0.0000 5.9837 0.0 0
M  V30 6 C 6.7632 0.0000 0.0 0
M  V30 7 C 7.7936 1.7849 0.0 0
M  V30 8 C 9.2400 5.9837 0.0 0
M  V30 9 C 8.4700 4.6500 0.0 0
M  V30 10 N 10.7800 5.9837 0.0 0
M  V30 11 N 9.2400 3.3164 0.0 0
M  V30 12 O 6.9300 4.6500 0.0 0
M  V30 13 O 11.5500 7.3175 0.0 0
M  V30 14 C 10.7800 3.3164 0.0 0
M  V30 15 C 13.0900 7.3175 0.0 0
M  V30 16 C 4.6200 3.3164 0.0 0
M  V30 17 C 3.8500 4.6500 0.0 0
M  V30 18 C 3.8500 1.9828 0.0 0
M  V30 19 O 6.1263 2.9962 0.0 0
M  V30 20 C 2.3100 4.6500 0.0 0
M  V30 21 C 2.3100 1.9828 0.0 0
M  V30 22 C 4.8804 0.8382 0.0 0
M  V30 23 C 6.2874 1.4645 0.0 0
M  V30 24 C 1.5400 3.3164 0.0 0
M  V30 25 C 6.9300 7.3175 0.0 0
M  V30 26 C 8.4700 7.3175 0.0 0
M  V30 27 C 6.1600 8.6511 0.0 0
M  V30 28 C 9.2400 8.6511 0.0 0
M  V30 29 C 6.9300 9.9847 0.0 0
M  V30 30 C 8.4700 9.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 25
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 20
M  V30 7 1 6 23
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 2 20 24
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925227-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925227-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-1,2,4-Triazole, 3-[bromo(3-bromophenyl)methyl]-4-methyl-
C10H9Br2N3
2925236-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 Br 3.7711 0.0000 0.0 0
M  V30 3 Br 9.1059 1.5400 0.0 0
M  V30 4 C 0.7103 0.1773 0.0 0
M  V30 5 C 5.1047 2.3100 0.0 0
M  V30 6 C 6.4385 1.5400 0.0 0
M  V30 7 C 5.1047 3.8501 0.0 0
M  V30 8 C 7.7722 2.3100 0.0 0
M  V30 9 C 6.4385 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 C 2.4374 2.3100 0.0 0
M  V30 12 N 1.0304 1.6837 0.0 0
M  V30 13 N 2.2763 3.8416 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 15 N 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 8
M  V30 5 1 4 12
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3-Bromophenyl)-N,4-dimethyl-4H-1,2,4-triazole-3-methanamine
C11H13BrN4
1856323-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.3101 0.0 0
M  V30 2 N 3.7711 0.7700 0.0 0
M  V30 3 C 5.1048 0.0000 0.0 0
M  V30 4 C 0.7103 0.9473 0.0 0
M  V30 5 Br 9.1059 2.3101 0.0 0
M  V30 6 C 5.1048 3.0801 0.0 0
M  V30 7 C 6.4386 2.3101 0.0 0
M  V30 8 C 5.1048 4.6201 0.0 0
M  V30 9 C 7.7722 3.0801 0.0 0
M  V30 10 C 6.4386 5.3901 0.0 0
M  V30 11 C 7.7722 4.6201 0.0 0
M  V30 12 C 2.4374 3.0801 0.0 0
M  V30 13 N 1.0304 2.4537 0.0 0
M  V30 14 N 2.2763 4.6116 0.0 0
M  V30 15 C 0.0000 3.5981 0.0 0
M  V30 16 N 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 1 4 13
M  V30 6 1 5 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925236-53-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1856323-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36854283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of isoindolinone lactams as selective cbl-b inhibitors over
c-cbl treating cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huestis, Malcolm; Lambrecht, Michael John; Liang, Jun; Ung, Man Un; Wang,
Xiaojing; Zbieg, Jason Robert; Zhu, Bing-Yan; Barton, Lisa Marie;
Broccatelli, Fabio; Castanedo, Georgette Marie; Jakalian, Araz;
Larouche-Gauthier, Robin; Yadav, Arun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023081853 A1 2023-05-11

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-(1,3-benzodioxol-5-yl)-1-(3-oxetanyl)-
C12H12O4
2933196-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3710 1.4876 0.0 0
M  V30 2 C 7.7046 2.2576 0.0 0
M  V30 3 O 7.7046 3.7976 0.0 0
M  V30 4 C 2.3699 3.7976 0.0 0
M  V30 5 C 2.3699 2.2576 0.0 0
M  V30 6 C 3.7036 4.5676 0.0 0
M  V30 7 O 0.9052 4.2735 0.0 0
M  V30 8 C 3.7036 1.4876 0.0 0
M  V30 9 O 0.9052 1.7816 0.0 0
M  V30 10 C 5.0372 3.7976 0.0 0
M  V30 11 C 0.0000 3.0276 0.0 0
M  V30 12 C 5.0372 2.2576 0.0 0
M  V30 13 C 9.0383 1.4876 0.0 0
M  V30 14 C 10.5258 1.8862 0.0 0
M  V30 15 C 9.4368 0.0000 0.0 0
M  V30 16 O 10.9245 0.3987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-ethanamine, N-methyl-α-3-oxetanyl-
C13H17NO3
2933194-27-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5535 1.4876 0.0 0
M  V30 2 C 3.2198 2.2576 0.0 0
M  V30 3 N 3.2198 3.7977 0.0 0
M  V30 4 C 1.8862 4.5677 0.0 0
M  V30 5 C 8.5546 2.2576 0.0 0
M  V30 6 C 8.5546 3.7977 0.0 0
M  V30 7 C 7.2209 1.4876 0.0 0
M  V30 8 O 10.0193 1.7816 0.0 0
M  V30 9 C 7.2209 4.5677 0.0 0
M  V30 10 O 10.0193 4.2735 0.0 0
M  V30 11 C 5.8873 2.2576 0.0 0
M  V30 12 C 10.9245 3.0277 0.0 0
M  V30 13 C 5.8873 3.7977 0.0 0
M  V30 14 C 1.8862 1.4876 0.0 0
M  V30 15 C 1.4876 0.0000 0.0 0
M  V30 16 C 0.3987 1.8862 0.0 0
M  V30 17 O 0.0000 0.3987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2933196-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2933194-27-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36957476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel in stage 1,molecular sieves used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analogues of 3,4-methylenedioxymethamphetamine for modulating SERT, DAT,
and or NET activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pullella, Glenn; Gandy, Michael; Scaffidi, Adrian; King, Jasmine;
Piggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023092195 A1 2023-06-01

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Pyridinone, 1-[(2-chloro-4-pyrimidinyl)methyl]-4-[7-fluoro-1-[4-(triflu...
C24H14ClF4N5O
2972599-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.4457 0.8242 0.0 0
M  V30 2 C 1.5316 4.5867 0.0 0
M  V30 3 F 1.6925 6.1182 0.0 0
M  V30 4 F 0.0000 4.7478 0.0 0
M  V30 5 F 1.3705 3.0551 0.0 0
M  V30 6 O 12.7627 9.0810 0.0 0
M  V30 7 C 15.4301 7.5409 0.0 0
M  V30 8 Cl 20.7649 7.5409 0.0 0
M  V30 9 N 7.6580 3.9428 0.0 0
M  V30 10 C 8.4280 2.6091 0.0 0
M  V30 11 N 8.6884 5.0873 0.0 0
M  V30 12 C 9.9343 2.9293 0.0 0
M  V30 13 C 7.9520 1.1444 0.0 0
M  V30 14 C 10.0952 4.4609 0.0 0
M  V30 15 C 10.9647 1.7849 0.0 0
M  V30 16 C 8.9826 0.0000 0.0 0
M  V30 17 C 10.4889 0.3202 0.0 0
M  V30 18 C 6.1263 4.1037 0.0 0
M  V30 19 C 5.4999 5.5107 0.0 0
M  V30 20 C 5.2212 2.8578 0.0 0
M  V30 21 C 3.9684 5.6716 0.0 0
M  V30 22 C 3.6895 3.0189 0.0 0
M  V30 23 C 3.0631 4.4257 0.0 0
M  V30 24 C 11.4291 5.2309 0.0 0
M  V30 25 C 11.4291 6.7709 0.0 0
M  V30 26 C 12.7627 4.4609 0.0 0
M  V30 27 C 12.7627 7.5409 0.0 0
M  V30 28 C 14.0964 5.2309 0.0 0
M  V30 29 N 14.0964 6.7709 0.0 0
M  V30 30 C 16.7639 6.7709 0.0 0
M  V30 31 N 18.0976 7.5409 0.0 0
M  V30 32 C 16.7639 5.2309 0.0 0
M  V30 33 C 19.4312 6.7709 0.0 0
M  V30 34 C 18.0976 4.4609 0.0 0
M  V30 35 N 19.4312 5.2309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 23
M  V30 6 2 6 27
M  V30 7 1 7 29
M  V30 8 1 7 30
M  V30 9 1 8 33
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 18
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 24
M  V30 20 1 15 17
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2(1H)-Pyridinone, 4-[7-fluoro-1-[4-(trifluoromethyl)phenyl]-1H-indazol-3-yl]-...
C25H18F4N6O
2972598-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.4458 0.8242 0.0 0
M  V30 2 C 1.5317 4.5867 0.0 0
M  V30 3 F 1.3706 3.0551 0.0 0
M  V30 4 F 0.0000 4.7478 0.0 0
M  V30 5 F 1.6926 6.1182 0.0 0
M  V30 6 O 12.7628 9.0809 0.0 0
M  V30 7 C 15.4302 7.5409 0.0 0
M  V30 8 N 20.7650 7.5409 0.0 0
M  V30 9 C 22.0988 6.7709 0.0 0
M  V30 10 C 8.4281 2.6091 0.0 0
M  V30 11 N 7.6581 3.9428 0.0 0
M  V30 12 C 9.9344 2.9293 0.0 0
M  V30 13 C 7.9521 1.1444 0.0 0
M  V30 14 N 8.6885 5.0873 0.0 0
M  V30 15 C 10.0954 4.4608 0.0 0
M  V30 16 C 10.9649 1.7849 0.0 0
M  V30 17 C 8.9827 0.0000 0.0 0
M  V30 18 C 10.4890 0.3202 0.0 0
M  V30 19 C 6.1264 4.1037 0.0 0
M  V30 20 C 5.5001 5.5107 0.0 0
M  V30 21 C 5.2212 2.8578 0.0 0
M  V30 22 C 3.9685 5.6716 0.0 0
M  V30 23 C 3.6896 3.0189 0.0 0
M  V30 24 C 3.0633 4.4257 0.0 0
M  V30 25 C 11.4292 5.2309 0.0 0
M  V30 26 C 11.4292 6.7709 0.0 0
M  V30 27 C 12.7628 4.4608 0.0 0
M  V30 28 C 12.7628 7.5409 0.0 0
M  V30 29 C 14.0965 5.2309 0.0 0
M  V30 30 N 14.0965 6.7709 0.0 0
M  V30 31 C 16.7640 6.7709 0.0 0
M  V30 32 N 18.0977 7.5409 0.0 0
M  V30 33 C 16.7640 5.2309 0.0 0
M  V30 34 C 19.4313 6.7709 0.0 0
M  V30 35 C 18.0977 4.4608 0.0 0
M  V30 36 N 19.4313 5.2309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 24
M  V30 6 2 6 28
M  V30 7 1 7 30
M  V30 8 1 7 31
M  V30 9 1 8 9
M  V30 10 1 8 34
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 19
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 15
M  V30 20 1 15 25
M  V30 21 1 16 18
M  V30 22 2 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2972599-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2972598-95-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37800532
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazole derivatives for the treatment of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Qiangang; Gao, Zhenting; Zeng, Qinglong; Li, Jing; Xu, Ming;
Zhong, Xiaofeng; Guo, Xin; Zhu, Jidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023151560 A1 2023-08-17

$RFMT $RIREG SCHEME85 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzenesulfonyl chloride
C7H4ClF3O2S
2991-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 6 Cl 9.2400 1.5400 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 O 7.7000 3.0800 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-[[4-(trifluoromethyl)phenyl]sulfonyl]-2-propenamide
C12H12F3NO3S
1620220-78-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 F 10.7800 1.1273 0.0 0
M  V30 13 F 12.3200 2.6673 0.0 0
M  V30 14 F 10.7800 4.2073 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 8.4700 1.3336 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2991-42-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620220-78-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C10H13ClN2O2
3027135-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 6.1600 5.3347 0.0 0 CFG=1
M  V30 3 C 6.9300 6.6685 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 8.4700 6.6685 0.0 0
M  V30 6 C 1.5400 5.3347 0.0 0
M  V30 7 O 2.3100 6.6685 0.0 0
M  V30 8 O 0.0000 5.3347 0.0 0
M  V30 9 Cl 4.6200 0.0000 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0
M  V30 15 N 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarboxamide, 6-chloro-N-methyl-4-[[(1S)-1-methylpropyl]amino]-
C11H16ClN3O
3027135-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 N 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0 CFG=1
M  V30 7 C 7.7000 6.6685 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 Cl 5.3900 0.0000 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 4.6200 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 N 3.0800 1.3338 0.0 0
M  V30 16 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3027135-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3027135-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39080796
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, activity, and their relationships of 2,4-diaminonicotinamide
derivatives as EGFR inhibitors targeting C797S mutation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kageji, Hideaki; Momose, Takayuki; Nagamoto, Yasuhito; Togashi, Noriko;
Yasumatsu, Isao; Nishikawa, Yosuke; Kihara, Kawori; Hiramoto, Kumiko;
Minami, Megumi; Kasanuki, Naomi; Isoyama, Takeshi; Naito, Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2024), 98129575

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Imidazole-4-carboxaldehyde
C4H4N2O
3034-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 O 5.1049 1.8517 0.0 0
M  V30 3 C 2.4374 1.8517 0.0 0
M  V30 4 C 2.2765 0.3202 0.0 0
M  V30 5 N 1.0306 2.4782 0.0 0
M  V30 6 N 0.7700 0.0000 0.0 0
M  V30 7 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1H-Imidazol-5-ylmethylene)methanamine
C5H7N3
1374674-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1049 1.8517 0.0 0
M  V30 3 C 6.4386 2.6217 0.0 0
M  V30 4 C 2.4374 1.8517 0.0 0
M  V30 5 C 2.2765 0.3202 0.0 0
M  V30 6 N 1.0306 2.4782 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 4
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3034-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374674-33-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-890488
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of N-methyl-1-(4-imidazolyl) methanimine (HL). A methanol
solution (15.0 mL) of methylamine (0.310 g, 10.0 mmol) was added to a
methanol solution (35.0 mL) of 4-formylimidazole (0.998 g, 10.4 mmol).
The mixture was stirred for 5 h at 50°C. A product was obtained by
evaporation under reduced pressure. N-methyl-1-(4-imidazolyl) methanimine
(HL) as a light-yellow powder, yield 1.064 g, 94%. 1H NMR (400 MHz,
DMSO-d6): 8.26 (s, 1H), 7.76 (s, 1H) 7.44 (s, 1H), 3.41-3.40 (d, 3H). 13C
NMR (100 MHz, DMSO-d6): 55.9, 125.05, 131.1, 137.1, 153.9. MS: m/z Calcd
for C5H8N3 ([M+H]+) 110.1, found 110.1. CHN analysis found: C 54.17, H,
6.089, N 36.83%. IR (KBr disk, cm-1): 3134.6w, 2948.4w, 2885.3w, 2776.2m,
1658.3s, 1438.2w, 1089.0w, 1010.8w, 969.5m, 848.6w, 806.6w, 628.8w.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A High-Symmetry Coordination Cage from 38- or 62-Component Self-Assembly
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Xiao-Ping; Liu, Jie; Zhan, Shun-Ze; Yang, Ju-Rong; Li, Dan; Ng,
Kwan-Ming; Sun, Raymond Wai-Yin; Che, Chi-Ming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2012), 134(19), 8042-8045

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H20N2O5
3051716-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 6.6684 0.0 0
M  V30 3 C 3.0800 5.3347 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 O 4.6200 8.0021 0.0 0
M  V30 6 O 4.6200 2.6673 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 C 6.7236 2.1036 0.0 0
M  V30 10 C 6.1600 0.0000 0.0 0
M  V30 11 C 4.0564 0.5636 0.0 0
M  V30 12 N 10.0100 9.3358 0.0 0 VAL=5
M  V30 13 O 9.2400 10.6694 0.0 0
M  V30 14 O 11.5500 9.3358 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 3.0800 8.0021 0.0 0
M  V30 23 C 0.7700 6.6684 0.0 0
M  V30 24 C 2.3100 9.3358 0.0 0
M  V30 25 C 0.0000 8.0021 0.0 0
M  V30 26 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 15
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 18
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzamide
C8H8N2O3
3400-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3051716-60-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41165566
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nitrogen-dopedcarbon supportted
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, reusable catalyst,
cobalt supported on nitrogen-doped carbon catalyst prepared and used, no
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of secondary carboxamides and amidation of esters are
facilitated by magnetic Co@NC nanoparticles, as a highly efficient and
recyclable catalyst under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Vishal; Rajput, Khushbu; Mahaur, Priya; Singh, Sundaram;
Srivastava, Vandana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2024), 48(30), 13350-13357

$RFMT $RIREG SCHEME89 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethyl 2,6-bis(4-cyanophenyl)-1-methyl-4-oxo-3,5-piperidinedicarboxylate
C24H21N3O5
306994-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6698 2.3101 0.0 0
M  V30 2 O 10.6698 0.7700 0.0 0
M  V30 3 O 12.0035 3.0801 0.0 0
M  V30 4 C 12.0035 0.0000 0.0 0
M  V30 5 C 8.0023 6.9302 0.0 0
M  V30 6 O 8.0023 0.7700 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 O 5.3348 0.7700 0.0 0
M  V30 9 O 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 14.6708 7.7002 0.0 0
M  V30 12 N 16.0046 8.4702 0.0 0
M  V30 13 C 1.3338 7.7002 0.0 0
M  V30 14 N 0.0000 8.4702 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 3.0801 0.0 0
M  V30 17 N 8.0023 5.3901 0.0 0
M  V30 18 C 8.0023 2.3101 0.0 0
M  V30 19 C 6.6687 4.6201 0.0 0
M  V30 20 C 6.6687 3.0801 0.0 0
M  V30 21 C 10.6698 5.3901 0.0 0
M  V30 22 C 10.6698 6.9302 0.0 0
M  V30 23 C 12.0035 4.6201 0.0 0
M  V30 24 C 12.0035 7.7002 0.0 0
M  V30 25 C 13.3372 5.3901 0.0 0
M  V30 26 C 13.3372 6.9302 0.0 0
M  V30 27 C 5.3348 5.3901 0.0 0
M  V30 28 C 4.0012 4.6201 0.0 0
M  V30 29 C 5.3348 6.9302 0.0 0
M  V30 30 C 2.6675 5.3901 0.0 0
M  V30 31 C 4.0012 7.7002 0.0 0
M  V30 32 C 2.6675 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 2 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 20
M  V30 10 1 8 10
M  V30 11 3 11 12
M  V30 12 1 11 26
M  V30 13 3 13 14
M  V30 14 1 13 32
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 19 27
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,5-Dimethyl (1S,2S,4R,5R)-2,4-bis(4-cyanophenyl)-3,7-dimethyl-9-oxo-3,7-...
C27H26N4O5
306994-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5773 7.2078 0.0 0
M  V30 2 O 1.0903 7.6084 0.0 0
M  V30 3 O 2.9740 5.7197 0.0 0
M  V30 4 C 0.0000 6.5208 0.0 0
M  V30 5 O 5.6352 9.1738 0.0 0
M  V30 6 C 7.6025 7.2064 0.0 0
M  V30 7 C 7.6011 12.2316 0.0 0
M  V30 8 O 7.2006 13.7186 0.0 0
M  V30 9 O 9.0892 11.8349 0.0 0
M  V30 10 C 8.2883 14.8089 0.0 0
M  V30 11 C 2.5787 12.2302 0.0 0
M  V30 12 C 5.0906 1.5400 0.0 0
M  V30 13 N 5.0906 0.0000 0.0 0
M  V30 14 C 13.2689 9.7183 0.0 0
M  V30 15 N 14.8089 9.7183 0.0 0
M  V30 16 C 3.6677 8.2954 0.0 0 CFG=1
M  V30 17 C 5.0906 7.7000 0.0 0 CFG=1
M  V30 18 C 4.5462 10.2627 0.0 0
M  V30 19 C 3.0797 9.7109 0.0 0
M  V30 20 N 6.5136 8.2954 0.0 0
M  V30 21 C 6.5136 11.1413 0.0 0 CFG=1
M  V30 22 N 3.6677 11.1413 0.0 0
M  V30 23 C 7.1089 9.7183 0.0 0 CFG=1
M  V30 24 C 5.0980 11.7293 0.0 0
M  V30 25 C 5.0906 6.1600 0.0 0
M  V30 26 C 3.7570 5.3900 0.0 0
M  V30 27 C 6.4243 5.3900 0.0 0
M  V30 28 C 3.7570 3.8500 0.0 0
M  V30 29 C 6.4243 3.8500 0.0 0
M  V30 30 C 5.0906 3.0800 0.0 0
M  V30 31 C 8.6489 9.7183 0.0 0
M  V30 32 C 9.4189 8.3847 0.0 0
M  V30 33 C 9.4189 11.0520 0.0 0
M  V30 34 C 10.9589 8.3847 0.0 0
M  V30 35 C 10.9589 11.0520 0.0 0
M  V30 36 C 11.7289 9.7183 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 5 18
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 21
M  V30 10 1 8 10
M  V30 11 1 11 22
M  V30 12 3 12 13
M  V30 13 1 12 30
M  V30 14 3 14 15
M  V30 15 1 14 36
M  V30 16 1 16 17
M  V30 17 1 16 18 CFG=1
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 25 CFG=3
M  V30 21 1 21 18 CFG=1
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 1 22 24
M  V30 27 1 23 31 CFG=3
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 16 17 21 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 306994-57-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 306994-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-15518053
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Synthesis of
2,4-Diaryl-Substituted
1,5-Dialkyl-3,7-dimethyl-3,7-diaza-9-oxobicyclo-[3.3.1]nonane-1,5-dicarboxylates
11-19 (modified after procedures in ref 19). Exactly 0.0025 mol of the
piperidin-4-one was dissolved in 20 mL of methanol by refluxing. To this
solution, was added 0.6 mL of a 35% aqueous solution of HCHO, followed by
0.4 mL of a 40% aqueous solution of methylamine. The mixture was refluxed
for 7-8 min, and afterward it was allowed to stand for 3 h at ambient
temperature. Three different workup procedures were possible. First, the
obtained precipitate was filtered and washed with a mixture of
ethanol/diethyl ether. When no precipitate appeared within 24 h, the
solvent was removed in vacuo at 40-50 °C, and the remaining oil was
dissolved in a small amount of ethanol and diethyl ether. Crystals
usually appeared within 2 days. When no crystals were obtained during
this time, the solvent was removed again, and the remaining oil was
treated with diethyl ether. The raw product can be recrystallized from
ethanol. The perchlorates and oxalates of HZ2 were formed according to
known procedures.20 Entry: 11a Entry: 16a x 1/2 EtOH 1.15g; Yield: 94%
molecular formula: C27H26N4O5, 486.6 mp: 201-203°C elemental analyses
calc: 65.98%C, 5.74%H, 11.00%N found: 65.80%C, 5.34%H, 11.78%N
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Opioid Receptor Affinity of a Series of
2,4-Diaryl-Substituted 3,7-Diazabicyclononanones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Siener, Tom; Cambareri, Antonella; Kuhl, Ulrich; Englberger, Werner;
Haurand, Michael; Koegel, Babette; Holzgrabe, Ulrike
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(20), 3746-3751

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-pyridinecarboxaldehyde
C6H4BrNO
31181-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinemethanamine
C7H9BrN2
915707-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 N 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31181-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915707-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41544746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Four-Coordinate End-On Superoxocopper(II) Complex: Probing the Link
between Coordination Number and Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debnath, Suman; Laxmi, Shoba; McCubbin Stepanic, Olivia; Quek, Sebastian
Y.; van Gastel, Maurice; DeBeer, Serena; Kramer, Tobias; England, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2024), 146(34), 23704-23716

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-pyridinecarboxaldehyde
C6H4BrNO
31181-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinemethanamine
C7H9BrN2
915707-70-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 1.3337 0.0 0
M  V30 2 N 6.9301 2.6673 0.0 0
M  V30 3 C 8.4701 2.6673 0.0 0
M  V30 4 Br 0.0000 1.3337 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 N 3.8500 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 31181-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915707-70-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39857791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A four-coordinate end-on superoxocopper(II) complex: probing the link
between coordination number and reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Debnath, Suman; Laxmi, Shoba; Stepanic, Olivia McCubbin; Quek, Sebastian
Y.; van Gastel, Maurice; DeBeer, Serena; Kramer, Tobias; England, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2023), 1-12

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-3-cyano-5,6,7,8-tetrahydro-4-quinolinecarboxylate
C12H13N3O2
312268-17-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 O 4.6200 1.3336 0.0 0
M  V30 3 O 6.9300 2.6674 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 N 8.4700 5.3347 0.0 0
M  V30 7 N 5.3900 8.0021 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 N 3.0800 6.6685 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 4.6200 6.6685 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 1 7 16
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-6,7,8,9-tetrahydro-2-methyl-1H-pyrrolo[3,4-c]quinoline-1,3(2H)-dione
C12H13N3O2
447454-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0608 6.6519 0.0 0
M  V30 2 O 0.3503 1.9570 0.0 0
M  V30 3 N 3.0012 0.0000 0.0 0
M  V30 4 C 0.0000 5.2891 0.0 0
M  V30 5 C 3.7712 4.0011 0.0 0
M  V30 6 C 3.0012 2.6674 0.0 0
M  V30 7 C 5.3112 4.0011 0.0 0
M  V30 8 C 2.7406 5.1454 0.0 0
M  V30 9 C 1.4947 2.9876 0.0 0
M  V30 10 C 3.7712 1.3336 0.0 0
M  V30 11 C 6.0812 2.6674 0.0 0
M  V30 12 C 6.0812 5.3347 0.0 0
M  V30 13 N 1.3338 4.5191 0.0 0
M  V30 14 N 5.3112 1.3336 0.0 0
M  V30 15 C 7.6212 2.6674 0.0 0
M  V30 16 C 7.6212 5.3347 0.0 0
M  V30 17 C 8.3912 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 312268-17-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 447454-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7220297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6,7-Dialkyl-4-amino-2-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-1,3-diones
(4a-c) (Table 2). A suspension of pyridine 1a-c (1 mmol) in a saturated
solution of methylamine in dioxane (5 ml) was heated at 130°C in a sealed
ampul for 48 h. The end of the reaction was determined by TLC (eluent
ethyl acetate, the compound fluoresces yellow-green on UV irradiation).
After cooling to -10°C the ampul was opened carefully. The contents were
diluted with 1,4-dioxane (5 ml), the yellow solid was filtered off,
washed with 1,4-dioxane (10 ml), and purified by vacuum sublimation or
recrystallization from DMF. The product was dried in a vacuum desiccator
over P2O5. 4a. 1H NMR spectrum, δ, ppm: 1.78 (2H, m, CH2CH2CH2); 1.85
(2H, m, CH2CH2CH2); 2.75 (2H, t, CH2CH2); 2.93 (2H, t, CH2CH2); 2.97 (3H,
s, CH3); 6.50 (2H, s, NH2). mp: 224°C; C12H13N3O2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Interaction of methyl 5,6-dialkyl-2-amino-3-cyanopyridine-4-carboxylates
with primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vasiliev, A. N.; Lyshchikov, A. N.; Nasakin, O. E.; Kayukov, Ya. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United
States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii) (2004),
40(4), 460-464

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(4-hydroxyphenyl)-1H-benzimidazole-7-carboxylate
C15H12N2O3
313279-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0009 0.0 0
M  V30 2 O 0.7700 4.0009 0.0 0
M  V30 3 O 3.0800 5.3347 0.0 0
M  V30 4 C 0.0000 5.3347 0.0 0
M  V30 5 O 12.3921 6.2653 0.0 0
M  V30 6 C 4.6200 2.6673 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 N 5.6504 3.8118 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 N 6.8964 1.6538 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 7.0574 3.1853 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 8.3910 3.9553 0.0 0
M  V30 16 C 9.7246 3.1853 0.0 0
M  V30 17 C 8.3910 5.4953 0.0 0
M  V30 18 C 11.0584 3.9553 0.0 0
M  V30 19 C 9.7246 6.2653 0.0 0
M  V30 20 C 11.0584 5.4953 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Hydroxyphenyl)-1-methyl-1H-benzimidazole-4-carboxamide
C15H13N3O2
313279-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 2.3100 5.3348 0.0 0
M  V30 4 C 7.2709 0.6234 0.0 0
M  V30 5 O 11.6222 6.2654 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 4.6201 1.3337 0.0 0
M  V30 8 N 4.8805 3.8118 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 N 6.1265 1.6538 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 6.2874 3.1854 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 7.6211 3.9554 0.0 0
M  V30 16 C 8.9547 3.1854 0.0 0
M  V30 17 C 7.6211 5.4954 0.0 0
M  V30 18 C 10.2885 3.9554 0.0 0
M  V30 19 C 8.9547 6.2654 0.0 0
M  V30 20 C 10.2885 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313279-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 313279-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14410848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-Hydroxyphenyl)-1H-benzimidazole-4-N-methylcarboxamide (88). Methyl
2-(4'-hydroxyphenyl)-1H-benzimidazole-4-carboxylate (200 mg, 0.75 mmol)
was dissolved in ethanol containing 33% methylamine (10 mL) and stirred
overnight. Removal of solvents, followed by column chromatography
(DCM-7.5% MeOH) yielded an off-white solid, 187 mg, 94% (recrystallized
from DCM-MeOH): mp 289-290 °C; IR 3108, 1614, 1479 cm-1; 1H NMR δ
3.11-3.13 (3 H, d, J = 4.65), 4.22 (1 H, br s), 7.04-7.08 (2 H, d, J =
8.6), 7.35-7.43 (1 H, t), 7.75-7.79 (1 H, d), 7.93-7.97 (1 H, d),
8.21-8.26 (2 H, d, J = 8.6), 9.95-9.97 (1 H, d, J = 4.65), 10.22 (1 H, br
s), 13.25 (1 H, br s); HRMS (EI) m/z 267.1001 [M+ calcd 267.1008 for
C15H13N3O2]. Anal. (C15H13N3O2•H2O) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Resistance-Modifying Agents. 9.Synthesis and Biological Properties of
Benzimidazole Inhibitors of the DNA Repair Enzyme Poly(ADP-ribose)
Polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM White, Alex W.; Almassy, Robert; Calvert, A. Hilary; Curtin, Nicola J.;
Griffin, Roger J.; Hostomsky, Zdenek; Maegley, Karen; Newell, David R.;
Srinivasan, Sheila; Golding, Bernard T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(22), 4084-4097

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,2,3,4-Tetrahydro-1-oxopyrrolo[3,2,1-jk][1,4]benzodiazepin-6-yl)benzaldehyde
C18H14N2O2
328543-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.6499 0.0 0
M  V30 2 C 11.7329 3.1777 0.0 0
M  V30 3 O 13.0666 3.9477 0.0 0
M  V30 4 C 3.9705 2.6610 0.0 0
M  V30 5 N 4.9874 3.8056 0.0 0
M  V30 6 C 4.7274 1.3246 0.0 0
M  V30 7 C 2.4371 2.6887 0.0 0
M  V30 8 C 6.3981 3.1777 0.0 0
M  V30 9 C 4.7030 5.3273 0.0 0
M  V30 10 C 6.2368 1.6466 0.0 0
M  V30 11 C 3.9380 0.0000 0.0 0
M  V30 12 C 1.6481 1.3634 0.0 0
M  V30 13 C 1.5142 3.9311 0.0 0
M  V30 14 C 3.3332 6.0295 0.0 0
M  V30 15 C 2.3981 0.0185 0.0 0
M  V30 16 N 1.9274 5.4134 0.0 0
M  V30 17 C 7.7317 3.9477 0.0 0
M  V30 18 C 9.0654 3.1777 0.0 0
M  V30 19 C 7.7317 5.4878 0.0 0
M  V30 20 C 10.3991 3.9477 0.0 0
M  V30 21 C 9.0654 6.2578 0.0 0
M  V30 22 C 10.3991 5.4878 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 2 8 10
M  V30 14 1 8 17
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6-[3-[(methylamino)methyl]phenyl]pyrrolo[3,2,1-jk][1,4]benzodiaze...
C19H19N3O
328543-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.6499 0.0 0
M  V30 2 C 11.7327 3.1777 0.0 0
M  V30 3 N 13.0666 3.9477 0.0 0
M  V30 4 C 14.4002 3.1777 0.0 0
M  V30 5 C 3.9705 2.6610 0.0 0
M  V30 6 N 4.9874 3.8056 0.0 0
M  V30 7 C 4.7274 1.3246 0.0 0
M  V30 8 C 2.4371 2.6887 0.0 0
M  V30 9 C 6.3979 3.1777 0.0 0
M  V30 10 C 4.7030 5.3273 0.0 0
M  V30 11 C 6.2368 1.6466 0.0 0
M  V30 12 C 3.9379 0.0000 0.0 0
M  V30 13 C 1.6481 1.3634 0.0 0
M  V30 14 C 1.5142 3.9311 0.0 0
M  V30 15 C 3.3332 6.0295 0.0 0
M  V30 16 C 2.3981 0.0185 0.0 0
M  V30 17 N 1.9274 5.4134 0.0 0
M  V30 18 C 7.7317 3.9477 0.0 0
M  V30 19 C 9.0654 3.1777 0.0 0
M  V30 20 C 7.7317 5.4878 0.0 0
M  V30 21 C 10.3991 3.9477 0.0 0
M  V30 22 C 9.0654 6.2578 0.0 0
M  V30 23 C 10.3991 5.4878 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 2 9 11
M  V30 15 1 9 18
M  V30 16 1 10 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 328543-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 328543-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14823439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-85-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
6-(3-Dimethylaminomethyl-phenyl)-3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-one
(20). Dimethylamine (2 M) in methanol (16.34 mmol, 8.2 mL) was added to a
suspension of 55 (1.90 mmol, 0.55 g) in MeOH (110 mL) at room
temperature. The reaction mixture was heated to reflux until the
suspended solids went into solution. The reaction mixture was cooled to
room temperature, and a solution of NaCNBH3 (2.09 mmol, 0.131 g) and
ZnCl2 (1.05 mmol, 0.143 g) in MeOH (55 mL) was slowly added. The pH of
the reaction was adjusted to 3-4 using 2 M methanolic HCl. The reaction
mixture was stirred at room temperature for 2.5 h. Upon completion (TLC),
concentrated HCl was added (pH 1) and the solvent was removed in vacuo.
The residue was diluted with H2O, made basic (pH 12-14) with 50% aqueous
NaOH, and extracted with EtOAc several times. The combined organic layers
were dried over anhydrous MgSO4 and concentrated. The crude mixture was
purified by flash silica gel chromatography eluting with a gradient of
0-7% MeOH in CHCl3 followed by 3-7% MeOH/ NH3 in CHCl3.
6-(3-Methylaminomethyl-phenyl)-3,4-dihydro-2H-[1,4]-diazepino[6,7,1-hi]indol-1-one
(21). Pale yellow solid (94%); mp 128-130 °C. 1H NMR (DMSO-d 6): δ 2.29
(s, 3H), 3.48 (br s, 2H), 3.71 (s, 2H), 4.30-4.33 (m, 2H), 6.69 (s, 1H),
7.17 (t, 1H, J = 9.0 Hz), 7.38-7.39 (m, 1H), 7.44-7.46 (m, 2H), 7.54 (s,
1H), 7.80 (t, 2H, J = 9.0 Hz), 8.39 (t, 1H, J = 6.0 Hz). HRMS calcd for
C19H19N3O (M+), 305.3828; found (M+), 305.1520. Anal. (C19H19N3O•0.6 H2O)
C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Evaluation of
3,4-Dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as Inhibitors of
Poly(ADP-Ribose) Polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tikhe, Jayashree G.; Webber, Stephen E.; Hostomsky, Zdenek; Maegley,
Karen A.; Ekkers, Anne; Li, Jianke; Yu, Xiao-Hong; Almassy, Robert J.;
Kumpf, Robert A.; Boritzki, Theodore J.; Zhang, Cathy; Calabrese, Chris
R.; Curtin, Nicola J.; Kyle, Suzanne; Thomas, Huw D.; Wang, Lan-Zhen;
Calvert, A. Hilary; Golding, Bernard T.; Griffin, Roger J.; Newell, David
R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2004), 47(22), 5467-5481

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,2,3,4-Tetrahydro-1-oxopyrrolo[3,2,1-jk][1,4]benzodiazepin-6-yl)benzaldehyde
C18H14N2O2
328543-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.6499 0.0 0
M  V30 2 C 11.7329 3.1777 0.0 0
M  V30 3 O 13.0666 3.9477 0.0 0
M  V30 4 C 3.9705 2.6610 0.0 0
M  V30 5 N 4.9874 3.8056 0.0 0
M  V30 6 C 4.7274 1.3246 0.0 0
M  V30 7 C 2.4371 2.6887 0.0 0
M  V30 8 C 6.3981 3.1777 0.0 0
M  V30 9 C 4.7030 5.3273 0.0 0
M  V30 10 C 6.2368 1.6466 0.0 0
M  V30 11 C 3.9380 0.0000 0.0 0
M  V30 12 C 1.6481 1.3634 0.0 0
M  V30 13 C 1.5142 3.9311 0.0 0
M  V30 14 C 3.3332 6.0295 0.0 0
M  V30 15 C 2.3981 0.0185 0.0 0
M  V30 16 N 1.9274 5.4134 0.0 0
M  V30 17 C 7.7317 3.9477 0.0 0
M  V30 18 C 9.0654 3.1777 0.0 0
M  V30 19 C 7.7317 5.4878 0.0 0
M  V30 20 C 10.3991 3.9477 0.0 0
M  V30 21 C 9.0654 6.2578 0.0 0
M  V30 22 C 10.3991 5.4878 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 2 8 10
M  V30 14 1 8 17
M  V30 15 1 9 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-6-[3-[(methylamino)methyl]phenyl]pyrrolo[3,2,1-jk][1,4]benzodiaze...
C19H19N3O
328543-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.6499 0.0 0
M  V30 2 C 11.7327 3.1777 0.0 0
M  V30 3 N 13.0666 3.9477 0.0 0
M  V30 4 C 14.4002 3.1777 0.0 0
M  V30 5 C 3.9705 2.6610 0.0 0
M  V30 6 N 4.9874 3.8056 0.0 0
M  V30 7 C 4.7274 1.3246 0.0 0
M  V30 8 C 2.4371 2.6887 0.0 0
M  V30 9 C 6.3979 3.1777 0.0 0
M  V30 10 C 4.7030 5.3273 0.0 0
M  V30 11 C 6.2368 1.6466 0.0 0
M  V30 12 C 3.9379 0.0000 0.0 0
M  V30 13 C 1.6481 1.3634 0.0 0
M  V30 14 C 1.5142 3.9311 0.0 0
M  V30 15 C 3.3332 6.0295 0.0 0
M  V30 16 C 2.3981 0.0185 0.0 0
M  V30 17 N 1.9274 5.4134 0.0 0
M  V30 18 C 7.7317 3.9477 0.0 0
M  V30 19 C 9.0654 3.1777 0.0 0
M  V30 20 C 7.7317 5.4878 0.0 0
M  V30 21 C 10.3991 3.9477 0.0 0
M  V30 22 C 9.0654 6.2578 0.0 0
M  V30 23 C 10.3991 5.4878 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 2 9 11
M  V30 15 1 9 18
M  V30 16 1 10 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 1 15 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 328543-61-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 328543-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1778005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-85-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 82:
6-(4-Dimethylaminomethyl-phenyl)-3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-one.
2M Dimethylamine in methanol (8.2 mL, 16.34 mmol) was added to a
suspension of 4-(1-oxo-1,2,3
,4-tetrahydro-[1,4]diazepino[6,7-1-hi]indol-6-yl)-benzaldehyde (0.55 g,
1.90 mmol) in MeOH (110 mL) at rt. The reaction mixture was heated to
reflux until the suspension went into solution. The reaction mixture was
cooled to rt, and a solution of NaCNBH3 (0.131 g, 2.09 mmol) and ZnCl2
(0.143 g, 1.05 mmol) in MeOH (55 mL) was slowly added. ,The pH of the
reaction mixture was adjusted to from 3 to 4 using 2M HCl-methanol. The
reaction mixture was stirred at rt for 2.5 h. Upon completion of the
reaction, concentrated HCl was added (pH 1) and the solvent removed in
vacuo. The residue was diluted with H2O, made basic (pH 12-14) with 50%
aqueous NaOH and extracted with EtOAc several times. The combined organic
layers were dried over anhydrous MgSO4 and concentrated. The crude
mixture was purified by column chromatography eluting with a gradient of
0-7% MeOH in CHCl3 followed by 3-8% MeOH/NH3 in CHCl3.
6-(3-Methylaminomethyl-phenyl)-3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-one.
Using the reductive amination procedure described in Example 82, the
title compound was synthesized from
3-(1-oxo-1,2,3,4-tetrahydro-[1,4]diazepino[6,7-1-hi]indol-6-yl)-benzaldehyde
and methylamine in 94% yield as a pale-yellow solid: mp 128-130°C; 1H NMR
(DMSO-d6) δ 2.29 (s, 3H), 3.48 (br s, 2H), 3.71 (s, 2H), 4.30-4.33 (m,
2H), 6.69 (s, 1H), 7.17 (t, 1H, J = 9.0 Hz), 7.38-7.39 (m, 1H), 7.44-7.46
(m, 2H), 7.54 (s, 1H), 7.80 (t, 2H, J = 9.0 Hz), 8.39 (t, 1H, J = 6.0
Hz). HRMS calcd. for C19H19N3O 305.3828 (M+), found 305.1520. Anal.
(C19H19N3O·0.6 H2O) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic inhibitors of poly(ADP-ribose) polymerases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Webber, Stephen Evan; Skalitzky, Donald James; Tikhe, Jayashree Girish;
Kumpf, Robert Arnold; Marakovits, Joseph Timothy; Eastman, Walter Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001016136 A2 2001-03-08

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[ethoxy(2-methoxy-4,5-dimethylphenyl)methylene]-, (OC-...
C17H16CrO7
332847-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 8.5717 2.8351 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1266 4.8021 0.0 0 CHG=-2 VAL=4
M  V30 3 C 11.4068 2.8351 0.0 0
M  V30 4 C 5.7327 2.8351 0.0 0
M  V30 5 C 8.5717 0.0000 0.0 0
M  V30 6 C 11.0275 1.4195 0.0 0
M  V30 7 C 8.5717 5.6702 0.0 0
M  V30 8 O 5.1227 6.5618 0.0 0
M  V30 9 O 12.8263 2.8351 0.0 0 VAL=3
M  V30 10 O 4.3132 2.8351 0.0 0 VAL=3
M  V30 11 O 9.9873 0.0000 0.0 0 VAL=3
M  V30 12 O 12.4431 1.4195 0.0 0 VAL=3
M  V30 13 O 9.9873 5.6702 0.0 0 VAL=3
M  V30 14 C 6.3506 7.2696 0.0 0
M  V30 15 C 7.5785 6.5618 0.0 0
M  V30 16 O 2.5653 6.2802 0.0 0
M  V30 17 C 0.9581 7.2109 0.0 0
M  V30 18 C 2.5653 0.3676 0.0 0
M  V30 19 C 0.0000 1.8457 0.0 0
M  V30 20 C 3.8987 4.0943 0.0 0
M  V30 21 C 2.5653 4.8646 0.0 0
M  V30 22 C 3.8987 2.5535 0.0 0
M  V30 23 C 1.2318 4.0943 0.0 0
M  V30 24 C 2.5653 1.7832 0.0 0
M  V30 25 C 1.2318 2.5535 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 20
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 21
M  V30 18 1 18 24
M  V30 19 1 19 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[(2-methoxy-4,5-dimethylphenyl)(methylamino)methylene]...
C16H15CrNO6
332847-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 8.5806 2.8419 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1319 4.8109 0.0 0 CHG=-2 VAL=4
M  V30 3 C 11.4186 2.8419 0.0 0
M  V30 4 C 5.7387 2.8419 0.0 0
M  V30 5 C 8.5806 0.0000 0.0 0
M  V30 6 C 11.0389 1.4210 0.0 0
M  V30 7 C 8.5806 5.6800 0.0 0
M  V30 8 N 5.1319 6.2280 0.0 0
M  V30 9 O 12.8396 2.8419 0.0 0 VAL=3
M  V30 10 O 4.3177 2.8419 0.0 0 VAL=3
M  V30 11 O 9.9977 0.0000 0.0 0 VAL=3
M  V30 12 O 12.4560 1.4210 0.0 0 VAL=3
M  V30 13 O 9.9977 5.6800 0.0 0 VAL=3
M  V30 14 C 3.4722 7.1871 0.0 0
M  V30 15 O 2.5679 6.2906 0.0 0
M  V30 16 C 0.9591 7.2184 0.0 0
M  V30 17 C 2.5679 0.3680 0.0 0
M  V30 18 C 0.0000 1.8477 0.0 0
M  V30 19 C 3.9028 4.0985 0.0 0
M  V30 20 C 2.5679 4.8697 0.0 0
M  V30 21 C 3.9028 2.5601 0.0 0
M  V30 22 C 1.2331 4.0985 0.0 0
M  V30 23 C 2.5679 1.7889 0.0 0
M  V30 24 C 1.2331 2.5601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 19
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 20
M  V30 17 1 17 23
M  V30 18 1 18 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-63-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-75-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-15259984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 45:55 syn:anti
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethynyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purine
C12H12N4O
333780-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6646 3.0801 0.0 0
M  V30 2 C 10.9983 3.8501 0.0 0
M  V30 3 C 5.6635 2.3101 0.0 0
M  V30 4 N 4.5191 3.3405 0.0 0
M  V30 5 C 6.9973 3.0801 0.0 0
M  V30 6 N 5.6635 0.7700 0.0 0
M  V30 7 C 5.1454 4.7473 0.0 0
M  V30 8 C 8.3310 2.3101 0.0 0
M  V30 9 N 6.6771 4.5864 0.0 0
M  V30 10 C 6.9973 0.0000 0.0 0
M  V30 11 N 8.3310 0.7700 0.0 0
M  V30 12 C 3.0128 3.0203 0.0 0
M  V30 13 C 2.5367 1.5556 0.0 0
M  V30 14 O 1.9822 4.1647 0.0 0
M  V30 15 C 1.0304 1.2354 0.0 0
M  V30 16 C 0.4759 3.8445 0.0 0
M  V30 17 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 7 9
M  V30 12 1 8 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-N-Methyl-2-[9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl]ethenamine
C13H17N5O
920503-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6648 3.0801 0.0 0
M  V30 2 C 10.9985 2.3101 0.0 0
M  V30 3 N 12.3321 3.0801 0.0 0
M  V30 4 C 13.6660 2.3101 0.0 0
M  V30 5 C 5.6636 2.3101 0.0 0
M  V30 6 C 6.9973 3.0801 0.0 0
M  V30 7 N 4.5192 3.3405 0.0 0
M  V30 8 N 5.6636 0.7700 0.0 0
M  V30 9 C 8.3311 2.3101 0.0 0
M  V30 10 N 6.6771 4.5864 0.0 0
M  V30 11 C 5.1456 4.7473 0.0 0
M  V30 12 C 6.9973 0.0000 0.0 0
M  V30 13 N 8.3311 0.7700 0.0 0
M  V30 14 C 3.0128 3.0203 0.0 0 CFG=3
M  V30 15 C 1.9823 4.1647 0.0 0
M  V30 16 O 2.5369 1.5556 0.0 0
M  V30 17 C 0.4759 3.8445 0.0 0
M  V30 18 C 1.0306 1.2354 0.0 0
M  V30 19 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 14
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333780-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920503-70-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-12567155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of purines bearing functionalized C-substituents by the
conjugate addition of nucleophiles to 6-vinylpurines and 6-ethynylpurines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuchar, Martin; Pohl, Radek; Votruba, Ivan; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (22), 5083-5098

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
D-Mannopyranose, 2-azido-2-deoxy-6-O-[(1,1-dimethylethyl)dimethylsilyl]-2-C-[...
C44H59N3O7Si2
344615-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0563 6.4563 0.0 0
M  V30 2 O 6.0664 7.6359 0.0 0
M  V30 3 Si 4.5498 7.3686 0.0 0
M  V30 4 C 4.8171 5.8520 0.0 0
M  V30 5 C 3.3005 5.5845 0.0 0
M  V30 6 C 5.0846 4.3353 0.0 0
M  V30 7 C 6.3339 6.1193 0.0 0
M  V30 8 N 8.0462 8.1708 0.0 0
M  V30 9 N 9.0361 9.3504 0.0 0 CHG=1 VAL=4
M  V30 10 N 10.0260 10.5302 0.0 0 CHG=-1
M  V30 11 O 9.9065 9.0336 0.0 0
M  V30 12 C 11.2402 9.8036 0.0 0
M  V30 13 O 7.2392 4.4136 0.0 0
M  V30 14 O 12.5739 7.4936 0.0 0
M  V30 15 C 13.9076 6.7236 0.0 0
M  V30 16 C 12.5739 4.4136 0.0 0
M  V30 17 O 12.5739 2.8736 0.0 0
M  V30 18 Si 13.9076 2.1036 0.0 0
M  V30 19 C 15.2412 1.3336 0.0 0
M  V30 20 C 13.1376 0.7700 0.0 0
M  V30 21 C 14.6776 3.4373 0.0 0
M  V30 22 C 16.0112 2.6673 0.0 0
M  V30 23 C 16.5750 0.5636 0.0 0
M  V30 24 C 14.4712 0.0000 0.0 0
M  V30 25 O 19.2423 9.8036 0.0 0
M  V30 26 C 20.5759 9.0336 0.0 0
M  V30 27 C 8.5729 6.7236 0.0 0 CFG=1
M  V30 28 C 9.9065 7.4936 0.0 0 CFG=1
M  V30 29 C 8.5729 5.1836 0.0 0 CFG=3
M  V30 30 C 11.2403 6.7236 0.0 0 CFG=2
M  V30 31 O 9.9065 4.4136 0.0 0
M  V30 32 C 11.2403 5.1836 0.0 0 CFG=1
M  V30 33 C 11.2402 11.3436 0.0 0
M  V30 34 C 12.5739 12.1136 0.0 0
M  V30 35 C 9.9065 12.1136 0.0 0
M  V30 36 C 12.5739 13.6536 0.0 0
M  V30 37 C 9.9065 13.6536 0.0 0
M  V30 38 C 11.2402 14.4236 0.0 0
M  V30 39 C 3.0332 7.1011 0.0 0
M  V30 40 C 2.5065 5.6540 0.0 0
M  V30 41 C 2.0433 8.2809 0.0 0
M  V30 42 C 0.9899 5.3866 0.0 0
M  V30 43 C 0.5267 8.0134 0.0 0
M  V30 44 C 0.0000 6.5663 0.0 0
M  V30 45 C 4.2823 8.8852 0.0 0
M  V30 46 C 5.4621 9.8751 0.0 0
M  V30 47 C 2.8353 9.4119 0.0 0
M  V30 48 C 5.1946 11.3917 0.0 0
M  V30 49 C 2.5678 10.9285 0.0 0
M  V30 50 C 3.7476 11.9184 0.0 0
M  V30 51 C 15.2412 7.4936 0.0 0
M  V30 52 C 15.2412 9.0336 0.0 0
M  V30 53 C 16.5750 6.7236 0.0 0
M  V30 54 C 16.5749 9.8036 0.0 0
M  V30 55 C 17.9087 7.4936 0.0 0
M  V30 56 C 17.9087 9.0336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 39
M  V30 6 1 3 45
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 4 7
M  V30 10 2 8 9
M  V30 11 1 27 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 28 11 CFG=1
M  V30 15 1 12 33
M  V30 16 1 13 29
M  V30 17 1 14 15
M  V30 18 1 30 14 CFG=3
M  V30 19 1 15 51
M  V30 20 1 16 17
M  V30 21 1 32 16 CFG=1
M  V30 22 1 17 18
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 1 19 23
M  V30 28 1 19 24
M  V30 29 1 25 26
M  V30 30 1 25 56
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 49 2 45 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 49
M  V30 53 2 48 50
M  V30 54 1 49 50
M  V30 55 2 51 52
M  V30 56 1 51 53
M  V30 57 1 52 54
M  V30 58 2 53 55
M  V30 59 2 54 56
M  V30 60 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 27 28 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonamide, 2-azido-2-deoxy-6-O-[(1,1-dimethylethyl)dimethylsilyl]-2-C-[[[...
C45H62N4O7Si2
344615-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 10.3673 0.0 0
M  V30 2 O 6.1600 10.3673 0.0 0
M  V30 3 C 4.6200 8.8273 0.0 0
M  V30 4 C 6.9300 9.0336 0.0 0
M  V30 5 C 3.0800 8.8273 0.0 0
M  V30 6 C 4.6200 7.2873 0.0 0
M  V30 7 C 6.1600 8.8273 0.0 0
M  V30 8 C 8.4700 9.0336 0.0 0 CFG=1
M  V30 9 C 8.4700 7.4936 0.0 0 CFG=1
M  V30 10 C 8.4700 10.5736 0.0 0
M  V30 11 N 10.0100 9.0336 0.0 0
M  V30 12 C 9.8036 6.7236 0.0 0 CFG=1
M  V30 13 O 7.1364 6.7236 0.0 0
M  V30 14 N 9.8036 11.3436 0.0 0
M  V30 15 O 7.1364 11.3436 0.0 0
M  V30 16 N 10.7800 10.3673 0.0 0 CHG=1 VAL=4
M  V30 17 O 11.1373 7.4936 0.0 0
M  V30 18 C 9.8036 5.1836 0.0 0 CFG=2
M  V30 19 C 7.1364 5.1836 0.0 0
M  V30 20 C 9.8036 12.8836 0.0 0
M  V30 21 N 11.5500 11.7011 0.0 0 CHG=-1
M  V30 22 C 12.4711 6.7236 0.0 0
M  V30 23 C 8.4700 4.4136 0.0 0
M  V30 24 O 11.1373 4.4136 0.0 0
M  V30 25 O 8.4700 2.8736 0.0 0
M  V30 26 Si 9.8036 2.1036 0.0 0
M  V30 27 C 11.1373 1.3336 0.0 0
M  V30 28 C 9.0336 0.7700 0.0 0
M  V30 29 C 10.5736 3.4373 0.0 0
M  V30 30 C 11.9073 2.6673 0.0 0
M  V30 31 C 12.4711 0.5636 0.0 0
M  V30 32 C 10.3673 0.0000 0.0 0
M  V30 33 O 17.8058 9.8036 0.0 0
M  V30 34 C 19.1394 9.0336 0.0 0
M  V30 35 C 3.0800 10.3673 0.0 0
M  V30 36 C 2.3100 9.0336 0.0 0
M  V30 37 C 2.3100 11.7011 0.0 0
M  V30 38 C 0.7700 9.0336 0.0 0
M  V30 39 C 0.7700 11.7011 0.0 0
M  V30 40 C 0.0000 10.3673 0.0 0
M  V30 41 C 4.6200 11.9073 0.0 0
M  V30 42 C 3.2864 12.6773 0.0 0
M  V30 43 C 5.9536 12.6773 0.0 0
M  V30 44 C 3.2864 14.2173 0.0 0
M  V30 45 C 5.9536 14.2173 0.0 0
M  V30 46 C 4.6200 14.9873 0.0 0
M  V30 47 C 5.8026 4.4136 0.0 0
M  V30 48 C 4.4689 5.1836 0.0 0
M  V30 49 C 5.8026 2.8736 0.0 0
M  V30 50 C 3.1353 4.4136 0.0 0
M  V30 51 C 4.4689 2.1036 0.0 0
M  V30 52 C 3.1353 2.8736 0.0 0
M  V30 53 C 13.8047 7.4936 0.0 0
M  V30 54 C 15.1384 6.7236 0.0 0
M  V30 55 C 13.8047 9.0336 0.0 0
M  V30 56 C 16.4721 7.4936 0.0 0
M  V30 57 C 15.1384 9.8036 0.0 0
M  V30 58 C 16.4721 9.0336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 35
M  V30 4 1 1 41
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=1
M  V30 12 1 8 11 CFG=3
M  V30 13 1 9 12
M  V30 14 1 9 13 CFG=3
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 12 17 CFG=3
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 1 18 24 CFG=3
M  V30 26 1 19 47
M  V30 27 1 22 53
M  V30 28 1 23 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 26 29
M  V30 33 1 27 30
M  V30 34 1 27 31
M  V30 35 1 27 32
M  V30 36 1 33 34
M  V30 37 1 33 58
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 50 2 47 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 2 49 51
M  V30 54 2 50 52
M  V30 55 1 51 52
M  V30 56 2 53 54
M  V30 57 1 53 55
M  V30 58 1 54 56
M  V30 59 2 55 57
M  V30 60 2 56 58
M  V30 61 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 344615-46-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 344615-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28011328
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 87413-09-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of sphingofungin E
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakamura, T.; Shiozaki, M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(14), 2701-2704

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylthio)benzaldehyde
C8H8OS
3446-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 S 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(methylthio)benzenemethanamine
C9H13NS
84212-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3446-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84212-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14042431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxidation of secondary amines by molecular oxygen and cyclohexanone
monooxygenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Colonna, Stefano; Pironti, Vincenza; Carrea, Giacomo; Pasta, Piero;
Zambianchi, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(3), 569-575

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-methyl-α-oxobenzeneacetate
C10H10O3
34966-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-α-oxobenzeneacetamide
C10H11NO2
149922-95-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34966-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149922-95-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9309806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimized on stoichiometry,reaction time and temperature
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antifungal bioactivity of methyl
2-methoxyimino-2-{2-[(substituted
benzylidene)aminooxymethyl]phenyl}acetate and
2-methoxyimino-2-{2-[(substituted
benzylidene)aminooxymethyl]phenyl}-N-methylacetamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Guohua; Yang, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2009), 27(10), 2055-2060

$RFMT $RIREG SCHEME99 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Fluorophenyl)sulfonyl]-N,2-dimethyl-2-propenamide
C11H12FNO3S
1620220-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 F 10.7800 2.6673 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 1.3336 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620220-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[[[[(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-1,1-dimethylund...
C22H15F17N2O3
350716-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 5.3348 5.1838 0.0 0
M  V30 3 C 8.0022 3.6437 0.0 0
M  V30 4 F 7.4385 5.7474 0.0 0
M  V30 5 F 5.8985 3.0801 0.0 0
M  V30 6 C 4.0010 5.9538 0.0 0
M  V30 7 F 6.1048 6.5174 0.0 0
M  V30 8 F 4.5648 3.8501 0.0 0
M  V30 9 C 9.3358 2.8737 0.0 0
M  V30 10 F 8.7722 4.9774 0.0 0
M  V30 11 F 7.2322 2.3101 0.0 0
M  V30 12 C 2.6673 6.7238 0.0 0
M  V30 13 F 4.7710 7.2874 0.0 0
M  V30 14 F 3.2310 4.6201 0.0 0
M  V30 15 C 10.6697 2.1037 0.0 0
M  V30 16 F 10.1059 4.2074 0.0 0
M  V30 17 F 8.5658 1.5400 0.0 0
M  V30 18 C 1.3337 7.4938 0.0 0
M  V30 19 F 3.4374 8.0575 0.0 0
M  V30 20 F 1.8973 5.3901 0.0 0
M  V30 21 C 12.0033 1.3337 0.0 0
M  V30 22 F 11.4397 3.4374 0.0 0
M  V30 23 F 9.8996 0.7700 0.0 0
M  V30 24 F 0.0000 8.2638 0.0 0
M  V30 25 F 2.1037 8.8275 0.0 0
M  V30 26 F 0.5637 6.1601 0.0 0
M  V30 27 C 13.3370 2.1037 0.0 0
M  V30 28 C 14.6707 1.3337 0.0 0
M  V30 29 O 15.4407 2.6673 0.0 0
M  V30 30 C 16.0045 0.5637 0.0 0
M  V30 31 C 13.9007 0.0000 0.0 0
M  V30 32 C 16.9807 2.6673 0.0 0
M  V30 33 O 17.7507 4.0012 0.0 0
M  V30 34 O 17.7507 1.3337 0.0 0
M  V30 35 N 19.2908 4.0012 0.0 0
M  V30 36 C 20.0608 5.3348 0.0 0
M  V30 37 C 19.2908 6.6685 0.0 0
M  V30 38 N 18.5208 8.0022 0.0 0
M  V30 39 C 21.6008 5.3348 0.0 0
M  V30 40 C 22.3708 6.6685 0.0 0
M  V30 41 C 22.3708 4.0010 0.0 0
M  V30 42 C 23.9109 6.6685 0.0 0
M  V30 43 C 23.9109 4.0010 0.0 0
M  V30 44 C 24.6809 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 32 33
M  V30 33 2 32 34
M  V30 34 1 33 35
M  V30 35 2 35 36 CFG=2
M  V30 36 1 36 37
M  V30 37 1 36 39
M  V30 38 3 37 38
M  V30 39 2 39 40
M  V30 40 1 39 41
M  V30 41 1 40 42
M  V30 42 2 41 43
M  V30 43 2 42 44
M  V30 44 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Dodecanol, 5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-heptadecafluoro-2-methy...
C15H14F17NO2
956484-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.4137 0.0 0
M  V30 2 C 5.3348 3.6437 0.0 0
M  V30 3 C 8.0022 5.1838 0.0 0
M  V30 4 F 7.4385 3.0801 0.0 0
M  V30 5 F 5.8985 5.7474 0.0 0
M  V30 6 C 4.0010 2.8737 0.0 0
M  V30 7 F 6.1048 2.3101 0.0 0
M  V30 8 F 4.5648 4.9774 0.0 0
M  V30 9 C 9.3358 5.9538 0.0 0
M  V30 10 F 8.7722 3.8501 0.0 0
M  V30 11 F 7.2322 6.5174 0.0 0
M  V30 12 C 2.6673 2.1037 0.0 0
M  V30 13 F 4.7710 1.5400 0.0 0
M  V30 14 F 3.2310 4.2074 0.0 0
M  V30 15 C 10.6697 6.7238 0.0 0
M  V30 16 F 10.1059 4.6201 0.0 0
M  V30 17 F 8.5658 7.2874 0.0 0
M  V30 18 C 1.3337 1.3337 0.0 0
M  V30 19 F 3.4374 0.7700 0.0 0
M  V30 20 F 1.8973 3.4374 0.0 0
M  V30 21 C 12.0033 7.4938 0.0 0
M  V30 22 F 11.4397 5.3901 0.0 0
M  V30 23 F 9.8996 8.0575 0.0 0
M  V30 24 F 0.0000 0.5637 0.0 0
M  V30 25 F 2.1037 0.0000 0.0 0
M  V30 26 F 0.5637 2.6673 0.0 0
M  V30 27 C 13.3370 6.7238 0.0 0
M  V30 28 C 14.6707 7.4938 0.0 0
M  V30 29 O 15.4407 6.1601 0.0 0
M  V30 30 C 13.9007 8.8275 0.0 0
M  V30 31 C 16.0045 8.2638 0.0 0
M  V30 32 C 16.9807 6.1601 0.0 0
M  V30 33 N 17.7507 4.8265 0.0 0
M  V30 34 O 17.7507 7.4938 0.0 0
M  V30 35 C 19.2908 4.8265 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 29 32
M  V30 32 1 32 33
M  V30 33 2 32 34
M  V30 34 1 33 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 350716-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 956484-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13390564
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of
FBoc-ammonia surrogates 3a-c To a round flask was added 1 (2 g, 2.94
mmol) in dichloromethane (30 ml) followed by amine 2 (excess) and Et3N
(0.067 ml, 0.47 mmol). The mixture was stirred at room temperature
overnight. The solvent was removed under reduced pressure and the residue
thus obtained was placed onto a FluoroFlash silica gel cartridge (10 g)
which was pre-treated with a MeOH/H2O (4/1) mixture (30 ml). The
cartridge was initially eluted with MeOH/H2O (4/1) (100 ml) to remove
non-fluorinated organic components. This fraction was discarded. Then the
elution was done with pure with MeOH (200 ml) and the resulting fraction
was collected and concentrated under reduced pressure to afford the
corresponding pure ammonia surrogate 3 as a white solid. Carbamic acid
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-1,1-dimethylundecylester
(3a) Methylcarbamic acid
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoro-1,1-dimethylundecylester
(3b) The compound was synthesized from 14 mmol of 2b following the
general procedure. Yield: 94 %, white solid. mp = 57 °C; 1H NMR (500 MHz,
CDCl3): δ = 4.45 (br s, 1H), 2.68 (br s, 3H), 2.09-1.91 (m, 4H), 1.42 (s,
6H); HRMS (ES), m/e Calcd. for C15H14F17NO2: 563.2561; Found: 563.2575;
Anal. Calcd. for C15H14F17NO2: C, 31.99; H, 2.51; N, 2.49. Found, C,
32.03; H, 2.48; N, 2.52.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorous-Tagged Carbamates for the Pd-Catalyzed Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trabanco, Andres A.; Vega, Juan A.; Fernandez, M. Alejandro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(21), 8146-8148

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-4-fluorobenzenesulfonyl chloride
C7H3ClFNO2S
351003-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 N 8.0023 3.8501 0.0 0
M  V30 7 F 6.6687 0.0000 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 3 5 6
M  V30 6 1 5 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Cyano-4-fluoro-N-methylbenzenesulfonamide
C8H7FN2O2S
1339256-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 N 0.0000 3.8501 0.0 0
M  V30 8 F 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351003-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1339256-68-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23080549
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfamides as TEAD inhibitors and their preparation, pharmaceutical
compositions and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Alfredo C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020243415 A2 2020-12-03

$RFMT $RIREG SCHEME104 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)thiourea
C7H7N3O2S
3696-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0
M  V30 4 S 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-5-methyl-1-(4-nitrophenyl)-1,3,5-triazine-2(1H)-thione
C10H12N4O2S
207855-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 6.9301 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 N 9.3359 1.5400 0.0 0 VAL=5
M  V30 4 O 10.6695 2.3100 0.0 0
M  V30 5 O 9.3359 0.0000 0.0 0
M  V30 6 N 4.0011 4.6201 0.0 0
M  V30 7 C 4.0011 6.1601 0.0 0
M  V30 8 C 2.6673 3.8500 0.0 0
M  V30 9 N 2.6673 6.9301 0.0 0
M  V30 10 N 1.3337 4.6201 0.0 0
M  V30 11 C 1.3337 6.1601 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 6.6684 4.6201 0.0 0
M  V30 15 C 6.6684 1.5400 0.0 0
M  V30 16 C 8.0022 3.8500 0.0 0
M  V30 17 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3696-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207855-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-14052419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of the appropriately substituted
thiourea (29.4 mmol) in EtOH (20 mL), is added 40% aqueous methylamine
(32.3 mmol, 1.1 molar eq) and 37% aqueous formaldehyde (64.7 mmol, 2.2
molar eq). The solution is refluxed under nitrogen until complete by TLC
(10% MeOH/CH2Cl2 or 2:1 Hex/EtOAc). The reaction mixture is cooled to
room temperature and the precipitated product is filtered, washed with
50% aqueous ethanol and recrystallized, if necessary (recrystallization
solvent provided in parenthesis).
1-(4Nitro-phenyl)-5-methyl-tetrahydro-1,3,5-triazin-2(1H)-thione.
Prepared in 94% yield according to procedure A described above; yellow
powder. m.p. 170-172°C. (EtOH). Anal. Calcd. for C10H12N4O2S: C, 47.61;
H, 4.79; N, 22.21. Found: C, 47.43; H, 4.75: N, 22.25. Mass spectrum (EI,
m/z): 252 [M]+.
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted tetrahydro-1,3,5-triazine-2(1H)-thiones as
anti-atherosclerotic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Memoli, Kevin A.; Strike, Donald P.; Failli, Amedeo A.; Steffan, Robert
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6160114 A 2000-12-12

$RFMT $RIREG SCHEME105 STEP1
$RXN



  3  1
$MOL
Ethyl 1H-indole-2-carboxylate
C11H11NO2
3770-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 O 7.4148 2.3101 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 8.7486 1.5400 0.0 0
M  V30 5 C 10.0823 2.3101 0.0 0
M  V30 6 C 2.3101 2.8281 0.0 0
M  V30 7 C 3.0801 4.1618 0.0 0
M  V30 8 C 3.3405 1.6836 0.0 0
M  V30 9 C 0.7700 2.8281 0.0 0
M  V30 10 N 4.5865 3.8416 0.0 0
M  V30 11 C 2.3101 5.4955 0.0 0
M  V30 12 C 4.7475 2.3101 0.0 0
M  V30 13 C 0.0000 4.1618 0.0 0
M  V30 14 C 0.7700 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl iodide
CH3I
74-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 I 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3770-50-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-88-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6624913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 1. Preparation of
1-methyl-2-(methylaminomethyl)indole. a)
N,1-Dimethylindole-2-carboxamide. To a stirred solution of ethyl
indole-2-carboxylate (25.0 g, 132.1 mmole) in dry DMF (100 mL) at 5 °C
was added 60% NaH (6.9 g, 171.7 mmole). After 10 min, methyl iodide (56.2
g, 396.3 mmole) was added and the reaction slurry was allowed to warm RT
and stirred for 12 hr. The reaction contents were poured into H2O (200
mL) and extracted with EtOAc (2 × 150 mL). The combined organic phases
were washed sequentially with H20 and brine, then were dried over Na2SO4.
Concentration under reduced pressure gave a yellow oil. This oil was
suspended in a 40% methylaminefH2O solution (100 mL) containing THF (50
mL) and stirred vigorously at RT for 24 hr. The reaction solution was
concentrated under vacuum to remove the THF and then poured into H2O (400
mL). The precipitate was filtered, washed with H2O and dried under vacuum
at RT. (23.3 g, 94 %); white solid. MS (ES) m/e 189 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carboxamides as Fab I
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000063187 A1 2000-10-26

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,5R)-5-(6-Chloro-9H-purin-9-yl)tetrahydro-3-thiophenemethanol
C10H11ClN4OS
381211-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0801 0.0 0
M  V30 2 C 10.5371 3.9071 0.0 0
M  V30 3 O 11.7831 3.0020 0.0 0
M  V30 4 N 5.1457 3.3405 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 4.5192 4.7473 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 N 2.9877 4.5864 0.0 0
M  V30 10 C 1.3338 2.3101 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 N 1.3338 0.7700 0.0 0
M  V30 13 C 6.6520 3.0203 0.0 0 CFG=2
M  V30 14 C 7.7966 4.0508 0.0 0
M  V30 15 S 7.2785 1.6133 0.0 0
M  V30 16 C 9.1302 3.2807 0.0 0 CFG=2
M  V30 17 C 8.8101 1.7744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 13 4 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3R,5R)-Tetrahydro-5-[6-(methylamino)-9H-purin-9-yl]-3-thiophenemethanol
C11H15N5OS
381211-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 11.8707 3.9071 0.0 0
M  V30 4 O 13.1168 3.0020 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 N 6.4794 3.3405 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 N 5.3348 0.7700 0.0 0
M  V30 9 C 5.8529 4.7473 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.3213 4.5864 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 N 2.6675 0.7700 0.0 0
M  V30 14 C 7.9857 3.0203 0.0 0 CFG=2
M  V30 15 C 9.1302 4.0508 0.0 0
M  V30 16 S 8.6122 1.6133 0.0 0
M  V30 17 C 10.4639 3.2807 0.0 0 CFG=2
M  V30 18 C 10.1437 1.7744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 17 3 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 14 6 CFG=1
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 381211-54-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 381211-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10155905
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of novel thioapio dideoxynucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moon, Hyung Ryong; Kim, Hea Ok; Lee, Sang Kook; Choi, Won Jun; Chun, Moon
Woo; Jeong, Lak Shin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2002), 10(5), 1499-1507

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
N-(2-Cyanoethyl)-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carboxamide
C13H18N4O3
386252-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 6.6374 0.0 0
M  V30 2 C 1.7849 7.1133 0.0 0
M  V30 3 C 1.4646 8.6197 0.0 0
M  V30 4 C 2.6091 9.6502 0.0 0
M  V30 5 C 0.0000 9.0956 0.0 0
M  V30 6 C 6.3103 5.2746 0.0 0
M  V30 7 N 7.6440 4.5046 0.0 0
M  V30 8 O 6.3103 6.8146 0.0 0
M  V30 9 C 8.9776 5.2746 0.0 0
M  V30 10 C 10.3115 4.5046 0.0 0
M  V30 11 C 11.6451 5.2746 0.0 0
M  V30 12 N 12.9788 6.0446 0.0 0
M  V30 13 N 2.6829 1.2459 0.0 0 VAL=5
M  V30 14 O 1.1512 1.0850 0.0 0
M  V30 15 O 3.5880 0.0000 0.0 0
M  V30 16 N 3.5696 5.1309 0.0 0
M  V30 17 C 4.9766 4.5046 0.0 0
M  V30 18 C 2.5392 3.9865 0.0 0
M  V30 19 C 4.8155 2.9730 0.0 0
M  V30 20 C 3.3092 2.6529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 3 11 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 20
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Imino-3-(methylamino)propyl]-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carb...
C14H23N5O3
386252-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 6.6374 0.0 0
M  V30 2 C 1.7847 7.1132 0.0 0
M  V30 3 C 1.4646 8.6197 0.0 0
M  V30 4 C 2.6091 9.6501 0.0 0
M  V30 5 C 0.0000 9.0956 0.0 0
M  V30 6 C 6.3103 5.2746 0.0 0
M  V30 7 N 7.6439 4.5046 0.0 0
M  V30 8 O 6.3103 6.8146 0.0 0
M  V30 9 C 8.9776 5.2746 0.0 0
M  V30 10 C 10.3114 4.5046 0.0 0
M  V30 11 C 11.6451 5.2746 0.0 0
M  V30 12 N 12.9787 4.5046 0.0 0
M  V30 13 N 11.6451 6.8146 0.0 0
M  V30 14 C 14.3124 5.2746 0.0 0
M  V30 15 N 2.6827 1.2459 0.0 0 VAL=5
M  V30 16 O 1.1512 1.0849 0.0 0
M  V30 17 O 3.5880 0.0000 0.0 0
M  V30 18 N 3.5696 5.1309 0.0 0
M  V30 19 C 4.9766 4.5046 0.0 0
M  V30 20 C 2.5392 3.9865 0.0 0
M  V30 21 C 4.8155 2.9730 0.0 0
M  V30 22 C 3.3092 2.6529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 19
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 2 15 17
M  V30 17 1 15 22
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 386252-74-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 386252-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-317-CAS-11916705
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used, HCl gas used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of polyamide analogs possessing antibacterial, antifungal,
and/or antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dyatkina, Natalia B.; Shi, Dong-fang; Roberts, Christopher Don; Velligan,
Mark Douglas; Liehr, Sebastian Johannes Reinhard; Botyanszki, Janos;
Zhang, Wentao; Khorlin, Alexander; Nelson, Peter Harold; Muchowski,
Joseph Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003057212 A1 2003-07-17

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
N-(2-Cyanoethyl)-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carboxamide
C13H18N4O3
386252-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 6.6374 0.0 0
M  V30 2 C 1.7849 7.1133 0.0 0
M  V30 3 C 1.4646 8.6197 0.0 0
M  V30 4 C 2.6091 9.6502 0.0 0
M  V30 5 C 0.0000 9.0956 0.0 0
M  V30 6 C 6.3103 5.2746 0.0 0
M  V30 7 N 7.6440 4.5046 0.0 0
M  V30 8 O 6.3103 6.8146 0.0 0
M  V30 9 C 8.9776 5.2746 0.0 0
M  V30 10 C 10.3115 4.5046 0.0 0
M  V30 11 C 11.6451 5.2746 0.0 0
M  V30 12 N 12.9788 6.0446 0.0 0
M  V30 13 N 2.6829 1.2459 0.0 0 VAL=5
M  V30 14 O 1.1512 1.0850 0.0 0
M  V30 15 O 3.5880 0.0000 0.0 0
M  V30 16 N 3.5696 5.1309 0.0 0
M  V30 17 C 4.9766 4.5046 0.0 0
M  V30 18 C 2.5392 3.9865 0.0 0
M  V30 19 C 4.8155 2.9730 0.0 0
M  V30 20 C 3.3092 2.6529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 17
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 3 11 12
M  V30 13 2 13 14
M  V30 14 2 13 15
M  V30 15 1 13 20
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Methylamino)-3-(methylimino)propyl]-1-(3-methylbutyl)-4-nitro-1H-pyrrol...
C15H25N5O3
386252-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2622 5.8577 0.0 0
M  V30 2 C 11.7686 5.5375 0.0 0
M  V30 3 C 12.7991 6.6821 0.0 0
M  V30 4 C 12.3232 8.1466 0.0 0
M  V30 5 C 14.3054 6.3619 0.0 0
M  V30 6 C 6.9302 6.2080 0.0 0
M  V30 7 N 5.3901 6.2080 0.0 0
M  V30 8 O 7.7002 7.5417 0.0 0
M  V30 9 C 4.6201 7.5417 0.0 0
M  V30 10 C 3.0801 7.5417 0.0 0
M  V30 11 C 2.3101 8.8754 0.0 0
M  V30 12 N 3.0801 10.2090 0.0 0
M  V30 13 N 0.7700 8.8754 0.0 0
M  V30 14 C 2.3101 11.5429 0.0 0
M  V30 15 C 0.0000 7.5417 0.0 0
M  V30 16 N 8.0571 0.9052 0.0 0 VAL=5
M  V30 17 O 6.6503 0.2789 0.0 0
M  V30 18 O 9.3032 0.0000 0.0 0
M  V30 19 N 9.2317 4.7133 0.0 0
M  V30 20 C 7.7002 4.8742 0.0 0
M  V30 21 C 9.5519 3.2070 0.0 0
M  V30 22 C 7.0737 3.4674 0.0 0
M  V30 23 C 8.2182 2.4369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12 CFG=2
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 386252-74-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 386252-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27840621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used, HCl gas used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of polyamide analogs possessing antibacterial, antifungal,
and/or antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dyatkina, Natalia B.; Shi, Dong-fang; Roberts, Christopher Don; Velligan,
Mark Douglas; Liehr, Sebastian Johannes Reinhard; Botyanszki, Janos;
Zhang, Wentao; Khorlin, Alexander; Nelson, Peter Harold; Muchowski,
Joseph Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003057212 A1 2003-07-17

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
N-(3-Amino-3-iminopropyl)-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carboxamide
C13H21N5O3
386252-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0432 5.8576 0.0 0
M  V30 2 C 2.5367 5.5373 0.0 0
M  V30 3 C 1.5063 6.6819 0.0 0
M  V30 4 C 1.9822 8.1464 0.0 0
M  V30 5 C 0.0000 6.3617 0.0 0
M  V30 6 C 7.3752 6.2078 0.0 0
M  V30 7 N 8.9152 6.2078 0.0 0
M  V30 8 O 6.6052 7.5415 0.0 0
M  V30 9 C 9.6852 7.5415 0.0 0
M  V30 10 C 11.2252 7.5415 0.0 0
M  V30 11 C 11.9952 8.8752 0.0 0
M  V30 12 N 11.2252 10.2088 0.0 0
M  V30 13 N 13.5353 8.8752 0.0 0
M  V30 14 N 6.2482 0.9051 0.0 0 VAL=5
M  V30 15 O 5.0022 0.0000 0.0 0
M  V30 16 O 7.6550 0.2787 0.0 0
M  V30 17 N 5.0736 4.7131 0.0 0
M  V30 18 C 6.6052 4.8740 0.0 0
M  V30 19 C 4.7534 3.2068 0.0 0
M  V30 20 C 7.2316 3.4672 0.0 0
M  V30 21 C 6.0871 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 21
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Imino-3-(methylamino)propyl]-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carb...
C14H23N5O3
386252-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2495 6.6374 0.0 0
M  V30 2 C 1.7847 7.1132 0.0 0
M  V30 3 C 1.4646 8.6197 0.0 0
M  V30 4 C 2.6091 9.6501 0.0 0
M  V30 5 C 0.0000 9.0956 0.0 0
M  V30 6 C 6.3103 5.2746 0.0 0
M  V30 7 N 7.6439 4.5046 0.0 0
M  V30 8 O 6.3103 6.8146 0.0 0
M  V30 9 C 8.9776 5.2746 0.0 0
M  V30 10 C 10.3114 4.5046 0.0 0
M  V30 11 C 11.6451 5.2746 0.0 0
M  V30 12 N 12.9787 4.5046 0.0 0
M  V30 13 N 11.6451 6.8146 0.0 0
M  V30 14 C 14.3124 5.2746 0.0 0
M  V30 15 N 2.6827 1.2459 0.0 0 VAL=5
M  V30 16 O 1.1512 1.0849 0.0 0
M  V30 17 O 3.5880 0.0000 0.0 0
M  V30 18 N 3.5696 5.1309 0.0 0
M  V30 19 C 4.9766 4.5046 0.0 0
M  V30 20 C 2.5392 3.9865 0.0 0
M  V30 21 C 4.8155 2.9730 0.0 0
M  V30 22 C 3.3092 2.6529 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 19
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 2 15 17
M  V30 17 1 15 22
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 386252-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 386252-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-9316297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: Synthesis of 1-(3-Methybutyl)-4-nitro-1H-pyrrole-2-carboxylic
acid [2-(N-methylcarbamimidoyl)-ethyl]-amide 259. The solution of
1-(3-methybutyl)-4-nitro-1H-pyrrole-2-carboxylic acid
(2-cyano-ethyl)-amidine 242 (0.5g) in 50 ml of dry ethanol was cooled to
0-5°C and saturated with HCl gas. The mixture was sealed and refrigerated
for 20 hours. The mixture was allowed to warm to room temperature and
ethanol was evaporated . The solid was dissolved in 10 ml of dry ethanol
and 1M solution of methylamine (3 ml) in methanol was added. The sealed
mixture was kept overnight at 15°C and evaporated. The solid was
dissolved in 10 ml of methanol, and ether was added to precipitate of
1-(3-Methybutyl)-4-nitro-1H-pyrrole-2- carboxylic acid
[2-(N-methylcarbamimidoyl)-ethyl]-amide 259. White solid; Yield: (2.4,
94%) ES MS: 310.94 (M+ H+). H1-NMR (DMSO-d6): 0.86-0.88 (d, 6H,
CH3-isopentyl), 1.43-1.61 (m, 3H, CH & CH2-CH), 2.60-2.65 (t, 2H, CH2
CH2-amidine), 3,37 (s, 3H, CH3-NH), 3.49- 3.55 (m, 2H, CH2-NHCO),
4.33-4.38 (t, 2H, CH2-N), 7.51 and 8.18 (d, 1H, pyrrole), 8.73 (t, 1H,
NHCO).
$DTYPE RXN:VAR(1):NOTES
$DATUM HCl gas used, sealed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel compounds possessing antibacterial, antifungal or
antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wentao; Liehr, Sebastian Johannes R.; Velligan, Mark Douglas;
Dyatkina, Natalia B.; Botyanszki, Janos; Shi, Dong-Fang; Roberts,
Christopher Don; Khorlin, Alexander; Nelson, Peter Harold; Muchowski,
Joseph Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002000650 A2 2002-01-03

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
N-(3-Amino-3-iminopropyl)-1-(3-methylbutyl)-4-nitro-1H-pyrrole-2-carboxamide
C13H21N5O3
386252-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0432 5.8576 0.0 0
M  V30 2 C 2.5367 5.5373 0.0 0
M  V30 3 C 1.5063 6.6819 0.0 0
M  V30 4 C 1.9822 8.1464 0.0 0
M  V30 5 C 0.0000 6.3617 0.0 0
M  V30 6 C 7.3752 6.2078 0.0 0
M  V30 7 N 8.9152 6.2078 0.0 0
M  V30 8 O 6.6052 7.5415 0.0 0
M  V30 9 C 9.6852 7.5415 0.0 0
M  V30 10 C 11.2252 7.5415 0.0 0
M  V30 11 C 11.9952 8.8752 0.0 0
M  V30 12 N 11.2252 10.2088 0.0 0
M  V30 13 N 13.5353 8.8752 0.0 0
M  V30 14 N 6.2482 0.9051 0.0 0 VAL=5
M  V30 15 O 5.0022 0.0000 0.0 0
M  V30 16 O 7.6550 0.2787 0.0 0
M  V30 17 N 5.0736 4.7131 0.0 0
M  V30 18 C 6.6052 4.8740 0.0 0
M  V30 19 C 4.7534 3.2068 0.0 0
M  V30 20 C 7.2316 3.4672 0.0 0
M  V30 21 C 6.0871 2.4368 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 21
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Methylamino)-3-(methylimino)propyl]-1-(3-methylbutyl)-4-nitro-1H-pyrrol...
C15H25N5O3
386252-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2622 5.8577 0.0 0
M  V30 2 C 11.7686 5.5375 0.0 0
M  V30 3 C 12.7991 6.6821 0.0 0
M  V30 4 C 12.3232 8.1466 0.0 0
M  V30 5 C 14.3054 6.3619 0.0 0
M  V30 6 C 6.9302 6.2080 0.0 0
M  V30 7 N 5.3901 6.2080 0.0 0
M  V30 8 O 7.7002 7.5417 0.0 0
M  V30 9 C 4.6201 7.5417 0.0 0
M  V30 10 C 3.0801 7.5417 0.0 0
M  V30 11 C 2.3101 8.8754 0.0 0
M  V30 12 N 3.0801 10.2090 0.0 0
M  V30 13 N 0.7700 8.8754 0.0 0
M  V30 14 C 2.3101 11.5429 0.0 0
M  V30 15 C 0.0000 7.5417 0.0 0
M  V30 16 N 8.0571 0.9052 0.0 0 VAL=5
M  V30 17 O 6.6503 0.2789 0.0 0
M  V30 18 O 9.3032 0.0000 0.0 0
M  V30 19 N 9.2317 4.7133 0.0 0
M  V30 20 C 7.7002 4.8742 0.0 0
M  V30 21 C 9.5519 3.2070 0.0 0
M  V30 22 C 7.0737 3.4674 0.0 0
M  V30 23 C 8.2182 2.4369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12 CFG=2
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 2 16 18
M  V30 18 1 16 23
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 386252-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 386252-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-10140963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A; Synthesis of 1-(3-Methybutyl)-4-nitro-1H-pyrrole-2-carboxylic
acid [2-(N, N'-dimethylcarbamimidoyl)-ethyl]-amide 270. The solution of
1-(3-methybutyl)-4-nitro-1H-pyrrole-2-carboxylic acid (2-cyano-
ethyl)-amidine 242 (0.5g) in 50 ml of dry ethanol was cooled to 0-50C and
saturated with HCl gas. The mixture was sealed and refrigerated for 20
hours. The mixture was allowed to warm to room temperature and ethanol
was evaporated . The solid was dissolved in 10 ml of dry ethanol and 1M
solution of methylamine (6 ml) in methanol was added. The sealed mixture
was kept overnight at 55°C and evaporated. The solid was dissoved in 10
ml of methanol, and ether was added to precipitate of the target product.
White solid; Yield: (2.4 g, 94%). ES MS: 324.74 (M+ H+). 1 (DMSO-d6):
0.85-0.87 (d, 6H, CH3-isopentyl), 1.43-1.61 (m, 3H, CH & CH2-CH),
2.76-2.79 (m, 5H, CH2CH2-amidine and CH3-NH), 2.96-2.98 (d, 3H, CH3- NH),
3.46-3.55 (m, 2H, CH2-NHCO), 4.34-4.39 (t, 2H, CH2-N), 7.51 and 8.18 (d,
1H, pyrrole), 9.76 (t, 1H, NHCO).
$DTYPE RXN:VAR(1):NOTES
$DATUM HCl gas used, sealed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel compounds possessing antibacterial, antifungal or
antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wentao; Liehr, Sebastian Johannes R.; Velligan, Mark Douglas;
Dyatkina, Natalia B.; Botyanszki, Janos; Shi, Dong-Fang; Roberts,
Christopher Don; Khorlin, Alexander; Nelson, Peter Harold; Muchowski,
Joseph Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002000650 A2 2002-01-03

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Bis(3-pyridyl)-1,4-pentadien-3-one
C15H12N2O
3939-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 9.2400 4.0011 0.0 0
M  V30 8 C 10.0100 2.6674 0.0 0
M  V30 9 C 10.0100 5.3349 0.0 0
M  V30 10 C 11.5500 2.6674 0.0 0
M  V30 11 N 11.5500 5.3349 0.0 0
M  V30 12 C 12.3200 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 3.0800 1.3338 0.0 0
M  V30 16 C 0.0000 1.3338 0.0 0
M  V30 17 N 2.3100 0.0000 0.0 0
M  V30 18 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6 CFG=2
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2,6-di-3-pyridinyl-4-piperidinone
C16H17N3O
1275577-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 O 5.3348 0.0000 0.0 0
M  V30 3 C 4.0012 3.8501 0.0 0
M  V30 4 N 5.3348 4.6201 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 6.6685 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 3.8501 0.0 0
M  V30 11 C 2.6673 6.1601 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 N 1.3337 6.9302 0.0 0
M  V30 14 C 0.0000 6.1601 0.0 0
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 C 8.0023 6.1601 0.0 0
M  V30 17 C 9.3360 3.8501 0.0 0
M  V30 18 C 9.3360 6.9302 0.0 0
M  V30 19 N 10.6697 4.6201 0.0 0
M  V30 20 C 10.6697 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 15
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3939-04-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1275577-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6012250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methyl-2,6-di(pyridine-3-yl)piperidin-4-one (NW-B593). A suspension of
(1E,4E)-1,5-di(pyridin-3-yl)penta-1,4-dien-3-one (1 g, 3.2 mmol) in DMF
(10 mL) was treated with N-methylamine (40 % in H2O, 2.8 mL, 32 mmol) at
0 °C The solution was stirred for 6 h at 0 °C. The reaction mixture was
poured into ice-water (150 mL) and was extracted with DCM. The combined
organic layers were dried with MgSO4, filtered and evaporated in vacuo.
The crude product was purified by flash-chromatography (CH2CH/MeOH 9:1)
to obtain NW-B593 as a bright yellow solid (814 mg, 94%). mp: 103- 106°C.
1H NMR (300 MHz, CDCl3) δ (ppm): 8.67 (d, 4J= 1.8 Hz, 2H, HAr), 8.59 (dd,
3J= 4.8 HZ, 4J= 1.6 Hz, 2H, HAr), 7.85 (d, 3J= 7.9 Hz, 2H, HAr), 7.37
(dd, 3J= 7.9 Hz, 3J= 4.8 Hz, 2H, HAr), 3.58 (dd, 3J= 12.0 Hz, J= 2.8 Hz,
2H, CH2), 2.84 (t, 3J= 13.0 Hz, 2H, CH), 2.55 (dd, 3J= 13.9 Hz, J= 1.8
Hz, 2H, CH2), 1.64 (s, 3H, CH3). 13C NMR (75 MHz, CDCl3) δ (ppm): 204.9
(C), 149.4 (CH), 148.8 (CH), 138.1 (C), 134.8 (CH), 124.1 (CH), 67.5
(CH), 50.2 (CH2), 41.0 (CH3). MS (FAB) m/z: 268.2 (M+). Anal. calcd for
C16H17N3O · 0.3H2O: C 70.46, H 6.50, N 15.41, found: C 70.45, H 6.38, N
15.32%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dibenzylidene- and heteroarylideneacetone derivatives as kinetoplastideae
parasiticides and their preparation, pharmaceutical compositions and use
in the treatment of trypanosomiasis and leishmaniasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Davioud-Charvet, Elisabeth; Wenzel, Ingrid Nicole; Mueller, Thomas J.J.;
Hanquet, Gilles; Lanfranchi, Don Antoine; Leroux, Frederic; Gendron,
Thibault
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011033115 A2 2011-03-24

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3-pyridineacetic acid
C7H6BrNO2
39891-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 N 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-bromo-3-pyridineacetate
C8H8BrNO2
118650-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 N 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39891-12-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 118650-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30994784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6200 0.0 0
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-amino-3-(methylamino)-
C8H10N2O2
66630-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0011 0.0 0
M  V30 2 C 6.9301 2.6675 0.0 0
M  V30 3 N 4.6201 6.6686 0.0 0
M  V30 4 C 1.5400 1.3338 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 0.0000 1.3338 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 2.6675 0.0 0
M  V30 9 C 3.8500 5.3348 0.0 0
M  V30 10 C 2.3100 2.6675 0.0 0
M  V30 11 C 2.3100 5.3348 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-21-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 66630-74-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21635285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to
the Treatment of River Blindness: Part 1. Amide Linked Analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akama, Tsutomu; Freund, Yvonne R.; Berry, Pamela W.; Carter, David S.;
Easom, Eric E.; Jarnagin, Kurt; Lunde, Christopher S.; Plattner, Jacob
J.; Rock, Fernando; Stefanakis, Rianna; Fischer, Chelsea; Bulman,
Christina A.; Lim, Kee Chong; Suzuki, Brian M.; Tricoche, Nancy; Mansour,
Abdelmoneim; DiCosty, Utami; McCall, Scott; Carson, Ben; McCall, John W.;
McKerrow, James; Hubner, Marc P.; Specht, Sabine; Hoerauf, Achim;
Lustigman, Sara; Sakanari, Judy A.; Jacobs, Robert T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2020), 6(2), 173-179

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenoxybenzoyl chloride
C13H9ClO2
40501-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 1.5400 4.0011 0.0 0
M  V30 3 Cl 2.3100 5.3349 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 1.3338 0.0 0
M  V30 9 C 3.8500 0.0000 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 6
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenoxybenzamide
C14H13NO2
349400-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 N 9.2400 4.0011 0.0 0
M  V30 4 O 6.9300 5.3349 0.0 0
M  V30 5 C 10.0100 5.3349 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 7.7000 1.3338 0.0 0
M  V30 10 C 5.3900 0.0000 0.0 0
M  V30 11 C 6.9300 0.0000 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 7
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40501-36-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349400-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-methylbenz[g]imidazo[1,2-a]quinoxaline
C15H10ClN3
409369-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.3778 0.0000 0.0 0
M  V30 2 Cl 0.0000 5.7308 0.0 0
M  V30 3 C 4.0012 3.4207 0.0 0
M  V30 4 N 2.6675 2.6507 0.0 0
M  V30 5 C 4.0012 4.9608 0.0 0
M  V30 6 C 5.3348 2.6507 0.0 0
M  V30 7 C 1.3337 3.4207 0.0 0
M  V30 8 C 2.3472 1.1444 0.0 0
M  V30 9 C 5.3348 5.7308 0.0 0
M  V30 10 N 2.6675 5.7308 0.0 0
M  V30 11 C 6.6685 3.4207 0.0 0
M  V30 12 C 1.3337 4.9608 0.0 0
M  V30 13 N 0.1893 2.3903 0.0 0
M  V30 14 C 0.8156 0.9835 0.0 0
M  V30 15 C 6.6685 4.9608 0.0 0
M  V30 16 C 8.0023 2.6507 0.0 0
M  V30 17 C 8.0023 5.7308 0.0 0
M  V30 18 C 9.3360 3.4207 0.0 0
M  V30 19 C 9.3360 4.9608 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 2 10 12
M  V30 16 1 11 15
M  V30 17 2 11 16
M  V30 18 1 13 14
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethylbenz[g]imidazo[1,2-a]quinoxalin-4-amine
C16H14N4
409369-76-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.4494 0.4294 0.0 0
M  V30 2 N 9.2400 3.7035 0.0 0
M  V30 3 C 10.0100 5.0372 0.0 0
M  V30 4 N 5.3900 2.3699 0.0 0
M  V30 5 C 4.6200 3.7035 0.0 0
M  V30 6 C 6.9300 2.3699 0.0 0
M  V30 7 C 4.9141 0.9052 0.0 0
M  V30 8 C 5.3900 5.0372 0.0 0
M  V30 9 C 3.0800 3.7035 0.0 0
M  V30 10 C 7.7000 3.7035 0.0 0
M  V30 11 N 7.4059 0.9052 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 4.6200 6.3708 0.0 0
M  V30 14 N 6.9300 5.0372 0.0 0
M  V30 15 C 2.3100 5.0372 0.0 0
M  V30 16 C 3.0800 6.3708 0.0 0
M  V30 17 C 0.7700 5.0372 0.0 0
M  V30 18 C 2.3100 7.7046 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 14
M  V30 16 1 11 12
M  V30 17 1 13 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 409369-86-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 409369-76-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8472241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 4-amino derivatives of
benzimidazoquinoxaline, benzimidazoquinoline, and
benzopyrazoloquinazoline as potent IKK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beaulieu, Francis; Ouellet, Carl; Ruediger, Edward H.; Belema, Makonen;
Qiu, Yuping; Yang, Xuejie; Banville, Jacques; Burke, James R.; Gregor,
Kurt R.; MacMaster, John F.; Martel, Alain; McIntyre, Kim W.; Pattoli,
Mark A.; Zusi, F. Christopher; Vyas, Dolatrai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(5), 1233-1237

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-D-Galactopyranose, 2,3,4,6-tetraacetate 1-(4-nitrophenyl carbonate)
C21H23NO14
415918-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 9.2400 0.0 0
M  V30 2 C 6.6685 10.0100 0.0 0
M  V30 3 C 8.0021 9.2400 0.0 0
M  V30 4 O 6.6685 11.5500 0.0 0
M  V30 5 O 2.6674 7.7000 0.0 0
M  V30 6 C 2.6674 9.2400 0.0 0
M  V30 7 C 4.0011 10.0100 0.0 0
M  V30 8 O 1.3338 10.0100 0.0 0
M  V30 9 O 8.0021 7.7000 0.0 0
M  V30 10 C 9.3358 6.9300 0.0 0
M  V30 11 O 10.6694 7.7000 0.0 0
M  V30 12 O 9.3358 5.3900 0.0 0
M  V30 13 O 2.6674 4.6200 0.0 0
M  V30 14 C 1.3338 5.3900 0.0 0
M  V30 15 C 0.0000 4.6200 0.0 0
M  V30 16 O 1.3338 6.9300 0.0 0
M  V30 17 C 5.3347 3.0800 0.0 0
M  V30 18 O 6.6685 2.3100 0.0 0
M  V30 19 C 6.6685 0.7700 0.0 0
M  V30 20 C 5.3347 0.0000 0.0 0
M  V30 21 O 8.0021 0.0000 0.0 0
M  V30 22 N 16.0041 4.6200 0.0 0 VAL=5
M  V30 23 O 17.3379 5.3900 0.0 0
M  V30 24 O 16.0041 3.0800 0.0 0
M  V30 25 C 5.3347 7.7000 0.0 0 CFG=1
M  V30 26 C 4.0011 6.9300 0.0 0 CFG=1
M  V30 27 C 6.6685 6.9300 0.0 0 CFG=2
M  V30 28 C 4.0011 5.3900 0.0 0 CFG=1
M  V30 29 O 6.6685 5.3900 0.0 0
M  V30 30 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 31 C 12.0032 6.9300 0.0 0
M  V30 32 C 13.3369 7.7000 0.0 0
M  V30 33 C 12.0032 5.3900 0.0 0
M  V30 34 C 14.6705 6.9300 0.0 0
M  V30 35 C 13.3369 4.6200 0.0 0
M  V30 36 C 14.6705 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 25 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 27 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 31
M  V30 14 1 13 14
M  V30 15 1 28 13 CFG=3
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 17 18
M  V30 19 1 30 17 CFG=3
M  V30 20 1 18 19
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 22 23
M  V30 24 2 22 24
M  V30 25 1 22 36
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 32 2 31 32
M  V30 33 1 31 33
M  V30 34 1 32 34
M  V30 35 2 33 35
M  V30 36 2 34 36
M  V30 37 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 25 26 27 28 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C16H23NO11
2890149-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 7.7002 0.0 0
M  V30 2 C 2.6673 9.2402 0.0 0
M  V30 3 C 4.0012 10.0102 0.0 0
M  V30 4 O 1.3337 10.0102 0.0 0
M  V30 5 O 5.3348 9.2402 0.0 0
M  V30 6 C 6.6685 10.0102 0.0 0
M  V30 7 C 8.0022 9.2402 0.0 0
M  V30 8 O 6.6685 11.5503 0.0 0
M  V30 9 O 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 O 0.0000 4.6201 0.0 0
M  V30 13 O 8.0022 7.7002 0.0 0
M  V30 14 C 9.3360 6.9302 0.0 0
M  V30 15 N 10.6697 7.7002 0.0 0
M  V30 16 O 9.3360 5.3901 0.0 0
M  V30 17 C 12.0033 6.9302 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 O 6.6685 2.3101 0.0 0
M  V30 20 C 6.6685 0.7700 0.0 0
M  V30 21 C 8.0022 0.0000 0.0 0
M  V30 22 O 5.3348 0.0000 0.0 0
M  V30 23 C 4.0012 6.9302 0.0 0 CFG=1
M  V30 24 C 5.3348 7.7002 0.0 0 CFG=1
M  V30 25 C 4.0012 5.3901 0.0 0 CFG=1
M  V30 26 C 6.6685 6.9302 0.0 0 CFG=2
M  V30 27 C 5.3348 4.6201 0.0 0 CFG=1
M  V30 28 O 6.6685 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 24 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 25 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=3
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 27 18 CFG=3
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 415918-01-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2890149-41-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35688650
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hajjaj, Bouchra; MacCormick, Somhairle; Veeneman, Gerrit Herman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022271018 A1 2022-12-29

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-iodobenzoic acid
C12H14INO4
445479-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 8.5660 4.4137 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 10.1060 1.7464 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 O 4.0012 0.0000 0.0 0
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 I 0.0000 5.3901 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H17IN2O3
2249913-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 8.0023 3.8501 0.0 0
M  V30 4 O 6.6685 6.1601 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.1060 3.2864 0.0 0
M  V30 7 C 10.6697 5.3901 0.0 0
M  V30 8 C 8.5660 5.9538 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0
M  V30 11 O 4.0012 1.5400 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 I 0.0000 6.9302 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 445479-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2249913-96-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20869985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino-aryl-benzamide compounds useful for treatment of
fatty liver disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Ke; Wang, Belle Xiaohong; Li, Yongmei; Li, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018204775 A1 2018-11-08

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Ethyl 5,6,7,8-tetrafluoro-4-oxo-2-phenyl-4H-1-benzopyran-3-carboxylate
C18H10F4O4
4517-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 5.3347 0.0 0
M  V30 2 O 2.3100 6.6684 0.0 0
M  V30 3 O 2.3100 4.0011 0.0 0
M  V30 4 C 0.7700 6.6684 0.0 0
M  V30 5 C 0.0000 8.0021 0.0 0
M  V30 6 O 4.6200 8.0021 0.0 0
M  V30 7 F 10.0100 4.0011 0.0 0
M  V30 8 F 6.9300 9.3358 0.0 0
M  V30 9 F 11.5500 6.6684 0.0 0
M  V30 10 F 10.0100 9.3358 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 O 6.9300 4.0011 0.0 0
M  V30 14 C 5.3900 6.6684 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 6.6684 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 18 C 7.7000 8.0021 0.0 0
M  V30 19 C 10.0100 6.6684 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 4.6200 2.6674 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 2.3100 1.3336 0.0 0
M  V30 25 C 4.6200 0.0000 0.0 0
M  V30 26 C 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 14
M  V30 7 1 7 17
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 1 10 20
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 21
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanamine, sulfate (1:?)
CH5N.xH2O4S
74356-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 3.0800 0.0 0 VAL=6
M  V30 2 O 0.0000 3.0800 0.0 0
M  V30 3 O 3.0800 3.0800 0.0 0
M  V30 4 O 1.5400 1.5400 0.0 0
M  V30 5 O 1.5400 4.6200 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 N 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,8-Trifluoro-7-(methylamino)-3-[(methylamino)phenylmethylene]-2H-1-benzopy...
C18H13F3N2O3
1443627-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 0.7700 0.0 0
M  V30 2 F 9.3360 0.7700 0.0 0
M  V30 3 F 9.3360 6.9302 0.0 0
M  V30 4 C 4.0010 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 F 12.0033 2.3101 0.0 0
M  V30 8 N 12.0033 5.3901 0.0 0
M  V30 9 C 13.3370 4.6201 0.0 0
M  V30 10 O 4.0010 5.3901 0.0 0
M  V30 11 C 8.0022 3.0801 0.0 0
M  V30 12 C 8.0022 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 O 6.6685 5.3901 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 10.6697 3.0801 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 1.3337 5.3901 0.0 0
M  V30 25 C 0.0000 3.0801 0.0 0
M  V30 26 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 2 4 17 CFG=2
M  V30 6 1 4 21
M  V30 7 1 5 6
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 1 8 19
M  V30 11 2 10 20
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4517-87-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74356-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1443627-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14605718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of flavones IIIа, IIIb and chromone
VII with amines. To a solution of 1 mmol of compound IIIа, IIIb, VII in
15 ml of an appropriate solvent was added 1 mmol of amine (or 1 mmol of
methylamine sulfate at the preparation of ester Vb, coumarins mixture
VIb, VII, 2 mmol for the synthesis of coumarin X). Ethanol or
acetonitrile were used in the syntheses of compounds Vа-Ve, XII, VIа,
VIb, VId, VIe, X, XIII, DMSO, for preparation of chromones XIа, XIb. The
reaction mixture was vigorously stirred for 24 h at 25°С (at the
synthesis of compounds Vа-Ve, XII, IVа-IVc, VIIIа, VIIIb, XIа, Xb, XIII)
or at 50°С (at the synthesis of coumarins VIа, VIb, VId, VIe, X). The
reaction progress was monitored by TLC. The solvent was distilled off,
the solid residue was crystallized from an appropriate solvent. The
mixtures of esters Vd, Ve or coumarins VId, VIe, and also the mixture of
coumarins VIb, X were separated by column chromatography, eluent
chloroform. 7-(Methylamino)-3-[(methylamino)(phenyl)
methylidene]-5,6,8-trifluoro-2Н-chromene-2,4(3Н)- dione (X). Yield 0.341
g (94%), yellow powder. Mp 221°С (from ethanol). 1Н NMR spectrum, δ, ppm:
2.80 s (3Н, С7NHCH3), 3.33 s (3Н, C9NHCH3), 6.62 br.s (С7NHCH3),
7.28-7.51 m (5Н, СН, 12.19 br.s (1Н, C9NHCH3). 19F NMR spectrum, δ, ppm:
-1.37 m, 1.59 m, 14.09 m (1F each). Found, %: C 63.18; H 4.59; F 15.61; N
8.05. С19Н15F3N2O2. Calculated, %: C 63.33; H 4.20; F 15.82; N 7.77.
$DTYPE RXN:VAR(1):NOTES
$DATUM acetonitrile can be used as alternative solvent, product depends on
reaction temperature, product depends on methylamine sulfate amount,
chromone-coumarin rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Features of reactions of polyfluorinated ethyl
4-oxo-2-phenyl-4H-chromene-3-carboxylates with N-nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, K. V.; Burgart, Ya. V.; Saloutin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2013), 49(5), 719-729

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-nitropyridine
C5H3ClN2O2
4548-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Dimethylamino-5-aminopyridine
C7H11N3
4928-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4548-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4928-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29683148
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-2,N-2-Dimethyl-pyridine-2,5-diamine A solution of
2-chloro-5-nitro-pyridine (10 g, 63.1 mmol) in EtOH (170 ml) was treated
dropwise with dimethylamine (25% solution in H2O 43 ml, 210 mmol). The
mixture was heated to 80°C. for 1 h and then allowed to cool to RT. A
precipitate formed and it was filtered, washed with cold EtOH, and dried.
This solid was then diluted with THF, treated with Pd/C (10%, 655 mg) and
stirred at RT under H2 for 1 h. The mixture was then filtered and
concentrated in vacuo to give N-2,N-2-dimethyl-pyridine-2,5-diamine. Red
liquid, yield (6.8 g, 94%). HPLC (System 1, 0-100% CH3CN): tR=0.858 min,
TLC (EtOAc/NH3 99:1): Rf=0.38.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazoles and related compounds as modulators of
metabotropic glutamate receptor-5 for treating gastrointestinal, urinary,
and nervous system disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glatthar, Ralf; Carcache, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090105266 A1 2009-04-23

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-nitropyridine
C5H3ClN2O2
4548-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Dimethylamino-5-aminopyridine
C7H11N3
4928-43-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 N 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 N 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4548-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4928-43-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23682701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: The starting
material is prepared as described below:
7-Chloro-2-(5,6-dichloro-pyridin-3-yl)-1-propyl-1H-benzoimidazole. A
mixture of 5,6-dichloro-nicotinic acid (25 g, 128 mmol) and SOCl2 (10.6
ml, 146 mmol) in toluene (125 ml) was treated with DMF (197 μl, 2.55
mmol) at RT and the mixture was then heated to 100 °C for 18 h. The
mixture was allowed to cool to RT and then concentrated in vacuo to give
the crude acid chloride, which was diluted in anhydrous THF (500 ml) and
treated with 3-chloro-N-2-propyl-benzene-1,2-diamine (24.6 g, 133 mmol).
The solution was stirred at RT for 2 h, and then heated to 60 °C for 4 h.
the mixture was cooled to RT and stirred for 18 h. The precipitate was
filtered and dried in vacuo. The crude product was taken up in EtOAc and
washed with a sat. aq. soln. of NaHCO3, dried over Na2SO4, filtered and
concentrated in vacuo to give pure
7-chloro-2-(5,6-dichloro-pyridin-3-yl)-1-propyl-1H-benzoimidazole (30.3
g, 67 %). Example 59:
[3-Chloro-5-(7-chloro-1-propyl-1H-benzoimidazol-2-yl)-pyridin-2-yl]-pyridin-4-yl-amine.
A mixture of
7-chloro-2-(5,6-dichloro-pyridin-3-yl)-1-propyl-1H-benzoimidazole (800
mg, 2.35 mmol), 4-aminopyridine (271 mg, 2.82 mmol), Pd(OAc)2 (11 mg,
0.05 mmol), rac- BINAP (29 mg, 0.05 mmol), and CS2CO3 (3.9 g, 11.7 mmol)
in toluene (20 ml) was heated to reflux for 18 h. It was then allowed to
cool to RT and the mixture was filtered. The filtrate was concentrated in
vacuo and the crude product was purified by flash chromatography
(Hex/EtOAc 100:0 to 0:100)) and re-crystallization from Hex/EtOAc. The
starting material is prepared as described below:.
N-2,N-2-Dimethyl-pyridine-2,5-diamine. A solution of
2-chloro-5-nitro-pyridine (10 g, 63.1 mmol) in EtOH (170 ml) was treated
dropwise with dimethylamine (25% solution in H2O 43 ml, 210 mmol). The
mixture was heated to 80 °C for 1 h and then allowed to cool to RT. A
precipitate formed and it was filtered, washed with cold EtOH, and dried.
This solid was then diluted with THF, treated with Pd/C (10%, 655 mg) and
stirred at RT under H2. for 1h. The mixture was then filtered and
concentrated in vacuo to give N-2,N-2-dimethyl-pyridine-2,5-diamine as a
red liquid (6.8 g, 94%). HPLC (System 1,0-100% CH3CN): tR = 0.858 min,
TLC (EtOAc/NH3 99:1): Rf = 0.38.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzimidazoles and related compounds as modulators of
metabotropic glutamate receptor-5 for treating gastrointestinal, urinary,
and nervous system disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Glatthar, Ralf; Carcache, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008128968 A1 2008-10-30

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Trifluoromethyl)benzaldehyde
C8H5F3O
454-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethyl)benzenemethanamine
C9H10F3N
90390-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 2.1037 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5637 1.7464 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 N 8.0023 2.3101 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 454-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90390-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiophosgene
CCl2S
463-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl isothiocyanate
C2H3NS
556-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 N 2.6673 0.0000 0.0 0
M  V30 3 S 0.0000 1.5400 0.0 0
M  V30 4 C 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 463-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 556-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-16629701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 471-34-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-amino-1,3-thiazoles suppressed lipopolysaccharide-induced IL-β and
TNF-α
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nam, Kee Dal; Han, Minsoo; Yoon, Jun; Kim, Eun-A.; Cho, Sung-Woo; Hahn,
Hoh-Gyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2013), 34(1), 271-274

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-methanamine
C10H12N2
36284-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 C 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36284-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1396681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 16 Preparation of 3-(methylaminomethyl)-1H-indole a)
3-(Methylaminomethyl)-1H-indole [0690] To a solution of
indole-3-carboxaldehyde (5.4 g, 34.1 mmole) in MeOH (30 mL) was added a
solution of 2.0 M CH3NH2 in MeOH (51.3 mL, 102.6 mmole). The reaction was
stirred at RT overnight, then was concentrated to a light yellow oil.
This oil was dissolved in EtOH (40 mL), and NaBH4 (1.3 g, 34.1 mmole) was
added. After 16 hrs the reaction was concentrated to a slurry and
dissolved in 10% Na2CO3 (100 mL). The aqueous solution was extracted with
EtOAc (2×200 mL) and the combined organic fractions were dried over
Na2SO4 and concentrated. Drying in high vacuum left the title compound
(5.2 g, 94%) as a faintly yellow oil. MS (ES) m/e 161 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-methanamine
C10H12N2
36284-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 C 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36284-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-300079
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-methanamine
C10H12N2
36284-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 C 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36284-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11209801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-3-carboxaldehyde
C9H7NO
487-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1884 0.0 0
M  V30 2 O 7.1954 2.7125 0.0 0
M  V30 3 C 3.0800 2.4782 0.0 0
M  V30 4 C 2.3100 1.1444 0.0 0
M  V30 5 C 4.5864 2.1580 0.0 0
M  V30 6 C 2.3100 3.8118 0.0 0
M  V30 7 N 3.3405 0.0000 0.0 0
M  V30 8 C 0.7700 1.1444 0.0 0
M  V30 9 C 4.7473 0.6263 0.0 0
M  V30 10 C 0.7700 3.8118 0.0 0
M  V30 11 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-methanamine
C10H12N2
36284-95-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 C 8.3399 3.7431 0.0 0
M  V30 4 C 3.0801 2.4782 0.0 0
M  V30 5 C 2.3101 1.1444 0.0 0
M  V30 6 C 4.5864 2.1580 0.0 0
M  V30 7 C 2.3101 3.8119 0.0 0
M  V30 8 N 3.3405 0.0000 0.0 0
M  V30 9 C 0.7700 1.1444 0.0 0
M  V30 10 C 4.7473 0.6263 0.0 0
M  V30 11 C 0.7700 3.8119 0.0 0
M  V30 12 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 487-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36284-95-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6185001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 51. Preparation of 1-benzyl-3-(methylaminomethyl)-1H-indole.
a) 3-(Methylaminomethyl)-1H-indole. To a solution of
indole-3-carboxaldehyde (5.4 g, 34.1 mmole) in MeOH (30 mL) was added a
solution of 2.0 M CH3NH2 in MeOH (51.3 mL, 102.6 mmole). The reaction was
stirred at RT overnight, then was concentrated to a light yellow oil.
This oil was dissolved in EtOH (40 mL), and NaBH4 (1.3 g, 34.1 mmole) was
added. After 16 hrs the reaction was concentrated to a slurry and
dissolved in 10% Na2CO3(100 mL). The aqueous solution was extracted with
EtOAc (2 × 200 mL) and the combined organic fractions were dried over
Na2SO4 and concentrated. Drying in high vacuum left the title compound.
Yield: (5.2 g, 94%) as a faintly yellow oil. MS (ES) m/e 161 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME123 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzenesulfonyl chloride
C7H4ClNO2S
49584-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Cyanophenyl)sulfonyl]-N,2-dimethyl-2-propenamide
C12H12N2O3S
2595973-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 N 12.3200 2.6673 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 14 C 6.9300 1.3336 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 8.4700 1.3336 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 3 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 49584-26-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2595973-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME124 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thiourea
CH4N2S
62-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 2.3101 0.0 0
M  V30 3 N 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tetrahydro-5-methyl-1,3,5-triazine-2(1H)-thione
C4H9N3S
6746-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 0.0000 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 N 2.3100 0.0000 0.0 0
M  V30 5 N 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62-56-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6746-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41471511
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of new functionalized thiazolidin-4-ones by the condensation of
thioureas with dialkyl acetylenedicarboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Streltsov, Andrey A.; Izmest'ev, Alexei N.; Strelenko, Yurii A.;
Kravchenko, Angelina N.; Gazieva, Galina A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Mendeleev Communications (2024), 34(4), 563-565

$RFMT $RIREG SCHEME125 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Binaphthalene]-2,2′,7,7′-tetrol, (1R)-
C20H14O4
69677-99-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 4.6201 0.0 0
M  V30 2 O 2.6673 3.0801 0.0 0
M  V30 3 O 0.0000 4.6201 0.0 0
M  V30 4 O 10.6697 3.0801 0.0 0
M  V30 5 C 5.3348 4.6201 0.0 0
M  V30 6 C 4.0012 5.3901 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 C 4.0012 6.9302 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 6.6685 6.9302 0.0 0
M  V30 11 C 5.3348 7.7002 0.0 0
M  V30 12 C 2.6673 7.7002 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 6.6685 0.7700 0.0 0
M  V30 19 C 8.0023 3.0801 0.0 0
M  V30 20 C 4.0012 0.7700 0.0 0
M  V30 21 C 5.3348 0.0000 0.0 0
M  V30 22 C 8.0023 0.0000 0.0 0
M  V30 23 C 9.3360 2.3101 0.0 0
M  V30 24 C 9.3360 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 17
M  V30 3 1 3 13
M  V30 4 1 4 23
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 11
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 2 20 21
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(10R)-2,2′,3,3′-Tetrahydro-2,2′-dimethyl[10,10′-bi-1H-naphth[1,2-e][1,3]oxazi...
C26H24N2O4
1574389-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 1.1550 0.0 0
M  V30 2 O 6.0015 7.7000 0.0 0
M  V30 3 C 5.3347 8.8550 0.0 0
M  V30 4 C 6.0015 0.0000 0.0 0
M  V30 5 C 2.6673 4.2350 0.0 0
M  V30 6 C 4.0011 3.4650 0.0 0
M  V30 7 C 2.6673 5.7750 0.0 0
M  V30 8 C 1.3336 3.4650 0.0 0
M  V30 9 C 4.0011 1.9250 0.0 0
M  V30 10 C 1.3336 6.5450 0.0 0
M  V30 11 C 4.0011 6.5450 0.0 0
M  V30 12 C 0.0000 4.2350 0.0 0
M  V30 13 C 1.3336 1.9250 0.0 0
M  V30 14 C 2.6673 1.1550 0.0 0
M  V30 15 C 0.0000 5.7750 0.0 0
M  V30 16 O 1.3336 8.0850 0.0 0
M  V30 17 N 4.0011 8.0850 0.0 0
M  V30 18 C 2.6673 8.8550 0.0 0
M  V30 19 C 7.3352 5.3900 0.0 0
M  V30 20 C 8.6690 4.6200 0.0 0
M  V30 21 C 7.3352 6.9300 0.0 0
M  V30 22 C 8.6690 3.0800 0.0 0
M  V30 23 C 10.0026 5.3900 0.0 0
M  V30 24 C 8.6690 7.7000 0.0 0
M  V30 25 C 10.0026 2.3100 0.0 0
M  V30 26 C 7.3352 2.3100 0.0 0
M  V30 27 C 11.3362 4.6200 0.0 0
M  V30 28 C 10.0026 6.9300 0.0 0
M  V30 29 C 11.3362 3.0800 0.0 0
M  V30 30 O 10.0026 0.7700 0.0 0
M  V30 31 N 7.3352 0.7700 0.0 0
M  V30 32 C 8.6690 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 21
M  V30 3 1 3 17
M  V30 4 1 4 31
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 19
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 8 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 1 12 15
M  V30 19 2 13 14
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 22 25
M  V30 28 1 22 26
M  V30 29 2 23 27
M  V30 30 1 23 28
M  V30 31 2 24 28
M  V30 32 2 25 29
M  V30 33 1 25 30
M  V30 34 1 26 31
M  V30 35 1 27 29
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 69677-99-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1574389-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15248584
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of enantiomerically pure helicene like bis-oxazines from
atropisomeric 7,7'-dihydroxy BINOL: preliminary measurements of the
circularly polarized luminescence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shyam Sundar, M.; Talele, Harish R.; Mande, Hemant M.; Bedekar, Ashutosh
V.; Tovar, Roberto C.; Muller, Gilles
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(10), 1760-1764

$RFMT $RIREG SCHEME126 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Eugenol
C10H12O2
97-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-8-methoxy-3-methyl-6-(2-propen-1-yl)-2H-1,3-benzoxazine
C13H17NO2
1628226-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 5.3901 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 C 0.0000 7.7002 0.0 0
M  V30 6 C 9.3360 5.3901 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 5.3901 0.0 0
M  V30 10 C 6.6685 5.3901 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 O 6.6685 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 N 8.0023 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 16 C 8.0023 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 97-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628226-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-10746966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and brine shrimp lethality test of some benzoxazine and
aminomethyl derivatives of eugenol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudyanto, Marcellino; Ekowati, Juni; Widiandani, Tri; Honda, Toshio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmacy and Pharmaceutical Sciences (2014),
6(Suppl. 2), 465-467

$RFMT $RIREG SCHEME126 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Eugenol
C10H12O2
97-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 6.1600 4.0011 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 C 8.4700 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-8-methoxy-3-methyl-6-(2-propen-1-yl)-2H-1,3-benzoxazine
C13H17NO2
1628226-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.7700 0.0 0
M  V30 2 C 2.6675 0.0000 0.0 0
M  V30 3 C 1.3337 5.3901 0.0 0
M  V30 4 C 1.3337 6.9302 0.0 0
M  V30 5 C 0.0000 7.7002 0.0 0
M  V30 6 C 9.3360 5.3901 0.0 0
M  V30 7 C 5.3348 4.6201 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 5.3901 0.0 0
M  V30 10 C 6.6685 5.3901 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 O 6.6685 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 N 8.0023 4.6201 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 16 C 8.0023 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 97-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1628226-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-10652894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and brine shrimp lethality test of some benzoxazine and
aminomethyl derivatives of eugenol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudyanto, Marcellino; Ekowati, Juni; Widiandani, Tri; Honda, Toshio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Pharmacy and Pharmaceutical Sciences (2014),
6(2), 96-98, 3 pp.

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-methyl-2-phenylthieno[2,3-d]pyrimidine
C13H9ClN2S
500694-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6506 0.0000 0.0 0
M  V30 2 C 0.0000 1.9570 0.0 0
M  V30 3 C 3.4206 4.0011 0.0 0
M  V30 4 C 2.6506 2.6673 0.0 0
M  V30 5 N 4.9606 4.0011 0.0 0
M  V30 6 S 2.3902 5.1454 0.0 0
M  V30 7 C 3.4206 1.3336 0.0 0
M  V30 8 C 1.1444 2.9876 0.0 0
M  V30 9 C 5.7306 2.6673 0.0 0
M  V30 10 C 0.9834 4.5191 0.0 0
M  V30 11 N 4.9606 1.3336 0.0 0
M  V30 12 C 7.2706 2.6673 0.0 0
M  V30 13 C 8.0406 4.0011 0.0 0
M  V30 14 C 8.0406 1.3336 0.0 0
M  V30 15 C 9.5806 4.0011 0.0 0
M  V30 16 C 9.5806 1.3336 0.0 0
M  V30 17 C 10.3506 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-d]pyrimidin-4-amine, N,5-dimethyl-2-phenyl-
C14H13N3S
3032519-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6507 1.3337 0.0 0
M  V30 2 C 3.4207 0.0000 0.0 0
M  V30 3 C 0.0000 3.2907 0.0 0
M  V30 4 C 2.6507 4.0011 0.0 0
M  V30 5 C 3.4207 5.3348 0.0 0
M  V30 6 C 3.4207 2.6673 0.0 0
M  V30 7 C 1.1444 4.3213 0.0 0
M  V30 8 N 4.9607 5.3348 0.0 0
M  V30 9 S 2.3903 6.4792 0.0 0
M  V30 10 N 4.9607 2.6673 0.0 0
M  V30 11 C 0.9835 5.8528 0.0 0
M  V30 12 C 5.7307 4.0011 0.0 0
M  V30 13 C 7.2707 4.0011 0.0 0
M  V30 14 C 8.0407 5.3348 0.0 0
M  V30 15 C 8.0407 2.6673 0.0 0
M  V30 16 C 9.5808 5.3348 0.0 0
M  V30 17 C 9.5808 2.6673 0.0 0
M  V30 18 C 10.3508 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 1 12 13
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500694-83-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032519-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34552021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidine-Core Compounds Show Activity against Clinically
Relevant Gram-Positive Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riabova, Olga; Egorova, Anna; Lepioshkin, Alexander; Li, Yan; Voigt,
Kerstin; Kloss, Florian; Makarov, Vadim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2022), 17(17), e202200207

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
α-D-Mannopyranose, 2-azido-2-deoxy-6-O-[(1,1-dimethylethyl)dimethylsilyl]-2-C...
C44H59N3O7Si2
500783-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  56 60 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3847 8.1708 0.0 0
M  V30 2 O 4.8681 8.4383 0.0 0
M  V30 3 Si 4.3414 9.8853 0.0 0
M  V30 4 C 5.7886 10.4121 0.0 0
M  V30 5 C 5.2619 11.8592 0.0 0
M  V30 6 C 7.2357 10.9388 0.0 0
M  V30 7 C 6.3152 8.9650 0.0 0
M  V30 8 N 5.3948 6.4563 0.0 0
M  V30 9 N 4.8681 5.0092 0.0 0 CHG=1 VAL=4
M  V30 10 N 4.3414 3.5620 0.0 0 CHG=-1
M  V30 11 O 8.2452 9.0336 0.0 0
M  V30 12 C 9.5788 9.8036 0.0 0
M  V30 13 O 5.5777 4.4136 0.0 0
M  V30 14 O 10.9124 7.4936 0.0 0
M  V30 15 C 12.2461 6.7236 0.0 0
M  V30 16 C 10.9124 4.4136 0.0 0
M  V30 17 O 10.9124 2.8736 0.0 0
M  V30 18 Si 12.2461 2.1036 0.0 0
M  V30 19 C 13.5799 1.3336 0.0 0
M  V30 20 C 11.4761 0.7700 0.0 0
M  V30 21 C 13.0161 3.4373 0.0 0
M  V30 22 C 14.3499 2.6673 0.0 0
M  V30 23 C 14.9135 0.5636 0.0 0
M  V30 24 C 12.8099 0.0000 0.0 0
M  V30 25 O 17.5809 9.8036 0.0 0
M  V30 26 C 18.9146 9.0336 0.0 0
M  V30 27 C 6.9114 6.7236 0.0 0 CFG=1
M  V30 28 C 8.2452 7.4936 0.0 0 CFG=1
M  V30 29 C 6.9114 5.1836 0.0 0 CFG=1
M  V30 30 C 9.5788 6.7236 0.0 0 CFG=2
M  V30 31 O 8.2452 4.4136 0.0 0
M  V30 32 C 9.5788 5.1836 0.0 0 CFG=1
M  V30 33 C 9.5788 11.3436 0.0 0
M  V30 34 C 10.9124 12.1136 0.0 0
M  V30 35 C 8.2452 12.1136 0.0 0
M  V30 36 C 10.9124 13.6536 0.0 0
M  V30 37 C 8.2452 13.6536 0.0 0
M  V30 38 C 9.5788 14.4236 0.0 0
M  V30 39 C 3.8147 11.3324 0.0 0
M  V30 40 C 4.8046 12.5122 0.0 0
M  V30 41 C 2.2981 11.5999 0.0 0
M  V30 42 C 4.2778 13.9593 0.0 0
M  V30 43 C 1.7715 13.0470 0.0 0
M  V30 44 C 2.7612 14.2267 0.0 0
M  V30 45 C 2.8943 9.3586 0.0 0
M  V30 46 C 1.7146 10.3485 0.0 0
M  V30 47 C 2.6269 7.8420 0.0 0
M  V30 48 C 0.2675 9.8218 0.0 0
M  V30 49 C 1.1798 7.3153 0.0 0
M  V30 50 C 0.0000 8.3052 0.0 0
M  V30 51 C 13.5799 7.4936 0.0 0
M  V30 52 C 14.9135 6.7236 0.0 0
M  V30 53 C 13.5799 9.0336 0.0 0
M  V30 54 C 16.2472 7.4936 0.0 0
M  V30 55 C 14.9135 9.8036 0.0 0
M  V30 56 C 16.2472 9.0336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 27 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 39
M  V30 6 1 3 45
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 4 7
M  V30 10 2 8 9
M  V30 11 1 27 8 CFG=1
M  V30 12 2 9 10
M  V30 13 1 11 12
M  V30 14 1 28 11 CFG=1
M  V30 15 1 12 33
M  V30 16 1 29 13 CFG=3
M  V30 17 1 14 15
M  V30 18 1 30 14 CFG=3
M  V30 19 1 15 51
M  V30 20 1 16 17
M  V30 21 1 32 16 CFG=1
M  V30 22 1 17 18
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 1 19 23
M  V30 28 1 19 24
M  V30 29 1 25 26
M  V30 30 1 25 56
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 49 2 45 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 2 47 49
M  V30 53 2 48 50
M  V30 54 1 49 50
M  V30 55 2 51 52
M  V30 56 1 51 53
M  V30 57 1 52 54
M  V30 58 2 53 55
M  V30 59 2 54 56
M  V30 60 1 55 56
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 27 28 29 30 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Mannonamide, 2-azido-2-deoxy-6-O-[(1,1-dimethylethyl)dimethylsilyl]-2-C-[[[...
C45H62N4O7Si2
344615-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 61 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 10.3673 0.0 0
M  V30 2 O 6.1600 10.3673 0.0 0
M  V30 3 C 4.6200 8.8273 0.0 0
M  V30 4 C 6.9300 9.0336 0.0 0
M  V30 5 C 3.0800 8.8273 0.0 0
M  V30 6 C 4.6200 7.2873 0.0 0
M  V30 7 C 6.1600 8.8273 0.0 0
M  V30 8 C 8.4700 9.0336 0.0 0 CFG=1
M  V30 9 C 8.4700 7.4936 0.0 0 CFG=1
M  V30 10 C 8.4700 10.5736 0.0 0
M  V30 11 N 10.0100 9.0336 0.0 0
M  V30 12 C 9.8036 6.7236 0.0 0 CFG=1
M  V30 13 O 7.1364 6.7236 0.0 0
M  V30 14 N 9.8036 11.3436 0.0 0
M  V30 15 O 7.1364 11.3436 0.0 0
M  V30 16 N 10.7800 10.3673 0.0 0 CHG=1 VAL=4
M  V30 17 O 11.1373 7.4936 0.0 0
M  V30 18 C 9.8036 5.1836 0.0 0 CFG=2
M  V30 19 C 7.1364 5.1836 0.0 0
M  V30 20 C 9.8036 12.8836 0.0 0
M  V30 21 N 11.5500 11.7011 0.0 0 CHG=-1
M  V30 22 C 12.4711 6.7236 0.0 0
M  V30 23 C 8.4700 4.4136 0.0 0
M  V30 24 O 11.1373 4.4136 0.0 0
M  V30 25 O 8.4700 2.8736 0.0 0
M  V30 26 Si 9.8036 2.1036 0.0 0
M  V30 27 C 11.1373 1.3336 0.0 0
M  V30 28 C 9.0336 0.7700 0.0 0
M  V30 29 C 10.5736 3.4373 0.0 0
M  V30 30 C 11.9073 2.6673 0.0 0
M  V30 31 C 12.4711 0.5636 0.0 0
M  V30 32 C 10.3673 0.0000 0.0 0
M  V30 33 O 17.8058 9.8036 0.0 0
M  V30 34 C 19.1394 9.0336 0.0 0
M  V30 35 C 3.0800 10.3673 0.0 0
M  V30 36 C 2.3100 9.0336 0.0 0
M  V30 37 C 2.3100 11.7011 0.0 0
M  V30 38 C 0.7700 9.0336 0.0 0
M  V30 39 C 0.7700 11.7011 0.0 0
M  V30 40 C 0.0000 10.3673 0.0 0
M  V30 41 C 4.6200 11.9073 0.0 0
M  V30 42 C 3.2864 12.6773 0.0 0
M  V30 43 C 5.9536 12.6773 0.0 0
M  V30 44 C 3.2864 14.2173 0.0 0
M  V30 45 C 5.9536 14.2173 0.0 0
M  V30 46 C 4.6200 14.9873 0.0 0
M  V30 47 C 5.8026 4.4136 0.0 0
M  V30 48 C 4.4689 5.1836 0.0 0
M  V30 49 C 5.8026 2.8736 0.0 0
M  V30 50 C 3.1353 4.4136 0.0 0
M  V30 51 C 4.4689 2.1036 0.0 0
M  V30 52 C 3.1353 2.8736 0.0 0
M  V30 53 C 13.8047 7.4936 0.0 0
M  V30 54 C 15.1384 6.7236 0.0 0
M  V30 55 C 13.8047 9.0336 0.0 0
M  V30 56 C 16.4721 7.4936 0.0 0
M  V30 57 C 15.1384 9.8036 0.0 0
M  V30 58 C 16.4721 9.0336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 35
M  V30 4 1 1 41
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=1
M  V30 12 1 8 11 CFG=3
M  V30 13 1 9 12
M  V30 14 1 9 13 CFG=3
M  V30 15 1 10 14
M  V30 16 2 10 15
M  V30 17 2 11 16
M  V30 18 1 12 17 CFG=3
M  V30 19 1 12 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 2 16 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 1 18 24 CFG=3
M  V30 26 1 19 47
M  V30 27 1 22 53
M  V30 28 1 23 25
M  V30 29 1 25 26
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 26 29
M  V30 33 1 27 30
M  V30 34 1 27 31
M  V30 35 1 27 32
M  V30 36 1 33 34
M  V30 37 1 33 58
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 44 2 41 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 2 43 45
M  V30 48 2 44 46
M  V30 49 1 45 46
M  V30 50 2 47 48
M  V30 51 1 47 49
M  V30 52 1 48 50
M  V30 53 2 49 51
M  V30 54 2 50 52
M  V30 55 1 51 52
M  V30 56 2 53 54
M  V30 57 1 53 55
M  V30 58 1 54 56
M  V30 59 2 55 57
M  V30 60 2 56 58
M  V30 61 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 500783-32-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 344615-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25678129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 87413-09-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7772-98-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of sphingofungin E from D-glucose derivative
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nakamura, Tsuyoshi; Shiozaki, Masao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(43), 8779-8791

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[[[2-oxo-2-[2-[[(1S)-1-phenylethyl]amino]-4-pyridinyl]-1-[3-(t...
C36H35F3N4O4
501901-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.3200 6.6685 0.0 0 CFG=3
M  V30 2 C 13.8600 6.6685 0.0 0
M  V30 3 N 11.5500 8.0021 0.0 0
M  V30 4 O 14.6300 5.3347 0.0 0
M  V30 5 C 10.0100 8.0021 0.0 0
M  V30 6 O 9.2400 6.6685 0.0 0
M  V30 7 C 12.3200 1.3338 0.0 0
M  V30 8 F 10.9864 0.5638 0.0 0
M  V30 9 F 13.0900 0.0000 0.0 0
M  V30 10 F 13.6536 2.1038 0.0 0
M  V30 11 N 18.4800 9.3358 0.0 0
M  V30 12 C 19.2500 10.6694 0.0 0 CFG=2
M  V30 13 C 18.4800 12.0032 0.0 0
M  V30 14 C 6.9300 13.3369 0.0 0
M  V30 15 O 5.3900 13.3369 0.0 0
M  V30 16 O 7.7000 14.6705 0.0 0
M  V30 17 C 4.6200 14.6705 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 11.5500 2.6674 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 10.0100 2.6674 0.0 0
M  V30 24 C 14.6300 8.0021 0.0 0
M  V30 25 C 16.1700 8.0021 0.0 0
M  V30 26 C 13.8600 9.3358 0.0 0
M  V30 27 C 16.9400 9.3358 0.0 0
M  V30 28 C 14.6300 10.6696 0.0 0
M  V30 29 N 16.1700 10.6696 0.0 0
M  V30 30 C 9.2400 9.3358 0.0 0
M  V30 31 C 10.0100 10.6696 0.0 0
M  V30 32 C 7.7000 9.3358 0.0 0
M  V30 33 C 9.2400 12.0032 0.0 0
M  V30 34 C 6.9300 10.6696 0.0 0
M  V30 35 N 7.7000 12.0032 0.0 0
M  V30 36 C 20.7900 10.6696 0.0 0
M  V30 37 C 21.5600 9.3358 0.0 0
M  V30 38 C 21.5600 12.0032 0.0 0
M  V30 39 C 23.1000 9.3358 0.0 0
M  V30 40 C 23.1000 12.0032 0.0 0
M  V30 41 C 23.8700 10.6694 0.0 0
M  V30 42 C 3.0800 14.6705 0.0 0
M  V30 43 C 2.3100 13.3369 0.0 0
M  V30 44 C 2.3100 16.0043 0.0 0
M  V30 45 C 0.7700 13.3369 0.0 0
M  V30 46 C 0.7700 16.0043 0.0 0
M  V30 47 C 0.0000 14.6705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 2 2 4
M  V30 5 1 2 24
M  V30 6 1 3 5
M  V30 7 2 5 6
M  V30 8 1 5 30
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 21
M  V30 13 1 11 12
M  V30 14 1 11 27
M  V30 15 1 12 13 CFG=1
M  V30 16 1 12 36
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 14 35
M  V30 20 1 15 17
M  V30 21 1 17 42
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 46 2 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 2 44 46
M  V30 50 2 45 47
M  V30 51 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 4-[1-methyl-5-[2-[[(1S)-1-phenylethyl]amino]-4-pyridinyl]-4-[3-(...
C37H36F3N5O2
189442-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 52 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3422 10.5359 0.0 0
M  V30 2 C 9.9596 1.2459 0.0 0
M  V30 3 F 11.2055 2.1511 0.0 0
M  V30 4 F 10.8647 0.0000 0.0 0
M  V30 5 F 8.7136 0.3407 0.0 0
M  V30 6 N 4.3159 11.0209 0.0 0
M  V30 7 C 2.7844 11.1818 0.0 0 CFG=2
M  V30 8 C 1.8791 9.9359 0.0 0
M  V30 9 C 16.4040 11.4832 0.0 0
M  V30 10 O 17.7378 10.7132 0.0 0
M  V30 11 O 16.4040 13.0232 0.0 0
M  V30 12 C 19.0715 11.4832 0.0 0
M  V30 13 C 9.4020 6.5514 0.0 0
M  V30 14 C 8.6320 7.8851 0.0 0
M  V30 15 N 10.9083 6.8716 0.0 0
M  V30 16 N 9.6624 9.0296 0.0 0
M  V30 17 C 11.0692 8.4031 0.0 0
M  V30 18 C 8.7755 5.1446 0.0 0
M  V30 19 C 9.6807 3.8986 0.0 0
M  V30 20 C 7.2440 4.9835 0.0 0
M  V30 21 C 9.0544 2.4918 0.0 0
M  V30 22 C 6.6176 3.5767 0.0 0
M  V30 23 C 7.5229 2.3308 0.0 0
M  V30 24 C 7.1003 8.0462 0.0 0
M  V30 25 C 6.4740 9.4530 0.0 0
M  V30 26 C 6.1952 6.8001 0.0 0
M  V30 27 C 4.9424 9.6139 0.0 0
M  V30 28 C 4.6635 6.9612 0.0 0
M  V30 29 N 4.0372 8.3680 0.0 0
M  V30 30 C 12.4030 9.1732 0.0 0
M  V30 31 C 13.7367 8.4031 0.0 0
M  V30 32 C 12.4030 10.7132 0.0 0
M  V30 33 C 15.0704 9.1732 0.0 0
M  V30 34 C 13.7367 11.4832 0.0 0
M  V30 35 N 15.0704 10.7132 0.0 0
M  V30 36 C 2.1580 12.5886 0.0 0
M  V30 37 C 3.0633 13.8347 0.0 0
M  V30 38 C 0.6265 12.7497 0.0 0
M  V30 39 C 2.4368 15.2415 0.0 0
M  V30 40 C 0.0000 14.1565 0.0 0
M  V30 41 C 0.9052 15.4024 0.0 0
M  V30 42 C 20.4052 10.7132 0.0 0
M  V30 43 C 20.4052 9.1732 0.0 0
M  V30 44 C 21.7388 11.4832 0.0 0
M  V30 45 C 21.7388 8.4031 0.0 0
M  V30 46 C 23.0726 10.7132 0.0 0
M  V30 47 C 23.0726 9.1732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 21
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 7 8 CFG=1
M  V30 9 1 7 36
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 35
M  V30 13 1 10 12
M  V30 14 1 12 42
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 18
M  V30 18 1 14 16
M  V30 19 1 14 24
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 1 17 30
M  V30 23 2 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 2 20 22
M  V30 27 2 21 23
M  V30 28 1 22 23
M  V30 29 1 24 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501901-71-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 189442-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6955284
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical synthesis of tetrasubstituted imidazole p38 MAP kinase
inhibitors: A new method for the synthesis of α-amidoketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murry, Jerry A.; Frantz, Doug; Frey, Lisa; Soheili, Arash; Marcantonio,
Karen; Tillyer, Richard; Grabowski, Edward J. J.; Reider, Paul J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Symposium Series (2004), 870161-180

$RFMT $RIREG SCHEME130 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonyl chloride
C6H5ClO2S
98-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Methylenebenzeneacetyl chloride
C9H7ClO
51491-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 C 5.3901 4.0010 0.0 0
M  V30 4 Cl 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-methylene-N-(phenylsulfonyl)benzeneacetamide
C16H15NO3S
2139278-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 2.3101 0.0 0 VAL=6
M  V30 2 N 5.3348 1.5400 0.0 0
M  V30 3 O 3.2311 0.9764 0.0 0
M  V30 4 O 4.7712 3.6437 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 O 6.6685 3.8501 0.0 0
M  V30 9 C 8.0022 0.0000 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 C 9.3360 2.3101 0.0 0
M  V30 17 C 10.6697 1.5400 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 12.0033 2.3101 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 51491-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139278-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690456
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,4-dimethoxybenzenebutanoate
C13H18O4
51686-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 C 7.7002 5.3348 0.0 0
M  V30 7 C 9.2402 5.3348 0.0 0
M  V30 8 C 10.0102 6.6687 0.0 0
M  V30 9 O 11.5503 6.6687 0.0 0
M  V30 10 O 9.2402 8.0023 0.0 0
M  V30 11 C 12.3203 8.0023 0.0 0
M  V30 12 C 3.0801 2.6675 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 3.0801 5.3348 0.0 0
M  V30 16 C 5.3901 4.0012 0.0 0
M  V30 17 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenebutanamide
C13H19NO3
2402782-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 0.7700 4.0012 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 C 6.9302 4.0012 0.0 0
M  V30 6 C 7.7002 5.3348 0.0 0
M  V30 7 C 9.2402 5.3348 0.0 0
M  V30 8 C 10.0102 6.6687 0.0 0
M  V30 9 N 11.5503 6.6687 0.0 0
M  V30 10 O 9.2402 8.0023 0.0 0
M  V30 11 C 12.3203 8.0023 0.0 0
M  V30 12 C 3.0801 2.6675 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 3.0801 5.3348 0.0 0
M  V30 16 C 5.3901 4.0012 0.0 0
M  V30 17 C 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51686-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2402782-03-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20876711
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Medium-Ring-sized Benzolactams by Using Strong Electrophiles
and Quantitative Evaluation of Ring-size Dependency of the Cyclization
Reaction Rate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kurouchi, Hiroaki; Ohwada, Tomohiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(2), 876-901

$RFMT $RIREG SCHEME132 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-hydroxy-3-methylbutyl]-4-thiazolecarboxylate
C11H17NO3S
942133-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.4580 0.0 0 CFG=1
M  V30 2 C 2.6675 2.6880 0.0 0
M  V30 3 O 4.0011 4.9980 0.0 0
M  V30 4 C 1.3337 3.4580 0.0 0
M  V30 5 C 1.3337 4.9980 0.0 0
M  V30 6 C 0.0000 2.6880 0.0 0
M  V30 7 C 9.3037 2.3308 0.0 0
M  V30 8 O 10.2090 1.0849 0.0 0
M  V30 9 O 9.9301 3.7378 0.0 0
M  V30 10 C 11.7405 1.2459 0.0 0
M  V30 11 C 12.6457 0.0000 0.0 0
M  V30 12 C 5.3348 2.6880 0.0 0
M  V30 13 N 6.7417 3.3143 0.0 0
M  V30 14 S 5.4957 1.1564 0.0 0
M  V30 15 C 7.7722 2.1699 0.0 0
M  V30 16 C 7.0022 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-3-methyl-1-[[(methylamino)carbonyl]oxy]butyl]-4-thiazolecarboxy...
C13H20N2O4S
942133-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 3.8500 5.3347 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 N 1.5400 6.6684 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 9.7758 5.6763 0.0 0
M  V30 12 O 11.1826 5.0498 0.0 0
M  V30 13 O 9.6147 7.2079 0.0 0
M  V30 14 C 12.4285 5.9551 0.0 0
M  V30 15 C 13.8354 5.3287 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 N 7.0652 5.2470 0.0 0
M  V30 18 S 7.0652 2.7552 0.0 0
M  V30 19 C 8.5299 4.7711 0.0 0
M  V30 20 C 8.5299 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 942133-16-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942133-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-10929958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Carbamate 35. Alcohol 31 (1.35 g, 5.55 mmol) was combined in CH2Cl2 (60
mL) with 1.09 g (6.70 mmol, 1.2 equiv.) of carbonyldiimidazole. The
solution was stirred at ambient rt for 1 h. The reaction was then cooled
down to 0 °C and of methylamine (0.38 g, 12.3 mmol, 2.2 equiv., 2 M in
THF) was added. The reaction mixture was warmed up to rt and stirred for
further 3 h. Then the solution was washed with 0.01M HCl until
neutrality. The organic layer was separated, dried with MgSO4 and
filtered. The solvent was removed in vacuo. The obtained crude product
was purified by flash chromatography on silica gel (hexanes / EtOAc =
1:1). The title compound 35 was isolated as white solid crystals (1.57 g,
5.20 mmol, 94%): R f = 0.74 (EtOAc); m.p. 172 °C; [α]D 20 = -32.6 (c = 1,
CHCl3); 1H NMR (400 MHz, CDCl3) δ = 0.92 (d, J = 6.6 Hz, 3H), 0.94 (d, J
= 6.6 Hz, 3H), 1.35 (t, J = 7.2 Hz, 3H), 1.72 (ddd, J = 19.9 Hz, J = 13.3
Hz, J = 6.9 Hz, 1H), 1.87 (m, 1H), 2.78 (d, J = 4.9 Hz, 3H), 4.37 (q, J =
7.2 Hz, 1H), 4.90 (bs, 1H), 6.07 (dd, J = 8.2 Hz, J = 5.8 Hz, 1 H), 8.07
(s, 1H); 13C NMR (100 MHz, CDCl3) δ = 14.3, 21.8, 23.1, 24.6, 27.6, 44.3,
61.4, 72.2, 127.2, 147.2, 155.8, 161.3, 172.5. HRMS calculated for
C13H20N2O4NaS: 323.1042, found: 323.1042.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Total Synthesis of Archazolid A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Menche, Dirk; Hassfeld, Jorma; Li, Jun; Mayer, Kerstin; Rudolph, Sven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(19), 7220-7229

$RFMT $RIREG SCHEME132 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-hydroxy-3-methylbutyl]-4-thiazolecarboxylate
C11H17NO3S
942133-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.4580 0.0 0 CFG=1
M  V30 2 C 2.6675 2.6880 0.0 0
M  V30 3 O 4.0011 4.9980 0.0 0
M  V30 4 C 1.3337 3.4580 0.0 0
M  V30 5 C 1.3337 4.9980 0.0 0
M  V30 6 C 0.0000 2.6880 0.0 0
M  V30 7 C 9.3037 2.3308 0.0 0
M  V30 8 O 10.2090 1.0849 0.0 0
M  V30 9 O 9.9301 3.7378 0.0 0
M  V30 10 C 11.7405 1.2459 0.0 0
M  V30 11 C 12.6457 0.0000 0.0 0
M  V30 12 C 5.3348 2.6880 0.0 0
M  V30 13 N 6.7417 3.3143 0.0 0
M  V30 14 S 5.4957 1.1564 0.0 0
M  V30 15 C 7.7722 2.1699 0.0 0
M  V30 16 C 7.0022 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-3-methyl-1-[[(methylamino)carbonyl]oxy]butyl]-4-thiazolecarboxy...
C13H20N2O4S
942133-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 3.8500 5.3347 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 N 1.5400 6.6684 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 9.7758 5.6763 0.0 0
M  V30 12 O 11.1826 5.0498 0.0 0
M  V30 13 O 9.6147 7.2079 0.0 0
M  V30 14 C 12.4285 5.9551 0.0 0
M  V30 15 C 13.8354 5.3287 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 N 7.0652 5.2470 0.0 0
M  V30 18 S 7.0652 2.7552 0.0 0
M  V30 19 C 8.5299 4.7711 0.0 0
M  V30 20 C 8.5299 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 942133-16-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942133-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-11273832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-Ethyl 2-(3-methyl-1-(methylcarbamoyloxy)butyl)thiazole-4-carboxylate
(22). (S)-Ethyl 2-(1-hydroxy-3-methylbutyl)thiazole-4-carboxylate (1.35
g, 5.55 mmol) was combined in CH2Cl2 (60 mL) with 1.09 g (6.70 mmol, 1.2
eq.) of carbonyldiimidazole. The solution was stirred at ambient
temperature for 1 h. The reaction was then cooled down to 0 °C and 0.38 g
of methylamine (12.3 mmol, 2.2 eq., 2M in THF) was added. The reaction
mixture was warmed up to rt and stirred for further 3 h. Then the
solution was washed with 0.01M HCl until neutrality. The organic layer
was separated, dried with MgSO4 and filtered. The solvent was removed in
vacuum. The obtained crude product was purified by flash chromatography
on silica gel (hexanes / EtOAc = 1:1). The title compound 22 (S)-Ethyl
2-(3-methyl-1-(methylcarbamoyloxy)butyl)thiazole-4-carboxylate (22),
yield 94% white solid crystals Rf = 0.74 (EtOAc); [α]D20 = -32.6 (c = 1,
CHCl3); 1H NMR (400 MHz, CDCl3) δ = 0.92 (d, J = 6.6 Hz, 3H), 0.94 (d, J
= 6.6 Hz, 3H), 1.35 (t, J = 7.2 Hz, 3H), 1.72 (ddd, J = 19.9 Hz, J = 13.3
Hz, J = 6.9 Hz, 1H), 1.87 (m, 1H), 2.78 (d, J = 4.9 Hz, 3H), 4.37 (q, J =
7.2 Hz, 1H), 4.90 (bs, 1H), 6.07 (dd, J = 8.2 Hz, J = 5.8 Hz, 1 H), 8.07
(s, 1H); 13C NMR (100 MHz, CDCl3) δ = 14.3, 21.8, 23.1, 24.6, 27.6, 44.3,
61.4, 72.2, 127.2, 147.2, 155.8, 161.3, 172.5. HRMS calculated for
C13H20N2O4NaS: 323.1042, found: 323.1042
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Archazolid A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Menche, Dirk; Hassfeld, Jorma; Li, Jun; Rudolph, Sven
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2007), 129(19), 6100-6101

$RFMT $RIREG SCHEME132 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-1-hydroxy-3-methylbutyl]-4-thiazolecarboxylate
C11H17NO3S
942133-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.4580 0.0 0 CFG=1
M  V30 2 C 2.6675 2.6880 0.0 0
M  V30 3 O 4.0011 4.9980 0.0 0
M  V30 4 C 1.3337 3.4580 0.0 0
M  V30 5 C 1.3337 4.9980 0.0 0
M  V30 6 C 0.0000 2.6880 0.0 0
M  V30 7 C 9.3037 2.3308 0.0 0
M  V30 8 O 10.2090 1.0849 0.0 0
M  V30 9 O 9.9301 3.7378 0.0 0
M  V30 10 C 11.7405 1.2459 0.0 0
M  V30 11 C 12.6457 0.0000 0.0 0
M  V30 12 C 5.3348 2.6880 0.0 0
M  V30 13 N 6.7417 3.3143 0.0 0
M  V30 14 S 5.4957 1.1564 0.0 0
M  V30 15 C 7.7722 2.1699 0.0 0
M  V30 16 C 7.0022 0.8362 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-3-methyl-1-[[(methylamino)carbonyl]oxy]butyl]-4-thiazolecarboxy...
C13H20N2O4S
942133-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 2 O 3.8500 5.3347 0.0 0
M  V30 3 C 3.8500 2.6674 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 N 1.5400 6.6684 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 3.8500 0.0000 0.0 0
M  V30 9 C 6.1600 1.3336 0.0 0
M  V30 10 C 0.0000 6.6684 0.0 0
M  V30 11 C 9.7758 5.6763 0.0 0
M  V30 12 O 11.1826 5.0498 0.0 0
M  V30 13 O 9.6147 7.2079 0.0 0
M  V30 14 C 12.4285 5.9551 0.0 0
M  V30 15 C 13.8354 5.3287 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 N 7.0652 5.2470 0.0 0
M  V30 18 S 7.0652 2.7552 0.0 0
M  V30 19 C 8.5299 4.7711 0.0 0
M  V30 20 C 8.5299 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 942133-16-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942133-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-18193583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (S)-Ethyl 2-(3-methyl-1-(methylcarbamoyloxy)butyl)thiazole-4-carboxylate
(57): (S)-Ethyl 2-(1-hydroxy-3-methylbutyl)thiazole-4-carboxylate (56,
1.35 g, 5.55 mmol) was combined in CH2Cl2 (60 mL) with 1.09 g (6.70 mmol,
1.2 eq.) of carbonyldiimidazole. The solution was stirred at ambient
temperature for 1 hr. The reaction was then cooled down to 0 degC and
0.38 g of methylamine (12.3 mmol, 2.2 eq., 2M in THF) was added. The
reaction mixture was warmed up to rt and stirred for further 3 hr. Then
the solution was washed with 0.01 M HCl until neutrality. The organic
layer was separated, dried with MgSO4 and filtered. The solvent was
removed in vacuum. The obtained crude product was purified by flash
chromatography on silica gel (hexanes/EtOAc = 1:1). The title compound 57
was isolated as white solid crystals (1.57 g, 5.20 mmol, 94 %). Rf = 0.74
(EtOAc); [alpha 20 D] = -32.6 deg (c = 1 in CHCl3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure elucidation and total synthesis of complex polyketides and
development of direct methods for the synthesis of chiral amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Menche, Dirk
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2007), (D1204-2), No pp.

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodophenol
C6H5IO
540-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-p-aminophenol
C7H9NO
150-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 540-38-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 150-75-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9513843
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-2-nitropyridine
C5H3FN2O2
54231-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 N 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-3-pyridinamine
C6H7N3O2
32605-06-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 N 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54231-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32605-06-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16608678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cross-coupling reaction of 2-halo-1-methyl-1H-imidazo[4,5-b]pyridine
offers a new synthetic route to mutagenic heterocyclic amine-PHIP and
DMIP
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sajith, Ayyiliath M.; Muralidharan, Arayambath; Karuvalam, Ranjith P.;
Haridas, Karickal R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Korean Chemical Society (2013), 57(3), 361-364

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Bis(benzyloxy)benzaldehyde
C21H18O3
5447-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 6.6685 0.0 0
M  V30 2 C 3.0801 6.6685 0.0 0
M  V30 3 O 7.7002 6.6685 0.0 0
M  V30 4 C 9.2402 6.6685 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 O 5.3901 0.0000 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 7.7002 4.0012 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 2.3101 8.0023 0.0 0
M  V30 14 C 3.0801 9.3360 0.0 0
M  V30 15 C 0.7700 8.0023 0.0 0
M  V30 16 C 2.3101 10.6697 0.0 0
M  V30 17 C 0.0000 9.3360 0.0 0
M  V30 18 C 0.7700 10.6697 0.0 0
M  V30 19 C 10.0102 8.0023 0.0 0
M  V30 20 C 11.5503 8.0023 0.0 0
M  V30 21 C 9.2402 9.3360 0.0 0
M  V30 22 C 12.3203 9.3360 0.0 0
M  V30 23 C 10.0102 10.6697 0.0 0
M  V30 24 C 11.5503 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 1 4 19
M  V30 7 2 5 6
M  V30 8 1 5 11
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[3,4-Bis(phenylmethoxy)phenyl]methylene]methanamine
C22H21NO2
220627-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 5.3348 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0
M  V30 3 O 5.3901 8.0023 0.0 0
M  V30 4 C 4.6201 9.3360 0.0 0
M  V30 5 C 11.5503 8.0023 0.0 0
M  V30 6 N 12.3203 9.3360 0.0 0
M  V30 7 C 13.8603 9.3360 0.0 0
M  V30 8 C 7.7002 6.6685 0.0 0
M  V30 9 C 6.9302 8.0023 0.0 0
M  V30 10 C 9.2402 6.6685 0.0 0
M  V30 11 C 7.7002 9.3360 0.0 0
M  V30 12 C 10.0102 8.0023 0.0 0
M  V30 13 C 9.2402 9.3360 0.0 0
M  V30 14 C 6.9302 2.6673 0.0 0
M  V30 15 C 7.7002 1.3337 0.0 0
M  V30 16 C 5.3901 2.6673 0.0 0
M  V30 17 C 6.9302 0.0000 0.0 0
M  V30 18 C 4.6201 1.3337 0.0 0
M  V30 19 C 5.3901 0.0000 0.0 0
M  V30 20 C 3.0801 9.3360 0.0 0
M  V30 21 C 2.3101 10.6697 0.0 0
M  V30 22 C 2.3101 8.0023 0.0 0
M  V30 23 C 0.7700 10.6697 0.0 0
M  V30 24 C 0.7700 8.0023 0.0 0
M  V30 25 C 0.0000 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 20
M  V30 7 2 5 6 CFG=2
M  V30 8 1 5 12
M  V30 9 1 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5447-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220627-61-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17668097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diketoindenoisoquinolines as antineoplastic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cushman, Mark S.; Nagafuji, Pamela M.; Jayaraman, Muthusamy; Pommier,
Yves G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000021537 A1 2000-04-20

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloropurine
C5H2Cl2N4
5451-40-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-9H-purin-6-amine
C6H6ClN5
82499-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 N 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5451-40-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 82499-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9242058
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Chloro-N6-methyladenine was prepared as follows: A solution of
2,6-dichloropurine (1.38 g, 7.32 mmol) in 40% methylamine in water (12
mL) was heated at 100 °C for 1 h in a sealed bottle. Solid precipitate
was filtered, washed with cold water, and dried to give the title
compound. Yield (1.25 g, 93.5%). 1H NMR (DMSO-d6) δ 2.91 (br s, 3 H,
CH3), 8.09 (s, 1 H, H-8), 7.90 (br s, 1 H, NH), 13.07 (br s, 1 H, NH).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed bottle used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Biological Activity, and Molecular Modeling of Ribose-Modified
Deoxyadenosine Bisphosphate Analogues as P2Y1 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nandanan, Erathodiyil; Jang, Soo-Yeon; Moro, Stefano; Kim, Hea Ok;
Siddiqui, Maqbool A.; Russ, Pamela; Marquez, Victor E.; Busson, Roger;
Herdewijn, Piet; Harden, T. Kendall; Boyer, Jose L.; Jacobson, Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(5), 829-842

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloropyridine-2-carboxylic acid
C6H4ClNO2
5470-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 N 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5470-22-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9654017
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sorafenib analogs useful in therapy of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stockwell, Brent R.; Dixon, Scott J.; Skouta, Rachid
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015051149 A1 2015-04-09

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-1-[[1-(3-methylbutyl)-5-[[(methylsulfonyl)oxy]methyl]-1H-benzimid...
C25H32N4O4S
554457-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 6.4641 0.0 0
M  V30 2 O 6.5936 9.5249 0.0 0
M  V30 3 C 4.1037 11.7667 0.0 0
M  V30 4 C 2.8578 12.6719 0.0 0
M  V30 5 C 5.5107 12.3932 0.0 0
M  V30 6 C 7.2002 3.7535 0.0 0
M  V30 7 C 8.2306 2.6091 0.0 0
M  V30 8 C 7.7548 1.1444 0.0 0
M  V30 9 C 8.7852 0.0000 0.0 0
M  V30 10 C 6.2485 0.8242 0.0 0
M  V30 11 C 13.1418 8.0041 0.0 0
M  V30 12 O 14.4756 7.2341 0.0 0
M  V30 13 S 15.8092 8.0041 0.0 0 VAL=6
M  V30 14 C 15.0392 9.3378 0.0 0
M  V30 15 O 17.1429 8.7741 0.0 0
M  V30 16 O 16.5793 6.6705 0.0 0
M  V30 17 N 4.4608 7.7977 0.0 0
M  V30 18 C 2.9293 7.9588 0.0 0
M  V30 19 C 5.0873 9.2047 0.0 0
M  V30 20 C 2.6091 9.4651 0.0 0
M  V30 21 C 1.7849 6.9283 0.0 0
M  V30 22 N 3.9428 10.2351 0.0 0
M  V30 23 C 1.1444 9.9410 0.0 0
M  V30 24 C 0.3202 7.4041 0.0 0
M  V30 25 C 0.0000 8.9106 0.0 0
M  V30 26 C 6.7709 6.4641 0.0 0
M  V30 27 N 7.6761 5.2182 0.0 0
M  V30 28 N 7.6761 7.7100 0.0 0
M  V30 29 C 9.1408 5.6941 0.0 0
M  V30 30 C 9.1408 7.2341 0.0 0
M  V30 31 C 10.4745 4.9241 0.0 0
M  V30 32 C 10.4745 8.0041 0.0 0
M  V30 33 C 11.8081 5.6941 0.0 0
M  V30 34 C 11.8081 7.2341 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 2 2 19
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 1 6 27
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 18 21
M  V30 22 1 19 22
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dihydro-1-[[5-[(methylamino)methyl]-1-(3-methylbutyl)-1H-benzimidazol-2-y...
C25H33N5O
554457-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 5.0494 0.0 0
M  V30 2 O 6.0810 8.3813 0.0 0
M  V30 3 C 3.0203 9.7441 0.0 0
M  V30 4 C 1.5556 10.2199 0.0 0
M  V30 5 C 4.1646 10.7745 0.0 0
M  V30 6 C 8.4412 3.0800 0.0 0
M  V30 7 C 9.7750 2.3100 0.0 0
M  V30 8 C 9.7750 0.7700 0.0 0
M  V30 9 C 11.1087 0.0000 0.0 0
M  V30 10 C 8.4412 0.0000 0.0 0
M  V30 11 C 12.7785 8.9585 0.0 0
M  V30 12 N 14.2849 8.6383 0.0 0
M  V30 13 C 15.3153 9.7827 0.0 0
M  V30 14 C 3.0800 5.7596 0.0 0
M  V30 15 N 4.5863 6.0798 0.0 0
M  V30 16 C 2.3100 7.0933 0.0 0
M  V30 17 C 2.3100 4.4258 0.0 0
M  V30 18 C 4.7472 7.6113 0.0 0
M  V30 19 N 3.3404 8.2376 0.0 0
M  V30 20 C 0.7700 7.0933 0.0 0
M  V30 21 C 0.7700 4.4258 0.0 0
M  V30 22 C 0.0000 5.7596 0.0 0
M  V30 23 C 7.1954 5.5252 0.0 0
M  V30 24 N 8.4412 4.6200 0.0 0
M  V30 25 N 7.6712 6.9898 0.0 0
M  V30 26 C 9.6872 5.5252 0.0 0
M  V30 27 C 9.2112 6.9898 0.0 0
M  V30 28 C 11.1935 5.2051 0.0 0
M  V30 29 C 10.2418 8.1343 0.0 0
M  V30 30 C 12.2239 6.3494 0.0 0
M  V30 31 C 11.7481 7.8141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 23
M  V30 3 2 2 18
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 19
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 554457-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 554457-16-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8945594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(heterocyclylmethyl)benzimidazoles as respiratory
syncytial virus antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Kuo-long; Wang, Xiangdong; Sun, Yaxiong; Cianci, Christopher;
Thuring, Jan Willem; Combrink, Keith; Meanwell, Nicholas; Zhang, Yi;
Civiello, Rita L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003053344 A2 2003-07-03

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Propanediol, 1-(2-thienyl)-, 3-methanesulfonate, (1S)-
C8H12O4S2
556801-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0 CFG=1
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 S 9.1059 2.6218 0.0 0 VAL=6
M  V30 7 C 8.3359 3.9554 0.0 0
M  V30 8 O 10.4396 3.3918 0.0 0
M  V30 9 O 9.8759 1.2881 0.0 0
M  V30 10 C 2.4374 1.8517 0.0 0
M  V30 11 C 1.0304 2.4782 0.0 0
M  V30 12 S 2.2763 0.3202 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-[2-(Methylamino)ethyl]-2-thiophenemethanol
C8H13NOS
116539-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0 CFG=1
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 N 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 S 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 556801-68-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 116539-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10346757
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective hydrogenation of β-keto esters using chiral
diphosphine-ruthenium complexes: Optimization for academic and industrial
purposes and synthetic applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ratovelomanana-Vidal, V.; Girard, C.; Touati, R.; Tranchier, J. P.; Ben
Hassine, B.; Genet, J. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2003), 345(1+2), 261-274

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,6-dimethylbenzaldehyde
C9H9BrO
5769-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 C 2.3100 5.3349 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 Br 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2,6-trimethylbenzenemethanamine
C10H14BrN
1037089-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 N 6.9300 4.0011 0.0 0
M  V30 3 C 8.4700 4.0011 0.0 0
M  V30 4 C 4.6200 5.3349 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5769-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037089-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-127747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 112:
3,17,18-Trimethyl-14-(4-oxo-3,4-dihydro-quinazolin-6-ylamino)-9-
(propane-2-sulfonyl)-3,5,12-triaza-tricyclo[13.2.2.16,10]icosa-1(18),6(20),7,9,15(19),16-hexaene-4,13-dione
trifluoroacetate. 112A: To a solution of 111B (213 mg, 1.00 mmol) in MeOH
(6 mL), methylamine, 2 M in THF (1 mL, 2.0 mmol) was added dropwise. The
reaction mixture was stirred at rt for 1 h. The reaction mixture was
cooled to 0 °C, then sodium borohydride (113 mg, 3.00 mmol) was added.
The reaction mixture was stirred at rt for 2 h, then was concentrated.
The residue was taken up in EtOAc (20 mL). The organic phase was washed
with water, and brine, dried (Na2SO4) and concentrated to afford 112A
(223 mg, 94 % yield) as a yellow oil. MS (ESI) m/z 228.3 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic amino acid derivatives as factor VIIa
inhibitors useful as anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurtz, Nicholas Ronald; Priestley, Eldon Scott; Cheney, Daniel L.; Glunz,
Peter W.; Zhang, Xiaojun; Ladziata, Vladimir; Parkhurst, Brandon;
Mueller, Luciano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008079836 A2 2008-07-03

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-(3-chlorophenyl)-2-nitrobenzeneacetate
C15H12ClNO4
581059-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0831 3.8500 0.0 0
M  V30 2 C 5.0831 2.3100 0.0 0
M  V30 3 O 6.4167 1.5400 0.0 0
M  V30 4 O 3.7493 1.5400 0.0 0
M  V30 5 C 6.4167 0.0000 0.0 0
M  V30 6 N 1.5166 3.3608 0.0 0 VAL=5
M  V30 7 O 0.0000 3.6281 0.0 0
M  V30 8 O 2.0434 1.9136 0.0 0
M  V30 9 Cl 10.4178 3.8500 0.0 0
M  V30 10 C 3.9942 4.9390 0.0 0
M  V30 11 C 2.5065 4.5404 0.0 0
M  V30 12 C 4.3927 6.4266 0.0 0
M  V30 13 C 1.4176 5.6293 0.0 0
M  V30 14 C 3.3038 7.5155 0.0 0
M  V30 15 C 1.8161 7.1170 0.0 0
M  V30 16 C 6.4167 4.6200 0.0 0
M  V30 17 C 7.7504 3.8500 0.0 0
M  V30 18 C 6.4167 6.1600 0.0 0
M  V30 19 C 9.0840 4.6200 0.0 0
M  V30 20 C 7.7504 6.9300 0.0 0
M  V30 21 C 9.0840 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3-Chlorophenyl)-N-methyl-2-nitrobenzeneacetamide
C15H13ClN2O3
581059-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0831 3.8500 0.0 0
M  V30 2 C 5.0831 2.3100 0.0 0
M  V30 3 N 6.4167 1.5400 0.0 0
M  V30 4 O 3.7493 1.5400 0.0 0
M  V30 5 C 6.4167 0.0000 0.0 0
M  V30 6 N 1.5166 3.3608 0.0 0 VAL=5
M  V30 7 O 0.0000 3.6281 0.0 0
M  V30 8 O 2.0434 1.9136 0.0 0
M  V30 9 Cl 10.4178 3.8500 0.0 0
M  V30 10 C 3.9942 4.9390 0.0 0
M  V30 11 C 2.5065 4.5404 0.0 0
M  V30 12 C 4.3927 6.4266 0.0 0
M  V30 13 C 1.4176 5.6293 0.0 0
M  V30 14 C 3.3038 7.5155 0.0 0
M  V30 15 C 1.8161 7.1170 0.0 0
M  V30 16 C 6.4167 4.6200 0.0 0
M  V30 17 C 7.7504 3.8500 0.0 0
M  V30 18 C 6.4167 6.1600 0.0 0
M  V30 19 C 9.0840 4.6200 0.0 0
M  V30 20 C 7.7504 6.9300 0.0 0
M  V30 21 C 9.0840 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 1 9 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 581059-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 581059-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11202151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzene derivatives for inhibiting insulin secretion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pei, Yazhong; James, Ian W.; Ghosh, Soumitra S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003066035 A2 2003-08-14

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Adenosine
C10H13N5O4
58-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5369 3.9148 0.0 0
M  V30 3 C 0.6966 1.4646 0.0 0
M  V30 4 O 1.1724 0.0000 0.0 0
M  V30 5 O 0.0000 4.7418 0.0 0
M  V30 6 N 5.3914 4.1752 0.0 0
M  V30 7 C 6.5359 3.1447 0.0 0
M  V30 8 C 6.0178 5.5820 0.0 0
M  V30 9 C 7.8696 3.9148 0.0 0
M  V30 10 N 6.5359 1.6047 0.0 0
M  V30 11 N 7.5494 5.4211 0.0 0
M  V30 12 C 9.2032 3.1447 0.0 0
M  V30 13 C 7.8696 0.8347 0.0 0
M  V30 14 N 9.2032 1.6047 0.0 0
M  V30 15 C 3.8850 3.8550 0.0 0 CFG=1
M  V30 16 O 3.2586 2.4480 0.0 0
M  V30 17 C 2.7405 4.8854 0.0 0 CFG=2
M  V30 18 C 1.7270 2.6091 0.0 0 CFG=2
M  V30 19 C 1.4068 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N6-Methyladenosine
C11H15N5O4
1867-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5371 3.9148 0.0 0
M  V30 3 C 11.8709 3.1447 0.0 0
M  V30 4 C 0.6967 1.4646 0.0 0
M  V30 5 O 1.1726 0.0000 0.0 0
M  V30 6 O 0.0000 4.7418 0.0 0
M  V30 7 N 5.3915 4.1752 0.0 0
M  V30 8 C 6.5361 3.1447 0.0 0
M  V30 9 C 6.0178 5.5820 0.0 0
M  V30 10 C 7.8697 3.9148 0.0 0
M  V30 11 N 6.5361 1.6047 0.0 0
M  V30 12 N 7.5496 5.4211 0.0 0
M  V30 13 C 9.2034 3.1447 0.0 0
M  V30 14 C 7.8697 0.8347 0.0 0
M  V30 15 N 9.2034 1.6047 0.0 0
M  V30 16 C 3.8852 3.8550 0.0 0 CFG=1
M  V30 17 O 3.2587 2.4480 0.0 0
M  V30 18 C 2.7406 4.8854 0.0 0 CFG=2
M  V30 19 C 1.7271 2.6091 0.0 0 CFG=2
M  V30 20 C 1.4070 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 58-61-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1867-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-6270363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New highly active antiplatelet agents with dual specificity for platelet
P2Y1 and P2Y12 adenosine diphosphate receptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yanachkov, Ivan B.; Chang, Hung; Yanachkova, Milka I.; Dix, Edward J.;
Berny-Lang, Michelle A.; Gremmel, Thomas; Michelson, Alan D.; Wright,
George E.; Frelinger, Andrew L. III
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 107204-218

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,4aS,10aR)-1,2,3,4,4a,9,10,10a-Octahydro-6-hydroxy-1,4a-dimethyl-1-phenant...
C17H22O3
5947-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.0444 1.5400 0.0 0
M  V30 2 C 1.5166 3.7572 0.0 0
M  V30 3 O 2.5065 4.9369 0.0 0
M  V30 4 O 0.0000 4.0245 0.0 0
M  V30 5 C 0.5267 2.0427 0.0 0
M  V30 6 O 10.0456 2.3100 0.0 0
M  V30 7 C 4.7108 2.3100 0.0 0 CFG=1
M  V30 8 C 3.3771 3.0800 0.0 0 CFG=1
M  V30 9 C 6.0444 3.0800 0.0 0
M  V30 10 C 4.7108 0.7700 0.0 0
M  V30 11 C 2.0433 2.3100 0.0 0 CFG=1
M  V30 12 C 3.3771 4.6201 0.0 0
M  V30 13 C 6.0444 4.6201 0.0 0
M  V30 14 C 7.3781 2.3100 0.0 0
M  V30 15 C 3.3771 0.0000 0.0 0
M  V30 16 C 2.0433 0.7700 0.0 0
M  V30 17 C 4.7108 5.3901 0.0 0
M  V30 18 C 7.3781 5.3901 0.0 0
M  V30 19 C 8.7119 3.0800 0.0 0
M  V30 20 C 8.7119 4.6201 0.0 0
M  V30 21 H 2.0433 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 11 2 CFG=3
M  V30 5 1 11 5 CFG=1
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 8 21 CFG=1
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 17
M  V30 19 2 13 18
M  V30 20 1 14 19
M  V30 21 1 15 16
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (1S,4aS,10aR)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-1-...
C18H24O3
4614-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.6566 4.0011 0.0 0
M  V30 2 C 2.6268 4.3450 0.0 0
M  V30 3 O 1.1798 4.8716 0.0 0
M  V30 4 O 2.8943 2.8282 0.0 0
M  V30 5 C 0.0000 3.8817 0.0 0
M  V30 6 C 2.6268 6.3246 0.0 0
M  V30 7 O 10.7366 1.3338 0.0 0
M  V30 8 C 6.1166 4.0011 0.0 0 CFG=1
M  V30 9 C 4.5766 4.0011 0.0 0 CFG=1
M  V30 10 C 6.8866 2.6674 0.0 0
M  V30 11 C 6.8866 5.3347 0.0 0
M  V30 12 C 3.8066 5.3347 0.0 0 CFG=1
M  V30 13 C 3.8066 2.6674 0.0 0
M  V30 14 C 6.1166 1.3338 0.0 0
M  V30 15 C 8.4266 2.6674 0.0 0
M  V30 16 C 6.1166 6.6685 0.0 0
M  V30 17 C 4.5766 6.6685 0.0 0
M  V30 18 C 4.5766 1.3338 0.0 0
M  V30 19 C 6.8866 0.0000 0.0 0
M  V30 20 C 9.1966 1.3338 0.0 0
M  V30 21 C 8.4266 0.0000 0.0 0
M  V30 22 H 3.0366 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 12 2 CFG=1
M  V30 5 1 3 5
M  V30 6 1 12 6 CFG=3
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 9 22 CFG=3
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 18
M  V30 19 1 14 18
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 16 17
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5947-49-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4614-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26624075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Linoleic acid
C18H32O2
60-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 10.0102 0.0 0
M  V30 2 C 4.0010 9.2402 0.0 0
M  V30 3 C 6.6685 9.2402 0.0 0
M  V30 4 C 2.6673 10.0102 0.0 0
M  V30 5 C 8.0022 10.0102 0.0 0
M  V30 6 C 1.3337 9.2402 0.0 0
M  V30 7 C 9.3358 9.2402 0.0 0
M  V30 8 C 1.3337 7.7002 0.0 0
M  V30 9 C 10.6697 10.0102 0.0 0
M  V30 10 C 0.0000 6.9302 0.0 0
M  V30 11 C 12.0033 9.2402 0.0 0
M  V30 12 C 0.0000 5.3901 0.0 0
M  V30 13 C 13.3370 10.0102 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 O 14.6707 9.2402 0.0 0
M  V30 16 O 13.3370 11.5503 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 2.3101 0.0 0
M  V30 19 C 2.6673 0.7700 0.0 0
M  V30 20 C 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl linoleate
C19H34O2
112-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 6.6684 0.0 0
M  V30 2 C 6.9301 8.0022 0.0 0
M  V30 3 C 9.2401 6.6684 0.0 0
M  V30 4 C 5.3901 8.0022 0.0 0
M  V30 5 C 10.0101 5.3348 0.0 0
M  V30 6 C 4.6201 9.3359 0.0 0
M  V30 7 C 11.5501 5.3348 0.0 0
M  V30 8 C 3.0800 9.3359 0.0 0
M  V30 9 C 12.3201 4.0011 0.0 0
M  V30 10 C 2.3100 8.0022 0.0 0
M  V30 11 C 13.8602 4.0011 0.0 0
M  V30 12 C 0.7700 8.0022 0.0 0
M  V30 13 O 14.6302 2.6675 0.0 0
M  V30 14 O 14.6302 5.3348 0.0 0
M  V30 15 C 0.0000 6.6684 0.0 0
M  V30 16 C 16.1702 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.0000 1.3337 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 60-33-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 112-63-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-019-CAS-10916269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME145 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-bromocrotonate
C6H9BrO2
6065-32-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 8.0023 2.3101 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 Br 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5 CFG=2
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-methyl-2-thioxo-4-thiazolidineacetate
C8H13NO2S2
2624299-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3028 1.3628 0.0 0
M  V30 2 C 6.6365 2.1328 0.0 0
M  V30 3 O 7.9701 1.3628 0.0 0
M  V30 4 O 6.6365 3.6728 0.0 0
M  V30 5 C 9.3038 2.1328 0.0 0
M  V30 6 C 10.6376 1.3628 0.0 0
M  V30 7 C 2.2420 0.0000 0.0 0
M  V30 8 S 0.0000 2.4899 0.0 0
M  V30 9 C 3.9690 2.1328 0.0 0
M  V30 10 N 2.5622 1.5065 0.0 0
M  V30 11 C 3.8080 3.6644 0.0 0
M  V30 12 C 1.5317 2.6509 0.0 0
M  V30 13 S 2.3017 3.9847 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 2 8 12
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 6065-32-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624299-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-24331273
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alkylation/intramolecular Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem Alkylation/Michael Addition Reaction of Dithiocarbamic Acids with
Alkyl γ-Bromocrotonates: Access to Functionalized
1,3-Thiazolidine-2-thiones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khalili Foumeshi, Maryam; Ziyaei Halimehjani, Azim; Alaei, Ali;
Klepetarova, Blanka; Beier, Petr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2021), 53(13), 2219-2228

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,6-Trichloropyridazine
C4HCl3N2
6082-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dichloro-N-methyl-4-pyridazinamine
C5H5Cl2N3
17645-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 Cl 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 N 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 N 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6082-66-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17645-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4132801
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, sealed glass tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New short access to pyrrolo[2,3-c]pyridazin-6-ones via β-spirolactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stoll, Theodor; Alker, Andre; Kolczewski, Sabine; Menzi, Andrea;
Revil-Baudard, Vincent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(6), 772-774

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Bis(trimethylsilyl)-1,4-pentadiyn-3-one
C11H18OSi2
60836-10-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 2.6673 3.0801 0.0 0
M  V30 6 C 8.0023 3.0801 0.0 0
M  V30 7 Si 1.3337 3.8501 0.0 0
M  V30 8 Si 9.3360 3.8501 0.0 0
M  V30 9 C 0.0000 4.6201 0.0 0
M  V30 10 C 0.5637 2.5164 0.0 0
M  V30 11 C 2.1037 5.1838 0.0 0
M  V30 12 C 10.6697 4.6201 0.0 0
M  V30 13 C 8.5660 5.1838 0.0 0
M  V30 14 C 10.1060 2.5164 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 3 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(Trimethylsilyl)-1-[2-(trimethylsilyl)ethynyl]-2-propyn-1-ylidene]methan...
C12H21NSi2
2269488-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3101 0.0 0
M  V30 2 C 4.0012 3.0801 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 5.3348 0.7700 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 C 8.0023 3.8501 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 Si 1.3337 4.6201 0.0 0
M  V30 9 Si 9.3360 4.6201 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 2.1037 5.9538 0.0 0
M  V30 12 C 0.5637 3.2864 0.0 0
M  V30 13 C 10.6697 5.3901 0.0 0
M  V30 14 C 10.1060 3.2864 0.0 0
M  V30 15 C 8.5660 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 3 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 9 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60836-10-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2269488-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19606908
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Terminal Acetylenic Iminium Salts - Synthesis and Reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keim, Michael; Kratzer, Philipp; Derksen, Helena; Isakov, Dajana; Maas,
Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2019), 2019(4), 826-844

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
2-Nitrobenzyl alcohol
C7H7NO3
612-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenemethanamine
C8H10N2O2
56222-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 612-25-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56222-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-15307844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, I. P.; Atkins, R. J.; Badham, N. F.; Bellingham, R. K.; Breen,
G. F.; Carey, J. S.; Etridge, S. K.; Hayes, J. F.; Hussain, N.; Morgan,
D. O.; Share, A. C.; Smith, S. A. C.; Walsgrove, T. C.; Wells, A. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(29), 4915-4917

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]benzenepropanoic acid
C19H20ClNO4
61629-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 O 4.0011 6.1600 0.0 0
M  V30 4 C 6.6685 4.6200 0.0 0
M  V30 5 C 8.0021 3.8500 0.0 0
M  V30 6 O 1.3338 6.1600 0.0 0
M  V30 7 C 0.0000 6.9300 0.0 0
M  V30 8 Cl 1.3338 0.0000 0.0 0
M  V30 9 C 13.3369 6.9300 0.0 0
M  V30 10 C 14.6705 6.1600 0.0 0
M  V30 11 C 16.0041 6.9300 0.0 0
M  V30 12 O 17.3379 6.1600 0.0 0
M  V30 13 O 16.0041 8.4700 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 1.3338 4.6200 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3338 1.5400 0.0 0
M  V30 19 C 0.0000 2.3100 0.0 0
M  V30 20 C 9.3358 4.6200 0.0 0
M  V30 21 C 9.3358 6.1600 0.0 0
M  V30 22 C 10.6694 3.8500 0.0 0
M  V30 23 C 10.6694 6.9300 0.0 0
M  V30 24 C 12.0032 4.6200 0.0 0
M  V30 25 C 12.0032 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 15
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-[(5-Chloro-2-methoxybenzoyl)amino]ethyl]-N-methylbenzenepropanamide
C20H23ClN2O3
1586757-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 O 4.0011 6.1600 0.0 0
M  V30 4 C 6.6684 4.6200 0.0 0
M  V30 5 C 8.0021 3.8500 0.0 0
M  V30 6 O 1.3336 6.1600 0.0 0
M  V30 7 C 0.0000 6.9300 0.0 0
M  V30 8 Cl 1.3336 0.0000 0.0 0
M  V30 9 C 13.3369 6.9300 0.0 0
M  V30 10 C 14.6705 6.1600 0.0 0
M  V30 11 C 16.0041 6.9300 0.0 0
M  V30 12 N 17.3379 6.1600 0.0 0
M  V30 13 O 16.0041 8.4700 0.0 0
M  V30 14 C 18.6716 6.9300 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 1.3336 4.6200 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 0.0000 3.8500 0.0 0
M  V30 19 C 1.3336 1.5400 0.0 0
M  V30 20 C 0.0000 2.3100 0.0 0
M  V30 21 C 9.3358 4.6200 0.0 0
M  V30 22 C 9.3358 6.1600 0.0 0
M  V30 23 C 10.6694 3.8500 0.0 0
M  V30 24 C 10.6694 6.9300 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 12.0032 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 26
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 61629-60-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1586757-16-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15940546
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenylethylbenzamide derivatives as modulators of DNMT3
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kabro, Anzhelika; Lachance, Hugo; Marcoux-Archambault, Iris; Perrier,
Valerie; Dore, Vicky; Gros, Christina; Masson, Veronique; Gregoire,
Jean-Marc; Ausseil, Frederic; Cheishvili, David; Laulan, Nathalie Bibens;
St-Pierre, Yves; Szyf, Moshe; Arimondo, Paola B.; Gagnon, Alexandre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2013), 4(12), 1562-1570

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
2-Furancarbonitrile
C5H3NO
617-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 1.2459 0.0 0
M  V30 2 N 5.4498 1.2459 0.0 0
M  V30 3 C 2.3698 1.2459 0.0 0
M  V30 4 C 1.4645 0.0000 0.0 0
M  V30 5 O 1.4645 2.4917 0.0 0
M  V30 6 C 0.0000 0.4759 0.0 0
M  V30 7 C 0.0000 2.0159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-furancarbothioamide
C6H7NOS
89332-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 S 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 O 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 617-90-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89332-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27134221
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12135-76-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of nitrile (1 mmol) in
C6(mim)2Cl2 (1.1 mmol), ammonium sulfide (1.2 mmol) was added. The
resulting mixture was stirred at 70 °C for the appropriate time shown in
Table 2. After the completion of the reaction, as indicated by TLC, amine
(5 mmol) was added to the reaction and stirred at 70 °C for 10 min to 5 h
(Table 3). Then the reaction took place, was quenched with ice-water (10
ml) and stirred at room temperature for 10 min. The above mixture was
extracted with ethyl acetate (3 × 5 ml) and the organic layers were
combined. When the residue was dried and concentrated in vacuo, it was
chromatographied on silica gel (n-heptane/ethyl acetate as eluent) to
afford the pure products in 70-95% yields. Compound: 3g, Yield (%): 94,
Time (min): 10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalytic media)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and green protocol for the synthesis of thioamides in
C6(mim)2Cl2 as a dicationic ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khosropour, A. R.; Noei, J.; Mirjafari, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2010), 7(3), 752-758

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-3-[6-[N-[(methoxycarbonyl)met...
C22H23ClN4O3
620174-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 O 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-N-methyl-3-[6-[[2-(methylami...
C22H24ClN5O2
620174-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 N 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2757997
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: EXAMPLE 21 Preparation of
(E)-N-methyl-N-(2-methyl-1H-indol-3-ylmethyl)-3-[6-[N-(methy
laminocarbonylmethyl)amino]pyridin-3-yl]acrylamide EXAMPLE 53 Preparation
of
(E)-N-(7-chloro-1-methyl-1H-indol-3-ylmethyl)-N-methyl-3-[6-[N-(methylaminocarbonylmethyl)amino]pyridin-3-yl]acrylamide
[1033] According to the procedure of Example 21, except substituting
(E)-N-(7-chloro-1-methyl-1H-indol-3-ylmethyl)-3-[6-[N-(metho
xycarbonylmethyl)amino]pyridin-3-yl]-N-methylacrylamide (0.75 g, 1.8
mmole) for the
(E)-3-[6-[N-(methoxycarbonylmethyl)amino]pyridin-3-yl]-N-met
hyl-N-(2-methyl-1H-indol-3-ylmethyl)acrylamide, the title compound (0.721
g, 94%) was prepared as a white solid. MS (ES) m/e 426.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-3-[6-[N-[(methoxycarbonyl)met...
C22H23ClN4O3
620174-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 O 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-N-methyl-3-[6-[[2-(methylami...
C22H24ClN5O2
620174-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 N 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1616805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-3-[6-[N-[(methoxycarbonyl)met...
C22H23ClN4O3
620174-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 O 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-[(7-Chloro-1-methyl-1H-indol-3-yl)methyl]-N-methyl-3-[6-[[2-(methylami...
C22H24ClN5O2
620174-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3078 4.6201 0.0 0
M  V30 2 N 7.6416 3.8501 0.0 0
M  V30 3 C 8.9753 4.6201 0.0 0
M  V30 4 C 7.6416 2.3101 0.0 0
M  V30 5 C 10.3090 3.8501 0.0 0
M  V30 6 O 8.9753 6.1601 0.0 0
M  V30 7 C 11.6427 4.6201 0.0 0
M  V30 8 C 2.6804 0.5915 0.0 0
M  V30 9 Cl 0.0000 2.5078 0.0 0
M  V30 10 N 16.9775 1.5400 0.0 0
M  V30 11 C 18.3113 2.3101 0.0 0
M  V30 12 C 19.6450 1.5400 0.0 0
M  V30 13 N 20.9786 2.3101 0.0 0
M  V30 14 O 19.6450 0.0000 0.0 0
M  V30 15 C 22.3123 1.5400 0.0 0
M  V30 16 C 3.5673 4.4766 0.0 0
M  V30 17 C 2.5367 3.3320 0.0 0
M  V30 18 C 4.9742 3.8501 0.0 0
M  V30 19 C 3.0913 5.9411 0.0 0
M  V30 20 N 3.3068 1.9983 0.0 0
M  V30 21 C 1.0304 3.6523 0.0 0
M  V30 22 C 4.8132 2.3185 0.0 0
M  V30 23 C 1.5850 6.2615 0.0 0
M  V30 24 C 0.5546 5.1169 0.0 0
M  V30 25 C 12.9765 3.8501 0.0 0
M  V30 26 C 12.9765 2.3101 0.0 0
M  V30 27 C 14.3101 4.6201 0.0 0
M  V30 28 C 14.3101 1.5400 0.0 0
M  V30 29 N 15.6438 3.8501 0.0 0
M  V30 30 C 15.6438 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 5 7
M  V30 8 1 7 25
M  V30 9 1 8 20
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620174-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620174-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12897963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 O 9.0163 4.1647 0.0 0
M  V30 3 O 1.3338 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 3.2909 5.7308 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.4794 3.3405 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.3213 4.5864 0.0 0
M  V30 12 C 5.8529 4.7473 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 N 9.0161 4.1647 0.0 0
M  V30 3 C 10.5224 3.8445 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 3.2907 5.7308 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 6.4792 3.3405 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 N 4.3213 4.5864 0.0 0
M  V30 13 C 5.8529 4.7473 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-401395
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole c)
7-Methoxy-1-methyl-3-(methylaminomethyl)-1H-indole [0755] According to
the procedure of Preparation 13(c), except substituting
7-methoxy-1-methyl-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (1.6 g, 94%)
was obtained as an amber oil. MS (ES) m/e 205.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 O 9.0163 4.1647 0.0 0
M  V30 3 O 1.3338 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 3.2909 5.7308 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.4794 3.3405 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.3213 4.5864 0.0 0
M  V30 12 C 5.8529 4.7473 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 N 9.0161 4.1647 0.0 0
M  V30 3 C 10.5224 3.8445 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 3.2907 5.7308 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 6.4792 3.3405 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 N 4.3213 4.5864 0.0 0
M  V30 13 C 5.8529 4.7473 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7426098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-76-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 O 9.0163 4.1647 0.0 0
M  V30 3 O 1.3338 3.0801 0.0 0
M  V30 4 C 0.0000 2.3101 0.0 0
M  V30 5 C 3.2909 5.7308 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.4794 3.3405 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 N 4.3213 4.5864 0.0 0
M  V30 12 C 5.8529 4.7473 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 3.0203 0.0 0
M  V30 2 N 9.0161 4.1647 0.0 0
M  V30 3 C 10.5224 3.8445 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 3.2907 5.7308 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0010 3.0801 0.0 0
M  V30 9 C 6.4792 3.3405 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 N 4.3213 4.5864 0.0 0
M  V30 13 C 5.8529 4.7473 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-76-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7260107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methylphenyl isothiocyanate
C8H7NS
621-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 C 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N′-(3-methylphenyl)thiourea
C9H12N2S
35524-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 S 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 621-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35524-89-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-11043295
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM SAR studies of 4-pyridyl heterocyclic anilines that selectively induce
autophagic cell death in von Hippel-Lindau-deficient renal cell carcinoma
cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bonnet, Muriel; Flanagan, Jack U.; Chan, Denise A.; Lai, Edwin W.;
Nguyen, Phuong; Giaccia, Amato J.; Hay, Michael P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(11), 3347-3356

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzonitrile
C7H4BrN
623-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 Br 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)benzonitrile
C8H8N2
4714-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 N 0.7700 1.3337 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4714-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6350927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. N-Methyl-4-cyanoaniline (Table 2-9) The reaction of
4-cyano-bromobenzene (1.820 g, 10 mmol), aqueous methylamine (5.4 mL, 5
eq), copper powder (0.032 g, 5 mol%) produced 1.238 g (93.7 %) of
N-methyl-4-cyanoaniline as a white solid. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.69-2.71(d, J = 4.8 Hz, 3H), 6.16-6.17(d, J = 4.8 Hz, 1H),
6.48-6.51(d, J = 8.7 Hz, 2H), 7.64-7.66(d, J = 8.7 Hz, 2H); 13C NMR (75
MHz, d 6-DMSO) δ (ppm): 28.9, 109.8, 120.3, 128.6, 151.8, 167.6.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroanisole
C7H7ClO
623-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenamine
C8H11NO
5961-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5961-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22797083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-47-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2495200-16-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Pd-Catalyzed Monoarylation of Small Primary Alkyl Amines
through Backbone-Modification in Ylide-Functionalized Phosphines (YPhos)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodstein, Ilja; Prendes, Daniel Sowa; Wickert, Leon; Paassen, Maurice;
Gessner, Viktoria H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(22), 14674-14683

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
2,5-Dimethylfuran
C6H8O
625-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 2.6218 0.0 0
M  V30 2 C 5.3026 1.4946 0.0 0
M  V30 3 O 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,5-Trimethyl-1H-pyrrole
C7H11N
930-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 C 0.0000 1.9692 0.0 0
M  V30 3 C 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 625-86-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 930-87-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37303778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of diketones and pyrrole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giannini, Luca; Galimberti, Maurizio Stefano; Barbera, Vincenzina;
Naddeo, Simone
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023119110 A1 2023-06-29

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromopyridine
C5H4BrN
626-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 2 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)pyridine
C6H8N2
18364-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 N 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-55-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18364-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3172932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Copper-Catalyzed on
Water Ullmann Reaction. A mixture of an aryl halide (10.0 mmol), 30%
aqueous methylamine solution (5.4mL, 50 mmol), copper powder (0.032 g,
0.5 mmol), and a stirring bar was sealed in a 30 mL screwed tube and
stirred electromagnetically in an oil bath at 100 °C. During the
reaction, most of the copper powder was dissolved. After the reaction was
completed or proceeded to the times in Tables 1-3, the reaction mixture
was cooled to room temperature and ethyl acetate (20 mL) was added to
extract the aryl amine. The organic layer was separated and the aqueous
layer was extracted by ethyl acetate (3 x 10 mL). The combined extracts
were dried by anhydrous sodium sulfate and the solvent was removed under
reduced pressure to give crude product that was purified by silica gel
column chromatography (eluent: petroleum ether/ethyl acetate). The pure
product. 3-Methylaminopyridine (Table 2-20) The reaction of
3-bromopyridine (1.580 g, 10 mmol), aqueous methylamine (5.4 mL, 5 eq),
copper powder (0.032 g, 5 mol%) produced 1.011 g (93.5 %) of
3-methylaminopyridine as a yellow oil. 1H NMR (300 MHz, d 6-DMSO) δ
(ppm): 2.69(s, 3H), 5.76(s, 1H), 6.84–6.86(d, J = 6.6 Hz, 1H),
7.05–7.09(q, 1H), 7.76–7.77(d, J = 3.9 Hz, 1H), 7.94(s, 1H); 13C NMR (75
MHz, d 6-DMSO) δ (ppm): 29.7, 117.3, 124.1, 135.5, 137.1, 146.3.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann amination, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Facile and Practical Copper Powder-Catalyzed, Organic Solvent- and
Ligand-Free Ullmann Amination of Aryl Halides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Jiao; Zhang, Xi-Ru; Chang, Ning-Hui; Wang, Jie; Wei, Jun-Fa; Shi,
Xian-Ying; Chen, Zhan-Guo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(4), 1180-1183

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloroethoxy)ethanol
C4H9ClO2
628-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 Cl 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Methylamino)ethoxy]ethanol
C5H13NO2
85475-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 N 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 628-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85475-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42702666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of PROTAC degraders of tissue transglutaminase 2 (TG2)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schiltz, Gary E.; Matei, Daniela Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20240287033 A1 2024-08-29

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-pyridinesulfonyl chloride
C5H3Cl2NO2S
6684-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-3-pyridinesulfonamide
C6H7ClN2O2S
38030-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 Cl 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6684-06-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 38030-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38402098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed Domino Reaction for the Synthesis of 3-Amino
1,2,4-Benzothiadiazine 1,1-Dioxides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hommelsheim, Rene; van Nahl, Robin; Hanek, Lena M.; Ward, Jas S.;
Rissanen, Kari; Bolm, Carsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2024), 366(4), 717-724

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
2-(4-Fluorophenyl)-5-(1-methylethoxy)-6-[(methylsulfonyl)amino]-3-benzofuranc...
C19H18FNO6S
691857-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 8.9879 7.6507 0.0 0
M  V30 3 O 6.4512 8.4749 0.0 0
M  V30 4 O 1.5400 6.1600 0.0 0
M  V30 5 C 1.5400 7.7000 0.0 0
M  V30 6 C 0.2064 8.4700 0.0 0
M  V30 7 C 2.8738 8.4700 0.0 0
M  V30 8 N 1.5400 3.0800 0.0 0
M  V30 9 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 O 0.0000 1.5400 0.0 0
M  V30 12 O 3.0800 1.5400 0.0 0
M  V30 13 F 14.0710 4.6200 0.0 0
M  V30 14 C 5.5411 5.3900 0.0 0
M  V30 15 C 5.5411 3.8500 0.0 0
M  V30 16 C 7.0058 5.8659 0.0 0
M  V30 17 C 4.2074 6.1600 0.0 0
M  V30 18 O 7.0058 3.3741 0.0 0
M  V30 19 C 4.2074 3.0800 0.0 0
M  V30 20 C 7.9110 4.6200 0.0 0
M  V30 21 C 2.8738 5.3900 0.0 0
M  V30 22 C 2.8738 3.8500 0.0 0
M  V30 23 C 9.4510 4.6200 0.0 0
M  V30 24 C 10.2210 5.9536 0.0 0
M  V30 25 C 10.2210 3.2864 0.0 0
M  V30 26 C 11.7610 5.9536 0.0 0
M  V30 27 C 11.7610 3.2864 0.0 0
M  V30 28 C 12.5310 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 1 4 21
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 9 12
M  V30 13 1 13 28
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 1 19 22
M  V30 23 1 20 23
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-N-methyl-5-(1-methylethoxy)-6-[(methylsulfonyl)amino]-3-be...
C20H21FN2O5S
691852-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3304 0.0 0
M  V30 2 N 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6506 0.0 0
M  V30 4 C 6.9271 9.9395 0.0 0
M  V30 5 O 1.5400 6.1600 0.0 0
M  V30 6 C 1.5400 7.7000 0.0 0
M  V30 7 C 2.8738 8.4700 0.0 0
M  V30 8 C 0.2064 8.4700 0.0 0
M  V30 9 N 1.5400 3.0800 0.0 0
M  V30 10 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 11 C 1.5400 0.0000 0.0 0
M  V30 12 O 3.0800 1.5400 0.0 0
M  V30 13 O 0.0000 1.5400 0.0 0
M  V30 14 F 14.0710 4.6200 0.0 0
M  V30 15 C 5.5411 5.3900 0.0 0
M  V30 16 C 7.0058 5.8659 0.0 0
M  V30 17 C 5.5411 3.8500 0.0 0
M  V30 18 C 4.2074 6.1600 0.0 0
M  V30 19 C 7.9110 4.6200 0.0 0
M  V30 20 O 7.0058 3.3740 0.0 0
M  V30 21 C 4.2074 3.0800 0.0 0
M  V30 22 C 2.8738 5.3900 0.0 0
M  V30 23 C 2.8738 3.8500 0.0 0
M  V30 24 C 9.4510 4.6200 0.0 0
M  V30 25 C 10.2210 5.9536 0.0 0
M  V30 26 C 10.2210 3.2862 0.0 0
M  V30 27 C 11.7610 5.9536 0.0 0
M  V30 28 C 11.7610 3.2862 0.0 0
M  V30 29 C 12.5310 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 14 29
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 1 19 24
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 691857-10-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 691852-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8164289
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofuran compounds for treatment and prophylaxis of
hepatitis C viral infections and associated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burns, Christopher J.; Del Vecchio, Alfred M.; Bailey, Thomas R.;
Kulkarni, Bheemashankar A.; Faitg, Thomas H.; Sherk, Susan R.;
Blackledge, Charles W.; Rys, David J.; Lessen, Thomas A.; Swestock, John;
Deng, Yijun; Nitz, Theodore J.; Reinhardt, Jason A.; Feng, Hao; Saha,
Ashis K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004041201 A2 2004-05-21

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphor(isothiocyanatido)thioic acid, O,O-bis(1-methylethyl) ester
C7H14NO2PS2
69674-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.8500 3.0800 0.0 0 VAL=5
M  V30 2 O 2.5162 2.3100 0.0 0
M  V30 3 O 5.1837 3.8500 0.0 0
M  V30 4 N 3.0800 4.4137 0.0 0
M  V30 5 S 4.6201 1.7464 0.0 0
M  V30 6 C 2.5162 0.7700 0.0 0
M  V30 7 C 6.5174 3.0800 0.0 0
M  V30 8 C 1.5400 4.4137 0.0 0
M  V30 9 C 1.1826 0.0000 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 7.8510 3.8500 0.0 0
M  V30 12 C 6.5174 1.5400 0.0 0
M  V30 13 S 0.0000 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O,O-Bis(1-methylethyl) N-[(methylamino)thioxomethyl]phosphoramidothioate
C8H19N2O2PS2
1190881-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.0010 4.0011 0.0 0 VAL=5
M  V30 2 N 4.7710 5.3348 0.0 0
M  V30 3 O 3.2310 2.6675 0.0 0
M  V30 4 O 2.6673 4.7711 0.0 0
M  V30 5 S 5.3348 3.2311 0.0 0
M  V30 6 C 6.3110 5.3348 0.0 0
M  V30 7 C 4.0010 1.3338 0.0 0
M  V30 8 C 1.3337 4.0011 0.0 0
M  V30 9 N 7.0810 6.6686 0.0 0
M  V30 10 S 7.0810 4.0011 0.0 0
M  V30 11 C 5.5410 1.3338 0.0 0
M  V30 12 C 3.2310 0.0000 0.0 0
M  V30 13 C 0.0000 4.7711 0.0 0
M  V30 14 C 1.3337 2.4611 0.0 0
M  V30 15 C 8.6210 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69674-00-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1190881-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-2221083
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-(thio)phosphorylated thiosemicarbazides RC(S)NHP(X)(OiPr)2
(X = S, R = NH2N(Me)-; X = O, R = NH2N(Me)-, PhNHNH-): Reaction of
NH2N(Me)C(S)NHP(S)(OiPr)2 with acetone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Babashkina, Maria G.; Safin, Damir A.; Bolte, Michael; Klein, Axel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2009), 28(13), 2693-2697

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pentafluoropyridine
C5F5N
700-16-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 2.6674 0.0 0
M  V30 2 F 1.5400 5.3349 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 4.6200 5.3349 0.0 0
M  V30 5 F 6.1600 2.6674 0.0 0
M  V30 6 C 1.5400 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 N 3.8500 1.3338 0.0 0
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridinamine, 2,3,5,6-tetrafluoro-N-methyl-
C6H4F4N2
65171-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6686 3.8500 0.0 0
M  V30 3 F 5.3348 1.5400 0.0 0
M  V30 4 F 2.6675 6.1601 0.0 0
M  V30 5 F 2.6675 0.0000 0.0 0
M  V30 6 F 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 C 2.6675 1.5400 0.0 0
M  V30 11 C 1.3338 3.8500 0.0 0
M  V30 12 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700-16-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65171-12-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7293518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polyfluorinated arylnitramines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Platonov, V. E.; Haas, A.; Schelvis, M.; Lieb, M.; Dvornikova, K. V.;
Osina, O. I.; Gatilov, Y. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 109(2), 131-139

$RFMT $RIREG SCHEME163 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
701-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 F 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-[(3-fluorophenyl)sulfonyl]-N,2-dimethyl-
C11H12FNO3S
3056449-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 3.0801 0.0 0 VAL=6
M  V30 2 N 6.6685 3.8501 0.0 0
M  V30 3 O 4.5648 4.4137 0.0 0
M  V30 4 O 6.1048 1.7464 0.0 0
M  V30 5 C 8.0023 3.0801 0.0 0
M  V30 6 C 6.6685 5.3901 0.0 0
M  V30 7 C 9.3360 3.8501 0.0 0
M  V30 8 O 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 5.3901 0.0 0
M  V30 10 C 10.6697 3.0801 0.0 0
M  V30 11 F 0.0000 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 0.0000 0.0 0
M  V30 17 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 15
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 701-27-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056449-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-2-carboxaldehyde
C11H11NO
709649-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 0.0000 1.3172 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 O 7.4148 2.1327 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 N 3.3406 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.5864 3.6643 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 C 4.7474 2.1327 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-2-methanamine
C12H16N2
709649-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 C 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 N 7.3470 4.4136 0.0 0
M  V30 5 C 8.8870 4.4136 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 2.6673 3.8500 0.0 0
M  V30 8 N 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 4.1320 4.3259 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 5.0370 3.0800 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 709649-50-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10159961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1,7-Dimethyl-1H-indol-2-ylmethyl)methylamine [0822] To
1,7-dimethyl-1H-indole-2-carbaldehyde (1.57 g, 9.06 mmol) was added a
solution of 2 M solution of methylamine in methanol (30 mL) and the
resulting mixture stirred overnight at room temperature. The mixture was
concentrated under reduced pressure and the residue taken up in ethanol
(30 mL). The solution was cooled to 0° C. and then NaBH4 (0.34 g, 9.1
mmol) was added in one portion. The mixture was stirred overnight.
Additional NaBH4 (0.18 g, 4.5 mmol) was added and the mixture was again
stirred overnight. The mixture was concentrated under reduced pressure
and the residue combined with 1 M NaOH (200 mL). The mixture was
extracted with diethyl ether (3×150 mL). The combined organics were
washed with brine (100 mL), dried over Na2SO4, filtered and concentrated
under reduced pressure to give the title compound as a pale yellow oil
(1.60 g, 94%). 1H NMR (300 MHz, CDCl3) δ 7.37 (d, J=7.8 Hz, 1H),
6.93-6.87 (m, 2H), 6.34 (s, 1H), 4.02 (s, 3H), 3.84 (s, 2H), 2.77 (s,
3H), 2.50 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of reagent in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-2-carboxaldehyde
C11H11NO
709649-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 0.0000 1.3172 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 O 7.4148 2.1327 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 N 3.3406 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.5864 3.6643 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 C 4.7474 2.1327 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-2-methanamine
C12H16N2
709649-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 C 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 N 7.3470 4.4136 0.0 0
M  V30 5 C 8.8870 4.4136 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 2.6673 3.8500 0.0 0
M  V30 8 N 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 4.1320 4.3259 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 5.0370 3.0800 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 709649-50-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9022975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of reagent in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7-Dimethyl-1H-indole-2-carboxaldehyde
C11H11NO
709649-50-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0204 0.0000 0.0 0
M  V30 2 C 0.0000 1.3172 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 O 7.4148 2.1327 0.0 0
M  V30 5 C 2.3100 2.6508 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 N 3.3406 1.5064 0.0 0
M  V30 8 C 0.7700 2.6508 0.0 0
M  V30 9 C 4.5864 3.6643 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 C 4.7474 2.1327 0.0 0
M  V30 12 C 0.0000 3.9844 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,7-Trimethyl-1H-indole-2-methanamine
C12H16N2
709649-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.3694 0.0 0
M  V30 2 C 1.3336 0.0000 0.0 0
M  V30 3 C 6.5770 3.0800 0.0 0
M  V30 4 N 7.3470 4.4136 0.0 0
M  V30 5 C 8.8870 4.4136 0.0 0
M  V30 6 C 2.6673 2.3100 0.0 0
M  V30 7 C 2.6673 3.8500 0.0 0
M  V30 8 N 4.1320 1.8341 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 4.1320 4.3259 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 5.0370 3.0800 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 709649-50-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12723873
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1,7-Dimethyl-1H-indol-2-ylmethyl)methylamine To
1,7-dimethyl-1H-indole-2-carbaldehyde (1.57 g, 9.06 mmol) was added a
solution of 2 M solution of methylamine in methanol (30 mL) and the
resulting mixture stirred overnight at room temperature. The mixture was
concentrated under reduced pressure and the residue taken up in ethanol
(30 mL). The solution was cooled to 0 °C and then NaBH4 (0.34 g, 9.1
mmol) was added in one portion. The mixture was stirred overnight.
Additional NaBH4 (0.18 g, 4.5 mmol) was added and the mixture was again
stirred overnight. The mixture was concentrated under reduced pressure
and the residue combined with 1 M NaOH (200 mL). The mixture was
extracted with diethyl ether (3 x 150 mL). The combined organics were
washed with brine (100 mL), dried over Na2SO4, filtered and concentrated
under reduced pressure to give the title compound as a pale yellow oil.
(1,7-Dimethyl-1H-indol-2-ylmethyl)methylamine, yield 1.60 g, 94%. 1H NMR
(300 MHz, CDCl3) δ 7.37 (d, J = 7.8 Hz, 1H), 6.93-6.87 (m, 2H), 6.34 (s,
1H), 4.02 (s, 3H), 3.84 (s, 2H), 2.77 (s, 3H), 2.50 (s, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of NaBH4 in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-chloro-3-nitroquinoline
C9H4BrClN2O2
723281-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 Br 9.3359 1.5400 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 5.3348 3.8500 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 C 6.6684 4.6201 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 8.0022 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 8.0022 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-3-nitro-4-quinolinamine
C10H8BrN3O2
1289187-99-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 4.0012 0.0000 0.0 0
M  V30 3 N 8.0023 2.3101 0.0 0 VAL=5
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 O 9.3360 3.0801 0.0 0
M  V30 6 Br 0.0000 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 6.6685 3.0801 0.0 0
M  V30 12 N 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 6.6685 4.6201 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 723281-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1289187-99-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20461692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM DCM solvent may also be used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel,
potent and PI3Kδ selective inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bahekar, Rajesh; Dave, Bhushan; Soman, Shubhangi; Patel, Dipam; Chopade,
Rajendra; Funde, Radhika; Kumar, Jeevan; Sachchidanand, S.; Giri, Poonam;
Chatterjee, Abhijit; Mahapatra, Jogeswar; Vyas, Purvi; Ghoshdastidar,
Krishnarup; Bandyopadhyay, Debdutta; Desai, Ranjit C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2019), 29(11), 1313-1319

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[ethoxy(η6-phenyl)methylene]]di-
C17H10Cr2O9
73769-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3337 0.7711 0.0 0
M  V30 2 O 6.1048 0.7711 0.0 0 VAL=3
M  V30 3 C 2.6658 0.7711 0.0 0
M  V30 4 O 1.8947 0.7711 0.0 0 VAL=3
M  V30 5 C 3.9998 0.0000 0.0 0
M  V30 6 O 4.7708 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4604 7.7701 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4604 10.0493 0.0 0 CHG=1 VAL=7
M  V30 9 O 9.1274 7.3856 0.0 0
M  V30 10 C 7.7127 11.3960 0.0 0
M  V30 11 C 9.2060 8.7005 0.0 0
M  V30 12 C 9.8071 10.7949 0.0 0
M  V30 13 C 8.4604 11.5893 0.0 0
M  V30 14 C 7.1116 9.3016 0.0 0
M  V30 15 C 9.7944 7.7701 0.0 0
M  V30 16 O 7.0436 11.7805 0.0 0 VAL=3
M  V30 17 O 9.8730 8.3160 0.0 0 VAL=3
M  V30 18 O 10.4741 10.4104 0.0 0 VAL=3
M  V30 19 O 7.7913 11.9738 0.0 0 VAL=3
M  V30 20 O 6.4446 9.6861 0.0 0 VAL=3
M  V30 21 C 10.4678 7.3962 0.0 0
M  V30 22 Cr 3.9998 1.5400 0.0 0 CHG=1 VAL=9
M  V30 23 C 7.7935 7.3856 0.0 0 VAL=5
M  V30 24 C 5.3316 5.9497 0.0 0 VAL=5
M  V30 25 C 5.3316 8.8215 0.0 0 VAL=5
M  V30 26 C 2.4598 8.8215 0.0 0 VAL=5
M  V30 27 C 2.4598 5.9497 0.0 0 VAL=5
M  V30 28 C 0.0000 7.3856 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 22
M  V30 3 3 3 4
M  V30 4 1 3 22
M  V30 5 3 5 6
M  V30 6 1 5 22
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 23
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 15 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 27 1 22 28
M  V30 28 1 23 24
M  V30 29 2 23 25
M  V30 30 2 24 27
M  V30 31 1 25 26
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-(methylamino)phenylmethylene]]di-
C16H9Cr2NO8
332847-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3331 0.7710 0.0 0
M  V30 2 O 6.1041 0.7710 0.0 0 VAL=3
M  V30 3 C 2.6655 0.7710 0.0 0
M  V30 4 O 1.8945 0.7710 0.0 0 VAL=3
M  V30 5 C 3.9993 0.0000 0.0 0
M  V30 6 O 4.7682 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4574 7.7692 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4574 10.0482 0.0 0 CHG=1 VAL=7
M  V30 9 N 9.1243 7.3848 0.0 0
M  V30 10 C 7.7098 11.3947 0.0 0
M  V30 11 C 9.2050 8.6995 0.0 0
M  V30 12 C 9.8039 10.7937 0.0 0
M  V30 13 C 8.4574 11.5880 0.0 0
M  V30 14 C 7.1108 9.3006 0.0 0
M  V30 15 C 9.8846 7.8223 0.0 0
M  V30 16 O 7.0429 11.7792 0.0 0 VAL=3
M  V30 17 O 9.8719 8.3151 0.0 0 VAL=3
M  V30 18 O 10.4708 10.4092 0.0 0 VAL=3
M  V30 19 O 7.7905 11.9724 0.0 0 VAL=3
M  V30 20 O 6.4418 9.6850 0.0 0 VAL=3
M  V30 21 Cr 3.9993 1.5398 0.0 0 CHG=1 VAL=9
M  V30 22 C 7.7905 7.3848 0.0 0 VAL=5
M  V30 23 C 5.3289 5.9490 0.0 0 VAL=5
M  V30 24 C 5.3289 8.8206 0.0 0 VAL=5
M  V30 25 C 2.4595 8.8206 0.0 0 VAL=5
M  V30 26 C 2.4595 5.9490 0.0 0 VAL=5
M  V30 27 C 0.0000 7.3848 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 21
M  V30 3 3 3 4
M  V30 4 1 3 21
M  V30 5 3 5 6
M  V30 6 1 5 21
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 21 27
M  V30 27 1 22 23
M  V30 28 2 22 24
M  V30 29 2 23 26
M  V30 30 1 24 25
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 73769-68-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-15529695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine
C16H17BrN4O7
74465-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 9.0262 0.0 0
M  V30 2 C 4.3083 9.9314 0.0 0
M  V30 3 C 2.9015 9.3049 0.0 0
M  V30 4 O 4.4694 11.4629 0.0 0
M  V30 5 O 2.6527 7.3510 0.0 0
M  V30 6 C 1.4068 6.4457 0.0 0
M  V30 7 C 0.0000 7.0721 0.0 0
M  V30 8 O 1.5679 4.9142 0.0 0
M  V30 9 C 3.3494 4.0738 0.0 0
M  V30 10 O 3.8252 2.6091 0.0 0
M  V30 11 C 2.7948 1.4647 0.0 0
M  V30 12 C 3.2707 0.0000 0.0 0
M  V30 13 O 1.2884 1.7849 0.0 0
M  V30 14 Br 13.1896 6.5238 0.0 0
M  V30 15 C 6.5378 6.4641 0.0 0 CFG=2
M  V30 16 C 5.3933 7.4946 0.0 0 CFG=2
M  V30 17 O 5.9113 5.0573 0.0 0
M  V30 18 C 4.0596 6.7246 0.0 0 CFG=2
M  V30 19 C 4.3798 5.2182 0.0 0 CFG=2
M  V30 20 N 8.0441 6.7842 0.0 0
M  V30 21 C 9.1885 5.7538 0.0 0
M  V30 22 C 8.6704 8.1912 0.0 0
M  V30 23 C 10.5223 6.5238 0.0 0
M  V30 24 N 9.1885 4.2138 0.0 0
M  V30 25 N 10.2021 8.0303 0.0 0
M  V30 26 C 11.8560 5.7538 0.0 0
M  V30 27 C 10.5223 3.4438 0.0 0
M  V30 28 N 11.8560 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 19 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 26
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20 CFG=3
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 2 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N6-Methyladenosine
C11H15N5O4
1867-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5371 3.9148 0.0 0
M  V30 3 C 11.8709 3.1447 0.0 0
M  V30 4 C 0.6967 1.4646 0.0 0
M  V30 5 O 1.1726 0.0000 0.0 0
M  V30 6 O 0.0000 4.7418 0.0 0
M  V30 7 N 5.3915 4.1752 0.0 0
M  V30 8 C 6.5361 3.1447 0.0 0
M  V30 9 C 6.0178 5.5820 0.0 0
M  V30 10 C 7.8697 3.9148 0.0 0
M  V30 11 N 6.5361 1.6047 0.0 0
M  V30 12 N 7.5496 5.4211 0.0 0
M  V30 13 C 9.2034 3.1447 0.0 0
M  V30 14 C 7.8697 0.8347 0.0 0
M  V30 15 N 9.2034 1.6047 0.0 0
M  V30 16 C 3.8852 3.8550 0.0 0 CFG=1
M  V30 17 O 3.2587 2.4480 0.0 0
M  V30 18 C 2.7406 4.8854 0.0 0 CFG=2
M  V30 19 C 1.7271 2.6091 0.0 0 CFG=2
M  V30 20 C 1.4070 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74465-47-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1867-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2571294
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for the Preparation of N 6-Substituted Adenosine
Analogues. The amine (10 equiv.) was added to a solution of the
6-bromonebularine triacetate (0.656-1.09 mmol) in MeOH (10 mL). The
reaction mixture was stirred at room temperature for 8h. It was
concentrated under reduced pressure and the solid was triturated with
EtOAc. The respective N 6-substituted product (vide infra). N
6-Methyladenosine (9). White solid (94%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substrate Analogues for an RNA-Editing Adenosine Deaminase: Mechanistic
Investigation and Inhibitor Design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veliz, Eduardo A.; Easterwood, LaHoma M.; Beal, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2003), 125(36), 10867-10876

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purine
C16H17BrN4O7
74465-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 9.0262 0.0 0
M  V30 2 C 4.3083 9.9314 0.0 0
M  V30 3 C 2.9015 9.3049 0.0 0
M  V30 4 O 4.4694 11.4629 0.0 0
M  V30 5 O 2.6527 7.3510 0.0 0
M  V30 6 C 1.4068 6.4457 0.0 0
M  V30 7 C 0.0000 7.0721 0.0 0
M  V30 8 O 1.5679 4.9142 0.0 0
M  V30 9 C 3.3494 4.0738 0.0 0
M  V30 10 O 3.8252 2.6091 0.0 0
M  V30 11 C 2.7948 1.4647 0.0 0
M  V30 12 C 3.2707 0.0000 0.0 0
M  V30 13 O 1.2884 1.7849 0.0 0
M  V30 14 Br 13.1896 6.5238 0.0 0
M  V30 15 C 6.5378 6.4641 0.0 0 CFG=2
M  V30 16 C 5.3933 7.4946 0.0 0 CFG=2
M  V30 17 O 5.9113 5.0573 0.0 0
M  V30 18 C 4.0596 6.7246 0.0 0 CFG=2
M  V30 19 C 4.3798 5.2182 0.0 0 CFG=2
M  V30 20 N 8.0441 6.7842 0.0 0
M  V30 21 C 9.1885 5.7538 0.0 0
M  V30 22 C 8.6704 8.1912 0.0 0
M  V30 23 C 10.5223 6.5238 0.0 0
M  V30 24 N 9.1885 4.2138 0.0 0
M  V30 25 N 10.2021 8.0303 0.0 0
M  V30 26 C 11.8560 5.7538 0.0 0
M  V30 27 C 10.5223 3.4438 0.0 0
M  V30 28 N 11.8560 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 19 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 26
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 20 CFG=3
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 2 22 25
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, N-methyl-, 2′,3′,5′-triacetate
C17H21N5O7
56787-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5543 9.0262 0.0 0
M  V30 2 C 4.3084 9.9315 0.0 0
M  V30 3 C 4.4693 11.4630 0.0 0
M  V30 4 O 2.9016 9.3050 0.0 0
M  V30 5 O 2.6527 7.3510 0.0 0
M  V30 6 C 1.4068 6.4458 0.0 0
M  V30 7 C 0.0000 7.0721 0.0 0
M  V30 8 O 1.5677 4.9142 0.0 0
M  V30 9 C 3.3494 4.0738 0.0 0
M  V30 10 O 3.8253 2.6091 0.0 0
M  V30 11 C 2.7947 1.4647 0.0 0
M  V30 12 C 3.2707 0.0000 0.0 0
M  V30 13 O 1.2884 1.7849 0.0 0
M  V30 14 N 13.1897 6.5239 0.0 0
M  V30 15 C 14.5234 5.7538 0.0 0
M  V30 16 C 6.5377 6.4641 0.0 0 CFG=2
M  V30 17 C 5.3933 7.4947 0.0 0 CFG=2
M  V30 18 O 5.9114 5.0573 0.0 0
M  V30 19 C 4.0597 6.7247 0.0 0 CFG=2
M  V30 20 C 4.3798 5.2182 0.0 0 CFG=2
M  V30 21 N 8.0442 6.7843 0.0 0
M  V30 22 C 9.1886 5.7538 0.0 0
M  V30 23 C 8.6705 8.1912 0.0 0
M  V30 24 C 10.5224 6.5239 0.0 0
M  V30 25 N 9.1886 4.2138 0.0 0
M  V30 26 N 10.2020 8.0303 0.0 0
M  V30 27 C 11.8560 5.7538 0.0 0
M  V30 28 C 10.5224 3.4438 0.0 0
M  V30 29 N 11.8560 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 20 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 27
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 2 23 26
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74465-47-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56787-20-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4762582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reaction of
6-Bromopurine Derivatives with Aliphatic Amines. The amine was added to a
solution of the 6-bromopurine derivative (0.109-0. 116 mmol) in the
appropriate solvent (5 mL). With the exception of methylamine (40%
aqueous solution, 6 equiv), all other amines were present in 2.5 equiv.
The reaction mixture was stirred at room temperature until completion by
TLC (see Table 1). The reaction mixture was diluted with EtOAc (10 mL)
and washed with brine (1 x 15 mL). The organic layer was dried (Na2SO4),
filtered, and concentrated under reduced pressure. The crude products
were purified by flash column chromatography on silica gel using
appropriate solvent systems (listed under individual compound headings,
vide infra). N-Methyladenosine (3a). Triturated with EtOAc. White solid
(94%). Spectral data agreed with reported values.32
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 6-Bromopurine Nucleosides as Reagents for Nucleoside Analog Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veliz, Eduardo A.; Beal, Peter A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(25), 8592-8598

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
8-[[(2-Ethyl-6-methylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyrazine-...
C19H22N4O2
750571-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 5.3901 0.0 0
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 C 11.9867 5.3305 0.0 0
M  V30 4 C 10.6241 8.3913 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 4.0010 7.7002 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 N 9.3358 4.6201 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 N 8.3223 6.8966 0.0 0
M  V30 15 C 9.3358 3.0801 0.0 0
M  V30 16 C 10.4804 5.6507 0.0 0
M  V30 17 N 6.6685 3.0801 0.0 0
M  V30 18 C 9.8541 7.0575 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 1.3337 7.7002 0.0 0
M  V30 25 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 20
M  V30 4 1 3 16
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[[(2-Ethyl-6-methylphenyl)methyl]amino]-N,2,3-trimethylimidazo[1,2-a]pyrazi...
C20H25N5O
750571-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.2436 0.0 0
M  V30 2 C 7.7000 6.5772 0.0 0
M  V30 3 C 1.1394 1.9694 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 C 2.3100 7.9108 0.0 0
M  V30 6 N 0.7700 7.9108 0.0 0
M  V30 7 O 3.0800 9.2446 0.0 0
M  V30 8 C 0.0000 9.2446 0.0 0
M  V30 9 C 9.2400 9.2446 0.0 0
M  V30 10 C 10.0100 10.5783 0.0 0
M  V30 11 C 9.2400 3.9099 0.0 0
M  V30 12 C 4.6200 3.9099 0.0 0
M  V30 13 N 3.0800 3.9099 0.0 0
M  V30 14 C 5.3900 5.2436 0.0 0
M  V30 15 N 5.0959 2.4452 0.0 0
M  V30 16 C 2.3100 5.2436 0.0 0
M  V30 17 C 2.6041 2.4452 0.0 0
M  V30 18 N 4.6200 6.5772 0.0 0
M  V30 19 C 3.8500 1.5400 0.0 0
M  V30 20 C 3.0800 6.5772 0.0 0
M  V30 21 C 9.2400 6.5772 0.0 0
M  V30 22 C 10.0100 7.9108 0.0 0
M  V30 23 C 10.0100 5.2436 0.0 0
M  V30 24 C 11.5500 7.9108 0.0 0
M  V30 25 C 11.5500 5.2436 0.0 0
M  V30 26 C 12.3200 6.5772 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 21
M  V30 4 1 3 17
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 750571-45-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 750571-48-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5993524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors
of the gastric H+/K+-ATPase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zimmermann, Peter Jan; Brehm, Christof; Buhr, Wilm; Palmer, Andreas Marc;
Volz, Juergen; Simon, Wolfgang-Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(1), 536-541

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
8-[[(2-Ethyl-6-methylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyrazine-...
C19H22N4O2
750571-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 5.3901 0.0 0
M  V30 2 C 4.0010 4.6201 0.0 0
M  V30 3 C 11.9867 5.3305 0.0 0
M  V30 4 C 10.6241 8.3913 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 9.3358 0.0000 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 4.0010 7.7002 0.0 0
M  V30 11 C 8.0022 5.3901 0.0 0
M  V30 12 N 9.3358 4.6201 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 N 8.3223 6.8966 0.0 0
M  V30 15 C 9.3358 3.0801 0.0 0
M  V30 16 C 10.4804 5.6507 0.0 0
M  V30 17 N 6.6685 3.0801 0.0 0
M  V30 18 C 9.8541 7.0575 0.0 0
M  V30 19 C 8.0022 2.3101 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 2.6673 6.9302 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 1.3337 7.7002 0.0 0
M  V30 25 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 20
M  V30 4 1 3 16
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[[(2-Ethyl-6-methylphenyl)methyl]amino]-N,2,3-trimethylimidazo[1,2-a]pyrazi...
C20H25N5O
750571-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.2436 0.0 0
M  V30 2 C 7.7000 6.5772 0.0 0
M  V30 3 C 1.1394 1.9694 0.0 0
M  V30 4 C 3.8500 0.0000 0.0 0
M  V30 5 C 2.3100 7.9108 0.0 0
M  V30 6 N 0.7700 7.9108 0.0 0
M  V30 7 O 3.0800 9.2446 0.0 0
M  V30 8 C 0.0000 9.2446 0.0 0
M  V30 9 C 9.2400 9.2446 0.0 0
M  V30 10 C 10.0100 10.5783 0.0 0
M  V30 11 C 9.2400 3.9099 0.0 0
M  V30 12 C 4.6200 3.9099 0.0 0
M  V30 13 N 3.0800 3.9099 0.0 0
M  V30 14 C 5.3900 5.2436 0.0 0
M  V30 15 N 5.0959 2.4452 0.0 0
M  V30 16 C 2.3100 5.2436 0.0 0
M  V30 17 C 2.6041 2.4452 0.0 0
M  V30 18 N 4.6200 6.5772 0.0 0
M  V30 19 C 3.8500 1.5400 0.0 0
M  V30 20 C 3.0800 6.5772 0.0 0
M  V30 21 C 9.2400 6.5772 0.0 0
M  V30 22 C 10.0100 7.9108 0.0 0
M  V30 23 C 10.0100 5.2436 0.0 0
M  V30 24 C 11.5500 7.9108 0.0 0
M  V30 25 C 11.5500 5.2436 0.0 0
M  V30 26 C 12.3200 6.5772 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 21
M  V30 4 1 3 17
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 20
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 750571-45-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 750571-48-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-299122
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 9.
8-(2-Ethyl-6-methyl-benzylamino)-6-(methylaminocarbonyl)-2,3-dimethyl-imidazo[1,2-a]-pyrazine
To a suspension of 1.02 g (3 mmol) of
8-(2-ethyl-6-methyl-benzylamino)-2,3-dimethyl-imidazo[1,2-a]-pyrazine-6-carboxylic
acid in 20 ml of dichloromethane are added 1.61 g (5 mmol) of
0-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate
(TBTU). After 30 min stirring at room temperature 1 ml (8 mmol) of
methylamine (8M in ethanol) is added. After 1 h, a further amount of 0.5
ml (4 mmol) of methylamine (8M in ethanol) is added and stirring is
continued for 16 h. The reaction mixture is extracted with 2N aqueous
sodium hydroxide solution, the organic phase is separated, dried over
anhydrous magnesium sulfate and evaporated. Purification of the residue
by column chromatography on silica gel using ethyl acetate/light
petroleum ether (1:1, v/v) and crystallization from
ethylacetate/n-heptane yields the title compound. Colourless solid, yield
0.99 g, 94%. m.p. 120 °C.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (methylamine) (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-substituted imidazopyrazines with gastric antisecretory
activity for treatment of gastrointestinal disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chiesa, M. Vittoria; Palmer, Andreas; Brehm, Christof; Grundler, Gerhard;
Senn-Bilfinger, Joerg; Simon, Wolfgang-Alexander; Postius, Stefan;
Kromer, Wolfgang; Zimmermann, Peter Jan; Buhr, Wilm
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004074289 A1 2004-09-02

$RFMT $RIREG SCHEME170 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Oxalyl chloride
C2Cl2O2
79-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-2-thioxo-4,5-imidazolidinedione
C4H4N2O2S
29181-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3628 0.0 0
M  V30 2 C 3.0608 0.0000 0.0 0
M  V30 3 O 0.3502 4.6949 0.0 0
M  V30 4 S 5.3026 2.4899 0.0 0
M  V30 5 C 1.3337 2.1328 0.0 0
M  V30 6 N 2.7406 1.5065 0.0 0
M  V30 7 C 1.4946 3.6644 0.0 0
M  V30 8 C 3.7711 2.6509 0.0 0
M  V30 9 N 3.0011 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 2 3 7
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29181-62-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-21099654
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 100-85-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triton-B mediated efficient synthesis of thioxoimidazolidine-4,5-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kishore, Ram; Kamboj, M.; Shukla, M.; Chaturvedi, Devdutt
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Chemistry (2020), 32(1), 183-186

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
4-Bromo-3-methylbenzoic acid
C8H7BrO2
7697-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,3-dimethylbenzamide
C9H10BrNO
149104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 7697-28-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149104-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20729368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of naphthyridine compounds as inhibitors of HPK1 useful for
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chan, Bryan; Daniels, Blake; Drobnick, Joy; Gazzard, Lewis; Heffron,
Timothy; Huestis, Malcolm; Liang, Jun; Malhotra, Sushant; Mendonca,
Rohan; Rajapaksa, Naomi; Siu, Michael; Stivala, Craig; Tellis, John;
Wang, Weiru; Wei, Binqing; Zhou, Aihe; Cartwright, Matthew W.; Gancia,
Emanuela; Jones, Graham; Lainchbury, Michael; Madin, Andrew; Seward,
Eileen; Favor, David; Fong, Kin Chiu; Hu, Yonghan; Good, Andrew; Hu,
Baihua; Lu, Aijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018183956 A1 2018-10-04

$RFMT $RIREG SCHEME172 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Mesitylenesulfonyl chloride
C9H11ClO2S
773-64-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6674 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6674 0.0 0
M  V30 3 O 1.5400 4.2074 0.0 0
M  V30 4 O 1.5400 1.1274 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 5.3349 0.0 0
M  V30 7 C 7.7000 2.6674 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N,2-dimethyl-N-[(2,4,6-trimethylphenyl)sulfonyl]-
C14H19NO3S
3056449-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6674 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6674 0.0 0
M  V30 3 O 4.6200 4.2074 0.0 0
M  V30 4 O 4.6200 1.1274 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 0.7700 4.0011 0.0 0
M  V30 8 O 3.0800 5.3349 0.0 0
M  V30 9 C 0.0000 5.3349 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 6.1600 5.3349 0.0 0
M  V30 12 C 6.1600 0.0000 0.0 0
M  V30 13 C 10.7800 2.6674 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 6.9300 1.3338 0.0 0
M  V30 17 C 8.4700 4.0011 0.0 0
M  V30 18 C 8.4700 1.3338 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 15
M  V30 12 1 12 16
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 773-64-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056449-96-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690427
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME173 STEP1
$RXN



  3  1
$MOL
Oxalyl chloride
C2Cl2O2
79-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluorobenzamide
C7H5F2NO
85118-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 N 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoro-N-[(methylamino)carbonyl]benzamide
C9H8F2N2O2
2851992-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 3.8500 4.0011 0.0 0
M  V30 3 O 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 N 1.5400 5.3349 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 F 6.1600 0.0000 0.0 0
M  V30 9 F 10.7800 2.6674 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 6.9300 1.3338 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0
M  V30 13 C 8.4700 1.3338 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 11
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 85118-02-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2851992-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34886915
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfonamide compounds as cardiac sarcomere activators and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gardina, Jeffrey; Chandra, Aroop; Ashcraft, Luke W.; Collibee, Scott;
Chuang, Chihyuan; Muci - Deceased, Alex; Morgan, Bradley P.; Romero,
Antonio; Johnson, Michael; Moebius, David; Zhang, Hanmo; Gonzalez, Felix
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20220332708 A1 2022-10-20

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-2,2-dimethyl-2H-1-benzopyran-6-carboxaldehyde
C13H14O3
79571-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.5178 0.7700 0.0 0
M  V30 2 C 6.8515 0.0000 0.0 0
M  V30 3 C 8.1853 2.3101 0.0 0
M  V30 4 O 9.5189 3.0801 0.0 0
M  V30 5 C 0.0000 4.3526 0.0 0
M  V30 6 C 0.9899 6.0671 0.0 0
M  V30 7 C 4.1841 3.0801 0.0 0
M  V30 8 C 5.5178 2.3101 0.0 0
M  V30 9 C 4.1841 4.6201 0.0 0
M  V30 10 C 2.8504 2.3101 0.0 0
M  V30 11 C 6.8515 3.0801 0.0 0
M  V30 12 O 2.8504 5.3901 0.0 0
M  V30 13 C 5.5178 5.3901 0.0 0
M  V30 14 C 1.5166 3.0801 0.0 0
M  V30 15 C 6.8515 4.6201 0.0 0
M  V30 16 C 1.5166 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 11
M  V30 5 1 5 16
M  V30 6 1 6 16
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N,2,2-trimethyl-2H-1-benzopyran-6-methanamine
C14H19NO2
357973-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.5178 0.7700 0.0 0
M  V30 2 C 6.8515 0.0000 0.0 0
M  V30 3 C 8.1851 2.3101 0.0 0
M  V30 4 N 9.5189 3.0801 0.0 0
M  V30 5 C 10.8526 2.3101 0.0 0
M  V30 6 C 0.0000 4.3526 0.0 0
M  V30 7 C 0.9899 6.0671 0.0 0
M  V30 8 C 4.1841 3.0801 0.0 0
M  V30 9 C 5.5178 2.3101 0.0 0
M  V30 10 C 4.1841 4.6201 0.0 0
M  V30 11 C 2.8503 2.3101 0.0 0
M  V30 12 C 6.8515 3.0801 0.0 0
M  V30 13 O 2.8503 5.3901 0.0 0
M  V30 14 C 5.5178 5.3901 0.0 0
M  V30 15 C 1.5166 3.0801 0.0 0
M  V30 16 C 6.8515 4.6201 0.0 0
M  V30 17 C 1.5166 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 6 17
M  V30 7 1 7 17
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79571-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 357973-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7818232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A short synthesis of 5-methoxy-2,2-dimethyl-2H-1-benzopyran-6-propanoic
acid methyl ester
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Henry, G. E.; Jacobs, H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(25), 5335-5338

$RFMT $RIREG SCHEME175 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonyl chloride
C6H5ClO2S
98-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acryloyl chloride
C3H3ClO
814-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 Cl 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-N-(phenylsulfonyl)-2-propenamide
C10H11NO3S
1620220-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 2.3101 0.0 0 VAL=6
M  V30 2 N 5.3348 1.5400 0.0 0
M  V30 3 O 4.7712 3.6437 0.0 0
M  V30 4 O 3.2311 0.9764 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 8.0023 1.5400 0.0 0
M  V30 8 O 6.6685 3.8501 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 814-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620220-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2-dihydro-6-hydroxy-4-oxo-4H-pyrrolo[3,2,1-ij]quinoline-5-carboxylate
C14H13NO4
84088-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6870 1.5507 0.0 0
M  V30 2 O 4.0253 6.1628 0.0 0
M  V30 3 C 6.7024 4.6343 0.0 0
M  V30 4 O 8.0361 3.8643 0.0 0
M  V30 5 O 6.7024 6.1743 0.0 0
M  V30 6 C 9.3699 4.6343 0.0 0
M  V30 7 C 10.7035 3.8643 0.0 0
M  V30 8 C 2.7291 2.3339 0.0 0
M  V30 9 N 4.0115 1.5448 0.0 0
M  V30 10 C 2.6821 3.8525 0.0 0
M  V30 11 C 1.4977 1.4672 0.0 0
M  V30 12 C 5.3556 2.3248 0.0 0
M  V30 13 C 3.5689 0.0474 0.0 0
M  V30 14 C 4.0287 4.6227 0.0 0
M  V30 15 C 1.2905 4.5382 0.0 0
M  V30 16 C 2.0318 0.0000 0.0 0
M  V30 17 C 0.1080 2.1628 0.0 0
M  V30 18 C 5.3687 3.8643 0.0 0
M  V30 19 C 0.0000 3.6984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 1 12 18
M  V30 18 1 13 16
M  V30 19 2 14 18
M  V30 20 2 15 19
M  V30 21 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-6-hydroxy-N-methyl-4-oxo-4H-pyrrolo[3,2,1-ij]quinoline-5-carboxamide
C13H12N2O3
384365-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6869 1.5506 0.0 0
M  V30 2 O 4.0253 6.1627 0.0 0
M  V30 3 C 6.7023 4.6342 0.0 0
M  V30 4 N 8.0361 3.8642 0.0 0
M  V30 5 O 6.7023 6.1742 0.0 0
M  V30 6 C 9.3698 4.6342 0.0 0
M  V30 7 C 2.7291 2.3339 0.0 0
M  V30 8 N 4.0116 1.5448 0.0 0
M  V30 9 C 2.6821 3.8525 0.0 0
M  V30 10 C 1.4977 1.4672 0.0 0
M  V30 11 C 5.3556 2.3248 0.0 0
M  V30 12 C 3.5688 0.0474 0.0 0
M  V30 13 C 4.0287 4.6227 0.0 0
M  V30 14 C 1.2905 4.5381 0.0 0
M  V30 15 C 2.0319 0.0000 0.0 0
M  V30 16 C 0.1081 2.1628 0.0 0
M  V30 17 C 5.3687 3.8642 0.0 0
M  V30 18 C 0.0000 3.6984 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 10 15
M  V30 15 2 10 16
M  V30 16 1 11 17
M  V30 17 1 12 15
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 84088-82-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 384365-15-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13177155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]quinoline-2-carboxylic
Acid Methylamide (2a). A solution of the ethyl ester 1 (2.59 g, 0.01 mol)
in ethanol (20 ml) was saturated with gaseous methylamine and left at
room temperature for 3 h. The reaction mixture was diluted with cold
water and acidified with dilute (1 : 1) HCl to pH 4.5-5.0. The
precipitated amide was filtered off, washed with water, and dried. Yield,
%: 94. Empirical formula: C13H12N2O3, Found, %: C 63.93, H 4.95, N 11.47,
Calculated, %: C 63.81, H 4.86, N 11.55, mp, °C (ethanol): 187-189, 1H
NMR: Chemical shifts, δ, ppm (J, Hz): 17.20 (1-OH (1H, s)), 10.11 (q, J =
4.2) (NH (1H)), Pirroloquinoline ring: 7.71 (J = 8.2) (H-9 (1H, d)), 7.41
(J = 7.3) (H-7 (1H, d)), 7.13 (J = 7.5) (H-8 (1H, t)), 4.34 (J = 7.9)
(5-CH2 (2H, t)), 3.42 (J = 8.1) (6-CH2 (2H, t)), R: 2.99 (3H, d, J = 4.8,
CH3).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-hydroxy-2-quinolones. Part 121. Synthesis and biological properties of
1-hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1-ij]quinoline-2-carboxylic
acid alkylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ukrainets, I. V.; Bereznyakova, N. L.; Mospanova, E. V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Heterocyclic Compounds (New York, NY, United States) (2007),
43(7), 856-862

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(5-bromo-1H-indol-3-yl)-1-propanone
C11H9Br2NO
843626-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 3.5673 0.6403 0.0 0
M  V30 4 Br 0.0000 2.6091 0.0 0
M  V30 5 C 0.5546 0.0000 0.0 0
M  V30 6 Br 8.4784 2.9553 0.0 0
M  V30 7 C 4.4773 3.7253 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 4.4773 5.2653 0.0 0
M  V30 10 C 5.8111 2.9553 0.0 0
M  V30 11 C 2.1075 4.4953 0.0 0
M  V30 12 N 3.0127 5.7411 0.0 0
M  V30 13 C 5.8111 6.0353 0.0 0
M  V30 14 C 7.1447 3.7253 0.0 0
M  V30 15 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-1H-indol-3-yl)-2-(methylamino)-1-propanone
C12H13BrN2O
2764945-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 3.7710 0.0 0
M  V30 2 C 7.5950 3.7710 0.0 0
M  V30 3 O 5.2850 5.1048 0.0 0
M  V30 4 N 8.3650 5.1048 0.0 0
M  V30 5 C 8.3650 2.4374 0.0 0
M  V30 6 C 9.9050 5.1048 0.0 0
M  V30 7 Br 0.0000 3.8614 0.0 0
M  V30 8 C 3.7534 2.2764 0.0 0
M  V30 9 C 5.2850 2.4374 0.0 0
M  V30 10 C 3.4333 0.7700 0.0 0
M  V30 11 C 2.6091 3.3068 0.0 0
M  V30 12 C 5.9114 1.0306 0.0 0
M  V30 13 N 4.7669 0.0000 0.0 0
M  V30 14 C 1.9686 0.2941 0.0 0
M  V30 15 C 1.1444 2.8310 0.0 0
M  V30 16 C 0.8242 1.3247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 843626-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764945-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37063968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specialized combinations for mental disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Dalziel, Sean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107715 A1 2023-06-15

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-1-(5-bromo-1H-indol-3-yl)-1-propanone
C11H9Br2NO
843626-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5369 1.7847 0.0 0
M  V30 2 C 1.0304 1.4645 0.0 0
M  V30 3 O 3.5673 0.6403 0.0 0
M  V30 4 Br 0.0000 2.6091 0.0 0
M  V30 5 C 0.5546 0.0000 0.0 0
M  V30 6 Br 8.4784 2.9553 0.0 0
M  V30 7 C 4.4773 3.7253 0.0 0
M  V30 8 C 3.0127 3.2494 0.0 0
M  V30 9 C 4.4773 5.2653 0.0 0
M  V30 10 C 5.8111 2.9553 0.0 0
M  V30 11 C 2.1075 4.4953 0.0 0
M  V30 12 N 3.0127 5.7411 0.0 0
M  V30 13 C 5.8111 6.0353 0.0 0
M  V30 14 C 7.1447 3.7253 0.0 0
M  V30 15 C 7.1447 5.2653 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromo-1H-indol-3-yl)-2-(methylamino)-1-propanone
C12H13BrN2O
2764945-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0550 3.7710 0.0 0
M  V30 2 C 7.5950 3.7710 0.0 0
M  V30 3 O 5.2850 5.1048 0.0 0
M  V30 4 N 8.3650 5.1048 0.0 0
M  V30 5 C 8.3650 2.4374 0.0 0
M  V30 6 C 9.9050 5.1048 0.0 0
M  V30 7 Br 0.0000 3.8614 0.0 0
M  V30 8 C 3.7534 2.2764 0.0 0
M  V30 9 C 5.2850 2.4374 0.0 0
M  V30 10 C 3.4333 0.7700 0.0 0
M  V30 11 C 2.6091 3.3068 0.0 0
M  V30 12 C 5.9114 1.0306 0.0 0
M  V30 13 N 4.7669 0.0000 0.0 0
M  V30 14 C 1.9686 0.2941 0.0 0
M  V30 15 C 1.1444 2.8310 0.0 0
M  V30 16 C 0.8242 1.3247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 843626-95-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2764945-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31874092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of advantageous tryptamine compositions for mental disorders
or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022061242 A1 2022-03-24

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3-Diaziridinedicarboxylic acid, 1-methyl-, dimethyl ester, (1R,2R)-rel-
C6H10N2O4
850670-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.2071 0.0 0
M  V30 2 O 1.3337 2.4371 0.0 0
M  V30 3 O 2.6673 4.7471 0.0 0
M  V30 4 C 0.0000 3.2071 0.0 0
M  V30 5 C 4.9909 3.6168 0.0 0
M  V30 6 O 6.5075 3.3494 0.0 0
M  V30 7 O 4.4642 5.0639 0.0 0
M  V30 8 C 7.4975 4.5291 0.0 0
M  V30 9 C 2.2946 0.0000 0.0 0
M  V30 10 C 4.0010 2.4371 0.0 0
M  V30 11 N 3.4743 0.9899 0.0 0
M  V30 12 N 4.9909 1.2573 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 9 11
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Diaziridinecarboxylic acid, 1-methyl-3-[(methylamino)carbonyl]-, methyl est...
C6H11N3O3
850670-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 3.2071 0.0 0
M  V30 2 N 1.3337 2.4371 0.0 0
M  V30 3 O 2.6673 4.7471 0.0 0
M  V30 4 C 0.0000 3.2071 0.0 0
M  V30 5 C 4.9909 3.6168 0.0 0
M  V30 6 O 6.5075 3.3494 0.0 0
M  V30 7 O 4.4642 5.0639 0.0 0
M  V30 8 C 7.4975 4.5291 0.0 0
M  V30 9 C 2.2946 0.0000 0.0 0
M  V30 10 C 4.0010 2.4371 0.0 0
M  V30 11 N 3.4743 0.9899 0.0 0
M  V30 12 N 4.9909 1.2573 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 9 11
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 850670-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850670-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5941037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric nitrogen. Part 92: Stereochemistry of
1,2,4,5-tetraazanorbornanes and diaziridines: exciting history and news
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kostyanovsky, Remir G.; Malyshev, Oleg R.; Lyssenko, Konstantin A.;
Strelenko, Yuri A.; Kadorkina, Gulnara K.; Kostyanovsky, Vasily R.;
Nabiev, Orudzh G.; Fedyanin, Ivan V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Mendeleev Communications (2004), (6), 315-318

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
6-Methoxy-2-methylbenzo[b]thiophene-3-carboxylic acid
C11H10O3S
854515-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 3.3321 0.0 0
M  V30 2 O 1.7849 4.8384 0.0 0
M  V30 3 O 0.0000 2.8561 0.0 0
M  V30 4 C 1.1145 0.0000 0.0 0
M  V30 5 O 8.7355 2.6217 0.0 0
M  V30 6 C 9.5055 3.9555 0.0 0
M  V30 7 C 4.1155 2.6217 0.0 0
M  V30 8 C 2.6091 2.3015 0.0 0
M  V30 9 C 4.8855 1.2881 0.0 0
M  V30 10 C 4.8855 3.9555 0.0 0
M  V30 11 C 2.4481 0.7700 0.0 0
M  V30 12 S 3.8549 0.1437 0.0 0
M  V30 13 C 6.4255 1.2881 0.0 0
M  V30 14 C 6.4255 3.9555 0.0 0
M  V30 15 C 7.1955 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N,2-dimethylbenzo[b]thiophene-3-carboxamide
C12H13NO2S
638216-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 3.3321 0.0 0
M  V30 2 N 1.1444 2.8561 0.0 0
M  V30 3 O 2.9292 4.8384 0.0 0
M  V30 4 C 0.0000 3.8867 0.0 0
M  V30 5 C 2.2587 0.0000 0.0 0
M  V30 6 O 9.8797 2.6217 0.0 0
M  V30 7 C 10.6497 3.9555 0.0 0
M  V30 8 C 5.2597 2.6217 0.0 0
M  V30 9 C 3.7534 2.3015 0.0 0
M  V30 10 C 6.0297 1.2881 0.0 0
M  V30 11 C 6.0297 3.9555 0.0 0
M  V30 12 C 3.5925 0.7700 0.0 0
M  V30 13 S 4.9993 0.1437 0.0 0
M  V30 14 C 7.5697 1.2881 0.0 0
M  V30 15 C 7.5697 3.9555 0.0 0
M  V30 16 C 8.3397 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 854515-01-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638216-86-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2987892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 12: Preparation of
6-methoxy-2-methylbenzo[b]thiophene-3-carboxylic acid cyclopropylamide A
3 liter, 3-neck flask is charged with
6-methoxy-2-methylbenzo[b]thiophene-3- carboxylic acid (100.0 g, 0.4500
mol) and tetrahydrofuran (900 mL) (notes 1, 2). Carbonyldiimidazole
(87.56 g, 0.5400 mol) is added to the slurry in one portion (notes 3, 4).
After 15 minutes, the mixture is homogeneous and yellow in color. After 1
hour, HPLC analysis shows <1% of the
6-methoxy-2-methylbenzo[b]thiophene-3-carboxylic acid remaining (note 5).
The mixture is cooled to 10 °C with an ice-water bath and methylamine
(CH3NH2) solution (77.6 mL, 40% by wt. in water, 0.896 mol) is slowly
added by addition funnel (note 6). After complete addition of the
solution, the cold bath is removed and the mixture is allowed to warm to
room temperature. After 3 hours, HPLC analysis shows <3% of the
"acylimidizole" intermediate remaining wherein the reaction is deemed
complete (note7). Water (900 mL) is added to the mixture and the mixture
is distilled under atmospheric pressure to a total volume of 1.1 to 1.2 L
(notes 8 and 9). The heating is removed and the solution is allowed to
cool to room temperature overnight with continuous stirring. After 18
hours, the solution is filtered and the solids are rinsed with a 5:1
water/tetrahydrofuran solution (250 mL) (note 10). The white solids are
dried to provide 99.50 g (94%) of the title product (notes 11,12).
6-methoxy-2-methylbenzo[b]thiophene-3-carboxylic acid cyclopropylamide,
yield 99.50 g (94%). 1H (300 MHz, CDCl3): 2.66 (s, 3), 3.07 (d, 3,
J=4.9), 3.88 (s, 3), 5.93 (br s, 1), 6.99 (dd, 1, J=2.4, 8.9), 7.23 (d, 1
J=2.4), 7.75 (d, 1 J=8.9). 13C(75 MHz, ds-DMSO): 14.65, 25.95,
55.40,104.82, 114.16,123.33,129.55,132.08, 137.56, 138.62 156.77, 164.53.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of
2-(imidazol-2-yl)-7-(indol-6-yloxy)thieno[3,2-b]pyridines and related
compounds from 6-halothieno[3,2-b]pyridines.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrison, Katheryn E.; Neville, Sean Timothy; Scott, Robert William;
Tucker, John Lloyd
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007026221 A2 2007-03-08

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-(2-methoxyphenyl)phenylphosphin...
C27H27FeO3P
859839-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3936 6.4755 0.0 0
M  V30 2 C 3.6013 2.8553 0.0 0
M  V30 3 O 3.6013 1.7157 0.0 0
M  V30 4 C 2.6129 3.4282 0.0 0
M  V30 5 C 2.6129 1.1427 0.0 0
M  V30 6 C 1.6244 1.7157 0.0 0
M  V30 7 O 2.6129 0.0000 0.0 0
M  V30 8 O 1.3348 7.6686 0.0 0
M  V30 9 C 0.0000 8.4367 0.0 0
M  V30 10 Fe 7.3601 7.6245 0.0 0 CHG=2 VAL=10
M  V30 11 C 6.3181 4.4293 0.0 0 VAL=5
M  V30 12 C 4.5898 3.4282 0.0 0 CHG=-1 VAL=4
M  V30 13 C 8.3202 4.4293 0.0 0 VAL=5
M  V30 14 C 7.3003 1.6653 0.0 0 VAL=5
M  V30 15 C 10.0579 3.4282 0.0 0 VAL=5
M  V30 16 C 10.1178 11.8807 0.0 0 CHG=-1 VAL=4
M  V30 17 C 4.6559 11.8807 0.0 0 VAL=5
M  V30 18 C 6.3811 10.8764 0.0 0 VAL=5
M  V30 19 C 8.3832 10.8764 0.0 0 VAL=5
M  V30 20 C 7.3601 13.6404 0.0 0 VAL=5
M  V30 21 C 2.4051 5.9057 0.0 0
M  V30 22 C 1.3348 6.5259 0.0 0
M  V30 23 C 2.4051 4.6654 0.0 0
M  V30 24 C 0.2581 5.9057 0.0 0
M  V30 25 C 1.3348 4.0484 0.0 0
M  V30 26 C 0.2581 4.6654 0.0 0
M  V30 27 C 3.3936 7.6182 0.0 0
M  V30 28 C 4.4671 8.2352 0.0 0
M  V30 29 C 2.3232 8.2384 0.0 0
M  V30 30 C 4.4702 9.4787 0.0 0
M  V30 31 C 2.3201 9.4756 0.0 0
M  V30 32 C 3.3967 10.0957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 12
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 1 10 17
M  V30 19 1 10 18
M  V30 20 1 10 19
M  V30 21 1 10 20
M  V30 22 1 11 12
M  V30 23 2 11 13
M  V30 24 1 12 14
M  V30 25 1 13 15
M  V30 26 2 14 15
M  V30 27 1 16 19
M  V30 28 1 16 20
M  V30 29 1 17 18
M  V30 30 2 17 20
M  V30 31 2 18 19
M  V30 32 2 21 22
M  V30 33 1 21 23
M  V30 34 1 22 24
M  V30 35 2 23 25
M  V30 36 2 24 26
M  V30 37 1 25 26
M  V30 38 2 27 28
M  V30 39 1 27 29
M  V30 40 1 28 30
M  V30 41 2 29 31
M  V30 42 2 30 32
M  V30 43 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(S)-(2-methoxyphenyl)phenylphosphino]-2-[(1R)-1-(methylamino)et...
C26H28FeNOP
859839-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 7.6400 12.6510 0.0 0
M  V30 2 C 3.2522 15.3833 0.0 0
M  V30 3 N 2.0944 16.0507 0.0 0
M  V30 4 C 4.4100 16.0507 0.0 0
M  V30 5 C 0.7485 15.3022 0.0 0
M  V30 6 O 10.0552 14.0448 0.0 0
M  V30 7 C 11.2130 14.7122 0.0 0
M  V30 8 Fe 3.2522 6.9911 0.0 0 CHG=2 VAL=10
M  V30 9 C 6.4822 11.9836 0.0 0 CHG=-1 VAL=4
M  V30 10 C 3.2522 14.0448 0.0 0 VAL=5
M  V30 11 C 4.4505 10.8074 0.0 0 VAL=5
M  V30 12 C 0.0737 11.9836 0.0 0 VAL=5
M  V30 13 C 2.1017 10.8074 0.0 0 VAL=5
M  V30 14 C 0.0000 2.0686 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.4122 2.0686 0.0 0 VAL=5
M  V30 16 C 4.3768 3.2448 0.0 0 VAL=5
M  V30 17 C 2.0280 3.2448 0.0 0 VAL=5
M  V30 18 C 3.1784 0.0000 0.0 0 VAL=5
M  V30 19 C 8.7978 11.9836 0.0 0
M  V30 20 C 10.0552 12.7063 0.0 0
M  V30 21 C 8.7978 10.5308 0.0 0
M  V30 22 C 11.3125 11.9836 0.0 0
M  V30 23 C 10.0552 9.8045 0.0 0
M  V30 24 C 11.3125 10.5308 0.0 0
M  V30 25 C 7.6400 13.9895 0.0 0
M  V30 26 C 6.3827 14.7122 0.0 0
M  V30 27 C 8.8974 14.7122 0.0 0
M  V30 28 C 6.3827 16.1650 0.0 0
M  V30 29 C 8.8974 16.1650 0.0 0
M  V30 30 C 7.6400 16.8914 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 1 9 11
M  V30 22 2 10 12
M  V30 23 2 11 13
M  V30 24 1 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 23 24
M  V30 36 2 25 26
M  V30 37 1 25 27
M  V30 38 1 26 28
M  V30 39 2 27 29
M  V30 40 2 28 30
M  V30 41 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25341980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc, SFc,
SP)-2-[(1-N-Methylamino)ethyl]-1-[(2-methoxyphenyl)phenylphosphino]ferrocene
[(Rc, SFc, SP)-8a]: A solution of (Rc, SFe, SP)-7a (1.21 g, 2.5 mmol) and
40% methylamine aqueous solution (6.0 mL) in THF (20 mL) and MeOH (5 mL)
was stirred for 3 days at 40 °C, and concentrated. The residue was
dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4), and
evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane-EtOAc-Et3N = 80:15:5) to give the title
compound as orange crystals. (Rc, SFc,
SP)-2-[(1-N-Methylamino)ethyl]-1-[(2-methoxyphenyl)phenylphosphino]ferrocene,
yield 1.07 g, 94%. 1H NMR (CDCl3, 250.13 MHz): δ 1.44 (d, 3H, J = 6.5
Hz); 1.94 (s, 3H); 3.91 (m, 2H); 3.95 (s, 3H); 4.05 (s, 5H); 4.29 (t, 1H,
J = 2.5 Hz); 4.46 (m, 1H); 7.90 (dt, 1H, J = 7.3 and 1.0 Hz), 6.97 (ddd,
1H, J = 8.3, 5.0 and 1.0 Hz), 7.15 (ddd, 1H, J = 7.3, 5.5 and 1.8
Hz),7.23 (m, 5H); 7.36 (ddd, 1H, J = 8.3, 7.3 and 1.8 Hz),. 31P NMR
(CDCl3, 101 MHz): δ -41.43.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Very Simple, Highly Stereoselective and Modular Synthesis of
Ferrocene-Based P-Chiral Phosphine Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Weiping; Mbafor, William; Roberts, Stanley M.; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2006), 128(12), 3922-3923

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-(2-methoxyphenyl)phenylphosphin...
C27H27FeO3P
859839-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3936 6.4755 0.0 0
M  V30 2 C 3.6013 2.8553 0.0 0
M  V30 3 O 3.6013 1.7157 0.0 0
M  V30 4 C 2.6129 3.4282 0.0 0
M  V30 5 C 2.6129 1.1427 0.0 0
M  V30 6 C 1.6244 1.7157 0.0 0
M  V30 7 O 2.6129 0.0000 0.0 0
M  V30 8 O 1.3348 7.6686 0.0 0
M  V30 9 C 0.0000 8.4367 0.0 0
M  V30 10 Fe 7.3601 7.6245 0.0 0 CHG=2 VAL=10
M  V30 11 C 6.3181 4.4293 0.0 0 VAL=5
M  V30 12 C 4.5898 3.4282 0.0 0 CHG=-1 VAL=4
M  V30 13 C 8.3202 4.4293 0.0 0 VAL=5
M  V30 14 C 7.3003 1.6653 0.0 0 VAL=5
M  V30 15 C 10.0579 3.4282 0.0 0 VAL=5
M  V30 16 C 10.1178 11.8807 0.0 0 CHG=-1 VAL=4
M  V30 17 C 4.6559 11.8807 0.0 0 VAL=5
M  V30 18 C 6.3811 10.8764 0.0 0 VAL=5
M  V30 19 C 8.3832 10.8764 0.0 0 VAL=5
M  V30 20 C 7.3601 13.6404 0.0 0 VAL=5
M  V30 21 C 2.4051 5.9057 0.0 0
M  V30 22 C 1.3348 6.5259 0.0 0
M  V30 23 C 2.4051 4.6654 0.0 0
M  V30 24 C 0.2581 5.9057 0.0 0
M  V30 25 C 1.3348 4.0484 0.0 0
M  V30 26 C 0.2581 4.6654 0.0 0
M  V30 27 C 3.3936 7.6182 0.0 0
M  V30 28 C 4.4671 8.2352 0.0 0
M  V30 29 C 2.3232 8.2384 0.0 0
M  V30 30 C 4.4702 9.4787 0.0 0
M  V30 31 C 2.3201 9.4756 0.0 0
M  V30 32 C 3.3967 10.0957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 12
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 1 10 17
M  V30 19 1 10 18
M  V30 20 1 10 19
M  V30 21 1 10 20
M  V30 22 1 11 12
M  V30 23 2 11 13
M  V30 24 1 12 14
M  V30 25 1 13 15
M  V30 26 2 14 15
M  V30 27 1 16 19
M  V30 28 1 16 20
M  V30 29 1 17 18
M  V30 30 2 17 20
M  V30 31 2 18 19
M  V30 32 2 21 22
M  V30 33 1 21 23
M  V30 34 1 22 24
M  V30 35 2 23 25
M  V30 36 2 24 26
M  V30 37 1 25 26
M  V30 38 2 27 28
M  V30 39 1 27 29
M  V30 40 1 28 30
M  V30 41 2 29 31
M  V30 42 2 30 32
M  V30 43 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(S)-(2-methoxyphenyl)phenylphosphino]-2-[(1R)-1-(methylamino)et...
C26H28FeNOP
859839-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 7.6400 12.6510 0.0 0
M  V30 2 C 3.2522 15.3833 0.0 0
M  V30 3 N 2.0944 16.0507 0.0 0
M  V30 4 C 4.4100 16.0507 0.0 0
M  V30 5 C 0.7485 15.3022 0.0 0
M  V30 6 O 10.0552 14.0448 0.0 0
M  V30 7 C 11.2130 14.7122 0.0 0
M  V30 8 Fe 3.2522 6.9911 0.0 0 CHG=2 VAL=10
M  V30 9 C 6.4822 11.9836 0.0 0 CHG=-1 VAL=4
M  V30 10 C 3.2522 14.0448 0.0 0 VAL=5
M  V30 11 C 4.4505 10.8074 0.0 0 VAL=5
M  V30 12 C 0.0737 11.9836 0.0 0 VAL=5
M  V30 13 C 2.1017 10.8074 0.0 0 VAL=5
M  V30 14 C 0.0000 2.0686 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.4122 2.0686 0.0 0 VAL=5
M  V30 16 C 4.3768 3.2448 0.0 0 VAL=5
M  V30 17 C 2.0280 3.2448 0.0 0 VAL=5
M  V30 18 C 3.1784 0.0000 0.0 0 VAL=5
M  V30 19 C 8.7978 11.9836 0.0 0
M  V30 20 C 10.0552 12.7063 0.0 0
M  V30 21 C 8.7978 10.5308 0.0 0
M  V30 22 C 11.3125 11.9836 0.0 0
M  V30 23 C 10.0552 9.8045 0.0 0
M  V30 24 C 11.3125 10.5308 0.0 0
M  V30 25 C 7.6400 13.9895 0.0 0
M  V30 26 C 6.3827 14.7122 0.0 0
M  V30 27 C 8.8974 14.7122 0.0 0
M  V30 28 C 6.3827 16.1650 0.0 0
M  V30 29 C 8.8974 16.1650 0.0 0
M  V30 30 C 7.6400 16.8914 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 1 9 11
M  V30 22 2 10 12
M  V30 23 2 11 13
M  V30 24 1 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 23 24
M  V30 36 2 25 26
M  V30 37 1 25 27
M  V30 38 1 26 28
M  V30 39 2 27 29
M  V30 40 2 28 30
M  V30 41 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28831413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc, SFe,
Sp)-2-[(1-N-Methylamino)ethyl]-1-[(2-methoxyphenyl)phenylphosphino]ferrocene
[(Re,SFe,Sp)-17]: A solution of (Rc, SFe, Sp)-11 (1.21 g, 2.5 mmol) and
40% methylamine aqueous solution (6.0 mL) in THF (20 mL) and MeOH (5 mL)
was stirred for 3 days at 40°C, and concentrated. The residue was
dissolved in Et2O (20 mL), washed with brine (10 mL), dried (Na2SO4), and
evaporated under reduced pressure. The crude product was purified by
chromatography (SiO2, hexane-EtOAc-Et3N = 80:15:5) to give the title
compound (1.07 g, 94%) as orange crystals. (Rc, SFe,
Sp)-2-[(1-N-Methylamino)ethyl]-1-[(2-methoxyphenyl)phenylphosphino]ferrocene
[(Re,SFe,Sp)-17], yield (1.07 g, 94%) 1H NMR (CDCl3, 250.13 MHz): δ 1.44
(d, 3H, J= 6.5 Hz); 1.94 (s, 3H); 3.91 (m, 2H); 3.95 (s, 3H); 4.05 (s,
5H); 4.29 (t, 1H, J= 2.5 Hz); 4.46 (m, 1H); 7.90 (dt, 1H, J= 7.3 and 1.0
Hz), 6.97 (ddd, 1H, J= 8.3, 5.0 and 1.0 Hz), 7.15 (ddd1H, J= 7.3, 5.5 and
1.8 Hz),7.23 (m, 5H); 7.36 (ddd, 1H, J= 8.3, 7.3 and 1.8 Hz),. 31P NMR
(CDCl3, 101 MHz): δ -41.43.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparation of ferrocene-based chiral phosphines or arsines
as transformation catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068478 A1 2005-07-28

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(acetyloxy)ethyl]-2-[(S)-(2-methoxyphenyl)phenylphosphin...
C27H27FeO3P
859839-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 3.3936 6.4755 0.0 0
M  V30 2 C 3.6013 2.8553 0.0 0
M  V30 3 O 3.6013 1.7157 0.0 0
M  V30 4 C 2.6129 3.4282 0.0 0
M  V30 5 C 2.6129 1.1427 0.0 0
M  V30 6 C 1.6244 1.7157 0.0 0
M  V30 7 O 2.6129 0.0000 0.0 0
M  V30 8 O 1.3348 7.6686 0.0 0
M  V30 9 C 0.0000 8.4367 0.0 0
M  V30 10 Fe 7.3601 7.6245 0.0 0 CHG=2 VAL=10
M  V30 11 C 6.3181 4.4293 0.0 0 VAL=5
M  V30 12 C 4.5898 3.4282 0.0 0 CHG=-1 VAL=4
M  V30 13 C 8.3202 4.4293 0.0 0 VAL=5
M  V30 14 C 7.3003 1.6653 0.0 0 VAL=5
M  V30 15 C 10.0579 3.4282 0.0 0 VAL=5
M  V30 16 C 10.1178 11.8807 0.0 0 CHG=-1 VAL=4
M  V30 17 C 4.6559 11.8807 0.0 0 VAL=5
M  V30 18 C 6.3811 10.8764 0.0 0 VAL=5
M  V30 19 C 8.3832 10.8764 0.0 0 VAL=5
M  V30 20 C 7.3601 13.6404 0.0 0 VAL=5
M  V30 21 C 2.4051 5.9057 0.0 0
M  V30 22 C 1.3348 6.5259 0.0 0
M  V30 23 C 2.4051 4.6654 0.0 0
M  V30 24 C 0.2581 5.9057 0.0 0
M  V30 25 C 1.3348 4.0484 0.0 0
M  V30 26 C 0.2581 4.6654 0.0 0
M  V30 27 C 3.3936 7.6182 0.0 0
M  V30 28 C 4.4671 8.2352 0.0 0
M  V30 29 C 2.3232 8.2384 0.0 0
M  V30 30 C 4.4702 9.4787 0.0 0
M  V30 31 C 2.3201 9.4756 0.0 0
M  V30 32 C 3.3967 10.0957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 1 27
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 12
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 2 5 7
M  V30 10 1 8 9
M  V30 11 1 8 22
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 1 10 17
M  V30 19 1 10 18
M  V30 20 1 10 19
M  V30 21 1 10 20
M  V30 22 1 11 12
M  V30 23 2 11 13
M  V30 24 1 12 14
M  V30 25 1 13 15
M  V30 26 2 14 15
M  V30 27 1 16 19
M  V30 28 1 16 20
M  V30 29 1 17 18
M  V30 30 2 17 20
M  V30 31 2 18 19
M  V30 32 2 21 22
M  V30 33 1 21 23
M  V30 34 1 22 24
M  V30 35 2 23 25
M  V30 36 2 24 26
M  V30 37 1 25 26
M  V30 38 2 27 28
M  V30 39 1 27 29
M  V30 40 1 28 30
M  V30 41 2 29 31
M  V30 42 2 30 32
M  V30 43 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(S)-(2-methoxyphenyl)phenylphosphino]-2-[(1R)-1-(methylamino)et...
C26H28FeNOP
859839-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 7.6400 12.6510 0.0 0
M  V30 2 C 3.2522 15.3833 0.0 0
M  V30 3 N 2.0944 16.0507 0.0 0
M  V30 4 C 4.4100 16.0507 0.0 0
M  V30 5 C 0.7485 15.3022 0.0 0
M  V30 6 O 10.0552 14.0448 0.0 0
M  V30 7 C 11.2130 14.7122 0.0 0
M  V30 8 Fe 3.2522 6.9911 0.0 0 CHG=2 VAL=10
M  V30 9 C 6.4822 11.9836 0.0 0 CHG=-1 VAL=4
M  V30 10 C 3.2522 14.0448 0.0 0 VAL=5
M  V30 11 C 4.4505 10.8074 0.0 0 VAL=5
M  V30 12 C 0.0737 11.9836 0.0 0 VAL=5
M  V30 13 C 2.1017 10.8074 0.0 0 VAL=5
M  V30 14 C 0.0000 2.0686 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.4122 2.0686 0.0 0 VAL=5
M  V30 16 C 4.3768 3.2448 0.0 0 VAL=5
M  V30 17 C 2.0280 3.2448 0.0 0 VAL=5
M  V30 18 C 3.1784 0.0000 0.0 0 VAL=5
M  V30 19 C 8.7978 11.9836 0.0 0
M  V30 20 C 10.0552 12.7063 0.0 0
M  V30 21 C 8.7978 10.5308 0.0 0
M  V30 22 C 11.3125 11.9836 0.0 0
M  V30 23 C 10.0552 9.8045 0.0 0
M  V30 24 C 11.3125 10.5308 0.0 0
M  V30 25 C 7.6400 13.9895 0.0 0
M  V30 26 C 6.3827 14.7122 0.0 0
M  V30 27 C 8.8974 14.7122 0.0 0
M  V30 28 C 6.3827 16.1650 0.0 0
M  V30 29 C 8.8974 16.1650 0.0 0
M  V30 30 C 7.6400 16.8914 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 3
M  V30 5 1 2 4
M  V30 6 1 2 10
M  V30 7 1 3 5
M  V30 8 1 6 7
M  V30 9 1 6 20
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 14
M  V30 16 1 8 15
M  V30 17 1 8 16
M  V30 18 1 8 17
M  V30 19 1 8 18
M  V30 20 1 9 10
M  V30 21 1 9 11
M  V30 22 2 10 12
M  V30 23 2 11 13
M  V30 24 1 12 13
M  V30 25 1 14 17
M  V30 26 1 14 18
M  V30 27 1 15 16
M  V30 28 2 15 18
M  V30 29 2 16 17
M  V30 30 2 19 20
M  V30 31 1 19 21
M  V30 32 1 20 22
M  V30 33 2 21 23
M  V30 34 2 22 24
M  V30 35 1 23 24
M  V30 36 2 25 26
M  V30 37 1 25 27
M  V30 38 1 26 28
M  V30 39 2 27 29
M  V30 40 2 28 30
M  V30 41 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 859839-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859839-78-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28344960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Rc,SFe,Sp)-2-[(1-N-Methylamino) ethyl] (2- methoxyphenyl)
phenylphosphino]ferrocene [(Rc,SFe,SP)-17] : A solution of (Re,SFe,Sp)-11
(1.21 g, 2.5 mmol) and 40% methylamine aqueous solution (6.0 mL) in THF
(20 mL) and MeOH (5 mL) was stirred for 3 days at 40 °C, and
concentrated. The residue was dissolved in Et2O (20 mL), washed with
brine (10 mL), dried (Na2SO4), and evaporated under reduced pressure. The
crude product was purified by chromatography (SiO2, hexane-EtOAc-Et3N =
80: 15: 5) to give the title compound as orange crystals, yield 1.07 g,
94%. 1H NMR(CDCl3, 250.13 MHz):δ 1.44 (d, 3H, J = 6.5 Hz); 1.94 (s, 3H);
3.91 (m, 2H); 3.95 (s, 3H); 4.05 (s, 5H); 4.29 (t, 1 H, J = 2.5 Hz); 4.46
(m, 1 H) ; 7.90 (dt, 1 H, J = 7. 3 and 1.0 Hz), 6.97 (ddd, 1 H, J = 8.3,
5.0 and 1.0 Hz), 7.15 (ddd, 1 H, J = 7.3, 5.5 and 1.8 Hz), 7.23 (m, 5H);
7.36 (ddd, 1 H, J = 8.3, 7.3 and 1.8 Hz), . 31P NMR(CDCl3, 101
MHz):δ-41.43.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metallocene-based chiral phosphine or arsine ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Wei-Ping; Whittall, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005068477 A1 2005-07-28

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
1-[(tert-Butoxycarbonyl)amino]cyclopropanecarboxylic acid
C9H15NO4
88950-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8402 1.8569 0.0 0
M  V30 2 C 5.1738 2.6269 0.0 0
M  V30 3 O 6.5075 1.8569 0.0 0
M  V30 4 O 5.1738 4.1669 0.0 0
M  V30 5 C 7.8411 2.6269 0.0 0
M  V30 6 C 7.0711 3.9605 0.0 0
M  V30 7 C 9.1748 3.3969 0.0 0
M  V30 8 C 8.6111 1.2931 0.0 0
M  V30 9 C 1.5166 1.4471 0.0 0
M  V30 10 O 2.0434 0.0000 0.0 0
M  V30 11 O 0.0000 1.7146 0.0 0
M  V30 12 C 2.5065 2.6269 0.0 0
M  V30 13 C 3.0333 4.0740 0.0 0
M  V30 14 C 1.5166 3.8065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[1-[(methylamino)carbonyl]cyclopropyl]carbamate
C10H18N2O3
1022970-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6071 3.6806 0.0 0
M  V30 2 N 8.7868 4.6705 0.0 0
M  V30 3 O 7.8745 2.1640 0.0 0
M  V30 4 C 10.2339 4.1438 0.0 0
M  V30 5 N 5.3900 2.8736 0.0 0
M  V30 6 C 3.8500 2.8736 0.0 0
M  V30 7 O 3.0800 1.5400 0.0 0
M  V30 8 O 3.0800 4.2073 0.0 0
M  V30 9 C 1.5400 1.5400 0.0 0
M  V30 10 C 1.5400 3.0800 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 1.5400 0.0000 0.0 0
M  V30 13 C 6.1600 4.2073 0.0 0
M  V30 14 C 6.4273 5.7239 0.0 0
M  V30 15 C 4.9802 5.1972 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 88950-64-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022970-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15316357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1196a) A solution of 1-tert-butoxycarbonylamino-cyclopropanecarboxylic
acid (1.00 g, 4.97 mmol in tetrahydrofuran (15 mL, 180 mmol) was treated
with N,N-carbonyldiimidazole (1.61 g, 9.94 mmol) for 1 hour at room
temperature, and then the reaction mixture was treated with 2.000 M
methylamine in tetrahydrofuran (7.45 mL) dropwise, and was stirred
overnight. The reaction mixture was partitioned between dilute NaHCO3 and
dichloromethane, and then the aqueous layer was extracted twice with
dichloromethane. The combined organic extracts were washed with water,
then dried (MgSO-t), and concentrated to generate the product, which was
used without further purification:
(1-methylcarbamoyl-cyclopropyl)-carbamic acid tert-butyl ester: white
waxy solid (1.1 g, 94%). (1-methylcarbamoyl-cyclopropyl)-carbamic acid
tert-butyl ester, yield 1.1 g, 94% LC/MS (ESI+): 237.03 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK
and c-Met kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmed, Gulzar; Bohnstedt, Adolph; Breslin, Henry Joseph; Burke, Jason;
Curry, Matthew A.; Diebold, James L.; Dorsey, Bruce; Dugan, Benjamin J.;
Feng, Daming; Gingrich, Diane E.; Guo, Tao; Ho, Koc-Kan; Learn, Keith S.;
Lisko, Joseph G.; Liu, Rong-Qiang; Mesaros, Eugen F.; Milkiewicz, Karen;
Ott, Gregory R.; Parrish, Jonathan; Theroff, Jay P.; Thieu, Tho V.;
Tripathy, Rabindranath; Underiner, Theodore L.; Wagner, Jason C.;
Weinberg, Linda; Wells, Gregory J.; You, Ming; Zificsak, Craig A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051547 A1 2008-05-02

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(3-formylphenoxy)methyl]-1-piperidinecarboxylate
C18H25NO4
892406-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.3901 0.0 0
M  V30 2 O 2.6675 4.6201 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 C 1.3338 5.3901 0.0 0
M  V30 5 C 0.5638 4.0564 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 2.1038 6.7238 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 10.6697 3.0801 0.0 0
M  V30 10 C 16.0045 3.0801 0.0 0
M  V30 11 O 17.3383 2.3101 0.0 0
M  V30 12 N 5.3348 4.6201 0.0 0
M  V30 13 C 6.6687 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 8.0023 4.6201 0.0 0
M  V30 16 C 6.6687 2.3101 0.0 0
M  V30 17 C 8.0023 3.0801 0.0 0
M  V30 18 C 12.0035 2.3101 0.0 0
M  V30 19 C 13.3372 3.0801 0.0 0
M  V30 20 C 12.0035 0.7700 0.0 0
M  V30 21 C 14.6708 2.3101 0.0 0
M  V30 22 C 13.3372 0.0000 0.0 0
M  V30 23 C 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 18
M  V30 11 2 10 11
M  V30 12 1 10 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[[3-[(methylamino)methyl]phenoxy]methyl]-1-piperidinecarb...
C19H30N2O3
892406-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 5.3901 0.0 0
M  V30 2 O 2.6675 4.6201 0.0 0
M  V30 3 O 4.0012 6.9302 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 C 0.5637 4.0564 0.0 0
M  V30 6 C 0.0000 6.1601 0.0 0
M  V30 7 C 2.1037 6.7238 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 10.6697 3.0801 0.0 0
M  V30 10 C 16.0045 3.0801 0.0 0
M  V30 11 N 17.3383 2.3101 0.0 0
M  V30 12 C 18.6720 3.0801 0.0 0
M  V30 13 N 5.3348 4.6201 0.0 0
M  V30 14 C 6.6685 5.3901 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 8.0023 4.6201 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 8.0023 3.0801 0.0 0
M  V30 19 C 12.0035 2.3101 0.0 0
M  V30 20 C 13.3372 3.0801 0.0 0
M  V30 21 C 12.0035 0.7700 0.0 0
M  V30 22 C 14.6708 2.3101 0.0 0
M  V30 23 C 13.3372 0.0000 0.0 0
M  V30 24 C 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 892406-34-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 892406-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13448844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: 4-(3-Methylaminomethyl-phenoxymethyl)-piperidine-1-carboxylic
acid tert- butyl ester. To a solution of
4-(3-formyl-phenoxymethyl)-piperidine-1 -carboxylic acid tert-butyl ester
(5.95 g, 18.6 mmol) in MeOH (100 mL) was added MeNH2 (4 mL, 40% solution
in water) and the mixture was stirred at 23°C for 1 h. The mixture was
then cooled to 0°C and NaBH4 (1.34 g, 35.8 mmol) was added in four
portions. After 3 d at 23°C, the mixture was concentrated, diluted with 1
M NaOH, and stirred for 1 h. The mixture was extracted with EtOAc, dried
(Na2SO4), and concentrated to give the desired compound, yield 5.83 g,
94%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinolines as histamine H3 receptor and
serotonin transporter modulators for treatment of central nervous system
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carruthers, Nicholas I.; Gomez, Leslie A.; Jablonowski, Jill A.; Keith,
John M.; Letavic, Michael A.; Ly, Kiev S.; Miller, Jennifer M. B.;
Stocking, Emily M.; Wolin, Ronald L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006066197 A1 2006-06-22

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-(1-methylethyl)benzaldehyde
C12H16O2
894851-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 1.3337 3.8500 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 6.6686 3.8500 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N-methyl-3-(1-methylethyl)benzenemethanamine
C13H21NO
894851-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-47-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-11999789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (2-Ethoxy-3-isopropylbenzyl)methylamine [1304] A solution of
methylamine (30 mL of a 2.0 M solution, 60 mmol) was added to
2-ethoxy-3-isopropylbenzaldehyde (1.49 g, 7.75 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The residue was dissolved in EtOH (30 mL) and treated with NaBH4 (0.293
g, 7.75 mmol). After stirring for 18 h, the reaction mixture was
concentrated under reduced pressure and then dissolved in 1 N NaOH (30
mL). The mixture was extracted with Et2O (3×50 mL). The combined organics
were collected, washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (1.51 g, 94%) as a light yellow
oil. 1H NMR (300 MHz, DMSO-d6) δ 7.21-7.13 (m, 2H), 7.04 (t, J=7.5 Hz,
1H), 3.79 (q, J=7.0 Hz, 2H), 3.63 (s, 2H), 3.28-3.23 (m, 1H), 2.29 (s,
3H), 1.93 (br s, 1H), 1.35 (t, J=3.8 Hz, 3H), 1.16 (d, J=6.9 Hz, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME183 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-(1-methylethyl)benzaldehyde
C12H16O2
894851-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 1.3337 3.8500 0.0 0
M  V30 5 C 1.3337 2.3100 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 6.6686 3.8500 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 6.1601 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 11
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N-methyl-3-(1-methylethyl)benzenemethanamine
C13H21NO
894851-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 N 8.0023 4.6201 0.0 0
M  V30 6 C 9.3360 3.8501 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 2.6675 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-47-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2552877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (2-Ethoxy-3-isopropylbenzyl)methylamine A solution of methylamine (30
mL of a 2.0 M solution, 60 mmol) was added to
2-ethoxy-3-isopropylbenzaldehyde (1.49 g, 7.75 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The residue was dissolved in EtOH (30 mL) and treated with NaBH4 (0.293
g, 7.75 mmol). After stirring for 18 h, the reaction mixture was
concentrated under reduced pressure and then dissolved in 1 N NaOH (30
mL). The mixture was extracted with Et2O (3×50 mL). The combined organics
were collected, washed with brine (2×100 mL), dried (Na2SO4) and
concentrated to yield the title compound (1.51 g, 94%) as a light yellow
oil: 1H NMR (300 MHz, DMSO-d6 ) δ 7.21-7.13 (m, 2H), 7.04 (t, J = 7.5 Hz,
1H), 3.79 (q, J = 7.0 Hz, 2H), 3.63 (s, 2H), 3.28-3.23 (m, 1H), 2.29 (s,
3H), 1.93 (br s, 1H), 1.35 (t, J = 3.8 Hz, 3H), 1.16 (d, J = 6.9 Hz, 6H).
C13H21NO Exact Mass: 207.16.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-(trifluoromethyl)benzaldehyde
C8H4F4O
89763-93-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 F 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 O 8.4700 4.0011 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-(trifluoromethyl)benzenemethanamine
C9H9F4N
145943-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 1.1273 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 4.2073 0.0 0
M  V30 5 F 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 8.4700 4.0011 0.0 0
M  V30 8 C 10.0100 4.0011 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 3.8500 1.3336 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 1 6 7
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89763-93-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 145943-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490476
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3bS,5aR,6aS,10aR,10bS,10cR)-5a,6a,7,8,9,10,10a,10b,10c,11-Decahydro-7,7,10a-...
C20H24O4
899444-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2660 6.9689 0.0 0
M  V30 2 O 7.0944 0.0000 0.0 0
M  V30 3 O 1.5520 2.7788 0.0 0
M  V30 4 C 0.9901 4.4259 0.0 0
M  V30 5 C 0.0000 6.1404 0.0 0
M  V30 6 C 5.5030 3.5956 0.0 0 CFG=1
M  V30 7 C 5.5370 5.1145 0.0 0 CFG=2
M  V30 8 C 6.7418 2.7393 0.0 0 CFG=2
M  V30 9 C 4.2273 2.7955 0.0 0 CFG=1
M  V30 10 C 4.1840 5.8732 0.0 0 CFG=2
M  V30 11 C 6.9227 5.8119 0.0 0
M  V30 12 C 8.1253 3.4467 0.0 0
M  V30 13 C 6.2200 1.2677 0.0 0
M  V30 14 C 2.8767 3.5642 0.0 0
M  V30 15 O 4.6827 1.3021 0.0 0
M  V30 16 C 2.8505 5.1034 0.0 0 CFG=2
M  V30 17 C 4.1840 7.4132 0.0 0
M  V30 18 C 8.2203 4.9837 0.0 0
M  V30 19 C 9.5578 2.8813 0.0 0
M  V30 20 C 1.5166 5.8732 0.0 0
M  V30 21 C 2.8504 8.1832 0.0 0
M  V30 22 O 9.7115 5.3684 0.0 0
M  V30 23 C 10.5382 4.0690 0.0 0
M  V30 24 C 1.5166 7.4132 0.0 0
M  V30 25 H 6.8748 4.2955 0.0 0
M  V30 26 H 6.2189 6.4952 0.0 0
M  V30 27 H 7.9000 1.7245 0.0 0
M  V30 28 H 3.0247 1.8335 0.0 0
M  V30 29 H 1.5235 4.3218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 2 2 13
M  V30 3 2 3 14
M  V30 4 1 4 20
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 25 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 26 CFG=3
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 8 27 CFG=3
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 9 28 CFG=3
M  V30 19 1 10 16
M  V30 20 1 10 17
M  V30 21 1 11 18
M  V30 22 2 12 18
M  V30 23 1 12 19
M  V30 24 1 13 15
M  V30 25 1 14 16
M  V30 26 1 16 20
M  V30 27 1 16 29 CFG=3
M  V30 28 1 17 21
M  V30 29 1 18 22
M  V30 30 2 19 23
M  V30 31 1 20 24
M  V30 32 1 21 24
M  V30 33 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 6 7 8 9 10 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4aS,6R,6aR,7S,11aS,11bR)-1,2,3,4,4a,5,6,6a,7,11,11a,11b-Dodecahydro-6-hydrox...
C21H29NO4
1032906-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7959 0.9440 0.0 0
M  V30 2 C 2.3101 5.1456 0.0 0
M  V30 3 N 0.7700 5.1456 0.0 0
M  V30 4 O 3.0801 6.4792 0.0 0
M  V30 5 C 0.0000 6.4792 0.0 0
M  V30 6 O 4.6201 6.4792 0.0 0
M  V30 7 O 7.7002 6.4792 0.0 0
M  V30 8 C 10.6872 4.3386 0.0 0
M  V30 9 C 8.9727 5.3285 0.0 0
M  V30 10 C 5.3901 2.4781 0.0 0 CFG=2
M  V30 11 C 4.6201 3.8119 0.0 0 CFG=1
M  V30 12 C 6.9302 2.4781 0.0 0 CFG=2
M  V30 13 C 4.6201 1.1444 0.0 0
M  V30 14 C 3.0801 3.8119 0.0 0 CFG=2
M  V30 15 C 5.3901 5.1456 0.0 0 CFG=1
M  V30 16 C 7.7002 3.8119 0.0 0 CFG=2
M  V30 17 C 7.7002 1.1444 0.0 0
M  V30 18 C 3.0801 1.1444 0.0 0
M  V30 19 C 2.3101 2.4781 0.0 0
M  V30 20 C 6.9302 5.1456 0.0 0
M  V30 21 C 9.2402 3.8119 0.0 0
M  V30 22 C 9.2402 1.1444 0.0 0
M  V30 23 O 2.0495 0.0000 0.0 0
M  V30 24 C 0.8036 2.1579 0.0 0
M  V30 25 C 10.0102 2.4781 0.0 0
M  V30 26 C 0.6427 0.6263 0.0 0
M  V30 27 H 5.5243 0.9440 0.0 0
M  V30 28 H 3.8501 5.1456 0.0 0
M  V30 29 H 8.4702 5.1456 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 14 2 CFG=1
M  V30 5 1 3 5
M  V30 6 1 15 6 CFG=1
M  V30 7 2 7 20
M  V30 8 1 8 21
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 27 CFG=3
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 28 CFG=1
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 20
M  V30 22 1 16 20
M  V30 23 1 16 21
M  V30 24 1 16 29 CFG=3
M  V30 25 1 17 22
M  V30 26 2 18 19
M  V30 27 1 18 23
M  V30 28 1 19 24
M  V30 29 1 21 25
M  V30 30 1 22 25
M  V30 31 1 23 26
M  V30 32 2 24 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(6 10 11 12 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 899444-75-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032906-43-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11127734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibition and uncoupling of photosynthetic electron transport by
diterpene lactone amide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castelo-Branco, Pedro A.; dos Santos, Flavio J. L.; Rubinger, Mayura M.
M.; Ferreira-Alves, Dalton L.; Pilo-Veloso, Dorila; King-Diaz, Beatriz;
Lotina-Hennsen, Blas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, C: Journal of Biosciences (2008),
63(3/4), 251-259

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Tris(dodecyloxy)benzaldehyde
C43H78O4
908336-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.6720 20.0204 0.0 0
M  V30 2 O 20.0057 20.7905 0.0 0
M  V30 3 O 21.3395 18.4804 0.0 0
M  V30 4 C 22.6731 17.7104 0.0 0
M  V30 5 C 24.0068 18.4804 0.0 0
M  V30 6 C 25.3405 17.7104 0.0 0
M  V30 7 C 26.6743 18.4804 0.0 0
M  V30 8 C 28.0080 17.7104 0.0 0
M  V30 9 C 29.3416 18.4804 0.0 0
M  V30 10 C 30.6753 17.7104 0.0 0
M  V30 11 C 32.0091 18.4804 0.0 0
M  V30 12 C 33.3428 17.7104 0.0 0
M  V30 13 C 34.6765 18.4804 0.0 0
M  V30 14 C 36.0101 17.7104 0.0 0
M  V30 15 C 37.3440 18.4804 0.0 0
M  V30 16 O 16.0045 18.4804 0.0 0
M  V30 17 C 14.6708 17.7104 0.0 0
M  V30 18 C 13.3372 18.4804 0.0 0
M  V30 19 C 12.0035 17.7104 0.0 0
M  V30 20 C 10.6697 18.4804 0.0 0
M  V30 21 C 9.3360 17.7104 0.0 0
M  V30 22 C 8.0023 18.4804 0.0 0
M  V30 23 C 6.6687 17.7104 0.0 0
M  V30 24 C 5.3348 18.4804 0.0 0
M  V30 25 C 4.0012 17.7104 0.0 0
M  V30 26 C 2.6675 18.4804 0.0 0
M  V30 27 C 1.3338 17.7104 0.0 0
M  V30 28 C 0.0000 18.4804 0.0 0
M  V30 29 O 18.6720 13.8603 0.0 0
M  V30 30 C 17.3383 13.0903 0.0 0
M  V30 31 C 17.3383 11.5503 0.0 0
M  V30 32 C 16.0045 10.7802 0.0 0
M  V30 33 C 16.0045 9.2402 0.0 0
M  V30 34 C 14.6708 8.4702 0.0 0
M  V30 35 C 14.6708 6.9302 0.0 0
M  V30 36 C 13.3372 6.1601 0.0 0
M  V30 37 C 13.3372 4.6201 0.0 0
M  V30 38 C 12.0035 3.8501 0.0 0
M  V30 39 C 12.0035 2.3101 0.0 0
M  V30 40 C 10.6697 1.5400 0.0 0
M  V30 41 C 10.6697 0.0000 0.0 0
M  V30 42 C 18.6720 18.4804 0.0 0
M  V30 43 C 20.0057 17.7104 0.0 0
M  V30 44 C 17.3383 17.7104 0.0 0
M  V30 45 C 20.0057 16.1704 0.0 0
M  V30 46 C 17.3383 16.1704 0.0 0
M  V30 47 C 18.6720 15.4003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 42
M  V30 3 1 3 4
M  V30 4 1 3 43
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 44
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 29 30
M  V30 30 1 29 47
M  V30 31 1 30 31
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 2 42 43
M  V30 43 1 42 44
M  V30 44 1 43 45
M  V30 45 2 44 46
M  V30 46 2 45 47
M  V30 47 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenemethanamine, 2,4,6-tris(dodecyloxy)-N-methyl-
C44H83NO3
3030438-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.6720 20.0204 0.0 0
M  V30 2 N 20.0057 20.7905 0.0 0
M  V30 3 C 20.0057 22.3305 0.0 0
M  V30 4 O 21.3395 18.4804 0.0 0
M  V30 5 C 22.6731 17.7104 0.0 0
M  V30 6 C 24.0068 18.4804 0.0 0
M  V30 7 C 25.3405 17.7104 0.0 0
M  V30 8 C 26.6743 18.4804 0.0 0
M  V30 9 C 28.0080 17.7104 0.0 0
M  V30 10 C 29.3416 18.4804 0.0 0
M  V30 11 C 30.6753 17.7104 0.0 0
M  V30 12 C 32.0091 18.4804 0.0 0
M  V30 13 C 33.3428 17.7104 0.0 0
M  V30 14 C 34.6765 18.4804 0.0 0
M  V30 15 C 36.0101 17.7104 0.0 0
M  V30 16 C 37.3440 18.4804 0.0 0
M  V30 17 O 16.0045 18.4804 0.0 0
M  V30 18 C 14.6708 17.7104 0.0 0
M  V30 19 C 13.3372 18.4804 0.0 0
M  V30 20 C 12.0035 17.7104 0.0 0
M  V30 21 C 10.6697 18.4804 0.0 0
M  V30 22 C 9.3360 17.7104 0.0 0
M  V30 23 C 8.0023 18.4804 0.0 0
M  V30 24 C 6.6687 17.7104 0.0 0
M  V30 25 C 5.3348 18.4804 0.0 0
M  V30 26 C 4.0012 17.7104 0.0 0
M  V30 27 C 2.6675 18.4804 0.0 0
M  V30 28 C 1.3338 17.7104 0.0 0
M  V30 29 C 0.0000 18.4804 0.0 0
M  V30 30 O 18.6720 13.8603 0.0 0
M  V30 31 C 17.3383 13.0903 0.0 0
M  V30 32 C 17.3383 11.5503 0.0 0
M  V30 33 C 16.0045 10.7802 0.0 0
M  V30 34 C 16.0045 9.2402 0.0 0
M  V30 35 C 14.6708 8.4702 0.0 0
M  V30 36 C 14.6708 6.9302 0.0 0
M  V30 37 C 13.3372 6.1601 0.0 0
M  V30 38 C 13.3372 4.6201 0.0 0
M  V30 39 C 12.0035 3.8501 0.0 0
M  V30 40 C 12.0035 2.3101 0.0 0
M  V30 41 C 10.6697 1.5400 0.0 0
M  V30 42 C 10.6697 0.0000 0.0 0
M  V30 43 C 18.6720 18.4804 0.0 0
M  V30 44 C 20.0057 17.7104 0.0 0
M  V30 45 C 17.3383 17.7104 0.0 0
M  V30 46 C 20.0057 16.1704 0.0 0
M  V30 47 C 17.3383 16.1704 0.0 0
M  V30 48 C 18.6720 15.4003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 43
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 44
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 1 17 45
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 20 21
M  V30 22 1 21 22
M  V30 23 1 22 23
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 30 31
M  V30 31 1 30 48
M  V30 32 1 31 32
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 1 34 35
M  V30 36 1 35 36
M  V30 37 1 36 37
M  V30 38 1 37 38
M  V30 39 1 38 39
M  V30 40 1 39 40
M  V30 41 1 40 41
M  V30 42 1 41 42
M  V30 43 2 43 44
M  V30 44 1 43 45
M  V30 45 1 44 46
M  V30 46 2 45 47
M  V30 47 2 46 48
M  V30 48 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 908336-60-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3030438-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39442458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure vessel used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tuning the Structure of 4-Aminopyridine Catalysts for Improved Activity
and Selectivity in Functionalization of Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saady, Fatma; Targel, Tom; Fleischer, Or; Amer, Ibrahim; Portnoy, Moshe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2024), 9(2), e202304502

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-5-(2,3,4,5,6-pentafluorophenyl)-1,2,4-oxadiazole
C9H3F5N2O
910645-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6200 0.0000 0.0 0
M  V30 2 F 4.6200 5.3349 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 1.5400 5.3349 0.0 0
M  V30 5 C 9.7756 4.3427 0.0 0
M  V30 6 F 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 N 7.0652 3.9133 0.0 0
M  V30 15 O 7.0652 1.4216 0.0 0
M  V30 16 C 8.5298 3.4374 0.0 0
M  V30 17 N 8.5298 1.8974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 10
M  V30 4 1 4 11
M  V30 5 1 5 16
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5,6-Tetrafluoro-N-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)benzenamine
C10H7F4N3O
910645-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 6.6686 1.5400 0.0 0
M  V30 2 F 4.0011 6.1601 0.0 0
M  V30 3 F 4.0011 0.0000 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 C 10.6376 4.9772 0.0 0
M  V30 6 N 1.3338 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 6.6686 4.6201 0.0 0
M  V30 15 N 8.0754 3.9936 0.0 0
M  V30 16 O 6.8295 6.1516 0.0 0
M  V30 17 C 9.1059 5.1381 0.0 0
M  V30 18 N 8.3358 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 910645-56-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 910645-59-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11384822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fluorinated indazoles through ANRORC-like rearrangement of
1,2,4-oxadiazoles with hydrazine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palumbo Piccionello, Antonio; Pace, Andrea; Pibiri, Ivana; Buscemi,
Silvestre; Vivona, Nicolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2006), 62(37), 8792-8797

$RFMT $RIREG SCHEME188 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthalenesulfonyl chloride
C10H7ClO2S
93-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 2 Cl 8.4700 2.6673 0.0 0
M  V30 3 O 6.9300 1.1273 0.0 0
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 2.3100 2.6673 0.0 0
M  V30 7 C 4.6200 1.3336 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 5.3900 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 4.6200 4.0011 0.0 0
M  V30 14 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-(2-naphthalenylsulfonyl)-2-propenamide
C15H15NO3S
2139278-79-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 2.3101 0.0 0 VAL=6
M  V30 2 N 8.0022 1.5400 0.0 0
M  V30 3 O 7.4385 3.6437 0.0 0
M  V30 4 O 5.8985 0.9764 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 8.0022 0.0000 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 O 9.3360 3.8501 0.0 0
M  V30 9 C 12.0033 2.3101 0.0 0
M  V30 10 C 10.6697 0.0000 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 0.0000 3.0801 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-11-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2139278-79-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690433
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME189 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenesulfonyl chloride
C6H5ClO2S
98-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 Cl 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 1.5400 0.0 0
M  V30 6 C 2.3100 0.2064 0.0 0
M  V30 7 C 2.3100 2.8736 0.0 0
M  V30 8 C 0.7700 0.2064 0.0 0
M  V30 9 C 0.7700 2.8736 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 5
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-(phenylsulfonyl)-2-propenamide
C11H13NO3S
1456707-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 3.0800 0.0 0 VAL=6
M  V30 2 N 5.3348 3.8500 0.0 0
M  V30 3 O 3.2311 4.4137 0.0 0
M  V30 4 O 4.7711 1.7464 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 5.3348 5.3901 0.0 0
M  V30 7 C 8.0022 3.8500 0.0 0
M  V30 8 O 6.6684 1.5400 0.0 0
M  V30 9 C 8.0022 5.3901 0.0 0
M  V30 10 C 9.3359 3.0800 0.0 0
M  V30 11 C 2.6675 2.3100 0.0 0
M  V30 12 C 2.6675 0.7700 0.0 0
M  V30 13 C 1.3337 3.0800 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 11
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-09-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME190 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzenesulfonyl chloride
C6H4BrClO2S
98-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Bromophenyl)sulfonyl]-N,2-dimethyl-2-propenamide
C11H12BrNO3S
1620220-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 Br 10.7800 2.6673 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 1.3336 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-58-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620220-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690435
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME191 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosyl chloride
C7H7ClO2S
98-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-[(4-methylphenyl)sulfonyl]-2-propenamide
C12H15NO3S
1456707-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 1.3336 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-59-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME192 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorobenzenesulfonyl chloride
C6H4Cl2O2S
98-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 Cl 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Chlorophenyl)sulfonyl]-N,2-dimethyl-2-propenamide
C11H12ClNO3S
1456707-38-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 Cl 10.7800 2.6673 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 1.3336 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-60-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-38-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME193 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodobenzenesulfonyl chloride
C6H4ClIO2S
98-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 I 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propenamide, N-[(4-iodophenyl)sulfonyl]-N,2-dimethyl-
C11H12INO3S
3056449-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 0.0000 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 I 10.7800 2.6673 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 6.9300 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.4700 1.3336 0.0 0
M  V30 16 C 8.4700 4.0011 0.0 0
M  V30 17 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-61-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3056449-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME194 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzenesulfonyl chloride
C7H7ClO3S
98-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 O 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Methoxyphenyl)sulfonyl]-N,2-dimethyl-2-propenamide
C12H15NO4S
1456707-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 2.3101 0.0 0 VAL=6
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 O 6.1048 0.9764 0.0 0
M  V30 4 O 4.5648 3.6437 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 4.0012 0.0000 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 O 10.6697 5.3901 0.0 0
M  V30 12 C 12.0033 4.6201 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-68-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME195 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-[(4-nitrophenyl)sulfonyl]-2-propenamide
C11H12N2O5S
1652572-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 4.6201 0.0 0 VAL=6
M  V30 2 N 4.0012 5.3901 0.0 0
M  V30 3 O 4.5648 3.2864 0.0 0
M  V30 4 O 6.1048 5.9538 0.0 0
M  V30 5 C 2.6673 4.6201 0.0 0
M  V30 6 C 4.0012 6.9302 0.0 0
M  V30 7 C 1.3337 5.3901 0.0 0
M  V30 8 O 2.6673 3.0801 0.0 0
M  V30 9 C 1.3337 6.9302 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 N 10.6697 1.5400 0.0 0 VAL=5
M  V30 12 O 12.0033 2.3101 0.0 0
M  V30 13 O 10.6697 0.0000 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 8.0022 1.5400 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1652572-67-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(4-methylphenyl)-6-(methylthio)-2-[4-(methylthio)phenyl]-5-pyrimid...
C20H18ClN3OS2
929090-14-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 4.0011 0.0 0
M  V30 2 N 6.1600 5.3347 0.0 0
M  V30 3 O 6.1600 2.6674 0.0 0
M  V30 4 S 8.4700 1.3338 0.0 0
M  V30 5 C 9.2400 0.0000 0.0 0
M  V30 6 Cl 8.4700 6.6685 0.0 0
M  V30 7 C 0.0000 5.3347 0.0 0
M  V30 8 S 17.7100 4.0011 0.0 0
M  V30 9 C 18.4800 5.3347 0.0 0
M  V30 10 C 8.4700 4.0011 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 N 10.7800 2.6674 0.0 0
M  V30 14 N 10.7800 5.3347 0.0 0
M  V30 15 C 11.5500 4.0011 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.8500 6.6685 0.0 0
M  V30 19 C 2.3100 4.0011 0.0 0
M  V30 20 C 2.3100 6.6685 0.0 0
M  V30 21 C 1.5400 5.3347 0.0 0
M  V30 22 C 13.0900 4.0011 0.0 0
M  V30 23 C 13.8600 5.3347 0.0 0
M  V30 24 C 13.8600 2.6674 0.0 0
M  V30 25 C 15.4000 5.3347 0.0 0
M  V30 26 C 15.4000 2.6674 0.0 0
M  V30 27 C 16.1700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 12
M  V30 8 1 7 21
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 15 22
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-N-(4-methylphenyl)-6-(methylthio)-2-[4-(methylthio)phenyl]-5-...
C21H22N4OS2
929090-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 4.0011 0.0 0
M  V30 2 N 6.1601 5.3348 0.0 0
M  V30 3 O 6.1601 2.6675 0.0 0
M  V30 4 N 8.4701 1.3337 0.0 0
M  V30 5 C 9.2401 0.0000 0.0 0
M  V30 6 S 8.4701 6.6686 0.0 0
M  V30 7 C 9.2401 8.0022 0.0 0
M  V30 8 C 0.0000 5.3348 0.0 0
M  V30 9 S 17.7102 4.0011 0.0 0
M  V30 10 C 18.4802 2.6675 0.0 0
M  V30 11 C 8.4701 4.0011 0.0 0
M  V30 12 C 9.2401 2.6675 0.0 0
M  V30 13 C 9.2401 5.3348 0.0 0
M  V30 14 N 10.7801 2.6675 0.0 0
M  V30 15 N 10.7801 5.3348 0.0 0
M  V30 16 C 11.5501 4.0011 0.0 0
M  V30 17 C 4.6201 5.3348 0.0 0
M  V30 18 C 3.8500 4.0011 0.0 0
M  V30 19 C 3.8500 6.6686 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 2.3100 6.6686 0.0 0
M  V30 22 C 1.5400 5.3348 0.0 0
M  V30 23 C 13.0901 4.0011 0.0 0
M  V30 24 C 13.8602 2.6675 0.0 0
M  V30 25 C 13.8602 5.3348 0.0 0
M  V30 26 C 15.4002 2.6675 0.0 0
M  V30 27 C 15.4002 5.3348 0.0 0
M  V30 28 C 16.1702 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 17
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 7
M  V30 8 1 6 13
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 9 28
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 16 23
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 929090-14-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 929090-15-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4944319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 5 can be alternatively synthesized as follows: To a solution of
4-Chloro-N-(4-methylphenyl)-6-(methylthio)-2-[4-(methylthio)phenyl]pyrimidine-5-carboxamide
(0.05g, 0.12 mmol, obtained according to the procedure described in
example 4) in THF (5ml) was added 10% methylamine in THF (5 ml, prepared
by purging methylamine gas into THF at 0°C to get a 10% solution) at 0°C
under stirring. The reaction mixture was stirred at this temperature
until completion (TLC) and was subsequently poured onto ice-water mixture
and extracted with ethylacetate. The organic layer was dried over
anhydrous sodium sulphate and distilled under vacuum to yield the title
compound, 0.03g, yield 61%. MS m/z: 411.1 (M++1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine carboxamides as inhibitors of cytokines and
COX-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tadiparthi, Ravikumar; Aggarwal, Pawan; Parameswaran, Venkatesan;
Thirunavukkarasu, Sappanimuthu; Barik, Rajib; Rajagopal, Sriram; Reddy,
Gaddam Om
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007031829 A2 2007-03-22

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,11,17,23-Tetrakis(1,1-dimethylethyl)-26,28-bis(3-isocyanatopropoxy)pentacyc...
C52H66N2O6
936716-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 64 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.4660 8.5952 0.0 0
M  V30 2 C 12.0060 8.5952 0.0 0
M  V30 3 C 12.7760 9.9289 0.0 0
M  V30 4 C 14.3159 9.9289 0.0 0
M  V30 5 N 15.0859 11.2625 0.0 0
M  V30 6 C 16.6259 11.2625 0.0 0
M  V30 7 O 18.1659 11.2625 0.0 0
M  V30 8 C 13.7288 4.9332 0.0 0
M  V30 9 C 14.4987 6.2669 0.0 0
M  V30 10 C 15.0624 4.1632 0.0 0
M  V30 11 C 12.9588 3.5995 0.0 0
M  V30 12 O 9.5511 12.0098 0.0 0
M  V30 13 O 5.5113 5.0129 0.0 0
M  V30 14 C 11.1094 14.7090 0.0 0
M  V30 15 C 9.7756 15.4789 0.0 0
M  V30 16 C 11.8794 16.0426 0.0 0
M  V30 17 C 12.4430 13.9390 0.0 0
M  V30 18 C 3.9530 2.3138 0.0 0
M  V30 19 C 5.2867 1.5438 0.0 0
M  V30 20 C 3.1830 0.9802 0.0 0
M  V30 21 C 2.6193 3.0838 0.0 0
M  V30 22 O 6.9998 8.1279 0.0 0
M  V30 23 C 6.6013 6.6404 0.0 0
M  V30 24 C 7.6902 5.5515 0.0 0
M  V30 25 C 7.2915 4.0638 0.0 0
M  V30 26 N 8.3804 2.9749 0.0 0
M  V30 27 C 7.9819 1.4875 0.0 0
M  V30 28 O 7.5833 0.0000 0.0 0
M  V30 29 C 1.3336 12.0896 0.0 0
M  V30 30 C 2.1036 13.4232 0.0 0
M  V30 31 C 0.0000 12.8596 0.0 0
M  V30 32 C 0.5636 10.7558 0.0 0
M  V30 33 C 9.6960 7.2616 0.0 0
M  V30 34 C 11.0383 8.0347 0.0 0
M  V30 35 C 9.6976 5.7124 0.0 0
M  V30 36 C 11.2506 9.5080 0.0 0
M  V30 37 C 12.3968 7.2635 0.0 0
M  V30 38 C 8.5278 4.7920 0.0 0
M  V30 39 C 11.0447 4.9216 0.0 0
M  V30 40 C 10.3302 10.6777 0.0 0
M  V30 41 C 12.3951 5.7032 0.0 0
M  V30 42 C 7.0545 5.0043 0.0 0
M  V30 43 C 8.7811 10.6762 0.0 0
M  V30 44 C 11.1210 12.0249 0.0 0
M  V30 45 C 6.2814 6.3466 0.0 0
M  V30 46 C 6.2833 3.6459 0.0 0
M  V30 47 C 8.0079 12.0185 0.0 0
M  V30 48 C 10.3394 13.3753 0.0 0
M  V30 49 C 4.7322 6.3450 0.0 0
M  V30 50 C 4.7230 3.6474 0.0 0
M  V30 51 C 6.5346 12.2308 0.0 0
M  V30 52 C 8.7791 13.3770 0.0 0
M  V30 53 C 3.8118 7.5148 0.0 0
M  V30 54 C 3.9414 4.9978 0.0 0
M  V30 55 C 5.3648 11.3104 0.0 0
M  V30 56 C 4.0241 8.9881 0.0 0
M  V30 57 C 5.3664 9.7613 0.0 0
M  V30 58 C 4.0176 12.1012 0.0 0
M  V30 59 C 2.6657 9.7593 0.0 0
M  V30 60 C 2.6674 11.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 33
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 41
M  V30 12 1 12 43
M  V30 13 1 13 45
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 48
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 50
M  V30 22 1 22 23
M  V30 23 1 22 57
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 1 25 26
M  V30 27 2 26 27
M  V30 28 2 27 28
M  V30 29 1 29 30
M  V30 30 1 29 31
M  V30 31 1 29 32
M  V30 32 1 29 60
M  V30 33 1 33 34
M  V30 34 2 33 35
M  V30 35 1 34 36
M  V30 36 2 34 37
M  V30 37 1 35 38
M  V30 38 1 35 39
M  V30 39 1 36 40
M  V30 40 1 37 41
M  V30 41 1 38 42
M  V30 42 2 39 41
M  V30 43 1 40 43
M  V30 44 2 40 44
M  V30 45 1 42 45
M  V30 46 2 42 46
M  V30 47 2 43 47
M  V30 48 1 44 48
M  V30 49 2 45 49
M  V30 50 1 46 50
M  V30 51 1 47 51
M  V30 52 1 47 52
M  V30 53 2 48 52
M  V30 54 1 49 53
M  V30 55 1 49 54
M  V30 56 2 50 54
M  V30 57 1 51 55
M  V30 58 1 53 56
M  V30 59 1 55 57
M  V30 60 2 55 58
M  V30 61 2 56 57
M  V30 62 1 56 59
M  V30 63 1 58 60
M  V30 64 2 59 60
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′′-[[5,11,17,23-Tetrakis(1,1-dimethylethyl)-26,28-dihydroxypentacyclo[19.3...
C54H76N4O6
936716-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  64 68 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3355 8.9259 0.0 0
M  V30 2 C 8.0017 9.6958 0.0 0
M  V30 3 C 6.6681 8.9259 0.0 0
M  V30 4 C 5.3345 9.6958 0.0 0
M  V30 5 N 4.0009 8.9259 0.0 0
M  V30 6 C 2.6672 9.6958 0.0 0
M  V30 7 N 1.3336 8.9259 0.0 0
M  V30 8 O 2.6672 11.2358 0.0 0
M  V30 9 C 0.0000 9.6958 0.0 0
M  V30 10 C 8.3408 13.7285 0.0 0
M  V30 11 C 7.0072 12.9585 0.0 0
M  V30 12 C 7.5709 15.0623 0.0 0
M  V30 13 C 9.6744 14.4985 0.0 0
M  V30 14 O 8.4204 5.5113 0.0 0
M  V30 15 O 15.4174 9.5509 0.0 0
M  V30 16 C 5.7215 3.9531 0.0 0
M  V30 17 C 6.4915 2.6195 0.0 0
M  V30 18 C 4.3878 3.1831 0.0 0
M  V30 19 C 4.9516 5.2866 0.0 0
M  V30 20 C 18.1163 11.1092 0.0 0
M  V30 21 C 16.7827 11.8792 0.0 0
M  V30 22 C 18.1163 12.6492 0.0 0
M  V30 23 C 19.4500 10.3392 0.0 0
M  V30 24 O 14.5023 6.1364 0.0 0
M  V30 25 C 15.8361 5.3664 0.0 0
M  V30 26 C 17.1697 6.1364 0.0 0
M  V30 27 C 18.5033 5.3664 0.0 0
M  V30 28 N 19.8369 6.1364 0.0 0
M  V30 29 C 21.1706 5.3664 0.0 0
M  V30 30 N 22.5042 6.1364 0.0 0
M  V30 31 O 21.1706 3.8265 0.0 0
M  V30 32 C 23.8378 5.3664 0.0 0
M  V30 33 C 15.4970 1.3338 0.0 0
M  V30 34 C 13.9570 1.3338 0.0 0
M  V30 35 C 14.7270 0.0000 0.0 0
M  V30 36 C 17.0369 1.3338 0.0 0
M  V30 37 C 10.6691 9.6958 0.0 0
M  V30 38 C 9.1200 9.6974 0.0 0
M  V30 39 C 11.4423 11.0382 0.0 0
M  V30 40 C 8.1995 8.5278 0.0 0
M  V30 41 C 8.3293 11.0447 0.0 0
M  V30 42 C 12.9156 11.2506 0.0 0
M  V30 43 C 10.6709 12.3966 0.0 0
M  V30 44 C 8.4118 7.0545 0.0 0
M  V30 45 C 9.1108 12.3949 0.0 0
M  V30 46 C 14.0852 10.3300 0.0 0
M  V30 47 C 9.7542 6.2813 0.0 0
M  V30 48 C 7.0534 6.2832 0.0 0
M  V30 49 C 14.0836 8.7810 0.0 0
M  V30 50 C 15.4325 11.1208 0.0 0
M  V30 51 C 9.7527 4.7323 0.0 0
M  V30 52 C 7.0551 4.7230 0.0 0
M  V30 53 C 15.4260 8.0077 0.0 0
M  V30 54 C 16.7827 10.3392 0.0 0
M  V30 55 C 10.9223 3.8117 0.0 0
M  V30 56 C 8.4054 3.9415 0.0 0
M  V30 57 C 15.6384 6.5345 0.0 0
M  V30 58 C 16.7844 8.7791 0.0 0
M  V30 59 C 12.3955 4.0240 0.0 0
M  V30 60 C 14.7178 5.3649 0.0 0
M  V30 61 C 13.1687 5.3664 0.0 0
M  V30 62 C 13.1669 2.6657 0.0 0
M  V30 63 C 15.5085 4.0176 0.0 0
M  V30 64 C 14.7270 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 37
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 45
M  V30 14 1 14 47
M  V30 15 1 15 49
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 52
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 20 54
M  V30 24 1 24 25
M  V30 25 1 24 61
M  V30 26 1 25 26
M  V30 27 1 26 27
M  V30 28 1 27 28
M  V30 29 1 28 29
M  V30 30 1 29 30
M  V30 31 2 29 31
M  V30 32 1 30 32
M  V30 33 1 33 34
M  V30 34 1 33 35
M  V30 35 1 33 36
M  V30 36 1 33 64
M  V30 37 1 37 38
M  V30 38 2 37 39
M  V30 39 1 38 40
M  V30 40 2 38 41
M  V30 41 1 39 42
M  V30 42 1 39 43
M  V30 43 1 40 44
M  V30 44 1 41 45
M  V30 45 1 42 46
M  V30 46 2 43 45
M  V30 47 1 44 47
M  V30 48 2 44 48
M  V30 49 1 46 49
M  V30 50 2 46 50
M  V30 51 2 47 51
M  V30 52 1 48 52
M  V30 53 2 49 53
M  V30 54 1 50 54
M  V30 55 1 51 55
M  V30 56 1 51 56
M  V30 57 2 52 56
M  V30 58 1 53 57
M  V30 59 1 53 58
M  V30 60 2 54 58
M  V30 61 1 55 59
M  V30 62 1 57 60
M  V30 63 1 59 61
M  V30 64 2 59 62
M  V30 65 2 60 61
M  V30 66 1 60 63
M  V30 67 1 62 64
M  V30 68 2 63 64
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 936716-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 936716-70-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-11076370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 3. Yield: 94%. Mp: 144-145 °C.1H NMR (CDCl3): δ 0.98 (18H, s),
1.29 (18H, s), 2.16 (4H, m), 2.78 (6H, d, J = 3.3 Hz), 3.40 (4H, d, J =
13.2 Hz), 3.66 (4H, q, J = 7.8 Hz), 4.07 (4H, t, J = 6.0 Hz), 4.19 (4H,
d, J = 13.2 Hz), 5.18 (2H, q, J = 4.7 Hz), 5.79 (2H, t, J = 4 Hz), 6.85
and 7.08 (4H each, 2s). 13C NMR (CDCl3): δ 26.9, 30.3, 30.9, 31.5, 31.7,
33.8, 34.0, 38.2, 75.2, 125.2, 125.7, 127.8, 132.6, 142.7, 147.7, 149.3,
149.5, 159.9. ESI-MS: m/z 899.7 ([M + Na]+, 100). Anal. Calcd for
C54H76N4O6‚2.5H2O: C, 70.33; H, 8.85; N, 6.07. Found: C, 70.57; H, 8.45;
N, 6.09
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Linked Peptidocalix[4]arene Bisureas as Enantioselective Receptors for
Amino Acid Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yakovenko, Anton V.; Boyko, Vyacheslav I.; Kalchenko, Vitaly I.; Baldini,
Laura; Casnati, Alessandro; Sansone, Francesco; Ungaro, Rocco
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(9), 3223-3231

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
4-[(4-Methyl-2-nitrophenyl)thio]benzoic acid
C14H11NO4S
943616-64-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3347 2.3100 0.0 0
M  V30 2 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 C 0.0000 5.3900 0.0 0
M  V30 6 C 10.6694 5.3900 0.0 0
M  V30 7 O 12.0031 4.6200 0.0 0
M  V30 8 O 10.6694 6.9300 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 2.6673 2.3100 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 3.0800 0.0 0
M  V30 13 C 2.6673 5.3900 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 6.6684 3.0800 0.0 0
M  V30 16 C 6.6684 4.6200 0.0 0
M  V30 17 C 8.0020 2.3100 0.0 0
M  V30 18 C 8.0020 5.3900 0.0 0
M  V30 19 C 9.3358 3.0800 0.0 0
M  V30 20 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[(4-methyl-2-nitrophenyl)thio]benzamide
C15H14N2O3S
943616-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 2.3101 0.0 0
M  V30 2 N 2.6673 0.7700 0.0 0 VAL=5
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 5.3901 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 N 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 C 13.3370 5.3901 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 6.6685 3.0801 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 9.3360 3.0801 0.0 0
M  V30 20 C 8.0022 5.3901 0.0 0
M  V30 21 C 9.3360 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 21
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 943616-64-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943616-68-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4504198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example 84b.
4-(4-Methyl-2-nitro-phenylsulfanyl)-benzamide. The product from Example
84a (0.3 g, 1.04 mmol) was dissolved in THF (15mL) and treated with
N-methylmorpholine (0.131 mL, 1.19 mmol) followed by cooling in an ice
bath and addition of isobutylchloroforamte (0.148 mL, 1.14 mmol). The
resulting mixture was allowed warm to room temperature with stirring for
thirty minutes. Subsequent coo1ing in an ice bath was followed by
addition of ammonia gas and warming to room temperature. The title
compound was isolated by the addition of water and collection of the
solid by vacuum filtration was used without further purification
N-Methyl-4-(4-nitro-phenylsulafanyl)-benzamide. 94 %.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,6- and 1,8-naphthyridines as antiviral compounds for
treatment of HCV infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rockway, Todd W.; Betebenner, David A.; Krueger, Allan C.; Iwasaki,
Nobuhiko; Cooper, Curt S.; Anderson, David D.; Kempf, Dale J.; Madigan,
Darold L.; Motter, Christopher E.; Shanley, Jason P.; Tufano, Michael D.;
Wagner, Rolf; Zhang, Rong; Molla, Akhteruzzaman; Mo, Hongmei;
Pilot-Matias, Tami; Masse, Sherie V. L.; Carrick, Robert J.; He, Weping;
Lu, Liangjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007076035 A2 2007-07-05

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-4-ethanol, 3-(phenylsulfonyl)-, 4-(4-methylbenzenesulfonate)
C23H21NO5S2
945000-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.2506 2.4581 0.0 0 VAL=6
M  V30 2 O 4.7264 3.9228 0.0 0
M  V30 3 O 3.7747 0.9935 0.0 0
M  V30 4 C 4.6200 5.7323 0.0 0
M  V30 5 C 5.3900 7.0660 0.0 0
M  V30 6 O 6.9300 7.0660 0.0 0
M  V30 7 S 7.7000 8.3998 0.0 0 VAL=6
M  V30 8 O 8.4700 9.7334 0.0 0
M  V30 9 O 6.3664 9.1698 0.0 0
M  V30 10 C 13.0349 5.3198 0.0 0
M  V30 11 C 2.3100 4.3987 0.0 0
M  V30 12 C 2.7860 2.9340 0.0 0
M  V30 13 C 0.7700 4.3987 0.0 0
M  V30 14 C 3.0800 5.7323 0.0 0
M  V30 15 C 1.5400 2.0288 0.0 0
M  V30 16 N 0.2941 2.9340 0.0 0
M  V30 17 C 0.0000 5.7323 0.0 0
M  V30 18 C 2.3100 7.0660 0.0 0
M  V30 19 C 0.7700 7.0660 0.0 0
M  V30 20 C 5.7152 1.9823 0.0 0
M  V30 21 C 6.0354 0.4759 0.0 0
M  V30 22 C 6.8596 3.0127 0.0 0
M  V30 23 C 7.5000 0.0000 0.0 0
M  V30 24 C 8.3243 2.5368 0.0 0
M  V30 25 C 8.6445 1.0306 0.0 0
M  V30 26 C 9.0338 7.6298 0.0 0
M  V30 27 C 9.0338 6.0898 0.0 0
M  V30 28 C 10.3674 8.3998 0.0 0
M  V30 29 C 10.3674 5.3198 0.0 0
M  V30 30 C 11.7011 7.6298 0.0 0
M  V30 31 C 11.7011 6.0898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 20
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 2 7 8
M  V30 10 2 7 9
M  V30 11 1 7 26
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(phenylsulfonyl)-1H-indole-4-ethanamine
C17H18N2O2S
944998-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.7534 6.5393 0.0 0 VAL=6
M  V30 2 O 6.5234 7.8729 0.0 0
M  V30 3 O 4.9834 5.2056 0.0 0
M  V30 4 C 3.5673 4.0737 0.0 0
M  V30 5 C 3.0915 2.6091 0.0 0
M  V30 6 N 4.1220 1.4646 0.0 0
M  V30 7 C 3.6460 0.0000 0.0 0
M  V30 8 C 3.0128 6.6828 0.0 0
M  V30 9 C 4.4197 7.3093 0.0 0
M  V30 10 C 1.9823 7.8273 0.0 0
M  V30 11 C 2.5369 5.2182 0.0 0
M  V30 12 C 4.2586 8.8408 0.0 0
M  V30 13 N 2.7523 9.1610 0.0 0
M  V30 14 C 0.4759 7.5072 0.0 0
M  V30 15 C 1.0306 4.8981 0.0 0
M  V30 16 C 0.0000 6.0425 0.0 0
M  V30 17 C 7.0871 5.7693 0.0 0
M  V30 18 C 8.4207 6.5393 0.0 0
M  V30 19 C 7.0871 4.2292 0.0 0
M  V30 20 C 9.7545 5.7693 0.0 0
M  V30 21 C 8.4207 3.4592 0.0 0
M  V30 22 C 9.7545 4.2292 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 17
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945000-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944998-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15139913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor
antagonists: Identification, synthesis and activity of novel
4-aminoethyl-3-(phenylsulfonyl)-1H-indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heffernan, Gavin D.; Coghlan, Richard D.; Manas, Eric S.; McDevitt,
Robert E.; Li, Yanfang; Mahaney, Paige E.; Robichaud, Albert J.;
Huselton, Christine; Alfinito, Peter; Bray, Jenifer A.; Cosmi, Scott A.;
Johnston, Grace H.; Kenney, Thomas; Koury, Elizabeth; Winneker, Richard
C.; Deecher, Darlene C.; Trybulski, Eugene J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(22), 7802-7815

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[3.1.0]hexane-1-methanol, 2-(acetyloxy)-4-(6-chloro-2-iodo-9H-purin-9-...
C16H16ClIN4O4
945565-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6616 5.0988 0.0 0
M  V30 2 O 11.5668 6.3446 0.0 0
M  V30 3 C 13.0983 6.1837 0.0 0
M  V30 4 C 13.7246 4.7769 0.0 0
M  V30 5 O 14.0035 7.4296 0.0 0
M  V30 6 O 9.8403 2.6091 0.0 0
M  V30 7 C 9.3644 1.1444 0.0 0
M  V30 8 C 7.8580 0.8242 0.0 0
M  V30 9 O 10.3948 0.0000 0.0 0
M  V30 10 Cl 0.0000 5.0591 0.0 0
M  V30 11 I 2.6674 0.4391 0.0 0
M  V30 12 C 9.1300 5.2599 0.0 0 CFG=2
M  V30 13 C 7.7962 6.0299 0.0 0 CFG=1
M  V30 14 C 8.8099 3.7534 0.0 0 CFG=1
M  V30 15 C 9.1300 6.7999 0.0 0
M  V30 16 C 6.6519 4.9993 0.0 0 CFG=1
M  V30 17 C 7.2782 3.5925 0.0 0
M  V30 18 N 5.1454 5.3195 0.0 0
M  V30 19 C 4.0011 4.2891 0.0 0
M  V30 20 C 4.5191 6.7264 0.0 0
M  V30 21 C 2.6674 5.0591 0.0 0
M  V30 22 N 4.0011 2.7491 0.0 0
M  V30 23 N 2.9876 6.5655 0.0 0
M  V30 24 C 1.3336 4.2891 0.0 0
M  V30 25 C 2.6674 1.9791 0.0 0
M  V30 26 N 1.3336 2.7491 0.0 0
M  V30 27 H 6.8912 7.2757 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 14 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 10 24
M  V30 11 1 11 25
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 27 CFG=3
M  V30 18 1 14 17
M  V30 19 1 16 17
M  V30 20 1 16 18 CFG=3
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 1 22 25
M  V30 29 1 24 26
M  V30 30 2 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 13 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,2S,4S,5S)-2-Hydroxy-4-[2-iodo-6-(methylamino)-9H-purin-9-yl]bicyclo[3.1.0...
C13H16IN5O2
945565-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.9051 4.6597 0.0 0
M  V30 2 O 0.0000 5.9057 0.0 0
M  V30 3 O 1.7265 2.1700 0.0 0
M  V30 4 N 11.5666 4.6200 0.0 0
M  V30 5 C 12.9003 3.8500 0.0 0
M  V30 6 I 8.8994 0.0000 0.0 0
M  V30 7 C 2.4367 4.8208 0.0 0 CFG=1
M  V30 8 C 3.7704 5.5908 0.0 0 CFG=1
M  V30 9 C 2.4367 6.3608 0.0 0
M  V30 10 C 2.7569 3.3144 0.0 0 CFG=1
M  V30 11 C 4.9148 4.5602 0.0 0 CFG=1
M  V30 12 C 4.2884 3.1535 0.0 0
M  V30 13 N 6.4212 4.8804 0.0 0
M  V30 14 C 7.5656 3.8500 0.0 0
M  V30 15 C 7.0475 6.2874 0.0 0
M  V30 16 C 8.8994 4.6200 0.0 0
M  V30 17 N 7.5656 2.3100 0.0 0
M  V30 18 N 8.5790 6.1264 0.0 0
M  V30 19 C 10.2330 3.8500 0.0 0
M  V30 20 C 8.8994 1.5400 0.0 0
M  V30 21 N 10.2330 2.3100 0.0 0
M  V30 22 H 4.6756 6.8367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=1
M  V30 3 1 10 3 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 9
M  V30 11 1 8 11
M  V30 12 1 8 22 CFG=1
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 11 13 CFG=1
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 1 17 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 7 8 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 945565-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 945565-66-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9203814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1’R,2’S,4’S,5’S)-1-Hydroxymethyl-4-(2-iodo-6-methylaminopurin-9-yl)-bicyclo[3.1.0]hexan-2-ol
(32). To a solution of acetic acid
1-acetoxymethyl-4-(6-chloro-2-iodopurin-9-yl)-bicyclo[3.1.0]- hex-2-yl
ester (31, 20 mg, 0.041 mmol) in THF (0.030 mL) was added 2 N MeNH2 in
THF (0.30 mL), and the reaction mixture was stirred at rt for 6.5 h. MeOH
(0.10 mL) and 3 N NaOH aq (0.040 mL) were added to the reaction mixture,
which was stirred overnight at rt. The solvent was removed under vacuum,
and the residue obtained was purified by silica gel column chromatography
(AcOEt then CHCl3/MeOH) 5/1), which furnished 32.
(1’R,2’S,4’S,5’S-1-Hydroxymethyl-4-(2-iodo-6-methylaminopurin-9-yl)-bicyclo[3.1.0]hexan-2-ol
(32), yield 94% 1H NMR (CD3OD) δ 8.36 (s, 1H), 4.96 (d, 1H, J = 6.6 Hz),
4.86 (t, 1H, J = 8.7 Hz), 4.25 (d, 1H, J = 11.7 Hz), 3.37 (d, 1H, J =
11.7 Hz), 3.05 (bs, 3H), 2.01 (m, 1H), 1.81 (m, 1H), 1.63 (dd, 1H, J =
3.6, 8.4 Hz), 1.01 (dd, 1H, J = 3.9, 5.7 Hz), 0.77 (dd, 1H, J = 6.0, 8.7
Hz). MS (m/e ) (CI) 402 (M+ +H). HPLC 11.4 min (99%, System C), 31.5 min
(99%, System E).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM P2Y1 Antagonists: Combining Receptor-Based Modeling and QSAR for a
Quantitative Prediction of the Biological Activity Based on Consensus
Scoring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Costanzi, Stefano; Tikhonova, Irina G.; Ohno, Michihiro; Roh, Eun Joo;
Joshi, Bhalchandra V.; Colson, Anny-Odile; Houston, Dayle; Maddileti,
Savitri; Harden, T. Kendall; Jacobson, Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(14), 3229-3241

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
1-(6-Amino-9H-purin-9-yl)-1-deoxy-2-O-methyl-β-D-ribofuranuronic acid
C11H13N5O5
946530-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7115 0.9052 0.0 0
M  V30 2 C 2.4656 0.0000 0.0 0
M  V30 3 O 0.8099 2.5803 0.0 0
M  V30 4 C 1.5065 5.8576 0.0 0
M  V30 5 O 1.9823 7.3222 0.0 0
M  V30 6 O 0.0000 5.5375 0.0 0
M  V30 7 N 11.3469 3.4075 0.0 0
M  V30 8 N 6.2012 3.1470 0.0 0
M  V30 9 C 7.3458 4.1775 0.0 0
M  V30 10 C 6.8277 1.7402 0.0 0
M  V30 11 C 8.6794 3.4075 0.0 0
M  V30 12 N 7.3458 5.7175 0.0 0
M  V30 13 N 8.3593 1.9012 0.0 0
M  V30 14 C 10.0131 4.1775 0.0 0
M  V30 15 C 8.6794 6.4875 0.0 0
M  V30 16 N 10.0131 5.7175 0.0 0
M  V30 17 C 4.6949 3.4672 0.0 0 CFG=2
M  V30 18 C 3.5504 2.4368 0.0 0 CFG=2
M  V30 19 O 4.0684 4.8742 0.0 0
M  V30 20 C 2.2167 3.2068 0.0 0 CFG=2
M  V30 21 C 2.5369 4.7131 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 18 1 CFG=3
M  V30 3 1 20 3 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 21 4 CFG=1
M  V30 7 1 7 14
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 18 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-methyl-2-O-methyl-β-D-ribofuranuronamide
C12H16N6O4
946530-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7417 0.9052 0.0 0
M  V30 2 C 3.4959 0.0000 0.0 0
M  V30 3 O 1.8402 2.5803 0.0 0
M  V30 4 C 2.5369 5.8577 0.0 0
M  V30 5 N 1.0304 5.5375 0.0 0
M  V30 6 O 3.0128 7.3222 0.0 0
M  V30 7 C 0.0000 6.6819 0.0 0
M  V30 8 N 12.3772 3.4075 0.0 0
M  V30 9 C 5.7252 3.4672 0.0 0 CFG=2
M  V30 10 C 4.5808 2.4368 0.0 0 CFG=2
M  V30 11 O 5.0989 4.8742 0.0 0
M  V30 12 C 3.2471 3.2068 0.0 0 CFG=2
M  V30 13 C 3.5673 4.7131 0.0 0 CFG=2
M  V30 14 N 7.2317 3.1470 0.0 0
M  V30 15 C 8.3761 4.1775 0.0 0
M  V30 16 C 7.8580 1.7402 0.0 0
M  V30 17 C 9.7099 3.4075 0.0 0
M  V30 18 N 8.3761 5.7175 0.0 0
M  V30 19 N 9.3897 1.9012 0.0 0
M  V30 20 C 11.0435 4.1775 0.0 0
M  V30 21 C 9.7099 6.4875 0.0 0
M  V30 22 N 11.0435 5.7175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=3
M  V30 3 1 12 3 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 13 4 CFG=1
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 946530-53-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946530-62-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11004344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological evaluation of LNA nucleosides as
adenosine A3 receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ravn, Jacob; Qvortrup, Katrine; Rosenbohm, Christoph; Koch, Troels
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2007), 15(16), 5440-5447

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-5-nitrobenzaldehyde
C10H9NO3S
960234-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 2.3101 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 9.5424 3.0801 0.0 0
M  V30 15 C 8.7723 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-N-methyl-5-nitrobenzenemethanamine
C11H14N2O2S
1037082-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 3.8501 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 6 O 1.3337 8.4702 0.0 0
M  V30 7 O 0.0000 6.1601 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 6.1601 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 8.7723 5.9538 0.0 0
M  V30 16 C 9.5424 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960234-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16054040
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Potent, Selective, and Orally Bioavailable
Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor
Complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Johnson, James A.; Jiang, Wen;
Jacutin-Porte, Swanee; Ladziata, Vladimir; Zou, Yan; Phillips, Monique
S.; Wurtz, Nicholas R.; Parkhurst, Brandon; Rendina, Alan R.; Harper,
Timothy M.; Cheney, Daniel L.; Luettgen, Joseph M.; Wong, Pancras C.;
Seiffert, Dietmar; Wexler, Ruth R.; Priestley, E. Scott
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(15), 7125-7137

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-5-nitrobenzaldehyde
C10H9NO3S
960234-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 2.3101 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 9.5424 3.0801 0.0 0
M  V30 15 C 8.7723 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-N-methyl-5-nitrobenzenemethanamine
C11H14N2O2S
1037082-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 3.8501 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 6 O 1.3337 8.4702 0.0 0
M  V30 7 O 0.0000 6.1601 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 6.1601 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 8.7723 5.9538 0.0 0
M  V30 16 C 9.5424 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960234-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13505424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic compounds as factor VIIa inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojun; Glunz, Peter W.; Priestley, Eldon Scott; Johnson, James
A.; Wurtz, Nicholas Ronald; Ladziata, Vladimir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013184734 A1 2013-12-12

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-5-nitrobenzaldehyde
C10H9NO3S
960234-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 2.3101 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 5.3901 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 9.5424 3.0801 0.0 0
M  V30 15 C 8.7723 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Cyclopropylthio)-N-methyl-5-nitrobenzenemethanamine
C11H14N2O2S
1037082-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6687 3.8501 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 2.6675 1.5400 0.0 0
M  V30 4 C 2.6675 0.0000 0.0 0
M  V30 5 N 1.3337 6.9302 0.0 0 VAL=5
M  V30 6 O 1.3337 8.4702 0.0 0
M  V30 7 O 0.0000 6.1601 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 6.1601 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 4.0012 6.9302 0.0 0
M  V30 13 C 2.6675 6.1601 0.0 0
M  V30 14 C 8.0023 4.6201 0.0 0
M  V30 15 C 8.7723 5.9538 0.0 0
M  V30 16 C 9.5424 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 1 3 4
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960234-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1037082-20-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3179382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 11B:To stirred solution of compound Intermediate 11A (10.0
g, 4.4 mmol) in methanol (100 mL) was added 30 % methanolic methyl amine
solution (14 mL, 13 mmol) dropwise and stirred for 1 h. The reaction
mixture was cooled to 0 °C, sodium borohydride (3.4 g, 8.9 mmol) was
added portionwise and the mixture was stirred at rt for over night. The
reaction mixture was concentrated, diluted with ethyl acetate washed with
water, brine dried over sodium sulphate and concentrated.
Recrystalization from hexane (10 g, 94 %) yielded Intermediate 11B. LC-MS
= 238.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic amino acid derivatives as factor VIIa
inhibitors useful as anticoagulants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wurtz, Nicholas Ronald; Priestley, Eldon Scott; Cheney, Daniel L.; Glunz,
Peter W.; Zhang, Xiaojun; Ladziata, Vladimir; Parkhurst, Brandon;
Mueller, Luciano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008079836 A2 2008-07-03

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzenesulfonyl chloride
C7H7ClO3S
10130-74-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 O 6.6687 3.0801 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenesulfonamide
C8H11NO3S
1538358-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6675 3.0801 0.0 0 VAL=6
M  V30 2 N 1.3337 3.8501 0.0 0
M  V30 3 O 1.8975 1.7464 0.0 0
M  V30 4 O 3.4375 4.4137 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10130-74-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538358-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5991834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Purines and 7-Deazapurines as Potent and Selective Type
I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lawhorn, Brian G.; Philp, Joanne; Zhao, Yongdong; Louer, Christopher;
Hammond, Marlys; Cheung, Mui; Fries, Harvey; Graves, Alan P.; Shewchuk,
Lisa; Wang, Liping; Cottom, Joshua E.; Qi, Hongwei; Zhao, Huizhen;
Totoritis, Rachel; Zhang, Guofeng; Schwartz, Benjamin; Li, Hu; Sweitzer,
Sharon; Holt, Dennis A.; Gatto, Gregory J. Jr.; Kallander, Lara S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(18), 7431-7448

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6098828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature procedure
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Aminobenzaldehydes as Versatile Substrates for Rhodium-Catalyzed Alkyne
Hydroacylation: Application to Dihydroquinolone Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castaing, Matthias; Wason, Sacha L.; Estepa, Beatriz; Hooper, Joel F.;
Willis, Michael C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2013), 52(50), 13280-13283

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6540668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM EtOH/H2 (1 atm), 70-100 C/3-6 h., NaBH4, r.t./5 h., Amination,
C-Amination, Condensation, Reduction, Reductive amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxter, Ellen W.; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Reactions (Hoboken, NJ, United States) (2002), 59No pp. given

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-(methoxycarbonyl)-3-pyridinyl]-1-piperazinecarboxylate
C16H23N3O4
1354355-85-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 O 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 1.5400 0.0 0
M  V30 20 C 10.7801 4.2073 0.0 0
M  V30 21 C 12.3201 1.5400 0.0 0
M  V30 22 N 12.3201 4.2073 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[6-[(methylamino)carbonyl]-3-pyridinyl]-1-piperazinecarbo...
C16H24N4O3
2589532-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 14.6302 2.8737 0.0 0
M  V30 9 N 15.4002 4.2073 0.0 0
M  V30 10 O 15.4002 1.5400 0.0 0
M  V30 11 C 16.9402 4.2073 0.0 0
M  V30 12 N 8.4701 2.8737 0.0 0
M  V30 13 C 7.7001 4.2073 0.0 0
M  V30 14 C 7.7001 1.5400 0.0 0
M  V30 15 C 6.1601 4.2073 0.0 0
M  V30 16 C 6.1601 1.5400 0.0 0
M  V30 17 N 5.3901 2.8737 0.0 0
M  V30 18 C 10.0101 2.8737 0.0 0
M  V30 19 C 10.7801 4.2073 0.0 0
M  V30 20 C 10.7801 1.5400 0.0 0
M  V30 21 C 12.3201 4.2073 0.0 0
M  V30 22 N 12.3201 1.5400 0.0 0
M  V30 23 C 13.0901 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 23
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354355-85-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2589532-06-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42575081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl picolinamide derivatives as PARP1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024178125 A1 2024-08-29

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22382388
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Highly Selective Sigma-2 Receptor Ligand,
1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one
(CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Intagliata, Sebastiano; Sharma, Abhisheak; King, Tamara I.; Mesangeau,
Christophe; Seminerio, Michael; Chin, Frederick T.; Wilson, Lisa L.;
Matsumoto, Rae R.; McLaughlin, Jay P.; Avery, Bonnie A.; McCurdy,
Christopher R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM AAPS Journal (2020), 22(5), 94

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2505630
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Potent and
selective p70S6 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bandarage, Upul; Hare, Brian; Parsons, Jonathan; Pham, Ly; Marhefka,
Craig; Bemis, Guy; Tang, Qing; Moody, Cameron Stuver; Rodems, Steve;
Shah, Sundeep; Adams, Chris; Bravo, Jose; Charonnet, Emmanuelle; Savic,
Vladimir; Come, Jon H.; Green, Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5191-5194

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2206469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors
based on tipifarnib scaffold: synthesis and activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Qun; Li, Tongmei; Woods, Keith W.; Gu, Wen-Zhen; Cohen, Jerry; Stoll,
Vincent S.; Galicia, Tomas; Hutchins, Charles; Frost, David; Rosenberg,
Saul H.; Sham, Hing L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(11), 2918-2922

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-(methylamino)-4-nitro-, methyl ester
C9H10N2O4
251643-13-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251643-13-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40576612
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of
Overcoming a Variety of FLT3 Mutations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhijie; Cai, Jiongheng; Ren, Jiwei; Chen, Yun; Wu, Yingli; Cheng,
Jie; Jia, Kun; Huang, Fei; Cheng, Zitian; Sheng, Tiancheng; Song, Shiyu;
Heng, Hao; Zhu, Yifan; Tang, Weifang; Li, Hongmei; Lu, Tao; Chen, Yadong;
Lu, Shuai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14664-14701

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trichloro-1-(1H-pyrrol-2-yl)ethanone
C6H4Cl3NO
35302-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 Cl 0.5637 0.9764 0.0 0
M  V30 5 Cl 0.0000 3.0801 0.0 0
M  V30 6 Cl 2.1037 3.6437 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.1621 3.8416 0.0 0
M  V30 9 N 5.4080 1.6836 0.0 0
M  V30 10 C 5.6686 4.1618 0.0 0
M  V30 11 C 6.4386 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-pyrrole-2-carboxamide
C6H8N2O
132911-42-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 N 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 35302-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132911-42-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-18205322
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective synthesis of N-substituted pyrrolo[1,2-a]pyrazin-1(2H)-one
derivatives via alkyne cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cetinkaya, Yasin; Balci, Metin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(49), 6698-6702

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
53484-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53484-26-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4270138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Bromo-N-methyl-2-nitroaniline (Intermediate 5)
4-Bromo-1-fluoro-2-nitrobenzene (1.50g, 6.82mmol) and K2CO3 (1.88g,
13.6mmol) were suspended in DCM (7mL). MeNH2 (40% in H2O, 7mL) was added
slowly and the mixture stirred at room temperature for 4h. The mixture
was diluted with H2O and extracted with DCM (3x40mL). The combined DCM
layers were washed with brine, dried (MgSO4), filtered and concentrated
to afford the product as a bright orange solid (1.47g, 93%).
4-Bromo-N-methyl-2-nitroaniline (Intermediate 5), Yield (1.47g, 93%). 1H
NMR (CDCl3): 8.32 (1 H, d, J 2.4), 8.03 (1 H, br s), 7.52 (1 H, dd, J 9.2
and 2.5), 6.76 (1 H, d, J 9.2) and 3.02 (3 H, d, J 4.2).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bibenzo[d]imidazoles and other biheteroaryl compounds as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wilson, Francis Xavier; Johnson, Peter David; Vickers, Richard; Storer,
Richard; Wynne, Graham Michael; Roach, Alan Geoffrey; De Moor, Olivier;
Dorgan, Colin Richard; Davis, Paul James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010063996 A2 2010-06-10

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethanol, 2-(2-hydroxyethoxy)-, 1-(4-methylbenzenesulfonate)
C11H16O5S
118591-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 5.3347 0.0 0 VAL=6
M  V30 2 O 6.1049 4.0011 0.0 0
M  V30 3 O 4.5649 6.6685 0.0 0
M  V30 4 O 6.6685 6.1047 0.0 0
M  V30 5 C 7.6449 4.0011 0.0 0
M  V30 6 C 8.4149 2.6674 0.0 0
M  V30 7 O 9.9549 2.6674 0.0 0
M  V30 8 C 10.7249 1.3338 0.0 0
M  V30 9 C 12.2649 1.3338 0.0 0
M  V30 10 O 13.0349 0.0000 0.0 0
M  V30 11 C 0.0000 2.2547 0.0 0
M  V30 12 C 4.0011 4.5647 0.0 0
M  V30 13 C 4.0011 3.0247 0.0 0
M  V30 14 C 2.6674 5.3347 0.0 0
M  V30 15 C 2.6674 2.2547 0.0 0
M  V30 16 C 1.3338 4.5647 0.0 0
M  V30 17 C 1.3338 3.0247 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[2-(Methylamino)ethoxy]ethanol
C5H13NO2
85475-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 O 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 N 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118591-58-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85475-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24506984
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional molecules useful as TEAD modulators for
treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zbieg, Jason Robert; Villemure, Elisia; Rudolph, Joachim; Beroza, Paul
Powell; Crawford, James John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021178339 A1 2021-09-10

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9074642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Ag-Cu bimetallic nanoparticle catalyst prepared and used, recyclable
catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bimetallic Ag-Cu alloy nanoparticles as a highly active catalyst for the
enamination of 1,3-dicarbonyl compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rout, Lipeeka; Kumar, Aniket; Dhaka, Rajendra S.; Dash, Priyabrat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(55), 49923-49940

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Oxa-6-azaspiro[2.5]octane-6-carboxylic acid, 1,1-dimethylethyl ester
C11H19NO3
147804-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 2.8737 0.0 0
M  V30 2 O 6.7237 1.5400 0.0 0
M  V30 3 O 6.7237 4.2073 0.0 0
M  V30 4 C 8.2637 1.5400 0.0 0
M  V30 5 C 8.2637 0.0000 0.0 0
M  V30 6 C 9.8037 1.5400 0.0 0
M  V30 7 C 8.2637 3.0800 0.0 0
M  V30 8 C 1.3337 2.8737 0.0 0
M  V30 9 C 0.0000 2.1037 0.0 0
M  V30 10 O 0.0000 3.6437 0.0 0
M  V30 11 C 2.1037 1.5400 0.0 0
M  V30 12 C 2.1037 4.2073 0.0 0
M  V30 13 C 3.6437 1.5400 0.0 0
M  V30 14 C 3.6437 4.2073 0.0 0
M  V30 15 N 4.4137 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-hydroxy-4-[(methylamino)methyl]-, 1,1-dimethyl...
C12H24N2O3
1073559-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6498 3.8636 0.0 0
M  V30 2 N 11.0968 3.3369 0.0 0
M  V30 3 C 12.2766 4.3268 0.0 0
M  V30 4 O 9.6498 1.8837 0.0 0
M  V30 5 C 3.8500 2.8736 0.0 0
M  V30 6 O 3.0800 1.5400 0.0 0
M  V30 7 O 3.0800 4.2074 0.0 0
M  V30 8 C 1.5400 1.5400 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 1.5400 3.0800 0.0 0
M  V30 12 C 8.4700 2.8736 0.0 0
M  V30 13 C 7.7000 4.2074 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 6.1600 4.2074 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 17 N 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147804-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1073559-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-22899855
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydroxylated derivatives of 1-oxa-4,9-diazaspiro undecane
compounds having multimodal analgesic activity against pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Virgili Bernado, Marina; Almansa Rosales, Carmen; Garcia Lopez, Monica
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020157026 A1 2020-08-06

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Oxa-6-azaspiro[2.5]octane-6-carboxylic acid, 1,1-dimethylethyl ester
C11H19NO3
147804-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 2.8737 0.0 0
M  V30 2 O 6.7237 1.5400 0.0 0
M  V30 3 O 6.7237 4.2073 0.0 0
M  V30 4 C 8.2637 1.5400 0.0 0
M  V30 5 C 8.2637 0.0000 0.0 0
M  V30 6 C 9.8037 1.5400 0.0 0
M  V30 7 C 8.2637 3.0800 0.0 0
M  V30 8 C 1.3337 2.8737 0.0 0
M  V30 9 C 0.0000 2.1037 0.0 0
M  V30 10 O 0.0000 3.6437 0.0 0
M  V30 11 C 2.1037 1.5400 0.0 0
M  V30 12 C 2.1037 4.2073 0.0 0
M  V30 13 C 3.6437 1.5400 0.0 0
M  V30 14 C 3.6437 4.2073 0.0 0
M  V30 15 N 4.4137 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 10
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-hydroxy-4-[(methylamino)methyl]-, 1,1-dimethyl...
C12H24N2O3
1073559-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6498 3.8636 0.0 0
M  V30 2 N 11.0968 3.3369 0.0 0
M  V30 3 C 12.2766 4.3268 0.0 0
M  V30 4 O 9.6498 1.8837 0.0 0
M  V30 5 C 3.8500 2.8736 0.0 0
M  V30 6 O 3.0800 1.5400 0.0 0
M  V30 7 O 3.0800 4.2074 0.0 0
M  V30 8 C 1.5400 1.5400 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 1.5400 3.0800 0.0 0
M  V30 12 C 8.4700 2.8736 0.0 0
M  V30 13 C 7.7000 4.2074 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 6.1600 4.2074 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 17 N 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 147804-30-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1073559-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-18587902
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazaspiro compounds for the treatment of drug abuse
and addiction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Virgili-Bernado, Marina; Almansa-Rosales, Carmen; Alegret-Molina, Carlos
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017084752 A1 2017-05-26

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-1,6-naphthyridine-2-carboxylic acid
C9H5BrN2O2
197507-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3336 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 N 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-1,6-naphthyridine-2-carboxamide
C10H8BrN3O
875514-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.6684 1.5400 0.0 0
M  V30 3 N 8.0022 2.3100 0.0 0
M  V30 4 O 6.6684 0.0000 0.0 0
M  V30 5 C 9.3359 1.5400 0.0 0
M  V30 6 C 2.6675 2.3100 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 N 4.0011 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 197507-55-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875514-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15652898
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted-Isoquinolines
with Potent, Selective Affinity for CDK8/19
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mallinger, Aurelie; Schiemann, Kai; Rink, Christian; Sejberg, Jimmy;
Honey, Mark A.; Czodrowski, Paul; Stubbs, Mark; Poeschke, Oliver; Busch,
Michael; Schneider, Richard; Schwarz, Daniel; Musil, Djordje; Burke,
Rosemary; Urbahns, Klaus; Workman, Paul; Wienke, Dirk; Clarke, Paul A.;
Raynaud, Florence I.; Eccles, Suzanne A.; Esdar, Christina; Rohdich,
Felix; Blagg, Julian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2016), 7(6), 573-578

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15449572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Chloro-N-methylpyridine-2-carboxamide (3). 2 (3.106 g, 18.10 mmol) was
dissolved in aqueous methylamine solution (40% w/v; 30 mL) at room
temperature. After stirring for 30 min, water (150 mL) was added, and the
aqueous solution was extracted with dichloromethane (3 × 100 mL). The
combined extracts were dried over Na2SO4 and concentrated. The residue
was purified by silica gel DCVC using stepwise gradient elution with
ethyl acetate/hexane (20:80 to 80:20, v/v). 2.872 g (93%) of 3 as a pale
yellow solid. Mp 38−39 °C (lit. mp 41−43 °C).14 1H NMR (400 MHz, DMSO-d
6): δ 8.83 (br, 1H), 8.60 (dd, J = 5.2, 0.8 Hz, 1H), 7.99 (dd, J = 2.4,
0.4 Hz, 1H), 7.73 (dd, J = 5.2, 2.4 Hz, 1H), 2.80 (d, J = 4.8 Hz, 3H).
13C NMR (100 MHz, DMSO-d 6): δ 163.6, 152.3, 150.4, 144.9, 126.7, 122.2,
26.5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cytochrome P450-Mediated Biotransformation of Sorafenib and Its N-Oxide
Metabolite: Implications for Cell Viability and Human Toxicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gillani, Tina B.; Rawling, Tristan; Murray, Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Research in Toxicology (2015), 28(1), 92-102

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-4-(3,4-Dichlorophenyl)-1-tetralone
C16H12Cl2O
124379-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14 CFG=1
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(4S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
312620-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0 CFG=2
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=1
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124379-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 312620-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10621616
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric reduction of substituted indanones and tetralones catalyzed by
chiral dendrimer and its application to the synthesis of (+)-sertraline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Guangyin; Zheng, Changwu; Zhao, Gang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2006), 17(14), 2074-2081

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloropretadalafil
C22H19ClN2O5
171489-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Tadalafil
C22H19N3O4
171596-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171489-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171596-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9608876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example: Preparation of Tadalafil Methyl amine solution (25% in methanol,
163 ml) is added to a suspension of (6R,12aR)-Methyl
1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxy
phenyl)-9H-pyrido[3,4-b]indole-3-carboxylate (Chloro acetyl intermediate)
(79 g) in methanol (790 ml). Temperature of the reaction mass is raised
and maintained at 50°C to 55°C for 6 hrs. The reaction mass is then
cooled and maintained at 25°C to 30°C for 1 hr, filtered, washed with
methanol (50 ml) and dried at 45°C to 50°C. Dry wt of the crude Tadalafil
is 67 g (92.5 % yield).
$DTYPE RXN:VAR(1):NOTES
$DATUM work-up and purification given
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of Tadalafil
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Satyanarayana, Chava; Ramanjaneyulu, Gorantla Seeta; Rao, Gogulapati
Venkata Panakala
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005116030 A1 2005-12-08

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloropyrimidine
C4H2BrClN2
32779-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 N 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(methylamino)pyrimidine
C5H6BrN3
31402-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 N 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32779-36-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 31402-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3784919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 2-Aminomethyl-5-bromopyrimidine Methylamine (2.0 M in
methanol, 40 mL, 80mmol) was added to 5-bromo-2-chloropyrimidine (5.6 g,
29.0 mmol) in a scalable reaction vessel. After allowing to vent for a
few minutes, the vessel was sealed, placed behind a safety shield and
heated in a 115 °C oil bath for 48 hours. Upon cooling the volatiles were
removed in vacuo. The material was dissolved in CH2Cl2 (200 mL) and
washed with 1M NaOH (40 mL). The aqueous layer was extracted further with
CH2Cl2 (2x50 mL). The combined organics were dried over MgSO4, filtered
and concentrated yielding an off white solid (5.1 g, 93%).
2-Aminomethyl-5-bromopyrimidine, Yield (5.1 g, 93%). LCMS (m/z):
188.0/190.0 (MH+).
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrimidine derivatives used as PI-3 kinase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pick, Teresa; Barsanti, Paul; Iwanowicz, Edwin; Fantl, Wendy;
Hendryckson, Tom; Knapp, Mark; Meritt, Hanne; Voliva, Charles; Wiesmann,
Marion; Xin, Xiahua; Burger, Matthew; Ni, Zhi-Jie; Pecchi, Sabina;
Atallah, Gordana; Bartullis, Sarah; Frazier, Kelly; Smith, Aaron;
Verhagen, Joelle; Zhang, Yanchen; Wagman, Allan; Ng, Simon; Pfister,
Keith; Poon, Daniel; Louie, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007084786 A1 2007-07-26

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
329-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-methyl-4-(trifluoromethyl)-
C9H8F3NO
65017-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65017-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11774122
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quantitative insights into energy contributions of intermolecular
interactions in fluorine and trifluoromethyl substituted isomeric
N-phenylacetamides and N-methylbenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Panini, Piyush; Chopra, Deepak
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM CrystEngComm (2013), 15(18), 3711-3733

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(1S)-2-cyclopropyl-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-...
C15H27NO3S3
1203455-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.2073 0.0 0 CFG=1
M  V30 2 C 6.1600 2.8736 0.0 0
M  V30 3 N 3.8500 4.2073 0.0 0
M  V30 4 S 3.0800 5.5411 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 5.5411 0.0 0
M  V30 6 O 3.8500 6.8747 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 5.5411 0.0 0
M  V30 9 C 1.5400 7.0811 0.0 0
M  V30 10 C 7.4060 4.6359 0.0 0
M  V30 11 O 8.8128 5.2622 0.0 0
M  V30 12 O 7.2449 3.1042 0.0 0
M  V30 13 C 10.0587 4.3570 0.0 0
M  V30 14 C 11.4656 4.9834 0.0 0
M  V30 15 C 6.1600 5.5411 0.0 0
M  V30 16 S 7.1906 6.6854 0.0 0
M  V30 17 S 4.7532 6.1674 0.0 0
M  V30 18 C 6.4206 8.0191 0.0 0
M  V30 19 C 4.9141 7.6989 0.0 0
M  V30 20 C 5.3900 1.5400 0.0 0
M  V30 21 C 4.0564 0.7700 0.0 0
M  V30 22 C 5.3900 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 1 4 5 CFG=3
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 15
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[(1S)-2-Cyclopropyl-1-[[(S)-(1,1-dimethylethyl)sulfinyl]amino]ethyl]-N-meth...
C14H26N2O2S3
1203455-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.2073 0.0 0 CFG=1
M  V30 2 C 6.1600 2.8737 0.0 0
M  V30 3 N 3.8500 4.2073 0.0 0
M  V30 4 S 3.0800 5.5411 0.0 0 CFG=1 VAL=4
M  V30 5 C 1.5400 5.5411 0.0 0
M  V30 6 O 3.8500 6.8747 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 5.5411 0.0 0
M  V30 9 C 1.5400 7.0811 0.0 0
M  V30 10 C 7.4059 4.6359 0.0 0
M  V30 11 N 8.8128 5.2622 0.0 0
M  V30 12 O 7.2450 3.1042 0.0 0
M  V30 13 C 10.0587 4.3570 0.0 0
M  V30 14 C 6.1600 5.5411 0.0 0
M  V30 15 S 4.7532 6.1674 0.0 0
M  V30 16 S 7.1905 6.6855 0.0 0
M  V30 17 C 4.9142 7.6990 0.0 0
M  V30 18 C 6.4204 8.0191 0.0 0
M  V30 19 C 5.3900 1.5400 0.0 0
M  V30 20 C 5.3900 0.0000 0.0 0
M  V30 21 C 4.0564 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 1 4 5 CFG=3
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1203455-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1203455-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3414933
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 8: Preparation of
(S,s)-2-[1-(tert-butylsulfinylamino)-2-cyclopropylethyl]-N-methyl-1,3-dithiolane-2-carboxamide.
A heavy-walled glass tube was charged with ethyl
(S,Ss)-2-[1-(tert-butylsulfinylamino)-2-cyclopropylethyl]-1,3-dithiolane-2-carboxylate
(2.00 g, 5.47 mmol) and a chilled 8.0 M solution of methylamine in
ethanol (5 mL, 40 mmol). The mixture was allowed to warm to room
temperature and was stirred for 2 hours at which time reaction was
complete by HPLC analysis. Distillation of the solvent at reduced
pressure afforded the title compound (1.79 g, 93%) as an amber glass.
1H-NMR (500 MHz, DMSO-d6): δ 7.38 (s, 1 H), 4.06-4.00 (m, 2 H), 3.97-3.88
(m, 1 H), 3.45-3.40 (m, 1 H), 3.34-2.95 (m, 2 H), 2.77 (s, 3 H) 1.60-1.54
(m, 1 H), 1.15 (s, 9H), 1.05-0.99 (m, 1 H), 0.83-0.74 (m, 1 H), 0.46-0.40
(m, 1 H), 0.35-0.30 (m, 1 H), 0.06-0,03 (m, 2 H). 13C-NMR (125 MHz,
DMSO-d6): δ 171.0, 77.2, 63.2, 56.0, 40.1, 39.9, 26.8, 22.5, 9.1, 5.9,
4.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for the preparation of protected α-keto-β-amino ester and amide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nugent, William A.; Looker, Adam R.; Forslund, Raymond E.; Martinot,
Theodore A.; Harrison, Cristian L.; Ibrahim, Sheree
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010002474 A1 2010-01-07

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-nitro-, methyl ester
C8H6ClNO4
14719-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14719-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16652551
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (methylamine and THF)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as PAD4 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amans, Dominique; Atkinson, Stephen John; Barker, Michael David;
Campbell, Matthew; Diallo, Hawa; Douault, Clement; Garton, Neil Stuart;
Liddle, John; Renaux, Jessica Fanny; Sheppard, Robert John; Walker, Ann
Louise; Wellaway, Christopher Roland; Wilson, David Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016185279 A1 2016-11-24

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3-nitro-, methyl ester
C8H6ClNO4
14719-83-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 Cl 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14719-83-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7903004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Barker, Michael David; Campbell, Matthew; Diallo,
Hawa; Douault, Clement; Garton, Neil Stuart; Liddle, John; Sheppard,
Robert John; Walker, Ann Louise; Wellaway, Christopher; Wilson, David
Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014015905 A1 2014-01-30

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-(Methylimino)bis[propanenitrile]
C7H11N3
1555-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 N 0.0000 3.0801 0.0 0
M  V30 10 N 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 3 7 9
M  V30 9 3 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1555-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1639116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrile-functionalized tertiary amines as highly efficient and reversible
SO2 absorbents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hong, Sung Yun; Kim, Heehwan; Kim, Young Jin; Jeong, Junkyo; Cheong,
Minserk; Lee, Hyunjoo; Kim, Hoon Sik; Lee, Je Seung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Hazardous Materials (2014), 264136-143

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Benzyloxy)-2-(hydroxymethyl)-4-pyrone
C13H12O4
15771-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 11.5500 2.6674 0.0 0
M  V30 5 O 12.3200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 O 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 2 3 7
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-1-methyl-5-(phenylmethoxy)-4(1H)-pyridinone
C14H15NO3
89539-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 6.9300 0.0000 0.0 0
M  V30 4 C 10.0100 5.3349 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 O 12.3200 1.3338 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 9.2400 1.3338 0.0 0
M  V30 11 N 9.2400 4.0011 0.0 0
M  V30 12 C 10.0100 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 2.3100 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 0.7700 5.3349 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15771-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89539-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35491675
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown,key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Pqs Quorum Sensing System Inhibitor as an Antibacterial Synergist
against Multidrug-Resistant Pseudomonas aeruginosa
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Jun; Hou, Jin-Song; Chang, Yi-Qun; Peng, Li-Jun; Zhang, Xiao-Yi;
Miao, Zhi-Ying; Sun, Ping-Hua; Lin, Jing; Chen, Wei-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(1), 688-709

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenesulfonamide
C7H8N2O4S
23530-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0 VAL=6
M  V30 2 N 5.3900 5.3349 0.0 0
M  V30 3 O 5.9536 3.2311 0.0 0
M  V30 4 O 3.2864 4.7711 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 7 O 2.3100 5.3349 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 1.5400 1.3338 0.0 0
M  V30 13 C 3.8500 0.0000 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 10
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23530-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20731458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Unified Approach to the Chemoselective α-Functionalization of Amides
with Heteroatom Nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goncalves, Carlos R.; Lemmerer, Miran; Teskey, Christopher J.; Adler,
Pauline; Kaiser, Daniel; Maryasin, Boris; Gonzalez, Leticia; Maulide,
Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2019), 141(46), 18437-18443

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzamide
C8H7FN2O3
915087-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915087-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19319214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solid state forms of Apalutamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Muthusamy, Anantha Rajmohan; Kanniah, Sundara Lakshmi; Arote, Nitin
Dnyaneshwar; Bhagwat, Omkar Vilas; Sonar, Jitendra Kamalakar; Poundkar,
Vitthal Baburao; Wagh, Yogesh Dhananjay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018112001 A1 2018-06-21

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,7aR)-7-(2-Bromoethyl)-3a,4,5,7a-tetrahydro-2,2-dimethyl-1,3-benzodioxole
C11H17BrO2
1315613-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 C 7.3176 3.9437 0.0 0
M  V30 3 Br 8.6512 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3164 3.1737 0.0 0 CFG=2
M  V30 7 C 1.9828 3.9437 0.0 0 CFG=2
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 O 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4837 0.0 0
M  V30 12 C 4.6501 5.4837 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3164 6.2537 0.0 0
M  V30 15 H 4.5623 2.2685 0.0 0
M  V30 16 H 0.5758 4.5700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 16 CFG=3
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,7aS)-3a,6,7,7a-Tetrahydro-N,2,2-trimethyl-1,3-benzodioxole-4-ethanamine
C12H21NO2
1315613-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2536 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 N 8.5637 5.3349 0.0 0
M  V30 4 C 10.1037 5.3349 0.0 0
M  V30 5 C 0.0000 2.8653 0.0 0
M  V30 6 C 1.0304 4.6502 0.0 0
M  V30 7 C 3.9436 2.6674 0.0 0 CFG=2
M  V30 8 C 3.1736 1.3338 0.0 0 CFG=2
M  V30 9 C 5.4836 2.6674 0.0 0
M  V30 10 O 2.9132 3.8118 0.0 0
M  V30 11 O 1.6674 1.6540 0.0 0
M  V30 12 C 3.9436 0.0000 0.0 0
M  V30 13 C 6.2536 1.3338 0.0 0
M  V30 14 C 1.5063 3.1855 0.0 0
M  V30 15 C 5.4836 0.0000 0.0 0
M  V30 16 H 4.5700 4.0742 0.0 0
M  V30 17 H 2.2684 0.0879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 17 CFG=1
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315613-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315613-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16297876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic Total Synthesis of Hydromorphone by an Oxidative
Dearomatization/Intramolecular [4 + 2] Cycloaddition Sequence: A
Second-Generation Approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rycek, Lukas; Hayward, John J.; Abdel Latif, Marwa; Tanko, James;
Simionescu, Razvan; Hudlicky, Tomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(22), 10930-10941

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,7aR)-7-(2-Bromoethyl)-3a,4,5,7a-tetrahydro-2,2-dimethyl-1,3-benzodioxole
C11H17BrO2
1315613-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 C 7.3176 3.9437 0.0 0
M  V30 3 Br 8.6512 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3164 3.1737 0.0 0 CFG=2
M  V30 7 C 1.9828 3.9437 0.0 0 CFG=2
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 O 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4837 0.0 0
M  V30 12 C 4.6501 5.4837 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3164 6.2537 0.0 0
M  V30 15 H 4.5623 2.2685 0.0 0
M  V30 16 H 0.5758 4.5700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 16 CFG=3
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,7aS)-3a,6,7,7a-Tetrahydro-N,2,2-trimethyl-1,3-benzodioxole-4-ethanamine
C12H21NO2
1315613-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2536 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 N 8.5637 5.3349 0.0 0
M  V30 4 C 10.1037 5.3349 0.0 0
M  V30 5 C 0.0000 2.8653 0.0 0
M  V30 6 C 1.0304 4.6502 0.0 0
M  V30 7 C 3.9436 2.6674 0.0 0 CFG=2
M  V30 8 C 3.1736 1.3338 0.0 0 CFG=2
M  V30 9 C 5.4836 2.6674 0.0 0
M  V30 10 O 2.9132 3.8118 0.0 0
M  V30 11 O 1.6674 1.6540 0.0 0
M  V30 12 C 3.9436 0.0000 0.0 0
M  V30 13 C 6.2536 1.3338 0.0 0
M  V30 14 C 1.5063 3.1855 0.0 0
M  V30 15 C 5.4836 0.0000 0.0 0
M  V30 16 H 4.5700 4.0742 0.0 0
M  V30 17 H 2.2684 0.0879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 17 CFG=1
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315613-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315613-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16774240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of morphine compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Varghese, Vimal; Hudlicky, Tomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150239860 A1 2015-08-27

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3aS,9aS)-1-[(1,1-dimethylethoxy)carbonyl]-1,2,3,3a,4,7,9,9a-octahydro...
C17H26N2O5
1000049-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8738 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2074 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 O 5.3709 4.0607 0.0 0
M  V30 9 C 7.9566 4.9009 0.0 0
M  V30 10 C 9.4709 5.1815 0.0 0
M  V30 11 O 10.4709 4.0105 0.0 0
M  V30 12 O 9.9849 6.6331 0.0 0
M  V30 13 C 11.9852 4.2911 0.0 0
M  V30 14 C 4.1197 6.2952 0.0 0 CFG=2
M  V30 15 N 2.8738 5.3900 0.0 0
M  V30 16 C 3.6438 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4918 5.5961 0.0 0
M  V30 18 C 1.6279 6.2952 0.0 0
M  V30 19 C 2.1038 7.7598 0.0 0
M  V30 20 C 4.3430 9.1319 0.0 0
M  V30 21 N 6.9565 6.0719 0.0 0
M  V30 22 C 5.8075 9.6078 0.0 0
M  V30 23 C 7.6555 7.4441 0.0 0
M  V30 24 C 7.1796 8.9086 0.0 0
M  V30 25 H 4.2404 4.7598 0.0 0
M  V30 26 H 2.8391 9.0728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 25 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 26 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3aS,9aS)-2,3,3a,4,7,8,9,9a-octahydro-8-[2-(methylamino)-2-...
C17H27N3O4
1000049-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8738 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2074 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 O 5.3709 4.0607 0.0 0
M  V30 9 C 7.9566 4.9009 0.0 0
M  V30 10 C 9.4709 5.1815 0.0 0
M  V30 11 N 10.4709 4.0105 0.0 0
M  V30 12 O 9.9849 6.6331 0.0 0
M  V30 13 C 11.9852 4.2911 0.0 0
M  V30 14 C 4.1197 6.2952 0.0 0 CFG=2
M  V30 15 N 2.8738 5.3900 0.0 0
M  V30 16 C 3.6438 7.7598 0.0 0 CFG=1
M  V30 17 C 5.4918 5.5961 0.0 0
M  V30 18 C 1.6279 6.2952 0.0 0
M  V30 19 C 2.1038 7.7598 0.0 0
M  V30 20 C 4.3430 9.1319 0.0 0
M  V30 21 N 6.9563 6.0719 0.0 0
M  V30 22 C 5.8075 9.6078 0.0 0
M  V30 23 C 7.6555 7.4441 0.0 0
M  V30 24 C 7.1796 8.9086 0.0 0
M  V30 25 H 4.2404 4.7598 0.0 0
M  V30 26 H 2.8391 9.0728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 17
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 25 CFG=3
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 26 CFG=1
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1000049-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000049-40-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-36024
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: tert-Butyl
(3aR,8aS)-7-(2-Methoxy-2-oxoethyl)-8-oxo-3,3a,6,7,8,-
8a-hexahydropyrrolo[2,3-c]azepine-1(2H)-carboxylate (11a). Diene 10a (5.0
mg, 0.0142 mmol, see Supporting Information) was dissolved in CH2Cl2 (7
mL), and a solution of the Grubbs’ catalyst of the second generation (I,
0.6 mg)22 in CH2Cl2 (0.5 mL) was added. The mixture was stirred for 2 h
under reflux conditions, and then silica gel (50 mg) was added.
Evaporation and subsequent flash chromatography (petrol ether-EtOAc, 1:1)
of the residue afforded 11a (3.5 mg, 76%) as a colorless oil. tert-Butyl
(3aS,9aS)-8-[2-(Methylamino)-2-oxoethyl)]-9-oxo-
2,3,3a,4,7,8,9,9a-octahydro-1H-pyrrolo[2,3-c]azocine-1-carboxylate (3d).
Aminolysis of 11d (4.0 mg, 0.0118 mmol) was analogously performed with
methyl amine in EtOH (1 mL, 8.03 M) as described for 11a. Reaction time:
1 h. Column chromatography (CH2Cl2-MeOH 97:3) gave 3d (3.7 mg, 93%) as a
colorless oil. [α]D 20 -200.9° (c = 0.492, CHCl3); IR (film) 3366, 1690,
1667 cm-1; 1H NMR δ 1.39 (s, 1.8H, t-Bu, first conf.), 1.46 (s, 7.2H,
t-Bu, second conf.), 1.61-1.75 (m, 1H, H-3), 1.90-2.05 (m, 2H,
H-3′/H-3a), 2.33-2.45 (m, 2H, H-4/H-4′.), 2.75 and 2.77 (2Χ d, J = 4.9
and 4.7 Hz, 3H, HNCH 3, conf.), 3.38 (ddd, J = 11.7, 10.6, 5.3 Hz, 1H,
H-2), 3.42 and 3.59 (2Χ dd, J = 15.0, 7.3 Hz and 15.7, 6.6 Hz, 1H, H-7, 2
conf.), 3.62 (d, J = 16.2 Hz, 0.8 H, NCH2, second conf.), 3.66 and 3.79
(2Χ dd, each J = 10.7, 7.9 Hz, 1H, H-2′, 2 conf.), 3.97 (d, J = 14.5 Hz,
0.2 H, NCH2, first conf.), 4.03 (d, J = 14.5 Hz, 0.2 H, NCH2, first
conf.), 4.39 and 4.48 (2Χ dd, J = 15.0, 9.1 Hz and 15.7, 9.2 Hz, 1, H-7′,
2 conf.), 4.52 (d, J = 16.2 Hz, 0.8 H, NCH2, second conf.), 4.52 (d, J =
9.1 Hz, 1 H, H-9a), 5.87-6.02 (m, 2H, H-5/H-6), 6.64 (s, 0.2H, HNCH3,
first conf.), 6.92 (s, 0.8H, HNCH3, second conf.); 13C NMR δ 26.0, 26.1
(HNCH3, conf.), 28.3, 28.4 (C(CH3)3, conf.), 31.2, 31.6, (C-4, conf.)
33.1, 33.4 (C-3, conf.), 41.4 (C-3a), 45.2, 45.6 (C-7, conf.), 46.1, 46.6
(C-2, conf.), 51.9, 52.6 (NCH2, conf.), 64.4, 64.8 (C-9a), 79.7, 80.1
(C(CH3)3), 128.9, 129.3 (C-6, conf.), 133.6, 134.5 (C-5, conf.), 153.4,
154.4 (COOtBu, conf.), 169.5, 170.2 (HNCH3, conf.), 172.9, 173.3 (C-9,
conf.); EIMS 337 [M+]. Anal. Calcd for C17H27N3O4 (337.42): C, 60.51; H,
8.07; N, 12.45. Found: C, 60.64; H, 8.05; N, 12.44.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular Building Kit of Fused-Proline-Derived Peptide Mimetics Allowing
Specific Adjustment of the Dihedral Ψ Angle
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Einsiedel, Juergen; Lanig, Harald; Waibel, Reiner; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(24), 9102-9113

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-nitrobenzene
C6H4ClNO2
100-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitroaniline
C7H8N2O2
100-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7348180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 44: Methyl-(4-nitro-phenyl)-amine.
1-Chloro-4-nitro-benzene (5.0 g, 31.7 mmol) was added to excess aqueous
methylamine solution (40%, 30 mL) and heated in a pressure bomb for 16 h.
The reaction mass was cooled to room temperature and a solid filtered
off. The filtrate was evaporated to dryness and the combined solids were
purified by trituration with pentane to afford
methyl-(4-nitro-phenyl)-amine (4.5 g, 93%) as a solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolizine compounds for use in antifungal combination
therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Birch, Michael; Sibley, Graham Edward Morris; Law, Derek; Oliver, Jason
David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009144473 A1 2009-12-03

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-nitrobenzene
C6H4ClNO2
100-00-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitroaniline
C7H8N2O2
100-15-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-00-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-15-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11499246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 44: Methyl-(4-nitro-phenyl)-amine.
1-Chloro-4-nitro-benzene (5.0 g, 31.7 mmol) was added to excess aqueous
methylamine solution-(40%, 30 mL) and heated in a pressure bomb for 16 h.
The reaction mass was cooled to room temperature and a solid filtered
off. The filtrate was evaporated to dryness and the combined solids were
purified by trituration with pentane to afford
methyl-(4-nitro-phenyl)-amine (4.5 g, 93%) as a solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-[(2-Substituted)-indolizolin-3-yl]-2-oxoacetamide derivatives as
antifungal agents and their preparation, pharmaceutical and agricultural
compositions and use in the treatment of fungal diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Downham, Robert; Sibley, Graham Edward Morris; Payne, Lloyd James;
Edwards, Philip; Davies, Gareth Morse
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008062182 A1 2008-05-29

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2R)-2-(4-Bromophenyl)-2-chloroethyl]morpholine
C12H15BrClNO
1003878-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0 CFG=1
M  V30 2 C 4.6201 1.3337 0.0 0
M  V30 3 Cl 4.6201 4.0010 0.0 0
M  V30 4 Br 11.5503 2.6673 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 7.7002 1.3337 0.0 0
M  V30 7 C 7.7002 4.0010 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 10.0102 2.6673 0.0 0
M  V30 11 N 3.0801 1.3337 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 2.3101 2.6673 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.7700 2.6673 0.0 0
M  V30 16 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αR)-α-(4-Bromophenyl)-N-methyl-4-morpholineethanamine
C13H19BrN2O
1003878-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0 CFG=1
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0
M  V30 4 C 5.3900 0.0000 0.0 0
M  V30 5 Br 11.5500 2.6674 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 N 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1003878-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003878-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12459610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) [(1R)-1-(4-bromophenyl)-2-(4-morpholinyl)ethyl]methylamine Crude
4-[(2R)-2-(4-Bromophenyl)-2-chloroethyl]morpholine (34.5 g) was dissolved
in 200 mL of EtOH at room temperature with magnetic stirring. The
resulting solution was cooled to 0°C. and treated with MeNH2 (71 mL, 33
wt % in EtOH) under N2. The reaction flask was capped with a rubber
septum and the reaction mixture maintained at room temperature for 48 h.
The mixture was then concentrated and the residue was partitioned between
EtOAc and saturated aqueous NaHCO3. The organic layer was washed with
brine, dried over MgSO4, and filtered. The filtrate was concentrated to
yield the title compound as a yellow solid (32 g, 93%). MS (ES) m/e 300
[M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[1-biphenylyl-(morpholinyl- and
pyrrolidinyl)ethyl]glycinamide derivatives as antagonists of urotensin II
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Neeb, Michael J.; Sehon, Clark A.; Viet, Andrew Q.; Goodman, Krista B.;
Wang, Gren Z.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008011551 A1 2008-01-24

$RFMT $RIREG SCHEME229 STEP1
$RXN



  3  1
$MOL
Thiocarbonyldiimidazole
C7H6N4S
6160-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 S 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-C-Methyl-2′,3′-O-(1-methylethylidene)-N-[(3R)-tetrahydro-3-furanyl]adenosine
C18H25N5O5
1010382-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7138 6.3487 0.0 0
M  V30 2 C 3.8841 1.0304 0.0 0
M  V30 3 O 5.0284 0.0000 0.0 0
M  V30 4 C 1.0306 6.9976 0.0 0
M  V30 5 C 0.0000 5.2128 0.0 0
M  V30 6 N 11.1809 8.0724 0.0 0
M  V30 7 C 5.4501 4.6947 0.0 0 CFG=2
M  V30 8 C 3.9438 5.0149 0.0 0 CFG=1
M  V30 9 O 5.6110 3.1632 0.0 0
M  V30 10 C 3.1738 3.6812 0.0 0 CFG=2
M  V30 11 O 2.9132 6.1594 0.0 0
M  V30 12 C 4.2042 2.5369 0.0 0 CFG=2
M  V30 13 O 1.6674 4.0014 0.0 0
M  V30 14 C 1.5064 5.5329 0.0 0
M  V30 15 N 6.5946 5.7253 0.0 0
M  V30 16 C 8.1009 5.4050 0.0 0
M  V30 17 C 6.4335 7.2568 0.0 0
M  V30 18 C 8.8709 6.7388 0.0 0
M  V30 19 N 8.8709 4.0713 0.0 0
M  V30 20 N 7.8405 7.8831 0.0 0
M  V30 21 C 10.4109 6.7388 0.0 0
M  V30 22 C 10.4109 4.0713 0.0 0
M  V30 23 N 11.1809 5.4050 0.0 0
M  V30 24 C 12.7209 8.0724 0.0 0 CFG=1
M  V30 25 C 13.6261 6.8265 0.0 0
M  V30 26 C 13.6261 9.3183 0.0 0
M  V30 27 C 15.0908 7.3024 0.0 0
M  V30 28 O 15.0908 8.8424 0.0 0
M  V30 29 H 2.4038 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 12 2 CFG=3
M  V30 4 1 4 14
M  V30 5 1 5 14
M  V30 6 1 6 21
M  V30 7 1 24 6 CFG=1
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 15 CFG=3
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 10 29 CFG=3
M  V30 17 1 11 14
M  V30 18 1 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 16 19
M  V30 23 2 17 20
M  V30 24 1 18 20
M  V30 25 2 18 21
M  V30 26 1 19 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 10 12 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, 2′-C-methyl-2′,3′-O-(1-methylethylidene)-N-[(3R)-tetrahydro-3-fura...
C20H28N6O5S
1010382-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4388 9.4091 0.0 0
M  V30 2 C 2.0610 5.2182 0.0 0
M  V30 3 O 2.5369 3.7537 0.0 0
M  V30 4 C 1.5065 2.6091 0.0 0
M  V30 5 N 1.9823 1.1446 0.0 0
M  V30 6 S 0.0000 2.9295 0.0 0
M  V30 7 C 0.9519 0.0000 0.0 0
M  V30 8 C 2.5734 11.8130 0.0 0
M  V30 9 C 0.7887 10.7824 0.0 0
M  V30 10 N 11.9015 7.6684 0.0 0
M  V30 11 C 5.2495 7.6087 0.0 0 CFG=2
M  V30 12 C 4.1050 8.6391 0.0 0 CFG=1
M  V30 13 O 4.6232 6.2019 0.0 0
M  V30 14 C 2.7713 7.8691 0.0 0 CFG=2
M  V30 15 O 3.7848 10.1456 0.0 0
M  V30 16 C 3.0915 6.3628 0.0 0 CFG=2
M  V30 17 O 1.6269 8.8997 0.0 0
M  V30 18 C 2.2532 10.3065 0.0 0
M  V30 19 N 6.7558 7.9289 0.0 0
M  V30 20 C 7.9004 6.8984 0.0 0
M  V30 21 C 7.3823 9.3358 0.0 0
M  V30 22 C 9.2340 7.6684 0.0 0
M  V30 23 N 7.9004 5.3584 0.0 0
M  V30 24 N 8.9139 9.1748 0.0 0
M  V30 25 C 10.5677 6.8984 0.0 0
M  V30 26 C 9.2340 4.5884 0.0 0
M  V30 27 N 10.5677 5.3584 0.0 0
M  V30 28 C 13.2352 6.8984 0.0 0 CFG=1
M  V30 29 C 14.6420 7.5248 0.0 0
M  V30 30 C 13.3961 5.3669 0.0 0
M  V30 31 C 15.6726 6.3804 0.0 0
M  V30 32 O 14.9026 5.0467 0.0 0
M  V30 33 H 1.4376 7.0991 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 1 9 18
M  V30 10 1 10 25
M  V30 11 1 28 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 19 CFG=3
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 14 33 CFG=3
M  V30 21 1 15 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 2 21 24
M  V30 28 1 22 24
M  V30 29 2 22 25
M  V30 30 1 23 26
M  V30 31 1 25 27
M  V30 32 2 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 14 16 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6160-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1010382-32-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1010382-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-9793920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective
A1 adenosine receptor agonists: Affinity, efficacy, and selectivity for
A1 receptor from different species
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cappellacci, Loredana; Franchetti, Palmarisa; Vita, Patrizia; Petrelli,
Riccardo; Lavecchia, Antonio; Costa, Barbara; Spinetti, Francesca;
Martini, Claudia; Klotz, Karl-Norbert; Grifantini, Mario
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(1), 336-353

$RFMT $RIREG SCHEME230 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-2′-C-methyl-2′,3′-O-(1-methylethylidene)-N-[(3R)-tetrahydro-3-furany...
C18H24ClN5O5
1010382-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7138 6.3487 0.0 0
M  V30 2 C 3.8841 1.0304 0.0 0
M  V30 3 O 5.0284 0.0000 0.0 0
M  V30 4 C 1.0306 6.9976 0.0 0
M  V30 5 C 0.0000 5.2128 0.0 0
M  V30 6 N 11.1809 8.0724 0.0 0
M  V30 7 Cl 11.1809 2.7377 0.0 0
M  V30 8 C 5.4501 4.6947 0.0 0 CFG=2
M  V30 9 C 3.9438 5.0149 0.0 0 CFG=1
M  V30 10 O 5.6110 3.1632 0.0 0
M  V30 11 C 3.1738 3.6812 0.0 0 CFG=2
M  V30 12 O 2.9132 6.1594 0.0 0
M  V30 13 C 4.2042 2.5369 0.0 0 CFG=2
M  V30 14 O 1.6674 4.0014 0.0 0
M  V30 15 C 1.5064 5.5329 0.0 0
M  V30 16 N 6.5946 5.7253 0.0 0
M  V30 17 C 8.1009 5.4050 0.0 0
M  V30 18 C 6.4335 7.2568 0.0 0
M  V30 19 C 8.8709 6.7388 0.0 0
M  V30 20 N 8.8709 4.0713 0.0 0
M  V30 21 N 7.8405 7.8831 0.0 0
M  V30 22 C 10.4109 6.7388 0.0 0
M  V30 23 C 10.4109 4.0713 0.0 0
M  V30 24 N 11.1809 5.4050 0.0 0
M  V30 25 C 12.7209 8.0724 0.0 0 CFG=1
M  V30 26 C 13.6261 6.8265 0.0 0
M  V30 27 C 13.6261 9.3183 0.0 0
M  V30 28 C 15.0908 7.3024 0.0 0
M  V30 29 O 15.0908 8.8424 0.0 0
M  V30 30 H 2.4038 2.3476 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 13 2 CFG=3
M  V30 4 1 4 15
M  V30 5 1 5 15
M  V30 6 1 6 22
M  V30 7 1 25 6 CFG=1
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 16 CFG=3
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 11 30 CFG=3
M  V30 18 1 12 15
M  V30 19 1 14 15
M  V30 20 1 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 17 20
M  V30 24 2 18 21
M  V30 25 1 19 21
M  V30 26 2 19 22
M  V30 27 1 20 23
M  V30 28 1 22 24
M  V30 29 2 23 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 11 13 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, 2-chloro-2′-C-methyl-2′,3′-O-(1-methylethylidene)-N-[(3R)-tetrahyd...
C20H27ClN6O6
1010382-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4388 9.4091 0.0 0
M  V30 2 C 2.0610 5.2182 0.0 0
M  V30 3 O 2.5369 3.7537 0.0 0
M  V30 4 C 1.5065 2.6091 0.0 0
M  V30 5 N 1.9823 1.1445 0.0 0
M  V30 6 O 0.0000 2.9294 0.0 0
M  V30 7 C 0.9519 0.0000 0.0 0
M  V30 8 C 2.5734 11.8129 0.0 0
M  V30 9 C 0.7886 10.7824 0.0 0
M  V30 10 N 11.9015 7.6684 0.0 0
M  V30 11 Cl 9.2340 3.0483 0.0 0
M  V30 12 C 5.2495 7.6087 0.0 0 CFG=2
M  V30 13 C 4.1049 8.6391 0.0 0 CFG=1
M  V30 14 O 4.6232 6.2018 0.0 0
M  V30 15 C 2.7713 7.8691 0.0 0 CFG=2
M  V30 16 O 3.7848 10.1455 0.0 0
M  V30 17 C 3.0915 6.3628 0.0 0 CFG=2
M  V30 18 O 1.6269 8.8997 0.0 0
M  V30 19 C 2.2532 10.3065 0.0 0
M  V30 20 N 6.7558 7.9288 0.0 0
M  V30 21 C 7.9003 6.8984 0.0 0
M  V30 22 C 7.3823 9.3358 0.0 0
M  V30 23 C 9.2340 7.6684 0.0 0
M  V30 24 N 7.9003 5.3584 0.0 0
M  V30 25 N 8.9138 9.1747 0.0 0
M  V30 26 C 10.5677 6.8984 0.0 0
M  V30 27 C 9.2340 4.5884 0.0 0
M  V30 28 N 10.5677 5.3584 0.0 0
M  V30 29 C 13.2352 6.8984 0.0 0 CFG=1
M  V30 30 C 14.6420 7.5247 0.0 0
M  V30 31 C 13.3961 5.3668 0.0 0
M  V30 32 C 15.6726 6.3803 0.0 0
M  V30 33 O 14.9025 5.0467 0.0 0
M  V30 34 H 1.4376 7.0991 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 13 1 CFG=3
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 19
M  V30 9 1 9 19
M  V30 10 1 10 26
M  V30 11 1 29 10 CFG=3
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 20 CFG=3
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 15 34 CFG=3
M  V30 22 1 16 19
M  V30 23 1 18 19
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 21 24
M  V30 28 2 22 25
M  V30 29 1 23 25
M  V30 30 2 23 26
M  V30 31 1 24 27
M  V30 32 1 26 28
M  V30 33 2 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 15 17 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1010382-33-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1010382-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-358-CAS-12205317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective
A1 adenosine receptor agonists: Affinity, efficacy, and selectivity for
A1 receptor from different species
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cappellacci, Loredana; Franchetti, Palmarisa; Vita, Patrizia; Petrelli,
Riccardo; Lavecchia, Antonio; Costa, Barbara; Spinetti, Francesca;
Martini, Claudia; Klotz, Karl-Norbert; Grifantini, Mario
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2008), 16(1), 336-353

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
N-[5-[7,8-Dihydro-8-methyl-2-(methylthio)-7-oxopyrido[2,3-d]pyrimidin-6-yl]-2...
C23H24FN7O2S2
1012882-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 S 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.1462 3.4457 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.4681 6.5088 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 S 18.7451 3.9938 0.0 0
M  V30 33 N 17.4991 6.1517 0.0 0
M  V30 34 C 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[7,8-Dihydro-8-methyl-2-(methylamino)-7-oxopyrido[2,3-d]pyrimidin-6-yl]-...
C23H25FN8O2S
1012874-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.4681 6.5088 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.1462 3.4457 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 S 18.7451 3.9938 0.0 0
M  V30 33 N 17.4991 6.1517 0.0 0
M  V30 34 C 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1012882-09-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012874-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1285887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example A1: To a
solution of Example A3 (6.0 g, 19 mmol) in CH2Cl2 (50 mL) was added
m-chloroperoxybenzoic acid (mCPBA, 6.5 g, 38 mmol) in one portion. After
stirring for 2h at RT, sat. aq NaHCO3and aq NaHSO3 solution were added
and stirring was continued for a few minutes. The combined organic layer
was washed with brine, dried and concentrated in vacuo. The residue was
dissolved in DMSO (5 mL) and ammonia in dioxane (2 M, 200 mL, 400 mmol)
was added. The resultant reaction mixture was stirred overnight at RT.
The solvent was removed under reduced pressure and the residue was
purified by reverse phase prep-HPLC.
1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-3-(2-fluoro-4-methyl-5-(8-methyl-2-(methylamino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)urea
(0.311 g, 93% yield) as a white solid. 1H NMR (400 MHz, DMSO-d6):δ
7.822-7.75 (m, 3H), 7.69 (s, 1H), 7.39-7.37 (m, 1H), 7.34-7.30 (m, 1H),
7.16 (d, J = 12.0 Hz, 1H), 2.90 (brd, J = 4.8 Hz, 3H), 2.35 (s, 3H), 2.09
(s, 3H), 1.34 (s, 9H); MS (ESI) m/z: 497.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic ureas as kinase inhibitors useful for the
treatment of proliferative and inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kaufman, Michael D.; Patt, William C.; Petillo, Peter
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008034008 A2 2008-03-20

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[(2S)-1-(2,2-Dimethyl-1-oxopropyl)-2-azetidinyl]carbonyl]-L-alanine methyl...
C13H22N2O4
1013038-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 O 3.8500 0.2064 0.0 0
M  V30 4 C 1.5400 3.0800 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 6.6712 2.5022 0.0 0
M  V30 8 N 8.0048 3.2722 0.0 0
M  V30 9 O 6.6712 0.9622 0.0 0
M  V30 10 C 9.3386 2.5022 0.0 0 CFG=1
M  V30 11 C 10.6722 3.2722 0.0 0
M  V30 12 C 9.3386 0.9622 0.0 0
M  V30 13 O 12.0059 2.5022 0.0 0
M  V30 14 O 10.6722 4.8122 0.0 0
M  V30 15 C 13.3395 3.2722 0.0 0
M  V30 16 N 3.8500 2.8737 0.0 0
M  V30 17 C 5.3375 3.2722 0.0 0 CFG=2
M  V30 18 C 3.4513 4.3611 0.0 0
M  V30 19 C 4.9390 4.7597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Azetidinecarboxamide, 1-(2,2-dimethyl-1-oxopropyl)-N-[(1S)-1-methyl-2-(meth...
C13H23N3O3
1013038-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.5400 0.0 0
M  V30 2 C 1.5400 1.5400 0.0 0
M  V30 3 O 3.8500 0.2064 0.0 0
M  V30 4 C 1.5400 3.0800 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 6.6712 2.5022 0.0 0
M  V30 8 N 8.0048 3.2722 0.0 0
M  V30 9 O 6.6712 0.9622 0.0 0
M  V30 10 C 9.3386 2.5022 0.0 0 CFG=1
M  V30 11 C 10.6722 3.2722 0.0 0
M  V30 12 C 9.3386 0.9622 0.0 0
M  V30 13 N 12.0059 2.5022 0.0 0
M  V30 14 O 10.6722 4.8122 0.0 0
M  V30 15 C 13.3395 3.2722 0.0 0
M  V30 16 N 3.8500 2.8737 0.0 0
M  V30 17 C 5.3375 3.2722 0.0 0 CFG=2
M  V30 18 C 3.4513 4.3611 0.0 0
M  V30 19 C 4.9390 4.7597 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 17 7 CFG=1
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013038-66-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013038-69-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13665092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedures for the Preparation of
RCO-Xaa-Ala- NHMe Derivatives. Method A: The corresponding ester (4.22
mmol) was dissolved in MeNH2·EtOH (10 mL, 8M) and reacted over 2-12 h at
room temperature. When necessary, the reaction was purified by flash
chromatography or centrifugal circular thinlayer chromatography, using
the system of eluents indicated in each case. 2(S)-Piv-Aze-L-Ala-NHMe
(15a): White solid (mp 125-127 °C), 93% yield (from 11a, Method A).
Eluent: MeOH:CH2Cl2 (1: 20). [α]D -153.25 (c 1, CHCl3). 1H NMR (CDCl3): δ
7.60 (m, 1H, NH-Ala), 6.80 (m, 1H, NH-CH3), 4.78 (m, 1H, H-2), 4.36 (q,
1H, J = 7.1 Hz, α-H, Ala), 4.28 (t, 1H, J = 7.8 Hz, H-4), 2.81 (d, 3H, J
= 4.8 Hz, CH3-NH), 2.55 (m, 2H, H-3), 1.40 (d, 3H, J = 7.1 Hz, β-H, Ala),
1.24 (s, 9H, CH3-tBu). 1H NMR (DMSO-d6): δ 7.99 (m, 1H, NH-Ala), 7.75 (m,
1H, NH-CH3), 4.59 (m, 1H, H-2), 4.24 (m, 3H, α-H, Ala, H-4), 2.56 (d, 3H,
J = 4.6 Hz, CH3-NH), 2.38 (m, 1H, H-3), 2.05 (m, 1H, H-3), 1.18 (d, 3H, J
= 7.1 Hz, β-H, Ala), 1.08 (s, 9H, CH3-tBu). 13C NMR (CDCl3): δ 179.8
(COtBu), 172.4 and 170.8 (CON), 62.4 (2-C), 51.8 (4-C), 48.5 (α-C, Ala),
38.6 (C-tBu), 29.5 (CH3-NH), 26.9 (CH3-tBu), 19.3 (3-C), 17.6 (β-C, Ala).
ES-MS: 270.0 [M + 1]+, 292.0 [M + Na]+, 561.3 [2M + Na]+. Anal. Calcd for
C13H23N3O3: C 57.97, H 8.61, N 15.60. Found: C 58.04, H 8.91, N 15.87
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine-Derived Amino Acids versus Proline Derivatives. Alternative
Trends in Reverse Turn Induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baeza, Jose Luis; Gerona-Navarro, Guillermo; Perez de Vega, M. Jesus;
Garcia-Lopez, M. Teresa; Gonzalez-Muniz, Rosario; Martin-Martinez,
Mercedes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(5), 1704-1715

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Oxopyrrolidine-1-carboxylic acid tert-butyl ester
C9H15NO3
101385-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9554 0.0 0
M  V30 8 O 9.3037 1.4946 0.0 0
M  V30 9 N 5.3348 1.8517 0.0 0
M  V30 10 C 5.4958 0.3202 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 7.0021 0.0000 0.0 0
M  V30 13 C 7.7721 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-(methylamino)-1-pyrrolidinecarboxylate
C10H20N2O2
454712-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 N 9.0058 4.5489 0.0 0
M  V30 9 C 10.4126 3.9225 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.2952 4.1195 0.0 0
M  V30 12 C 6.2952 1.6278 0.0 0
M  V30 13 C 7.7598 3.6436 0.0 0
M  V30 14 C 7.7598 2.1036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101385-93-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 454712-26-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5164799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 46 1-(tert-butyloxycarbonyl)-3-methylaminopyrrolidine. To a
solution of 1-(tert-butyloxycarbonyl)pyrrolidin-3-one (74 g, 0.4 mol) in
MeOH (450 mL) was added an alcohol solution of MeNH2 (137.8 g, 1.2 mol)
at 0°C, and the resulting mixture was stirred at room temperature for 2
h. Then, NaBH4 (15.2 g, 0.4 mol) was added, and this mixture was stirred
at room temperature for another 1 h, then concentrated under reduced
pressure to give the residue. This residue was partitioned between CH2Cl2
(3 × 500 mL) and water (300 mL). The combined organic layers were dried
(Na2SO4), and evaporated to afforded 1-(tert-
butyloxycarbonyl)-3-methylaminopyrrolidine (74 g, 92.5%), which was used
in the next step without purification. 1H NMR (400 MHz, CDCl3) δ ppm 3.54
(m, 4 H), 3.29 (m, 2 H), 2.45 (s, 3 H), 2.20 (m, 1 H), 1.38 (s, 9 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bis-pyridylpyridones as melanin-concentrating hormone
receptor 1 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Scott; Blackwell, William C., III; Boros, Eric; Collins, Jon L.;
Hertzog, Don; Liang, Xi; Ray, John; Reister, Steven Michael; Samano,
Vicente; Sherrill, Ron
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009076387 A1 2009-06-18

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-Tetrahydro-2H-pyran-3-acetaldehyde
C7H12O2
1013937-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0 CFG=2
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.7700 2.6673 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[2-[(3R)-Tetrahydro-2H-pyran-3-yl]ethylidene]methanamine
C8H15NO
1013937-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013937-81-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013937-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-11261404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6. (R,E)-N-(2-(Tetrahydro-2H-pyran-3-yl)ethylidene)methanamine To a
magnetically stirred solution of
(R)-2-(tetrahydro-2H-pyran-3-yl)acetaldehyde (11 g, 85.8 mmol) in Et2O
(215 mL) at room temperature was added MeNH2 (2M in THF, 215 mL, 429.2
mmol) and molecular sieves (4Å, powdered, activated, 21.5 g). The
reaction was stirred at room temperature for 1 h. The resulting mixture
was then filtered and concentrated under reduced pressure.
(R,E)-N-(2-(tetrahydro-2H-pyran-3-yl)ethylidene)methanamine as a yellow
oil (11.3 g, 80 mmol, 93%). The crude material was carried on without
further purification. 1H NMR (400 MHz, CDCl3) δ 7.67 (m, 1H), 3.86-3.91
(m, 2H), 3.36-3.43 (m, 1H), 3.29 (s, 3H), 3.13 (dd, J = 1 1.0, 9.8 Hz,
1H), 1.95-2.14 (m, 2H), 1.86-1.91 (m, 2H), 1.62-1.68 (m, 2H), 1.21-1.30
(m, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyloxymethylbenzamide derivatives for use as aspartic
protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hammond, Marlys; Stoy, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009154766 A1 2009-12-23

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-Tetrahydro-2H-pyran-3-acetaldehyde
C7H12O2
1013937-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0 CFG=2
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.7700 2.6673 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[2-[(3R)-Tetrahydro-2H-pyran-3-yl]ethylidene]methanamine
C8H15NO
1013937-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013937-81-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013937-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3313557
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6. (R,E)-N-(2-(Tetrahydro-2H-pyran-3-yl)ethylidene)methanamine To a
magnetically stirred solution of
(R)-2-(tetrahydro-2H-pyran-3-yl)acetaldehyde (11 g, 85.8 mmol) in Et2O
(215 mL) at room temperature was added MeNH2 (2M in THF, 215 mL, 429.2
mmol) and molecular sieves (4Å, powdered, activated, 21.5 g). The
reaction mixture was stirred at room temperature for 1 h. The resulting
mixture was then filtered and concentrated under reduced pressure to
furnish (R,E)-N-(2-(tetrahydro-2H-pyran-3-yl)ethylidene)methanamine as a
yellow oil (11.3 g, 80 mmol, 93%). The crude material was carried on
without further purification. 1H NMR (400 MHz, CDCl3) δ 7.67 (m, 1H),
3.86-3.91 (m, 2H), 3.36-3.43 (m, 1H), 3.29 (s, 3H), 3.13 (dd, J = 11.0,
9.8 Hz, 1H), 1.95-2.14 (m, 2H), 1.86-1.91 (m, 2H), 1.62-1.68 (m, 2H),
1.21-1.30 (m, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for preparing tetrahydropyran derivatives as renin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hammond, Marlys; Stoy, Patrick; Thompson, Scott K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009038715 A1 2009-03-26

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-Tetrahydro-2H-pyran-3-acetaldehyde
C7H12O2
1013937-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0 CFG=2
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.7700 2.6673 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[2-[(3R)-Tetrahydro-2H-pyran-3-yl]ethylidene]methanamine
C8H15NO
1013937-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013937-81-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013937-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10993093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6. (R,E)-N-(2-(Tetrahydro-2H-pyran-3-yl)ethylidene)methanamine. To a
magnetically stirred solution of
(R)-2-(tetrahydro-2H-pyran-3-yl)acetaldehyde (11 g, 85.8 mmol) in Et2O
(215 mL) at room temperature was added MeNH2 (2M in THF, 215 mL, 429.2
mmol) and molecular sieves (4A, powdered, activated, 21.5 g). The
reaction was stirred at room temperature for 1 h. The resulting mixture
was then filtered and concentrated under reduced pressure to furnish
(R,E)-N-(2-(tetrahydro-2H-pyran-3-yl)ethylidene)methanamine as a yellow
oil (11.3 g, 80 mmol, 93%). 1H NMR (400 MHz, CDCl3) δ 7.67 (m, 1H),
3.86-3.91 (m, 2H), 3.36-3.43 (m, 1H), 3.29 (s, 3H), 3.13 (dd, J= 11.0,9.8
Hz, 1H), 1.95-2.14 (m, 2H), 1.86-1.91 (m, 2H), 1.62-1.68 (m, 2H),
1.21-1.30 (m, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenyl[((amino)phenyl)methoxy]ethylcarbamate derivatives
and analogs as renin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldwin, John J.; Cacatian, Salvacion; Claremon, David A.; Dillard,
Lawrence W.; Flaherty, Patrick T.; Ischenko, Alexey V.; McGeehan, Gerard;
Simpson, Robert D.; Singh, Suresh B.; Tice, Colin M.; Xu, Zhenrong; Yuan,
Jing; Zhao, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008156817 A2 2008-12-24

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3R)-Tetrahydro-2H-pyran-3-acetaldehyde
C7H12O2
1013937-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 O 6.9302 2.6673 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0 CFG=2
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 O 0.7700 2.6673 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[N(E)]-N-[2-[(3R)-Tetrahydro-2H-pyran-3-yl]ethylidene]methanamine
C8H15NO
1013937-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0 CFG=2
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 1.3337 3.0800 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3100 0.0 0
M  V30 10 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013937-81-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013937-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14891112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 6. (R,E)-N-(2-(Tetrahydro-2H-pyran-3-yl)ethylidene)methanamine To a
magnetically stirred solution of
(R)-2-(tetrahydro-2H-pyran-3-yl)acetaldehyde (11 g, 85.8 mmol) in Et2O
(215 mL) at room temperature was added MeNH2 (2M in THF, 215 mL, 429.2
mmol) and molecular sieves (4A, powdered, activated, 21.5 g). The
reaction was stirred at room temperature for 1 h. The resulting mixture
was then filtered and concentrated under reduced pressure to furnish
(R,E)-N-(2-(tetrahydro-2H-pyran-3-yl)ethylidene)methanamine as a yellow
oil (11.3 g, 80 mmol, 93%). The crude material was carried on without
further purification. 1H NMR (400 MHz, CDCl3) &#x03B4; 7.67 (m, 1H),
3.86-3.91 (m, 2H), 3.36-3.43 (m, 1H), 3.29 (s, 3H), 3.13 (dd, J=11.0, 9.8
Hz, 1H), 1.95-2.14 (m, 2H), 1.86-1.91 (m, 2H), 1.62-1.68 (m, 2H),
1.21-1.30 (m, 1H).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieve used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidine derivatives as renin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldwin, John J.; Claremon, David A.; Tice, Colin M.; Cacatian,
Salvacion; Dillard, Lawrence W.; Ishchenko, Alexey V.; Yuan, Jing; Xu,
Zhenrong; McGeehan, Gerard; Zhao, Wei; Simpson, Robert D.; Singh, Suresh
B.; Jia, Lanqi; Flaherty, Patrick T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008036247 A1 2008-03-27

$RFMT $RIREG SCHEME235 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester, (3S)-
C9H17NO3
101469-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.6218 0.0 0
M  V30 2 O 2.6673 1.8517 0.0 0
M  V30 3 O 4.0010 4.1618 0.0 0
M  V30 4 C 1.3337 2.6218 0.0 0
M  V30 5 C 0.5637 1.2881 0.0 0
M  V30 6 C 0.0000 3.3918 0.0 0
M  V30 7 C 2.1037 3.9554 0.0 0
M  V30 8 O 9.3037 1.4946 0.0 0
M  V30 9 N 5.3348 1.8517 0.0 0
M  V30 10 C 5.4958 0.3202 0.0 0
M  V30 11 C 6.7417 2.4782 0.0 0
M  V30 12 C 7.0021 0.0000 0.0 0
M  V30 13 C 7.7721 1.3337 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 13 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[(methylamino)carbonyl]oxy]-1-pyrrolidinecarboxylate
C11H20N2O4
2344749-47-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 9.0058 4.5489 0.0 0
M  V30 9 C 10.4126 3.9224 0.0 0
M  V30 10 N 11.6584 4.8276 0.0 0
M  V30 11 O 10.5736 2.3909 0.0 0
M  V30 12 C 13.0654 4.2013 0.0 0
M  V30 13 N 5.3900 2.8736 0.0 0
M  V30 14 C 6.2952 4.1195 0.0 0
M  V30 15 C 6.2952 1.6278 0.0 0
M  V30 16 C 7.7599 3.6436 0.0 0 CFG=1
M  V30 17 C 7.7599 2.1036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 16 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 101469-92-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2344749-47-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29468453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolopyrimidines having activity against the
respiratory syncytial virus (RSV)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rigaux,
Peter; Michaut, Antoine Benjamin; Mercey, Guillaume Jean Maurice
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019106004 A1 2019-06-06

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
4-[5-[[[5-[(Cyclopropylamino)carbonyl]-2-methylphenyl]amino]carbonyl]-2-thien...
C23H20N2O4S
1026766-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0337 4.0011 0.0 0
M  V30 2 N 8.2637 2.6674 0.0 0
M  V30 3 O 8.2637 5.3347 0.0 0
M  V30 4 C 17.9271 8.3918 0.0 0
M  V30 5 O 17.7661 9.9235 0.0 0
M  V30 6 O 19.3339 7.7655 0.0 0
M  V30 7 C 6.7237 0.0000 0.0 0
M  V30 8 C 3.6437 5.3347 0.0 0
M  V30 9 N 2.1037 5.3347 0.0 0
M  V30 10 O 4.4137 6.6685 0.0 0
M  V30 11 C 12.9435 4.7711 0.0 0
M  V30 12 S 11.4789 5.2470 0.0 0
M  V30 13 C 12.9435 3.2311 0.0 0
M  V30 14 C 10.5737 4.0011 0.0 0
M  V30 15 C 11.4789 2.7552 0.0 0
M  V30 16 C 14.1893 5.6763 0.0 0
M  V30 17 C 15.5963 5.0500 0.0 0
M  V30 18 C 14.0284 7.2079 0.0 0
M  V30 19 C 16.8421 5.9551 0.0 0
M  V30 20 C 15.2743 8.1131 0.0 0
M  V30 21 C 16.6812 7.4867 0.0 0
M  V30 22 C 6.7237 2.6674 0.0 0
M  V30 23 C 5.9537 4.0011 0.0 0
M  V30 24 C 5.9537 1.3338 0.0 0
M  V30 25 C 4.4137 4.0011 0.0 0
M  V30 26 C 4.4137 1.3338 0.0 0
M  V30 27 C 3.6437 2.6674 0.0 0
M  V30 28 C 1.3336 6.6685 0.0 0
M  V30 29 C 1.3336 8.2085 0.0 0
M  V30 30 C 0.0000 7.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 21
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 25
M  V30 12 1 9 28
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 16
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[(Cyclopropylamino)carbonyl]-2-methylphenyl]-5-[4-[(methylamino)carbonyl...
C24H23N3O3S
1026766-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0337 4.0011 0.0 0
M  V30 2 N 8.2637 2.6674 0.0 0
M  V30 3 O 8.2637 5.3347 0.0 0
M  V30 4 C 17.9271 8.3918 0.0 0
M  V30 5 N 19.3339 7.7655 0.0 0
M  V30 6 O 17.7661 9.9235 0.0 0
M  V30 7 C 20.5797 8.6707 0.0 0
M  V30 8 C 6.7237 0.0000 0.0 0
M  V30 9 C 3.6437 5.3347 0.0 0
M  V30 10 N 2.1037 5.3347 0.0 0
M  V30 11 O 4.4137 6.6685 0.0 0
M  V30 12 C 12.9435 4.7711 0.0 0
M  V30 13 S 11.4789 5.2470 0.0 0
M  V30 14 C 12.9435 3.2311 0.0 0
M  V30 15 C 10.5737 4.0011 0.0 0
M  V30 16 C 11.4789 2.7552 0.0 0
M  V30 17 C 14.1893 5.6763 0.0 0
M  V30 18 C 15.5963 5.0500 0.0 0
M  V30 19 C 14.0284 7.2079 0.0 0
M  V30 20 C 16.8421 5.9551 0.0 0
M  V30 21 C 15.2743 8.1131 0.0 0
M  V30 22 C 16.6812 7.4867 0.0 0
M  V30 23 C 6.7237 2.6674 0.0 0
M  V30 24 C 5.9537 4.0011 0.0 0
M  V30 25 C 5.9537 1.3338 0.0 0
M  V30 26 C 4.4137 4.0011 0.0 0
M  V30 27 C 4.4137 1.3338 0.0 0
M  V30 28 C 3.6437 2.6674 0.0 0
M  V30 29 C 1.3336 6.6685 0.0 0
M  V30 30 C 0.0000 7.4385 0.0 0
M  V30 31 C 1.3336 8.2085 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 22
M  V30 8 1 5 7
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 26
M  V30 13 1 10 29
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 12 17
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1026766-58-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1026766-93-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-405527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
4'-Chloro-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)biphenyl-3-carboxamide
To a solution of 4'-chlorobiphenyl-3-carboxylic acid (40 mg, 0.17 mmol)
in DMF (0.5 mL) was added EDCI (40 mg, 0.21 mmol) and HOBt (26 mg, 0.19
mmol) and the resulting solution was stirred at rt for 15 min. At this
time, DIPEA (0.042 mL, 0.26 mmol) was added and the mixture was stirred
at rt for ~ 16 h. Crushed ice (~ 2 mL volume) was added and the mixture
was stirred for 2 h and the product was collected by vacuum filtration,
washed with water and dried to afford 59 mg of a white solid as the title
compound (Example 128).
N-(5-(Cyclopropylcarbamoyl)-2-methylphenyl)-5-(4-(methylcarbamoyl)phenyl)thiophene-2-carboxamide
The title compound (Example 180) was prepared by reacting Example 21 with
methylamine using the method described in Example 128 to afford a white
solid in 93% yield. HPLC Ret. Time = 2.82 min, LCMS [M+H]+ 434.17.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic amide compounds useful as kinase inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of p38
kinase-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wrobleski, Stephen T.; Das, Jagabandhu; Dhar, T.g. Murali; Dyckman,
Alaric J.; Hynes, John; Leftheris, Katerina; Lin, James; Lin, Shuqun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008057775 A2 2008-05-15

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1-Benzothiazine, 3-[2-(chloromethyl)-2-propen-1-yl]-3,4-dihydro-1-phenyl...
C18H18ClNO2S
1033629-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 5.3901 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 Cl 12.0033 4.6201 0.0 0
M  V30 8 N 4.0012 4.6201 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 6.6685 3.0801 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 2.6673 0.7700 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 2.6673 5.3901 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 1.3337 7.7002 0.0 0
M  V30 22 C 0.0000 5.3901 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-2,1-Benzothiazine-3-propanamine, 3,4-dihydro-N-methyl-β-methylene-1-phenyl...
C19H22N2O2S
1033628-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3248 6.5698 0.0 0
M  V30 2 O 4.3449 6.5698 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 10.6697 5.3901 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 12.0033 4.6201 0.0 0
M  V30 8 C 13.3370 5.3901 0.0 0
M  V30 9 N 4.0010 4.6201 0.0 0
M  V30 10 C 4.0010 3.0801 0.0 0
M  V30 11 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6673 0.7700 0.0 0
M  V30 18 C 4.0010 0.0000 0.0 0
M  V30 19 C 2.6673 5.3901 0.0 0
M  V30 20 C 2.6673 6.9302 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 1.3337 7.7002 0.0 0
M  V30 23 C 0.0000 5.3901 0.0 0
M  V30 24 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033629-78-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033628-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1147487
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of
3-[2-(chloromethyl)prop-2-en-1-yl]-1-phenyl-3,4-dihydro-1H-2,1-benzothiazine
2,2-dioxide (0.14 g, 0.4 mmol) in an 8 M methyl amine solution in ethanol
(10 mL) was stirred at 22°C in a sealed tube for 8 h. The reaction
mixture was evaporated to provide crude
2-[(2,2-dioxido-1-phenyl-3,4-dihydro-1H-2,1-benzothiazin-3-yl)methyl]-N-methylprop-2-en-1-amine
hydrochloride as a white solid (150 mg, 93%):. HPLC retention time 7.0
min.; Xterra RP18, 3.5 μ, 150 × 4.6 mm column, 1.2 mL/min, 85/15-5/95
(Ammonium formate buffer, pH 3.5/CH3CN +MeOH) for 10 min., hold for 4
min. HRMS: calcd for C19H22N2O2S + H+, 343.14747; found (ESI, [M+H]+),
343.1485
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclic sulfonamide derivatives as monoamine reuptake inhibitors, their
preparation, pharmaceutical compositions, and use in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fensome, Andrew; Goldberg, Joel Adam; McComas, Casey Cameron; Mann,
Charles William; Melenski, Edward George; Sabatucci, Joseph P.;
Woodworth, Richard Page, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073956 A2 2008-06-19

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
6-Bromo-3-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-1-(3-methyl-2-buten-1-yl)-...
C20H24BrNO3
1040732-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.2896 6.7994 0.0 0
M  V30 2 C 4.0596 8.1331 0.0 0
M  V30 3 C 2.5196 8.1331 0.0 0
M  V30 4 C 1.7496 6.7994 0.0 0
M  V30 5 C 3.2896 9.4667 0.0 0
M  V30 6 C 2.6528 4.8393 0.0 0
M  V30 7 C 1.4070 5.7445 0.0 0
M  V30 8 O 1.5679 7.2761 0.0 0
M  V30 9 O 0.0000 5.1181 0.0 0
M  V30 10 O 5.3056 7.9109 0.0 0
M  V30 11 C 8.0160 5.9415 0.0 0
M  V30 12 C 9.1606 4.9111 0.0 0
M  V30 13 C 10.6251 5.3869 0.0 0
M  V30 14 C 11.7697 4.3565 0.0 0
M  V30 15 C 10.9453 6.8934 0.0 0
M  V30 16 Br 6.8456 0.0000 0.0 0
M  V30 17 C 4.0596 5.4656 0.0 0
M  V30 18 C 4.5356 4.0011 0.0 0
M  V30 19 C 5.3056 6.3709 0.0 0
M  V30 20 C 6.0756 4.0011 0.0 0
M  V30 21 C 3.7656 2.6673 0.0 0
M  V30 22 N 6.5515 5.4656 0.0 0
M  V30 23 C 6.8456 2.6673 0.0 0
M  V30 24 C 4.5356 1.3336 0.0 0
M  V30 25 C 6.0756 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 17
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 19
M  V30 11 1 11 12
M  V30 12 1 11 22
M  V30 13 2 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 16 25
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 23 25
M  V30 26 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-3-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-N-methyl-1-(3-methyl-2-but...
C21H27BrN2O2
1040732-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8987 4.8393 0.0 0
M  V30 2 C 2.6528 5.7445 0.0 0
M  V30 3 N 1.2459 5.1181 0.0 0
M  V30 4 O 2.8137 7.2761 0.0 0
M  V30 5 C 0.0000 6.0233 0.0 0
M  V30 6 C 4.5355 6.7994 0.0 0
M  V30 7 C 5.3055 8.1331 0.0 0
M  V30 8 C 3.7655 8.1331 0.0 0
M  V30 9 C 2.9955 6.7994 0.0 0
M  V30 10 C 4.5355 9.4667 0.0 0
M  V30 11 O 6.5515 7.9109 0.0 0
M  V30 12 C 9.2619 5.9415 0.0 0
M  V30 13 C 10.4064 4.9111 0.0 0
M  V30 14 C 11.8710 5.3869 0.0 0
M  V30 15 C 12.1912 6.8934 0.0 0
M  V30 16 C 13.0155 4.3565 0.0 0
M  V30 17 Br 8.0915 0.0000 0.0 0
M  V30 18 C 5.3055 5.4656 0.0 0
M  V30 19 C 5.7815 4.0011 0.0 0
M  V30 20 C 6.5515 6.3709 0.0 0
M  V30 21 C 7.3215 4.0011 0.0 0
M  V30 22 C 5.0115 2.6673 0.0 0
M  V30 23 N 7.7974 5.4656 0.0 0
M  V30 24 C 8.0915 2.6673 0.0 0
M  V30 25 C 5.7815 1.3336 0.0 0
M  V30 26 C 7.3215 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 18
M  V30 10 2 7 10
M  V30 11 2 11 20
M  V30 12 1 12 13
M  V30 13 1 12 23
M  V30 14 2 13 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 17 26
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 19 22
M  V30 22 1 20 23
M  V30 23 1 21 23
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 1 24 26
M  V30 27 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1040732-41-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1040732-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2797971
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 771-61-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-[6-Bromo-1-(3-methylbut-2-enyl)-3-(2-methylbut-3-en-2-yl)-2-oxoindolin-3-yl]-
N-methylacetamide (18a). A solution of 17a (186 mg, 0.46 mmol),
pentafluorophenol (253 mg, 1.37 mmol), triethylamine (127 mL, d ) 0.73,
0.92 mmol), and N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide (EDC) HCl
salt (132 mg, 0.69 mmol) in THF (6.5 mL) was kept at room temperature for
1.5 h. Gaseous methylamine was passed through the reaction mixture at
room temperature. After acidification with 10% HCl, the resulted mixture
was extracted with diethyl ether. The extract was washed with brine,
dried over MgSO4, and concentrated under reduced pressure. The residue
was purified by silica gel column chromatography with AcOEt as an eluent
to give 18a, yield 179 mg, 93% as crystals. mp 78-83 °C (AcOEt-hexane);
IR (CHCl3) 3463, 1698, 1603, 1525, 1487 cm-1; 1H NMR (CDCl3, 300 MHz) δ
0.95 (3H, s), 1.08 (3H, s), 1.73 (3H, s), 1.83 (3H, s), 2.50 (3H, d, J =
4.9 Hz), 2.65 (1H, d, J = 14.0 Hz), 3.00 (1H, d, J = 14.0 Hz), 4.21 (1H,
dd, J = 15.8, 6.6 Hz), 4.40 (1H, dd, J = 15.8, 6.6 Hz), 4.98 (1H, dd, J =
17.4, 1.1 Hz), 5.07-5.09 (1H, m), 5.10 (1H, dd, J = 10.8, 1.1 Hz,), 5.44
(1H, br), 5.96 (1H, dd, J = 17.4, 10.8 Hz), 6.89 (1H, d, J = 1.7 Hz),
7.04 (1H, d, J = 8.1 Hz), 7.11 (1H, dd, J = 8.1, 1.7 Hz); 13C NMR (CDCl3,
100 MHz) δ 18.3, 21.7, 22.1, 25.7, 26.1, 38.2, 38.6, 41.9, 55.4, 111.5,
114.0, 117.9, 121.5, 123.8, 126.1, 128.4, 136.4, 142.5, 145.2, 169.4,
178.0; MS m/z 420 (M + 2, 10), 418 (M+, 10), 352 (99), 350 (100), 294
(29), 292 (23), 238 (52), 236 (53), 225 (21), 223 (20), 69 (39), 41 (16);
HRMS (EI) m/z calcd for C21H27BrN2O2 418.1256, found 418.1257. Anal.
Calcd for C21H27BrN2O2: C, 60.15; H, 6.49; N, 6.68. Found: C, 60.34; H,
6.72; N, 6.41.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of (±)-flustramines A and C, (±)-flustramide A, and (-)-
and (+)-debromoflustramines A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kawasaki, Tomomi; Shinada, Masashi; Ohzono, Mayu; Ogawa, Atsuyo;
Terashima, Romi; Sakamoto, Masanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(15), 5959-5964

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-3-Chloro-N-ethyl-2-(phenylsulfinyl)-2-propenamide
C11H12ClNO2S
1043925-53-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 1.5400 0.0 0 CFG=3 VAL=4
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 N 8.0023 2.3101 0.0 0
M  V30 7 O 6.6685 0.0000 0.0 0
M  V30 8 Cl 4.0012 4.6201 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 10 C 10.6697 2.3101 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Ethyl-3-(methylamino)-2-(phenylsulfinyl)-2-propenamide
C12H16N2O2S
1294897-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 S 4.6200 5.3347 0.0 0 CFG=3 VAL=4
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 O 5.3900 6.6685 0.0 0
M  V30 6 N 7.7000 5.3347 0.0 0
M  V30 7 O 7.7000 2.6674 0.0 0
M  V30 8 N 5.3900 1.3338 0.0 0
M  V30 9 C 9.2400 5.3347 0.0 0
M  V30 10 C 4.6200 0.0000 0.0 0
M  V30 11 C 10.0100 6.6685 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 2.3100 6.6685 0.0 0
M  V30 15 C 0.7700 4.0011 0.0 0
M  V30 16 C 0.7700 6.6685 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 2 12
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1043925-53-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1294897-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8020006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Addition-substitution reactions of 2-thio-3-chloroacrylamides with
carbon, nitrogen, oxygen, sulfur and selenium nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kissane, Marie; Murphy, Maureen; O'Brien, Elisabeth; Chopra, Jay; Murphy,
Linda; Collins, Stuart G.; Lawrence, Simon E.; Maguire, Anita R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2011), 9(7), 2452-2472

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-3-pyridinecarboxylic acid
C6H4BrNO3
104612-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 7
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methyl-3-pyridinecarboxamide
C7H6BrClN2O
1189749-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104612-36-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1189749-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24145044
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycle-substituted N-methyl acrylamides as inhibitors
of fatty acid biosynthesis for bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rangarajan, Radha; Kumar, Rajinder; Prabhakar, B. V.; Mallikarjuma, P.;
Banerjee, Ankita
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2011CH03225 A 2013-06-21

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
5-Bromo-1,2-dihydro-2-oxo-3-pyridinecarboxylic acid
C6H4BrNO3
104612-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 N 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 7
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-chloro-N-methyl-3-pyridinecarboxamide
C7H6BrClN2O
1189749-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 Cl 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 N 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104612-36-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1189749-84-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15361739
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step-1. To a solution of 1 (3 g, 13.8 mmol) in SOCl2 (15 mL) was added
DMF (0.75 mL) slowly at room temperature. The mixture was refluxed at
80°C. for 2 h, then the solvent was removed under reduced pressure, and
the residue was dissolved in DCM (30 mL); to this was added 27%
MeNH2/MeOH (20 mL) at a rate such that the internal temperature remained
below 10°C., and stirred for 1 h at room temperature. Then the solvent
was removed under vacuum, the residue was added 60 mL H2O, extracted with
EtOAc (60 mL×3). The combined organic layers were dried with Na2SO4,
filtered and the solvent was removed under vacuum. To obtained the
desired compound 2. white solid. Yield was 93%: MS (ESI): m/z 251
(M+H)+..
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycle-substituted N-methyl acrylamides as inhibitors
of fatty acid biosynthesis for bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rangarajan, Radha; Kumar, Rajinder; Prabhakar, B V; Chandrasekhar, P.;
Mallikarjuna, P.; Banerjee, Ankita
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013042035 A1 2013-03-28

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitro-4-[[3-(trifluoromethyl)phenyl]methoxy]benzoic acid
C15H10F3NO5
1053144-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0010 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6673 6.9302 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 8.0022 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 F 14.1070 5.1838 0.0 0
M  V30 11 F 14.6707 3.0801 0.0 0
M  V30 12 F 12.5670 2.5164 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 5.3348 3.8501 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 C 9.3358 4.6201 0.0 0
M  V30 20 C 10.6697 3.8501 0.0 0
M  V30 21 C 9.3358 6.1601 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 23 C 10.6697 6.9302 0.0 0
M  V30 24 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 17
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 22
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitro-4-[[3-(trifluoromethyl)phenyl]methoxy]benzamide
C16H13F3N2O4
2659377-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.7238 4.0012 0.0 0
M  V30 2 C 5.9538 5.3348 0.0 0
M  V30 3 N 8.2638 1.3337 0.0 0 VAL=5
M  V30 4 O 6.7238 1.3337 0.0 0
M  V30 5 O 9.0338 0.0000 0.0 0
M  V30 6 C 12.8839 4.0012 0.0 0
M  V30 7 N 13.6539 5.3348 0.0 0
M  V30 8 O 13.6539 2.6675 0.0 0
M  V30 9 C 15.1940 5.3348 0.0 0
M  V30 10 C 1.3337 8.0023 0.0 0
M  V30 11 F 0.0000 7.2323 0.0 0
M  V30 12 F 0.5637 9.3360 0.0 0
M  V30 13 F 2.6673 8.7723 0.0 0
M  V30 14 C 8.2638 4.0012 0.0 0
M  V30 15 C 9.0338 2.6675 0.0 0
M  V30 16 C 9.0338 5.3348 0.0 0
M  V30 17 C 10.5739 2.6675 0.0 0
M  V30 18 C 10.5739 5.3348 0.0 0
M  V30 19 C 11.3439 4.0012 0.0 0
M  V30 20 C 4.4137 5.3348 0.0 0
M  V30 21 C 3.6437 6.6685 0.0 0
M  V30 22 C 3.6437 4.0012 0.0 0
M  V30 23 C 2.1037 6.6685 0.0 0
M  V30 24 C 2.1037 4.0012 0.0 0
M  V30 25 C 1.3337 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 20
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 23
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1053144-59-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2659377-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24121233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transcriptional enhanced associate doman (tead) transcription factor
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Zhang, Tinghu; Che, Jianwei; Kwiatkowski, Nicholas
Paul; Fan, Mengyang; Lu, Wenchao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021133896 A1 2021-07-01

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2,3-Dihydro-5-benzofuranyl)-4-methyl-5-thiazolecarboxylic acid
C13H11NO3S
1055043-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.9030 1.5315 0.0 0
M  V30 2 O 11.3098 2.1579 0.0 0
M  V30 3 O 9.7421 0.0000 0.0 0
M  V30 4 C 9.9030 4.8820 0.0 0
M  V30 5 C 6.2872 3.2068 0.0 0
M  V30 6 S 7.1925 1.9609 0.0 0
M  V30 7 N 7.1925 4.4526 0.0 0
M  V30 8 C 8.6572 2.4368 0.0 0
M  V30 9 C 8.6572 3.9768 0.0 0
M  V30 10 C 4.7472 3.2068 0.0 0
M  V30 11 C 3.9772 4.5404 0.0 0
M  V30 12 C 3.9772 1.8730 0.0 0
M  V30 13 C 2.4372 4.5404 0.0 0
M  V30 14 C 2.4372 1.8730 0.0 0
M  V30 15 C 1.6672 3.2068 0.0 0
M  V30 16 C 1.4068 5.6848 0.0 0
M  V30 17 O 0.1609 3.5269 0.0 0
M  V30 18 C 0.0000 5.0585 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(2,3-dihydro-5-benzofuranyl)-4-methyl-5-thiazolecarboxylate
C14H13NO3S
1549408-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.3399 2.9016 0.0 0
M  V30 2 O 10.9663 4.3085 0.0 0
M  V30 3 O 11.2451 1.6557 0.0 0
M  V30 4 C 12.4979 4.4695 0.0 0
M  V30 5 C 8.6646 0.0000 0.0 0
M  V30 6 C 6.3709 3.2587 0.0 0
M  V30 7 S 7.7779 3.8850 0.0 0
M  V30 8 N 6.5320 1.7271 0.0 0
M  V30 9 C 8.8083 2.7406 0.0 0
M  V30 10 C 8.0383 1.4070 0.0 0
M  V30 11 C 5.0373 4.0287 0.0 0
M  V30 12 C 3.7036 3.2587 0.0 0
M  V30 13 C 5.0373 5.5687 0.0 0
M  V30 14 C 2.3699 4.0287 0.0 0
M  V30 15 C 3.7036 6.3387 0.0 0
M  V30 16 C 2.3699 5.5687 0.0 0
M  V30 17 C 0.9052 3.5528 0.0 0
M  V30 18 O 0.9052 6.0446 0.0 0
M  V30 19 C 0.0000 4.7987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1055043-17-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1549408-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28083184
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 32589-78-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mild Esterification of Carboxylic Acids via Continuous Flow Diazotization
of Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Audubert, Clement; Lebel, Helene
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(16), 4407-4410

$RFMT $RIREG SCHEME243 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[Bis(ethylthio)methylene]-5-(4-chlorophenyl)-3-oxo-4-pentenamide
C16H18ClNO2S2
1055323-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 S 2.6673 4.6201 0.0 0
M  V30 4 S 4.0010 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 C 5.3348 6.1601 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 O 8.0022 4.6201 0.0 0
M  V30 11 N 6.6685 6.9302 0.0 0
M  V30 12 O 4.0010 6.9302 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 Cl 13.3370 4.6201 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 9.3360 3.8501 0.0 0
M  V30 19 C 10.6697 1.5400 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 12.0033 2.3101 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 2 9 15 CFG=2
M  V30 15 1 15 17
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-1,4,5,6-tetrahydro-1-methyl-2-(methylamino)-4-oxo-3-pyridi...
C14H16ClN3O2
1055323-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 C 0.7700 4.0012 0.0 0
M  V30 4 N 0.0000 2.6675 0.0 0
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 C 5.3901 1.3338 0.0 0
M  V30 7 O 2.3101 6.6687 0.0 0
M  V30 8 Cl 11.5503 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 2.3101 4.0012 0.0 0
M  V30 11 N 4.6201 2.6675 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 C 7.7002 5.3348 0.0 0
M  V30 17 C 7.7002 2.6675 0.0 0
M  V30 18 C 9.2402 5.3348 0.0 0
M  V30 19 C 9.2402 2.6675 0.0 0
M  V30 20 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 10
M  V30 6 1 6 11
M  V30 7 2 7 12
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1055323-63-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1055323-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2215767
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
1-Methyl-2-(methylamino)-4-oxo-6-p-tolyl-1,4,5,6-tetrahydropyridine-3-carboxamide
(3a); Typical Procedure To a soln of 1a (323 mg, 1.0 mmol) in DMF (5 mL)
was added aq 30% MeNH2 (0.31 mL, 3.0 mmol) at r.t. The reaction mixture
was stirred for 12 h at r.t. and then poured into brine (50 mL); the
resulting mixture was extracted with CH2Cl2 (3 × 20 mL). The combined
organic phase was washed with H2O (3 × 30 mL), dried (anhyd MgSO4),
filtered and concentrated under reduced pressure. The crude product was
purified by flash chromatography (silica gel, petroleum ether-Et2O, 2:1)
to give 3a
6-(4-Chlorophenyl)-1-methyl-2-(methylamino)-4-oxo-1,4,5,6-tetrahydropyridine-3-carboxamide
(3e). Pale-yellow solid, yield 93%. Mp 208-209 °C. IR (KBr): 1403, 1571,
2970, 3149, 3294 cm-1. 1H NMR (500 MHz, CDCl3): δ = 2.70 (dd, J = 16.0,
5.5 Hz, 1 H), 2.99 (dd, J = 16.0, 5.5 Hz, 1 H), 3.04 (d, J = 5.0 Hz, 3
H), 3.09 (s, 3 H), 4.43 (dd, J = 5.5, 5.5 Hz, 1 H), 5.20 (br, 1 H), 7.20
(d, J = 8.5 Hz, 2 H), 7.30 (d, J = 8.5 Hz, 2 H), 9.70 (br, 1 H), 11.40
(br, 1 H). 13C NMR (125 MHz, CDCl3): δ = 32.9, 40.5, 41.6, 61.1, 92.7,
128.0, 129.3, 134.1, 137.8, 170.3, 171.6, 187.6. Anal. Calcd for
C14H16ClN3O2: C, 57.24; H, 5.49; N, 14.30. Found: C, 57.38; H, 5.55; N,
14.36.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [5C + 1C/N/S/Se] annulations of α-alkenoyl α-carbamoyl ketene
dithioacetals: a facile and convenient synthesis of salicylamide,
nicotinamide and thio/selenopyran-3-carboxamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Dongwei; Xu, Xianxiu; Liu, Qun; Dong, Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2008), (12), 1895-1901

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-3-nitro-7-(trifluoromethyl)quinoline
C10H3Cl2F3N2O2
1060674-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 5.3347 0.0 0
M  V30 2 C 9.2400 4.0009 0.0 0
M  V30 3 F 9.2400 2.4609 0.0 0
M  V30 4 F 10.7800 4.0009 0.0 0
M  V30 5 F 9.2400 5.5409 0.0 0
M  V30 6 Cl 2.3100 0.0000 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 8 O 0.0000 1.3336 0.0 0
M  V30 9 O 0.0000 4.0009 0.0 0
M  V30 10 C 5.3900 2.6673 0.0 0
M  V30 11 C 4.6200 4.0009 0.0 0
M  V30 12 C 6.9300 2.6673 0.0 0
M  V30 13 N 4.6200 1.3336 0.0 0
M  V30 14 C 3.0800 4.0009 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 16 C 7.7000 4.0009 0.0 0
M  V30 17 C 3.0800 1.3336 0.0 0
M  V30 18 C 2.3100 2.6673 0.0 0
M  V30 19 C 6.9300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 16
M  V30 6 1 6 17
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 18
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 19
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-3-nitro-7-(trifluoromethyl)-4-quinolinamine
C11H7ClF3N3O2
1060674-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 5.3347 0.0 0
M  V30 2 C 3.0800 6.6685 0.0 0
M  V30 3 N 0.7700 2.6674 0.0 0 VAL=5
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 9.2400 4.0011 0.0 0
M  V30 7 F 9.2400 5.5411 0.0 0
M  V30 8 F 10.7800 4.0011 0.0 0
M  V30 9 F 9.2400 2.4611 0.0 0
M  V30 10 Cl 2.3100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 N 4.6200 1.3338 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 7.7000 4.0011 0.0 0
M  V30 20 C 3.0800 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 19
M  V30 10 1 10 20
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1060674-12-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1060674-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14971215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 5: Synthesis of
2-chloro-N-(4-methoxyphenyl)-3-nitro-7-(trifluoromethyl)quinolin-4-amine.
To a solution of 2,4-dichloro-3-nitro-7-trifluoromethyl-quinoline (220
mg; 0.70 mmol; 1eq) in dimethylformamide (3.5 mL), are added successively
triethylamine (105 μL; 0.76 mmol; 1.08eq) and 4-methoxyaniline (88 mg;
712 mmol; 1.01eq.). The reaction mixture is allowed to stir for 1 hour at
room temperature until the reaction is complete on TLC. The crude
solution is diluted with a 1M aqueous solution of HCl (5 mL) and then
extracted with ethyl acetate (40 mL). The organic layer is separated and
washed 3 times with a 1M aqueous solution of HCl (3×40 mL), dried over
sodium sulfate, filtrated and concentrated under vacuum to afford the
title compound as a yellow powder (280 mg; 0.70 mmol; 100%) which is used
without further purification. Example 25:
3-{[1-methyl-7-(trifluoromethyl)-1H-imidazo[4,5-c]quinolin-4-yl]amino}propan-1-ol.
Step 1: Synthesis of
2-chloro-N-methyl-3-nitro-7-(trifluoromethyl)quinolin-4-amine. Prepared
according to Example 24 Step 5 to afford the title compound as a yellow
powder (200 mg; 0.65 mmol; 93%). 1H NMR (DMSO-d6), δ (ppm): 8.59 (d, J=
8.8 Hz, 1H), 8.56 (brs, 1H), 8.15 (s, 1H), 7.97 (d, J= 8.8 Hz, 1H), 2.85
(d, J= 5.4 Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazolo-heteroaryl derivatives as DltA enzyme inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Escaich, Sonia; Denis, Alexis; Gerusz, Vincent; Moreau, Francois; Oxoby,
Mayalen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008117225 A2 2008-10-02

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-3-pyridinecarboxaldehyde
C6H3Cl2NO
1060811-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 Cl 2.3101 0.0000 0.0 0
M  V30 4 Cl 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4-(methylamino)-3-pyridinecarboxaldehyde
C7H7ClN2O
449811-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 N 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 Cl 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1060811-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 449811-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8443920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Aryl-heteroarylamines as FGFR4 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reynolds, Dominic; Hao, Ming-Hong; Wang, John; Prajapati, Sudeep; Satoh,
Takashi; Selvaraj, Anand
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015057963 A1 2015-04-23

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
1,1′-Bis(1,1-dimethylethyl) 4,4′-[(4-hydroxy-1-methylbutylidene)bis(4,1-pheny...
C41H48O7
1062142-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 4.6201 0.0 0
M  V30 2 C 16.0045 3.0801 0.0 0
M  V30 3 C 17.3382 3.8501 0.0 0
M  V30 4 C 14.6708 2.3101 0.0 0
M  V30 5 C 14.6708 0.7700 0.0 0
M  V30 6 O 13.3370 0.0000 0.0 0
M  V30 7 O 21.3393 7.7002 0.0 0
M  V30 8 C 22.6730 6.9302 0.0 0
M  V30 9 O 10.6697 7.7002 0.0 0
M  V30 10 C 9.3360 6.9302 0.0 0
M  V30 11 C 28.0078 10.0102 0.0 0
M  V30 12 O 29.3416 9.2402 0.0 0
M  V30 13 O 28.0078 11.5503 0.0 0
M  V30 14 C 30.6753 10.0102 0.0 0
M  V30 15 C 31.4453 8.6765 0.0 0
M  V30 16 C 32.0090 10.7802 0.0 0
M  V30 17 C 29.9053 11.3439 0.0 0
M  V30 18 C 4.0012 10.0102 0.0 0
M  V30 19 O 2.6673 9.2402 0.0 0
M  V30 20 O 4.0012 11.5503 0.0 0
M  V30 21 C 1.3337 10.0102 0.0 0
M  V30 22 C 0.5637 8.6765 0.0 0
M  V30 23 C 0.0000 10.7802 0.0 0
M  V30 24 C 2.1037 11.3439 0.0 0
M  V30 25 C 17.3382 5.3901 0.0 0
M  V30 26 C 18.6720 4.6201 0.0 0
M  V30 27 C 17.3382 6.9302 0.0 0
M  V30 28 C 20.0057 5.3901 0.0 0
M  V30 29 C 18.6720 7.7002 0.0 0
M  V30 30 C 20.0057 6.9302 0.0 0
M  V30 31 C 14.6708 5.3901 0.0 0
M  V30 32 C 13.3370 4.6201 0.0 0
M  V30 33 C 14.6708 6.9302 0.0 0
M  V30 34 C 12.0033 5.3901 0.0 0
M  V30 35 C 13.3370 7.7002 0.0 0
M  V30 36 C 12.0033 6.9302 0.0 0
M  V30 37 C 24.0068 7.7002 0.0 0
M  V30 38 C 25.3405 6.9302 0.0 0
M  V30 39 C 24.0068 9.2402 0.0 0
M  V30 40 C 26.6742 7.7002 0.0 0
M  V30 41 C 25.3405 10.0102 0.0 0
M  V30 42 C 26.6742 9.2402 0.0 0
M  V30 43 C 8.0022 7.7002 0.0 0
M  V30 44 C 6.6685 6.9302 0.0 0
M  V30 45 C 8.0022 9.2402 0.0 0
M  V30 46 C 5.3348 7.7002 0.0 0
M  V30 47 C 6.6685 10.0102 0.0 0
M  V30 48 C 5.3348 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 25
M  V30 4 1 1 31
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 30
M  V30 10 1 8 37
M  V30 11 1 9 10
M  V30 12 1 9 36
M  V30 13 1 10 43
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 11 42
M  V30 17 1 12 14
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 14 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 1 18 48
M  V30 24 1 19 21
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 21 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 2 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 2 39 41
M  V30 44 2 40 42
M  V30 45 1 41 42
M  V30 46 2 43 44
M  V30 47 1 43 45
M  V30 48 1 44 46
M  V30 49 2 45 47
M  V30 50 2 46 48
M  V30 51 1 47 48
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Bis(1,1-dimethylethyl) 4,4′-[[1-methyl-4-(methylamino)butylidene]bis(4,1...
C42H51NO6
1062142-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0045 6.1601 0.0 0
M  V30 2 C 16.0045 4.6201 0.0 0
M  V30 3 C 17.3382 5.3901 0.0 0
M  V30 4 C 14.6708 3.8501 0.0 0
M  V30 5 C 14.6708 2.3101 0.0 0
M  V30 6 N 13.3370 1.5400 0.0 0
M  V30 7 C 13.3370 0.0000 0.0 0
M  V30 8 O 21.3393 9.2402 0.0 0
M  V30 9 C 22.6730 8.4702 0.0 0
M  V30 10 O 10.6697 9.2402 0.0 0
M  V30 11 C 9.3360 8.4702 0.0 0
M  V30 12 C 28.0078 11.5503 0.0 0
M  V30 13 O 29.3416 10.7802 0.0 0
M  V30 14 O 28.0078 13.0903 0.0 0
M  V30 15 C 30.6753 11.5503 0.0 0
M  V30 16 C 29.9053 12.8839 0.0 0
M  V30 17 C 32.0090 12.3203 0.0 0
M  V30 18 C 31.4453 10.2166 0.0 0
M  V30 19 C 4.0012 11.5503 0.0 0
M  V30 20 O 2.6673 10.7802 0.0 0
M  V30 21 O 4.0012 13.0903 0.0 0
M  V30 22 C 1.3337 11.5503 0.0 0
M  V30 23 C 0.5637 10.2166 0.0 0
M  V30 24 C 0.0000 12.3203 0.0 0
M  V30 25 C 2.1037 12.8839 0.0 0
M  V30 26 C 17.3382 6.9302 0.0 0
M  V30 27 C 17.3382 8.4702 0.0 0
M  V30 28 C 18.6718 6.1601 0.0 0
M  V30 29 C 18.6718 9.2402 0.0 0
M  V30 30 C 20.0057 6.9302 0.0 0
M  V30 31 C 20.0057 8.4702 0.0 0
M  V30 32 C 14.6708 6.9302 0.0 0
M  V30 33 C 14.6708 8.4702 0.0 0
M  V30 34 C 13.3370 6.1601 0.0 0
M  V30 35 C 13.3370 9.2402 0.0 0
M  V30 36 C 12.0033 6.9302 0.0 0
M  V30 37 C 12.0033 8.4702 0.0 0
M  V30 38 C 24.0068 9.2402 0.0 0
M  V30 39 C 25.3405 8.4702 0.0 0
M  V30 40 C 24.0068 10.7802 0.0 0
M  V30 41 C 26.6742 9.2402 0.0 0
M  V30 42 C 25.3405 11.5503 0.0 0
M  V30 43 C 26.6742 10.7802 0.0 0
M  V30 44 C 8.0022 9.2402 0.0 0
M  V30 45 C 8.0022 10.7802 0.0 0
M  V30 46 C 6.6685 8.4702 0.0 0
M  V30 47 C 6.6685 11.5503 0.0 0
M  V30 48 C 5.3348 9.2402 0.0 0
M  V30 49 C 5.3348 10.7802 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 26
M  V30 4 1 1 32
M  V30 5 1 2 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 1 9 38
M  V30 12 1 10 11
M  V30 13 1 10 37
M  V30 14 1 11 44
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 43
M  V30 18 1 13 15
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 49
M  V30 25 1 20 22
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 41 2 38 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 2 40 42
M  V30 45 2 41 43
M  V30 46 1 42 43
M  V30 47 2 44 45
M  V30 48 1 44 46
M  V30 49 1 45 47
M  V30 50 2 46 48
M  V30 51 2 47 49
M  V30 52 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1062142-22-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1062142-25-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-302457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mimicking of iron-sulfur cluster proteins: synthesis and electrochemical
behavior of amphiphilic dendrimers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharma, Anil K.; Kim, Namjin; Gorman, Christopher B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polymer Preprints (American Chemical Society, Division of Polymer
Chemistry) (2007), 48(2), 533-534

$RFMT $RIREG SCHEME247 STEP1
$RXN



  3  1
$MOL
1-Bromo-4-chlorobenzene
C6H4BrCl
106-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Cl 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloral
C2HCl3O
75-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.3337 0.0 0
M  V30 2 C 2.6673 2.1037 0.0 0
M  V30 3 Cl 2.1037 0.0000 0.0 0
M  V30 4 Cl 0.0000 0.5637 0.0 0
M  V30 5 Cl 0.5637 2.6673 0.0 0
M  V30 6 O 4.0010 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzamide
C8H8ClNO
6873-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 106-39-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-87-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6873-44-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25579747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7439-95-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7447-41-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 507-40-4
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 7757-83-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-metal-free transformation of aryl bromides into aromatic
esters and amides via aryl trichloromethyl ketones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dohi, Souya; Moriyama, Katsuhiko; Togo, Hideo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(34), 7815-7822

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Chloro-2-methoxyphenyl)-2-[(dimethylamino)methylene]-3-oxobutanamide
C14H17ClN2O3
1088988-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 C 6.6684 6.9301 0.0 0
M  V30 4 O 4.0011 6.9301 0.0 0
M  V30 5 C 8.0022 6.1601 0.0 0
M  V30 6 C 6.6684 8.4701 0.0 0
M  V30 7 N 9.3359 6.9301 0.0 0
M  V30 8 C 5.3348 9.2401 0.0 0
M  V30 9 O 8.0022 9.2401 0.0 0
M  V30 10 C 9.3359 8.4701 0.0 0
M  V30 11 C 10.6695 6.1601 0.0 0
M  V30 12 O 5.3348 1.5400 0.0 0
M  V30 13 C 5.3348 0.0000 0.0 0
M  V30 14 Cl 0.0000 4.6201 0.0 0
M  V30 15 C 4.0011 3.8500 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 1.5400 0.0 0
M  V30 19 C 1.3337 3.8500 0.0 0
M  V30 20 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 13
M  V30 13 1 12 16
M  V30 14 1 14 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(5-chloro-2-methoxyphenyl)-2-[(methylamino)methylene]-3-oxo-
C13H15ClN2O3
2197964-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 C 6.6685 6.9302 0.0 0
M  V30 4 O 4.0012 6.9302 0.0 0
M  V30 5 C 8.0023 6.1601 0.0 0
M  V30 6 C 6.6685 8.4702 0.0 0
M  V30 7 N 9.3360 6.9302 0.0 0
M  V30 8 C 5.3348 9.2402 0.0 0
M  V30 9 O 8.0023 9.2402 0.0 0
M  V30 10 C 10.6697 6.1601 0.0 0
M  V30 11 O 5.3348 1.5400 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 Cl 0.0000 4.6201 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 2.6673 1.5400 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 19 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 15
M  V30 13 1 13 18
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1088988-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-(methylthio)-α-phenyl-5-pyrimidinemethanol
C12H10Cl2N2OS
1137576-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 Cl 6.6685 0.0000 0.0 0
M  V30 4 Cl 4.0012 4.6201 0.0 0
M  V30 5 S 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 3.8501 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 N 8.0023 2.3101 0.0 0
M  V30 11 N 6.6685 4.6201 0.0 0
M  V30 12 C 8.0023 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 1.3337 1.5400 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 8
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 5 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-2-(methylthio)-α-phenyl-5-pyrimidinemethanol
C13H14ClN3OS
2246957-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 O 2.3100 2.6675 0.0 0
M  V30 3 N 4.6201 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 Cl 4.6201 6.6686 0.0 0
M  V30 6 S 9.2401 4.0011 0.0 0
M  V30 7 C 10.0101 5.3348 0.0 0
M  V30 8 C 4.6201 4.0011 0.0 0
M  V30 9 C 5.3901 2.6675 0.0 0
M  V30 10 C 5.3901 5.3348 0.0 0
M  V30 11 N 6.9301 2.6675 0.0 0
M  V30 12 N 6.9301 5.3348 0.0 0
M  V30 13 C 7.7001 4.0011 0.0 0
M  V30 14 C 2.3100 5.3348 0.0 0
M  V30 15 C 3.0800 6.6686 0.0 0
M  V30 16 C 0.7700 5.3348 0.0 0
M  V30 17 C 2.3100 8.0022 0.0 0
M  V30 18 C 0.0000 6.6686 0.0 0
M  V30 19 C 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 5 10
M  V30 7 1 6 7
M  V30 8 1 6 13
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1137576-47-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2246957-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19235301
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of 1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one
derivatives from 4,6-dichloro-2-(methylsulfanyl)pyrimidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Tsunomori, Yuka; Nogi, Takashi; Hiyoshi, Hidetaka;
Umezu, Kazuto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2018), 96(4), 757-765

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-bromo-2-pyridinyl)thio]-1-(2-chloropheny...
C17H13BrClN3O2S
1138037-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.6398 0.0 0
M  V30 2 Cl 9.1262 2.1049 0.0 0
M  V30 3 C 9.7758 7.3148 0.0 0
M  V30 4 O 11.1826 6.6885 0.0 0
M  V30 5 O 9.6147 8.8465 0.0 0
M  V30 6 C 12.4284 7.5937 0.0 0
M  V30 7 C 13.8354 6.9674 0.0 0
M  V30 8 Br 0.0000 8.3071 0.0 0
M  V30 9 N 7.0652 4.3938 0.0 0
M  V30 10 C 6.1600 5.6398 0.0 0
M  V30 11 N 8.5299 4.8698 0.0 0
M  V30 12 C 7.0652 6.8856 0.0 0
M  V30 13 C 8.5299 6.4098 0.0 0
M  V30 14 C 6.5894 2.9292 0.0 0
M  V30 15 C 7.6198 1.7847 0.0 0
M  V30 16 C 5.0829 2.6091 0.0 0
M  V30 17 C 7.1439 0.3202 0.0 0
M  V30 18 C 4.6071 1.1444 0.0 0
M  V30 19 C 5.6376 0.0000 0.0 0
M  V30 20 C 3.8500 6.9734 0.0 0
M  V30 21 N 2.3100 6.9734 0.0 0
M  V30 22 C 4.6200 8.3071 0.0 0
M  V30 23 C 1.5400 8.3071 0.0 0
M  V30 24 C 3.8500 9.6407 0.0 0
M  V30 25 C 2.3100 9.6407 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-bromo-2-pyridinyl)thio]-1-(2-chlorophenyl)-N...
C16H12BrClN4OS
1138037-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.8085 5.6398 0.0 0
M  V30 2 Cl 3.3024 2.1049 0.0 0
M  V30 3 C 2.6528 7.3149 0.0 0
M  V30 4 N 1.2459 6.6886 0.0 0
M  V30 5 O 2.8137 8.8466 0.0 0
M  V30 6 C 0.0000 7.5938 0.0 0
M  V30 7 Br 12.4285 8.3071 0.0 0
M  V30 8 N 5.3632 4.3938 0.0 0
M  V30 9 C 6.2684 5.6398 0.0 0
M  V30 10 N 3.8987 4.8698 0.0 0
M  V30 11 C 5.3632 6.8857 0.0 0
M  V30 12 C 3.8987 6.4098 0.0 0
M  V30 13 C 5.8391 2.9292 0.0 0
M  V30 14 C 4.8087 1.7847 0.0 0
M  V30 15 C 7.3455 2.6091 0.0 0
M  V30 16 C 5.2845 0.3202 0.0 0
M  V30 17 C 7.8214 1.1444 0.0 0
M  V30 18 C 6.7910 0.0000 0.0 0
M  V30 19 C 8.5785 6.9735 0.0 0
M  V30 20 N 10.1185 6.9735 0.0 0
M  V30 21 C 7.8085 8.3071 0.0 0
M  V30 22 C 10.8885 8.3071 0.0 0
M  V30 23 C 8.5785 9.6408 0.0 0
M  V30 24 C 10.1185 9.6408 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1253975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 277
5-[(6-bromopyridin-2-yl)thio]-1-(2-chlorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-bromopyridin-2-yl)thio]-1-(2-chlorophenyl)-1H-pyrazole-3-carboxylate
(1.38 g) in methanol (6 mL) was added 40% methylamine-methanol solution
(1.5 mL) at 0&#x00B0; C. The mixture was stirred at room temperature for
3 hr, and concentrated under reduced pressure. Saturated aqueous sodium
hydrogen carbonate solution was added to the residue, and the mixture was
extracted with ethyl acetate. The extract was washed successively with
saturated aqueous sodium hydrogen carbonate solution, water and saturated
brine, dried over anhydrous sodium sulfate, and concentrated under
reduced pressure to give the title compound as a yellow oil (466 mg,
yield 93%). 1H-NMR (CDCl3) &#x03B4; : 3.00 (3H, d, J=5.4 Hz), 6.85-6.90
(2H, m), 7.16-7.18 (1H, m), 7.28-7.34 (3H, m), 7.38-7.43 (2H, m),
7.47-7.51 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,4-difluoro...
C17H12ClF2N3O2S
1138037-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4233 8.6445 0.0 0
M  V30 2 F 1.1091 6.5096 0.0 0
M  V30 3 C 5.2962 3.3420 0.0 0
M  V30 4 O 4.0504 2.4367 0.0 0
M  V30 5 O 6.7032 2.7156 0.0 0
M  V30 6 C 4.2114 0.9052 0.0 0
M  V30 7 C 2.9654 0.0000 0.0 0
M  V30 8 F 0.0000 11.7277 0.0 0
M  V30 9 Cl 12.5833 8.6445 0.0 0
M  V30 10 N 4.1218 7.1499 0.0 0
M  V30 11 C 5.6533 7.3108 0.0 0
M  V30 12 N 3.8016 5.6435 0.0 0
M  V30 13 C 6.2798 5.9041 0.0 0
M  V30 14 C 5.1353 4.8735 0.0 0
M  V30 15 C 3.0914 8.2943 0.0 0
M  V30 16 C 1.5850 7.9741 0.0 0
M  V30 17 C 3.5673 9.7590 0.0 0
M  V30 18 C 0.5546 9.1186 0.0 0
M  V30 19 C 2.5368 10.9034 0.0 0
M  V30 20 C 1.0304 10.5832 0.0 0
M  V30 21 C 7.9633 8.6445 0.0 0
M  V30 22 C 8.7333 9.9783 0.0 0
M  V30 23 C 8.7333 7.3108 0.0 0
M  V30 24 C 10.2733 9.9783 0.0 0
M  V30 25 N 10.2733 7.3108 0.0 0
M  V30 26 C 11.0433 8.6445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 20
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,4-difluorophen...
C16H11ClF2N4OS
1138037-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.4233 7.7394 0.0 0
M  V30 2 F 1.1091 5.6044 0.0 0
M  V30 3 C 5.2962 2.4367 0.0 0
M  V30 4 N 4.0504 1.5315 0.0 0
M  V30 5 O 6.7032 1.8104 0.0 0
M  V30 6 C 4.2114 0.0000 0.0 0
M  V30 7 F 0.0000 10.8225 0.0 0
M  V30 8 Cl 12.5833 7.7394 0.0 0
M  V30 9 N 4.1218 6.2447 0.0 0
M  V30 10 C 5.6533 6.4056 0.0 0
M  V30 11 N 3.8016 4.7384 0.0 0
M  V30 12 C 6.2798 4.9988 0.0 0
M  V30 13 C 5.1353 3.9684 0.0 0
M  V30 14 C 3.0914 7.3891 0.0 0
M  V30 15 C 1.5850 7.0689 0.0 0
M  V30 16 C 3.5673 8.8538 0.0 0
M  V30 17 C 0.5546 8.2134 0.0 0
M  V30 18 C 2.5368 9.9981 0.0 0
M  V30 19 C 1.0304 9.6780 0.0 0
M  V30 20 C 7.9633 7.7394 0.0 0
M  V30 21 C 8.7333 9.0731 0.0 0
M  V30 22 C 8.7333 6.4056 0.0 0
M  V30 23 C 10.2733 9.0731 0.0 0
M  V30 24 N 10.2733 6.4056 0.0 0
M  V30 25 C 11.0433 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 19
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-33-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-57-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5522256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 279
5-[(6-chloropyridin-3-yl)thio]-1-(2,4-difluorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2,4-difluorophenyl)-1H-pyrazole-3-carboxylate
(348 mg) in methanol (5 mL) was added 40% methylamine-methanol solution
(5 mL) at room temperature. The mixture was stirred for 1 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=3:1&#x2192;1:1) to give the title compound as a pale-yellow solid
(312 mg, yield 93%). 1H-NMR (CDCl3) &#x03B4; : 2.98 (3H, d, J=5.4 Hz),
6.82 (1H, br), 6.94-7.01 (2H, m), 7.18-7.21 (2H, m), 7.24-7.32 (1H, m),
7.35-7.39 (1H, m), 8.04-8.06 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-5-m...
C18H15ClFN3O2S
1138037-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3171 4.9301 0.0 0
M  V30 2 F 1.6472 4.1219 0.0 0
M  V30 3 C 3.6896 8.9586 0.0 0
M  V30 4 O 2.1580 9.1197 0.0 0
M  V30 5 O 4.5948 10.2047 0.0 0
M  V30 6 C 1.5317 10.5265 0.0 0
M  V30 7 C 0.0000 10.6875 0.0 0
M  V30 8 C 6.2251 0.0000 0.0 0
M  V30 9 Cl 12.6519 8.0101 0.0 0
M  V30 10 N 4.5765 5.0736 0.0 0
M  V30 11 C 5.9833 5.7001 0.0 0
M  V30 12 N 3.5461 6.2182 0.0 0
M  V30 13 C 5.8224 7.2316 0.0 0
M  V30 14 C 4.3161 7.5518 0.0 0
M  V30 15 C 4.2563 3.5673 0.0 0
M  V30 16 C 2.7916 3.0914 0.0 0
M  V30 17 C 5.4007 2.5367 0.0 0
M  V30 18 C 2.4714 1.5850 0.0 0
M  V30 19 C 5.0805 1.0304 0.0 0
M  V30 20 C 3.6160 0.5546 0.0 0
M  V30 21 C 8.6508 5.7001 0.0 0
M  V30 22 C 9.9844 4.9301 0.0 0
M  V30 23 C 8.6508 7.2401 0.0 0
M  V30 24 C 11.3181 5.7001 0.0 0
M  V30 25 N 9.9844 8.0101 0.0 0
M  V30 26 C 11.3181 7.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 19
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluoro-5-methy...
C17H14ClFN4OS
1138037-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8690 7.7393 0.0 0
M  V30 2 F 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4368 0.0 0
M  V30 4 N 3.4960 1.5315 0.0 0
M  V30 5 O 6.1486 1.8104 0.0 0
M  V30 6 C 3.6569 0.0000 0.0 0
M  V30 7 C 2.4582 11.4629 0.0 0
M  V30 8 Cl 12.0290 7.7393 0.0 0
M  V30 9 N 3.5673 6.2447 0.0 0
M  V30 10 C 5.0990 6.4057 0.0 0
M  V30 11 N 3.2471 4.7383 0.0 0
M  V30 12 C 5.7253 4.9989 0.0 0
M  V30 13 C 4.5809 3.9683 0.0 0
M  V30 14 C 2.5369 7.3891 0.0 0
M  V30 15 C 1.0306 7.0689 0.0 0
M  V30 16 C 3.0127 8.8538 0.0 0
M  V30 17 C 0.0000 8.2135 0.0 0
M  V30 18 C 1.9823 9.9982 0.0 0
M  V30 19 C 0.4760 9.6780 0.0 0
M  V30 20 C 7.4090 7.7393 0.0 0
M  V30 21 C 8.1790 9.0731 0.0 0
M  V30 22 C 8.1790 6.4057 0.0 0
M  V30 23 C 9.7190 9.0731 0.0 0
M  V30 24 N 9.7190 6.4057 0.0 0
M  V30 25 C 10.4890 7.7393 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 18
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-39-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7934058
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 284
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-5-methylphenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluoro-5-methylphenyl)-1H-pyrazole-3-carboxylate
(1.1 g) in methanol (5 mL) was added 40% methylamine-methanol solution (5
mL) at room temperature. The mixture was stirred for 1 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=3:1&#x2192;1:2) to give the title compound as a colorless
amorphous solid (956 mg, yield 93%). 1H-NMR (CDCl3) &#x03B4; : 2.34 (3H,
s), 2.97 (3H, d, J=5.1 Hz), 6.83 (1H, br), 7.01-7.11 (2H, m), 7.16-7.19
(2H, m), 7.24-7.28 (1H, m), 7.35-7.39 (1H, m), 8.02-8.03 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,6′-Di-9-acridinyl[1,1′-biphenyl]-2,2′-dicarboxaldehyde
C40H24N2O2
1141733-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0032 6.1600 0.0 0
M  V30 2 O 12.0032 4.6200 0.0 0
M  V30 3 C 6.6684 3.8500 0.0 0
M  V30 4 O 6.6684 5.3900 0.0 0
M  V30 5 C 4.0011 4.6200 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 2.6674 5.3900 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 2.6674 6.9300 0.0 0
M  V30 12 N 1.3336 3.0800 0.0 0
M  V30 13 C 2.6674 0.7700 0.0 0
M  V30 14 C 5.3347 0.7700 0.0 0
M  V30 15 C 0.0000 5.3900 0.0 0
M  V30 16 C 1.3336 7.7000 0.0 0
M  V30 17 C 4.0011 0.0000 0.0 0
M  V30 18 C 0.0000 6.9300 0.0 0
M  V30 19 C 8.0021 6.9300 0.0 0
M  V30 20 C 9.3358 6.1600 0.0 0
M  V30 21 C 8.0021 8.4700 0.0 0
M  V30 22 C 10.6694 6.9300 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 10.6694 8.4700 0.0 0
M  V30 25 C 9.3358 3.8500 0.0 0
M  V30 26 C 10.6694 3.0800 0.0 0
M  V30 27 C 8.0021 3.0800 0.0 0
M  V30 28 C 10.6694 1.5400 0.0 0
M  V30 29 C 8.0021 1.5400 0.0 0
M  V30 30 C 9.3358 0.7700 0.0 0
M  V30 31 C 14.6705 5.3900 0.0 0
M  V30 32 C 14.6705 6.9300 0.0 0
M  V30 33 C 16.0041 4.6200 0.0 0
M  V30 34 C 16.0041 7.7000 0.0 0
M  V30 35 C 13.3369 7.7000 0.0 0
M  V30 36 C 17.3379 5.3900 0.0 0
M  V30 37 C 16.0041 3.0800 0.0 0
M  V30 38 N 17.3379 6.9300 0.0 0
M  V30 39 C 16.0041 9.2400 0.0 0
M  V30 40 C 13.3369 9.2400 0.0 0
M  V30 41 C 18.6716 4.6200 0.0 0
M  V30 42 C 17.3379 2.3100 0.0 0
M  V30 43 C 14.6705 10.0100 0.0 0
M  V30 44 C 18.6716 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 22
M  V30 3 2 3 4
M  V30 4 1 3 27
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 2 9 14
M  V30 15 2 10 12
M  V30 16 1 10 15
M  V30 17 2 11 16
M  V30 18 2 13 17
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 25
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 26 31
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 1 31 32
M  V30 37 2 31 33
M  V30 38 2 32 34
M  V30 39 1 32 35
M  V30 40 1 33 36
M  V30 41 1 33 37
M  V30 42 1 34 38
M  V30 43 1 34 39
M  V30 44 2 35 40
M  V30 45 2 36 38
M  V30 46 1 36 41
M  V30 47 2 37 42
M  V30 48 2 39 43
M  V30 49 1 40 43
M  V30 50 2 41 44
M  V30 51 1 42 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-[(6,6′-Di-9-acridinyl[1,1′-biphenyl]-2,2′-diyl)dimethylidyne]bis[methana...
C42H30N4
1227181-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0586 10.5463 0.0 0
M  V30 2 N 12.8286 11.8800 0.0 0
M  V30 3 C 12.0586 13.2136 0.0 0
M  V30 4 C 7.4385 5.2113 0.0 0
M  V30 5 N 6.6685 3.8777 0.0 0
M  V30 6 C 7.4385 2.5440 0.0 0
M  V30 7 C 12.0586 7.8788 0.0 0
M  V30 8 C 12.8286 6.5451 0.0 0
M  V30 9 C 12.8286 9.2125 0.0 0
M  V30 10 C 14.3687 6.5451 0.0 0
M  V30 11 C 14.3687 9.2125 0.0 0
M  V30 12 C 15.1387 7.8788 0.0 0
M  V30 13 C 7.4385 7.8788 0.0 0
M  V30 14 C 6.6685 9.2125 0.0 0
M  V30 15 C 6.6685 6.5451 0.0 0
M  V30 16 C 5.1285 9.2125 0.0 0
M  V30 17 C 5.1285 6.5451 0.0 0
M  V30 18 C 4.3584 7.8788 0.0 0
M  V30 19 C 16.1630 4.6201 0.0 0
M  V30 20 C 16.1630 3.0801 0.0 0
M  V30 21 C 17.4966 5.3901 0.0 0
M  V30 22 C 17.4966 2.3101 0.0 0
M  V30 23 C 14.8291 2.3101 0.0 0
M  V30 24 C 18.8303 4.6201 0.0 0
M  V30 25 C 17.4966 6.9302 0.0 0
M  V30 26 N 18.8303 3.0801 0.0 0
M  V30 27 C 17.4966 0.7700 0.0 0
M  V30 28 C 14.8291 0.7700 0.0 0
M  V30 29 C 20.1640 5.3901 0.0 0
M  V30 30 C 18.8303 7.7002 0.0 0
M  V30 31 C 16.1630 0.0000 0.0 0
M  V30 32 C 20.1640 6.9302 0.0 0
M  V30 33 C 4.0010 10.7525 0.0 0
M  V30 34 C 2.6673 9.9825 0.0 0
M  V30 35 C 4.0010 12.2925 0.0 0
M  V30 36 C 1.3337 10.7525 0.0 0
M  V30 37 C 2.6673 8.4425 0.0 0
M  V30 38 C 2.6673 13.0626 0.0 0
M  V30 39 C 5.3348 13.0626 0.0 0
M  V30 40 N 1.3337 12.2925 0.0 0
M  V30 41 C 0.0000 9.9825 0.0 0
M  V30 42 C 1.3337 7.6724 0.0 0
M  V30 43 C 2.6673 14.6026 0.0 0
M  V30 44 C 5.3348 14.6026 0.0 0
M  V30 45 C 0.0000 8.4425 0.0 0
M  V30 46 C 4.0010 15.3726 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 8 19
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 14 33
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 20 23
M  V30 26 1 21 24
M  V30 27 1 21 25
M  V30 28 1 22 26
M  V30 29 1 22 27
M  V30 30 2 23 28
M  V30 31 2 24 26
M  V30 32 1 24 29
M  V30 33 2 25 30
M  V30 34 2 27 31
M  V30 35 1 28 31
M  V30 36 2 29 32
M  V30 37 1 30 32
M  V30 38 1 33 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 34 37
M  V30 42 1 35 38
M  V30 43 1 35 39
M  V30 44 1 36 40
M  V30 45 1 36 41
M  V30 46 2 37 42
M  V30 47 2 38 40
M  V30 48 1 38 43
M  V30 49 2 39 44
M  V30 50 2 41 45
M  V30 51 1 42 45
M  V30 52 2 43 46
M  V30 53 1 44 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1141733-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227181-30-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10066558
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Halochromic chiroptical response of novel bis(9-acridinyl)-type
fluorophores with a helical π framework
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nehira, Tatsuo; Yoshimoto, Yasuyo; Wada, Kazuhisa; Kawai, Hidetoshi;
Fujiwara, Kenshu; Suzuki, Takanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2010), 39(3), 165-167

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-[(dimethylamino)methylene]-2-[[(dimethylamino)methylene]amino]-5-(eth...
C17H25N5O4
1142934-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1530 7.9433 0.0 0
M  V30 2 C 3.6655 7.5448 0.0 0
M  V30 3 C 5.5516 9.4308 0.0 0
M  V30 4 O 2.5766 8.6337 0.0 0
M  V30 5 O 3.2670 6.0571 0.0 0
M  V30 6 N 7.0390 9.8294 0.0 0
M  V30 7 C 1.0889 8.2350 0.0 0
M  V30 8 C 7.4378 11.3169 0.0 0
M  V30 9 C 8.1281 8.7404 0.0 0
M  V30 10 C 0.0000 9.3241 0.0 0
M  V30 11 C 5.3586 4.0528 0.0 0
M  V30 12 O 6.0096 2.6571 0.0 0
M  V30 13 O 3.8244 4.1871 0.0 0
M  V30 14 C 5.1262 1.3957 0.0 0
M  V30 15 C 5.7770 0.0000 0.0 0
M  V30 16 N 10.2430 7.6244 0.0 0
M  V30 17 C 11.5767 6.8544 0.0 0
M  V30 18 N 12.9103 7.6244 0.0 0
M  V30 19 C 14.2441 6.8544 0.0 0
M  V30 20 C 12.9103 9.1644 0.0 0
M  V30 21 C 6.2419 6.8544 0.0 0
M  V30 22 C 6.2419 5.3144 0.0 0
M  V30 23 N 7.5756 7.6244 0.0 0
M  V30 24 C 7.5756 4.5444 0.0 0
M  V30 25 C 8.9094 6.8544 0.0 0
M  V30 26 N 8.9094 5.3144 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 22
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 2 16 17 CFG=2
M  V30 17 1 16 25
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-amino-5,6-dihydro-6-methyl-5-oxopyrido[4,3-d]pyrimidine-8-carboxylate
C11H12N4O3
1142934-76-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.8500 0.0 0
M  V30 2 O 6.6684 4.6200 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 O 0.0000 6.9300 0.0 0
M  V30 7 N 1.3336 0.0000 0.0 0
M  V30 8 C 2.6674 8.4700 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 N 2.6674 2.3100 0.0 0
M  V30 13 C 1.3336 6.1600 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 15 C 4.0011 6.1600 0.0 0
M  V30 16 C 1.3336 1.5400 0.0 0
M  V30 17 N 2.6674 6.9300 0.0 0
M  V30 18 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 13
M  V30 7 1 7 16
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1142934-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1142934-76-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8586848
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transformations of diethyl
2-[(dimethylamino)methylene]-3-oxopentanedioate. A simple synthesis of
substituted
2-amino-5-oxo-5,6-dihydropyrido[4,3-d]pyrimidine-8-carboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zupancic, Silvo; Svete, Jurij; Stanovnik, Branko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2009), 77(2), 899-908

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3R,4R)-4-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]dihydro-3-(pheny...
C28H32O4Si
1144104-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 3.0800 5.1047 0.0 0
M  V30 2 O 3.8500 3.7710 0.0 0
M  V30 3 C 1.7464 4.3347 0.0 0
M  V30 4 C 5.3900 3.7710 0.0 0
M  V30 5 C 2.5164 3.0010 0.0 0
M  V30 6 C 0.4126 3.5647 0.0 0
M  V30 7 C 0.9764 5.6685 0.0 0
M  V30 8 O 8.7220 3.4208 0.0 0
M  V30 9 C 10.2284 3.1007 0.0 0
M  V30 10 O 9.4187 0.1437 0.0 0
M  V30 11 C 2.3100 6.4385 0.0 0
M  V30 12 C 0.7700 6.4385 0.0 0
M  V30 13 C 3.0800 7.7721 0.0 0
M  V30 14 C 0.0000 7.7721 0.0 0
M  V30 15 C 2.3100 9.1058 0.0 0
M  V30 16 C 0.7700 9.1058 0.0 0
M  V30 17 C 4.4137 5.8747 0.0 0
M  V30 18 C 5.7473 5.1047 0.0 0
M  V30 19 C 4.4137 7.4147 0.0 0
M  V30 20 C 7.0811 5.8747 0.0 0
M  V30 21 C 5.7473 8.1847 0.0 0
M  V30 22 C 7.0811 7.4147 0.0 0
M  V30 23 C 6.1600 2.4374 0.0 0 CFG=2
M  V30 24 C 7.6916 2.2763 0.0 0 CFG=2
M  V30 25 C 5.5337 1.0304 0.0 0
M  V30 26 C 8.0118 0.7700 0.0 0
M  V30 27 O 6.6781 0.0000 0.0 0
M  V30 28 C 11.2589 4.2450 0.0 0
M  V30 29 C 10.7830 5.7097 0.0 0
M  V30 30 C 12.7653 3.9249 0.0 0
M  V30 31 C 11.8134 6.8541 0.0 0
M  V30 32 C 13.7957 5.0694 0.0 0
M  V30 33 C 13.3199 6.5340 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 23 4 CFG=1
M  V30 10 1 8 9
M  V30 11 1 24 8 CFG=3
M  V30 12 1 9 28
M  V30 13 2 10 26
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R)-4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-3-(hydroxymethyl)-N-met...
C29H37NO4Si
1144105-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0010 6.6685 0.0 0
M  V30 2 O 4.7710 5.3348 0.0 0
M  V30 3 C 5.3348 7.4385 0.0 0
M  V30 4 C 6.3111 5.3348 0.0 0
M  V30 5 C 4.5648 8.7723 0.0 0
M  V30 6 C 6.6685 8.2085 0.0 0
M  V30 7 C 6.1048 6.1048 0.0 0
M  V30 8 C 7.0811 4.0012 0.0 0 CFG=2
M  V30 9 C 8.6211 4.0012 0.0 0 CFG=1
M  V30 10 C 6.3111 2.6673 0.0 0
M  V30 11 O 9.3911 5.3348 0.0 0
M  V30 12 C 9.3911 2.6673 0.0 0
M  V30 13 O 4.7710 2.6673 0.0 0
M  V30 14 C 10.9312 5.3348 0.0 0
M  V30 15 N 8.6211 1.3337 0.0 0
M  V30 16 O 10.9312 2.6673 0.0 0
M  V30 17 C 9.3911 0.0000 0.0 0
M  V30 18 C 3.2310 8.0023 0.0 0
M  V30 19 C 1.6910 8.0023 0.0 0
M  V30 20 C 4.0010 9.3360 0.0 0
M  V30 21 C 0.9209 9.3360 0.0 0
M  V30 22 C 3.2310 10.6697 0.0 0
M  V30 23 C 1.6910 10.6697 0.0 0
M  V30 24 C 2.6673 5.8985 0.0 0
M  V30 25 C 1.3337 6.6685 0.0 0
M  V30 26 C 2.6673 4.3584 0.0 0
M  V30 27 C 0.0000 5.8985 0.0 0
M  V30 28 C 1.3337 3.5884 0.0 0
M  V30 29 C 0.0000 4.3584 0.0 0
M  V30 30 C 11.7012 6.6685 0.0 0
M  V30 31 C 10.9312 8.0023 0.0 0
M  V30 32 C 13.2412 6.6685 0.0 0
M  V30 33 C 11.7012 9.3360 0.0 0
M  V30 34 C 14.0112 8.0023 0.0 0
M  V30 35 C 13.2412 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=1
M  V30 12 1 9 11 CFG=3
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 14 30
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1144104-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1144105-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6664350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Extremely high regio- and stereoselective C-C bond formation of
substituted γ-hydroxylactams: synthesis of macronecines based on their
structural duality
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sengoku, Tetsuya; Suzuki, Takamasa; Kakimoto, Tatsuro; Takahashi, Masaki;
Yoda, Hidemi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(12), 2415-2423

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4R)-4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[[(meth...
C17H35NO6SSi
114676-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3647 4.0597 0.0 0
M  V30 2 O 6.2699 2.8138 0.0 0
M  V30 3 S 5.6436 1.4068 0.0 0 VAL=6
M  V30 4 C 7.0504 0.7805 0.0 0
M  V30 5 O 5.0171 0.0000 0.0 0
M  V30 6 O 4.2366 2.0333 0.0 0
M  V30 7 C 3.6895 6.9613 0.0 0
M  V30 8 O 3.0631 8.3682 0.0 0
M  V30 9 O 2.7844 5.7154 0.0 0
M  V30 10 C 1.5316 8.5292 0.0 0
M  V30 11 C 1.6925 10.0607 0.0 0
M  V30 12 C 0.0000 8.6901 0.0 0
M  V30 13 C 1.3706 6.9976 0.0 0
M  V30 14 O 8.9923 8.0884 0.0 0
M  V30 15 Si 10.3259 7.3184 0.0 0
M  V30 16 C 11.6596 6.5484 0.0 0
M  V30 17 C 9.5559 5.9847 0.0 0
M  V30 18 C 11.0959 8.6521 0.0 0
M  V30 19 C 12.4296 7.8820 0.0 0
M  V30 20 C 12.9933 5.7784 0.0 0
M  V30 21 C 10.8896 5.2147 0.0 0
M  V30 22 C 5.9912 5.4667 0.0 0 CFG=2
M  V30 23 N 5.2212 6.8003 0.0 0
M  V30 24 C 7.4975 5.7868 0.0 0
M  V30 25 C 6.2516 7.9447 0.0 0
M  V30 26 C 7.6584 7.3184 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 22 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 23
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 26 14 CFG=3
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 16 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-[(m...
C17H36N2O3Si
2926570-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3038 5.5543 0.0 0
M  V30 2 O 9.9301 6.9613 0.0 0
M  V30 3 O 10.2089 4.3084 0.0 0
M  V30 4 C 11.4617 7.1222 0.0 0
M  V30 5 C 11.3008 8.6538 0.0 0
M  V30 6 C 12.9933 7.2831 0.0 0
M  V30 7 C 11.6226 5.5906 0.0 0
M  V30 8 C 7.6286 2.6527 0.0 0
M  V30 9 N 6.7233 1.4068 0.0 0
M  V30 10 C 7.3497 0.0000 0.0 0
M  V30 11 O 4.0010 6.6814 0.0 0
M  V30 12 Si 2.6673 5.9114 0.0 0
M  V30 13 C 1.3337 5.1414 0.0 0
M  V30 14 C 1.8973 7.2451 0.0 0
M  V30 15 C 3.4374 4.5778 0.0 0
M  V30 16 C 2.1037 3.8077 0.0 0
M  V30 17 C 0.0000 4.3714 0.0 0
M  V30 18 C 0.5637 6.4751 0.0 0
M  V30 19 N 7.7721 5.3934 0.0 0
M  V30 20 C 7.0021 4.0597 0.0 0 CFG=2
M  V30 21 C 6.7417 6.5378 0.0 0
M  V30 22 C 5.4958 4.3799 0.0 0
M  V30 23 C 5.3348 5.9114 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 20 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 23 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114676-92-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2926570-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40283592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazolines, their compositions and methods for
inhibition of KRAS
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zuhui; Wang, Bin; Wallace, Eli; Xu, Rui; Wehn, Paul; Yang, Yue;
Lightstone, Felice; Pei, Jun; Maciag, Anna Elzbieta; Turner, David
Michael; Simanshu, Dhirendra Kumar; Chan, Albert Hay Wah; Brassard,
Christopher John; Liao, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024030633 A1 2024-02-08

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R,5S,7R,8S,9S,10R)-2-acetyl-8,9,10-trihydroxy-3,7-bis(hydroxymeth...
C14H23NO9
1148055-62-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 O 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4032 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 3.2068 8.3547 0.0 0
M  V30 8 O 0.7700 7.2697 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 O 9.9301 3.8501 0.0 0
M  V30 13 O 5.9290 0.0000 0.0 0
M  V30 14 O 8.5965 1.5400 0.0 0
M  V30 15 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 16 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 17 C 3.1885 3.2238 0.0 0
M  V30 18 O 5.9290 4.6201 0.0 0
M  V30 19 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 20 N 2.9279 5.7020 0.0 0
M  V30 21 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 22 C 7.2628 3.8501 0.0 0 CFG=2
M  V30 23 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 24 C 7.2628 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 22 11 CFG=3
M  V30 13 1 23 13 CFG=3
M  V30 14 1 24 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 21
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3R,5S,7R,8S,9S,10R)-2-Acetyl-8,9,10-trihydroxy-3,7-bis(hydroxymethyl)-N-m...
C14H24N2O8
1148055-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.5788 6.4122 0.0 0
M  V30 2 N 5.2586 7.9185 0.0 0
M  V30 3 O 7.0435 5.9364 0.0 0
M  V30 4 C 6.4032 8.9491 0.0 0
M  V30 5 O 3.2616 1.5400 0.0 0
M  V30 6 C 2.3016 7.1088 0.0 0
M  V30 7 C 0.7700 7.2697 0.0 0
M  V30 8 O 3.2068 8.3547 0.0 0
M  V30 9 C 0.6263 4.2072 0.0 0
M  V30 10 O 0.0000 2.8004 0.0 0
M  V30 11 C 8.5965 4.6201 0.0 0
M  V30 12 O 9.9301 3.8501 0.0 0
M  V30 13 O 5.9290 0.0000 0.0 0
M  V30 14 O 8.5965 1.5400 0.0 0
M  V30 15 C 4.5953 3.8501 0.0 0 CFG=1
M  V30 16 C 4.4344 5.3818 0.0 0 CFG=1
M  V30 17 C 3.1885 3.2238 0.0 0
M  V30 18 O 5.9290 4.6201 0.0 0
M  V30 19 C 4.5953 2.3101 0.0 0 CFG=2
M  V30 20 N 2.9279 5.7020 0.0 0
M  V30 21 C 2.1579 4.3682 0.0 0 CFG=2
M  V30 22 C 7.2628 3.8501 0.0 0 CFG=2
M  V30 23 C 5.9290 1.5400 0.0 0 CFG=1
M  V30 24 C 7.2628 2.3101 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 9 10
M  V30 10 1 21 9 CFG=3
M  V30 11 1 11 12
M  V30 12 1 22 11 CFG=3
M  V30 13 1 23 13 CFG=3
M  V30 14 1 24 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17 CFG=1
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 21
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 19 21 22 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1148055-62-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1148055-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-54447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1S)-2,3,4,6-Tetrahydroxy-1'-N-acetyl-5′(R)-hydroxymethylenespiro[
1,5-anhydro-D-glucitol-1,3′-L-proline methylamide] (8). Compound 4 (30
mg, 0.09 mmol) was dissolved in a solution of methylamine in absolute
ethanol (4.5 mL, 33% wt) and stirred for 18 hours at room temperature.
The mixture was concentrated and purified by the flash column
chromatography (dichloromethane/ methanol: 2/1) to get compound 8 as a
colorless oil (28 mg, 93%) [α]D = 62.3 (c 0.6, MeOH); 1H NMR (500 MHz,
D2O) δ = 1.86 (s, cis, 2.22H), 2.05 (s, trans, 0.78H), 2.11 (m, cis,
0.74H), 2.25 (m, 1.26H), 2.56 (s, trans, 0.78H), 2.61 (s, cis, 2.22H),
3.25-3.35 (m, 2H), 3.37-3.43 (m, 1H), 3.53-3.61 (m, 2.79H), 3.64-3.70 (m,
1.21H), 3.96-4.04 (m, 1H), 4.07 (s, cis, 0.74H), 4.09-4.18 (m, 1H), 4.19
(s, trans, 0.26H); 13C NMR (75 MHz, CD3OD) cis rotamer, δ = 23.1, 26.0,
26.4, 59.6, 60.7, 62.7, 71.1, 71.3, 74.5, 75.6, 77.4, 87.0, 172.9, 173.8;
trans rotamer, δ = 21.9, 28.4, 26.3, 59.3, 62.3, 63.1, 71.1, 71.6, 73.3,
75.9, 77.4, 85.5, 173.2, 173.8; HRMS calcd for C14H25N2O8 [M + H]+
349.1611, found 349.1618.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular Hydrogen Bond-Controlled Prolyl Amide Isomerization in
Glucosyl 3'(S)-Hydroxy-5'-hydroxymethylproline Hybrids: Influence of a
C-5'-Hydroxymethyl Substituent on the Thermodynamics and Kinetics of
Prolyl Amide Cis/Trans Isomerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Kaidong; Teklebrhan, Robel B.; Schreckenbach, G.; Wetmore, Stacey;
Schweizer, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(10), 3735-3743

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
6-(4-Methoxyphenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carboxylic acid
C14H12O5S
115411-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 2.3101 6.6687 0.0 0
M  V30 4 C 0.7700 4.0012 0.0 0
M  V30 5 O 0.0000 2.6675 0.0 0
M  V30 6 O 0.0000 5.3348 0.0 0
M  V30 7 O 11.5503 4.0012 0.0 0
M  V30 8 C 12.3203 5.3348 0.0 0
M  V30 9 C 5.3901 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 O 4.6201 5.3348 0.0 0
M  V30 12 C 3.0801 2.6675 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 7.7002 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 9.2402 5.3348 0.0 0
M  V30 20 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Methoxyphenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
C15H15NO4S
1512808-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 S 3.8501 1.3338 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 3.8501 6.6687 0.0 0
M  V30 8 O 13.0903 4.0012 0.0 0
M  V30 9 C 13.8603 5.3348 0.0 0
M  V30 10 C 3.8501 4.0012 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 6.1601 5.3348 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 C 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 12
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 115411-57-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512808-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1120529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the preparation of
substituted 4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamides (11) To
a stirring solution of appropriately substituted 10 (0.76 mmoles) in DMF
at rt, HATU (0.83 mmoles) and diisopropylethylamine (2.29 mmoles) was
added. Appropriately substituted amine (0.76 mmoles) was added after 15
min and stirring continued for another 1h at rt. The reaction was
monitored by TLC and then poured into ice water with stirring. The so
formed precipitate was filtered off and recrystallized from a mixture of
ethyl acetate and n-hexane to get pure compound.
6-(4-fluorophenyl)-4-(methylthio)-2-oxo-N-phenyl-2H-pyran-3-carboxamide
6-(4-methoxyphenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
Light yellow powder; Yield 93 %. mp 205-206°C; Mass [M++1] = 306.0; 1H
NMR: (400 MHz, DMSO-d6): δ 2.57 (s, 3H, Me), 2.74-2.76 (d, J = 4.4 Hz,
3H, Me), 3.85 (s, 3H, OMe), 7.03 (s, 1H, Pyrone), 7.10-7.12 (d, J = 8.8
Hz, 2H, ArH), 7.96-7.98 (d, J = 8.4 Hz, 2H, ArH), 8.66-8.67 (q, J = 4.8
Hz, 1H, NH amide).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide
Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konreddy, Ananda Kumar; Toyama, Massaki; Ito, Wataru; Bal, Chandralata;
Baba, Masanori; Sharon, Ashoke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(3), 259-263

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[4-(2,2-dichloroethenyl)-2-ethoxyphenoxy]methyl]-α-(methoxyimi...
C21H21Cl2NO5
1159342-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 6.1601 0.0 0
M  V30 2 C 9.3357 6.9301 0.0 0
M  V30 3 N 12.0032 6.9301 0.0 0
M  V30 4 O 9.3357 8.4701 0.0 0
M  V30 5 O 8.0021 6.1601 0.0 0
M  V30 6 O 13.3369 6.1601 0.0 0
M  V30 7 C 10.6695 9.2401 0.0 0
M  V30 8 C 14.6705 6.9301 0.0 0
M  V30 9 C 8.0021 4.6201 0.0 0
M  V30 10 O 6.6684 3.8500 0.0 0
M  V30 11 O 4.0010 2.3100 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 1.3337 8.4701 0.0 0
M  V30 16 Cl 2.6673 9.2401 0.0 0
M  V30 17 Cl 0.0000 9.2401 0.0 0
M  V30 18 C 10.6695 4.6201 0.0 0
M  V30 19 C 9.3357 3.8500 0.0 0
M  V30 20 C 12.0032 3.8500 0.0 0
M  V30 21 C 9.3357 2.3100 0.0 0
M  V30 22 C 12.0032 2.3100 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 4.0010 3.8500 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 28 C 4.0010 6.9301 0.0 0
M  V30 29 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 29
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[4-(2,2-Dichloroethenyl)-2-ethoxyphenoxy]methyl]-α-(methoxyimino)-N-m...
C21H22Cl2N2O4
1159342-52-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 6.1601 0.0 0
M  V30 2 C 9.3357 6.9301 0.0 0
M  V30 3 N 12.0032 6.9301 0.0 0
M  V30 4 N 9.3357 8.4701 0.0 0
M  V30 5 O 8.0021 6.1601 0.0 0
M  V30 6 O 13.3369 6.1601 0.0 0
M  V30 7 C 10.6695 9.2401 0.0 0
M  V30 8 C 14.6705 6.9301 0.0 0
M  V30 9 C 8.0021 4.6201 0.0 0
M  V30 10 O 6.6684 3.8500 0.0 0
M  V30 11 O 4.0010 2.3100 0.0 0
M  V30 12 C 2.6673 1.5400 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 1.3337 6.9301 0.0 0
M  V30 15 C 1.3337 8.4701 0.0 0
M  V30 16 Cl 2.6673 9.2401 0.0 0
M  V30 17 Cl 0.0000 9.2401 0.0 0
M  V30 18 C 10.6695 4.6201 0.0 0
M  V30 19 C 9.3357 3.8500 0.0 0
M  V30 20 C 12.0032 3.8500 0.0 0
M  V30 21 C 9.3357 2.3100 0.0 0
M  V30 22 C 12.0032 2.3100 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 4.0010 3.8500 0.0 0
M  V30 26 C 5.3348 6.1601 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 28 C 4.0010 6.9301 0.0 0
M  V30 29 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 25
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 29
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-52-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8386368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 60: Preparation of
(E)-2-(2-((4-(2,2-dichlorovinyl)-2-ethoxyphenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((4-(2,2-dichlorovinyl)-2-ethoxyphenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.438g,
1mmol) obtained in Example 59 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.407g, 93%). 1H-NMR(CDCl3, TMS)δ(ppm):
1.33(t, 3H), 2.74(s, 3H), 3.98(m, 2H), 4.00(s, 3H), 5.02(s, 2H),
6.62-7.44(m, 8H) MS : 436.1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-1-(phenylmethyl)-L-tryptophan phenylmethyl e...
C30H32N2O4
1163710-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7239 9.3358 0.0 0
M  V30 2 C 5.9539 8.0021 0.0 0 CFG=2
M  V30 3 C 6.7239 6.6685 0.0 0
M  V30 4 N 4.4139 8.0021 0.0 0
M  V30 5 O 5.9539 5.3348 0.0 0
M  V30 6 O 8.2639 6.6685 0.0 0
M  V30 7 C 3.6439 9.3358 0.0 0
M  V30 8 C 6.7239 4.0010 0.0 0
M  V30 9 O 2.1038 9.3358 0.0 0
M  V30 10 O 4.4139 10.6696 0.0 0
M  V30 11 C 1.3338 10.6696 0.0 0
M  V30 12 C 2.6675 11.4396 0.0 0
M  V30 13 C 0.5638 12.0033 0.0 0
M  V30 14 C 0.0000 9.8996 0.0 0
M  V30 15 C 11.8796 7.6607 0.0 0
M  V30 16 C 9.1691 10.5818 0.0 0
M  V30 17 C 8.2639 9.3358 0.0 0
M  V30 18 C 10.6337 10.1058 0.0 0
M  V30 19 C 8.8488 12.0881 0.0 0
M  V30 20 C 9.1691 8.0899 0.0 0
M  V30 21 N 10.6337 8.5658 0.0 0
M  V30 22 C 11.7783 11.1364 0.0 0
M  V30 23 C 9.9934 13.1185 0.0 0
M  V30 24 C 11.4579 12.6427 0.0 0
M  V30 25 C 13.2866 8.2870 0.0 0
M  V30 26 C 13.4475 9.8186 0.0 0
M  V30 27 C 14.5324 7.3818 0.0 0
M  V30 28 C 14.8543 10.4451 0.0 0
M  V30 29 C 15.9393 8.0081 0.0 0
M  V30 30 C 16.1003 9.5398 0.0 0
M  V30 31 C 5.9539 2.6673 0.0 0
M  V30 32 C 6.7239 1.3337 0.0 0
M  V30 33 C 4.4139 2.6673 0.0 0
M  V30 34 C 5.9539 0.0000 0.0 0
M  V30 35 C 3.6439 1.3337 0.0 0
M  V30 36 C 4.4139 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 31
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 21
M  V30 17 1 15 25
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-(methylamino)-2-oxo-1-[[1-(phenylmethyl)-1H-indol...
C24H29N3O3
2230510-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3763 5.3347 0.0 0
M  V30 2 C 10.1463 4.0011 0.0 0 CFG=1
M  V30 3 N 11.6864 4.0011 0.0 0
M  V30 4 C 9.3763 2.6674 0.0 0
M  V30 5 C 12.4564 5.3347 0.0 0
M  V30 6 N 10.1463 1.3336 0.0 0
M  V30 7 O 7.8363 2.6674 0.0 0
M  V30 8 O 13.9964 5.3347 0.0 0
M  V30 9 O 11.6864 6.6684 0.0 0
M  V30 10 C 9.3763 0.0000 0.0 0
M  V30 11 C 14.7664 6.6684 0.0 0
M  V30 12 C 16.1002 5.8984 0.0 0
M  V30 13 C 15.5364 8.0022 0.0 0
M  V30 14 C 13.4327 7.4384 0.0 0
M  V30 15 C 4.2207 3.6595 0.0 0
M  V30 16 C 6.9311 6.5806 0.0 0
M  V30 17 C 5.4666 6.1047 0.0 0
M  V30 18 C 7.8363 5.3347 0.0 0
M  V30 19 C 7.2514 8.0870 0.0 0
M  V30 20 N 5.4666 4.5647 0.0 0
M  V30 21 C 4.3220 7.1352 0.0 0
M  V30 22 C 6.9311 4.0889 0.0 0
M  V30 23 C 6.1069 9.1175 0.0 0
M  V30 24 C 4.6424 8.6416 0.0 0
M  V30 25 C 2.8137 4.2860 0.0 0
M  V30 26 C 2.6528 5.8175 0.0 0
M  V30 27 C 1.5679 3.3808 0.0 0
M  V30 28 C 1.2460 6.4439 0.0 0
M  V30 29 C 0.1611 4.0071 0.0 0
M  V30 30 C 0.0000 5.5386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 20
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163710-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230510-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19706579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric α-arylation of amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel J.; Ward, John W.; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature (London, United Kingdom) (2018), 562(7725), 105-109

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-1-(phenylmethyl)-L-tryptophan phenylmethyl e...
C30H32N2O4
1163710-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7239 9.3358 0.0 0
M  V30 2 C 5.9539 8.0021 0.0 0 CFG=2
M  V30 3 C 6.7239 6.6685 0.0 0
M  V30 4 N 4.4139 8.0021 0.0 0
M  V30 5 O 5.9539 5.3348 0.0 0
M  V30 6 O 8.2639 6.6685 0.0 0
M  V30 7 C 3.6439 9.3358 0.0 0
M  V30 8 C 6.7239 4.0010 0.0 0
M  V30 9 O 2.1038 9.3358 0.0 0
M  V30 10 O 4.4139 10.6696 0.0 0
M  V30 11 C 1.3338 10.6696 0.0 0
M  V30 12 C 2.6675 11.4396 0.0 0
M  V30 13 C 0.5638 12.0033 0.0 0
M  V30 14 C 0.0000 9.8996 0.0 0
M  V30 15 C 11.8796 7.6607 0.0 0
M  V30 16 C 9.1691 10.5818 0.0 0
M  V30 17 C 8.2639 9.3358 0.0 0
M  V30 18 C 10.6337 10.1058 0.0 0
M  V30 19 C 8.8488 12.0881 0.0 0
M  V30 20 C 9.1691 8.0899 0.0 0
M  V30 21 N 10.6337 8.5658 0.0 0
M  V30 22 C 11.7783 11.1364 0.0 0
M  V30 23 C 9.9934 13.1185 0.0 0
M  V30 24 C 11.4579 12.6427 0.0 0
M  V30 25 C 13.2866 8.2870 0.0 0
M  V30 26 C 13.4475 9.8186 0.0 0
M  V30 27 C 14.5324 7.3818 0.0 0
M  V30 28 C 14.8543 10.4451 0.0 0
M  V30 29 C 15.9393 8.0081 0.0 0
M  V30 30 C 16.1003 9.5398 0.0 0
M  V30 31 C 5.9539 2.6673 0.0 0
M  V30 32 C 6.7239 1.3337 0.0 0
M  V30 33 C 4.4139 2.6673 0.0 0
M  V30 34 C 5.9539 0.0000 0.0 0
M  V30 35 C 3.6439 1.3337 0.0 0
M  V30 36 C 4.4139 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 31
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 21
M  V30 17 1 15 25
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-(methylamino)-2-oxo-1-[[1-(phenylmethyl)-1H-indol...
C24H29N3O3
2230510-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3763 5.3347 0.0 0
M  V30 2 C 10.1463 4.0011 0.0 0 CFG=1
M  V30 3 N 11.6864 4.0011 0.0 0
M  V30 4 C 9.3763 2.6674 0.0 0
M  V30 5 C 12.4564 5.3347 0.0 0
M  V30 6 N 10.1463 1.3336 0.0 0
M  V30 7 O 7.8363 2.6674 0.0 0
M  V30 8 O 13.9964 5.3347 0.0 0
M  V30 9 O 11.6864 6.6684 0.0 0
M  V30 10 C 9.3763 0.0000 0.0 0
M  V30 11 C 14.7664 6.6684 0.0 0
M  V30 12 C 16.1002 5.8984 0.0 0
M  V30 13 C 15.5364 8.0022 0.0 0
M  V30 14 C 13.4327 7.4384 0.0 0
M  V30 15 C 4.2207 3.6595 0.0 0
M  V30 16 C 6.9311 6.5806 0.0 0
M  V30 17 C 5.4666 6.1047 0.0 0
M  V30 18 C 7.8363 5.3347 0.0 0
M  V30 19 C 7.2514 8.0870 0.0 0
M  V30 20 N 5.4666 4.5647 0.0 0
M  V30 21 C 4.3220 7.1352 0.0 0
M  V30 22 C 6.9311 4.0889 0.0 0
M  V30 23 C 6.1069 9.1175 0.0 0
M  V30 24 C 4.6424 8.6416 0.0 0
M  V30 25 C 2.8137 4.2860 0.0 0
M  V30 26 C 2.6528 5.8175 0.0 0
M  V30 27 C 1.5679 3.3808 0.0 0
M  V30 28 C 1.2460 6.4439 0.0 0
M  V30 29 C 0.1611 4.0071 0.0 0
M  V30 30 C 0.0000 5.5386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 20
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163710-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230510-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20359329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quaternary unnatural amino acids and hydantoins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel Jamie; Ward, John William; Clayden, Jonathan Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United Kingdom, GB2557931 A 2018-07-04

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-1-(phenylmethyl)-L-tryptophan phenylmethyl e...
C30H32N2O4
1163710-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.7239 9.3358 0.0 0
M  V30 2 C 5.9539 8.0021 0.0 0 CFG=2
M  V30 3 C 6.7239 6.6685 0.0 0
M  V30 4 N 4.4139 8.0021 0.0 0
M  V30 5 O 5.9539 5.3348 0.0 0
M  V30 6 O 8.2639 6.6685 0.0 0
M  V30 7 C 3.6439 9.3358 0.0 0
M  V30 8 C 6.7239 4.0010 0.0 0
M  V30 9 O 2.1038 9.3358 0.0 0
M  V30 10 O 4.4139 10.6696 0.0 0
M  V30 11 C 1.3338 10.6696 0.0 0
M  V30 12 C 2.6675 11.4396 0.0 0
M  V30 13 C 0.5638 12.0033 0.0 0
M  V30 14 C 0.0000 9.8996 0.0 0
M  V30 15 C 11.8796 7.6607 0.0 0
M  V30 16 C 9.1691 10.5818 0.0 0
M  V30 17 C 8.2639 9.3358 0.0 0
M  V30 18 C 10.6337 10.1058 0.0 0
M  V30 19 C 8.8488 12.0881 0.0 0
M  V30 20 C 9.1691 8.0899 0.0 0
M  V30 21 N 10.6337 8.5658 0.0 0
M  V30 22 C 11.7783 11.1364 0.0 0
M  V30 23 C 9.9934 13.1185 0.0 0
M  V30 24 C 11.4579 12.6427 0.0 0
M  V30 25 C 13.2866 8.2870 0.0 0
M  V30 26 C 13.4475 9.8186 0.0 0
M  V30 27 C 14.5324 7.3818 0.0 0
M  V30 28 C 14.8543 10.4451 0.0 0
M  V30 29 C 15.9393 8.0081 0.0 0
M  V30 30 C 16.1003 9.5398 0.0 0
M  V30 31 C 5.9539 2.6673 0.0 0
M  V30 32 C 6.7239 1.3337 0.0 0
M  V30 33 C 4.4139 2.6673 0.0 0
M  V30 34 C 5.9539 0.0000 0.0 0
M  V30 35 C 3.6439 1.3337 0.0 0
M  V30 36 C 4.4139 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 31
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 21
M  V30 17 1 15 25
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 18 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-(methylamino)-2-oxo-1-[[1-(phenylmethyl)-1H-indol...
C24H29N3O3
2230510-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3763 5.3347 0.0 0
M  V30 2 C 10.1463 4.0011 0.0 0 CFG=1
M  V30 3 N 11.6864 4.0011 0.0 0
M  V30 4 C 9.3763 2.6674 0.0 0
M  V30 5 C 12.4564 5.3347 0.0 0
M  V30 6 N 10.1463 1.3336 0.0 0
M  V30 7 O 7.8363 2.6674 0.0 0
M  V30 8 O 13.9964 5.3347 0.0 0
M  V30 9 O 11.6864 6.6684 0.0 0
M  V30 10 C 9.3763 0.0000 0.0 0
M  V30 11 C 14.7664 6.6684 0.0 0
M  V30 12 C 16.1002 5.8984 0.0 0
M  V30 13 C 15.5364 8.0022 0.0 0
M  V30 14 C 13.4327 7.4384 0.0 0
M  V30 15 C 4.2207 3.6595 0.0 0
M  V30 16 C 6.9311 6.5806 0.0 0
M  V30 17 C 5.4666 6.1047 0.0 0
M  V30 18 C 7.8363 5.3347 0.0 0
M  V30 19 C 7.2514 8.0870 0.0 0
M  V30 20 N 5.4666 4.5647 0.0 0
M  V30 21 C 4.3220 7.1352 0.0 0
M  V30 22 C 6.9311 4.0889 0.0 0
M  V30 23 C 6.1069 9.1175 0.0 0
M  V30 24 C 4.6424 8.6416 0.0 0
M  V30 25 C 2.8137 4.2860 0.0 0
M  V30 26 C 2.6528 5.8175 0.0 0
M  V30 27 C 1.5679 3.3808 0.0 0
M  V30 28 C 1.2460 6.4439 0.0 0
M  V30 29 C 0.1611 4.0071 0.0 0
M  V30 30 C 0.0000 5.5386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 20
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 24
M  V30 26 2 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1163710-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230510-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19299335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quaternary unnatural amino acids and hydantoins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leonard, Daniel Jamie; Ward, John William; Clayden, Jonathan Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018109496 A2 2018-06-21

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(methylamino)-1,4-naphthalenedione
C11H8ClNO2
15252-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 Cl 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15252-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32680033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel 2-Aniline-1,4-naphthoquinones as Potential New Drug
Treatment for Leber's Hereditary Optic Neuropathy (LHON)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Varricchio, Carmine; Beirne, Kathy; Aeschlimann, Pascale; Heard, Charles;
Rozanowska, Malgorzata; Votruba, Marcela; Brancale, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(22), 13638-13655

$RFMT $RIREG SCHEME263 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Aminobenzaldehyde
C7H7NO
1709-44-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 N 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Aminophenyl)-2,3-dihydro-3-methyl-4(1H)-quinazolinone
C15H15N3O
1547295-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 0.0000 0.0 0
M  V30 2 O 7.7000 0.0000 0.0 0
M  V30 3 N 0.0000 5.3349 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 N 5.3900 1.3338 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 6.9300 1.3338 0.0 0
M  V30 9 C 7.7000 2.6674 0.0 0
M  V30 10 C 7.7000 5.3349 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3349 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 2.3100 1.3338 0.0 0
M  V30 17 C 0.7700 4.0011 0.0 0
M  V30 18 C 0.7700 1.3338 0.0 0
M  V30 19 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1709-44-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1547295-92-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21402854
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10,11-Dihydro-4-methyl-11-oxodibenz[b,f]oxepin-10-acetic acid
C17H14O4
1184947-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4114 3.8179 0.0 0
M  V30 2 C 8.3716 5.0219 0.0 0
M  V30 3 O 9.8944 4.7924 0.0 0
M  V30 4 O 7.8090 6.4555 0.0 0
M  V30 5 O 6.5636 6.5665 0.0 0
M  V30 6 C 0.0000 5.3116 0.0 0
M  V30 7 C 5.0211 2.7750 0.0 0
M  V30 8 C 3.4854 2.6599 0.0 0
M  V30 9 C 5.8886 4.0474 0.0 0
M  V30 10 C 5.8886 1.5026 0.0 0
M  V30 11 O 2.4379 3.7888 0.0 0
M  V30 12 C 2.8172 1.2724 0.0 0
M  V30 13 C 5.4346 5.5190 0.0 0
M  V30 14 C 5.2204 0.1150 0.0 0
M  V30 15 C 2.6673 5.3116 0.0 0
M  V30 16 C 3.6847 0.0000 0.0 0
M  V30 17 C 4.0010 6.0816 0.0 0
M  V30 18 C 1.3337 6.0816 0.0 0
M  V30 19 C 4.0010 7.6216 0.0 0
M  V30 20 C 1.3337 7.6216 0.0 0
M  V30 21 C 2.6673 8.3916 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 13
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10,11-Dihydro-N,4-dimethyl-11-oxodibenz[b,f]oxepin-10-acetamide
C18H17NO3
1184947-17-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4115 3.8179 0.0 0
M  V30 2 C 8.3717 5.0219 0.0 0
M  V30 3 N 9.8945 4.7924 0.0 0
M  V30 4 O 7.8090 6.4555 0.0 0
M  V30 5 C 10.8547 5.9964 0.0 0
M  V30 6 O 6.5636 6.5665 0.0 0
M  V30 7 C 0.0000 5.3116 0.0 0
M  V30 8 C 5.0211 2.7750 0.0 0
M  V30 9 C 5.8886 4.0473 0.0 0
M  V30 10 C 3.4854 2.6599 0.0 0
M  V30 11 C 5.8886 1.5026 0.0 0
M  V30 12 C 5.4348 5.5190 0.0 0
M  V30 13 O 2.4379 3.7888 0.0 0
M  V30 14 C 2.8172 1.2724 0.0 0
M  V30 15 C 5.2204 0.1150 0.0 0
M  V30 16 C 4.0011 6.0816 0.0 0
M  V30 17 C 2.6675 5.3116 0.0 0
M  V30 18 C 3.6847 0.0000 0.0 0
M  V30 19 C 4.0011 7.6216 0.0 0
M  V30 20 C 1.3338 6.0816 0.0 0
M  V30 21 C 2.6675 8.3916 0.0 0
M  V30 22 C 1.3338 7.6216 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 12
M  V30 7 1 7 20
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 17
M  V30 20 2 16 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1184947-13-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1184947-17-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13119791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
N-Methyl-2-(4-methyl-11-oxo-10,11-dihydro-dibenzo[b,f]oxepin-10-yl)-acetamide
(F): The acid E (34.5 g, 120 mmol, 1.0 eq) was suspended in
tetrahydrofuran (200 mL) under nitrogen. To the mixture was added
N,N-diisopropylethylamine (31.3 mL, 180 mmol, 1.5 eq), methyl amine (120
mL, 240 mmol, 2.0 eq) and TBTU (46.2 g, 144 mmol, 1.2 eq). The reaction
was stirred at room temperature for 2 hours. Between 30 and 60 minutes, a
thick precipitate forms and the reaction turns light green. Another 100
mL of tetrahydrofuran was added and slow stirring resumed.
N,N-dimethylformamide (100 mL) was added followed by additional amount of
TBTU (15 g). The reaction mixture was concentrated to near dryness and
the product was partitioned between diethyl ether and a 50% aqueous
solution of sodium bicarbonate. The aqueous was washed with diethyl ether
and all organics were combined and concentrated. The resulting solid was
triturated in 300 mL 1:1 diethyl ether/hexanes, filtered and dried to
give 33.3 g off-white solid (93%). 1H NMR (400 MHz, CDCl3) 7.84 (dd, 1H),
7.43 (m, 1H), 7.25-7.20 (m, 3H), 7.16 (m, 1H), 7.06 (t, 1H), 4.96 (dd,
1H), 3.33 (m, 1H), 2.82 (d, 3H), 2.75 (dd, 1H), 2.57 (s, 3H); MS: (M+H)+
= 296.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of TBTU
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Le Bourdonnec, Bertrand; Dolle, Roland
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009105507 A2 2009-08-27

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(2S)-1-[(1,1-Dimethylethoxy)carbonyl]-2-pyrrolidinyl]methyl]-1H-1,2,3-tri...
C13H20N4O4
1185885-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9564 4.5934 0.0 0
M  V30 2 C 7.0170 5.9560 0.0 0
M  V30 3 O 8.3508 6.7260 0.0 0
M  V30 4 O 7.0170 4.4160 0.0 0
M  V30 5 C 9.6845 5.9560 0.0 0
M  V30 6 C 8.9145 4.6223 0.0 0
M  V30 7 C 11.0181 5.1860 0.0 0
M  V30 8 C 10.4545 7.2898 0.0 0
M  V30 9 C 2.9211 1.4070 0.0 0
M  V30 10 O 2.2946 0.0000 0.0 0
M  V30 11 O 4.4526 1.5679 0.0 0
M  V30 12 C 4.2766 6.0997 0.0 0 CFG=2
M  V30 13 N 5.6834 6.7260 0.0 0
M  V30 14 C 3.2460 7.2442 0.0 0
M  V30 15 C 5.5225 8.2577 0.0 0
M  V30 16 C 4.0160 8.5778 0.0 0
M  V30 17 C 2.4917 4.1174 0.0 0
M  V30 18 C 2.0159 2.6528 0.0 0
M  V30 19 N 1.2459 5.0226 0.0 0
M  V30 20 N 0.4759 2.6528 0.0 0
M  V30 21 N 0.0000 4.1174 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 12 1 CFG=3
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 18
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[5-[(methylamino)carbonyl]-1H-1,2,3-triazol-4-yl]me...
C14H23N5O3
1185885-06-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8736 3.8500 0.0 0
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 4.2074 3.0800 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 1.5400 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 5.5842 5.8194 0.0 0
M  V30 9 C 8.8613 5.1228 0.0 0
M  V30 10 N 10.3930 4.9617 0.0 0
M  V30 11 O 7.9561 3.8768 0.0 0
M  V30 12 C 11.0193 3.5549 0.0 0
M  V30 13 N 2.8736 5.3900 0.0 0
M  V30 14 C 4.1195 6.2952 0.0 0 CFG=2
M  V30 15 C 1.6278 6.2952 0.0 0
M  V30 16 C 3.6436 7.7599 0.0 0
M  V30 17 C 2.1036 7.7599 0.0 0
M  V30 18 C 6.7287 6.8498 0.0 0
M  V30 19 C 8.2350 6.5296 0.0 0
M  V30 20 N 6.5676 8.3813 0.0 0
M  V30 21 N 9.0050 7.8632 0.0 0
M  V30 22 N 7.9746 9.0078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 14 8 CFG=1
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1185885-05-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1185885-06-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4519689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel triazolopeptides: chirospecific synthesis and conformational
studies of proline derived analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Paul, Andreas; Einsiedel, Juergen; Waibel, Reiner; Heinemann, Frank W.;
Meyer, Karsten; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(31), 6156-6168

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-5-[(4-methoxyphenyl)methoxy]-4H-pyran-4-one
C14H14O5
118708-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 O 5.3900 0.0000 0.0 0
M  V30 4 C 0.7700 2.6674 0.0 0
M  V30 5 O 0.0000 4.0011 0.0 0
M  V30 6 O 13.8600 4.0011 0.0 0
M  V30 7 C 14.6300 5.3349 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 3.0800 1.3338 0.0 0
M  V30 12 O 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 9.2400 4.0011 0.0 0
M  V30 15 C 10.0100 5.3349 0.0 0
M  V30 16 C 10.0100 2.6674 0.0 0
M  V30 17 C 11.5500 5.3349 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 2 3 9
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Hydroxymethyl)-5-[(4-methoxyphenyl)methoxy]-1-methyl-4(1H)-pyridinone
C15H17NO4
132182-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 O 4.0010 6.1601 0.0 0
M  V30 4 C 4.0010 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 13.3370 6.9302 0.0 0
M  V30 8 C 14.6707 6.1601 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0010 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 N 4.0010 1.5400 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 9.3358 4.6201 0.0 0
M  V30 16 C 9.3358 6.1601 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 10.6697 6.9302 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 12.0033 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 2 3 10
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118708-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132182-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30878684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of 2-substituted benzothiazole derivatives as
triple-functional agents with potential for AD therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Liu; Zhang, Minkui; Tang, Li; Weng, Qinjie; Shen, Yanhong; Hu,
Yongzhou; Sheng, Rong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(21), 17318-17327

$RFMT $RIREG SCHEME267 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chloroform-d
CCl3D
865-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 Cl 3.0800 1.5400 0.0 0
M  V30 4 Cl 1.5400 0.0000 0.0 0
M  V30 5 H 1.5400 3.0800 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Anthranilic acid
C7H7NO2
118-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H15Cl3DNO
2416931-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0
M  V30 2 N 4.6201 2.6675 0.0 0
M  V30 3 C 4.6201 5.3348 0.0 0
M  V30 4 C 5.3901 1.3338 0.0 0
M  V30 5 Cl 3.2864 4.5648 0.0 0
M  V30 6 Cl 3.8501 6.6687 0.0 0
M  V30 7 Cl 5.9538 6.1048 0.0 0
M  V30 8 O 11.5503 4.0012 0.0 0
M  V30 9 C 12.3203 5.3348 0.0 0
M  V30 10 C 6.9302 4.0012 0.0 0
M  V30 11 C 7.7002 2.6675 0.0 0
M  V30 12 C 7.7002 5.3348 0.0 0
M  V30 13 C 9.2402 2.6675 0.0 0
M  V30 14 C 9.2402 5.3348 0.0 0
M  V30 15 C 10.0102 4.0012 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 2.3101 1.3338 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 0.7700 1.3338 0.0 0
M  V30 20 C 0.7700 4.0012 0.0 0
M  V30 21 C 0.0000 2.6675 0.0 0
M  V30 22 H 3.0801 0.0000 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 16
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 8 9
M  V30 10 1 8 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 17 22
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 865-49-6
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 118-92-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416931-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-544-CAS-22447803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-46-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 865-49-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Old and New Aryne Precursor, Anthranilic Acid: Multicomponent Reaction of
Benzyne with Quinolines or Imines and Pronucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okuma, Kentaro; Qu, Yuxuan; Fujiie, Nonoka; Nagahora, Noriyoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry Letters (2020), 49(5), 446-449

$RFMT $RIREG SCHEME268 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclobutanone
C4H6O
1191-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7179 1.0889 0.0 0
M  V30 2 C 2.1779 1.0889 0.0 0
M  V30 3 C 1.0889 2.1779 0.0 0
M  V30 4 C 1.0889 0.0000 0.0 0
M  V30 5 C 0.0000 1.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-2-isocyanatopropanoate
C5H7NO3
30293-82-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 2 C 2.6675 1.5400 0.0 0
M  V30 3 N 5.3348 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 O 8.0022 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-1-(methylamino)cyclobutanecarbonyl-...
C20H33N3O6
1256239-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5533 3.7710 0.0 0
M  V30 2 C 7.0133 3.7710 0.0 0
M  V30 3 C 9.3233 2.4374 0.0 0
M  V30 4 O 6.2433 5.1048 0.0 0
M  V30 5 C 10.6570 4.3348 0.0 0
M  V30 6 N 11.9906 5.1048 0.0 0
M  V30 7 O 10.6570 2.7948 0.0 0
M  V30 8 C 13.3242 4.3348 0.0 0 CFG=1
M  V30 9 C 14.6580 5.1048 0.0 0
M  V30 10 C 13.3242 2.7948 0.0 0
M  V30 11 O 15.9917 4.3348 0.0 0
M  V30 12 O 14.6580 6.6448 0.0 0
M  V30 13 C 17.3253 5.1048 0.0 0
M  V30 14 C 3.6812 3.4208 0.0 0
M  V30 15 O 2.1749 3.1006 0.0 0
M  V30 16 O 4.1571 4.8855 0.0 0
M  V30 17 C 1.1444 4.2450 0.0 0
M  V30 18 C 2.2889 5.2756 0.0 0
M  V30 19 C 0.1140 5.3895 0.0 0
M  V30 20 C 0.0000 3.2146 0.0 0
M  V30 21 C 9.3233 5.1048 0.0 0
M  V30 22 C 7.9895 5.8748 0.0 0
M  V30 23 C 10.0933 6.4384 0.0 0
M  V30 24 C 8.7595 7.2084 0.0 0
M  V30 25 C 6.2433 2.4374 0.0 0 CFG=2
M  V30 26 N 4.7116 2.2764 0.0 0
M  V30 27 C 6.8696 1.0306 0.0 0
M  V30 28 C 4.3915 0.7700 0.0 0
M  V30 29 C 5.7253 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 25 2 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 26
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191-95-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 30293-82-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256239-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10489642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure for the Ugi 4CR Ketones (9.48 mmol)
was added to a solution of 40% methylamine in MeOH (4.75 mL, 9.48 mmol)
and allowed to precondense for 1.5 h. N-Boc-L-proline (2.04g, 9.48 mmol)
added and resulting mixture stirred for 15 min., then isocyanide derived
from L-alanine methyl ester (1.08 g, 9.48 mmol) was added. Reaction was
left to stir for 5 days at room temperature, then concentrated in vacuo.
Crude product was loaded onto a 80 mm x 50 mm Si gel resin bed and eluted
with 7:3 EtOAc:hexanes. Cyclobutanone Ugi Tripeptide (6): Yield: 3.62 g
(8.81 mmol, 93%). stains white with p-anisaldehyde. Rf=0.25 (7:3
EtOAc:hexanes), 1H NMR (CDCl3, mixture of rotamers) 7.65 (1H, d), 4.42
(2H, m), 3.52 (3H, s), 3.45 (1H, m), 3.40 (1H, m), 2.87 (3H, s), 2.54
(4H, m), 2.03 (3H, m), 1.65 (2H, m), 1.54 (1H, m), 1.38 (3H, d), 1.28
(9H, s). 13C NMR (CDCl3, mixture of rotamers) 173.7, 173.3, 173.2, 154.7,
153.6, 79.7, 65.6, 60.5, 56.7, 53.6.0, 52.2, 48.1, 46.9, 33.2, 31.8, 28.5
(3C), 24.5, 23.4, 17.5, 14.5. HRMS (FAB): calcd for C20H33N3O6Na [M+Na]+
434.2267, obsd 434.2282 (∆ = 3.4 ppm).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity oriented synthesis of enopeptins and their use as
antibacterials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sello, Jason K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012135615 A2 2012-10-04

$RFMT $RIREG SCHEME269 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclobutanone
C4H6O
1191-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7179 1.0889 0.0 0
M  V30 2 C 2.1779 1.0889 0.0 0
M  V30 3 C 1.0889 2.1779 0.0 0
M  V30 4 C 1.0889 0.0000 0.0 0
M  V30 5 C 0.0000 1.0889 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-Proline
C10H17NO4
15761-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.5254 2.6218 0.0 0
M  V30 2 O 5.8592 1.8517 0.0 0
M  V30 3 O 4.5254 4.1618 0.0 0
M  V30 4 C 7.1929 2.6218 0.0 0
M  V30 5 C 6.4229 3.9554 0.0 0
M  V30 6 C 8.5266 3.3918 0.0 0
M  V30 7 C 7.9629 1.2881 0.0 0
M  V30 8 C 1.4646 3.9845 0.0 0
M  V30 9 O 2.6091 5.0150 0.0 0
M  V30 10 O 0.0000 4.4604 0.0 0
M  V30 11 N 3.1917 1.8517 0.0 0
M  V30 12 C 1.7849 2.4781 0.0 0 CFG=2
M  V30 13 C 3.0308 0.3202 0.0 0
M  V30 14 C 0.7543 1.3337 0.0 0
M  V30 15 C 1.5243 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 12 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-2-isocyanopropanoate
C5H7NO2
799779-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0 CFG=2
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0 CHG=1 VAL=4
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0 CHG=-1
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 3 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethoxy)carbonyl]-L-prolyl-1-(methylamino)cyclobutanecarbonyl-...
C20H33N3O6
1256239-28-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.5533 3.7710 0.0 0
M  V30 2 C 7.0133 3.7710 0.0 0
M  V30 3 C 9.3233 2.4374 0.0 0
M  V30 4 O 6.2433 5.1048 0.0 0
M  V30 5 C 10.6570 4.3348 0.0 0
M  V30 6 N 11.9906 5.1048 0.0 0
M  V30 7 O 10.6570 2.7948 0.0 0
M  V30 8 C 13.3242 4.3348 0.0 0 CFG=1
M  V30 9 C 14.6580 5.1048 0.0 0
M  V30 10 C 13.3242 2.7948 0.0 0
M  V30 11 O 15.9917 4.3348 0.0 0
M  V30 12 O 14.6580 6.6448 0.0 0
M  V30 13 C 17.3253 5.1048 0.0 0
M  V30 14 C 3.6812 3.4208 0.0 0
M  V30 15 O 2.1749 3.1006 0.0 0
M  V30 16 O 4.1571 4.8855 0.0 0
M  V30 17 C 1.1444 4.2450 0.0 0
M  V30 18 C 2.2889 5.2756 0.0 0
M  V30 19 C 0.1140 5.3895 0.0 0
M  V30 20 C 0.0000 3.2146 0.0 0
M  V30 21 C 9.3233 5.1048 0.0 0
M  V30 22 C 7.9895 5.8748 0.0 0
M  V30 23 C 10.0933 6.4384 0.0 0
M  V30 24 C 8.7595 7.2084 0.0 0
M  V30 25 C 6.2433 2.4374 0.0 0 CFG=2
M  V30 26 N 4.7116 2.2764 0.0 0
M  V30 27 C 6.8696 1.0306 0.0 0
M  V30 28 C 4.3915 0.7700 0.0 0
M  V30 29 C 5.7253 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 2 4
M  V30 5 1 25 2 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 21
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=3
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 26
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191-95-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15761-39-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 799779-64-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256239-28-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8183332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Ugi 4-component reaction, key step
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the
discovery of a potent antibacterial agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Socha, Aaron M.; Tan, Nicholas Y.; LaPlante, Kerry L.; Sello, Jason K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(20), 7193-7202

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid
C11H12O4
1220993-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2112 4.3725 0.0 0
M  V30 2 O 9.3001 5.4615 0.0 0
M  V30 3 O 8.6097 2.8851 0.0 0
M  V30 4 O 2.3100 1.3338 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 O 0.7700 4.0011 0.0 0
M  V30 7 C 0.0000 5.3349 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 5.3349 0.0 0
M  V30 10 C 6.7237 4.7711 0.0 0 CFG=1
M  V30 11 C 4.6200 2.6674 0.0 0
M  V30 12 C 5.9537 6.1049 0.0 0
M  V30 13 C 3.0800 5.3349 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(7S)-3,4-Dimethoxy-N-methylbicyclo[4.2.0]octa-1,3,5-triene-7-carboxamide
C12H15NO3
1220993-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.2113 4.3725 0.0 0
M  V30 2 N 9.3002 5.4615 0.0 0
M  V30 3 O 8.6098 2.8850 0.0 0
M  V30 4 C 10.7877 5.0629 0.0 0
M  V30 5 O 2.3100 1.3338 0.0 0
M  V30 6 C 3.0800 0.0000 0.0 0
M  V30 7 O 0.7700 4.0011 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 6.7236 4.7711 0.0 0 CFG=1
M  V30 12 C 4.6200 2.6674 0.0 0
M  V30 13 C 5.9536 6.1049 0.0 0
M  V30 14 C 3.0800 5.3349 0.0 0
M  V30 15 C 3.0800 2.6674 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1220993-44-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1220993-43-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8289418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Acid chloride and amide (VII) formation 13.5 g (64.8 mmol)
(S)-3,4-dimethoxy-bicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid of
formula (VIb) was suspended in 70 ml of dichloromethane and 0.1 ml of
dimethylformamide was added. The suspension was stirred at 15-25°C and
the solution of 5.8 ml (67.6 mmol) oxalylchloride and 20 ml of
dichloromethane was added in 15-30 minutes at 25°C. After the reaction
had been completed, the mixture was added to a stirred mixture of 25 ml
of 40% aqueous solution of methylamine and 140 ml of dichloromethane at
0-10°C. After the reaction had been completed the reaction mixture was
heated to 20-25°C and diluted with 25 ml of water. The phases were
separated and the aqueous phase was washed with 1x25 ml of
dichloromethane. The combined organic phase was evaporated to 80 g weight
and 80 ml n-hexane was added. Yield 13.4 g, 93%. Enantiomer purity:
>99.8% ee (chiral HPLC). 1H-NMR (ppm) V-400 (1H: 400MHz, DMSO-d6): 8.66br
(0.15H); 7.80 br (1H); 6.81 s (1H); 6.78 s (1H); 4.01 dd (1H); 3.70 s
(6H); 3.10-3.22 m (2H); 2.61 d (0.66H); 2.66 d (3H)
$DTYPE RXN:VAR(1):NOTES
$DATUM ee = >99.8%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method for preparation of ivabradine salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ujvari, Viktor; Bodi, Jozsef; Farago, Janos; Szoke, Katalin; Faigl,
Ferenc; Nemet, Zoltan; Temesvari, Krisztina; Kiss, Robert; Matravolgyi,
Bela; Kassai, Ferencne; Kiss-Bartos, Dorottya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011138625 A1 2011-11-10

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-[(Ethoxycarbonyl)amino]-3,4-dihydrospiro[naphthalene-2(1H),4′(5′H)-oxazole...
C16H18N2O5
1221134-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.5458 4.3427 0.0 0
M  V30 2 C 11.9526 3.7162 0.0 0
M  V30 3 O 13.1985 4.6214 0.0 0
M  V30 4 O 12.1135 2.1847 0.0 0
M  V30 5 C 14.6054 3.9951 0.0 0
M  V30 6 C 15.8513 4.9003 0.0 0
M  V30 7 C 1.5400 4.0011 0.0 0
M  V30 8 O 0.0000 4.0011 0.0 0
M  V30 9 O 2.3100 5.3349 0.0 0
M  V30 10 C 6.9300 2.6674 0.0 0
M  V30 11 C 6.1600 1.3338 0.0 0
M  V30 12 N 7.8353 3.9133 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 7.8353 1.4216 0.0 0
M  V30 15 C 4.6200 1.3338 0.0 0
M  V30 16 C 9.3000 3.4375 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 O 9.3000 1.8974 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 C 3.8500 0.0000 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 2.3100 0.0000 0.0 0
M  V30 23 C 1.5400 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 15 20
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-[3,4-dihydro-5-[(methylamino)carbonyl]spiro[naphthalene-2(1H),4′(5′H)...
C17H21N3O4
1221134-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.3158 4.3427 0.0 0
M  V30 2 C 12.7226 3.7162 0.0 0
M  V30 3 O 13.9685 4.6214 0.0 0
M  V30 4 O 12.8835 2.1846 0.0 0
M  V30 5 C 15.3754 3.9951 0.0 0
M  V30 6 C 16.6213 4.9003 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 O 3.0800 5.3349 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 C 7.7000 2.6674 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 N 8.6052 3.9133 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 8.6052 1.4216 0.0 0
M  V30 16 C 5.3900 1.3338 0.0 0
M  V30 17 C 10.0698 3.4374 0.0 0
M  V30 18 C 5.3900 4.0011 0.0 0
M  V30 19 O 10.0699 1.8974 0.0 0
M  V30 20 C 4.6200 2.6674 0.0 0
M  V30 21 C 4.6200 0.0000 0.0 0
M  V30 22 C 3.0800 2.6674 0.0 0
M  V30 23 C 3.0800 0.0000 0.0 0
M  V30 24 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 22
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 16 21
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1221134-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1221134-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2815583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spiroaminooxazoline analogs as alpha2C adrenergic receptor modulators and
their preparation and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McCormick, Kevin D.; Dong, Li; Boyce, Christopher W.; De Lera Ruiz,
Manuel; Zheng, Junying; Won, Walter S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010042475 A1 2010-04-15

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl 3-[[[(4-chlorophenyl)methyl]amino]carbonyl]-8-fluoro-6-(4-morpholinylm...
C30H27ClFN3O5
1224582-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5503 9.3358 0.0 0
M  V30 2 C 5.3901 9.3358 0.0 0
M  V30 3 C 4.6201 10.6697 0.0 0
M  V30 4 O 3.0801 10.6697 0.0 0
M  V30 5 O 5.3901 12.0033 0.0 0
M  V30 6 F 5.3901 6.6685 0.0 0
M  V30 7 C 10.0102 12.0033 0.0 0
M  V30 8 N 11.5503 12.0033 0.0 0
M  V30 9 O 9.2402 13.3370 0.0 0
M  V30 10 C 12.3203 13.3370 0.0 0
M  V30 11 C 10.0102 4.0010 0.0 0
M  V30 12 Cl 18.4804 13.3370 0.0 0
M  V30 13 C 9.2402 8.0022 0.0 0
M  V30 14 C 7.7002 8.0022 0.0 0
M  V30 15 C 10.0102 9.3358 0.0 0
M  V30 16 C 10.0102 6.6685 0.0 0
M  V30 17 N 6.9302 9.3358 0.0 0
M  V30 18 C 6.9302 6.6685 0.0 0
M  V30 19 C 9.2402 10.6697 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 7.7002 10.6697 0.0 0
M  V30 22 C 7.7002 5.3348 0.0 0
M  V30 23 N 9.2402 2.6673 0.0 0
M  V30 24 C 7.7002 2.6673 0.0 0
M  V30 25 C 10.0102 1.3337 0.0 0
M  V30 26 C 6.9302 1.3337 0.0 0
M  V30 27 C 9.2402 0.0000 0.0 0
M  V30 28 O 7.7002 0.0000 0.0 0
M  V30 29 C 2.3101 12.0033 0.0 0
M  V30 30 C 0.7700 12.0033 0.0 0
M  V30 31 C 3.0801 13.3370 0.0 0
M  V30 32 C 0.0000 13.3370 0.0 0
M  V30 33 C 2.3101 14.6707 0.0 0
M  V30 34 C 0.7700 14.6707 0.0 0
M  V30 35 C 13.8603 13.3370 0.0 0
M  V30 36 C 14.6303 14.6707 0.0 0
M  V30 37 C 14.6303 12.0033 0.0 0
M  V30 38 C 16.1704 14.6707 0.0 0
M  V30 39 C 16.1704 12.0033 0.0 0
M  V30 40 C 16.9404 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 29
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 19
M  V30 11 1 8 10
M  V30 12 1 10 35
M  V30 13 1 11 20
M  V30 14 1 11 23
M  V30 15 1 12 40
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 2 14 18
M  V30 21 1 15 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 2 19 21
M  V30 26 2 20 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[(4-Chlorophenyl)methyl]amino]carbonyl]-8-fluoro-N-methyl-6-(4-morpholiny...
C25H26ClFN4O4
556025-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 9.3360 0.0 0
M  V30 2 C 10.0102 4.0010 0.0 0
M  V30 3 C 9.2402 2.6673 0.0 0
M  V30 4 N 10.0102 1.3337 0.0 0
M  V30 5 O 7.7002 2.6673 0.0 0
M  V30 6 C 9.2402 0.0000 0.0 0
M  V30 7 F 12.3203 5.3348 0.0 0
M  V30 8 C 5.3901 6.6685 0.0 0
M  V30 9 N 4.6201 8.0022 0.0 0
M  V30 10 O 4.6201 5.3348 0.0 0
M  V30 11 C 3.0801 8.0022 0.0 0
M  V30 12 C 12.3203 10.6697 0.0 0
M  V30 13 Cl 0.0000 13.3370 0.0 0
M  V30 14 C 9.2402 8.0022 0.0 0
M  V30 15 C 10.0102 6.6685 0.0 0
M  V30 16 C 7.7002 8.0022 0.0 0
M  V30 17 C 10.0102 9.3360 0.0 0
M  V30 18 N 9.2402 5.3348 0.0 0
M  V30 19 C 11.5503 6.6685 0.0 0
M  V30 20 C 6.9302 6.6685 0.0 0
M  V30 21 C 11.5503 9.3360 0.0 0
M  V30 22 C 7.7002 5.3348 0.0 0
M  V30 23 C 12.3203 8.0022 0.0 0
M  V30 24 N 13.8603 10.6697 0.0 0
M  V30 25 C 14.6303 9.3360 0.0 0
M  V30 26 C 14.6303 12.0033 0.0 0
M  V30 27 C 16.1704 9.3360 0.0 0
M  V30 28 C 16.1704 12.0033 0.0 0
M  V30 29 O 16.9404 10.6697 0.0 0
M  V30 30 C 2.3101 9.3360 0.0 0
M  V30 31 C 0.7700 9.3360 0.0 0
M  V30 32 C 3.0801 10.6697 0.0 0
M  V30 33 C 0.0000 10.6697 0.0 0
M  V30 34 C 2.3101 12.0033 0.0 0
M  V30 35 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 20
M  V30 11 1 9 11
M  V30 12 1 11 30
M  V30 13 1 12 21
M  V30 14 1 12 24
M  V30 15 1 13 35
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1224582-37-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 556025-46-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11081935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The design and development of 2-aryl-2-hydroxy ethylamine substituted
1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human
cytomegalovirus polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tanis, Steven P.; Strohbach, Joseph W.; Parker, Timothy T.; Moon, Malcom
W.; Thaisrivongs, Suvit; Perrault, William R.; Hopkins, Todd A.;
Knechtel, Mary L.; Oien, Nancee L.; Wieber, Janet L.; Stephanski, Kevin
J.; Wathen, Michael W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2010), 20(6), 1994-2000

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-[3-[4-[(4-fluorophenyl)methyl]-4-hydroxy-3,3-dimethyl-1-pip...
C32H37ClFNO5
1233228-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 5.3347 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 C 11.5500 6.6684 0.0 0
M  V30 4 C 12.3200 8.0020 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 O 6.9300 1.3336 0.0 0
M  V30 7 O 9.2400 2.6673 0.0 0
M  V30 8 C 7.7000 0.0000 0.0 0
M  V30 9 O 4.6200 8.0020 0.0 0
M  V30 10 C 3.0800 8.0020 0.0 0
M  V30 11 Cl 3.0800 5.3347 0.0 0
M  V30 12 C 17.6171 9.8625 0.0 0
M  V30 13 C 15.9025 10.8524 0.0 0
M  V30 14 C 18.1196 7.0122 0.0 0
M  V30 15 O 18.1196 8.9919 0.0 0
M  V30 16 F 23.9082 9.1190 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 5.3900 6.6684 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 25 C 3.0800 10.6694 0.0 0
M  V30 26 C 0.0000 10.6694 0.0 0
M  V30 27 C 2.3100 12.0031 0.0 0
M  V30 28 C 0.7700 12.0031 0.0 0
M  V30 29 N 13.8600 8.0020 0.0 0
M  V30 30 C 14.6300 9.3358 0.0 0
M  V30 31 C 14.6300 6.6684 0.0 0
M  V30 32 C 16.1700 9.3358 0.0 0
M  V30 33 C 16.1700 6.6684 0.0 0
M  V30 34 C 16.9400 8.0020 0.0 0
M  V30 35 C 19.5668 7.5389 0.0 0
M  V30 36 C 20.7466 6.5490 0.0 0
M  V30 37 C 19.8343 9.0555 0.0 0
M  V30 38 C 22.1937 7.0757 0.0 0
M  V30 39 C 21.2814 9.5822 0.0 0
M  V30 40 C 22.4611 8.5923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 29
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 21
M  V30 12 1 10 23
M  V30 13 1 11 22
M  V30 14 1 12 32
M  V30 15 1 13 32
M  V30 16 1 14 34
M  V30 17 1 14 35
M  V30 18 1 15 34
M  V30 19 1 16 40
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-[3-[4-[(4-fluorophenyl)methyl]-4-hydroxy-3,3-dimethyl-1-piperidiny...
C32H38ClFN2O4
1233228-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 5.3347 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 C 11.5500 6.6684 0.0 0
M  V30 4 C 12.3200 8.0020 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 N 6.9300 1.3336 0.0 0
M  V30 7 O 9.2400 2.6673 0.0 0
M  V30 8 C 7.7000 0.0000 0.0 0
M  V30 9 O 4.6200 8.0020 0.0 0
M  V30 10 C 3.0800 8.0020 0.0 0
M  V30 11 Cl 3.0800 5.3347 0.0 0
M  V30 12 C 17.6171 9.8625 0.0 0
M  V30 13 C 15.9025 10.8524 0.0 0
M  V30 14 C 18.1196 7.0121 0.0 0
M  V30 15 O 18.1196 8.9919 0.0 0
M  V30 16 F 23.9082 9.1190 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 6.9300 6.6684 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 5.3900 6.6684 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 3.0800 10.6694 0.0 0
M  V30 25 C 0.7700 9.3358 0.0 0
M  V30 26 C 2.3100 12.0031 0.0 0
M  V30 27 C 0.0000 10.6694 0.0 0
M  V30 28 C 0.7700 12.0031 0.0 0
M  V30 29 N 13.8600 8.0020 0.0 0
M  V30 30 C 14.6300 9.3358 0.0 0
M  V30 31 C 14.6300 6.6684 0.0 0
M  V30 32 C 16.1700 9.3358 0.0 0
M  V30 33 C 16.1700 6.6684 0.0 0
M  V30 34 C 16.9400 8.0020 0.0 0
M  V30 35 C 19.5668 7.5389 0.0 0
M  V30 36 C 20.7466 6.5490 0.0 0
M  V30 37 C 19.8343 9.0555 0.0 0
M  V30 38 C 22.1937 7.0757 0.0 0
M  V30 39 C 21.2814 9.5822 0.0 0
M  V30 40 C 22.4611 8.5923 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 29
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 18
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 21
M  V30 12 1 10 23
M  V30 13 1 11 22
M  V30 14 1 12 32
M  V30 15 1 13 32
M  V30 16 1 14 34
M  V30 17 1 14 35
M  V30 18 1 15 34
M  V30 19 1 16 40
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 34
M  V30 38 2 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1233228-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1233228-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10163118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step-6:
4-Benzyloxy-5-chloro-2-{3-[4-(4-fluoro-benzyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propoxy}-N-methyl-Benz
amide To a solution of
4-Benzyloxy-5-chloro-2-{3-[4-(4-fluoro-benzyl)-4-hydroxy-3,3-dimethyl
piperidin-1-yl]-propoxy}-benzoic acid methyl ester (200 mg, 0.35 mmol) in
ethanol was added a solution of methylamine in ethanol solution and
heated at 70° C. for overnight in sealed tube. It was cooled and
concentrated. The organics was diluted with water and extracted with
ethyl acetate, washed with water and brine. It was dried over Na2SO4 and
concentrated to afford 185 mg (92.7%) of
4-Benzyloxy-5-chloro-2-{3-[4-(4-fluoro-benzyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propoxy}-N-methyl-Benz
amide. LC/MS [M+H]+: 569.6.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel piperidine, morpholine and oxazepane compounds useful as CC
chemokine receptor ligands and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khamrai, Uttam; Karak, Sumit Kumar; Ronsheim, Matthew; Saha, Ashis Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20100168080 A1 2010-07-01

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iridium, di-μ-chlorodichlorobis[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclo...
C20H30Cl4Ir2
12354-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.5489 5.0684 0.0 0 CHG=-1 VAL=1
M  V30 2 C 0.0000 7.6734 0.0 0
M  V30 3 C 4.1079 7.6734 0.0 0
M  V30 4 C 2.3262 7.7870 0.0 0
M  V30 5 C 1.7817 7.7870 0.0 0
M  V30 6 C 2.0432 9.1248 0.0 0
M  V30 7 Cl 5.9946 4.0564 0.0 0 CHG=-1 VAL=1
M  V30 8 C 6.5628 1.4386 0.0 0
M  V30 9 C 2.4570 1.4515 0.0 0
M  V30 10 C 4.2365 1.3357 0.0 0
M  V30 11 C 4.7833 1.3357 0.0 0
M  V30 12 C 4.5002 0.0000 0.0 0
M  V30 13 Ir 2.0432 5.4972 0.0 0 CHG=3 VAL=8
M  V30 14 C 0.7611 7.5104 0.0 0 VAL=5
M  V30 15 C 3.3489 7.5104 0.0 0 CHG=-1 VAL=4
M  V30 16 C 2.5278 7.0366 0.0 0 VAL=5
M  V30 17 C 1.5801 7.0366 0.0 0 VAL=5
M  V30 18 C 2.0432 8.3466 0.0 0 VAL=5
M  V30 19 Cl 4.5002 5.4972 0.0 0 CHG=-1 VAL=2
M  V30 20 Cl 2.0389 3.6276 0.0 0 CHG=-1 VAL=2
M  V30 21 Ir 4.5002 3.6276 0.0 0 CHG=3 VAL=8
M  V30 22 C 5.8059 1.6123 0.0 0 CHG=-1 VAL=4
M  V30 23 C 3.2181 1.6123 0.0 0 VAL=5
M  V30 24 C 4.0350 2.0883 0.0 0 VAL=5
M  V30 25 C 4.9848 2.0883 0.0 0 VAL=5
M  V30 26 C 4.5002 0.7783 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 14
M  V30 3 1 3 15
M  V30 4 1 4 16
M  V30 5 1 5 17
M  V30 6 1 6 18
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 23
M  V30 10 1 10 24
M  V30 11 1 11 25
M  V30 12 1 12 26
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 19 1 13 20
M  V30 20 1 14 17
M  V30 21 2 14 18
M  V30 22 1 15 16
M  V30 23 1 15 18
M  V30 24 2 16 17
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 1 21 24
M  V30 30 1 21 25
M  V30 31 1 21 26
M  V30 32 1 22 25
M  V30 33 1 22 26
M  V30 34 1 23 24
M  V30 35 2 23 26
M  V30 36 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dichloro(methanamine)[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-...
C11H20Cl2IrN
1071750-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.6287 0.7712 0.0 0 VAL=4
M  V30 2 C 4.3638 1.1940 0.0 0
M  V30 3 Cl 0.9603 0.7712 0.0 0 CHG=-1 VAL=1
M  V30 4 Cl 2.2945 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 5 C 1.9291 3.7434 0.0 0
M  V30 6 C 2.2945 5.2264 0.0 0
M  V30 7 C 4.5890 3.7116 0.0 0
M  V30 8 C 2.6620 3.7434 0.0 0
M  V30 9 C 0.0000 3.7116 0.0 0
M  V30 10 Ir 2.2945 1.5403 0.0 0 CHG=3 VAL=8
M  V30 11 C 1.7294 2.9977 0.0 0 CHG=-1 VAL=4
M  V30 12 C 2.2945 4.4552 0.0 0 VAL=5
M  V30 13 C 3.8327 3.5650 0.0 0 VAL=5
M  V30 14 C 2.8618 2.9977 0.0 0 VAL=5
M  V30 15 C 0.7563 3.5650 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 12 13
M  V30 18 2 12 15
M  V30 19 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 12354-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1071750-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-7123060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-64-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Reactivity of Ir(I) and Ir(III) Complexes with MeNH2,
Me2C:NR (R = H, Me), C,N-C6H4{C(Me):N(Me)}-2, and
N,N'-RN:C(Me)CH2C(Me2)NHR (R = H, Me) Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vicente, Jose; Chicote, Maria Teresa; Vicente-Hernandez, Inmaculada;
Bautista, Delia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2008), 47(20), 9592-9605

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2′S)-1′-acetyl-2-oxospiro[3H-indole-3,2′-piperidine]-1(2H)-acetate
C17H20N2O4
1236108-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.1752 1.7086 0.0 0
M  V30 2 C 3.2109 1.2298 0.0 0
M  V30 3 C 4.7393 1.0423 0.0 0
M  V30 4 O 2.2840 0.0000 0.0 0
M  V30 5 C 6.8856 3.6780 0.0 0
M  V30 6 C 8.0302 4.7084 0.0 0
M  V30 7 O 9.4947 4.2325 0.0 0
M  V30 8 O 7.7100 6.2147 0.0 0
M  V30 9 C 10.6392 5.2629 0.0 0
M  V30 10 C 2.9292 4.1538 0.0 0 CFG=2
M  V30 11 C 3.4052 5.6184 0.0 0
M  V30 12 C 4.1752 3.2486 0.0 0
M  V30 13 N 2.6091 2.6474 0.0 0
M  V30 14 C 1.7849 5.1843 0.0 0
M  V30 15 C 4.9452 5.6184 0.0 0
M  V30 16 C 2.6352 6.9522 0.0 0
M  V30 17 N 5.4211 4.1538 0.0 0
M  V30 18 C 1.1445 2.1716 0.0 0
M  V30 19 C 0.3202 4.7084 0.0 0
M  V30 20 C 5.7152 6.9522 0.0 0
M  V30 21 C 3.4052 8.2858 0.0 0
M  V30 22 C 0.0000 3.2021 0.0 0
M  V30 23 C 4.9452 8.2858 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11 CFG=1
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 17
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2′S)-1′-Acetyl-N-methyl-2-oxospiro[3H-indole-3,2′-piperidine]-1(2H)-acetamide
C17H21N3O3
1236108-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.1752 1.7086 0.0 0
M  V30 2 C 3.2109 1.2298 0.0 0
M  V30 3 C 4.7393 1.0423 0.0 0
M  V30 4 O 2.2840 0.0000 0.0 0
M  V30 5 C 6.8856 3.6780 0.0 0
M  V30 6 C 8.0302 4.7084 0.0 0
M  V30 7 N 9.4947 4.2325 0.0 0
M  V30 8 O 7.7100 6.2147 0.0 0
M  V30 9 C 10.6392 5.2629 0.0 0
M  V30 10 C 2.9292 4.1538 0.0 0 CFG=2
M  V30 11 C 3.4052 5.6184 0.0 0
M  V30 12 C 4.1752 3.2486 0.0 0
M  V30 13 N 2.6091 2.6474 0.0 0
M  V30 14 C 1.7849 5.1843 0.0 0
M  V30 15 C 4.9452 5.6184 0.0 0
M  V30 16 C 2.6352 6.9522 0.0 0
M  V30 17 N 5.4211 4.1538 0.0 0
M  V30 18 C 1.1445 2.1716 0.0 0
M  V30 19 C 0.3202 4.7084 0.0 0
M  V30 20 C 5.7152 6.9522 0.0 0
M  V30 21 C 3.4052 8.2858 0.0 0
M  V30 22 C 0.0000 3.2021 0.0 0
M  V30 23 C 4.9452 8.2858 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11 CFG=1
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 1 15 17
M  V30 20 2 15 20
M  V30 21 1 16 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1236108-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1236108-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5062249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The spiropiperidine-3,3'-oxindole scaffold: a type II β-turn peptide
isostere
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Landoni, Nicola; Sacchetti, Alessandro; Silvani,
Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(25), 4474-4478

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R)-2-Bromo-1-[(dodecyloxy)methyl]ethoxy]dodecane
C27H55BrO2
1239978-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 15.4000 2.6673 0.0 0 CFG=2
M  V30 2 C 16.1700 4.0011 0.0 0
M  V30 3 O 13.8600 2.6673 0.0 0
M  V30 4 C 16.1700 1.3336 0.0 0
M  V30 5 O 17.7100 4.0011 0.0 0
M  V30 6 C 13.0900 4.0011 0.0 0
M  V30 7 Br 15.4000 0.0000 0.0 0
M  V30 8 C 18.4800 5.3347 0.0 0
M  V30 9 C 11.5500 4.0011 0.0 0
M  V30 10 C 20.0200 5.3347 0.0 0
M  V30 11 C 10.7800 5.3347 0.0 0
M  V30 12 C 20.7900 6.6684 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 22.3300 6.6684 0.0 0
M  V30 15 C 8.4700 6.6684 0.0 0
M  V30 16 C 23.1000 8.0020 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 C 24.6400 8.0020 0.0 0
M  V30 19 C 6.1600 8.0020 0.0 0
M  V30 20 C 25.4100 9.3358 0.0 0
M  V30 21 C 4.6200 8.0020 0.0 0
M  V30 22 C 26.9500 9.3358 0.0 0
M  V30 23 C 3.8500 9.3358 0.0 0
M  V30 24 C 27.7200 10.6694 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 29.2600 10.6694 0.0 0
M  V30 27 C 1.5400 10.6694 0.0 0
M  V30 28 C 30.0300 12.0031 0.0 0
M  V30 29 C 0.0000 10.6694 0.0 0
M  V30 30 C 31.5700 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-2,3-Bis(dodecyloxy)-N-methyl-1-propanamine
C28H59NO2
1239978-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 16.1700 4.0009 0.0 0 CFG=2
M  V30 2 C 15.4000 5.3347 0.0 0
M  V30 3 O 17.7100 4.0009 0.0 0
M  V30 4 C 15.4000 2.6673 0.0 0
M  V30 5 O 13.8600 5.3347 0.0 0
M  V30 6 C 18.4800 5.3347 0.0 0
M  V30 7 N 16.1700 1.3336 0.0 0
M  V30 8 C 13.0900 6.6684 0.0 0
M  V30 9 C 20.0200 5.3347 0.0 0
M  V30 10 C 15.4000 0.0000 0.0 0
M  V30 11 C 11.5500 6.6684 0.0 0
M  V30 12 C 20.7900 6.6684 0.0 0
M  V30 13 C 10.7800 8.0020 0.0 0
M  V30 14 C 22.3300 6.6684 0.0 0
M  V30 15 C 9.2400 8.0020 0.0 0
M  V30 16 C 23.1000 8.0020 0.0 0
M  V30 17 C 8.4700 9.3356 0.0 0
M  V30 18 C 24.6400 8.0020 0.0 0
M  V30 19 C 6.9300 9.3356 0.0 0
M  V30 20 C 25.4100 9.3358 0.0 0
M  V30 21 C 6.1600 10.6694 0.0 0
M  V30 22 C 26.9500 9.3358 0.0 0
M  V30 23 C 4.6200 10.6694 0.0 0
M  V30 24 C 27.7200 10.6694 0.0 0
M  V30 25 C 3.8500 12.0031 0.0 0
M  V30 26 C 29.2600 10.6694 0.0 0
M  V30 27 C 2.3100 12.0031 0.0 0
M  V30 28 C 30.0300 12.0031 0.0 0
M  V30 29 C 1.5400 13.3367 0.0 0
M  V30 30 C 31.5700 12.0031 0.0 0
M  V30 31 C 0.0000 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1239978-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239978-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3155480
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure tube used, no exptl. detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formation of Silica Precipitates on Membrane Surfaces in Two and Three
Dimensions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bernecker, Anja; Ziomkowska, Joanna; Heitmuller, Svenja; Wieneke, Ralph;
Geyer, Armin; Steinem, Claudia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Langmuir (2010), 26(16), 13422-13428

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[4′-fluoro-5-formyl-3′-(methylsulfonyl)[1,1′-biphenyl]-2...
C20H21FO6S
1242846-73-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 6.6684 0.0 0
M  V30 2 C 10.0100 6.6684 0.0 0
M  V30 3 C 10.7800 8.0021 0.0 0
M  V30 4 O 12.3200 8.0021 0.0 0
M  V30 5 O 10.0100 9.3358 0.0 0
M  V30 6 C 13.0900 9.3358 0.0 0
M  V30 7 C 11.7564 10.1058 0.0 0
M  V30 8 C 13.8600 10.6694 0.0 0
M  V30 9 C 14.4236 8.5658 0.0 0
M  V30 10 C 5.3900 1.3336 0.0 0
M  V30 11 O 6.1600 0.0000 0.0 0
M  V30 12 S 1.5400 8.0021 0.0 0 VAL=6
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 O 1.5400 6.4621 0.0 0
M  V30 15 O 1.5400 9.5421 0.0 0
M  V30 16 F 3.0800 10.6694 0.0 0
M  V30 17 C 6.1600 5.3347 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 5.3900 4.0011 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 6.1600 2.6673 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 C 5.3900 6.6684 0.0 0
M  V30 24 C 3.8500 6.6684 0.0 0
M  V30 25 C 6.1600 8.0021 0.0 0
M  V30 26 C 3.0800 8.0021 0.0 0
M  V30 27 C 5.3900 9.3358 0.0 0
M  V30 28 C 3.8500 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 21
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 12 15
M  V30 15 1 12 26
M  V30 16 1 16 28
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 23
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[[4′-fluoro-5-[(methylamino)methyl]-3′-(methylsulfonyl)[1...
C21H26FNO5S
1242846-74-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 8.0021 0.0 0
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 3.8500 9.3358 0.0 0
M  V30 4 O 3.0800 10.6694 0.0 0
M  V30 5 O 3.0800 8.0021 0.0 0
M  V30 6 C 1.5400 10.6694 0.0 0
M  V30 7 C 1.5400 12.2094 0.0 0
M  V30 8 C 0.0000 10.6694 0.0 0
M  V30 9 C 1.5400 9.1294 0.0 0
M  V30 10 C 12.3200 8.0021 0.0 0
M  V30 11 N 13.0900 9.3358 0.0 0
M  V30 12 C 14.6300 9.3358 0.0 0
M  V30 13 S 8.4700 1.3336 0.0 0 VAL=6
M  V30 14 C 9.2400 0.0000 0.0 0
M  V30 15 O 7.1364 0.5636 0.0 0
M  V30 16 O 9.8036 2.1036 0.0 0
M  V30 17 F 5.3900 1.3336 0.0 0
M  V30 18 C 8.4700 6.6684 0.0 0
M  V30 19 C 7.7000 8.0021 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 21 C 8.4700 9.3358 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 10.0100 9.3358 0.0 0
M  V30 24 C 7.7000 5.3347 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0
M  V30 26 C 6.1600 5.3347 0.0 0
M  V30 27 C 7.7000 2.6673 0.0 0
M  V30 28 C 5.3900 4.0011 0.0 0
M  V30 29 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 16 1 13 27
M  V30 17 1 17 29
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 18 24
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1242846-73-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1242846-74-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1611403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 30. t-butyl
2-(2-(4-fluoro-3-(methylsulfonyl)phenyl)-4-((methylamino)methyl)phenoxy)acetate
(30): Intermediate 29 (270 mg, 0.66 mmol, 1 eq) was stirred with
methylamine (1.5 mL of a 0.88 M THF solution, 1.32 mmol, 2 eq.) in MeOH
for 2 h. Sodium borohydride (50 mg, 0.66 mmol, 1 eq.) was added, and the
resulting mixture was stirred at room temperature for an additional 2 h.
Water (3 mL) was added and the MeOH was removed in vacuo. The resulting
solution was extracted with EtOAc, dried (Na2SO4), and concentrated in
vacuo to give 260 mg (93%) of t-butyl
2-(2-(4-fluoro-3-(methylsulfonyl)phenyl)-4-((methylamino)methyl)phenoxy)acetate
(30) as oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation biaryl oxyacetic acid compounds as inhibitors of CRTH2
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McGuinness, Brian F.; Ho, Koc-Kan; Babu, Suresh; Dong, Guizhen; Duo,
Jingqi; Le, Thuy X.H.; Saionz, Kurt W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010102154 A2 2010-09-10

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-ethoxy(2-methoxyphenyl)methylene]]di-
C18H12Cr2O10
125915-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3325 0.7709 0.0 0
M  V30 2 O 6.1034 0.7709 0.0 0 VAL=3
M  V30 3 C 2.6652 0.7709 0.0 0
M  V30 4 O 1.8943 0.7709 0.0 0 VAL=3
M  V30 5 C 3.9989 0.0000 0.0 0
M  V30 6 O 4.7676 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4564 7.7684 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4564 9.3101 0.0 0 CHG=1 VAL=7
M  V30 9 O 9.1233 7.3840 0.0 0
M  V30 10 C 7.7089 10.6565 0.0 0
M  V30 11 C 9.2040 7.9616 0.0 0
M  V30 12 C 9.8028 10.0555 0.0 0
M  V30 13 C 8.4564 10.8498 0.0 0
M  V30 14 C 7.1100 8.5626 0.0 0
M  V30 15 C 9.1233 6.6131 0.0 0
M  V30 16 O 7.0421 11.0409 0.0 0 VAL=3
M  V30 17 O 9.8708 7.5772 0.0 0 VAL=3
M  V30 18 O 10.4697 9.6712 0.0 0 VAL=3
M  V30 19 O 7.7896 11.2342 0.0 0 VAL=3
M  V30 20 O 6.4411 8.9470 0.0 0 VAL=3
M  V30 21 C 9.7901 6.2287 0.0 0
M  V30 22 O 5.3283 9.5905 0.0 0
M  V30 23 C 5.9951 9.9748 0.0 0
M  V30 24 Cr 3.9989 1.5418 0.0 0 CHG=1 VAL=9
M  V30 25 C 7.7896 7.3840 0.0 0 VAL=5
M  V30 26 C 5.3283 8.8196 0.0 0 VAL=5
M  V30 27 C 5.3283 5.9484 0.0 0 VAL=5
M  V30 28 C 2.4592 8.8196 0.0 0 VAL=5
M  V30 29 C 2.4592 5.9484 0.0 0 VAL=5
M  V30 30 C 0.0000 7.3840 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 24
M  V30 3 3 3 4
M  V30 4 1 3 24
M  V30 5 3 5 6
M  V30 6 1 5 24
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 15 21
M  V30 22 1 22 23
M  V30 23 1 22 26
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 24 27
M  V30 27 1 24 28
M  V30 28 1 24 29
M  V30 29 1 24 30
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-(2-methoxyphenyl)(methylamino)methylene]]di-
C17H11Cr2NO9
332847-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3318 0.7708 0.0 0
M  V30 2 O 6.1026 0.7708 0.0 0 VAL=3
M  V30 3 C 2.6648 0.7708 0.0 0
M  V30 4 O 1.8940 0.7708 0.0 0 VAL=3
M  V30 5 C 3.9983 0.0000 0.0 0
M  V30 6 O 4.7670 0.0000 0.0 0 VAL=3
M  V30 7 C 8.4552 7.7673 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 8.4552 9.3088 0.0 0 CHG=1 VAL=7
M  V30 9 N 9.1220 7.3829 0.0 0
M  V30 10 C 7.7078 10.6551 0.0 0
M  V30 11 C 9.2027 7.9605 0.0 0
M  V30 12 C 9.8015 10.0541 0.0 0
M  V30 13 C 8.4552 10.8483 0.0 0
M  V30 14 C 7.1090 8.5614 0.0 0
M  V30 15 C 9.1220 6.6122 0.0 0
M  V30 16 O 7.0411 11.0394 0.0 0 VAL=3
M  V30 17 O 9.8694 7.5762 0.0 0 VAL=3
M  V30 18 O 10.4682 9.6698 0.0 0 VAL=3
M  V30 19 O 7.7885 11.2326 0.0 0 VAL=3
M  V30 20 O 6.4402 8.9457 0.0 0 VAL=3
M  V30 21 O 5.3275 9.5891 0.0 0
M  V30 22 C 5.9943 9.9735 0.0 0
M  V30 23 Cr 3.9983 1.5416 0.0 0 CHG=1 VAL=9
M  V30 24 C 7.7885 7.3829 0.0 0 VAL=5
M  V30 25 C 5.3275 8.8183 0.0 0 VAL=5
M  V30 26 C 5.3275 5.9476 0.0 0 VAL=5
M  V30 27 C 2.4589 8.8183 0.0 0 VAL=5
M  V30 28 C 2.4589 5.9476 0.0 0 VAL=5
M  V30 29 C 0.0000 7.3829 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 23
M  V30 3 3 3 4
M  V30 4 1 3 23
M  V30 5 3 5 6
M  V30 6 1 5 23
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 24
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 21 22
M  V30 22 1 21 25
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 27
M  V30 27 1 23 28
M  V30 28 1 23 29
M  V30 29 1 24 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 125915-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8537907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME279 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2,5-Dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-6-O-(methylsulfonyl)-β-...
C18H32N2O7SSi
1261900-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 10.0765 0.0 0
M  V30 2 O 7.6285 3.7378 0.0 0
M  V30 3 Si 6.7232 2.4919 0.0 0
M  V30 4 C 5.8180 1.2460 0.0 0
M  V30 5 C 5.4774 3.3971 0.0 0
M  V30 6 C 7.9691 1.5867 0.0 0
M  V30 7 C 4.5722 2.1511 0.0 0
M  V30 8 C 4.9128 0.0000 0.0 0
M  V30 9 C 7.0639 0.3408 0.0 0
M  V30 10 C 9.3037 6.6393 0.0 0
M  V30 11 C 9.9300 8.0461 0.0 0
M  V30 12 O 11.4616 8.2072 0.0 0
M  V30 13 S 12.0880 9.6140 0.0 0 VAL=6
M  V30 14 C 13.4948 8.9877 0.0 0
M  V30 15 O 12.7144 11.0210 0.0 0
M  V30 16 O 10.6811 10.2403 0.0 0
M  V30 17 C 0.0000 6.9964 0.0 0
M  V30 18 O 0.0000 10.0765 0.0 0
M  V30 19 C 5.3348 6.9964 0.0 0 CFG=2
M  V30 20 C 5.4957 5.4649 0.0 0
M  V30 21 O 6.7416 7.6228 0.0 0
M  V30 22 C 7.0021 5.1446 0.0 0 CFG=2
M  V30 23 C 7.7721 6.4784 0.0 0 CFG=2
M  V30 24 N 4.0011 7.7665 0.0 0
M  V30 25 C 4.0011 9.3065 0.0 0
M  V30 26 C 2.6673 6.9964 0.0 0
M  V30 27 N 2.6673 10.0765 0.0 0
M  V30 28 C 1.3337 7.7665 0.0 0
M  V30 29 C 1.3337 9.3065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 25
M  V30 2 1 2 3
M  V30 3 1 22 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 11
M  V30 11 1 23 10 CFG=3
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 13 16
M  V30 17 1 17 28
M  V30 18 2 18 29
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 24 CFG=3
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Methoxytrityl chloride
C20H17ClO
14470-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.6201 0.0 0
M  V30 2 Cl 4.6201 6.1601 0.0 0
M  V30 3 O 10.7802 4.6201 0.0 0
M  V30 4 C 11.5503 5.9538 0.0 0
M  V30 5 C 6.1601 4.6201 0.0 0
M  V30 6 C 6.9302 3.2864 0.0 0
M  V30 7 C 6.9302 5.9538 0.0 0
M  V30 8 C 8.4702 3.2864 0.0 0
M  V30 9 C 8.4702 5.9538 0.0 0
M  V30 10 C 9.2402 4.6201 0.0 0
M  V30 11 C 4.6201 3.0801 0.0 0
M  V30 12 C 3.2864 2.3101 0.0 0
M  V30 13 C 5.9538 2.3101 0.0 0
M  V30 14 C 3.2864 0.7700 0.0 0
M  V30 15 C 5.9538 0.7700 0.0 0
M  V30 16 C 4.6201 0.0000 0.0 0
M  V30 17 C 3.0801 4.6201 0.0 0
M  V30 18 C 2.3101 3.2864 0.0 0
M  V30 19 C 2.3101 5.9538 0.0 0
M  V30 20 C 0.7700 3.2864 0.0 0
M  V30 21 C 0.7700 5.9538 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 3 4
M  V30 6 1 3 10
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-1-[2,5,6-trideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-6-[[(4-meth...
C38H49N3O5Si
1261900-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.9734 8.8112 0.0 0
M  V30 2 N 11.2034 7.4775 0.0 0
M  V30 3 C 9.6634 7.4775 0.0 0
M  V30 4 C 11.9734 6.1439 0.0 0
M  V30 5 C 8.8934 6.1439 0.0 0
M  V30 6 O 17.3081 5.7311 0.0 0
M  V30 7 C 18.6418 6.5011 0.0 0
M  V30 8 O 6.9240 3.4333 0.0 0
M  V30 9 Si 5.8936 2.2889 0.0 0
M  V30 10 C 4.8632 1.1444 0.0 0
M  V30 11 C 4.7491 3.3193 0.0 0
M  V30 12 C 7.0380 1.2583 0.0 0
M  V30 13 C 3.7187 2.1750 0.0 0
M  V30 14 C 3.8326 0.0000 0.0 0
M  V30 15 C 6.0076 0.1140 0.0 0
M  V30 16 O 2.1699 5.6611 0.0 0
M  V30 17 C 2.8137 11.7874 0.0 0
M  V30 18 O 0.0000 10.5346 0.0 0
M  V30 19 C 13.3071 8.0412 0.0 0
M  V30 20 C 14.6407 8.8112 0.0 0
M  V30 21 C 13.3071 6.5011 0.0 0
M  V30 22 C 15.9745 8.0412 0.0 0
M  V30 23 C 14.6407 5.7311 0.0 0
M  V30 24 C 15.9745 6.5011 0.0 0
M  V30 25 C 12.7434 10.1450 0.0 0
M  V30 26 C 14.2834 10.1450 0.0 0
M  V30 27 C 11.9734 11.4786 0.0 0
M  V30 28 C 15.0534 11.4786 0.0 0
M  V30 29 C 12.7434 12.8122 0.0 0
M  V30 30 C 14.2834 12.8122 0.0 0
M  V30 31 C 10.6398 9.5812 0.0 0
M  V30 32 C 10.6398 11.1212 0.0 0
M  V30 33 C 9.3060 8.8112 0.0 0
M  V30 34 C 9.3060 11.8912 0.0 0
M  V30 35 C 7.9723 9.5812 0.0 0
M  V30 36 C 7.9723 11.1212 0.0 0
M  V30 37 C 7.3534 6.1439 0.0 0 CFG=1
M  V30 38 C 6.4482 4.8980 0.0 0 CFG=1
M  V30 39 O 6.4482 7.3897 0.0 0
M  V30 40 C 4.9835 5.3739 0.0 0
M  V30 41 C 4.9835 6.9139 0.0 0 CFG=1
M  V30 42 N 3.7376 7.8191 0.0 0
M  V30 43 C 2.3308 7.1926 0.0 0
M  V30 44 C 3.8987 9.3506 0.0 0
M  V30 45 N 1.0849 8.0978 0.0 0
M  V30 46 C 2.6527 10.2558 0.0 0
M  V30 47 C 1.2459 9.6294 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 1 31
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 3 5
M  V30 8 1 37 5 CFG=3
M  V30 9 1 6 7
M  V30 10 1 6 24
M  V30 11 1 8 9
M  V30 12 1 38 8 CFG=1
M  V30 13 1 9 10
M  V30 14 1 9 11
M  V30 15 1 9 12
M  V30 16 1 10 13
M  V30 17 1 10 14
M  V30 18 1 10 15
M  V30 19 2 16 43
M  V30 20 1 17 46
M  V30 21 2 18 47
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 40 1 37 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 41
M  V30 44 1 40 41
M  V30 45 1 41 42 CFG=3
M  V30 46 1 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 2 44 46
M  V30 50 1 45 47
M  V30 51 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 37 38 41)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1261900-14-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 14470-28-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1261900-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13800245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Double-stranded DNA-templated cleavage of oligonucleotides containing a
P3'→N5' linkage triggered by triplex formation: the effects of chemical
modifications and remarkable enhancement in reactivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ito, Kosuke Ramon; Kodama, Tetsuya; Tomizu, Masaharu; Negoro, Yoshinori;
Orita, Ayako; Osaki, Tomohisa; Hosoki, Noritsugu; Tanaka, Takaya;
Imanishi, Takeshi; Obika, Satoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research (2010), 38(20), 7332-7342

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-2-(methylthio)-3-nitro-4H-1-benzopyran-4-one
C10H6ClNO4S
1264701-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 S 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 Cl 9.3358 1.5400 0.0 0
M  V30 5 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 1.3336 6.1600 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 O 4.0011 1.5400 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-2-(methylamino)-3-nitro-4H-1-benzopyran-4-one
C10H7ClN2O4
1264701-79-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 Cl 9.3358 1.5400 0.0 0
M  V30 5 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 1.3336 6.1600 0.0 0
M  V30 8 C 5.3347 2.3100 0.0 0
M  V30 9 C 5.3347 3.8500 0.0 0
M  V30 10 O 4.0011 1.5400 0.0 0
M  V30 11 C 6.6684 1.5400 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 6.6684 4.6200 0.0 0
M  V30 14 C 2.6674 2.3100 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1264701-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1264701-79-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11648454
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise synthetic strategy to functionalized chromenones via [5+1]
heteroannulation and facile C-N/C-S/C-O bond formation with various
nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savant, Mahesh M.; Gowda, Neetha S.; Pansuriya, Akshay M.; Bhuva, Chirag
V.; Kapuriya, Naval; Anandalwar, Sridhar M.; Prasad, Shashidhara J.;
Shah, Anamik; Naliapara, Yogesh T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(2), 254-257

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-2,3-Diethyl (2R,3R)-1-(phenylmethyl)-2,3-aziridinedicarboxylate
C15H19NO4
1269792-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 8.2085 0.0 0
M  V30 2 C 8.2636 6.1047 0.0 0
M  V30 3 O 9.0336 7.4385 0.0 0
M  V30 4 O 9.0336 4.7711 0.0 0
M  V30 5 C 10.5736 7.4384 0.0 0
M  V30 6 C 11.3436 8.7721 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 O 5.3900 2.6674 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 N 5.3900 6.8747 0.0 0
M  V30 13 C 6.7236 6.1047 0.0 0 CFG=1
M  V30 14 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 15 C 3.0800 8.2085 0.0 0
M  V30 16 C 2.3100 9.5421 0.0 0
M  V30 17 C 2.3100 6.8747 0.0 0
M  V30 18 C 0.7700 9.5421 0.0 0
M  V30 19 C 0.7700 6.8747 0.0 0
M  V30 20 C 0.0000 8.2085 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 13 2 CFG=1
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 14 7 CFG=3
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(2R,3R)-N2,N3-Dimethyl-1-(phenylmethyl)-2,3-aziridinedicarboxamide
C13H17N3O2
1269792-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.8747 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 N 5.3900 1.3338 0.0 0
M  V30 4 O 3.0800 2.6674 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 C 8.2636 4.7711 0.0 0
M  V30 7 N 9.0336 6.1047 0.0 0
M  V30 8 O 9.0336 3.4374 0.0 0
M  V30 9 C 10.5736 6.1047 0.0 0
M  V30 10 N 5.3900 5.5411 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0 CFG=1
M  V30 12 C 6.7236 4.7711 0.0 0 CFG=1
M  V30 13 C 3.0800 6.8747 0.0 0
M  V30 14 C 2.3100 8.2085 0.0 0
M  V30 15 C 2.3100 5.5411 0.0 0
M  V30 16 C 0.7700 8.2085 0.0 0
M  V30 17 C 0.7700 5.5411 0.0 0
M  V30 18 C 0.0000 6.8747 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 11 2 CFG=3
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 12 6 CFG=1
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1269792-47-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1269792-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13074113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aziridine Scaffolds for the Detection and Quantification of
Hydrogen-Bonding Interactions through Transition-State Stabilization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Giordano, Luciana; Hoang, Cam T.; Shipman, Michael; Tucker, James H. R.;
Walsh, Tiffany R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2011), 50(3), 741-744,
S741/1-S741/36

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-2-Methyl-4-(1-naphthalenylmethylene)-5(4H)-oxazolone
C15H11NO2
128858-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.7106 0.0 0
M  V30 2 O 7.3592 0.0000 0.0 0
M  V30 3 C 10.5457 4.3858 0.0 0
M  V30 4 C 4.6200 4.0442 0.0 0
M  V30 5 C 3.0800 4.0442 0.0 0
M  V30 6 C 5.3900 5.3779 0.0 0
M  V30 7 C 2.3100 5.3779 0.0 0
M  V30 8 C 2.3100 2.7106 0.0 0
M  V30 9 C 4.6200 6.7117 0.0 0
M  V30 10 C 3.0800 6.7117 0.0 0
M  V30 11 C 0.7700 5.3779 0.0 0
M  V30 12 C 0.7700 2.7106 0.0 0
M  V30 13 C 0.0000 4.0442 0.0 0
M  V30 14 C 6.9300 2.7106 0.0 0
M  V30 15 C 7.8353 1.4647 0.0 0
M  V30 16 N 7.8353 3.9564 0.0 0
M  V30 17 O 9.2998 1.9406 0.0 0
M  V30 18 C 9.2998 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 1 14
M  V30 3 2 2 15
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 10
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z)-2-(Acetylamino)-N-methyl-3-(1-naphthalenyl)-2-propenamide
C16H16N2O2
360078-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 N 2.3100 5.3347 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0
M  V30 6 O 0.7700 2.6674 0.0 0
M  V30 7 C 0.7700 5.3347 0.0 0
M  V30 8 C 2.3100 0.0000 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 O 0.0000 6.6685 0.0 0
M  V30 11 C 5.3900 5.3347 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 5.3900 8.0021 0.0 0
M  V30 17 C 6.9300 8.0021 0.0 0
M  V30 18 C 9.2400 6.6685 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 17
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 128858-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 360078-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2705803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):NOTES
$DATUM literature prepn., stereo-retention
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric photocyclization reactions of
N-acetyl-α-dehydro(1-naphthyl)alaninamides in the presence of chiral
amine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maekawa, Kei; Tanami, Toshiyuki; Igarashi, Tetsutaro; Sakurai, Tadamitsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2011), 83(10), 2255-2263

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-[(2E)-3-(4-methoxyphenyl)-1-oxo-2-propen-1-yl]-5,5-dimethyl-2-cyc...
C19H22O4
1308887-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 2.3101 0.0 0
M  V30 2 C 6.8515 3.0801 0.0 0
M  V30 3 O 5.5178 0.7700 0.0 0
M  V30 4 C 8.1851 2.3101 0.0 0
M  V30 5 O 2.8503 0.7700 0.0 0
M  V30 6 C 1.5166 0.0000 0.0 0
M  V30 7 O 5.5178 5.3901 0.0 0
M  V30 8 C 0.9899 6.0671 0.0 0
M  V30 9 C 0.0000 4.3526 0.0 0
M  V30 10 O 13.5200 5.3901 0.0 0
M  V30 11 C 14.8536 4.6201 0.0 0
M  V30 12 C 4.1840 3.0801 0.0 0
M  V30 13 C 2.8503 2.3101 0.0 0
M  V30 14 C 4.1840 4.6201 0.0 0
M  V30 15 C 1.5166 3.0801 0.0 0
M  V30 16 C 2.8503 5.3901 0.0 0
M  V30 17 C 1.5166 4.6201 0.0 0
M  V30 18 C 9.5188 3.0801 0.0 0
M  V30 19 C 10.8526 2.3101 0.0 0
M  V30 20 C 9.5188 4.6201 0.0 0
M  V30 21 C 12.1863 3.0801 0.0 0
M  V30 22 C 10.8526 5.3901 0.0 0
M  V30 23 C 12.1863 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 2 7 14
M  V30 9 1 8 17
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2E)-3-(4-Methoxyphenyl)-1-oxo-2-propen-1-yl]-5,5-dimethyl-3-(methylamino)...
C19H23NO3
1308887-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5178 2.3101 0.0 0
M  V30 2 C 6.8515 3.0801 0.0 0
M  V30 3 O 5.5178 0.7700 0.0 0
M  V30 4 C 8.1851 2.3101 0.0 0
M  V30 5 N 2.8503 0.7700 0.0 0
M  V30 6 C 1.5166 0.0000 0.0 0
M  V30 7 O 5.5178 5.3901 0.0 0
M  V30 8 C 0.9899 6.0671 0.0 0
M  V30 9 C 0.0000 4.3526 0.0 0
M  V30 10 O 13.5200 5.3901 0.0 0
M  V30 11 C 14.8536 4.6201 0.0 0
M  V30 12 C 4.1840 3.0801 0.0 0
M  V30 13 C 2.8503 2.3101 0.0 0
M  V30 14 C 4.1840 4.6201 0.0 0
M  V30 15 C 1.5166 3.0801 0.0 0
M  V30 16 C 2.8503 5.3901 0.0 0
M  V30 17 C 1.5166 4.6201 0.0 0
M  V30 18 C 9.5188 3.0801 0.0 0
M  V30 19 C 9.5188 4.6201 0.0 0
M  V30 20 C 10.8526 2.3101 0.0 0
M  V30 21 C 10.8526 5.3901 0.0 0
M  V30 22 C 12.1863 3.0801 0.0 0
M  V30 23 C 12.1863 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 4 18
M  V30 6 1 5 6
M  V30 7 1 5 13
M  V30 8 2 7 14
M  V30 9 1 8 17
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 10 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1308887-12-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1308887-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4905358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Enaminodiketones Va-Vp (general procedure).
The corresponding amine, 3 mmol, was added to a solution of 3 mmol of
methyl ether IVa-IVc in 25 ml of anhydrous chloroform, and the mixture
was stirred for 2-5 h at room temperature under nitrogen or argon. When
the reaction was complete (TLC), the mixture was filtered through a thin
layer of silica gel and evaporated on a rotary evaporator. The residue
was crystallized from ethyl acetate-petroleum ether.
2-[(E)-3-(4-Methoxyphenyl)prop-2-enoyl]-5,5-dimethyl-3-methylaminocyclohex-2-en-1-one
(Vc). Yield 93%. Mp 155-156°C. IR spectrum, ν, cm-1: 1630 m, 1580 v.s,
1550 s, 1515 s, 1470 m, 1420 m, 1250 v.s. 1H NMR spectrum, δ, ppm: 1.11 s
(6H, 5-CH3), 2.34 s (2H, 6-H), 2.47 s (2H, 4-H), 3.07 d (3H, NHCH3, J =
5.2 Hz), 3.83 s (3H, OCH3), 6.87 d (2H, 3'-H, 5'-H, J = 8.7 Hz), 7.56 d
(2H, 2'-H, 6'-H, J = 8.7 Hz), 7.57 d (1H, CH=CHAr, J = 15.5 Hz), 8.00 d
(1H, CH=CHAr, J = 15.5 Hz), 12.80 br.s (1H, NH). 13C NMR spectrum, δC,
ppm: 28.46 q, 28.46 q, 30.20 q, 30.61 s, 40.30 t, 52.10 t, 55.32 q,
108.41 s, 108.41 s, 114.05 d, 114.05 d, 126.66 d, 129.04 s, 129.84 d,
129.84 d, 129.84 d, 139.40 d, 160.64 s, 173.17 s, 190.73 s, 194.80 s.
Found, %: C 72.72; H 7.51; N 4.39. m/z 314 [M + 1]+. C19H23NO3.
Calculated, %: C 72.82; H 7.40; N 4.47. M 313.40.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of exo- and endocyclic enamino derivatives of
2-(3-arylprop-2-enoyl)cyclohexane-1,3-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rubinov, D. B.; Rubinova, I. L.; Lakhvich, F. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2011), 47(3), 319-330

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,5-Trichloro-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine
C12H16Cl3N3OSi
1313036-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3080 4.0287 0.0 0
M  V30 2 O 7.6418 3.2587 0.0 0
M  V30 3 C 8.9755 4.0287 0.0 0
M  V30 4 C 10.3091 3.2587 0.0 0
M  V30 5 Si 11.6428 4.0287 0.0 0
M  V30 6 C 12.9766 4.7987 0.0 0
M  V30 7 C 12.4128 2.6951 0.0 0
M  V30 8 C 10.8728 5.3624 0.0 0
M  V30 9 Cl 2.6806 0.0000 0.0 0
M  V30 10 Cl 0.0000 1.9164 0.0 0
M  V30 11 Cl 1.1093 7.1347 0.0 0
M  V30 12 C 3.5675 3.8850 0.0 0
M  V30 13 C 2.5369 2.7406 0.0 0
M  V30 14 N 4.9743 3.2587 0.0 0
M  V30 15 N 3.0915 5.3498 0.0 0
M  V30 16 C 3.3069 1.4070 0.0 0
M  V30 17 C 1.0306 3.0608 0.0 0
M  V30 18 C 4.8134 1.7271 0.0 0
M  V30 19 C 1.5852 5.6699 0.0 0
M  V30 20 N 0.5547 4.5255 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dichloro-N-methyl-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]p...
C13H20Cl2N4OSi
1700693-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 Cl 3.2907 7.2709 0.0 0
M  V30 4 C 7.9854 4.5603 0.0 0
M  V30 5 O 9.0160 5.7047 0.0 0
M  V30 6 C 10.5223 5.3845 0.0 0
M  V30 7 C 11.5529 6.5291 0.0 0
M  V30 8 Si 13.0592 6.2089 0.0 0
M  V30 9 C 14.5655 5.8887 0.0 0
M  V30 10 C 12.7390 4.7024 0.0 0
M  V30 11 C 13.3794 7.7152 0.0 0
M  V30 12 Cl 4.0010 0.0000 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 4.3211 6.1263 0.0 0
M  V30 17 N 6.4792 4.8805 0.0 0
M  V30 18 N 5.3348 2.3100 0.0 0
M  V30 19 N 2.6673 2.3100 0.0 0
M  V30 20 C 5.8528 6.2874 0.0 0
M  V30 21 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313036-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1700693-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16401490
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM LRRK2 inhibitors and methods of making and using the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John; Choi, Hwan Geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016130920 A2 2016-08-18

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,5-Trichloro-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine
C12H16Cl3N3OSi
1313036-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3080 4.0287 0.0 0
M  V30 2 O 7.6418 3.2587 0.0 0
M  V30 3 C 8.9755 4.0287 0.0 0
M  V30 4 C 10.3091 3.2587 0.0 0
M  V30 5 Si 11.6428 4.0287 0.0 0
M  V30 6 C 12.9766 4.7987 0.0 0
M  V30 7 C 12.4128 2.6951 0.0 0
M  V30 8 C 10.8728 5.3624 0.0 0
M  V30 9 Cl 2.6806 0.0000 0.0 0
M  V30 10 Cl 0.0000 1.9164 0.0 0
M  V30 11 Cl 1.1093 7.1347 0.0 0
M  V30 12 C 3.5675 3.8850 0.0 0
M  V30 13 C 2.5369 2.7406 0.0 0
M  V30 14 N 4.9743 3.2587 0.0 0
M  V30 15 N 3.0915 5.3498 0.0 0
M  V30 16 C 3.3069 1.4070 0.0 0
M  V30 17 C 1.0306 3.0608 0.0 0
M  V30 18 C 4.8134 1.7271 0.0 0
M  V30 19 C 1.5852 5.6699 0.0 0
M  V30 20 N 0.5547 4.5255 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 2 16 18
M  V30 20 1 17 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dichloro-N-methyl-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]p...
C13H20Cl2N4OSi
1700693-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 Cl 3.2907 7.2709 0.0 0
M  V30 4 C 7.9854 4.5603 0.0 0
M  V30 5 O 9.0160 5.7047 0.0 0
M  V30 6 C 10.5223 5.3845 0.0 0
M  V30 7 C 11.5529 6.5291 0.0 0
M  V30 8 Si 13.0592 6.2089 0.0 0
M  V30 9 C 14.5655 5.8887 0.0 0
M  V30 10 C 12.7390 4.7024 0.0 0
M  V30 11 C 13.3794 7.7152 0.0 0
M  V30 12 Cl 4.0010 0.0000 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 4.3211 6.1263 0.0 0
M  V30 17 N 6.4792 4.8805 0.0 0
M  V30 18 N 5.3348 2.3100 0.0 0
M  V30 19 N 2.6673 2.3100 0.0 0
M  V30 20 C 5.8528 6.2874 0.0 0
M  V30 21 C 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 16
M  V30 4 1 4 5
M  V30 5 1 4 17
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313036-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1700693-15-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4793701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective,
and Brain Penetrant LRRK2 Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatcher, John M.; Zhang, Jinwei; Choi, Hwan Geun; Ito, Genta; Alessi,
Dario R.; Gray, Nathanael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2015), 6(5), 584-589

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[trans-4-[[(5-Bromo-2-pyrazinyl)methylamino]methyl]cyclohexyl]glycine methy...
C15H23BrN4O2
1313366-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 O 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 N 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[trans-4-[[(5-Bromo-2-pyrazinyl)methylamino]methyl]cyclohexyl]amino]-N-met...
C15H24BrN5O
1313366-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 N 13.0900 2.6674 0.0 0
M  V30 6 C 13.8600 1.3338 0.0 0
M  V30 7 C 15.4000 1.3338 0.0 0
M  V30 8 N 16.1700 0.0000 0.0 0
M  V30 9 O 16.1700 2.6674 0.0 0
M  V30 10 C 17.7100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.8500 5.3349 0.0 0
M  V30 13 N 3.8500 2.6674 0.0 0
M  V30 14 N 2.3100 5.3349 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0 CFG=1
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 21 C 10.7800 1.3338 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 17 2 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 22 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1313366-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313366-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2386960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Intermediate 132.2:
2-(4-{[(5-Iodo-pyridin-2-yl)-methyl-amino]-methyl}-trans-cyclohexyl-amino)-N-methyl-acetamide.
The mixture of intermediate 130.3 (12.9 g, 30.6 mmol) and methylamine
(33% in EtOH) (191 mL, 1.53 mol) was stirred 16 hours at 80° C. The
mixture was concentrated to dryness and the residue was purified by
normal phase column chromatography, eluting with DCM-MeOH-aq. 30% NH4OH
(200:20:1). Intermediate 149.2:
2-(4-{[(5-Bromo-pyrazin-2-yl)-methyl-amino]-methyl}-trans-cyclohexyl-amino)-N-methyl-acetamide.
The title intermediate (10.7 g, 28.6 mmol, 93%) was obtained as white
crystals from Intermediate 139.1 (12.0 g, 30.7 mmol), analogously to
Intermediate 132.2. HPLC: Dt Ret =0.71 min; LC-MS: m/z 370/372 [M]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isoquinolinone and quinazolinone derivatives as MDM2 and MDM4 inhibitors
and their preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berghausen, Joerg; Buschmann, Nicole; Furet, Pascal; Gessier, Francois;
Hergovich Lisztwan, Joanna; Holzer, Philipp; Jacoby, Edgar; Kallen,
Joerg; Masuya, Keiichi; Pissot Soldermann, Carole; Ren, Haixia; Stutz,
Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011076786 A1 2011-06-30

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(4-Chlorophenyl)-N2-(5-fluoro-2,4-dinitrophenyl)-1,2-benzenediamine
C18H12ClFN4O4
1332634-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9301 4.0011 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0 VAL=5
M  V30 3 O 4.6201 0.0000 0.0 0
M  V30 4 O 6.9301 1.3337 0.0 0
M  V30 5 F 2.3100 6.6686 0.0 0
M  V30 6 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 7 O 0.0000 2.6675 0.0 0
M  V30 8 O 0.0000 5.3348 0.0 0
M  V30 9 N 10.0101 4.0011 0.0 0
M  V30 10 Cl 16.1702 4.0011 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 3.0800 2.6675 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 7.7001 5.3348 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 6.9301 6.6686 0.0 0
M  V30 20 C 10.0101 6.6686 0.0 0
M  V30 21 C 7.7001 8.0022 0.0 0
M  V30 22 C 9.2401 8.0022 0.0 0
M  V30 23 C 11.5501 4.0011 0.0 0
M  V30 24 C 12.3201 5.3348 0.0 0
M  V30 25 C 12.3201 2.6675 0.0 0
M  V30 26 C 13.8602 5.3348 0.0 0
M  V30 27 C 13.8602 2.6675 0.0 0
M  V30 28 C 14.6302 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 16
M  V30 10 1 9 18
M  V30 11 1 9 23
M  V30 12 1 10 28
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(4-Chlorophenyl)-N2-[5-(methylamino)-2,4-dinitrophenyl]-1,2-benzenediamine
C19H16ClN5O4
1426542-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9302 4.0012 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0 VAL=5
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 N 2.3101 6.6687 0.0 0
M  V30 6 C 3.0801 8.0023 0.0 0
M  V30 7 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 8 O 0.0000 2.6675 0.0 0
M  V30 9 O 0.0000 5.3348 0.0 0
M  V30 10 N 10.0102 4.0012 0.0 0
M  V30 11 Cl 16.1704 4.0012 0.0 0
M  V30 12 C 5.3901 4.0012 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 3.0801 2.6675 0.0 0
M  V30 16 C 3.0801 5.3348 0.0 0
M  V30 17 C 2.3101 4.0012 0.0 0
M  V30 18 C 7.7002 5.3348 0.0 0
M  V30 19 C 9.2402 5.3348 0.0 0
M  V30 20 C 6.9302 6.6687 0.0 0
M  V30 21 C 10.0102 6.6687 0.0 0
M  V30 22 C 7.7002 8.0023 0.0 0
M  V30 23 C 9.2402 8.0023 0.0 0
M  V30 24 C 11.5503 4.0012 0.0 0
M  V30 25 C 12.3203 5.3348 0.0 0
M  V30 26 C 12.3203 2.6675 0.0 0
M  V30 27 C 13.8603 5.3348 0.0 0
M  V30 28 C 13.8603 2.6675 0.0 0
M  V30 29 C 14.6303 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 18
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 1 10 19
M  V30 12 1 10 24
M  V30 13 1 11 29
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1332634-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1426542-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8283604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic evaluation of structure-activity relationships of the
riminophenazine class and discovery of a C2 pyridylamino series for the
treatment of multidrug-resistant tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Binna; Liu, Kai; Lu, Yu; Zhang, Dongfeng; Yang, Tianming; Li, Xuan;
Ma, Chen; Zheng, Meiqin; Bin, Wang; Zhang, Gang; Fei, Wang; Ma, Zhenkun;
Li, Chun; Huang, Haihong; Yin, Dali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 174545-4559

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Bromomethyl)-6-methoxyquinoline
C11H10BrNO
133772-25-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 9.3360 0.0000 0.0 0
M  V30 4 Br 10.6697 0.7700 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 6.6685 3.0801 0.0 0
M  V30 9 N 6.6685 0.0000 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.0023 0.7700 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 14
M  V30 15 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N-methyl-2-quinolinemethanamine
C12H14N2O
141770-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 C 12.0033 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 N 6.6685 3.0801 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 6.6685 0.0000 0.0 0
M  V30 12 C 8.0022 2.3101 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 2.6673 0.7700 0.0 0
M  V30 15 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133772-25-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 141770-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6182852
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring the effects of cooperative interactions on affinity using a
pinwheel sensor system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Paul D.; Glass, Timothy E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2004), 60(49), 11057-11065

$RFMT $RIREG SCHEME288 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzil
C14H10O2
134-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 2.6673 0.0 0
M  V30 13 C 7.7002 0.0000 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 15 C 9.2402 0.0000 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzaldehyde
C7H4BrFO
57848-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromo-2-fluorophenyl)-1-methyl-4,5-diphenyl-1H-imidazole
C22H16BrFN2
2086287-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0157 3.5103 0.0 0
M  V30 2 F 7.0322 9.1524 0.0 0
M  V30 3 Br 12.3670 9.1524 0.0 0
M  V30 4 C 5.3648 4.2206 0.0 0
M  V30 5 C 4.5948 5.5543 0.0 0
M  V30 6 N 6.8711 4.5408 0.0 0
M  V30 7 N 5.6252 6.6988 0.0 0
M  V30 8 C 7.0322 6.0723 0.0 0
M  V30 9 C 4.7385 2.8138 0.0 0
M  V30 10 C 5.6436 1.5677 0.0 0
M  V30 11 C 3.2068 2.6527 0.0 0
M  V30 12 C 5.0172 0.1609 0.0 0
M  V30 13 C 2.5805 1.2459 0.0 0
M  V30 14 C 3.4857 0.0000 0.0 0
M  V30 15 C 3.0633 5.7153 0.0 0
M  V30 16 C 2.1580 4.4693 0.0 0
M  V30 17 C 2.4368 7.1221 0.0 0
M  V30 18 C 0.6265 4.6304 0.0 0
M  V30 19 C 0.9052 7.2831 0.0 0
M  V30 20 C 0.0000 6.0372 0.0 0
M  V30 21 C 8.3659 6.8423 0.0 0
M  V30 22 C 8.3659 8.3824 0.0 0
M  V30 23 C 9.6995 6.0723 0.0 0
M  V30 24 C 9.6995 9.1524 0.0 0
M  V30 25 C 11.0332 6.8423 0.0 0
M  V30 26 C 11.0332 8.3824 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 22
M  V30 3 1 3 26
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 7 8
M  V30 11 1 8 21
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 134-81-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 57848-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2086287-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17274431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-38-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 1,2,4,5-tetrasubstituted
imidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Yue; Yuan, Rui; Ge, Wen-hui; Wang, Yuan-jiang; Liu, Gui-xiang; Li,
Ming-qi; Xu, Jiang-biao; Wan, Yu; Zhou, Sheng-liang; Han, Xi-guang;
Zhang, Peng; Liu, Jin-juan; Wu, Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2017), 43(8), 4413-4421

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Bromoacetyl)-2-(2-propyn-1-yl)-L-proline methyl ester
C11H14BrNO3
1349067-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6528 3.0959 0.0 0
M  V30 2 O 1.2459 3.7222 0.0 0
M  V30 3 O 2.8137 1.5642 0.0 0
M  V30 4 C 0.0000 2.8170 0.0 0
M  V30 5 C 4.6687 2.6673 0.0 0
M  V30 6 C 3.8987 1.3336 0.0 0
M  V30 7 C 3.1287 0.0000 0.0 0
M  V30 8 C 6.6391 3.8574 0.0 0
M  V30 9 C 7.9729 4.6274 0.0 0
M  V30 10 O 6.6391 2.3174 0.0 0
M  V30 11 Br 9.3066 3.8574 0.0 0
M  V30 12 C 3.8987 4.0011 0.0 0 CFG=2
M  V30 13 N 5.3055 4.6274 0.0 0
M  V30 14 C 2.8681 5.1455 0.0 0
M  V30 15 C 5.1446 6.1590 0.0 0
M  V30 16 C 3.6381 6.4791 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 12 5 CFG=1
M  V30 7 3 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(8aR)-Hexahydro-2-methyl-8a-(2-propyn-1-yl)pyrrolo[1,2-a]pyrazine-1,4-dione
C11H14N2O2
1349067-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4079 3.2235 0.0 0
M  V30 2 C 6.6538 4.1288 0.0 0
M  V30 3 C 7.8996 5.0340 0.0 0
M  V30 4 O 5.3347 1.5400 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 C 4.0009 3.8500 0.0 0 CFG=2
M  V30 8 N 2.6673 4.6200 0.0 0
M  V30 9 C 4.0009 2.3100 0.0 0
M  V30 10 C 5.1455 4.8804 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 2.9875 6.1263 0.0 0
M  V30 13 N 2.6673 1.5400 0.0 0
M  V30 14 C 4.5192 6.2872 0.0 0
M  V30 15 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 3 2 3
M  V30 4 2 4 9
M  V30 5 2 5 11
M  V30 6 1 6 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1349067-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1349067-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7302820
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Proline-Glycine N-Methyl DKP 15a Bromide 14 (1.90 g, 6.58 mmol) in
methanol (10 mL) was treated with a methylamine solution (2M in methanol;
33.0 mL, 65.8 mmol) at 0 °C. After 1.5 hours the reaction mixture was
concentrated under reduced pressure and the resulting yellow residue
treated with dichloromethane (20 mL). The resulting white precipitate was
removed by filtration and the filtrate concentrated under reduced
pressure. The residue was purified by column chromatography (eluent 100%
ethyl acetate then ethyl acetate/methanol, 9/1). The title compound 15a
as a white solid (1.17 g, 6.09 mmol, 93%). m.p. 128-130 °C; [α]D 20
−106.8 (c 1.00, CHCl3); FTIR (film) νmax 3284, 2974, 2888, 1651, 1454,
1408, 1339, 1311, 1224, 1013; 1H NMR (300 MHz, CDCl3) δ 4.46 (d, J=16.9,
1H), 3.89 (m, 1H), 3.80 (d, J=16.9, 1H), 3.57 (m, 1H), 3.02 (s, 3H), 2.79
(dd, J=17.3, 2.7, 1H) 2.59 (dd, J=17.3, 2.7, 1H), 2.20-1.95 (m, 4H), 2.05
(t, J=2.7, 1H); 13C NMR (75 MHz, CDCl3) δ 168.2, 162.9, 78.6, 72.0, 66.7,
53.8, 44.8, 35.3, 33.5, 28.4, 20.1; HRMS (ESI) calculated for C11H14N2O2
[M+Na]+ 229.0953 found 229.0947.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the Asperparaline Core by a Radical Cascade
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crick, Peter J.; Simpkins, Nigel S.; Highton, Adrian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2011), 13(24), 6472-6475

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Cyclohexanedione, 2-(4-methylphenyl)-
C13H14O2
1373402-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0800 0.0000 0.0 0
M  V30 2 O 3.0800 5.3349 0.0 0
M  V30 3 C 9.2401 2.6675 0.0 0
M  V30 4 C 3.0800 2.6675 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 C 0.0000 2.6675 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 C 5.3901 1.3338 0.0 0
M  V30 13 C 6.9301 4.0011 0.0 0
M  V30 14 C 6.9301 1.3338 0.0 0
M  V30 15 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 6
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-2-(4-methylphenyl)-2-cyclohexen-1-one
C14H17NO
1373402-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0801 1.3338 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 O 3.0801 6.6687 0.0 0
M  V30 4 C 9.2402 4.0012 0.0 0
M  V30 5 C 3.0801 4.0012 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 2.3101 5.3348 0.0 0
M  V30 8 C 0.7700 2.6675 0.0 0
M  V30 9 C 0.7700 5.3348 0.0 0
M  V30 10 C 0.0000 4.0012 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 6.9302 5.3348 0.0 0
M  V30 15 C 6.9302 2.6675 0.0 0
M  V30 16 C 7.7002 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 7
M  V30 4 1 4 16
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1373402-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373402-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12252671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of carbazolones and 3-acetylindoles via oxidative C-N bond
formation through PIFA-mediated annulation of 2-aryl enaminones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ban, Xu; Pan, Yan; Lin, Yingfu; Wang, Songqing; Du, Yunfei; Zhao, Kang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2012), 10(18), 3606-3609

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
5-Cyclopropyl-2-(4-fluorophenyl)-6-[[(4-methoxyphenyl)methyl](methylsulfonyl)...
C26H24FN3O5S
1378869-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0020 5.3950 0.0 0
M  V30 2 C 6.6684 4.6250 0.0 0
M  V30 3 S 8.0020 6.9350 0.0 0 VAL=6
M  V30 4 C 8.0020 8.4750 0.0 0
M  V30 5 O 6.4620 6.9350 0.0 0
M  V30 6 O 9.5420 6.9350 0.0 0
M  V30 7 C 13.9437 1.1444 0.0 0
M  V30 8 O 15.4500 0.8242 0.0 0
M  V30 9 O 12.9131 0.0000 0.0 0
M  V30 10 O 1.3336 7.7050 0.0 0
M  V30 11 C 0.0000 6.9350 0.0 0
M  V30 12 F 20.5329 3.8549 0.0 0
M  V30 13 C 9.3357 4.6250 0.0 0
M  V30 14 C 9.3357 3.0849 0.0 0
M  V30 15 C 10.6695 5.3950 0.0 0
M  V30 16 C 10.6695 2.3149 0.0 0
M  V30 17 N 12.0031 4.6250 0.0 0
M  V30 18 C 12.0031 3.0849 0.0 0
M  V30 19 N 13.4677 5.1008 0.0 0
M  V30 20 C 13.4677 2.6091 0.0 0
M  V30 21 C 14.3729 3.8549 0.0 0
M  V30 22 C 8.0020 2.3149 0.0 0
M  V30 23 C 7.2320 0.9813 0.0 0
M  V30 24 C 6.4620 2.3149 0.0 0
M  V30 25 C 5.3347 5.3950 0.0 0
M  V30 26 C 5.3347 6.9350 0.0 0
M  V30 27 C 4.0009 4.6250 0.0 0
M  V30 28 C 4.0009 7.7050 0.0 0
M  V30 29 C 2.6673 5.3950 0.0 0
M  V30 30 C 2.6673 6.9350 0.0 0
M  V30 31 C 15.9129 3.8549 0.0 0
M  V30 32 C 16.6829 5.1886 0.0 0
M  V30 33 C 16.6829 2.5213 0.0 0
M  V30 34 C 18.2229 5.1886 0.0 0
M  V30 35 C 18.2229 2.5213 0.0 0
M  V30 36 C 18.9929 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 25
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 3 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 12 36
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 14 22
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 21 31
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Cyclopropyl-2-(4-fluorophenyl)-6-[[(4-methoxyphenyl)methyl](methylsulfonyl)...
C27H27FN4O4S
1378869-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5892 2.6091 0.0 0
M  V30 2 N 7.6198 1.4645 0.0 0
M  V30 3 O 5.0829 2.2889 0.0 0
M  V30 4 C 7.1438 0.0000 0.0 0
M  V30 5 N 12.5308 6.8595 0.0 0
M  V30 6 C 13.8645 6.0895 0.0 0
M  V30 7 S 12.5308 8.3995 0.0 0 VAL=6
M  V30 8 C 12.5308 9.9395 0.0 0
M  V30 9 O 10.9908 8.3995 0.0 0
M  V30 10 O 14.0708 8.3995 0.0 0
M  V30 11 F 0.0000 5.3195 0.0 0
M  V30 12 O 19.1992 9.1695 0.0 0
M  V30 13 C 20.5328 8.3995 0.0 0
M  V30 14 C 8.5298 4.5495 0.0 0
M  V30 15 C 7.0652 4.0736 0.0 0
M  V30 16 N 8.5298 6.0895 0.0 0
M  V30 17 C 9.8634 3.7795 0.0 0
M  V30 18 C 6.1600 5.3195 0.0 0
M  V30 19 C 9.8634 6.8595 0.0 0
M  V30 20 N 7.0651 6.5655 0.0 0
M  V30 21 C 11.1972 4.5495 0.0 0
M  V30 22 C 11.1972 6.0895 0.0 0
M  V30 23 C 4.6200 5.3195 0.0 0
M  V30 24 C 3.8500 6.6533 0.0 0
M  V30 25 C 3.8500 3.9858 0.0 0
M  V30 26 C 2.3100 6.6533 0.0 0
M  V30 27 C 2.3100 3.9858 0.0 0
M  V30 28 C 1.5400 5.3195 0.0 0
M  V30 29 C 12.5308 3.7795 0.0 0
M  V30 30 C 13.3008 2.4458 0.0 0
M  V30 31 C 14.0708 3.7795 0.0 0
M  V30 32 C 15.1981 6.8595 0.0 0
M  V30 33 C 15.1981 8.3995 0.0 0
M  V30 34 C 16.5319 6.0895 0.0 0
M  V30 35 C 16.5319 9.1695 0.0 0
M  V30 36 C 17.8655 6.8595 0.0 0
M  V30 37 C 17.8655 8.3995 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 22
M  V30 8 1 6 32
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 37
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 20
M  V30 23 1 18 23
M  V30 24 2 19 22
M  V30 25 1 21 22
M  V30 26 1 21 29
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1378869-06-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1378869-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11369689
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 13:
5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(4-methoxybenzyl)methylsulfonamido)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide
To a solution of
5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(4-methoxybenzyl)methylsulfonamido)pyrazolo[1,5-a]pyridine-3-carboxylic
acid (7.5 g, 14.7 mmol) in dry DMF (100 mL) was added DIPEA (4.16 g, 32.3
mmol) and HATU (6.6 g, 17.6 mmol) at 21 °C under N2 atmosphere. After the
mixture was stirred for 15 mins, MeNH2 in THF (29.4 mL, 58.8 mmol) was
added and the mixture was stirred at rt for 30 min. The mixture was
diluted with water (300 mL) and extracted with EtOAc (3 x 300 mL). The
combined organic layers were washed with water (500 mL) and brine (500
mL) and dried over anhydrous Na2SO4. After the removal of solvent, the
crude product was purified with column chromatography to afford
5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(4-methoxybenzyl)methylsulfonamido)-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide.
Yield 7.2 g, 93%, white solid. LCMS (m/z, ES+) = 523.0 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Pyrazolopyridinyl)aminomethylboronic acid derivatives and their
preparation and use for the treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067664 A1 2012-05-24

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
2-(4-Fluorophenyl)-5-methoxy-6-[(methylsulfonyl)(phenylmethyl)amino]pyrazolo[...
C23H20FN3O5S
1378869-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 1.1444 0.0 0
M  V30 2 O 12.7826 0.8242 0.0 0
M  V30 3 O 10.2458 0.0000 0.0 0
M  V30 4 O 5.3347 2.3149 0.0 0
M  V30 5 C 5.3347 0.7749 0.0 0
M  V30 6 N 5.3347 5.3949 0.0 0
M  V30 7 C 4.0011 4.6249 0.0 0
M  V30 8 S 5.3347 6.9349 0.0 0 VAL=6
M  V30 9 C 5.3347 8.4750 0.0 0
M  V30 10 O 6.8747 6.9349 0.0 0
M  V30 11 O 3.7947 6.9349 0.0 0
M  V30 12 F 17.8656 3.8549 0.0 0
M  V30 13 C 9.3358 3.0849 0.0 0
M  V30 14 N 9.3358 4.6249 0.0 0
M  V30 15 C 10.8004 2.6091 0.0 0
M  V30 16 C 8.0020 2.3149 0.0 0
M  V30 17 N 10.8004 5.1008 0.0 0
M  V30 18 C 8.0020 5.3949 0.0 0
M  V30 19 C 11.7056 3.8549 0.0 0
M  V30 20 C 6.6684 3.0849 0.0 0
M  V30 21 C 6.6684 4.6249 0.0 0
M  V30 22 C 13.2456 3.8549 0.0 0
M  V30 23 C 14.0156 2.5213 0.0 0
M  V30 24 C 14.0156 5.1886 0.0 0
M  V30 25 C 15.5556 2.5213 0.0 0
M  V30 26 C 15.5556 5.1886 0.0 0
M  V30 27 C 16.3256 3.8549 0.0 0
M  V30 28 C 2.6673 5.3949 0.0 0
M  V30 29 C 1.3336 4.6249 0.0 0
M  V30 30 C 2.6673 6.9349 0.0 0
M  V30 31 C 0.0000 5.3949 0.0 0
M  V30 32 C 1.3336 7.7049 0.0 0
M  V30 33 C 0.0000 6.9349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 21
M  V30 9 1 7 28
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 8 11
M  V30 13 1 12 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Fluorophenyl)-5-methoxy-6-[(methylsulfonyl)(phenylmethyl)amino]pyrazolo[...
C23H21FN4O4S
1378869-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 1.1444 0.0 0
M  V30 2 N 12.7826 0.8242 0.0 0
M  V30 3 O 10.2458 0.0000 0.0 0
M  V30 4 O 5.3347 2.3149 0.0 0
M  V30 5 C 5.3347 0.7749 0.0 0
M  V30 6 N 5.3347 5.3949 0.0 0
M  V30 7 C 4.0011 4.6249 0.0 0
M  V30 8 S 5.3347 6.9349 0.0 0 VAL=6
M  V30 9 C 5.3347 8.4750 0.0 0
M  V30 10 O 6.8747 6.9349 0.0 0
M  V30 11 O 3.7947 6.9349 0.0 0
M  V30 12 F 17.8656 3.8549 0.0 0
M  V30 13 C 9.3358 3.0849 0.0 0
M  V30 14 N 9.3358 4.6249 0.0 0
M  V30 15 C 10.8004 2.6091 0.0 0
M  V30 16 C 8.0020 2.3149 0.0 0
M  V30 17 N 10.8004 5.1008 0.0 0
M  V30 18 C 8.0020 5.3949 0.0 0
M  V30 19 C 11.7056 3.8549 0.0 0
M  V30 20 C 6.6684 3.0849 0.0 0
M  V30 21 C 6.6684 4.6249 0.0 0
M  V30 22 C 13.2456 3.8549 0.0 0
M  V30 23 C 14.0156 2.5213 0.0 0
M  V30 24 C 14.0156 5.1886 0.0 0
M  V30 25 C 15.5556 2.5213 0.0 0
M  V30 26 C 15.5556 5.1886 0.0 0
M  V30 27 C 16.3256 3.8549 0.0 0
M  V30 28 C 2.6673 5.3949 0.0 0
M  V30 29 C 1.3336 4.6249 0.0 0
M  V30 30 C 2.6673 6.9349 0.0 0
M  V30 31 C 0.0000 5.3949 0.0 0
M  V30 32 C 1.3336 7.7049 0.0 0
M  V30 33 C 0.0000 6.9349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 5
M  V30 5 1 4 20
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 21
M  V30 9 1 7 28
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 8 11
M  V30 13 1 12 27
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 2 17 19
M  V30 22 2 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1378869-25-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1378869-26-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10061963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 10:
6-(N-benzylmethylsulfonamido)-2-(4-fluorophenyl)-5-methoxy-N-methylpyrazolo[1,5-a]pyridine-3-carboxamide
To a solution of
6-(N-benzylmethylsulfonamido)-2-(4-fluorophenyl)-5-methoxypyrazolo[1,5-a]pyridine-3-carboxylic
acid (13.4 g, 28.56 mmol) in dry DMF (60 mL) was added TEA (6.36 g, 62.8
mmol) and then HATU (13.1 g, 34.27 mmol) at 21 °C under nitrogen
atmosphere. After 15 min, MeNH2 in THF (57.1 mL, 115.2 mmol) was added
and the mixture was stirred at rt for 30 min. The mixture was diluted
with water (300 mL) and extracted with EtOAc (300 mL x 3). The combined
organic layers were washed with water (500 mL) and brine (500 mL) and
dried over anhydrous Na2SO4. After the removal of solvent, the residue
was purified with column chromatography to afford
6-(N-benzylmethylsulfonamido)-2-(4-fluorophenyl)-5-methoxy-N-methylpyrazolo[1,5-a]pyridine-3-
carboxamide. Yield 12.9 g, 93%, white solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (Pyrazolopyridinyl)aminomethylboronic acid derivatives and their
preparation and use for the treatment of viral infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johns, Brian Alvin; Shotwell, John Brad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012067664 A1 2012-05-24

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
17-Iodoandrost-16-en-3-one
C19H27IO
1382475-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6026 4.5675 0.0 0
M  V30 2 C 8.1631 6.9216 0.0 0
M  V30 3 I 9.9426 7.3305 0.0 0
M  V30 4 O 0.0000 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0 CFG=1
M  V30 6 C 5.3348 3.8500 0.0 0 CFG=2
M  V30 7 C 8.0022 3.8500 0.0 0 CFG=2
M  V30 8 C 6.6684 1.5400 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0 CFG=2
M  V30 10 C 5.3348 5.3900 0.0 0
M  V30 11 C 8.0022 5.3900 0.0 0 CFG=2
M  V30 12 C 9.4668 3.3740 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0 CFG=3
M  V30 15 C 2.6675 3.8500 0.0 0
M  V30 16 C 6.6684 6.1600 0.0 0
M  V30 17 C 9.4668 5.8659 0.0 0
M  V30 18 C 10.3720 4.6200 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 20 C 1.3337 3.0800 0.0 0
M  V30 21 C 1.3337 1.5400 0.0 0
M  V30 22 H 7.5518 1.8184 0.0 0
M  V30 23 H 4.2458 4.9390 0.0 0
M  V30 24 H 8.5540 2.4123 0.0 0
M  V30 25 H 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 11 2 CFG=1
M  V30 3 1 3 17
M  V30 4 2 4 21
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22 CFG=1
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 23 CFG=3
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 24 CFG=3
M  V30 15 1 8 13
M  V30 16 1 9 14
M  V30 17 1 9 15
M  V30 18 1 10 16
M  V30 19 1 11 16
M  V30 20 1 11 17
M  V30 21 1 12 18
M  V30 22 1 13 14
M  V30 23 1 14 19
M  V30 24 1 14 25
M  V30 25 1 15 20
M  V30 26 2 17 18
M  V30 27 1 19 21
M  V30 28 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 5 6 7 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
17-Iodo-N-methylandrost-16-en-3-amine
C20H32IN
1382475-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1365 4.4075 0.0 0
M  V30 2 C 1.7456 4.1193 0.0 0
M  V30 3 I 0.0000 3.5837 0.0 0
M  V30 4 N 11.8906 2.8733 0.0 0
M  V30 5 C 12.6606 4.2071 0.0 0
M  V30 6 C 5.7306 2.8733 0.0 0 CFG=2
M  V30 7 C 4.9606 1.5397 0.0 0 CFG=1
M  V30 8 C 7.2706 2.8733 0.0 0 CFG=2
M  V30 9 C 4.9606 4.2071 0.0 0
M  V30 10 C 3.4206 1.5397 0.0 0 CFG=2
M  V30 11 C 5.7306 0.2061 0.0 0
M  V30 12 C 8.0406 1.5397 0.0 0 CFG=3
M  V30 13 C 8.0406 4.2071 0.0 0
M  V30 14 C 3.4206 4.2071 0.0 0
M  V30 15 C 2.6506 2.8733 0.0 0 CFG=2
M  V30 16 C 2.3902 0.3953 0.0 0
M  V30 17 C 7.2706 0.2061 0.0 0
M  V30 18 C 9.5806 1.5397 0.0 0
M  V30 19 C 9.5806 4.2071 0.0 0
M  V30 20 C 1.1444 2.5532 0.0 0
M  V30 21 C 0.9834 1.0216 0.0 0
M  V30 22 C 10.3506 2.8733 0.0 0 CFG=3
M  V30 23 H 5.8649 4.4075 0.0 0
M  V30 24 H 4.8265 0.0055 0.0 0
M  V30 25 H 3.3939 0.0000 0.0 0
M  V30 26 H 8.8106 0.2061 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 8 1 CFG=3
M  V30 2 1 15 2 CFG=3
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 23 CFG=1
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 24 CFG=3
M  V30 13 1 8 12
M  V30 14 1 8 13
M  V30 15 1 9 14
M  V30 16 1 10 15
M  V30 17 1 10 16
M  V30 18 1 10 25 CFG=1
M  V30 19 1 11 17
M  V30 20 1 12 17
M  V30 21 1 12 18
M  V30 22 1 12 26
M  V30 23 1 13 19
M  V30 24 1 14 15
M  V30 25 1 15 20
M  V30 26 1 16 21
M  V30 27 1 18 22
M  V30 28 1 19 22
M  V30 29 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 6 7 8 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1382475-27-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1382475-31-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1552198
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Compound (212a) To a solution of compound (210c) (2.0 g,
5.0 mmol) in MeOH (30 mL) and THF (10 mL) was add a solution of
CH3NH2/MeOH (30%, 10 mL). The mixture was stirred at room temperature for
2 hours. Then NaBH4 (760 mg, 20 mmol) was added and stirred for another
0.5 hour. After that, water (20 mL) was added and extracted with ethyl
acetate (100 mL x 3). The organic layer was washed with water and brine,
dried and concentrated to give the crude product (212a) ,which was used
in next step without purification. White solid, yield 1.92 g, 93%. LC-MS
(m/z): 414 [M+H]+. 1H NMR (CDCl3, 400 MHz) major characteristic peaks: δ
(ppm) 0.72 (s, 3H), 0.81 (s, 3H), 2.42 (s, 3H), 6.12 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of steroidal CYP11B, CYP17, and/or CYP21 inhibitors for
treating androgen-dependent conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chu, Daniel; Wang, Bing; Ye, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012083112 A2 2012-06-21

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
4-[3-(4-Fluorophenyl)-1-methyl-1H-pyrazol-4-yl]furo[3,4-b]pyridine-5,7-dione
C17H10FN3O3
1383377-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.1271 3.5657 0.0 0
M  V30 2 O 0.0000 8.8682 0.0 0
M  V30 3 C 3.5197 0.0000 0.0 0
M  V30 4 F 11.1481 6.3386 0.0 0
M  V30 5 C 2.6217 5.8672 0.0 0
M  V30 6 C 4.0864 5.3914 0.0 0
M  V30 7 C 2.3015 7.3735 0.0 0
M  V30 8 C 1.2881 5.0972 0.0 0
M  V30 9 C 5.2308 6.4218 0.0 0
M  V30 10 C 0.7700 7.5346 0.0 0
M  V30 11 N 3.4459 8.4041 0.0 0
M  V30 12 O 0.1435 6.1277 0.0 0
M  V30 13 C 4.9106 7.9282 0.0 0
M  V30 14 C 4.4066 3.8850 0.0 0
M  V30 15 C 5.8133 3.2586 0.0 0
M  V30 16 C 3.3760 2.7406 0.0 0
M  V30 17 N 5.6524 1.7271 0.0 0
M  V30 18 N 4.1460 1.4069 0.0 0
M  V30 19 C 7.1470 4.0286 0.0 0
M  V30 20 C 8.4808 3.2586 0.0 0
M  V30 21 C 7.1470 5.5686 0.0 0
M  V30 22 C 9.8144 4.0286 0.0 0
M  V30 23 C 8.4808 6.3386 0.0 0
M  V30 24 C 9.8144 5.5686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 18
M  V30 4 1 4 24
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(4-Fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-6-methyl-5H-pyrrolo[3,4-b]pyr...
C18H13FN4O2
1383377-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4899 3.5658 0.0 0
M  V30 2 O 1.3628 8.8684 0.0 0
M  V30 3 C 0.0000 5.8076 0.0 0
M  V30 4 C 4.8827 0.0000 0.0 0
M  V30 5 F 12.5112 6.3388 0.0 0
M  V30 6 C 5.4492 5.3915 0.0 0
M  V30 7 C 3.9847 5.8674 0.0 0
M  V30 8 C 6.5938 6.4219 0.0 0
M  V30 9 C 3.6643 7.3737 0.0 0
M  V30 10 C 2.6508 5.0973 0.0 0
M  V30 11 C 6.2735 7.9284 0.0 0
M  V30 12 C 2.1328 7.5347 0.0 0
M  V30 13 N 4.8089 8.4042 0.0 0
M  V30 14 N 1.5065 6.1278 0.0 0
M  V30 15 C 5.7694 3.8850 0.0 0
M  V30 16 C 7.1764 3.2587 0.0 0
M  V30 17 C 4.7390 2.7406 0.0 0
M  V30 18 N 7.0153 1.7271 0.0 0
M  V30 19 N 5.5090 1.4070 0.0 0
M  V30 20 C 8.5100 4.0287 0.0 0
M  V30 21 C 8.5100 5.5687 0.0 0
M  V30 22 C 9.8437 3.2587 0.0 0
M  V30 23 C 9.8437 6.3388 0.0 0
M  V30 24 C 11.1774 4.0287 0.0 0
M  V30 25 C 11.1774 5.5687 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 14
M  V30 4 1 4 19
M  V30 5 1 5 25
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1383377-53-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1383377-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-18353945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification and Profiling of a Selective and Brain Penetrant
Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1
(CK1) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wager, Travis T.; Galatsis, Paul; Chandrasekaran, Ramalakshmi Y.; Butler,
Todd W.; Li, Jianke; Zhang, Lei; Mente, Scot; Subramanyam, Chakrapani;
Liu, Shenping; Doran, Angela C.; Chang, Cheng; Fisher, Katherine;
Grimwood, Sarah; Hedde, Joseph R.; Marconi, Michael; Schildknegt, Klaas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Chemical Neuroscience (2017), 8(9), 1995-2004

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,3-Difluorophenyl)-3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1H-2...
C22H24F2O3Si
1392119-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6685 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 Si 9.2400 8.0021 0.0 0
M  V30 4 C 10.7800 8.0021 0.0 0
M  V30 5 C 9.2400 6.4621 0.0 0
M  V30 6 C 9.2400 9.5421 0.0 0
M  V30 7 C 10.7800 6.4621 0.0 0
M  V30 8 C 12.3200 8.0021 0.0 0
M  V30 9 C 10.7800 9.5421 0.0 0
M  V30 10 F 3.0800 2.6674 0.0 0
M  V30 11 O 2.3100 9.3358 0.0 0
M  V30 12 F 4.6200 0.0000 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 5.3900 6.6685 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 O 4.6200 8.0021 0.0 0
M  V30 19 C 3.0800 8.0021 0.0 0
M  V30 20 C 0.7700 6.6685 0.0 0
M  V30 21 C 0.7700 4.0011 0.0 0
M  V30 22 C 0.0000 5.3347 0.0 0
M  V30 23 C 5.3900 4.0011 0.0 0
M  V30 24 C 4.6200 2.6674 0.0 0
M  V30 25 C 6.9300 4.0011 0.0 0
M  V30 26 C 5.3900 1.3336 0.0 0
M  V30 27 C 7.7000 2.6674 0.0 0
M  V30 28 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 24
M  V30 11 2 11 19
M  V30 12 1 12 26
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 23
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 19
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(2,3-Difluorophenyl)-3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-me...
C23H27F2NO2Si
1392119-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6685 0.0 0
M  V30 2 O 7.7000 8.0021 0.0 0
M  V30 3 Si 9.2400 8.0021 0.0 0
M  V30 4 C 10.7800 8.0021 0.0 0
M  V30 5 C 9.2400 6.4621 0.0 0
M  V30 6 C 9.2400 9.5421 0.0 0
M  V30 7 C 10.7800 6.4621 0.0 0
M  V30 8 C 12.3200 8.0021 0.0 0
M  V30 9 C 10.7800 9.5421 0.0 0
M  V30 10 C 5.3900 9.3358 0.0 0
M  V30 11 F 3.0800 2.6674 0.0 0
M  V30 12 O 2.3100 9.3358 0.0 0
M  V30 13 F 4.6200 0.0000 0.0 0
M  V30 14 C 4.6200 5.3347 0.0 0
M  V30 15 C 3.0800 5.3347 0.0 0
M  V30 16 C 5.3900 6.6685 0.0 0
M  V30 17 C 2.3100 6.6685 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 N 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 8.0021 0.0 0
M  V30 21 C 0.7700 6.6685 0.0 0
M  V30 22 C 0.7700 4.0011 0.0 0
M  V30 23 C 0.0000 5.3347 0.0 0
M  V30 24 C 5.3900 4.0011 0.0 0
M  V30 25 C 4.6200 2.6674 0.0 0
M  V30 26 C 6.9300 4.0011 0.0 0
M  V30 27 C 5.3900 1.3336 0.0 0
M  V30 28 C 7.7000 2.6674 0.0 0
M  V30 29 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 10 19
M  V30 11 1 11 25
M  V30 12 2 12 20
M  V30 13 1 13 27
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 24
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 2 17 21
M  V30 22 1 18 22
M  V30 23 1 19 20
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1392119-07-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1392119-09-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12669222
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-39-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step B
4-(2,3-Difluoro-phenyl)-3-hydroxymethyl-2-methyl-2H-isoquinolin-1-one
[00144]
3-(tert-Butyl-dimethyl-silanyloxymethyl)-4-(3,4-Difluoro-phenyl)-isochromen-1-one
(720 mg, 1.79 mmol) was dissolved in 4N NH3/EtOH (10 ml). The mixture was
stirred at 60 °C for 1h. TLC showed SM was consumed, the reaction mixture
was cooled to RT, then concentrated to dryness and the residue was
dissolved in THF(10 ml), added a aqueous solution of HF(50%, 10 ml), the
solution was stirred at RT for 2h, TLC showed the reaction was completed,
quenched by adding 2N NaOH to pH=7~8, extracted with EA and washed with
water and brine, dried over sodium sulfate and concentrated to dryness
and gave the desired product (m = 0.5 g, yield = 92.7%). HNMR: (400MHz,
CDCl3) δ 3.79 (s, 3H), 4.44 (m, 2H), 6.93 (d, J=8.0Hz, 1H), 6.98 (m, 1H),
7.16(m, 1H), 7.25 (dd, e Hz, J2=12.0Hz, 1H), 7.45(m, 2H), 8.44(d,
J=6.8Hz, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoquinoline compounds and methods for treating HIV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De La Rosa, Martha Alicia; Haydar, Simon N.; Johns, Brian Alvin;
Velthuisen, Emile Johann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012102985 A1 2012-08-02

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Amino-4-chlorophenyl)-1H-benzotriazol-1-ylmethanone
C13H9ClN4O
1397833-65-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 2.6674 0.0 0
M  V30 2 O 4.4608 1.3336 0.0 0
M  V30 3 N 6.7708 0.0000 0.0 0
M  V30 4 Cl 11.3908 2.6674 0.0 0
M  V30 5 C 2.9292 4.1620 0.0 0
M  V30 6 N 4.4608 4.0011 0.0 0
M  V30 7 C 2.6091 5.6684 0.0 0
M  V30 8 C 1.7849 3.1316 0.0 0
M  V30 9 N 5.0872 5.4079 0.0 0
M  V30 10 N 3.9427 6.4384 0.0 0
M  V30 11 C 1.1444 6.1443 0.0 0
M  V30 12 C 0.3202 3.6075 0.0 0
M  V30 13 C 0.0000 5.1139 0.0 0
M  V30 14 C 6.7708 2.6674 0.0 0
M  V30 15 C 7.5408 1.3336 0.0 0
M  V30 16 C 7.5408 4.0011 0.0 0
M  V30 17 C 9.0808 1.3336 0.0 0
M  V30 18 C 9.0808 4.0011 0.0 0
M  V30 19 C 9.8508 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 14
M  V30 4 1 3 15
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-4-chloro-N-methylbenzamide
C8H9ClN2O
104775-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 2.6673 0.0 0
M  V30 2 N 1.5400 4.0010 0.0 0
M  V30 3 O 1.5400 1.3337 0.0 0
M  V30 4 C 0.0000 4.0010 0.0 0
M  V30 5 N 3.8501 0.0000 0.0 0
M  V30 6 Cl 8.4702 2.6673 0.0 0
M  V30 7 C 3.8501 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 6.1601 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1397833-65-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104775-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-4604677
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new protocol for the synthesis of primary, secondary and tertiary
anthranilamides utilizing N-(2-aminoarylacyl)benzotriazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaniskan, Nevin; Kokten, Sule; Celik, Ilhami
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2012), (8), 198-213

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[6-(2-methoxyphenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-ben...
C25H22F3N3O4
1401450-13-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.3289 6.6685 0.0 0
M  V30 2 C 12.0989 8.0021 0.0 0
M  V30 3 C 13.6389 8.0021 0.0 0
M  V30 4 C 14.4089 9.3358 0.0 0
M  V30 5 F 15.1789 10.6694 0.0 0
M  V30 6 F 15.7425 8.5658 0.0 0
M  V30 7 F 13.0752 10.1058 0.0 0
M  V30 8 O 6.7089 4.0011 0.0 0
M  V30 9 C 3.4333 13.4313 0.0 0
M  V30 10 C 1.1444 11.3703 0.0 0
M  V30 11 O 0.8242 12.8767 0.0 0
M  V30 12 O 0.0000 10.3399 0.0 0
M  V30 13 O 5.1689 1.3338 0.0 0
M  V30 14 C 4.3989 0.0000 0.0 0
M  V30 15 C 7.4789 8.0021 0.0 0
M  V30 16 C 9.0189 8.0021 0.0 0
M  V30 17 N 7.0030 9.4667 0.0 0
M  V30 18 C 6.7089 6.6685 0.0 0
M  V30 19 C 9.7889 6.6685 0.0 0
M  V30 20 N 9.4947 9.4667 0.0 0
M  V30 21 C 8.2489 10.3719 0.0 0
M  V30 22 C 7.4789 5.3347 0.0 0
M  V30 23 C 9.0189 5.3347 0.0 0
M  V30 24 C 5.5383 9.9427 0.0 0
M  V30 25 C 5.2181 11.4490 0.0 0
M  V30 26 C 4.3939 8.9121 0.0 0
M  V30 27 C 3.7534 11.9248 0.0 0
M  V30 28 C 2.9292 9.3880 0.0 0
M  V30 29 C 2.6091 10.8944 0.0 0
M  V30 30 C 7.4789 2.6674 0.0 0
M  V30 31 C 6.7089 1.3338 0.0 0
M  V30 32 C 9.0189 2.6674 0.0 0
M  V30 33 C 7.4789 0.0000 0.0 0
M  V30 34 C 9.7889 1.3338 0.0 0
M  V30 35 C 9.0189 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 22
M  V30 9 1 8 30
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 29
M  V30 14 1 13 14
M  V30 15 1 13 31
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 17 24
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[6-(2-Methoxyphenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl...
C26H25F3N4O3
1401450-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.4136 6.6685 0.0 0
M  V30 2 C 3.6436 8.0021 0.0 0
M  V30 3 C 2.1036 8.0021 0.0 0
M  V30 4 C 1.3336 9.3358 0.0 0
M  V30 5 F 0.5636 10.6694 0.0 0
M  V30 6 F 0.0000 8.5658 0.0 0
M  V30 7 F 2.6673 10.1058 0.0 0
M  V30 8 O 9.0336 4.0011 0.0 0
M  V30 9 C 12.3091 13.4313 0.0 0
M  V30 10 C 14.5980 11.3703 0.0 0
M  V30 11 N 15.7425 10.3399 0.0 0
M  V30 12 O 14.9181 12.8767 0.0 0
M  V30 13 C 17.2070 10.8157 0.0 0
M  V30 14 O 10.5736 1.3338 0.0 0
M  V30 15 C 11.3436 0.0000 0.0 0
M  V30 16 C 8.2636 8.0021 0.0 0
M  V30 17 C 6.7236 8.0021 0.0 0
M  V30 18 N 8.7395 9.4667 0.0 0
M  V30 19 C 9.0336 6.6685 0.0 0
M  V30 20 C 5.9536 6.6685 0.0 0
M  V30 21 N 6.2478 9.4667 0.0 0
M  V30 22 C 7.4936 10.3719 0.0 0
M  V30 23 C 8.2636 5.3347 0.0 0
M  V30 24 C 6.7236 5.3347 0.0 0
M  V30 25 C 10.2042 9.9427 0.0 0
M  V30 26 C 10.5244 11.4490 0.0 0
M  V30 27 C 11.3486 8.9121 0.0 0
M  V30 28 C 11.9889 11.9248 0.0 0
M  V30 29 C 12.8133 9.3880 0.0 0
M  V30 30 C 13.1334 10.8944 0.0 0
M  V30 31 C 8.2636 2.6674 0.0 0
M  V30 32 C 9.0336 1.3338 0.0 0
M  V30 33 C 6.7236 2.6674 0.0 0
M  V30 34 C 8.2636 0.0000 0.0 0
M  V30 35 C 5.9536 1.3338 0.0 0
M  V30 36 C 6.7236 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 23
M  V30 9 1 8 31
M  V30 10 1 9 28
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 30
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 32
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 18 25
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401450-13-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401450-12-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8475803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 10:
4-{6-(3-Fluorophenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-N,2-dimethylbenzamide.
A mixture comprising 20 mg (42 μmol)
4-{6-(3-fluorophenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 10a, 31.7 μL
methanamine solution in tetrahydrofuran (2M), 24.1 mg
N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylmethanaminium
hexafluorophosphate, 7.7 mg N,N-dimethylpyridin-4-amine and 0.5 mL
N,N-dimethylformamide was stirred at 23°C overnight. The solvent was
removed and the residue purified by chromatography.
4-{6-(2-Methoxyphenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-N,2-dimethylbenzamide.
40 mg (82 μmol)
4-{6-(2-methoxyphenoxy)-4-[(3,3,3-trifluoropropyl)amino]-1H-benzimidazol-1-yl}-2-methylbenzoic
acid which was prepared according to intermediate example 39a were
transformed in analogy to example 10 to give after working up and
purification 40 mg (93%) of the title compound. 1H-NMR (DMSO-d6): δ =
2.34 (3H), 2.51-2.63 (2H), 2.72 (3H), 3.48 (2H), 3.72 (3H), 6.05 (1H),
6.11 (1H), 6.15 (1H), 6.87 (1H), 6.95 (1H), 7.09 (2H), 7.35 (1H), 7.39
(1H), 7.43 (1H), 8.22 (1H), 8.24 (1H) ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazoles for treating hyperproliferative
and angiogenesis disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Klar, Ulrich; Koppitz, Marcus; Nguyen, Duy; Kosemund, Dirk; Neuhaus,
Roland; Siemeister, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012130905 A1 2012-10-04

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1Z,5E)-7-Bromo-1-iodo-1,5-heptadiene
C7H10BrI
1412889-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 Br 9.3360 2.3101 0.0 0
M  V30 9 I 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E,6Z)-7-Iodo-N-methyl-2,6-heptadien-1-amine
C8H14IN
950697-11-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6673 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 1.3337 2.3101 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 N 9.3360 2.3101 0.0 0
M  V30 9 I 0.0000 0.0000 0.0 0
M  V30 10 C 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1412889-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 950697-11-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-22879124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isobenzofurans as Synthetic Intermediates: Synthesis and Biological
Activity of 8-epi-(-)-Ajudazol B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adair, Liam; Egan, Ben A.; Pearson, Colin M.; Lopez-Gonzalez, Ricardo;
Kuchar, Michal; Mendoza-Mendoza, Artemio; Prunet, Joelle; Marquez,
Rodolfo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2020), 2020(42), 6661-6672

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-methyl-5-pyrimidinecarboxaldehyde
C6H4Cl2N2O
14160-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 Cl 2.3100 5.3349 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-methyl-6-(methylamino)-5-pyrimidinecarboxaldehyde
C7H8ClN3O
1499972-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 Cl 2.3100 6.6686 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6201 2.6675 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14160-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1499972-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34919882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridopyrimidinone compounds as SOS1 inhibitors and their
use in the treatment of cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Kuo-Long; Gao, Cen; Liu, Bin; Kumar, Sanjeev
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022212531 A1 2022-10-06

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-methyl-5-pyrimidinecarboxaldehyde
C6H4Cl2N2O
14160-91-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6674 0.0 0
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 Cl 2.3100 5.3349 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 4.6200 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-methyl-6-(methylamino)-5-pyrimidinecarboxaldehyde
C7H8ClN3O
1499972-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 0.7700 4.0011 0.0 0
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 Cl 2.3100 6.6686 0.0 0
M  V30 6 C 6.9301 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 N 4.6201 2.6675 0.0 0
M  V30 10 C 3.0800 5.3348 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 4.6201 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 1 3 8
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14160-91-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1499972-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34578379
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted tricyclic aza-heterocycles as SOS1 inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Hongjian; Ji, Jingjing; Sun, Peihua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022187266 A1 2022-09-09

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-phenyl-5-pyrimidinecarboxaldehyde
C11H6Cl2N2O
14160-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3101 5.3350 0.0 0
M  V30 2 Cl 2.3101 0.0000 0.0 0
M  V30 3 C 0.7700 2.6675 0.0 0
M  V30 4 O 0.0000 4.0012 0.0 0
M  V30 5 C 5.3901 2.6675 0.0 0
M  V30 6 N 4.6201 4.0012 0.0 0
M  V30 7 N 4.6201 1.3338 0.0 0
M  V30 8 C 3.0801 4.0012 0.0 0
M  V30 9 C 3.0801 1.3338 0.0 0
M  V30 10 C 2.3101 2.6675 0.0 0
M  V30 11 C 6.9302 2.6675 0.0 0
M  V30 12 C 7.7002 1.3338 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 9.2402 1.3338 0.0 0
M  V30 15 C 9.2402 4.0012 0.0 0
M  V30 16 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-2-phenyl-5-pyrimidinecarboxaldehyde
C12H10ClN3O
1613296-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3101 1.3338 0.0 0
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 Cl 2.3101 6.6687 0.0 0
M  V30 4 C 0.7700 4.0012 0.0 0
M  V30 5 O 0.0000 5.3348 0.0 0
M  V30 6 C 5.3901 4.0012 0.0 0
M  V30 7 N 4.6201 2.6675 0.0 0
M  V30 8 N 4.6201 5.3348 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 2.3101 4.0012 0.0 0
M  V30 12 C 6.9302 4.0012 0.0 0
M  V30 13 C 7.7002 2.6675 0.0 0
M  V30 14 C 7.7002 5.3348 0.0 0
M  V30 15 C 9.2402 2.6675 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 10
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14160-92-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613296-27-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34552138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate from stage 1 added in stage 2 (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidine-Core Compounds Show Activity against Clinically
Relevant Gram-Positive Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riabova, Olga; Egorova, Anna; Lepioshkin, Alexander; Li, Yan; Voigt,
Kerstin; Kloss, Florian; Makarov, Vadim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2022), 17(17), e202200207

$RFMT $RIREG SCHEME301 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-Methoxychalcone
C16H14O2
22252-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 9.3360 1.5400 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 2 4
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H23NO3
2119616-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 8.0020 0.0 0
M  V30 2 O 2.3100 9.3358 0.0 0
M  V30 3 O 2.3100 6.6684 0.0 0
M  V30 4 C 0.7700 9.3358 0.0 0
M  V30 5 C 0.0000 10.6694 0.0 0
M  V30 6 N 4.6200 10.6694 0.0 0
M  V30 7 C 5.3900 12.0031 0.0 0
M  V30 8 O 2.3100 1.3336 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 5.3900 6.6684 0.0 0
M  V30 11 C 4.6200 8.0020 0.0 0
M  V30 12 C 6.9300 6.6684 0.0 0
M  V30 13 C 5.3900 9.3358 0.0 0
M  V30 14 C 7.7000 8.0020 0.0 0
M  V30 15 C 6.9300 9.3358 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 3.0800 5.3347 0.0 0
M  V30 19 C 4.6200 2.6673 0.0 0
M  V30 20 C 2.3100 4.0011 0.0 0
M  V30 21 C 3.0800 2.6673 0.0 0
M  V30 22 C 9.2400 8.0020 0.0 0
M  V30 23 C 10.0100 6.6684 0.0 0
M  V30 24 C 10.0100 9.3358 0.0 0
M  V30 25 C 11.5500 6.6684 0.0 0
M  V30 26 C 11.5500 9.3358 0.0 0
M  V30 27 C 12.3200 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 14 22
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 22252-15-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2119616-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29828002
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 118-75-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3109-63-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 55120-75-7
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, global time 5 h
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-Triggered Highly Facile Oxidative Benzannulation Reaction for the
Synthesis of Anthranilates under Solvent-Free Calcium(II) Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaragorla, Srinivasarao; Dada, Ravikrishna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(8), 4859-4869

$RFMT $RIREG SCHEME302 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-Chalcone
C15H12O
614-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 11 C 8.0023 2.3101 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 C 10.6697 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 2 4
M  V30 5 1 4 11
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H21NO2
2119616-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 5.3348 0.0 0
M  V30 2 O 2.3101 6.6685 0.0 0
M  V30 3 O 2.3101 4.0012 0.0 0
M  V30 4 C 0.7700 6.6685 0.0 0
M  V30 5 C 0.0000 8.0023 0.0 0
M  V30 6 N 4.6201 8.0023 0.0 0
M  V30 7 C 5.3901 9.3360 0.0 0
M  V30 8 C 5.3901 4.0012 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 6.9302 4.0012 0.0 0
M  V30 11 C 5.3901 6.6685 0.0 0
M  V30 12 C 7.7002 5.3348 0.0 0
M  V30 13 C 6.9302 6.6685 0.0 0
M  V30 14 C 4.6201 2.6675 0.0 0
M  V30 15 C 5.3901 1.3337 0.0 0
M  V30 16 C 3.0801 2.6675 0.0 0
M  V30 17 C 4.6201 0.0000 0.0 0
M  V30 18 C 2.3101 1.3337 0.0 0
M  V30 19 C 3.0801 0.0000 0.0 0
M  V30 20 C 9.2402 5.3348 0.0 0
M  V30 21 C 10.0102 6.6685 0.0 0
M  V30 22 C 10.0102 4.0012 0.0 0
M  V30 23 C 11.5503 6.6685 0.0 0
M  V30 24 C 11.5503 4.0012 0.0 0
M  V30 25 C 12.3203 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 12 20
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 614-47-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2119616-70-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28925077
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 118-75-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3109-63-5
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 55120-75-7
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, global time 5 h
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-Triggered Highly Facile Oxidative Benzannulation Reaction for the
Synthesis of Anthranilates under Solvent-Free Calcium(II) Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaragorla, Srinivasarao; Dada, Ravikrishna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2017), 2(8), 4859-4869

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 3-fluorobenzenesulfonate
C16H10ClFO5S
1427203-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 F 14.5752 5.3348 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 2.3101 4.0012 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 6.1601 2.6675 0.0 0
M  V30 14 O 3.8501 1.3338 0.0 0
M  V30 15 C 1.5400 2.6675 0.0 0
M  V30 16 C 6.1601 5.3348 0.0 0
M  V30 17 C 6.9302 4.0012 0.0 0
M  V30 18 C 2.3101 1.3338 0.0 0
M  V30 19 C 10.5740 4.5648 0.0 0
M  V30 20 C 11.9077 5.3348 0.0 0
M  V30 21 C 10.5740 3.0248 0.0 0
M  V30 22 C 13.2414 4.5648 0.0 0
M  V30 23 C 11.9077 2.2548 0.0 0
M  V30 24 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 19
M  V30 8 2 7 18
M  V30 9 1 8 22
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 2 16 17
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 3-fluorob...
C17H14FNO5S
1427203-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2888 2.5369 0.0 0
M  V30 2 C 2.6091 1.0306 0.0 0
M  V30 3 N 1.4646 0.0000 0.0 0
M  V30 4 O 4.0737 0.5546 0.0 0
M  V30 5 C 0.0000 0.4759 0.0 0
M  V30 6 O 9.5598 3.2472 0.0 0
M  V30 7 S 10.3298 4.5808 0.0 0 VAL=6
M  V30 8 O 11.0998 5.9147 0.0 0
M  V30 9 O 8.9961 5.3508 0.0 0
M  V30 10 F 15.6646 4.5808 0.0 0
M  V30 11 C 5.7097 4.5808 0.0 0
M  V30 12 C 4.9397 3.2472 0.0 0
M  V30 13 C 7.2497 4.5808 0.0 0
M  V30 14 O 4.6792 5.7254 0.0 0
M  V30 15 C 3.4334 3.5673 0.0 0
M  V30 16 C 5.7097 1.9135 0.0 0
M  V30 17 C 8.0197 3.2472 0.0 0
M  V30 18 C 3.2724 5.0991 0.0 0
M  V30 19 C 7.2497 1.9135 0.0 0
M  V30 20 C 11.6636 3.8108 0.0 0
M  V30 21 C 12.9973 4.5808 0.0 0
M  V30 22 C 11.6636 2.2708 0.0 0
M  V30 23 C 14.3309 3.8108 0.0 0
M  V30 24 C 12.9973 1.5008 0.0 0
M  V30 25 C 14.3309 2.2708 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 15
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 20
M  V30 11 1 10 23
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14378974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
3-Fluorobenzenesulfonate (22). 22 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 10% → 80%). Yield: 93%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.64 (d, J = 4.4 Hz, 3H), 5.24 (d, J = 2.5 Hz,
2H), 5.86 (t, J = 2.5 Hz, 1H), 6.58 (dd, J1 = 2.2 Hz, J2 = 8.8 Hz, 1H),
6.69 (d, J = 2.2 Hz, 1H), 7.69-7.73 (m, 3H), 7.78-7.80 (m, 1H), 8.04 (br
q, J = 4.4 Hz, 1H, disappears with D2O), 8.85 (d, J = 8.8 Hz, 1H). IC50 ±
SD (nM), MAO-A: 41 ± 3.2; MAO-B: 6 ± 0.5%. Calculated: C 56.19, H 3.88, N
3.85; Found: C 56.31, H 3.90, N 3.88.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylthio)benzoyl chloride
C8H7ClOS
1442-03-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 1.5400 4.0011 0.0 0
M  V30 4 Cl 0.0000 4.0011 0.0 0
M  V30 5 O 2.3100 5.3349 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(methylthio)benzamide
C9H11NOS
52369-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 3.8500 5.3349 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 S 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1442-03-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52369-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231795
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6′-Ethoxy-5-[[1-(2-methoxyethyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy][3,3′-bip...
C22H22N6O4
1443111-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2401 4.0011 0.0 0
M  V30 2 C 14.9710 7.3787 0.0 0
M  V30 3 C 16.4358 6.9029 0.0 0
M  V30 4 O 17.5801 7.9333 0.0 0
M  V30 5 C 19.0449 7.4574 0.0 0
M  V30 6 C 7.7001 1.3337 0.0 0
M  V30 7 N 9.2401 1.3337 0.0 0
M  V30 8 O 6.9301 0.0000 0.0 0
M  V30 9 O 2.3100 10.6696 0.0 0
M  V30 10 C 0.7700 10.6696 0.0 0
M  V30 11 C 0.0000 12.0033 0.0 0
M  V30 12 C 11.5502 5.3348 0.0 0
M  V30 13 C 12.3202 6.6685 0.0 0
M  V30 14 C 10.0102 5.3348 0.0 0
M  V30 15 C 12.5808 4.1903 0.0 0
M  V30 16 N 13.8266 6.3483 0.0 0
M  V30 17 N 11.5502 8.0021 0.0 0
M  V30 18 C 9.2401 6.6685 0.0 0
M  V30 19 N 13.9876 4.8167 0.0 0
M  V30 20 C 10.0102 8.0021 0.0 0
M  V30 21 C 7.7001 4.0011 0.0 0
M  V30 22 C 6.9301 2.6673 0.0 0
M  V30 23 C 6.9301 5.3348 0.0 0
M  V30 24 N 5.3901 2.6673 0.0 0
M  V30 25 C 5.3901 5.3348 0.0 0
M  V30 26 C 4.6201 4.0011 0.0 0
M  V30 27 C 4.6201 6.6685 0.0 0
M  V30 28 C 3.0800 6.6685 0.0 0
M  V30 29 C 5.3901 8.0021 0.0 0
M  V30 30 C 2.3100 8.0021 0.0 0
M  V30 31 N 4.6201 9.3359 0.0 0
M  V30 32 C 3.0800 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 22
M  V30 10 1 9 10
M  V30 11 1 9 32
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[6′-Ethoxy-5-[[1-(2-methoxyethyl)-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy][3,3′-...
C23H25N7O4
1442685-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.2400 6.6684 0.0 0
M  V30 2 C 14.9708 10.0460 0.0 0
M  V30 3 C 16.4355 9.5700 0.0 0
M  V30 4 O 17.5799 10.6006 0.0 0
M  V30 5 C 19.0446 10.1247 0.0 0
M  V30 6 N 7.7000 4.0009 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 N 7.7000 1.3336 0.0 0
M  V30 9 O 5.3900 2.6673 0.0 0
M  V30 10 C 6.9300 0.0000 0.0 0
M  V30 11 O 2.3100 13.3367 0.0 0
M  V30 12 C 0.7700 13.3367 0.0 0
M  V30 13 C 0.0000 14.6703 0.0 0
M  V30 14 C 11.5500 8.0020 0.0 0
M  V30 15 C 12.3200 9.3356 0.0 0
M  V30 16 C 10.0100 8.0020 0.0 0
M  V30 17 C 12.5806 6.8576 0.0 0
M  V30 18 N 13.8264 9.0155 0.0 0
M  V30 19 N 11.5500 10.6694 0.0 0
M  V30 20 C 9.2400 9.3356 0.0 0
M  V30 21 N 13.9874 7.4839 0.0 0
M  V30 22 C 10.0100 10.6694 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0
M  V30 24 C 6.9300 5.3347 0.0 0
M  V30 25 C 6.9300 8.0020 0.0 0
M  V30 26 N 5.3900 5.3347 0.0 0
M  V30 27 C 5.3900 8.0020 0.0 0
M  V30 28 C 4.6200 6.6684 0.0 0
M  V30 29 C 4.6200 9.3356 0.0 0
M  V30 30 C 3.0800 9.3356 0.0 0
M  V30 31 C 5.3900 10.6694 0.0 0
M  V30 32 C 2.3100 10.6694 0.0 0
M  V30 33 N 4.6200 12.0031 0.0 0
M  V30 34 C 3.0800 12.0031 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 18
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 34
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 2 20 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443111-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1442685-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27783769
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2712-78-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Urea compounds as GKa activators and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Houze, Jonathan B.; Dransfield, Paul; Pattaropong, Vatee; Du, Xiaohui;
Fu, Zice; Lai, Sujen; Park, Jaehyeon; Jiao, Xianyun; Kohn, Todd J.;
Aicher, Thomas Daniel; Boyd, Steven Armen; Bencsik, Josef; Condroski,
Kevin Ronald; Hinklin, Ronald Jay; Kraser, Christopher F.; Pratt, Scott;
Singh, Ajay; Wenglowsky, Steven Mark; Boys, Mark Laurence; Chicarelli,
Mark Joseph; Mohr, Peter J.; Cardozo, Mario G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013086397 A1 2013-06-13

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) 2-ethyl 5-amino-2,4-thiophenedicarboxylate
C12H17NO4S
1443279-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0058 4.3858 0.0 0
M  V30 10 O 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6584 4.6645 0.0 0
M  V30 13 C 13.0654 4.0382 0.0 0
M  V30 14 C 5.3900 2.7106 0.0 0
M  V30 15 C 6.2952 3.9564 0.0 0
M  V30 16 C 6.2952 1.4647 0.0 0
M  V30 17 C 7.7599 3.4806 0.0 0
M  V30 18 S 7.7599 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-amino-5-[(methylamino)carbonyl]-3-thiophenecarboxylate
C11H16N2O3S
2648644-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0057 4.3858 0.0 0
M  V30 10 N 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6585 4.6645 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 C 6.2952 3.9564 0.0 0
M  V30 15 C 6.2952 1.4647 0.0 0
M  V30 16 C 7.7598 3.4806 0.0 0
M  V30 17 S 7.7598 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443279-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648644-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35277248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyridinecarboxamide compounds as cereblon modulators and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottens, Sylvain; Kaczanowska, Katarzyna; Pluta, Roman
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022255890 A1 2022-12-08

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) 2-ethyl 5-amino-2,4-thiophenedicarboxylate
C12H17NO4S
1443279-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0058 4.3858 0.0 0
M  V30 10 O 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6584 4.6645 0.0 0
M  V30 13 C 13.0654 4.0382 0.0 0
M  V30 14 C 5.3900 2.7106 0.0 0
M  V30 15 C 6.2952 3.9564 0.0 0
M  V30 16 C 6.2952 1.4647 0.0 0
M  V30 17 C 7.7599 3.4806 0.0 0
M  V30 18 S 7.7599 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-amino-5-[(methylamino)carbonyl]-3-thiophenecarboxylate
C11H16N2O3S
2648644-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0057 4.3858 0.0 0
M  V30 10 N 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6585 4.6645 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 C 6.2952 3.9564 0.0 0
M  V30 15 C 6.2952 1.4647 0.0 0
M  V30 16 C 7.7598 3.4806 0.0 0
M  V30 17 S 7.7598 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443279-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648644-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35899508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeted protein degradation using bifunctional compounds that bind
ubiquitin ligase and target MCL protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottens, Sylvain; Drewniak-Switalska, Magda; Kaczanowska, Katarzyna;
Tomczyk, Tomasz; Tracz, Andrzej; Walczak, Michal; Wojcik, Karolina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022253713 A1 2022-12-08

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) 2-ethyl 5-amino-2,4-thiophenedicarboxylate
C12H17NO4S
1443279-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0058 4.3858 0.0 0
M  V30 10 O 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6584 4.6645 0.0 0
M  V30 13 C 13.0654 4.0382 0.0 0
M  V30 14 C 5.3900 2.7106 0.0 0
M  V30 15 C 6.2952 3.9564 0.0 0
M  V30 16 C 6.2952 1.4647 0.0 0
M  V30 17 C 7.7599 3.4806 0.0 0
M  V30 18 S 7.7599 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-amino-5-[(methylamino)carbonyl]-3-thiophenecarboxylate
C11H16N2O3S
2648644-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0057 4.3858 0.0 0
M  V30 10 N 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6585 4.6645 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 C 6.2952 3.9564 0.0 0
M  V30 15 C 6.2952 1.4647 0.0 0
M  V30 16 C 7.7598 3.4806 0.0 0
M  V30 17 S 7.7598 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443279-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648644-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35495939
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Targeted protein degradation using bifunctional compounds that bind
ubiquitin ligase and target MCL protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottens, Sylvain; Drewniak-Switalska, Magda; Kaczanowska, Katarzyna;
Tomczyk, Tomasz; Tracz, Andrzej; Walczak, Michal; Wojcik, Karolina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022255888 A1 2022-12-08

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl) 2-ethyl 5-amino-2,4-thiophenedicarboxylate
C12H17NO4S
1443279-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0058 4.3858 0.0 0
M  V30 10 O 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6584 4.6645 0.0 0
M  V30 13 C 13.0654 4.0382 0.0 0
M  V30 14 C 5.3900 2.7106 0.0 0
M  V30 15 C 6.2952 3.9564 0.0 0
M  V30 16 C 6.2952 1.4647 0.0 0
M  V30 17 C 7.7599 3.4806 0.0 0
M  V30 18 S 7.7599 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-amino-5-[(methylamino)carbonyl]-3-thiophenecarboxylate
C11H16N2O3S
2648644-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.7106 0.0 0
M  V30 2 O 3.0800 4.0442 0.0 0
M  V30 3 O 3.0800 1.3769 0.0 0
M  V30 4 C 1.5400 4.0442 0.0 0
M  V30 5 C 1.5400 2.5042 0.0 0
M  V30 6 C 0.0000 4.0442 0.0 0
M  V30 7 C 1.5400 5.5842 0.0 0
M  V30 8 N 5.8194 0.0000 0.0 0
M  V30 9 C 9.0057 4.3858 0.0 0
M  V30 10 N 10.4126 3.7593 0.0 0
M  V30 11 O 8.8447 5.9173 0.0 0
M  V30 12 C 11.6585 4.6645 0.0 0
M  V30 13 C 5.3900 2.7106 0.0 0
M  V30 14 C 6.2952 3.9564 0.0 0
M  V30 15 C 6.2952 1.4647 0.0 0
M  V30 16 C 7.7598 3.4806 0.0 0
M  V30 17 S 7.7598 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 16
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443279-50-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648644-10-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23815808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidine-2,6-dione derivatives which bind to cereblon,
and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaczanowska, Katarzyna; Cottens, Sylvain; Pluta, Roman; Dickinson, Niall;
Walczak, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021105335 A1 2021-06-03

$RFMT $RIREG SCHEME307 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[(1R)-3-Chloro-1-phenylpropoxy]benzo[b]thiophene
C17H15ClOS
476199-64-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 4.6200 0.0 0
M  V30 2 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 3 C 4.0011 2.3100 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 Cl 2.6673 0.0000 0.0 0
M  V30 6 C 9.3358 3.8500 0.0 0
M  V30 7 C 9.3358 2.3100 0.0 0
M  V30 8 C 8.0020 4.6200 0.0 0
M  V30 9 C 10.8004 4.3259 0.0 0
M  V30 10 C 8.0020 1.5400 0.0 0
M  V30 11 S 10.8004 1.8341 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 11.7056 3.0800 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 2.6673 4.6200 0.0 0
M  V30 16 C 2.6673 6.1600 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 15
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Oxalic acid
C2H2O4
144-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzenepropanamine, γ-(benzo[b]thien-5-yloxy)-N-methyl-, ethanedioate (1:1), ...
C18H19NOS.C2H2O4
476200-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 10.7801 0.0 0
M  V30 2 C 4.0011 10.0101 0.0 0 CFG=1
M  V30 3 C 4.0011 8.4701 0.0 0
M  V30 4 C 2.6673 7.7001 0.0 0
M  V30 5 N 2.6673 6.1601 0.0 0
M  V30 6 C 1.3336 5.3901 0.0 0
M  V30 7 C 9.3358 10.0101 0.0 0
M  V30 8 C 9.3358 8.4701 0.0 0
M  V30 9 C 8.0020 10.7801 0.0 0
M  V30 10 C 10.8004 10.4860 0.0 0
M  V30 11 C 8.0020 7.7001 0.0 0
M  V30 12 S 10.8004 7.9942 0.0 0
M  V30 13 C 6.6684 10.0101 0.0 0
M  V30 14 C 11.7056 9.2401 0.0 0
M  V30 15 C 6.6684 8.4701 0.0 0
M  V30 16 C 2.6673 10.7801 0.0 0
M  V30 17 C 2.6673 12.3201 0.0 0
M  V30 18 C 1.3336 10.0101 0.0 0
M  V30 19 C 1.3336 13.0901 0.0 0
M  V30 20 C 0.0000 10.7801 0.0 0
M  V30 21 C 0.0000 12.3201 0.0 0
M  V30 22 C 6.5196 1.5400 0.0 0
M  V30 23 C 5.1860 2.3101 0.0 0
M  V30 24 O 7.8533 2.3101 0.0 0
M  V30 25 O 6.5196 0.0000 0.0 0
M  V30 26 O 5.1860 3.8501 0.0 0
M  V30 27 O 3.8523 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 1 23 26
M  V30 28 2 23 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 476199-64-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 144-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476200-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3970257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed used in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-(heteroaryloxy)propanamines as serotonin and
norepinephrine reuptake inhibitors for treatment of pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallagher, Peter Thaddeus; Rathmell, Richard Edmund; Fagan, Maria Ann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002094262 A1 2002-11-28

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C44H46N6O8
1448441-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0462 3.5673 0.0 0
M  V30 2 O 12.3664 5.0737 0.0 0
M  V30 3 C 9.3356 5.5366 0.0 0
M  V30 4 N 8.0020 6.3066 0.0 0
M  V30 5 O 10.6694 6.3066 0.0 0
M  V30 6 N 14.9754 4.5191 0.0 0
M  V30 7 C 16.4401 4.9950 0.0 0
M  V30 8 O 17.5845 3.9644 0.0 0
M  V30 9 C 5.3347 7.8466 0.0 0
M  V30 10 N 4.0009 8.6166 0.0 0
M  V30 11 O 5.3347 6.3066 0.0 0
M  V30 12 N 19.3694 5.9467 0.0 0
M  V30 13 C 20.8340 6.4226 0.0 0
M  V30 14 O 21.1542 7.9290 0.0 0
M  V30 15 C 1.3336 10.1566 0.0 0
M  V30 16 O 0.0000 10.9266 0.0 0
M  V30 17 O 2.6673 10.9266 0.0 0
M  V30 18 C 0.0000 12.4666 0.0 0
M  V30 19 C 24.1112 7.1193 0.0 0
M  V30 20 C 25.6427 7.2802 0.0 0
M  V30 21 O 23.2060 8.3651 0.0 0
M  V30 22 C 25.4818 8.8117 0.0 0
M  V30 23 C 27.1742 7.4411 0.0 0
M  V30 24 C 25.8036 5.7487 0.0 0
M  V30 25 N 10.5816 3.0914 0.0 0
M  V30 26 C 9.3356 3.9966 0.0 0 CFG=1
M  V30 27 C 10.1056 1.6267 0.0 0
M  V30 28 C 8.0898 3.0914 0.0 0
M  V30 29 C 8.5656 1.6267 0.0 0
M  V30 30 C 13.1907 2.5368 0.0 0
M  V30 31 C 14.6553 3.0127 0.0 0
M  V30 32 C 12.8705 1.0304 0.0 0
M  V30 33 C 15.7998 1.9823 0.0 0
M  V30 34 C 14.0149 0.0000 0.0 0
M  V30 35 C 15.4796 0.4759 0.0 0
M  V30 36 C 8.0020 7.8466 0.0 0
M  V30 37 C 6.6684 8.6166 0.0 0
M  V30 38 C 9.3356 8.6166 0.0 0
M  V30 39 C 6.6684 10.1566 0.0 0
M  V30 40 C 9.3356 10.1566 0.0 0
M  V30 41 C 8.0020 10.9266 0.0 0
M  V30 42 C 16.7603 6.5013 0.0 0
M  V30 43 C 18.2250 6.9771 0.0 0
M  V30 44 C 15.6159 7.5317 0.0 0
M  V30 45 C 18.5451 8.4836 0.0 0
M  V30 46 C 15.9361 9.0381 0.0 0
M  V30 47 C 17.4006 9.5140 0.0 0
M  V30 48 C 2.6673 7.8466 0.0 0
M  V30 49 C 1.3336 8.6166 0.0 0
M  V30 50 C 2.6673 6.3066 0.0 0
M  V30 51 C 0.0000 7.8466 0.0 0
M  V30 52 C 1.3336 5.5366 0.0 0
M  V30 53 C 0.0000 6.3066 0.0 0
M  V30 54 C 21.9784 5.3922 0.0 0 CFG=2
M  V30 55 N 23.4848 5.7123 0.0 0
M  V30 56 C 21.8175 3.8606 0.0 0
M  V30 57 C 24.2548 4.3787 0.0 0
M  V30 58 C 23.2243 3.2342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 25
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 26 3 CFG=3
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 31
M  V30 10 2 7 8
M  V30 11 1 7 42
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 37
M  V30 15 1 10 48
M  V30 16 1 12 13
M  V30 17 1 12 43
M  V30 18 2 13 14
M  V30 19 1 54 13 CFG=1
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 15 49
M  V30 23 1 16 18
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 1 19 55
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 59 1 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(2,2-Dimethyl-1-oxopropyl)-L-prolyl-2-aminobenzoyl-2-aminobenzoyl-N-[2-[[[2...
C44H47N7O7
1448441-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  58 63 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.0463 3.5673 0.0 0
M  V30 2 O 12.3665 5.0737 0.0 0
M  V30 3 C 9.3358 5.5366 0.0 0
M  V30 4 N 8.0021 6.3066 0.0 0
M  V30 5 O 10.6694 6.3066 0.0 0
M  V30 6 N 14.9756 4.5191 0.0 0
M  V30 7 C 16.4403 4.9950 0.0 0
M  V30 8 O 17.5846 3.9644 0.0 0
M  V30 9 C 5.3347 7.8466 0.0 0
M  V30 10 N 4.0011 8.6166 0.0 0
M  V30 11 O 5.3347 6.3066 0.0 0
M  V30 12 N 19.3695 5.9467 0.0 0
M  V30 13 C 20.8340 6.4226 0.0 0
M  V30 14 O 21.1542 7.9290 0.0 0
M  V30 15 C 1.3338 10.1566 0.0 0
M  V30 16 N 0.0000 10.9266 0.0 0
M  V30 17 O 2.6674 10.9266 0.0 0
M  V30 18 C 0.0000 12.4666 0.0 0
M  V30 19 C 24.1113 7.1191 0.0 0
M  V30 20 C 25.6428 7.2802 0.0 0
M  V30 21 O 23.2061 8.3651 0.0 0
M  V30 22 C 24.7376 8.5261 0.0 0
M  V30 23 C 26.2692 8.6870 0.0 0
M  V30 24 C 26.5481 6.0343 0.0 0
M  V30 25 N 10.5816 3.0914 0.0 0
M  V30 26 C 9.3358 3.9966 0.0 0 CFG=1
M  V30 27 C 10.1058 1.6267 0.0 0
M  V30 28 C 8.0899 3.0914 0.0 0
M  V30 29 C 8.5658 1.6267 0.0 0
M  V30 30 C 13.1907 2.5368 0.0 0
M  V30 31 C 14.6554 3.0127 0.0 0
M  V30 32 C 12.8706 1.0304 0.0 0
M  V30 33 C 15.7998 1.9823 0.0 0
M  V30 34 C 14.0151 0.0000 0.0 0
M  V30 35 C 15.4796 0.4759 0.0 0
M  V30 36 C 8.0021 7.8466 0.0 0
M  V30 37 C 6.6685 8.6166 0.0 0
M  V30 38 C 9.3358 8.6166 0.0 0
M  V30 39 C 6.6685 10.1566 0.0 0
M  V30 40 C 9.3358 10.1566 0.0 0
M  V30 41 C 8.0021 10.9266 0.0 0
M  V30 42 C 16.7604 6.5013 0.0 0
M  V30 43 C 18.2250 6.9771 0.0 0
M  V30 44 C 15.6159 7.5318 0.0 0
M  V30 45 C 18.5451 8.4836 0.0 0
M  V30 46 C 15.9361 9.0381 0.0 0
M  V30 47 C 17.4008 9.5140 0.0 0
M  V30 48 C 2.6674 7.8466 0.0 0
M  V30 49 C 1.3338 8.6166 0.0 0
M  V30 50 C 2.6674 6.3066 0.0 0
M  V30 51 C 0.0000 7.8466 0.0 0
M  V30 52 C 1.3338 5.5366 0.0 0
M  V30 53 C 0.0000 6.3066 0.0 0
M  V30 54 C 21.9786 5.3922 0.0 0 CFG=2
M  V30 55 N 23.4848 5.7123 0.0 0
M  V30 56 C 21.8175 3.8606 0.0 0
M  V30 57 C 24.2548 4.3787 0.0 0
M  V30 58 C 23.2244 3.2342 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 25
M  V30 3 1 1 30
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 26 3 CFG=3
M  V30 7 1 4 36
M  V30 8 1 6 7
M  V30 9 1 6 31
M  V30 10 2 7 8
M  V30 11 1 7 42
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 9 37
M  V30 15 1 10 48
M  V30 16 1 12 13
M  V30 17 1 12 43
M  V30 18 2 13 14
M  V30 19 1 54 13 CFG=1
M  V30 20 1 15 16
M  V30 21 2 15 17
M  V30 22 1 15 49
M  V30 23 1 16 18
M  V30 24 1 19 20
M  V30 25 2 19 21
M  V30 26 1 19 55
M  V30 27 1 20 22
M  V30 28 1 20 23
M  V30 29 1 20 24
M  V30 30 1 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 29
M  V30 35 2 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 35
M  V30 41 2 36 37
M  V30 42 1 36 38
M  V30 43 1 37 39
M  V30 44 2 38 40
M  V30 45 2 39 41
M  V30 46 1 40 41
M  V30 47 2 42 43
M  V30 48 1 42 44
M  V30 49 1 43 45
M  V30 50 2 44 46
M  V30 51 2 45 47
M  V30 52 1 46 47
M  V30 53 2 48 49
M  V30 54 1 48 50
M  V30 55 1 49 51
M  V30 56 2 50 52
M  V30 57 2 51 53
M  V30 58 1 52 53
M  V30 59 1 54 55
M  V30 60 1 54 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 1 57 58
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 54)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448441-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448441-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3344033
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(S)-N-(2-((2-(methylcarbamoyl)phenyl)carbamoyl)phenyl)-1-(2-(2-((S)-1-pivaloyl
pyrrolidine-2-carboxamido)benzamido)benzoyl)pyrrolidine-2-carboxamide 5:
The ester 5a (0.2g, 0.25 mmol) was taken in saturated
methanolicmethylamine solution (2 mL) and stirred at room temperature for
2 h. Thesolvent was removed under reduced pressure, and the residue was
purified by column chromatography (eluent: 60% AcOEt/pet. Ether, Rf :
0.2) to afford 5.
2-[2-({1-[2-(2-{[1-(2,2-Dimethyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-benzoyl
amino)-benzoyl]-pyrrolidine-2-carbonyl}-amino)-benzoylamino]-benzoic acid
methyl amide 1: Compound 1 was synthesized from ester 3, following the
procedure for 5. Column chromatographic purification (eluent: 60%
AcOEt/pet. Ether, Rf: 0.2) of the residue afforded 1 as white solid
(93%). mp: 225-227 °C; [α ]25.84 D : 156.356° (c 1, CHCl3); IR (CHCl3) ν
(cm-1): 3260, 3020, 2401, 1681, 1651, 1623, 1583, 1520, 1428, 1297. 1H
NMR (400 MHz, CDCl3) δ: 12.78 (s, 1H, amide), 12.37 (s, 1H, amide),
11.59(s, 1H, amide ), 10.32 (s, 1H, amide), 8.98-8.96 (d, J = 8.28 Hz,
1H), 8.56-8.54 (d, J = 8.28 Hz, 1H), 8.48-8.46 (d, J = 8.53 Hz, 1H), 8.33
(s, 1H, amide), 8.29-8.27 (d, J = 8.53 Hz, 1H), 7.89-7.88 (d, J = 7.78
Hz, 1H ), 7.68-7.65 (d, J = 9.54 Hz, 1H ), 7.65-7.63 (d, J = 8.78 Hz,
1H), 7.59-7.55 (m, 1H), 7.5-7.46 (m, 1H), 7.25-7.12(m, 6H), 6.12-6.08 (m,
1H), 4.8-4.77 (dd, J = 2.76Hz, J = 7.78Hz, 1H), 4.5-4.27 (m, 1H),
4.4-4.37 (m, 1H), 4.13-4.08 (m, 1H), 4.03-3.97 (m, 1H), 3.9-3.77 (m, 2H),
2.78-2.77(d, 4.52Hz, 2H), 2.42- 2.4 (m, 2H), 2.14- 2.11 (m, 4H), 1.94-
1.91 (m, 2H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCl3) δ: 177.5, 171.0,
170.6, 169.6, 169.2, 167.7, 165.9, 140.7, 140.4, 138.4, 138.7, 137.8,
133.1, 132.7, 131.9, 131.3, 128.0, 127.7, 127.3, 127.0, 123.4, 123.1,
123.0, 122.5, 121.4, 120.5, 120.1, 119.1, 117.5, 64.0, 63.7, 50.7, 48.6,
38.9, 30.4, 28.5, 27.4, 26.8, 25.9, 25.0; MALDI-TOF/TOF: 809.8082
(M+Na)+, 825.7921 (M+K)+; Elemental analysis calculated for C44H47N7O7:
C, 67.25; H, 6.03; N, 12.48. Found: C, 67.09; H, 6.04; N, 12.47. Crystal
data of 1. C44H47N7O7, M = 785.89, colorless plate, 0.31 x 0.14 x 0.06
mm3 , orthorhombic, space group P212121, a = 9.3778(9), b = 13.4883(12),
c = 31.293(3) Å , V = 3958.3(6)Å 3 , Z = 2, T= 100(2) K, 2θ max = 50.00°,
Dcalc(g cm-3) = 1.319, F(000) = 1664, μ (mm-1) = 0.091, 20191 reflections
collected, 6958 uniquereflections (Rint = 0.0467), 6392 observed (I > 2σ
(I)) reflections, multi-scan absorption correction, Tmin = 0.973, Tmax =
0.995, 667 refined parameters, S = 1.165, R1=0.0497, wR2 =0.0948 (all
data R = 0.0563, wR2 = 0.975), maximum and minimum residual electron
densities; ∆ρ max = 0.19, ∆ρ min = -0.18 (eÅ -3 ).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Synthetic Zipper Peptide Motif Orchestrated via Co-operative Interplay
of Hydrogen Bonding, Aromatic Stacking, and Backbone Chirality
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nair, Roshna V.; Kheria, Sanjeev; Rayavarapu, Suresh; Kotmale, Amol S.;
Jagadeesh, Bharatam; Gonnade, Rajesh G.; Puranik, Vedavati G.;
Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(31), 11477-11480

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Butyn-1-yl)-3H-diazirine-3-propanoic acid
C8H10N2O2
1450754-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6673 0.0 0
M  V30 2 C 2.3100 2.6673 0.0 0
M  V30 3 C 1.5400 1.3336 0.0 0
M  V30 4 O 0.0000 1.3336 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 C 6.0671 3.4742 0.0 0
M  V30 7 C 7.2469 4.4642 0.0 0
M  V30 8 C 8.6941 3.9375 0.0 0
M  V30 9 C 10.1412 3.4108 0.0 0
M  V30 10 C 4.6200 4.0009 0.0 0
M  V30 11 N 3.4404 4.9908 0.0 0
M  V30 12 N 4.8875 5.5175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 10
M  V30 8 1 7 8
M  V30 9 3 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Butyn-1-yl)-N-methyl-3H-diazirine-3-propanamide
C9H13N3O
2089056-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8199 2.5018 0.0 0
M  V30 2 C 7.1538 3.2718 0.0 0
M  V30 3 C 8.4874 2.5018 0.0 0
M  V30 4 N 9.8211 3.2718 0.0 0
M  V30 5 O 8.4874 0.9618 0.0 0
M  V30 6 C 11.1548 2.5018 0.0 0
M  V30 7 C 3.4963 2.0921 0.0 0
M  V30 8 C 1.9797 2.3595 0.0 0
M  V30 9 C 0.9898 1.1798 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 4.4863 3.2718 0.0 0
M  V30 12 N 3.4963 4.4515 0.0 0
M  V30 13 N 5.0130 4.7190 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 11
M  V30 9 1 8 9
M  V30 10 3 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1450754-37-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089056-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17066183
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand and Target Discovery by Fragment-Based Screening in Human Cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Parker, Christopher G.; Galmozzi, Andrea; Wang, Yujia; Correia, Bruno E.;
Sasaki, Kenji; Joslyn, Christopher M.; Kim, Arthur S.; Cavallaro, Cullen
L.; Lawrence, R. Michael; Johnson, Stephen R.; Narvaiza, Inigo; Saez,
Enrique; Cravatt, Benjamin F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Cell (Cambridge, MA, United States) (2017), 168(3), 527-541.e29

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
5-Bromo-2-fluorobenzoic acid
C7H4BrFO2
146328-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-fluoro-N-methylbenzamide
C8H7BrFNO
1016777-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 N 5.3901 4.0011 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 C 6.9301 4.0011 0.0 0
M  V30 5 F 3.0800 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 146328-85-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1016777-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13418329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 5-bromo-2-fluoro-N-methylbenzamide. To a mixture of
5-bromo-2-fluorobenzoic acid (200 mg, 0.91 mmol) in dichloromethane (5
mL) was added oxalyl chloride (0.16 mL, 1.8 mmol), followed by 1 drop of
N,N-dimethylformamide. The reaction was stirred at room temperature for
1.5 hours. The reaction was concentrated and the resulting residue was
dissolved in dichloromethane (3 mL) and cooled to 0 °C. Methylamine (2.3
mL, 5 mmol, 2 M in tetrahydrofuran) was added and the reaction was
allowed to stir at 0 °C for 30 minutes. The reaction was quenched with
water and the mixture was concentrated. The residue was diluted with
water and the resulting solids were filtered, rinsed with water, and
dried under vacuum. 5-bromo-2-fluoro-N-methylbenzamide as a white solid,
yield 196.6 mg, 93%. +ESI (M+H+1) 234.1; 1H NMR (400 MHz, CDCI3, δ); 8.22
(dd, J = 6.83, 2.73 Hz, 1 H), 7.55 (ddd, J = 8.68, 4.49, 2.63 Hz, 1 H),
7.00 (dd, J = 11.32, 8.58 Hz, 1 H), 6.67 (br. s., 1 H), 3.02 (dd, J =
4.88, 1.17 Hz, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroarylcarbonyldihydrospiropiperidinepyrazolopyridinone
derivatives and analogs for use as acetyl-CoA carboxylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bagley, Scott William; Dow, Robert Lee; Griffith, David Andrew; Smith,
Aaron Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012056372 A1 2012-05-03

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C30H36N4O6
1467050-18-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 N 6.9898 5.3196 0.0 0
M  V30 4 C 8.5298 5.3196 0.0 0
M  V30 5 O 9.2998 6.6533 0.0 0
M  V30 6 C 1.9406 2.6091 0.0 0
M  V30 7 O 0.9100 1.4647 0.0 0
M  V30 8 O 3.4468 2.2889 0.0 0
M  V30 9 C 1.3860 0.0000 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0
M  V30 11 C 13.1498 5.3196 0.0 0
M  V30 12 O 13.9198 3.9860 0.0 0
M  V30 13 C 16.4819 5.6698 0.0 0
M  V30 14 C 17.9881 5.9900 0.0 0
M  V30 15 O 16.0060 4.2053 0.0 0
M  V30 16 C 17.6680 7.4964 0.0 0
M  V30 17 C 19.4946 6.3102 0.0 0
M  V30 18 C 18.3084 4.4837 0.0 0
M  V30 19 C 4.6798 6.6533 0.0 0
M  V30 20 C 6.2198 6.6533 0.0 0
M  V30 21 C 3.9098 7.9871 0.0 0
M  V30 22 C 6.9898 7.9869 0.0 0
M  V30 23 C 4.6798 9.3207 0.0 0
M  V30 24 C 6.2198 9.3207 0.0 0
M  V30 25 N 2.3698 5.3196 0.0 0
M  V30 26 C 1.4647 4.0738 0.0 0 CFG=2
M  V30 27 C 1.4647 6.5655 0.0 0
M  V30 28 C 0.0000 4.5496 0.0 0
M  V30 29 C 0.0000 6.0896 0.0 0
M  V30 30 C 9.2998 3.9860 0.0 0
M  V30 31 C 10.8398 3.9860 0.0 0
M  V30 32 C 8.5298 2.6522 0.0 0
M  V30 33 C 11.6098 2.6522 0.0 0
M  V30 34 C 9.2998 1.3185 0.0 0
M  V30 35 C 10.8398 1.3185 0.0 0
M  V30 36 C 13.9198 6.6533 0.0 0 CFG=2
M  V30 37 N 15.4514 6.8143 0.0 0
M  V30 38 C 13.2934 8.0602 0.0 0
M  V30 39 C 15.7716 8.3206 0.0 0
M  V30 40 C 14.4380 9.0906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 2 4 5
M  V30 7 1 4 30
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 26 6 CFG=3
M  V30 11 1 7 9
M  V30 12 1 10 11
M  V30 13 1 10 31
M  V30 14 2 11 12
M  V30 15 1 36 11 CFG=3
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 37
M  V30 19 1 14 16
M  V30 20 1 14 17
M  V30 21 1 14 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C30H37N5O5
1467050-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3196 0.0 0
M  V30 2 O 4.6798 3.9860 0.0 0
M  V30 3 N 6.9898 5.3196 0.0 0
M  V30 4 C 8.5298 5.3196 0.0 0
M  V30 5 O 9.2998 6.6533 0.0 0
M  V30 6 C 1.9406 2.6091 0.0 0
M  V30 7 N 0.9100 1.4647 0.0 0
M  V30 8 O 3.4468 2.2889 0.0 0
M  V30 9 C 1.3860 0.0000 0.0 0
M  V30 10 N 11.6098 5.3196 0.0 0
M  V30 11 C 13.1498 5.3196 0.0 0
M  V30 12 O 13.9198 3.9860 0.0 0
M  V30 13 C 16.4819 5.6698 0.0 0
M  V30 14 C 17.9881 5.9900 0.0 0
M  V30 15 O 16.0060 4.2053 0.0 0
M  V30 16 C 17.6680 7.4964 0.0 0
M  V30 17 C 19.4946 6.3102 0.0 0
M  V30 18 C 18.3084 4.4837 0.0 0
M  V30 19 C 4.6798 6.6533 0.0 0
M  V30 20 C 6.2198 6.6533 0.0 0
M  V30 21 C 3.9098 7.9871 0.0 0
M  V30 22 C 6.9898 7.9871 0.0 0
M  V30 23 C 4.6798 9.3207 0.0 0
M  V30 24 C 6.2198 9.3207 0.0 0
M  V30 25 N 2.3698 5.3196 0.0 0
M  V30 26 C 1.4647 4.0738 0.0 0 CFG=2
M  V30 27 C 1.4647 6.5655 0.0 0
M  V30 28 C 0.0000 4.5496 0.0 0
M  V30 29 C 0.0000 6.0896 0.0 0
M  V30 30 C 9.2998 3.9860 0.0 0
M  V30 31 C 10.8398 3.9860 0.0 0
M  V30 32 C 8.5298 2.6522 0.0 0
M  V30 33 C 11.6098 2.6522 0.0 0
M  V30 34 C 9.2998 1.3185 0.0 0
M  V30 35 C 10.8398 1.3185 0.0 0
M  V30 36 C 13.9198 6.6533 0.0 0 CFG=2
M  V30 37 N 15.4514 6.8143 0.0 0
M  V30 38 C 13.2934 8.0602 0.0 0
M  V30 39 C 15.7716 8.3206 0.0 0
M  V30 40 C 14.4380 9.0906 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 20
M  V30 6 2 4 5
M  V30 7 1 4 30
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 26 6 CFG=3
M  V30 11 1 7 9
M  V30 12 1 10 11
M  V30 13 1 10 31
M  V30 14 2 11 12
M  V30 15 1 36 11 CFG=3
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 37
M  V30 19 1 14 16
M  V30 20 1 14 17
M  V30 21 1 14 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 26 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1467050-18-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467050-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14687622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Switching the H-bonding network of a foldamer by modulating the backbone
chirality and constitutional ratio of amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramesh, Veera V. E.; Vijayadas, Kuruppanthara N.; Dhokale, Snehal;
Gonnade, Rajesh G.; Rajamohanan, Pattuparambil R.; Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(41), 7072-7075

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (αR)-5-methoxy-α-[2-[(methylsulfonyl)oxy]ethyl]-α-[[(methyl...
C18H27NO11S2
1501959-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.4137 0.0 0 CFG=1
M  V30 2 C 5.3901 5.7473 0.0 0
M  V30 3 C 4.8264 3.6437 0.0 0
M  V30 4 C 6.9301 3.0800 0.0 0
M  V30 5 C 3.8500 5.7473 0.0 0
M  V30 6 O 4.8264 2.1037 0.0 0
M  V30 7 O 3.4928 4.4137 0.0 0
M  V30 8 O 8.4701 3.0800 0.0 0
M  V30 9 O 3.0800 7.0812 0.0 0
M  V30 10 C 3.4928 1.3337 0.0 0
M  V30 11 S 9.2401 1.7464 0.0 0 VAL=6
M  V30 12 S 1.5400 7.0812 0.0 0 VAL=6
M  V30 13 C 4.2628 0.0000 0.0 0
M  V30 14 C 2.1591 0.5636 0.0 0
M  V30 15 C 2.7227 2.6673 0.0 0
M  V30 16 C 10.5739 2.5164 0.0 0
M  V30 17 O 10.0101 0.4126 0.0 0
M  V30 18 O 7.9064 0.9764 0.0 0
M  V30 19 C 1.5400 8.6212 0.0 0
M  V30 20 O 0.0000 7.0812 0.0 0
M  V30 21 O 1.5400 5.5411 0.0 0
M  V30 22 N 6.1601 7.4937 0.0 0 VAL=5
M  V30 23 O 4.8264 6.7237 0.0 0
M  V30 24 O 6.1601 9.0337 0.0 0
M  V30 25 O 11.4948 4.4137 0.0 0
M  V30 26 C 12.8286 5.1837 0.0 0
M  V30 27 C 7.4939 5.1837 0.0 0
M  V30 28 C 7.4939 6.7237 0.0 0
M  V30 29 C 8.8275 4.4137 0.0 0
M  V30 30 C 8.8275 7.4937 0.0 0
M  V30 31 C 10.1612 5.1837 0.0 0
M  V30 32 C 10.1612 6.7237 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 1 27
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 2 11 17
M  V30 18 2 11 18
M  V30 19 1 12 19
M  V30 20 2 12 20
M  V30 21 2 12 21
M  V30 22 2 22 23
M  V30 23 2 22 24
M  V30 24 1 22 28
M  V30 25 1 25 26
M  V30 26 1 25 31
M  V30 27 2 27 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 2 29 31
M  V30 31 2 30 32
M  V30 32 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3R)-3-(5-methoxy-2-nitrophenyl)-1-methyl-3-pyrrolidinecarb...
C17H24N2O5
1501960-00-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.7902 3.8987 0.0 0
M  V30 2 O 4.1637 2.4917 0.0 0
M  V30 3 O 6.3217 4.0596 0.0 0
M  V30 4 C 5.0689 1.2459 0.0 0
M  V30 5 C 6.3148 2.1511 0.0 0
M  V30 6 C 5.9742 0.0000 0.0 0
M  V30 7 C 3.8231 0.3406 0.0 0
M  V30 8 N 3.8850 8.2246 0.0 0 VAL=5
M  V30 9 O 2.5513 7.4546 0.0 0
M  V30 10 O 3.8850 9.7646 0.0 0
M  V30 11 C 0.0000 4.2577 0.0 0
M  V30 12 O 9.2197 5.1446 0.0 0
M  V30 13 C 10.5534 5.9146 0.0 0
M  V30 14 C 3.8850 5.1446 0.0 0 CFG=2
M  V30 15 C 3.2587 6.5513 0.0 0
M  V30 16 C 2.7404 4.1141 0.0 0
M  V30 17 C 1.7270 6.3904 0.0 0
M  V30 18 N 1.4068 4.8841 0.0 0
M  V30 19 C 5.2186 5.9146 0.0 0
M  V30 20 C 5.2186 7.4546 0.0 0
M  V30 21 C 6.5523 5.1446 0.0 0
M  V30 22 C 6.5523 8.2246 0.0 0
M  V30 23 C 7.8861 5.9146 0.0 0
M  V30 24 C 7.8861 7.4546 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 20
M  V30 11 1 11 18
M  V30 12 1 12 13
M  V30 13 1 12 23
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1501959-67-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1501960-00-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28387158
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM excess methylamine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Enantioselective Total Synthesis of (-)-Horsfiline
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hong, Suckchang; Jung, Myunggi; Park, Yohan; Ha, Min Woo; Park,
Cheonhyoung; Lee, Myungmo; Park, Hyeung-geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(29), 9599-9605

$RFMT $RIREG SCHEME313 STEP1
$RXN



  6  1
$MOL
Aminoacetonitrile
C2H4N2
540-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 N 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Tolyl isothiocyanate
C8H7NS
622-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-1,2-benzenedicarboxaldehyde
C9H8O2
15158-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 5.3349 0.0 0
M  V30 3 C 2.3100 1.3338 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
12-Methyl-2-(1-methylethenyl)-5-[1-(methylimino)ethyl]-7-[(4-methylphenyl)imi...
C33H28N4O2
2754289-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7801 4.1617 0.0 0
M  V30 2 N 11.5501 2.8281 0.0 0
M  V30 3 C 11.5501 5.4955 0.0 0
M  V30 4 C 13.0901 2.8281 0.0 0
M  V30 5 N 9.2401 9.4965 0.0 0
M  V30 6 C 6.9300 10.8303 0.0 0
M  V30 7 N 7.7001 12.1639 0.0 0
M  V30 8 C 3.1590 1.5400 0.0 0
M  V30 9 C 1.8254 2.3100 0.0 0
M  V30 10 C 3.1590 0.0000 0.0 0
M  V30 11 C 0.0000 6.8292 0.0 0
M  V30 12 C 15.4001 9.4965 0.0 0
M  V30 13 C 6.9300 5.4955 0.0 0
M  V30 14 C 6.1600 6.8292 0.0 0
M  V30 15 C 8.4701 5.4955 0.0 0
M  V30 16 C 6.1600 4.1617 0.0 0
M  V30 17 N 6.9300 8.1628 0.0 0
M  V30 18 C 4.6200 6.8292 0.0 0
M  V30 19 C 9.2401 4.1617 0.0 0
M  V30 20 O 9.2401 6.8292 0.0 0
M  V30 21 C 6.9300 2.8281 0.0 0
M  V30 22 O 4.6538 3.8416 0.0 0
M  V30 23 C 8.4701 8.1628 0.0 0
M  V30 24 C 6.1600 9.4965 0.0 0
M  V30 25 C 3.8500 8.1628 0.0 0
M  V30 26 C 3.8500 5.4955 0.0 0
M  V30 27 C 8.4701 2.8281 0.0 0
M  V30 28 C 5.8996 1.6837 0.0 0
M  V30 29 C 4.4927 2.3100 0.0 0
M  V30 30 C 4.6200 9.4965 0.0 0
M  V30 31 C 2.3100 8.1628 0.0 0
M  V30 32 C 2.3100 5.4955 0.0 0
M  V30 33 C 1.5400 6.8292 0.0 0
M  V30 34 C 10.7801 9.4965 0.0 0
M  V30 35 C 11.5501 8.1628 0.0 0
M  V30 36 C 11.5501 10.8303 0.0 0
M  V30 37 C 13.0901 8.1628 0.0 0
M  V30 38 C 13.0901 10.8303 0.0 0
M  V30 39 C 13.8601 9.4965 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 5 23 CFG=2
M  V30 6 1 5 34
M  V30 7 3 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 29
M  V30 12 1 11 33
M  V30 13 1 12 39
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 15 20
M  V30 21 2 16 21
M  V30 22 1 16 22
M  V30 23 1 17 23
M  V30 24 1 17 24
M  V30 25 1 18 25
M  V30 26 2 18 26
M  V30 27 2 19 27
M  V30 28 1 20 23
M  V30 29 1 21 27
M  V30 30 1 21 28
M  V30 31 1 22 29
M  V30 32 2 24 30
M  V30 33 1 25 30
M  V30 34 2 25 31
M  V30 35 1 26 32
M  V30 36 2 28 29
M  V30 37 1 31 33
M  V30 38 2 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 540-61-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-59-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 15158-36-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(6):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754289-93-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24903594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7789-23-3
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 12173-10-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, catalyst prepared and
used, catalyst can be recycled and reused, MWCNTs nanocomposite support
used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biosynthesis of Cu/KF/Clinoptilolite@MWCNTs nanocomposite and its
application as a recyclable nanocatalyst for the synthesis of new Schiff
base of benzoxazine derivatives and reduction of organic pollutants
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamedani, Naghmeh Faal; Hargalani, Fariba Zamani; Rostami-Charati,
Faramarz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2022), 26(4), 2069-2083

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
(3β,4α)-3-(Acetyloxy)olean-12-ene-23,28-dioic acid
C32H48O6
15341-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.4729 5.7182 0.0 0
M  V30 2 C 9.7829 1.3162 0.0 0
M  V30 3 C 6.4657 5.6715 0.0 0
M  V30 4 C 11.9596 5.7006 0.0 0
M  V30 5 O 13.1394 6.6905 0.0 0
M  V30 6 O 10.5125 6.2273 0.0 0
M  V30 7 C 13.6741 4.7107 0.0 0
M  V30 8 O 14.5370 2.8504 0.0 0
M  V30 9 C 15.3070 1.5166 0.0 0
M  V30 10 C 14.5370 0.1830 0.0 0
M  V30 11 O 16.8470 1.5166 0.0 0
M  V30 12 C 2.2170 5.5177 0.0 0
M  V30 13 O 0.6770 5.5177 0.0 0
M  V30 14 O 2.9871 6.8515 0.0 0
M  V30 15 C 1.7145 0.0000 0.0 0
M  V30 16 C 0.0000 0.9899 0.0 0
M  V30 17 C 8.3770 2.8504 0.0 0 CFG=2
M  V30 18 C 7.6070 4.1840 0.0 0 CFG=2
M  V30 19 C 9.9170 2.8504 0.0 0 CFG=2
M  V30 20 C 7.6070 1.5166 0.0 0
M  V30 21 C 6.0670 4.1840 0.0 0 CFG=1
M  V30 22 C 8.3771 5.5177 0.0 0
M  V30 23 C 10.6870 4.1840 0.0 0 CFG=2
M  V30 24 C 10.6870 1.5166 0.0 0
M  V30 25 C 6.0670 1.5167 0.0 0
M  V30 26 C 5.2970 2.8504 0.0 0
M  V30 27 C 5.2971 5.5177 0.0 0
M  V30 28 C 9.9171 5.5177 0.0 0
M  V30 29 C 12.2270 4.1840 0.0 0 CFG=2
M  V30 30 C 12.2270 1.5166 0.0 0
M  V30 31 C 3.7570 2.8504 0.0 0 CFG=2
M  V30 32 C 3.7571 5.5177 0.0 0
M  V30 33 C 12.9970 2.8504 0.0 0 CFG=1
M  V30 34 C 2.9870 4.1840 0.0 0 CFG=1
M  V30 35 C 2.9870 1.5167 0.0 0
M  V30 36 C 1.4470 4.1840 0.0 0
M  V30 37 C 1.4470 1.5167 0.0 0
M  V30 38 C 0.6770 2.8504 0.0 0
M  V30 39 H 8.7757 1.3627 0.0 0
M  V30 40 H 11.4571 5.5177 0.0 0
M  V30 41 H 4.5270 1.5167 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 19 2 CFG=1
M  V30 3 1 21 3 CFG=3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 29 4 CFG=3
M  V30 7 1 29 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 33 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 34 12 CFG=1
M  V30 15 1 15 37
M  V30 16 1 16 37
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 39 CFG=3
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 21 26
M  V30 27 1 21 27
M  V30 28 1 22 28
M  V30 29 1 23 28
M  V30 30 1 23 29
M  V30 31 1 23 40 CFG=3
M  V30 32 1 24 30
M  V30 33 2 25 26
M  V30 34 1 26 31
M  V30 35 1 27 32
M  V30 36 1 29 33
M  V30 37 1 30 33
M  V30 38 1 31 34
M  V30 39 1 31 35
M  V30 40 1 31 41 CFG=1
M  V30 41 1 32 34
M  V30 42 1 34 36
M  V30 43 1 35 37
M  V30 44 1 36 38
M  V30 45 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 17 18 19 21 23 29 31 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3β,4α)-3-(Acetyloxy)-N23,N28-dimethylolean-12-ene-23,28-diamide
C34H54N2O4
2588333-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 7.6566 0.0 0
M  V30 2 N 1.3338 8.4266 0.0 0
M  V30 3 O 2.6674 6.1166 0.0 0
M  V30 4 C 0.0000 7.6566 0.0 0
M  V30 5 C 6.0176 5.4909 0.0 0
M  V30 6 C 3.0112 12.6862 0.0 0
M  V30 7 C 4.9910 12.6862 0.0 0
M  V30 8 C 7.1188 4.8550 0.0 0
M  V30 9 C 11.3204 7.5123 0.0 0
M  V30 10 C 12.9931 2.6268 0.0 0
M  V30 11 N 12.4663 1.1796 0.0 0
M  V30 12 O 14.5097 2.8943 0.0 0
M  V30 13 C 13.4562 0.0000 0.0 0
M  V30 14 C 11.0133 2.6268 0.0 0
M  V30 15 O 14.6705 3.8066 0.0 0
M  V30 16 C 16.0041 4.5766 0.0 0
M  V30 17 C 17.3379 3.8066 0.0 0
M  V30 18 O 16.0041 6.1166 0.0 0
M  V30 19 C 4.0011 8.4266 0.0 0 CFG=1
M  V30 20 C 5.3347 9.1966 0.0 0 CFG=1
M  V30 21 C 4.0011 6.8866 0.0 0
M  V30 22 C 2.6674 9.1966 0.0 0
M  V30 23 C 6.6685 8.4266 0.0 0
M  V30 24 C 5.3347 10.7366 0.0 0
M  V30 25 C 5.3347 6.1166 0.0 0
M  V30 26 C 2.6674 10.7366 0.0 0
M  V30 27 C 6.6685 6.8866 0.0 0 CFG=1
M  V30 28 C 8.0021 9.1966 0.0 0
M  V30 29 C 4.0011 11.5066 0.0 0
M  V30 30 C 8.0021 6.1166 0.0 0 CFG=1
M  V30 31 C 9.3358 8.4266 0.0 0
M  V30 32 C 9.3358 6.8866 0.0 0 CFG=1
M  V30 33 C 8.0021 4.5766 0.0 0
M  V30 34 C 10.6694 6.1166 0.0 0 CFG=2
M  V30 35 C 9.3358 3.8066 0.0 0
M  V30 36 C 10.6694 4.5766 0.0 0 CFG=2
M  V30 37 C 12.0032 6.8866 0.0 0
M  V30 38 C 12.0032 3.8066 0.0 0 CFG=2
M  V30 39 C 13.3369 6.1166 0.0 0
M  V30 40 C 13.3369 4.5766 0.0 0 CFG=1
M  V30 41 H 6.6685 9.9666 0.0 0
M  V30 42 H 10.2191 8.1480 0.0 0
M  V30 43 H 10.6694 3.0366 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 27 5 CFG=1
M  V30 6 1 6 29
M  V30 7 1 7 29
M  V30 8 1 30 8 CFG=3
M  V30 9 1 34 9 CFG=3
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 38 10 CFG=1
M  V30 13 1 11 13
M  V30 14 1 38 14 CFG=3
M  V30 15 1 15 16
M  V30 16 1 40 15 CFG=3
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 1 20 41 CFG=3
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 2 23 28
M  V30 29 1 24 29
M  V30 30 1 25 27
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 28 31
M  V30 34 1 30 32
M  V30 35 1 30 33
M  V30 36 1 31 32
M  V30 37 1 32 34
M  V30 38 1 32 42 CFG=1
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 34 37
M  V30 42 1 35 36
M  V30 43 1 36 38
M  V30 44 1 36 43 CFG=1
M  V30 45 1 37 39
M  V30 46 1 38 40
M  V30 47 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(9 19 20 27 30 32 34 36 38 40)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 15341-02-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2588333-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23287635
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of gypsogenin and gypsogenic acid derivatives with antitumor
activity by damaging cell membranes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Guiying; Chu, Haiping; Wang, Jilei; Mu, Yanling; Sun, Jingyong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2019), 43(47), 18898-18914

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron(1+), carbonyl(η5-2,4-cyclopentadien-1-yl)bis(2-isocyano-1,3-dimethylbenz...
C24H23FeN2O.ClO4
1558991-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2259 7.6389 0.0 0 CHG=-1 VAL=4
M  V30 2 N 11.6454 7.6389 0.0 0 CHG=1 VAL=4
M  V30 3 C 5.3143 7.6389 0.0 0 CHG=-1 VAL=4
M  V30 4 N 3.8948 7.6389 0.0 0 CHG=1 VAL=4
M  V30 5 C 7.7701 6.2194 0.0 0
M  V30 6 O 9.1896 6.2194 0.0 0 VAL=3
M  V30 7 C 11.6454 4.6787 0.0 0
M  V30 8 C 14.2067 9.1170 0.0 0
M  V30 9 C 3.8948 4.6787 0.0 0
M  V30 10 C 1.3335 9.1170 0.0 0
M  V30 11 Fe 7.7701 9.0584 0.0 0 CHG=2 VAL=8
M  V30 12 C 7.7701 16.6447 0.0 0 CHG=-1 VAL=4
M  V30 13 C 6.2959 12.8515 0.0 0 VAL=5
M  V30 14 C 9.2443 12.8515 0.0 0 VAL=5
M  V30 15 C 11.7744 14.3258 0.0 0 VAL=5
M  V30 16 C 3.7619 14.3258 0.0 0 VAL=5
M  V30 17 C 12.8733 6.9272 0.0 0
M  V30 18 C 12.8733 5.3904 0.0 0
M  V30 19 C 14.2067 7.6975 0.0 0
M  V30 20 C 14.2067 4.6200 0.0 0
M  V30 21 C 15.5402 6.9272 0.0 0
M  V30 22 C 15.5402 5.3904 0.0 0
M  V30 23 C 2.6669 6.9272 0.0 0
M  V30 24 C 2.6669 5.3904 0.0 0
M  V30 25 C 1.3335 7.6975 0.0 0
M  V30 26 C 1.3335 4.6200 0.0 0
M  V30 27 C 0.0000 6.9272 0.0 0
M  V30 28 C 0.0000 5.3904 0.0 0
M  V30 29 Cl 7.7701 1.5400 0.0 0 VAL=7
M  V30 30 O 6.2301 1.5400 0.0 0
M  V30 31 O 9.3101 1.5400 0.0 0
M  V30 32 O 7.7701 0.0000 0.0 0
M  V30 33 O 7.7701 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 3 3 4
M  V30 5 1 3 11
M  V30 6 1 4 23
M  V30 7 3 5 6
M  V30 8 1 5 11
M  V30 9 1 7 18
M  V30 10 1 8 19
M  V30 11 1 9 24
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 2 13 16
M  V30 22 2 14 15
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 2 29 31
M  V30 37 2 29 32
M  V30 38 1 29 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H28FeN3O.ClO4
1558991-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2060 10.4062 0.0 0 CHG=-2 VAL=4
M  V30 2 N 10.2060 7.6342 0.0 0
M  V30 3 N 11.4319 11.1129 0.0 0
M  V30 4 C 12.7828 10.3360 0.0 0
M  V30 5 C 5.3021 10.4062 0.0 0 CHG=-1 VAL=4
M  V30 6 N 3.8887 10.4062 0.0 0 CHG=1 VAL=4
M  V30 7 C 7.7540 8.9890 0.0 0
M  V30 8 O 9.1713 8.9890 0.0 0 VAL=3
M  V30 9 C 10.2060 4.6825 0.0 0
M  V30 10 C 12.7672 9.1100 0.0 0
M  V30 11 C 3.8887 7.4507 0.0 0
M  V30 12 C 1.3275 11.8821 0.0 0
M  V30 13 Fe 7.7540 11.8235 0.0 0 CHG=4 VAL=9
M  V30 14 C 7.7540 19.3980 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.2821 15.6107 0.0 0 VAL=5
M  V30 16 C 9.2299 15.6107 0.0 0 VAL=5
M  V30 17 C 11.7521 17.0827 0.0 0 VAL=5
M  V30 18 C 3.7521 17.0827 0.0 0 VAL=5
M  V30 19 C 11.4319 6.9275 0.0 0
M  V30 20 C 11.4319 5.3892 0.0 0
M  V30 21 C 12.7672 7.6927 0.0 0
M  V30 22 C 12.7672 4.6200 0.0 0
M  V30 23 C 14.0947 6.9275 0.0 0
M  V30 24 C 14.0947 5.3892 0.0 0
M  V30 25 C 2.6628 9.6957 0.0 0
M  V30 26 C 2.6628 8.1612 0.0 0
M  V30 27 C 1.3275 10.4648 0.0 0
M  V30 28 C 1.3275 7.3921 0.0 0
M  V30 29 C 0.0000 9.6957 0.0 0
M  V30 30 C 0.0000 8.1612 0.0 0
M  V30 31 Cl 7.0474 1.5400 0.0 0 VAL=7
M  V30 32 O 5.5074 1.5400 0.0 0
M  V30 33 O 8.5874 1.5400 0.0 0
M  V30 34 O 7.0474 0.0000 0.0 0
M  V30 35 O 7.0474 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 13 CFG=2
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 3 5 6
M  V30 7 1 5 13
M  V30 8 1 6 25
M  V30 9 3 7 8
M  V30 10 1 7 13
M  V30 11 1 9 20
M  V30 12 1 10 21
M  V30 13 1 11 26
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 17
M  V30 21 1 14 18
M  V30 22 1 15 16
M  V30 23 2 15 18
M  V30 24 2 16 17
M  V30 25 2 19 20
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 2 21 23
M  V30 29 2 22 24
M  V30 30 1 23 24
M  V30 31 2 25 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 37 2 31 32
M  V30 38 2 31 33
M  V30 39 2 31 34
M  V30 40 1 31 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1558991-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1558991-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30875742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Half-sandwich iron(II) complexes with protic acyclic diaminocarbene
ligands: synthesis, deprotonation and metalation reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruiz, Javier; Garcia, Lucia; Vivanco, Marilin; Sol, Daniel;
Garcia-Granda, Santiago
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2017), 46(31), 10387-10398

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Iron(1+), carbonyl(η5-2,4-cyclopentadien-1-yl)bis(2-isocyano-1,3-dimethylbenz...
C24H23FeN2O.ClO4
1558991-56-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2259 7.6389 0.0 0 CHG=-1 VAL=4
M  V30 2 N 11.6454 7.6389 0.0 0 CHG=1 VAL=4
M  V30 3 C 5.3143 7.6389 0.0 0 CHG=-1 VAL=4
M  V30 4 N 3.8948 7.6389 0.0 0 CHG=1 VAL=4
M  V30 5 C 7.7701 6.2194 0.0 0
M  V30 6 O 9.1896 6.2194 0.0 0 VAL=3
M  V30 7 C 11.6454 4.6787 0.0 0
M  V30 8 C 14.2067 9.1170 0.0 0
M  V30 9 C 3.8948 4.6787 0.0 0
M  V30 10 C 1.3335 9.1170 0.0 0
M  V30 11 Fe 7.7701 9.0584 0.0 0 CHG=2 VAL=8
M  V30 12 C 7.7701 16.6447 0.0 0 CHG=-1 VAL=4
M  V30 13 C 6.2959 12.8515 0.0 0 VAL=5
M  V30 14 C 9.2443 12.8515 0.0 0 VAL=5
M  V30 15 C 11.7744 14.3258 0.0 0 VAL=5
M  V30 16 C 3.7619 14.3258 0.0 0 VAL=5
M  V30 17 C 12.8733 6.9272 0.0 0
M  V30 18 C 12.8733 5.3904 0.0 0
M  V30 19 C 14.2067 7.6975 0.0 0
M  V30 20 C 14.2067 4.6200 0.0 0
M  V30 21 C 15.5402 6.9272 0.0 0
M  V30 22 C 15.5402 5.3904 0.0 0
M  V30 23 C 2.6669 6.9272 0.0 0
M  V30 24 C 2.6669 5.3904 0.0 0
M  V30 25 C 1.3335 7.6975 0.0 0
M  V30 26 C 1.3335 4.6200 0.0 0
M  V30 27 C 0.0000 6.9272 0.0 0
M  V30 28 C 0.0000 5.3904 0.0 0
M  V30 29 Cl 7.7701 1.5400 0.0 0 VAL=7
M  V30 30 O 6.2301 1.5400 0.0 0
M  V30 31 O 9.3101 1.5400 0.0 0
M  V30 32 O 7.7701 0.0000 0.0 0
M  V30 33 O 7.7701 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 3 3 4
M  V30 5 1 3 11
M  V30 6 1 4 23
M  V30 7 3 5 6
M  V30 8 1 5 11
M  V30 9 1 7 18
M  V30 10 1 8 19
M  V30 11 1 9 24
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 15
M  V30 19 1 12 16
M  V30 20 1 13 14
M  V30 21 2 13 16
M  V30 22 2 14 15
M  V30 23 2 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 2 19 21
M  V30 27 2 20 22
M  V30 28 1 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 2 29 31
M  V30 37 2 29 32
M  V30 38 1 29 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H28FeN3O.ClO4
1558991-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.2060 10.4062 0.0 0 CHG=-2 VAL=4
M  V30 2 N 10.2060 7.6342 0.0 0
M  V30 3 N 11.4319 11.1129 0.0 0
M  V30 4 C 12.7828 10.3360 0.0 0
M  V30 5 C 5.3021 10.4062 0.0 0 CHG=-1 VAL=4
M  V30 6 N 3.8887 10.4062 0.0 0 CHG=1 VAL=4
M  V30 7 C 7.7540 8.9890 0.0 0
M  V30 8 O 9.1713 8.9890 0.0 0 VAL=3
M  V30 9 C 10.2060 4.6825 0.0 0
M  V30 10 C 12.7672 9.1100 0.0 0
M  V30 11 C 3.8887 7.4507 0.0 0
M  V30 12 C 1.3275 11.8821 0.0 0
M  V30 13 Fe 7.7540 11.8235 0.0 0 CHG=4 VAL=9
M  V30 14 C 7.7540 19.3980 0.0 0 CHG=-1 VAL=4
M  V30 15 C 6.2821 15.6107 0.0 0 VAL=5
M  V30 16 C 9.2299 15.6107 0.0 0 VAL=5
M  V30 17 C 11.7521 17.0827 0.0 0 VAL=5
M  V30 18 C 3.7521 17.0827 0.0 0 VAL=5
M  V30 19 C 11.4319 6.9275 0.0 0
M  V30 20 C 11.4319 5.3892 0.0 0
M  V30 21 C 12.7672 7.6927 0.0 0
M  V30 22 C 12.7672 4.6200 0.0 0
M  V30 23 C 14.0947 6.9275 0.0 0
M  V30 24 C 14.0947 5.3892 0.0 0
M  V30 25 C 2.6628 9.6957 0.0 0
M  V30 26 C 2.6628 8.1612 0.0 0
M  V30 27 C 1.3275 10.4648 0.0 0
M  V30 28 C 1.3275 7.3921 0.0 0
M  V30 29 C 0.0000 9.6957 0.0 0
M  V30 30 C 0.0000 8.1612 0.0 0
M  V30 31 Cl 7.0474 1.5400 0.0 0 VAL=7
M  V30 32 O 5.5074 1.5400 0.0 0
M  V30 33 O 8.5874 1.5400 0.0 0
M  V30 34 O 7.0474 0.0000 0.0 0
M  V30 35 O 7.0474 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 13 CFG=2
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 3 5 6
M  V30 7 1 5 13
M  V30 8 1 6 25
M  V30 9 3 7 8
M  V30 10 1 7 13
M  V30 11 1 9 20
M  V30 12 1 10 21
M  V30 13 1 11 26
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 14 17
M  V30 21 1 14 18
M  V30 22 1 15 16
M  V30 23 2 15 18
M  V30 24 2 16 17
M  V30 25 2 19 20
M  V30 26 1 19 21
M  V30 27 1 20 22
M  V30 28 2 21 23
M  V30 29 2 22 24
M  V30 30 1 23 24
M  V30 31 2 25 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 37 2 31 32
M  V30 38 2 31 33
M  V30 39 2 31 34
M  V30 40 1 31 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1558991-56-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1558991-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30214123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Strong electron-donating metalla-N-heterocyclic carbenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruiz, Javier; Garcia, Lucia; Mejuto, Carmen; Vivanco, Marilin; Diaz, M.
Rosario; Garcia-Granda, Santiago
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(17),
2129-2132

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(4-formylphenoxy)pentanoate
C13H16O4
156866-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6698 2.3101 0.0 0
M  V30 5 C 12.0035 3.0801 0.0 0
M  V30 6 C 13.3372 2.3101 0.0 0
M  V30 7 O 14.6708 3.0801 0.0 0
M  V30 8 O 13.3372 0.7700 0.0 0
M  V30 9 C 16.0046 2.3101 0.0 0
M  V30 10 C 1.3338 0.0000 0.0 0
M  V30 11 O 0.0000 0.7700 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 4.0012 3.0801 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 16 C 2.6675 2.3101 0.0 0
M  V30 17 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[4-[(methylamino)methyl]phenoxy]pentanoate
C14H21NO3
2454243-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 C 10.6697 3.0801 0.0 0
M  V30 4 C 12.0035 2.3101 0.0 0
M  V30 5 C 13.3372 3.0801 0.0 0
M  V30 6 C 14.6708 2.3101 0.0 0
M  V30 7 O 16.0045 3.0801 0.0 0
M  V30 8 O 14.6708 0.7700 0.0 0
M  V30 9 C 17.3383 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 C 0.0000 0.0000 0.0 0
M  V30 13 C 6.6687 2.3101 0.0 0
M  V30 14 C 6.6687 0.7700 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 5.3348 0.0000 0.0 0
M  V30 17 C 4.0012 2.3101 0.0 0
M  V30 18 C 4.0012 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 156866-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2454243-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24357542
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone
Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Guiyan; Liu, Na; Li, Chenglan; Tu, Jie; Li, Zhuang; Sheng, Chunquan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(10), 5341-5359

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dibromo-4-methoxybenzeneacetic acid
C9H8Br2O3
1571136-61-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 1.3337 3.8501 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 Br 2.6675 4.6201 0.0 0
M  V30 6 Br 5.3348 0.0000 0.0 0
M  V30 7 O 8.0023 4.6201 0.0 0
M  V30 8 C 9.3360 3.8501 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 6.6685 2.3101 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dibromo-4-methoxy-N-methylbenzeneacetamide
C10H11Br2NO2
1571136-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 1.5400 0.0 0
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 Br 4.0012 0.0000 0.0 0
M  V30 7 Br 6.6685 4.6201 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1571136-61-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1571136-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10016032
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Direct One-Pot Synthesis of Naphthoxindoles from 4-Bromooxindoles by
Suzuki-Miyaura Coupling and Aldol Condensation Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Kyeong-Yong; Kim, Bum Tae; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2014), 2014(1), 164-170

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chloro-5-nitro-4-pyridinyl)-4-methylpiperazine
C10H13ClN4O2
1613193-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0 VAL=5
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 O 2.6675 2.3100 0.0 0
M  V30 4 Cl 9.3359 4.6201 0.0 0
M  V30 5 C 0.0000 6.9301 0.0 0
M  V30 6 C 5.3348 3.8500 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 6.6684 4.6201 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 8.0022 3.8500 0.0 0
M  V30 11 N 8.0022 2.3100 0.0 0
M  V30 12 N 4.0011 4.6201 0.0 0
M  V30 13 C 4.0011 6.1601 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 2.6675 6.9301 0.0 0
M  V30 16 C 1.3337 4.6201 0.0 0
M  V30 17 N 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 10
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(4-methyl-1-piperazinyl)-5-nitro-2-pyridinamine
C11H17N5O2
1613193-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 N 1.5400 6.6685 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 C 10.7800 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 N 1.5400 4.0011 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 8.4700 5.3347 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1613193-40-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613193-51-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9572306
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo[1,5-a]pyrimidine carboxamides as atr kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmad, Nadia; Boyall, Dean; Charrier, Jean-Damien; Davis, Chris; Davis,
Rebecca; Durrant, Steven; Etxebarria i Jardi, Gorka; Fraysse, Damien;
Jimenez, Juan-Miguel; Kay, David; Knegtel, Ronald; Middleton, Donald;
O'Donnell, Michael; Panesar, Maninder; Pierard, Francoise; Pinder,
Joanne; Shaw, David; Storck, Pierre-Henri; Studley, John; Twin, Heather
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014089379 A1 2014-06-12

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole, 4-(2-bromoethyl)-3a,7a-dihydro-2,2-dimethyl-, (3aR-cis)-
C11H15BrO2
164021-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 C 7.3176 3.9437 0.0 0
M  V30 3 Br 8.6512 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3164 3.1737 0.0 0 CFG=2
M  V30 7 C 1.9828 3.9437 0.0 0 CFG=2
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 O 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4837 0.0 0
M  V30 12 C 4.6501 5.4837 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3164 6.2537 0.0 0
M  V30 15 H 4.5623 2.2685 0.0 0
M  V30 16 H 0.5758 4.5700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 16 CFG=3
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,7aS)-3a,6,7,7a-Tetrahydro-N,2,2-trimethyl-1,3-benzodioxole-4-ethanamine
C12H21NO2
1315613-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2536 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 N 8.5637 5.3349 0.0 0
M  V30 4 C 10.1037 5.3349 0.0 0
M  V30 5 C 0.0000 2.8653 0.0 0
M  V30 6 C 1.0304 4.6502 0.0 0
M  V30 7 C 3.9436 2.6674 0.0 0 CFG=2
M  V30 8 C 3.1736 1.3338 0.0 0 CFG=2
M  V30 9 C 5.4836 2.6674 0.0 0
M  V30 10 O 2.9132 3.8118 0.0 0
M  V30 11 O 1.6674 1.6540 0.0 0
M  V30 12 C 3.9436 0.0000 0.0 0
M  V30 13 C 6.2536 1.3338 0.0 0
M  V30 14 C 1.5063 3.1855 0.0 0
M  V30 15 C 5.4836 0.0000 0.0 0
M  V30 16 H 4.5700 4.0742 0.0 0
M  V30 17 H 2.2684 0.0879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 17 CFG=1
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 164021-80-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315613-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8762828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Short chemoenzymatic total synthesis of ent-hydromorphone: An oxidative
dearomatization/intramolecular [4+2] cycloaddition/amination sequence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Varghese, Vimal; Hudlicky, Tomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2014), 53(17), 4355-4358

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2S,4S)-4-chloro-1,2-pyrrolidinedicarboxylate
C11H18ClNO4
169032-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 5.3026 0.0 0
M  V30 2 O 2.1037 5.3026 0.0 0
M  V30 3 O 4.4137 6.6363 0.0 0
M  V30 4 C 1.3337 6.6363 0.0 0
M  V30 5 C 2.6675 7.4063 0.0 0
M  V30 6 C 0.5637 7.9700 0.0 0
M  V30 7 C 0.0000 5.8663 0.0 0
M  V30 8 C 6.9759 4.9524 0.0 0
M  V30 9 O 8.4822 4.6323 0.0 0
M  V30 10 O 6.5000 6.4170 0.0 0
M  V30 11 C 9.5128 5.7767 0.0 0
M  V30 12 Cl 4.7709 0.0000 0.0 0
M  V30 13 N 4.4137 3.9690 0.0 0
M  V30 14 C 5.9455 3.8079 0.0 0 CFG=2
M  V30 15 C 3.7874 2.5620 0.0 0
M  V30 16 C 6.2656 2.3016 0.0 0
M  V30 17 C 4.9320 1.5316 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S,4S)-4-chloro-2-[(methylamino)carbonyl]-1-pyrrolidinecar...
C11H19ClN2O3
1380446-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6437 5.3026 0.0 0
M  V30 2 O 2.1037 5.3026 0.0 0
M  V30 3 O 4.4137 6.6363 0.0 0
M  V30 4 C 1.3337 6.6363 0.0 0
M  V30 5 C 2.6675 7.4063 0.0 0
M  V30 6 C 0.5637 7.9700 0.0 0
M  V30 7 C 0.0000 5.8663 0.0 0
M  V30 8 C 6.9759 4.9524 0.0 0
M  V30 9 N 8.4822 4.6323 0.0 0
M  V30 10 O 6.5000 6.4170 0.0 0
M  V30 11 C 9.5128 5.7767 0.0 0
M  V30 12 Cl 4.7709 0.0000 0.0 0
M  V30 13 N 4.4137 3.9690 0.0 0
M  V30 14 C 5.9455 3.8079 0.0 0 CFG=2
M  V30 15 C 3.7874 2.5620 0.0 0
M  V30 16 C 6.2656 2.3016 0.0 0
M  V30 17 C 4.9320 1.5316 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 14 8 CFG=3
M  V30 11 1 9 11
M  V30 12 1 17 12 CFG=3
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 169032-99-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380446-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12559673
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conformational preferences of 4-chloroproline residues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Hae Sook; Byun, Byung Jin; Motooka, Daisuke; Kawahara, Kazuki; Doi,
Masamitsu; Nakazawa, Takashi; Kobayashi, Yuji; Kang, Young Kee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biopolymers (2012), 97(8), 629-641

$RFMT $RIREG SCHEME321 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-Diethyl 2,2′-[(4,5-dichloro-1,2-phenylene)diimino]bis[2-oxoacetate]
C14H14Cl2N2O6
179938-43-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2401 5.3348 0.0 0
M  V30 2 C 10.7801 5.3348 0.0 0
M  V30 3 C 11.5501 6.6686 0.0 0
M  V30 4 O 11.5501 4.0011 0.0 0
M  V30 5 O 13.0901 6.6686 0.0 0
M  V30 6 O 10.7801 8.0022 0.0 0
M  V30 7 C 13.8602 8.0022 0.0 0
M  V30 8 C 15.4002 8.0022 0.0 0
M  V30 9 N 6.1601 5.3348 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 3.8500 6.6686 0.0 0
M  V30 12 O 3.8500 4.0011 0.0 0
M  V30 13 O 2.3100 6.6686 0.0 0
M  V30 14 O 4.6201 8.0022 0.0 0
M  V30 15 C 1.5400 8.0022 0.0 0
M  V30 16 C 0.0000 8.0022 0.0 0
M  V30 17 Cl 9.2401 0.0000 0.0 0
M  V30 18 Cl 6.1601 0.0000 0.0 0
M  V30 19 C 8.4701 4.0011 0.0 0
M  V30 20 C 6.9301 4.0011 0.0 0
M  V30 21 C 9.2401 2.6675 0.0 0
M  V30 22 C 6.1601 2.6675 0.0 0
M  V30 23 C 8.4701 1.3337 0.0 0
M  V30 24 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 20
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 13 15
M  V30 16 1 15 16
M  V30 17 1 17 23
M  V30 18 1 18 24
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C12H12Cl2N4O4
2788839-66-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 3.0801 5.3348 0.0 0
M  V30 3 C 2.3101 6.6687 0.0 0
M  V30 4 O 2.3101 4.0012 0.0 0
M  V30 5 N 0.7700 6.6687 0.0 0
M  V30 6 O 3.0801 8.0023 0.0 0
M  V30 7 C 0.0000 8.0023 0.0 0
M  V30 8 N 7.7002 5.3348 0.0 0
M  V30 9 C 9.2402 5.3348 0.0 0
M  V30 10 C 10.0102 6.6687 0.0 0
M  V30 11 O 10.0102 4.0012 0.0 0
M  V30 12 N 11.5503 6.6687 0.0 0
M  V30 13 O 9.2402 8.0023 0.0 0
M  V30 14 C 12.3203 8.0023 0.0 0
M  V30 15 Cl 4.6201 0.0000 0.0 0
M  V30 16 Cl 7.7002 0.0000 0.0 0
M  V30 17 C 5.3901 4.0012 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 4.6201 2.6675 0.0 0
M  V30 20 C 7.7002 2.6675 0.0 0
M  V30 21 C 5.3901 1.3337 0.0 0
M  V30 22 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 12 14
M  V30 15 1 15 21
M  V30 16 1 16 22
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 179938-43-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2788839-66-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35689509
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand Radical Mediated Water Oxidation by a Family of Copper o-Phenylene
Bis-oxamidate Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chattopadhyay, Samir; Ghatak, Arnab; Ro, Youngju; Guillot, Regis; Halime,
Zakaria; Aukauloo, Ally; Dey, Abhishek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2021), 60(13), 9442-9455

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-[[4-(Bromomethyl)phenyl]methoxy]-3,4-dimethyl-2H-1-benzopyran-2-one
C19H17BrO3
1801157-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3347 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 C 15.4000 5.3347 0.0 0
M  V30 7 Br 16.1700 6.6685 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 O 3.8500 1.3338 0.0 0
M  V30 14 C 6.1600 5.3347 0.0 0
M  V30 15 C 1.5400 2.6674 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 10.7800 5.3347 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 11.5500 6.6685 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 C 13.0900 6.6685 0.0 0
M  V30 23 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 18
M  V30 6 2 5 17
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1-Benzopyran-2-one, 3,4-dimethyl-7-[[4-[(methylamino)methyl]phenyl]methoxy]-
C20H21NO3
3037140-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3347 0.0 0
M  V30 2 C 0.0000 2.6674 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 9.2400 5.3347 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 C 15.4000 5.3347 0.0 0
M  V30 7 N 16.1700 6.6685 0.0 0
M  V30 8 C 17.7100 6.6685 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 O 3.8500 1.3338 0.0 0
M  V30 15 C 6.1600 5.3347 0.0 0
M  V30 16 C 1.5400 2.6674 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 2.3100 1.3338 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 11.5500 4.0011 0.0 0
M  V30 21 C 11.5500 6.6685 0.0 0
M  V30 22 C 13.0900 4.0011 0.0 0
M  V30 23 C 13.0900 6.6685 0.0 0
M  V30 24 C 13.8600 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 4 19
M  V30 6 2 5 18
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1801157-79-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3037140-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40804188
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of benzylbromide reactant after every 45 minutes if
needed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational
Design, Synthesis, Biological Evaluation, and Early-ADME Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rullo, Mariagrazia; Cipolloni, Marco; Catto, Marco; Colliva, Carolina;
Miniero, Daniela Valeria; Latronico, Tiziana; de Candia, Modesto;
Benicchi, Tiziana; Linusson, Anna; Giacche, Nicola; Altomare, Cosimo
Damiano; Pisani, Leonardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(5), 3962-3977

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
[2,2′-Bipyridine]-5,5′-dicarboxylic acid
C12H8N2O4
1802-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 11.5503 1.3337 0.0 0
M  V30 5 O 12.3203 0.0000 0.0 0
M  V30 6 O 12.3203 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 3.0801 2.6673 0.0 0
M  V30 11 C 3.0801 0.0000 0.0 0
M  V30 12 C 2.3101 1.3337 0.0 0
M  V30 13 C 6.9302 1.3337 0.0 0
M  V30 14 C 7.7002 0.0000 0.0 0
M  V30 15 N 7.7002 2.6673 0.0 0
M  V30 16 C 9.2402 0.0000 0.0 0
M  V30 17 C 9.2402 2.6673 0.0 0
M  V30 18 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 18
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2,2′-Bipyridine]-5,5′-dicarboxamide, N5,N5′-dimethyl-
C14H14N4O2
685134-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 13.0903 1.3337 0.0 0
M  V30 6 N 13.8603 0.0000 0.0 0
M  V30 7 O 13.8603 2.6673 0.0 0
M  V30 8 C 15.4003 0.0000 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 N 6.1601 2.6673 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 4.6201 2.6673 0.0 0
M  V30 14 C 3.8501 1.3337 0.0 0
M  V30 15 C 8.4702 1.3337 0.0 0
M  V30 16 C 9.2402 2.6673 0.0 0
M  V30 17 N 9.2402 0.0000 0.0 0
M  V30 18 C 10.7802 2.6673 0.0 0
M  V30 19 C 10.7802 0.0000 0.0 0
M  V30 20 C 11.5503 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 20
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1802-30-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 685134-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7888414
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular design of functional peptides by utilizing unnatural amino
acids: toward artificial and photofunctional protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishida, Hitoshi; Kyakuno, Masato; Oishi, Shigero
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Biopolymers (2004), 76(1), 69-82

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
(γR)-γ-(2-Methylphenoxy)benzenepropanol
C16H18O2
180961-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0 CFG=1
M  V30 2 O 4.6201 5.3348 0.0 0
M  V30 3 C 4.6201 2.6675 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 O 4.6201 0.0000 0.0 0
M  V30 6 C 3.0801 8.0023 0.0 0
M  V30 7 C 6.9302 4.0012 0.0 0
M  V30 8 C 7.7002 2.6675 0.0 0
M  V30 9 C 7.7002 5.3348 0.0 0
M  V30 10 C 9.2402 2.6675 0.0 0
M  V30 11 C 9.2402 5.3348 0.0 0
M  V30 12 C 10.0102 4.0012 0.0 0
M  V30 13 C 3.0801 5.3348 0.0 0
M  V30 14 C 2.3101 6.6687 0.0 0
M  V30 15 C 2.3101 4.0012 0.0 0
M  V30 16 C 0.7700 6.6687 0.0 0
M  V30 17 C 0.7700 4.0012 0.0 0
M  V30 18 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 13
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Atomoxetine
C17H21NO
83015-26-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=1
M  V30 2 O 4.6201 6.6685 0.0 0
M  V30 3 C 4.6201 4.0012 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 4.6201 1.3337 0.0 0
M  V30 6 C 5.3901 0.0000 0.0 0
M  V30 7 C 3.0801 9.3360 0.0 0
M  V30 8 C 6.9302 5.3348 0.0 0
M  V30 9 C 7.7002 4.0012 0.0 0
M  V30 10 C 7.7002 6.6685 0.0 0
M  V30 11 C 9.2402 4.0012 0.0 0
M  V30 12 C 9.2402 6.6685 0.0 0
M  V30 13 C 10.0102 5.3348 0.0 0
M  V30 14 C 3.0801 6.6685 0.0 0
M  V30 15 C 2.3101 8.0023 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 8.0023 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 14
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 180961-72-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83015-26-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-12373489
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A stereospecific ruthenium-catalyzed allylic alkylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trost, Barry M.; Fraisse, Pierre L.; Ball, Zachary T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2002), 41(6), 1059-1061

$RFMT $RIREG SCHEME325 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[2-(4-Methyl-1-piperazinyl)-4-(phenylmethoxy)-5-pyrimidinyl]thio]benzoyl c...
C23H23ClN4O2S
1826043-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 5.3900 0.0 0
M  V30 2 C 5.3347 4.6200 0.0 0
M  V30 3 S 9.3358 6.9300 0.0 0
M  V30 4 C 14.6705 10.0100 0.0 0
M  V30 5 Cl 16.0043 9.2400 0.0 0
M  V30 6 O 14.6705 11.5500 0.0 0
M  V30 7 C 0.0000 12.3200 0.0 0
M  V30 8 C 6.6685 6.9300 0.0 0
M  V30 9 C 8.0021 7.7000 0.0 0
M  V30 10 N 5.3347 7.7000 0.0 0
M  V30 11 C 8.0021 9.2400 0.0 0
M  V30 12 C 5.3347 9.2400 0.0 0
M  V30 13 N 6.6685 10.0100 0.0 0
M  V30 14 C 10.6696 7.7000 0.0 0
M  V30 15 C 10.6696 9.2400 0.0 0
M  V30 16 C 12.0032 6.9300 0.0 0
M  V30 17 C 12.0032 10.0100 0.0 0
M  V30 18 C 13.3369 7.7000 0.0 0
M  V30 19 C 13.3369 9.2400 0.0 0
M  V30 20 N 4.0011 10.0100 0.0 0
M  V30 21 C 4.0011 11.5500 0.0 0
M  V30 22 C 2.6674 9.2400 0.0 0
M  V30 23 C 2.6674 12.3200 0.0 0
M  V30 24 C 1.3338 10.0100 0.0 0
M  V30 25 N 1.3338 11.5500 0.0 0
M  V30 26 C 5.3347 3.0800 0.0 0
M  V30 27 C 6.6685 2.3100 0.0 0
M  V30 28 C 4.0011 2.3100 0.0 0
M  V30 29 C 6.6685 0.7700 0.0 0
M  V30 30 C 4.0011 0.7700 0.0 0
M  V30 31 C 5.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 26
M  V30 4 1 3 9
M  V30 5 1 3 14
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 19
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 12 20
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[[2-(4-methyl-1-piperazinyl)-4-(phenylmethoxy)-5-pyrimidinyl]thio]...
C24H27N5O2S
1826042-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.3358 6.9300 0.0 0
M  V30 2 O 6.6685 5.3900 0.0 0
M  V30 3 C 5.3347 4.6200 0.0 0
M  V30 4 C 14.6705 10.0100 0.0 0
M  V30 5 N 16.0041 9.2400 0.0 0
M  V30 6 O 14.6705 11.5500 0.0 0
M  V30 7 C 17.3379 10.0100 0.0 0
M  V30 8 C 0.0000 12.3200 0.0 0
M  V30 9 C 8.0021 7.7000 0.0 0
M  V30 10 C 6.6685 6.9300 0.0 0
M  V30 11 C 8.0021 9.2400 0.0 0
M  V30 12 N 5.3347 7.7000 0.0 0
M  V30 13 N 6.6685 10.0100 0.0 0
M  V30 14 C 5.3347 9.2400 0.0 0
M  V30 15 C 10.6694 7.7000 0.0 0
M  V30 16 C 12.0032 6.9300 0.0 0
M  V30 17 C 10.6694 9.2400 0.0 0
M  V30 18 C 13.3369 7.7000 0.0 0
M  V30 19 C 12.0032 10.0100 0.0 0
M  V30 20 C 13.3369 9.2400 0.0 0
M  V30 21 N 4.0011 10.0100 0.0 0
M  V30 22 C 4.0011 11.5500 0.0 0
M  V30 23 C 2.6674 9.2400 0.0 0
M  V30 24 C 2.6674 12.3200 0.0 0
M  V30 25 C 1.3338 10.0100 0.0 0
M  V30 26 N 1.3338 11.5500 0.0 0
M  V30 27 C 5.3347 3.0800 0.0 0
M  V30 28 C 4.0011 2.3100 0.0 0
M  V30 29 C 6.6685 2.3100 0.0 0
M  V30 30 C 4.0011 0.7700 0.0 0
M  V30 31 C 6.6685 0.7700 0.0 0
M  V30 32 C 5.3347 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 27
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 4 20
M  V30 9 1 5 7
M  V30 10 1 8 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 14 21
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1826043-66-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1826042-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5992319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hetero)arylthiopyrimidine compounds as Hsp70 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chiosis, Gabriela; Kang, Yanlong; Patel, Hardik J.; Patel, Maulik;
Ochiana, Stefan; Rodina, Anna; Taldone, Tony; Shrestha, Liza
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015175707 A1 2015-11-19

$RFMT $RIREG SCHEME326 STEP1
$RXN



  3  1
$MOL
1,5-Dimethyl 3-oxopentanedioate
C7H10O5
1830-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 O 1.3337 2.3101 0.0 0
M  V30 8 O 2.6673 0.0000 0.0 0
M  V30 9 O 9.3360 2.3101 0.0 0
M  V30 10 O 8.0023 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1,6-dihydro-4-hydroxy-1-methyl-6-oxo-3-pyridinecarboxylate
C8H9NO4
1174525-17-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 O 6.9300 4.0011 0.0 0
M  V30 3 O 6.9300 1.3338 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 O 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 5.3349 0.0 0
M  V30 7 O 0.0000 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 N 2.3100 4.0011 0.0 0
M  V30 13 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1830-54-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1174525-17-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24781889
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transformations of dialkyl acetone-1,3-dicarboxylates via their
dimethylaminomethylidene derivatives into 1-substituted
4-ethoxycarbonyl-5-(ethoxycarbonylmethyl)pyrazoles,
7-amino-2-ethoxycarbonyl-1H,2H-pyrazolo[2,3-c]pyrimidin-5-one,
4-hydroxypyridin-2(1H)-ones and 6-substituted
3-benzoylamino-2,5-dioxo-5,6-dihydro-2H-pyrano[3,2-c]pyridine-8-carboxylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zupancic, Silvo; Svete, Jurij; Stanovnik, Branko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Acta Chimica Slovenica (2008), 55(4), 1009-1018

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Difluoro[3-iodo-5-[(4-iodo-5-methyl-2H-pyrrol-2-ylidene-κN)(methylthio)...
C12H11BF2I2N2S
1835282-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.2436 0.7700 0.0 0
M  V30 2 C 3.9099 0.0000 0.0 0
M  V30 3 F 6.2335 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 4 F 4.2536 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 5 C 1.9694 6.5606 0.0 0
M  V30 6 I 0.0000 3.8500 0.0 0
M  V30 7 C 8.5178 6.5606 0.0 0
M  V30 8 I 10.4871 3.8500 0.0 0
M  V30 9 C 3.9099 3.0800 0.0 0
M  V30 10 N 3.9099 4.6200 0.0 0 CHG=-1 VAL=3
M  V30 11 C 5.2436 2.3100 0.0 0
M  V30 12 C 2.4452 2.6041 0.0 0
M  V30 13 B 5.2436 5.3900 0.0 0 CHG=3 VAL=4
M  V30 14 C 2.4452 5.0959 0.0 0
M  V30 15 C 6.5772 3.0800 0.0 0
M  V30 16 C 1.5400 3.8500 0.0 0
M  V30 17 N 6.5772 4.6200 0.0 0 VAL=4
M  V30 18 C 8.0419 2.6041 0.0 0
M  V30 19 C 8.0419 5.0959 0.0 0
M  V30 20 C 8.9471 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 16
M  V30 7 1 7 19
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-Difluoro[4-iodo-α-(4-iodo-5-methyl-2H-pyrrol-2-ylidene-κN)-N,5-dimethyl...
C12H12BF2I2N3
1835282-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.2436 0.7700 0.0 0
M  V30 2 C 3.9099 0.0000 0.0 0
M  V30 3 F 6.2335 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 4 F 4.2536 6.5697 0.0 0 CHG=-1 VAL=1
M  V30 5 C 1.9694 6.5606 0.0 0
M  V30 6 I 0.0000 3.8500 0.0 0
M  V30 7 C 8.5178 6.5606 0.0 0
M  V30 8 I 10.4871 3.8500 0.0 0
M  V30 9 C 3.9099 3.0800 0.0 0
M  V30 10 N 3.9099 4.6200 0.0 0 CHG=-1 VAL=3
M  V30 11 C 5.2436 2.3100 0.0 0
M  V30 12 C 2.4452 2.6041 0.0 0
M  V30 13 B 5.2436 5.3900 0.0 0 CHG=3 VAL=4
M  V30 14 C 2.4452 5.0959 0.0 0
M  V30 15 C 6.5772 3.0800 0.0 0
M  V30 16 C 1.5400 3.8500 0.0 0
M  V30 17 N 6.5772 4.6200 0.0 0 VAL=4
M  V30 18 C 8.0419 2.6041 0.0 0
M  V30 19 C 8.0419 5.0959 0.0 0
M  V30 20 C 8.9471 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 13
M  V30 4 1 4 13
M  V30 5 1 5 14
M  V30 6 1 6 16
M  V30 7 1 7 19
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1835282-63-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1835282-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26112242
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Near-IR BODIPY Dyes a la Carte-Programmed Orthogonal Functionalization of
Rationally Designed Building Blocks
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gomez-Duran, Cesar F. A.; Esnal, Ixone; Valois-Escamilla, Ismael;
Urias-Benavides, Arlette; Banuelos, Jorge; Lopez Arbeloa, Inigo;
Garcia-Moreno, Inmaculada; Pena-Cabrera, Eduardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(3), 1048-1061

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Bis(3,5-dimethoxyphenyl)methanone
C17H18O5
184090-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 6.6685 6.9302 0.0 0
M  V30 3 O 1.3337 5.3901 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 O 4.0010 0.7700 0.0 0
M  V30 6 C 2.6673 0.0000 0.0 0
M  V30 7 O 12.0033 5.3901 0.0 0
M  V30 8 C 13.3370 4.6201 0.0 0
M  V30 9 O 9.3360 0.7700 0.0 0
M  V30 10 C 10.6697 0.0000 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 C 2.6673 3.0801 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 8.0022 3.0801 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 9.3360 2.3101 0.0 0
M  V30 22 C 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 3 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 1 9 10
M  V30 11 1 9 21
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,5-Dimethoxyphenyl)-3,5-dimethoxy-N-methylbenzenemethanamine
C18H23NO4
2765151-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 N 6.6685 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 C 0.0000 3.0801 0.0 0
M  V30 6 O 4.0010 6.9302 0.0 0
M  V30 7 C 2.6673 7.7002 0.0 0
M  V30 8 O 9.3360 6.9302 0.0 0
M  V30 9 C 10.6697 7.7002 0.0 0
M  V30 10 O 12.0033 2.3101 0.0 0
M  V30 11 C 13.3370 3.0801 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 8.0022 3.0801 0.0 0
M  V30 19 C 8.0022 4.6201 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 9.3360 5.3901 0.0 0
M  V30 22 C 10.6697 3.0801 0.0 0
M  V30 23 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 10 11
M  V30 12 1 10 22
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 184090-09-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2765151-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31629193
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Enantioselective Pictet-Spengler Reaction of α-Ketoamides
Catalyzed by a Single H-Bond Donor Organocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andres, Remi; Wang, Qian; Zhu, Jieping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2022), 61(19), e202201788

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2350309
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N,1-Dimethyl-1H-indole-2-carboxamide [0675] A suspension of ethyl
1-methyl-1H-indole-2-carboxylate (27.10 g, 133.34 mmole) in 40% aqueous
CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT. A solid tended to
gradually creep up the walls of the flask, and was washed down
periodically with MeOH. The flask was tightly stoppered to keep the
material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50-60° C. in high vacuum left the title
compound (23.45 g, 93%) as a faintly yellow solid:. 1H NMR (300 MHz,
CDCl3) δ 7.63 (d, J=8.0 Hz, 1H), 7.27-7.43 (m, 2H), 7.10-7.20 (m, 1H),
6.80 (s, 1H), 6.10-6.30 (m, 1H), 4.06 (s, 3H), 3.01 (d, J=4.9 Hz, 3H).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a tightly stoppered flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11039292
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a tightly stoppered flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14936591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stoppered flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5553802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N,1-DimethylH-indole-2-carboxamide. A suspension of ethyl
1-methylH-indole-2-carboxylate (27.10 g, 133.34 mmole) in 40% aqueous
CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT. A solid tended to
gradually creep up the walls of the flask, and was washed down
periodically with MeOH. The flask was tightly stoppered to keep the
material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50 - 60°C in high vacuum left the title
compound. Faintly yellow solid, Yield 93% (23.45 g) 1H NMR (300 MHz,
CDCl3) 8 7.63 (d, J = 8.0 Hz, 1 H), 7.27 - 7.43 (m, 2 H), 7.10 - 7.20 (m,
1 H), 6.80 (s, 1 H), 6.10 - 6.30 (m, 1 H), 4.06 (s, 3 H), 3.01 (d, J =
4.9 Hz, 3 H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Drug screening for effectors of enoyl ACP reductase encoded by fabK and
fabI genes of Streptococcus pneumoniae for treatment of bacterial
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dewolf, Walter E., Jr.; Payne, David J.; Seefeld, Mark A.; Wallis, Nicola
G.; West, Joshua M.; Brandt, Martin; Keller, Paul M.; Patel, Arunbhai H.;
Reed, Shannon L.; Tew, David G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002031128 A1 2002-04-18

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11217381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b) N,1-Dimethylindole-2-carboxamide. A suspension of ethyl
1-methylindole-2-carboxylate (27.10 g, 133.34 mmole) in 40% aqueous
CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT. A solid tended to
gradually creep up the walls of the flask, and was washed down
periodically with MeOH. The flask was tightly stoppered to keep the
material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50-60°C in high vacuum left the title
compound. Yield (23.45 g, 93%) as a faintly yellow solid. 1H NMR (300
MHz, CDCl3) δ 7.63 (d, J= 8.0 Hz, 1H), 7.27- 7.43 (m, 2 H), 7.10- 7.20
(m, 1H), 6.80 (s, 1H), 6.10- 6.30 (m, 1H), 4.06 (s, 3 H), 3.01 (d, J= 4.9
Hz, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-[indolyl(or indazolyl)methyl] benzamides as Fab I
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001026652 A1 2001-04-19

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-809778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: b) N,1-Dimethyl-1 H-indole-2-carboxamide. A
suspension of ethyl 1-methyl-1H-indole-2-carboxylate (27.10 g, 133.34
mmole) in 40% aqueous CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT.
A solid tended to gradually creep up the walls of the flask, and was
washed down periodically with MeOH. The flask was tightly stoppered to
keep the material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 25 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50-60°C in high vacuum left the title
compound. Yield: (23.45 g, 93%) as a faintly yellow solid. 1H NMR (300
MHz, CDCl3) 8 7.63 (d, J = 8.0 Hz, 1 H), 7.27-7.43 (m, 2 H), 7.10-7.20
(m, 1 H), 6.80 (s, 1 H), 6.10-6.30 (m, 1 H), 4.06 (s, 3 H), 3.01 (d, J =
4.9 Hz, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-methyl-1H-indole-2-carboxylate
C12H13NO2
18450-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 5.3182 0.0 0
M  V30 2 C 6.0811 3.9554 0.0 0
M  V30 3 O 7.4148 3.1854 0.0 0
M  V30 4 O 6.0811 5.4955 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 3.1854 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 4.5865 1.6538 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 N 3.3405 3.8119 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 4.7475 3.1854 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 13
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-indole-2-carboxamide
C11H12N2O
61939-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 C 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 N 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 18450-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61939-18-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19228790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(indolylmethyl) benzamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001026654 A1 2001-04-19

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazole-5-carboxylic acid, 1-amino-2-(tetrahydro-2H-pyran-4-yl)-, methyl...
C10H15N3O3
1889267-96-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0494 0.4963 0.0 0
M  V30 2 C 8.2356 1.5317 0.0 0
M  V30 3 O 9.6426 2.1580 0.0 0
M  V30 4 O 8.0747 0.0000 0.0 0
M  V30 5 C 10.8884 1.2528 0.0 0
M  V30 6 C 4.6200 3.2067 0.0 0
M  V30 7 N 5.5252 1.9609 0.0 0
M  V30 8 N 5.5252 4.4528 0.0 0
M  V30 9 C 6.9898 2.4367 0.0 0
M  V30 10 C 6.9898 3.9767 0.0 0
M  V30 11 C 3.0800 3.2067 0.0 0
M  V30 12 C 2.3100 1.8731 0.0 0
M  V30 13 C 2.3100 4.5405 0.0 0
M  V30 14 C 0.7700 1.8731 0.0 0
M  V30 15 C 0.7700 4.5405 0.0 0
M  V30 16 O 0.0000 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Amino-N-methyl-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazole-5-carboxamide
C10H16N4O2
2007972-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.0494 0.4963 0.0 0
M  V30 2 C 8.2356 1.5317 0.0 0
M  V30 3 N 9.6426 2.1580 0.0 0
M  V30 4 O 8.0747 0.0000 0.0 0
M  V30 5 C 10.8884 1.2528 0.0 0
M  V30 6 C 4.6200 3.2067 0.0 0
M  V30 7 N 5.5252 1.9609 0.0 0
M  V30 8 N 5.5252 4.4528 0.0 0
M  V30 9 C 6.9898 2.4367 0.0 0
M  V30 10 C 6.9898 3.9767 0.0 0
M  V30 11 C 3.0800 3.2067 0.0 0
M  V30 12 C 2.3100 4.5405 0.0 0
M  V30 13 C 2.3100 1.8731 0.0 0
M  V30 14 C 0.7700 4.5405 0.0 0
M  V30 15 C 0.7700 1.8731 0.0 0
M  V30 16 O 0.0000 3.2067 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 9
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1889267-96-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2007972-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16852479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazol[5,1-f][1,2,4]triazine derivatives as
phosphodiesterase 1 inhibitors useful for treatment of neurological and
psychiatric disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fujii, Yuki; Fujiwara, Hiroaki; Kawasumi, Muneo; Iwama, Seiji; Ikeda,
Tomoko; Kiyoshige, Saori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016147659 A1 2016-09-22

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2S)-3-[2-Ethyl-4-[5-(4-formylphenyl)-1,2,4-oxadiazol-3-yl]-6-methylphenox...
C23H25N3O6
1909221-92-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.3802 1.3336 0.0 0
M  V30 2 C 12.6102 0.0000 0.0 0
M  V30 3 C 13.3802 6.6684 0.0 0
M  V30 4 O 14.9202 4.0011 0.0 0
M  V30 5 C 15.6902 5.3347 0.0 0
M  V30 6 C 17.2302 5.3347 0.0 0 CFG=1
M  V30 7 C 18.0002 6.6684 0.0 0
M  V30 8 O 18.0002 4.0011 0.0 0
M  V30 9 N 19.5402 6.6684 0.0 0
M  V30 10 C 20.3102 8.0022 0.0 0
M  V30 11 C 21.8503 8.0022 0.0 0
M  V30 12 O 19.5402 9.3358 0.0 0
M  V30 13 O 22.6203 9.3358 0.0 0
M  V30 14 C 1.4068 8.3918 0.0 0
M  V30 15 O 0.0000 7.7655 0.0 0
M  V30 16 C 8.7602 4.0011 0.0 0
M  V30 17 N 7.8550 5.2470 0.0 0
M  V30 18 N 7.8550 2.7552 0.0 0
M  V30 19 C 6.3904 4.7711 0.0 0
M  V30 20 O 6.3904 3.2311 0.0 0
M  V30 21 C 10.3002 4.0011 0.0 0
M  V30 22 C 11.0702 2.6674 0.0 0
M  V30 23 C 11.0702 5.3347 0.0 0
M  V30 24 C 12.6102 2.6674 0.0 0
M  V30 25 C 12.6102 5.3347 0.0 0
M  V30 26 C 13.3802 4.0011 0.0 0
M  V30 27 C 5.1446 5.6763 0.0 0
M  V30 28 C 3.7376 5.0498 0.0 0
M  V30 29 C 5.3055 7.2079 0.0 0
M  V30 30 C 2.4917 5.9551 0.0 0
M  V30 31 C 4.0596 8.1131 0.0 0
M  V30 32 C 2.6527 7.4866 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 3 25
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 32
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 21
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 19 27
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(2S)-3-[2-Ethyl-6-methyl-4-[5-[4-[(methylamino)methyl]phenyl]-1,2,4-oxadia...
C24H30N4O5
1909221-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 1.3336 0.0 0
M  V30 2 C 10.0101 0.0000 0.0 0
M  V30 3 C 9.2400 6.6684 0.0 0
M  V30 4 O 7.7000 4.0011 0.0 0
M  V30 5 C 6.9300 5.3347 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 7 C 4.6200 6.6684 0.0 0
M  V30 8 O 4.6200 4.0011 0.0 0
M  V30 9 N 3.0800 6.6684 0.0 0
M  V30 10 C 2.3100 8.0022 0.0 0
M  V30 11 C 0.7700 8.0022 0.0 0
M  V30 12 O 3.0800 9.3358 0.0 0
M  V30 13 O 0.0000 9.3358 0.0 0
M  V30 14 C 21.2135 8.3918 0.0 0
M  V30 15 N 22.6203 7.7655 0.0 0
M  V30 16 C 23.8661 8.6707 0.0 0
M  V30 17 C 13.8601 4.0011 0.0 0
M  V30 18 N 14.7651 5.2470 0.0 0
M  V30 19 N 14.7651 2.7552 0.0 0
M  V30 20 C 16.2298 4.7711 0.0 0
M  V30 21 O 16.2298 3.2311 0.0 0
M  V30 22 C 12.3201 4.0011 0.0 0
M  V30 23 C 11.5501 2.6674 0.0 0
M  V30 24 C 11.5501 5.3347 0.0 0
M  V30 25 C 10.0101 2.6674 0.0 0
M  V30 26 C 10.0101 5.3347 0.0 0
M  V30 27 C 9.2400 4.0011 0.0 0
M  V30 28 C 17.4757 5.6763 0.0 0
M  V30 29 C 17.3148 7.2079 0.0 0
M  V30 30 C 18.8827 5.0498 0.0 0
M  V30 31 C 18.5606 8.1131 0.0 0
M  V30 32 C 20.1285 5.9551 0.0 0
M  V30 33 C 19.9676 7.4866 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 3 26
M  V30 4 1 4 5
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 33
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 22
M  V30 20 2 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 1 20 28
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1909221-92-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1909221-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15814064
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel S1P1 receptor agonists - Part 4: Alkylaminomethyl substituted aryl
head groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lescop, Cyrille; Muller, Claus; Mathys, Boris; Birker, Magdalena; de
Kanter, Ruben; Kohl, Christopher; Hess, Patrick; Nayler, Oliver; Rey,
Markus; Sieber, Patrick; Steiner, Beat; Weller, Thomas; Bolli, Martin H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2016), 116222-238

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloroimidazo[1,2-a]quinoxaline
C10H6ClN3
191349-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.6672 0.0000 0.0 0
M  V30 2 C 3.9772 4.0011 0.0 0
M  V30 3 N 2.4372 4.0011 0.0 0
M  V30 4 C 4.7472 2.6675 0.0 0
M  V30 5 C 4.7472 5.3349 0.0 0
M  V30 6 C 1.6672 2.6675 0.0 0
M  V30 7 C 1.4068 5.1456 0.0 0
M  V30 8 N 3.9772 1.3338 0.0 0
M  V30 9 C 6.2873 2.6675 0.0 0
M  V30 10 C 6.2873 5.3349 0.0 0
M  V30 11 C 2.4372 1.3338 0.0 0
M  V30 12 N 0.1609 2.9876 0.0 0
M  V30 13 C 0.0000 4.5192 0.0 0
M  V30 14 C 7.0573 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 2 7 13
M  V30 13 2 8 11
M  V30 14 1 9 14
M  V30 15 2 10 14
M  V30 16 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylimidazo[1,2-a]quinoxalin-4-amine
C11H10N4
452311-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 3.7035 0.0 0
M  V30 2 C 7.7000 5.0372 0.0 0
M  V30 3 N 3.0800 2.3699 0.0 0
M  V30 4 C 2.3100 3.7035 0.0 0
M  V30 5 C 4.6200 2.3699 0.0 0
M  V30 6 C 2.6041 0.9052 0.0 0
M  V30 7 C 3.0800 5.0372 0.0 0
M  V30 8 C 0.7700 3.7035 0.0 0
M  V30 9 C 5.3900 3.7035 0.0 0
M  V30 10 N 5.0959 0.9052 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 N 4.6200 5.0372 0.0 0
M  V30 13 C 2.3100 6.3710 0.0 0
M  V30 14 C 0.0000 5.0372 0.0 0
M  V30 15 C 0.7700 6.3710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 1 8 14
M  V30 14 2 9 12
M  V30 15 1 10 11
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 191349-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 452311-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11123439
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of aq. methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro
activity against human melanoma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deleuze-Masquefa, Carine; Moarbess, Georges; Khier, Sonia; David, Nadege;
Gayraud-Paniagua, Stephanie; Bressolle, Francoise; Pinguet, Frederic;
Bonnet, Pierre-Antoine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2009), 44(9), 3406-3411

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-2,3,4,9-tetrahydro-1-(2,3,4,5,6-pentafluorophenyl)-1H-pyrido[3...
C19H13F5N2O2
1918182-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 2.6673 5.0901 0.0 0
M  V30 2 F 5.3348 9.7101 0.0 0
M  V30 3 C 9.3359 7.4001 0.0 0
M  V30 4 O 10.6696 6.6301 0.0 0
M  V30 5 O 9.3359 8.9401 0.0 0
M  V30 6 C 12.0032 7.4001 0.0 0
M  V30 7 F 0.0000 6.6301 0.0 0
M  V30 8 F 2.6673 11.2502 0.0 0
M  V30 9 F 0.0000 9.7101 0.0 0
M  V30 10 C 5.3348 5.0901 0.0 0
M  V30 11 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 12 C 6.6684 4.3201 0.0 0
M  V30 13 N 4.1902 4.0597 0.0 0
M  V30 14 N 6.6684 7.4001 0.0 0
M  V30 15 C 6.3483 2.8138 0.0 0
M  V30 16 C 8.0021 5.0901 0.0 0
M  V30 17 C 4.8167 2.6527 0.0 0
M  V30 18 C 8.0021 6.6301 0.0 0 CFG=2
M  V30 19 C 7.2535 1.5679 0.0 0
M  V30 20 C 4.1902 1.2459 0.0 0
M  V30 21 C 6.6270 0.1609 0.0 0
M  V30 22 C 5.0955 0.0000 0.0 0
M  V30 23 C 4.0011 7.4001 0.0 0
M  V30 24 C 2.6673 6.6301 0.0 0
M  V30 25 C 4.0011 8.9401 0.0 0
M  V30 26 C 1.3337 7.4001 0.0 0
M  V30 27 C 2.6673 9.7101 0.0 0
M  V30 28 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 2 25
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 18 3 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 26
M  V30 8 1 8 27
M  V30 9 1 9 28
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 23 CFG=1
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 2 15 19
M  V30 21 1 16 18
M  V30 22 2 17 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-2,3,4,9-Tetrahydro-N-methyl-1-[2,3,5,6-tetrafluoro-4-(methylamino)phe...
C20H18F4N4O
1918182-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 F 6.2486 9.2400 0.0 0
M  V30 2 F 8.9159 4.6200 0.0 0
M  V30 3 C 4.9149 2.3100 0.0 0
M  V30 4 N 3.5811 1.5400 0.0 0
M  V30 5 O 6.2486 1.5400 0.0 0
M  V30 6 C 3.5811 0.0000 0.0 0
M  V30 7 F 8.9159 10.7800 0.0 0
M  V30 8 F 11.5833 6.1600 0.0 0
M  V30 9 N 11.5833 9.2400 0.0 0
M  V30 10 C 12.9169 8.4700 0.0 0
M  V30 11 C 4.9149 6.9300 0.0 0
M  V30 12 C 6.2486 6.1600 0.0 0 CFG=1
M  V30 13 C 3.5811 6.1600 0.0 0
M  V30 14 N 4.5948 8.4363 0.0 0
M  V30 15 N 6.2486 4.6200 0.0 0
M  V30 16 C 2.4367 7.1904 0.0 0
M  V30 17 C 3.5811 4.6200 0.0 0
M  V30 18 C 3.0631 8.5974 0.0 0
M  V30 19 C 4.9149 3.8500 0.0 0 CFG=2
M  V30 20 C 0.9052 7.0295 0.0 0
M  V30 21 C 2.1579 9.8432 0.0 0
M  V30 22 C 0.0000 8.2754 0.0 0
M  V30 23 C 0.6263 9.6823 0.0 0
M  V30 24 C 7.5822 6.9300 0.0 0
M  V30 25 C 7.5822 8.4700 0.0 0
M  V30 26 C 8.9159 6.1600 0.0 0
M  V30 27 C 8.9159 9.2400 0.0 0
M  V30 28 C 10.2497 6.9300 0.0 0
M  V30 29 C 10.2497 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 2 26
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 19 3 CFG=3
M  V30 6 1 4 6
M  V30 7 1 7 27
M  V30 8 1 8 28
M  V30 9 1 9 10
M  V30 10 1 9 29
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 24 CFG=1
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 2 16 20
M  V30 22 1 17 19
M  V30 23 2 18 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-22-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15869319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2-chloro-4-fluorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b...
C19H16ClFN2O2
1918182-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2-Chloro-4-fluorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4...
C19H17ClFN3O
1918182-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 F 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-69-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-72-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15942283
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME335 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[6-bromo-2-(methylsulfinyl)-7-oxopyrido[2,3-d]pyrimidi...
C16H21BrN4O4S
1926205-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 C 9.2400 6.6684 0.0 0
M  V30 4 N 10.7800 6.6684 0.0 0
M  V30 5 C 11.5500 8.0021 0.0 0
M  V30 6 O 13.0900 8.0021 0.0 0
M  V30 7 O 10.7800 9.3358 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 15.1936 8.5658 0.0 0
M  V30 10 C 14.6300 10.6694 0.0 0
M  V30 11 C 12.5264 10.1058 0.0 0
M  V30 12 O 8.4700 2.6673 0.0 0
M  V30 13 S 1.5400 6.6684 0.0 0 VAL=4
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 O 2.3100 8.0021 0.0 0
M  V30 16 Br 6.9300 0.0000 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0
M  V30 18 N 6.1600 4.0011 0.0 0
M  V30 19 C 3.8500 2.6673 0.0 0
M  V30 20 N 3.8500 5.3347 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 4.6200 1.3336 0.0 0
M  V30 23 C 2.3100 2.6673 0.0 0
M  V30 24 C 2.3100 5.3347 0.0 0
M  V30 25 C 6.1600 1.3336 0.0 0
M  V30 26 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 24
M  V30 16 1 16 25
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 2 22 25
M  V30 26 1 23 26
M  V30 27 2 24 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[6-bromo-2-(methylsulfonyl)-7-oxopyrido[2,3-d]pyrimidi...
C16H21BrN4O5S
1926205-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 5.3348 0.0 0
M  V30 2 C 8.2638 5.3348 0.0 0
M  V30 3 C 9.0338 6.6685 0.0 0
M  V30 4 N 10.5739 6.6685 0.0 0
M  V30 5 C 11.3439 8.0023 0.0 0
M  V30 6 O 12.8839 8.0023 0.0 0
M  V30 7 O 10.5739 9.3360 0.0 0
M  V30 8 C 13.6539 9.3360 0.0 0
M  V30 9 C 14.9876 8.5660 0.0 0
M  V30 10 C 14.4240 10.6697 0.0 0
M  V30 11 C 12.3203 10.1060 0.0 0
M  V30 12 O 8.2638 2.6673 0.0 0
M  V30 13 S 1.3337 6.6685 0.0 0 VAL=6
M  V30 14 C 0.5637 8.0023 0.0 0
M  V30 15 O 0.0000 5.8985 0.0 0
M  V30 16 O 2.6673 7.4385 0.0 0
M  V30 17 Br 6.7238 0.0000 0.0 0
M  V30 18 C 4.4137 4.0012 0.0 0
M  V30 19 N 5.9538 4.0012 0.0 0
M  V30 20 C 3.6437 2.6673 0.0 0
M  V30 21 N 3.6437 5.3348 0.0 0
M  V30 22 C 6.7238 2.6673 0.0 0
M  V30 23 C 4.4137 1.3337 0.0 0
M  V30 24 C 2.1037 2.6673 0.0 0
M  V30 25 C 2.1037 5.3348 0.0 0
M  V30 26 C 5.9538 1.3337 0.0 0
M  V30 27 N 1.3337 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 22
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 16 1 13 25
M  V30 17 1 17 26
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 2 23 26
M  V30 27 1 24 27
M  V30 28 2 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[3-[6-bromo-2-(methylamino)-7-oxopyrido[2,3-d]pyrimidin-8...
C16H22BrN5O3
1926205-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 5.3348 0.0 0
M  V30 2 C 8.4701 5.3348 0.0 0
M  V30 3 C 9.2401 6.6684 0.0 0
M  V30 4 N 10.7801 6.6684 0.0 0
M  V30 5 C 11.5501 8.0022 0.0 0
M  V30 6 O 13.0901 8.0022 0.0 0
M  V30 7 O 10.7801 9.3359 0.0 0
M  V30 8 C 13.8602 9.3359 0.0 0
M  V30 9 C 15.1938 8.5659 0.0 0
M  V30 10 C 14.6302 10.6695 0.0 0
M  V30 11 C 12.5265 10.1059 0.0 0
M  V30 12 O 8.4701 2.6673 0.0 0
M  V30 13 N 1.5400 6.6684 0.0 0
M  V30 14 C 0.0000 6.6684 0.0 0
M  V30 15 Br 6.9301 0.0000 0.0 0
M  V30 16 C 4.6201 4.0011 0.0 0
M  V30 17 N 6.1601 4.0011 0.0 0
M  V30 18 C 3.8500 2.6673 0.0 0
M  V30 19 N 3.8500 5.3348 0.0 0
M  V30 20 C 6.9301 2.6673 0.0 0
M  V30 21 C 4.6201 1.3337 0.0 0
M  V30 22 C 2.3100 2.6673 0.0 0
M  V30 23 C 2.3100 5.3348 0.0 0
M  V30 24 C 6.1601 1.3337 0.0 0
M  V30 25 N 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 20
M  V30 13 1 13 14
M  V30 14 1 13 23
M  V30 15 1 15 24
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 1 22 25
M  V30 26 2 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1926205-32-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1926205-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1926205-34-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30115656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart
Acute Cardiovascular Toxicity with a Narrow Therapeutic Window
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rudolph, Joachim; Murray, Lesley J.; Ndubaku, Chudi O.; O'Brien, Thomas;
Blackwood, Elizabeth; Wang, Weiru; Aliagas, Ignacio; Gazzard, Lewis;
Crawford, James J.; Drobnick, Joy; Lee, Wendy; Zhao, Xianrui; Hoeflich,
Klaus P.; Favor, David A.; Dong, Ping; Zhang, Haiming; Heise, Christopher
E.; Oh, Angela; Ong, Christy C.; La, Hank; Chakravarty, Paroma; Chan,
Connie; Jakubiak, Diana; Epler, Jennifer; Ramaswamy, Sreemathy; Vega,
Roxanne; Cain, Gary; Diaz, Dolores; Zhong, Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(11), 5520-5541

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-8-methyl-2-[1-phenyl-5-(trifluoromethyl)-1H-pyrazol-4-yl]-4H-3,1-ben...
C19H11ClF3N3O2
1962931-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3051 2.4873 0.0 0
M  V30 2 F 3.7986 2.8075 0.0 0
M  V30 3 F 4.9849 0.9810 0.0 0
M  V30 4 F 6.8114 2.1671 0.0 0
M  V30 5 O 9.6995 0.0000 0.0 0
M  V30 6 C 12.3669 6.1601 0.0 0
M  V30 7 Cl 15.0343 1.5400 0.0 0
M  V30 8 C 7.0321 4.6201 0.0 0
M  V30 9 C 5.6252 3.9936 0.0 0
M  V30 10 C 6.8711 6.1516 0.0 0
M  V30 11 N 4.5948 5.1381 0.0 0
M  V30 12 N 5.3648 6.4718 0.0 0
M  V30 13 C 8.3659 3.8501 0.0 0
M  V30 14 N 9.6995 4.6201 0.0 0
M  V30 15 O 8.3659 2.3100 0.0 0
M  V30 16 C 11.0332 3.8501 0.0 0
M  V30 17 C 9.6995 1.5400 0.0 0
M  V30 18 C 11.0332 2.3100 0.0 0
M  V30 19 C 12.3669 4.6201 0.0 0
M  V30 20 C 12.3669 1.5400 0.0 0
M  V30 21 C 13.7007 3.8501 0.0 0
M  V30 22 C 13.7007 2.3100 0.0 0
M  V30 23 C 3.0631 4.9772 0.0 0
M  V30 24 C 2.4368 3.5702 0.0 0
M  V30 25 C 2.1580 6.2231 0.0 0
M  V30 26 C 0.9052 3.4093 0.0 0
M  V30 27 C 0.6263 6.0622 0.0 0
M  V30 28 C 0.0000 4.6552 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 2 5 17
M  V30 6 1 6 19
M  V30 7 1 7 22
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 11 23
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Chloro-2-methyl-6-[(methylamino)carbonyl]phenyl]-1-phenyl-5-(trifluorome...
C20H16ClF3N4O2
1620895-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7293 5.9829 0.0 0
M  V30 2 F 8.2230 6.3030 0.0 0
M  V30 3 F 10.0495 7.4892 0.0 0
M  V30 4 F 11.2357 5.6627 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 5.3348 3.8501 0.0 0
M  V30 7 O 6.6685 6.1601 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 O 4.0011 1.5400 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 5.3348 6.9301 0.0 0
M  V30 13 Cl 0.0000 6.9301 0.0 0
M  V30 14 N 10.4395 3.3320 0.0 0
M  V30 15 C 9.4091 4.4764 0.0 0
M  V30 16 N 9.6695 1.9983 0.0 0
M  V30 17 C 8.0023 3.8501 0.0 0
M  V30 18 C 8.1632 2.3185 0.0 0
M  V30 19 C 11.9713 3.4929 0.0 0
M  V30 20 C 12.8763 2.2471 0.0 0
M  V30 21 C 12.5976 4.8998 0.0 0
M  V30 22 C 14.4080 2.4080 0.0 0
M  V30 23 C 14.1291 5.0608 0.0 0
M  V30 24 C 15.0344 3.8150 0.0 0
M  V30 25 C 4.0011 4.6201 0.0 0
M  V30 26 C 2.6675 3.8501 0.0 0
M  V30 27 C 4.0011 6.1601 0.0 0
M  V30 28 C 1.3337 4.6201 0.0 0
M  V30 29 C 2.6675 6.9301 0.0 0
M  V30 30 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 25
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 1 12 27
M  V30 14 1 13 30
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 19
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1962931-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620895-54-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16584411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and insecticidal activities of novel
1-substituted-5-(trifluoromethyl)-1H-pyrazole-4-carboxamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Zhi-Bing; Zhou, Xiang; Ye, Yi-Qiang; Wang, Pei-Yi; Yang, Song
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2017), 28(1), 121-125

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Bromopentyl)-3-methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-i...
C34H34BrNO2
1973474-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 6.3625 0.0 0
M  V30 2 C 10.2458 5.2182 0.0 0
M  V30 3 C 10.7217 3.7535 0.0 0
M  V30 4 C 9.6913 2.6091 0.0 0
M  V30 5 C 10.1671 1.1444 0.0 0
M  V30 6 Br 9.1367 0.0000 0.0 0
M  V30 7 C 11.2762 11.7837 0.0 0
M  V30 8 O 5.3347 10.6131 0.0 0
M  V30 9 C 4.0011 9.8431 0.0 0
M  V30 10 O 17.8656 9.0731 0.0 0
M  V30 11 C 18.6356 10.4068 0.0 0
M  V30 12 N 10.8004 7.8272 0.0 0
M  V30 13 C 11.7056 9.0731 0.0 0
M  V30 14 C 9.3358 8.3031 0.0 0
M  V30 15 C 10.8004 10.3190 0.0 0
M  V30 16 C 9.3358 9.8431 0.0 0
M  V30 17 C 8.0020 7.5331 0.0 0
M  V30 18 C 8.0020 10.6131 0.0 0
M  V30 19 C 6.6684 8.3031 0.0 0
M  V30 20 C 6.6684 9.8431 0.0 0
M  V30 21 C 13.2456 9.0731 0.0 0
M  V30 22 C 14.0156 7.7395 0.0 0
M  V30 23 C 14.0156 10.4068 0.0 0
M  V30 24 C 15.5556 7.7395 0.0 0
M  V30 25 C 15.5556 10.4068 0.0 0
M  V30 26 C 16.3256 9.0731 0.0 0
M  V30 27 C 2.6673 10.6131 0.0 0
M  V30 28 C 1.3336 9.8431 0.0 0
M  V30 29 C 2.6673 12.1531 0.0 0
M  V30 30 C 0.0000 10.6131 0.0 0
M  V30 31 C 1.3336 12.9231 0.0 0
M  V30 32 C 0.0000 12.1531 0.0 0
M  V30 33 C 20.1756 10.4068 0.0 0
M  V30 34 C 20.9456 9.0731 0.0 0
M  V30 35 C 20.9456 11.7406 0.0 0
M  V30 36 C 22.4857 9.0731 0.0 0
M  V30 37 C 22.4857 11.7406 0.0 0
M  V30 38 C 23.2557 10.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 11 33
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 13 21
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 1 15 16
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole-1-pentan...
C35H38N2O2
1973474-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 7.8272 0.0 0
M  V30 2 C 10.2458 6.6827 0.0 0
M  V30 3 C 10.7216 5.2181 0.0 0
M  V30 4 C 9.6912 4.0736 0.0 0
M  V30 5 C 10.1671 2.6091 0.0 0
M  V30 6 N 9.1367 1.4645 0.0 0
M  V30 7 C 9.6125 0.0000 0.0 0
M  V30 8 C 11.2762 13.2482 0.0 0
M  V30 9 O 5.3347 12.0776 0.0 0
M  V30 10 C 4.0011 11.3076 0.0 0
M  V30 11 O 17.8655 10.5376 0.0 0
M  V30 12 C 18.6355 11.8714 0.0 0
M  V30 13 N 10.8003 9.2917 0.0 0
M  V30 14 C 11.7055 10.5376 0.0 0
M  V30 15 C 9.3358 9.7676 0.0 0
M  V30 16 C 10.8003 11.7836 0.0 0
M  V30 17 C 9.3358 11.3076 0.0 0
M  V30 18 C 8.0020 8.9976 0.0 0
M  V30 19 C 8.0020 12.0776 0.0 0
M  V30 20 C 6.6684 9.7676 0.0 0
M  V30 21 C 6.6684 11.3076 0.0 0
M  V30 22 C 13.2455 10.5376 0.0 0
M  V30 23 C 14.0155 9.2040 0.0 0
M  V30 24 C 14.0155 11.8714 0.0 0
M  V30 25 C 15.5555 9.2040 0.0 0
M  V30 26 C 15.5555 11.8714 0.0 0
M  V30 27 C 16.3255 10.5376 0.0 0
M  V30 28 C 2.6673 12.0776 0.0 0
M  V30 29 C 1.3336 11.3076 0.0 0
M  V30 30 C 2.6673 13.6176 0.0 0
M  V30 31 C 0.0000 12.0776 0.0 0
M  V30 32 C 1.3336 14.3876 0.0 0
M  V30 33 C 0.0000 13.6176 0.0 0
M  V30 34 C 20.1755 11.8714 0.0 0
M  V30 35 C 20.9455 10.5376 0.0 0
M  V30 36 C 20.9455 13.2050 0.0 0
M  V30 37 C 22.4855 10.5376 0.0 0
M  V30 38 C 22.4855 13.2050 0.0 0
M  V30 39 C 23.2555 11.8714 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 12 34
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 14 22
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 17
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1973474-24-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1973474-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15986112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antiproliferative and pro-apoptotic activity of
2-phenylindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelly, Patrick M.; Bright, Sandra A.; Fayne, Darren; Pollock, Jade K.;
Zisterer, Daniela M.; Williams, D. Clive; Meegan, Mary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(18), 4075-4099

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-(2-chlorophenyl)-4H-3,1-benzoxazin-4-one
C14H7BrClNO2
198819-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 0.0000 0.0 0
M  V30 2 O 7.7000 0.0000 0.0 0
M  V30 3 Br 11.5500 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 6.9300 1.3338 0.0 0
M  V30 9 C 7.7000 2.6674 0.0 0
M  V30 10 C 7.7000 5.3349 0.0 0
M  V30 11 C 9.2400 2.6674 0.0 0
M  V30 12 C 9.2400 5.3349 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 3.0800 2.6674 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 1.3338 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 2 2 8
M  V30 3 1 3 13
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 5-bromo-2-[(2-chlorobenzoyl)amino]-N-methyl-
C15H12BrClN2O2
2919020-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 6.6684 0.0 0
M  V30 3 O 5.3900 8.0021 0.0 0
M  V30 4 C 6.9300 2.6674 0.0 0
M  V30 5 N 7.7000 1.3336 0.0 0
M  V30 6 O 5.3900 2.6674 0.0 0
M  V30 7 C 6.9300 0.0000 0.0 0
M  V30 8 Br 11.5500 5.3347 0.0 0
M  V30 9 Cl 3.0800 9.3358 0.0 0
M  V30 10 C 6.9300 5.3347 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 7.7000 6.6684 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 9.2400 6.6684 0.0 0
M  V30 15 C 10.0100 5.3347 0.0 0
M  V30 16 C 3.0800 6.6684 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 2.3100 5.3347 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 0.7700 5.3347 0.0 0
M  V30 21 C 0.0000 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 11
M  V30 8 1 5 7
M  V30 9 1 8 15
M  V30 10 1 9 17
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 198819-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2919020-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35751403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of New Quinazolin-4-one Derivatives with Negative
mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaczorowska, Katarzyna; Stankiewicz, Anna; Bugno, Ryszard; Paluchowska,
Maria H.; Burnat, Grzegorz; Branski, Piotr; Cieslik, Paulina; Wieronska,
Joanna M.; Milik, Mariusz; Nowak, Mateusz; Przybylowicz, Agnieszka;
Koziol, Aneta; Hogendorf, Agata; Hogendorf, Adam S.; Kalinowska-Tluscik,
Justyna; Duszynska, Beata; Pilc, Andrzej; Bojarski, Andrzej J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2023), 24(3), 1981

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
4-Methoxy-2′-methyl[1,1′-biphenyl]-2-carboxaldehyde
C15H14O2
2013383-87-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3338 0.0 0
M  V30 2 O 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 6.6687 0.0 0
M  V30 4 O 9.2402 4.0012 0.0 0
M  V30 5 C 10.0102 5.3348 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 C 5.3901 2.6675 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 6.9302 2.6675 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 7.7002 4.0012 0.0 0
M  V30 12 C 3.0801 4.0012 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 0.7700 5.3348 0.0 0
M  V30 16 C 0.7700 2.6675 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,2′-dimethyl[1,1′-biphenyl]-2-carboxamide
C16H17NO2
2097256-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 1.3336 0.0 0
M  V30 3 O 3.0800 2.6674 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 C 3.0800 8.0021 0.0 0
M  V30 6 O 9.2400 5.3347 0.0 0
M  V30 7 C 10.0100 6.6685 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 5.3900 6.6685 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 6.6685 0.0 0
M  V30 13 C 7.7000 5.3347 0.0 0
M  V30 14 C 3.0800 5.3347 0.0 0
M  V30 15 C 2.3100 6.6685 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 0.7700 6.6685 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2013383-87-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2097256-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-211-CAS-17176186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amide-Directed C-H Sodiation by a Sodium Hydride/Iodide Composite
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Yinhua; Chan, Guo Hao; Chiba, Shunsuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(23), 6544-6547

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5H-Bis1,2,3-triazolo[4,5-c:4′,5′-e]azepine-5-acetic acid, 1,4,6,9-tetrahydro-...
C23H23N7O2
2020058-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.1972 0.0 0
M  V30 2 C 5.9884 4.5329 0.0 0
M  V30 3 C 11.2061 10.2179 0.0 0
M  V30 4 C 12.6479 9.6767 0.0 0
M  V30 5 O 13.8374 10.6548 0.0 0
M  V30 6 O 12.9001 8.1575 0.0 0
M  V30 7 C 15.2791 10.1136 0.0 0
M  V30 8 C 6.9216 7.6918 0.0 0
M  V30 9 C 7.8997 6.5023 0.0 0
M  V30 10 N 5.3901 7.5308 0.0 0
M  V30 11 C 7.2418 9.1982 0.0 0
M  V30 12 N 7.4457 5.0308 0.0 0
M  V30 13 C 9.4395 6.5254 0.0 0
M  V30 14 N 4.7636 8.9378 0.0 0
M  V30 15 C 8.6192 9.8871 0.0 0
M  V30 16 N 5.9081 9.9682 0.0 0
M  V30 17 N 8.7051 4.1442 0.0 0
M  V30 18 C 10.3816 7.7437 0.0 0
M  V30 19 N 9.9373 5.0680 0.0 0
M  V30 20 N 10.0164 9.2396 0.0 0
M  V30 21 C 3.0800 6.1972 0.0 0
M  V30 22 C 2.3100 7.5308 0.0 0
M  V30 23 C 2.3100 4.8635 0.0 0
M  V30 24 C 0.7700 7.5308 0.0 0
M  V30 25 C 0.7700 4.8635 0.0 0
M  V30 26 C 0.0000 6.1972 0.0 0
M  V30 27 C 5.6908 3.0220 0.0 0
M  V30 28 C 6.8505 2.0088 0.0 0
M  V30 29 C 4.2334 2.5242 0.0 0
M  V30 30 C 6.5529 0.4977 0.0 0
M  V30 31 C 3.9358 1.0132 0.0 0
M  V30 32 C 5.0955 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 21
M  V30 3 1 2 12
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 1 3 20
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 1 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 2 14 16
M  V30 22 1 15 20
M  V30 23 2 17 19
M  V30 24 1 18 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5H-Bis1,2,3-triazolo[4,5-c:4′,5′-e]azepine-5-acetamide, 1,4,6,9-tetrahydro-N-...
C23H24N8O
2020058-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.1972 0.0 0
M  V30 2 C 5.9884 4.5329 0.0 0
M  V30 3 C 11.2061 10.2179 0.0 0
M  V30 4 C 12.6479 9.6767 0.0 0
M  V30 5 N 13.8374 10.6548 0.0 0
M  V30 6 O 12.9001 8.1575 0.0 0
M  V30 7 C 15.2791 10.1136 0.0 0
M  V30 8 C 6.9216 7.6918 0.0 0
M  V30 9 C 7.8997 6.5023 0.0 0
M  V30 10 N 5.3901 7.5308 0.0 0
M  V30 11 C 7.2418 9.1982 0.0 0
M  V30 12 N 7.4457 5.0308 0.0 0
M  V30 13 C 9.4395 6.5254 0.0 0
M  V30 14 N 4.7636 8.9378 0.0 0
M  V30 15 C 8.6192 9.8871 0.0 0
M  V30 16 N 5.9081 9.9682 0.0 0
M  V30 17 N 8.7051 4.1442 0.0 0
M  V30 18 C 10.3816 7.7437 0.0 0
M  V30 19 N 9.9373 5.0680 0.0 0
M  V30 20 N 10.0164 9.2396 0.0 0
M  V30 21 C 3.0800 6.1972 0.0 0
M  V30 22 C 2.3100 7.5308 0.0 0
M  V30 23 C 2.3100 4.8635 0.0 0
M  V30 24 C 0.7700 7.5308 0.0 0
M  V30 25 C 0.7700 4.8635 0.0 0
M  V30 26 C 0.0000 6.1972 0.0 0
M  V30 27 C 5.6908 3.0220 0.0 0
M  V30 28 C 6.8505 2.0088 0.0 0
M  V30 29 C 4.2334 2.5242 0.0 0
M  V30 30 C 6.5529 0.4977 0.0 0
M  V30 31 C 3.9358 1.0132 0.0 0
M  V30 32 C 5.0955 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 21
M  V30 3 1 2 12
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 1 3 20
M  V30 7 1 4 5
M  V30 8 2 4 6
M  V30 9 1 5 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 13 19
M  V30 21 2 14 16
M  V30 22 1 15 20
M  V30 23 2 17 19
M  V30 24 1 18 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2020058-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2020058-04-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19361967
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Medium Rings Bearing Bitriazolyls: Easily Accessible Structures with
Superior Performance as Cu Catalyst Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Lingjun; Huang, Shenlong; Shang, Tongpeng; Zhang, Bo; Guo, Yuanyang;
Zhu, Gongming; Zhou, Demin; Zhang, Guisheng; Zhu, Anlian; Zhang, Lihe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(21), 13166-13177

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-1-[4-fluoro-3-nitro-5-(trifluoromethyl)benzoyl]-3-p...
C18H21F4N3O5
2048228-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 5.3901 0.0 0
M  V30 2 O 6.6687 6.9302 0.0 0
M  V30 3 C 1.3338 5.3901 0.0 0
M  V30 4 F 2.1038 6.7238 0.0 0
M  V30 5 F 0.0000 6.1601 0.0 0
M  V30 6 F 0.5638 4.0564 0.0 0
M  V30 7 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 8 O 5.3348 0.0000 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 F 1.3338 2.3101 0.0 0
M  V30 11 N 12.0035 5.3901 0.0 0
M  V30 12 C 13.3372 4.6201 0.0 0
M  V30 13 O 14.6708 5.3901 0.0 0
M  V30 14 O 13.3372 3.0801 0.0 0
M  V30 15 C 16.0045 4.6201 0.0 0
M  V30 16 C 15.2345 3.2864 0.0 0
M  V30 17 C 17.3383 3.8501 0.0 0
M  V30 18 C 16.7745 5.9538 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 4.0012 5.3901 0.0 0
M  V30 21 C 5.3348 3.0801 0.0 0
M  V30 22 C 2.6675 4.6201 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 2.6675 3.0801 0.0 0
M  V30 25 N 8.0023 4.6201 0.0 0
M  V30 26 C 9.3360 5.3901 0.0 0
M  V30 27 C 8.0023 3.0801 0.0 0
M  V30 28 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 29 C 9.3360 2.3101 0.0 0
M  V30 30 C 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 22
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 23
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 28 11 CFG=3
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(3R)-1-[4-(methylamino)-3-nitro-5-(trifluoromethyl)benzo...
C19H25F3N4O5
2048228-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 5.3901 0.0 0
M  V30 2 O 6.6687 6.9302 0.0 0
M  V30 3 C 1.3338 5.3901 0.0 0
M  V30 4 F 0.5638 4.0564 0.0 0
M  V30 5 F 0.0000 6.1601 0.0 0
M  V30 6 F 2.1038 6.7238 0.0 0
M  V30 7 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 8 O 5.3348 0.0000 0.0 0
M  V30 9 O 2.6675 0.0000 0.0 0
M  V30 10 N 1.3338 2.3101 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 N 12.0035 5.3901 0.0 0
M  V30 13 C 13.3372 4.6201 0.0 0
M  V30 14 O 14.6708 5.3901 0.0 0
M  V30 15 O 13.3372 3.0801 0.0 0
M  V30 16 C 16.0045 4.6201 0.0 0
M  V30 17 C 15.2345 3.2864 0.0 0
M  V30 18 C 17.3383 3.8501 0.0 0
M  V30 19 C 16.7745 5.9538 0.0 0
M  V30 20 C 5.3348 4.6201 0.0 0
M  V30 21 C 4.0012 5.3901 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 C 2.6675 4.6201 0.0 0
M  V30 24 C 4.0012 2.3101 0.0 0
M  V30 25 C 2.6675 3.0801 0.0 0
M  V30 26 N 8.0023 4.6201 0.0 0
M  V30 27 C 9.3360 5.3901 0.0 0
M  V30 28 C 8.0023 3.0801 0.0 0
M  V30 29 C 10.6697 4.6201 0.0 0 CFG=2
M  V30 30 C 9.3360 2.3101 0.0 0
M  V30 31 C 10.6697 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 23
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 12 13
M  V30 14 1 29 12 CFG=3
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2048228-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2048228-34-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16652567
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as PAD4 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amans, Dominique; Atkinson, Stephen John; Barker, Michael David;
Campbell, Matthew; Diallo, Hawa; Douault, Clement; Garton, Neil Stuart;
Liddle, John; Renaux, Jessica Fanny; Sheppard, Robert John; Walker, Ann
Louise; Wellaway, Christopher Roland; Wilson, David Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016185279 A1 2016-11-24

$RFMT $RIREG SCHEME342 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 3-[[2,6-dichloro-8-(propylamino)pyrimido[5,4-d]pyrimidin-4-yl]ami...
C12H13Cl2F3N6O
2060001-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 C 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 3.8501 0.0 0
M  V30 4 C 1.3338 4.6201 0.0 0
M  V30 5 O 2.6675 2.3101 0.0 0
M  V30 6 F 0.0000 5.3901 0.0 0
M  V30 7 F 2.1038 5.9538 0.0 0
M  V30 8 F 0.5638 3.2864 0.0 0
M  V30 9 N 12.0035 4.6201 0.0 0
M  V30 10 C 13.3372 3.8501 0.0 0
M  V30 11 C 14.6708 4.6201 0.0 0
M  V30 12 C 16.0046 3.8501 0.0 0
M  V30 13 Cl 9.3360 0.0000 0.0 0
M  V30 14 Cl 8.0023 8.4702 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 6.6687 4.6201 0.0 0
M  V30 18 N 8.0023 2.3101 0.0 0
M  V30 19 C 10.6698 3.8501 0.0 0
M  V30 20 N 9.3360 6.1601 0.0 0
M  V30 21 N 6.6687 6.1601 0.0 0
M  V30 22 C 9.3360 1.5400 0.0 0
M  V30 23 N 10.6698 2.3101 0.0 0
M  V30 24 C 8.0023 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 1 9 19
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 22
M  V30 14 1 14 24
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 1 21 24
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 3-[[2,6-bis(methylamino)-8-(propylamino)pyrimido[5,4-d]pyrimidin-...
C14H21F3N8O
2060001-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 4.0012 5.3901 0.0 0
M  V30 3 C 2.6675 4.6201 0.0 0
M  V30 4 C 1.3338 5.3901 0.0 0
M  V30 5 O 2.6675 3.0801 0.0 0
M  V30 6 F 0.0000 6.1601 0.0 0
M  V30 7 F 0.5638 4.0564 0.0 0
M  V30 8 F 2.1038 6.7238 0.0 0
M  V30 9 N 12.0035 5.3901 0.0 0
M  V30 10 C 13.3372 4.6201 0.0 0
M  V30 11 C 14.6708 5.3901 0.0 0
M  V30 12 C 16.0046 4.6201 0.0 0
M  V30 13 N 9.3360 0.7700 0.0 0
M  V30 14 C 10.6698 0.0000 0.0 0
M  V30 15 N 8.0023 9.2402 0.0 0
M  V30 16 C 9.3360 10.0102 0.0 0
M  V30 17 C 8.0023 4.6201 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 6.6687 5.3901 0.0 0
M  V30 20 N 8.0023 3.0801 0.0 0
M  V30 21 C 10.6698 4.6201 0.0 0
M  V30 22 N 9.3360 6.9302 0.0 0
M  V30 23 N 6.6687 6.9302 0.0 0
M  V30 24 C 9.3360 2.3101 0.0 0
M  V30 25 N 10.6698 3.0801 0.0 0
M  V30 26 C 8.0023 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 24
M  V30 15 1 15 16
M  V30 16 1 15 26
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 2 21 25
M  V30 25 2 22 26
M  V30 26 1 23 26
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2060001-91-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2060001-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18357856
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used, product further converted into HCl salt with 76% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[5,4-d]pyrimidine derivatives as novel breathing
control modulating compounds for preventing and/or treating respiratory
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott L.; Mencel, James Joseph; Ozola, Vita; Suna, Edgars; Shubin,
Kirill
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017003822 A1 2017-01-05

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 1-[[2,6-dichloro-8-[(cyclopropylmethyl)amino]pyrimido[5,4-d]pyrim...
C14H18Cl2N6O
2060002-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 4.6201 0.0 0
M  V30 2 C 12.0033 3.8501 0.0 0
M  V30 3 N 4.0010 3.8501 0.0 0
M  V30 4 C 2.6673 4.6201 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 C 0.5637 5.1838 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 O 2.1037 2.5164 0.0 0
M  V30 9 Cl 6.6685 8.4702 0.0 0
M  V30 10 Cl 8.0022 0.0000 0.0 0
M  V30 11 C 8.0022 4.6201 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 N 8.0022 6.1601 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 N 6.6685 2.3101 0.0 0
M  V30 17 N 9.3360 2.3101 0.0 0
M  V30 18 C 6.6685 6.9302 0.0 0
M  V30 19 N 5.3348 6.1601 0.0 0
M  V30 20 C 8.0022 1.5400 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 14.8770 4.6201 0.0 0
M  V30 23 C 14.1070 5.9538 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 18
M  V30 11 1 10 20
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanol, 1-[[8-[(cyclopropylmethyl)amino]-2,6-bis(methylamino)pyrimido[5,4...
C16H26N8O
2060002-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6697 5.3901 0.0 0
M  V30 2 C 12.0033 4.6201 0.0 0
M  V30 3 N 4.0010 4.6201 0.0 0
M  V30 4 C 2.6673 5.3901 0.0 0
M  V30 5 C 1.3337 4.6201 0.0 0
M  V30 6 C 0.5637 5.9538 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 O 2.1037 3.2864 0.0 0
M  V30 9 N 6.6685 9.2402 0.0 0
M  V30 10 C 5.3348 10.0102 0.0 0
M  V30 11 N 8.0022 0.7700 0.0 0
M  V30 12 C 9.3360 0.0000 0.0 0
M  V30 13 C 8.0022 5.3901 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 9.3360 4.6201 0.0 0
M  V30 16 N 8.0022 6.9302 0.0 0
M  V30 17 C 5.3348 5.3901 0.0 0
M  V30 18 N 6.6685 3.0801 0.0 0
M  V30 19 N 9.3360 3.0801 0.0 0
M  V30 20 C 6.6685 7.7002 0.0 0
M  V30 21 N 5.3348 6.9302 0.0 0
M  V30 22 C 8.0022 2.3101 0.0 0
M  V30 23 C 13.3370 5.3901 0.0 0
M  V30 24 C 14.8770 5.3901 0.0 0
M  V30 25 C 14.1070 6.7238 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 23
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 10
M  V30 11 1 9 20
M  V30 12 1 11 12
M  V30 13 1 11 22
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 2 17 21
M  V30 22 2 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2060002-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2060002-28-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18357894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted into HCl salt with 73% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[5,4-d]pyrimidine derivatives as novel breathing
control modulating compounds for preventing and/or treating respiratory
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott L.; Mencel, James Joseph; Ozola, Vita; Suna, Edgars; Shubin,
Kirill
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017003822 A1 2017-01-05

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R)-4-(6-chloro-2-methoxy-4-pyrimidinyl)-2-morpholinecarboxylate
C11H14ClN3O4
2072804-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 3.8500 0.0 0
M  V30 2 O 12.0032 4.6201 0.0 0
M  V30 3 O 10.6695 2.3100 0.0 0
M  V30 4 C 13.3369 3.8500 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8500 0.0 0
M  V30 7 Cl 4.0010 0.0000 0.0 0
M  V30 8 N 6.6684 4.6201 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 9.3359 4.6201 0.0 0 CFG=2
M  V30 12 C 8.0021 6.9301 0.0 0
M  V30 13 O 9.3359 6.1601 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 4.0010 4.6201 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 N 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-4-(6-Chloro-2-methoxy-4-pyrimidinyl)-N-methyl-2-morpholinecarboxamide
C11H15ClN4O3
2072804-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6695 3.8500 0.0 0
M  V30 2 N 12.0032 4.6201 0.0 0
M  V30 3 O 10.6695 2.3100 0.0 0
M  V30 4 C 13.3369 3.8500 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8500 0.0 0
M  V30 7 Cl 4.0010 0.0000 0.0 0
M  V30 8 N 6.6684 4.6201 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 6.6684 6.1601 0.0 0
M  V30 11 C 9.3359 4.6201 0.0 0 CFG=2
M  V30 12 C 8.0021 6.9301 0.0 0
M  V30 13 O 9.3359 6.1601 0.0 0
M  V30 14 C 5.3348 3.8500 0.0 0
M  V30 15 N 4.0010 4.6201 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 17 C 2.6673 3.8500 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 N 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2072804-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2072804-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17449604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds that inhibit LRRK2 kinase activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Xiao; Jin, Yun; Liu, Qian; Ren, Feng; Sang, Yingxia; Stasi, Luigi
Piero; Wan, Zehong; Wang, Hailong; Xing, Weiqiang; Zhan, Yang; Zhao,
Baowei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017012576 A1 2017-01-26

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-hydroxy-4-(4-morpholinyl)benzoate
C12H15NO4
207850-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 0.0000 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 O 10.0102 4.0010 0.0 0
M  V30 4 O 10.0102 1.3337 0.0 0
M  V30 5 C 11.5503 4.0010 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 5.3901 4.0010 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 C 7.7002 2.6673 0.0 0
M  V30 12 N 3.0801 2.6673 0.0 0
M  V30 13 C 2.3101 4.0010 0.0 0
M  V30 14 C 2.3101 1.3337 0.0 0
M  V30 15 C 0.7700 4.0010 0.0 0
M  V30 16 C 0.7700 1.3337 0.0 0
M  V30 17 O 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-N-methyl-4-(4-morpholinyl)benzamide
C12H16N2O3
404009-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7002 0.0000 0.0 0
M  V30 2 C 9.2402 2.6673 0.0 0
M  V30 3 N 10.0102 4.0010 0.0 0
M  V30 4 O 10.0102 1.3337 0.0 0
M  V30 5 C 11.5503 4.0010 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 5.3901 4.0010 0.0 0
M  V30 9 C 6.9302 1.3337 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 C 7.7002 2.6673 0.0 0
M  V30 12 N 3.0801 2.6673 0.0 0
M  V30 13 C 2.3101 4.0010 0.0 0
M  V30 14 C 2.3101 1.3337 0.0 0
M  V30 15 C 0.7700 4.0010 0.0 0
M  V30 16 C 0.7700 1.3337 0.0 0
M  V30 17 O 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 207850-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 404009-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1769140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Hydroxy-N-methy4-morpholin-4-ybenzamide Weinreb Amidation Procedure: To
a cooled (0°C), stirred solution of methylamine in dry tetrahydrofuran
(1.27 mL of 2.0 M solution; 2.52 mmol) was slowly added a solution of
trimethylaluminum in dry toluene (1.27 mL of 2.0 M solution; 2.52 mmol)
via syringe under a nitrogen atmosphere. The resulting solution was
allowed to warm to room temperature and stir for 2 hours. To the
resulting solution, a solution of the 2-hydroxy-4-morpholin-4-ybenzoic
acid methyl ester (100 mg; 0.42 mmol) in dry toluene (4.0 mL) was added
via cannula and the resulting solution was heated to reflux for 2 hours.
After cooling to room temperature, the reaction was quenched with the
careful addition of 1 N aqueous hydrochloric acid to pH 4. The mixture
then was extracted with EtOAc (3 x 10 mL), and the combined organic
layers washed with brine, dried (Na2SO4), filtered and concentrated in
vacuo. The residue was recrystallized from CH2Cl2-hexanes to provide the
amide. yleld 93 mg, 93%. 1Η NMR (CDCl3, 400 MHz, mixture of rotomers): δ
12.60 (s, 1H), 7.20 (d, 1H), 6.38-6.33 (m, 2H), 6.14 (br s, 1H), 3.82 (t,
4H), 3.23 (t, 4H), 2.97 (d, 3H). LRMS (Electrospray, negative): Da/e
235.2 (m-1).
$DTYPE RXN:VAR(1):NOTES
$DATUM Weinreb amidation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylmorpholines as inhibitors of DNA-dependent protein
kinase and methods to potentiate cancer treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halbrook, James; Kesicki, Edward; Burgess, Laurence E.; Schlachter,
Stephen T.; Eary, Charles T.; Schiro, Justin G.; Huang, Hongmei; Evans,
Michael; Han, Yongxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002020500 A2 2002-03-14

$RFMT $RIREG SCHEME346 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-8-[[[(4-chlorophenyl)amino]carbonyl]amino]-3,4-dihydro-2-[[[3...
C28H27Cl2N3O6
2086689-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8806 5.8615 0.0 0
M  V30 2 N 6.7008 4.8716 0.0 0
M  V30 3 O 7.6131 7.3781 0.0 0
M  V30 4 C 9.5951 6.8513 0.0 0
M  V30 5 O 11.0423 7.3781 0.0 0
M  V30 6 O 8.4155 7.8412 0.0 0
M  V30 7 C 11.3096 8.8947 0.0 0
M  V30 8 C 9.5951 1.1508 0.0 0
M  V30 9 C 7.8806 2.1408 0.0 0
M  V30 10 N 13.9478 5.3347 0.0 0
M  V30 11 C 15.4878 5.3347 0.0 0
M  V30 12 N 16.2578 6.6685 0.0 0
M  V30 13 O 16.2578 4.0011 0.0 0
M  V30 14 Cl 13.9478 0.0000 0.0 0
M  V30 15 C 1.4471 3.9452 0.0 0
M  V30 16 O 0.0000 4.4720 0.0 0
M  V30 17 Cl 22.4178 6.6685 0.0 0
M  V30 18 C 9.3278 5.3347 0.0 0
M  V30 19 O 10.8678 5.3347 0.0 0
M  V30 20 C 8.5578 4.0011 0.0 0
M  V30 21 C 11.6378 4.0011 0.0 0
M  V30 22 C 9.3278 2.6674 0.0 0
M  V30 23 C 10.8678 2.6674 0.0 0
M  V30 24 C 13.1778 4.0011 0.0 0
M  V30 25 C 11.6378 1.3338 0.0 0
M  V30 26 C 13.9478 2.6674 0.0 0
M  V30 27 C 13.1778 1.3338 0.0 0
M  V30 28 C 5.2537 5.3983 0.0 0
M  V30 29 C 4.0741 4.4084 0.0 0
M  V30 30 C 4.9864 6.9149 0.0 0
M  V30 31 C 2.6269 4.9351 0.0 0
M  V30 32 C 3.5392 7.4416 0.0 0
M  V30 33 C 2.3594 6.4517 0.0 0
M  V30 34 C 17.7978 6.6685 0.0 0
M  V30 35 C 18.5678 8.0021 0.0 0
M  V30 36 C 18.5678 5.3347 0.0 0
M  V30 37 C 20.1078 8.0021 0.0 0
M  V30 38 C 20.1078 5.3347 0.0 0
M  V30 39 C 20.8778 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 1 8 22
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 34
M  V30 16 1 14 27
M  V30 17 1 15 16
M  V30 18 1 15 31
M  V30 19 1 17 39
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 23
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-8-[[[(4-chlorophenyl)amino]carbonyl]amino]-3,4-dihydro-N′-[3-(hydrox...
C28H28Cl2N4O5
2086689-60-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8806 5.8615 0.0 0
M  V30 2 N 6.7008 4.8716 0.0 0
M  V30 3 O 7.6131 7.3781 0.0 0
M  V30 4 C 9.5951 6.8513 0.0 0
M  V30 5 N 11.0423 7.3781 0.0 0
M  V30 6 O 8.4155 7.8412 0.0 0
M  V30 7 C 11.3096 8.8947 0.0 0
M  V30 8 C 9.5951 1.1508 0.0 0
M  V30 9 C 7.8806 2.1408 0.0 0
M  V30 10 N 13.9478 5.3347 0.0 0
M  V30 11 C 15.4878 5.3347 0.0 0
M  V30 12 N 16.2578 6.6685 0.0 0
M  V30 13 O 16.2578 4.0011 0.0 0
M  V30 14 Cl 13.9478 0.0000 0.0 0
M  V30 15 C 1.4471 3.9452 0.0 0
M  V30 16 O 0.0000 4.4720 0.0 0
M  V30 17 Cl 22.4178 6.6685 0.0 0
M  V30 18 C 9.3278 5.3347 0.0 0
M  V30 19 O 10.8678 5.3347 0.0 0
M  V30 20 C 8.5578 4.0011 0.0 0
M  V30 21 C 11.6378 4.0011 0.0 0
M  V30 22 C 9.3278 2.6674 0.0 0
M  V30 23 C 10.8678 2.6674 0.0 0
M  V30 24 C 13.1778 4.0011 0.0 0
M  V30 25 C 11.6378 1.3338 0.0 0
M  V30 26 C 13.9478 2.6674 0.0 0
M  V30 27 C 13.1778 1.3338 0.0 0
M  V30 28 C 5.2537 5.3983 0.0 0
M  V30 29 C 4.0741 4.4084 0.0 0
M  V30 30 C 4.9864 6.9149 0.0 0
M  V30 31 C 2.6269 4.9351 0.0 0
M  V30 32 C 3.5392 7.4416 0.0 0
M  V30 33 C 2.3594 6.4517 0.0 0
M  V30 34 C 17.7978 6.6685 0.0 0
M  V30 35 C 18.5678 5.3347 0.0 0
M  V30 36 C 18.5678 8.0021 0.0 0
M  V30 37 C 20.1078 5.3347 0.0 0
M  V30 38 C 20.1078 8.0021 0.0 0
M  V30 39 C 20.8778 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 28
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 1 8 22
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 24
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 12 34
M  V30 16 1 14 27
M  V30 17 1 15 16
M  V30 18 1 15 31
M  V30 19 1 17 39
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 21 24
M  V30 26 1 22 23
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2086689-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2086689-60-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16891676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A molecular receptor selective for zwitterionic alanine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rubio, Omayra H.; Taouil, Rachid; Muniz, Francisco M.; Monleon, Laura M.;
Simon, Luis; Sanz, Francisca; Moran, Joaquin R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(2), 477-485

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(phenylmethyl)[1,2,4]triazolo[4,3-a]quinoxalin-1-amine
C16H12ClN5
208921-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6519 5.3302 0.0 0
M  V30 2 C 7.6823 6.4748 0.0 0
M  V30 3 Cl 0.0000 5.3900 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 4.0011 3.0800 0.0 0
M  V30 6 C 2.6674 5.3900 0.0 0
M  V30 7 C 5.1456 5.6504 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 N 2.9876 6.8963 0.0 0
M  V30 11 C 1.3338 4.6200 0.0 0
M  V30 12 N 4.5191 7.0574 0.0 0
M  V30 13 N 1.3338 3.0800 0.0 0
M  V30 14 C 2.6674 0.7700 0.0 0
M  V30 15 C 5.3347 0.7700 0.0 0
M  V30 16 C 4.0011 0.0000 0.0 0
M  V30 17 C 9.1887 6.1546 0.0 0
M  V30 18 C 10.2191 7.2990 0.0 0
M  V30 19 C 9.6646 4.6899 0.0 0
M  V30 20 C 11.7256 6.9788 0.0 0
M  V30 21 C 11.1709 4.3698 0.0 0
M  V30 22 C 12.2014 5.5141 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 17
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 2 6 10
M  V30 11 1 6 11
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 12
M  V30 17 2 11 13
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Methyl-N1-(phenylmethyl)[1,2,4]triazolo[4,3-a]quinoxaline-1,4-diamine
C17H16N6
2529934-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.9856 5.3303 0.0 0
M  V30 2 C 9.0160 6.4748 0.0 0
M  V30 3 N 1.3336 5.3900 0.0 0
M  V30 4 C 0.0000 4.6200 0.0 0
M  V30 5 N 5.3348 4.6200 0.0 0
M  V30 6 C 5.3348 3.0800 0.0 0
M  V30 7 C 4.0011 5.3900 0.0 0
M  V30 8 C 6.4793 5.6505 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 6.6684 2.3100 0.0 0
M  V30 11 C 2.6675 4.6200 0.0 0
M  V30 12 N 4.3213 6.8963 0.0 0
M  V30 13 N 5.8528 7.0574 0.0 0
M  V30 14 N 2.6675 3.0800 0.0 0
M  V30 15 C 4.0011 0.7700 0.0 0
M  V30 16 C 6.6684 0.7700 0.0 0
M  V30 17 C 5.3348 0.0000 0.0 0
M  V30 18 C 10.5224 6.1547 0.0 0
M  V30 19 C 10.9983 4.6899 0.0 0
M  V30 20 C 11.5529 7.2990 0.0 0
M  V30 21 C 12.5047 4.3698 0.0 0
M  V30 22 C 13.0593 6.9789 0.0 0
M  V30 23 C 13.5352 5.5142 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 7 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 2 11 14
M  V30 18 1 12 13
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 208921-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2529934-41-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22845266
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole
derivatives as potent antiproliferative agents via a hybrid pharmacophore
approach
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaneko, Daiki; Ninomiya, Masayuki; Yoshikawa, Rina; Ono, Yukari;
Sonawane, Amol D.; Tanaka, Kaori; Nishina, Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 104104293

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[1-(2-Chloro-4-pyrimidinyl)cyclopropyl]carbonyl]amino]-4-methyl-N-[4-(4-m...
C27H25ClF3N5O3
2095851-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.0041 5.3900 0.0 0
M  V30 2 N 14.6705 4.6200 0.0 0
M  V30 3 O 16.0041 6.9300 0.0 0
M  V30 4 Cl 22.3509 6.4446 0.0 0
M  V30 5 C 14.6705 7.7000 0.0 0
M  V30 6 C 9.3358 4.6200 0.0 0
M  V30 7 N 8.0021 5.3900 0.0 0
M  V30 8 O 9.3358 3.0800 0.0 0
M  V30 9 C 2.6674 5.3900 0.0 0
M  V30 10 F 3.4374 6.7236 0.0 0
M  V30 11 F 1.3338 6.1600 0.0 0
M  V30 12 F 1.8974 4.0564 0.0 0
M  V30 13 C 17.3379 4.6200 0.0 0
M  V30 14 C 16.8111 3.1729 0.0 0
M  V30 15 C 18.3279 3.4404 0.0 0
M  V30 16 C 18.3279 5.7998 0.0 0
M  V30 17 N 19.8444 5.5323 0.0 0
M  V30 18 C 17.8010 7.2468 0.0 0
M  V30 19 C 20.8344 6.7121 0.0 0
M  V30 20 C 18.7909 8.4266 0.0 0
M  V30 21 N 20.3075 8.1591 0.0 0
M  V30 22 C 13.3369 5.3900 0.0 0
M  V30 23 C 12.0032 4.6200 0.0 0
M  V30 24 C 13.3369 6.9300 0.0 0
M  V30 25 C 10.6694 5.3900 0.0 0
M  V30 26 C 12.0032 7.7000 0.0 0
M  V30 27 C 10.6694 6.9300 0.0 0
M  V30 28 C 6.6685 4.6200 0.0 0
M  V30 29 C 5.3347 5.3900 0.0 0
M  V30 30 C 6.6685 3.0800 0.0 0
M  V30 31 C 4.0011 4.6200 0.0 0
M  V30 32 C 5.3347 2.3100 0.0 0
M  V30 33 C 4.0011 3.0800 0.0 0
M  V30 34 N 2.6674 2.3100 0.0 0
M  V30 35 C 1.3338 3.0800 0.0 0
M  V30 36 C 2.6674 0.7700 0.0 0
M  V30 37 C 0.0000 2.3100 0.0 0
M  V30 38 C 1.3338 0.0000 0.0 0
M  V30 39 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 22
M  V30 5 1 4 19
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 25
M  V30 10 1 7 28
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 31
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 33 34
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-[[[1-[2-(methylamino)-4-pyrimidinyl]cyclopropyl]carbonyl]amino]-N-...
C28H29F3N6O3
2095846-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1700 8.0021 0.0 0
M  V30 2 N 14.6300 8.0021 0.0 0
M  V30 3 O 16.9400 6.6684 0.0 0
M  V30 4 N 22.1937 10.2621 0.0 0
M  V30 5 C 23.6408 9.7354 0.0 0
M  V30 6 C 16.1700 5.3347 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 N 9.2400 4.0011 0.0 0
M  V30 9 O 9.2400 6.6684 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 F 3.2864 2.1036 0.0 0
M  V30 12 F 3.8500 0.0000 0.0 0
M  V30 13 F 5.9536 0.5636 0.0 0
M  V30 14 C 16.9400 9.3358 0.0 0
M  V30 15 C 15.7604 10.3257 0.0 0
M  V30 16 C 17.2075 10.8524 0.0 0
M  V30 17 C 18.3871 8.8091 0.0 0
M  V30 18 N 19.5669 9.7990 0.0 0
M  V30 19 C 18.6546 7.2925 0.0 0
M  V30 20 C 21.0139 9.2722 0.0 0
M  V30 21 C 20.1018 6.7657 0.0 0
M  V30 22 N 21.2814 7.7556 0.0 0
M  V30 23 C 13.8600 6.6684 0.0 0
M  V30 24 C 12.3200 6.6684 0.0 0
M  V30 25 C 14.6300 5.3347 0.0 0
M  V30 26 C 11.5500 5.3347 0.0 0
M  V30 27 C 13.8600 4.0011 0.0 0
M  V30 28 C 12.3200 4.0011 0.0 0
M  V30 29 C 7.7000 4.0011 0.0 0
M  V30 30 C 6.9300 2.6674 0.0 0
M  V30 31 C 6.9300 5.3347 0.0 0
M  V30 32 C 5.3900 2.6674 0.0 0
M  V30 33 C 5.3900 5.3347 0.0 0
M  V30 34 C 4.6200 4.0011 0.0 0
M  V30 35 N 3.0800 4.0011 0.0 0
M  V30 36 C 2.3100 5.3347 0.0 0
M  V30 37 C 2.3100 2.6674 0.0 0
M  V30 38 C 0.7700 5.3347 0.0 0
M  V30 39 C 0.7700 2.6674 0.0 0
M  V30 40 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 23
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 29
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 32
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 38 1 34 35
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2095851-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095846-69-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17233426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design, synthesis, and biological evaluation of Pan-Raf
inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhu, Gaoyuan; Zhang, Qing; Duan, Chunqi; Zhang, Yanmin; Zhang,
Zhimin; Zhou, Yujun; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(16), 3455-3465

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[[1-(2-Chloro-4-pyrimidinyl)cyclopropyl]carbonyl]amino]-4-methyl-N-[4-(4-m...
C28H27ClF3N5O3
2097023-25-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1701 8.0022 0.0 0
M  V30 2 N 14.6301 8.0022 0.0 0
M  V30 3 O 16.9401 6.6684 0.0 0
M  V30 4 Cl 22.1937 10.2622 0.0 0
M  V30 5 C 16.1701 5.3348 0.0 0
M  V30 6 C 10.0101 5.3348 0.0 0
M  V30 7 N 9.2401 4.0011 0.0 0
M  V30 8 O 9.2401 6.6684 0.0 0
M  V30 9 C 4.6200 1.3337 0.0 0
M  V30 10 F 3.2862 2.1037 0.0 0
M  V30 11 F 3.8500 0.0000 0.0 0
M  V30 12 F 5.9537 0.5636 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 16.9401 9.3359 0.0 0
M  V30 15 C 15.7603 10.3258 0.0 0
M  V30 16 C 17.2075 10.8525 0.0 0
M  V30 17 C 18.3873 8.8092 0.0 0
M  V30 18 N 19.5669 9.7991 0.0 0
M  V30 19 C 18.6546 7.2926 0.0 0
M  V30 20 C 21.0141 9.2723 0.0 0
M  V30 21 C 20.1018 6.7657 0.0 0
M  V30 22 N 21.2814 7.7557 0.0 0
M  V30 23 C 13.8601 6.6684 0.0 0
M  V30 24 C 12.3201 6.6684 0.0 0
M  V30 25 C 14.6301 5.3348 0.0 0
M  V30 26 C 11.5501 5.3348 0.0 0
M  V30 27 C 13.8601 4.0011 0.0 0
M  V30 28 C 12.3201 4.0011 0.0 0
M  V30 29 C 7.7001 4.0011 0.0 0
M  V30 30 C 6.9301 2.6675 0.0 0
M  V30 31 C 6.9301 5.3348 0.0 0
M  V30 32 C 5.3900 2.6675 0.0 0
M  V30 33 C 5.3900 5.3348 0.0 0
M  V30 34 C 4.6200 4.0011 0.0 0
M  V30 35 N 2.3100 5.3348 0.0 0
M  V30 36 C 3.0800 6.6684 0.0 0
M  V30 37 C 0.7700 5.3348 0.0 0
M  V30 38 C 2.3100 8.0022 0.0 0
M  V30 39 C 0.0000 6.6684 0.0 0
M  V30 40 O 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 23
M  V30 5 1 4 20
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 26
M  V30 10 1 7 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 32
M  V30 15 1 13 34
M  V30 16 1 13 35
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-3-[[[1-[2-(methylamino)-4-pyrimidinyl]cyclopropyl]carbonyl]amino]-N-...
C29H31F3N6O3
2095848-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 16.1700 8.0021 0.0 0
M  V30 2 N 14.6300 8.0021 0.0 0
M  V30 3 O 16.9400 6.6684 0.0 0
M  V30 4 N 22.1937 10.2621 0.0 0
M  V30 5 C 23.6408 9.7354 0.0 0
M  V30 6 C 16.1700 5.3347 0.0 0
M  V30 7 C 10.0100 5.3347 0.0 0
M  V30 8 N 9.2400 4.0011 0.0 0
M  V30 9 O 9.2400 6.6684 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 F 3.2864 2.1036 0.0 0
M  V30 12 F 3.8500 0.0000 0.0 0
M  V30 13 F 5.9536 0.5636 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 16.9400 9.3358 0.0 0
M  V30 16 C 17.2075 10.8524 0.0 0
M  V30 17 C 15.7604 10.3257 0.0 0
M  V30 18 C 18.3871 8.8091 0.0 0
M  V30 19 N 19.5669 9.7990 0.0 0
M  V30 20 C 18.6546 7.2925 0.0 0
M  V30 21 C 21.0139 9.2722 0.0 0
M  V30 22 C 20.1016 6.7657 0.0 0
M  V30 23 N 21.2814 7.7556 0.0 0
M  V30 24 C 13.8600 6.6684 0.0 0
M  V30 25 C 12.3200 6.6684 0.0 0
M  V30 26 C 14.6300 5.3347 0.0 0
M  V30 27 C 11.5500 5.3347 0.0 0
M  V30 28 C 13.8600 4.0011 0.0 0
M  V30 29 C 12.3200 4.0011 0.0 0
M  V30 30 C 7.7000 4.0011 0.0 0
M  V30 31 C 6.9300 2.6674 0.0 0
M  V30 32 C 6.9300 5.3347 0.0 0
M  V30 33 C 5.3900 2.6674 0.0 0
M  V30 34 C 5.3900 5.3347 0.0 0
M  V30 35 C 4.6200 4.0011 0.0 0
M  V30 36 N 2.3100 5.3347 0.0 0
M  V30 37 C 0.7700 5.3347 0.0 0
M  V30 38 C 3.0800 6.6684 0.0 0
M  V30 39 C 0.0000 6.6684 0.0 0
M  V30 40 C 2.3100 8.0021 0.0 0
M  V30 41 O 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 27
M  V30 11 1 8 30
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 33
M  V30 16 1 14 35
M  V30 17 1 14 36
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2097023-25-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2095848-44-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17233428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational design, synthesis, and biological evaluation of Pan-Raf
inhibitors to overcome resistance
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Lu; Zhu, Gaoyuan; Zhang, Qing; Duan, Chunqi; Zhang, Yanmin; Zhang,
Zhimin; Zhou, Yujun; Lu, Tao; Tang, Weifang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2017), 15(16), 3455-3465

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-9-(2-deoxy-α-D-arabino-hexopyranosyl)-6-methoxy-9H-purine
C12H15ClN4O5
2102027-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.1388 5.3256 0.0 0
M  V30 2 C 12.2833 6.3562 0.0 0
M  V30 3 Cl 7.5693 9.2902 0.0 0
M  V30 4 C 1.5400 1.3338 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 N 6.1600 4.0011 0.0 0
M  V30 9 C 7.0652 5.2469 0.0 0
M  V30 10 C 7.0652 2.7552 0.0 0
M  V30 11 C 8.5298 4.7711 0.0 0
M  V30 12 N 6.7450 6.7534 0.0 0
M  V30 13 N 8.5298 3.2311 0.0 0
M  V30 14 C 9.6743 5.8015 0.0 0
M  V30 15 C 7.8894 7.7838 0.0 0
M  V30 16 N 9.3541 7.3079 0.0 0
M  V30 17 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 18 O 3.8500 2.6674 0.0 0
M  V30 19 C 3.8500 5.3347 0.0 0
M  V30 20 C 2.3100 2.6674 0.0 0 CFG=2
M  V30 21 C 2.3100 5.3347 0.0 0 CFG=1
M  V30 22 C 1.5400 4.0011 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 15
M  V30 4 1 4 5
M  V30 5 1 20 4 CFG=3
M  V30 6 1 21 6 CFG=3
M  V30 7 1 22 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 20 21 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-(2-Deoxy-α-D-arabino-hexopyranosyl)-N2,N6-dimethyl-9H-purine-2,6-diamine
C13H20N6O4
2102027-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 11.1388 4.9948 0.0 0
M  V30 2 C 12.2833 3.9644 0.0 0
M  V30 3 N 7.5693 1.0304 0.0 0
M  V30 4 C 8.7138 0.0000 0.0 0
M  V30 5 C 1.5400 8.9868 0.0 0
M  V30 6 O 2.3100 10.3205 0.0 0
M  V30 7 O 1.5400 3.6521 0.0 0
M  V30 8 O 0.0000 6.3194 0.0 0
M  V30 9 N 6.1600 6.3194 0.0 0
M  V30 10 C 7.0652 5.0735 0.0 0
M  V30 11 C 7.0652 7.5654 0.0 0
M  V30 12 C 8.5298 5.5494 0.0 0
M  V30 13 N 6.7450 3.5673 0.0 0
M  V30 14 N 8.5298 7.0894 0.0 0
M  V30 15 C 9.6743 4.5190 0.0 0
M  V30 16 C 7.8894 2.5368 0.0 0
M  V30 17 N 9.3541 3.0127 0.0 0
M  V30 18 C 4.6200 6.3194 0.0 0 CFG=2
M  V30 19 O 3.8500 7.6532 0.0 0
M  V30 20 C 3.8500 4.9858 0.0 0
M  V30 21 C 2.3100 7.6532 0.0 0 CFG=2
M  V30 22 C 2.3100 4.9858 0.0 0 CFG=1
M  V30 23 C 1.5400 6.3194 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 1 21 5 CFG=1
M  V30 7 1 22 7 CFG=1
M  V30 8 1 23 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 18 9 CFG=3
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 18 21 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2102027-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2102027-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17698550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon sealed bomb used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Facile Approaches to 2-Deoxy-D-glucose and
2-Deoxy-α-D-glucopyranonucleosides from D-Glucal
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Wenke; Yang, Hui; Liu, Yingju; Hua, Yingchun; He, Bin; Ning, Xin;
Qin, Zhiyan; Liu, Hong-Min; Liu, Feng-Wu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2017), 49(16), 3686-3691

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-bromo-2-(1-bromoethyl)benzoate
C10H10Br2O2
2121476-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 O 1.5400 5.3349 0.0 0
M  V30 3 O 1.5400 2.6674 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 3.8500 1.3338 0.0 0
M  V30 6 Br 2.3100 1.3338 0.0 0
M  V30 7 C 4.6200 0.0000 0.0 0
M  V30 8 Br 8.4700 4.0011 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 6.1600 2.6674 0.0 0
M  V30 13 C 6.1600 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2,3-dihydro-2,3-dimethyl-1H-isoindol-1-one
C10H10BrNO
1345882-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9694 5.4211 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 0.0000 2.7106 0.0 0
M  V30 4 Br 7.9110 4.2506 0.0 0
M  V30 5 C 3.9099 3.4806 0.0 0
M  V30 6 C 3.9099 1.9406 0.0 0
M  V30 7 C 2.4452 3.9564 0.0 0
M  V30 8 C 5.2435 4.2506 0.0 0
M  V30 9 C 2.4452 1.4647 0.0 0
M  V30 10 C 5.2435 1.1706 0.0 0
M  V30 11 N 1.5400 2.7106 0.0 0
M  V30 12 C 6.5772 3.4806 0.0 0
M  V30 13 C 6.5772 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2121476-33-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1345882-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17456576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzenesulphonamide inhibitors of the cytolytic protein perforin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Spicer, Julie A.; Miller, Christian K.; O'Connor, Patrick D.; Jose,
Jiney; Huttunen, Kristiina M.; Jaiswal, Jagdish K.; Denny, William A.;
Akhlaghi, Hedieh; Browne, Kylie A.; Trapani, Joseph A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(4), 1050-1054

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-bromo-β-oxobenzenepropanoate
C11H11BrO3
21575-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 4.6201 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 O 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 C 10.6697 3.0801 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 Br 0.0000 3.0801 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 0.0000 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(3-bromophenyl)-3-(methylamino)-2-propenoate
C12H14BrNO2
371249-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 6.9300 4.0011 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 8.4700 4.0011 0.0 0
M  V30 7 O 6.1600 5.3347 0.0 0
M  V30 8 C 9.2400 5.3347 0.0 0
M  V30 9 C 10.7800 5.3347 0.0 0
M  V30 10 Br 0.0000 5.3347 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 1.5400 5.3347 0.0 0
M  V30 15 C 3.8500 6.6685 0.0 0
M  V30 16 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21575-91-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371249-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-29218376
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 6-(5-oxazolyl)-4(1H)-quinolinones as inhibitors of IMPDH
enzyme
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iwanowicz, Edwin J.; Watterson, Scott H.; Dhar, T. G. Murali; Pitts,
William J.; Gu, Henry H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001081340 A2 2001-11-01

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1-[(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-4-oxo-2H-1-b...
C19H16O10
2166373-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 3.0800 8.0021 0.0 0
M  V30 4 O 5.3900 9.3358 0.0 0
M  V30 5 C 2.3100 9.3358 0.0 0
M  V30 6 C 0.7700 9.3358 0.0 0
M  V30 7 O 0.0000 8.0021 0.0 0
M  V30 8 O 0.0000 10.6694 0.0 0
M  V30 9 O 6.9300 9.3358 0.0 0
M  V30 10 O 7.7000 0.0000 0.0 0
M  V30 11 O 9.2400 10.6694 0.0 0
M  V30 12 O 4.6200 0.0000 0.0 0
M  V30 13 O 13.8600 8.0021 0.0 0
M  V30 14 C 7.7000 5.3347 0.0 0 CFG=1
M  V30 15 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 16 O 9.2400 5.3347 0.0 0
M  V30 17 C 7.7000 8.0021 0.0 0
M  V30 18 C 10.0100 6.6684 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 11.5500 6.6684 0.0 0
M  V30 21 C 10.0100 9.3358 0.0 0
M  V30 22 C 12.3200 8.0021 0.0 0
M  V30 23 C 11.5500 9.3358 0.0 0
M  V30 24 C 6.9300 4.0011 0.0 0
M  V30 25 C 7.7000 2.6673 0.0 0
M  V30 26 C 5.3900 4.0011 0.0 0
M  V30 27 C 6.9300 1.3336 0.0 0
M  V30 28 C 4.6200 2.6673 0.0 0
M  V30 29 C 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 17
M  V30 10 1 10 27
M  V30 11 1 11 21
M  V30 12 1 12 29
M  V30 13 1 13 22
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 24 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Butanedioic acid, 1-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydrox...
C19H16O10.CH5N
2166373-41-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 8.2084 0.0 0
M  V30 2 C 4.6200 9.5421 0.0 0
M  V30 3 C 3.0800 9.5421 0.0 0
M  V30 4 O 5.3900 10.8758 0.0 0
M  V30 5 C 2.3100 10.8758 0.0 0
M  V30 6 C 0.7700 10.8758 0.0 0
M  V30 7 O 0.0000 9.5421 0.0 0
M  V30 8 O 0.0000 12.2094 0.0 0
M  V30 9 O 6.9300 10.8758 0.0 0
M  V30 10 O 7.7000 1.5400 0.0 0
M  V30 11 O 9.2400 12.2094 0.0 0
M  V30 12 O 4.6200 1.5400 0.0 0
M  V30 13 O 13.8600 9.5421 0.0 0
M  V30 14 C 7.7000 6.8747 0.0 0 CFG=1
M  V30 15 C 6.9300 8.2084 0.0 0 CFG=1
M  V30 16 O 9.2400 6.8747 0.0 0
M  V30 17 C 7.7000 9.5421 0.0 0
M  V30 18 C 10.0100 8.2084 0.0 0
M  V30 19 C 9.2400 9.5421 0.0 0
M  V30 20 C 11.5500 8.2084 0.0 0
M  V30 21 C 10.0100 10.8758 0.0 0
M  V30 22 C 12.3200 9.5421 0.0 0
M  V30 23 C 11.5500 10.8758 0.0 0
M  V30 24 C 6.9300 5.5411 0.0 0
M  V30 25 C 7.7000 4.2073 0.0 0
M  V30 26 C 5.3900 5.5411 0.0 0
M  V30 27 C 6.9300 2.8736 0.0 0
M  V30 28 C 4.6200 4.2073 0.0 0
M  V30 29 C 5.3900 2.8736 0.0 0
M  V30 30 C 6.1600 0.0000 0.0 0
M  V30 31 N 7.7000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 9 17
M  V30 10 1 10 27
M  V30 11 1 11 21
M  V30 12 1 12 29
M  V30 13 1 13 22
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 24 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2166373-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2166373-41-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25230747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM First Ionic Conjugates of Dihydroquercetin Monosuccinate with Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mamontova, N. V.; Chernyak, E. I.; Amosov, E. V.; Gatilov, Yu. V.;
Vinogradova, V. I.; Aripova, S. F.; Morozov, S. V.; Grigor'ev, I. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry of Natural Compounds (2017), 53(6), 1045-1051

$RFMT $RIREG SCHEME354 STEP1
$RXN



  3  1
$MOL
4-[(1,1-Dimethylethoxy)carbonyl]-L-phenylalanine
C14H19NO4
218962-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.7238 0.0 0
M  V30 2 C 2.6673 8.2638 0.0 0 CFG=2
M  V30 3 C 1.3337 9.0338 0.0 0
M  V30 4 N 4.0012 9.0338 0.0 0
M  V30 5 O 0.0000 8.2638 0.0 0
M  V30 6 O 1.3337 10.5739 0.0 0
M  V30 7 C 8.0023 3.6437 0.0 0
M  V30 8 O 8.0023 2.1037 0.0 0
M  V30 9 O 9.3360 4.4137 0.0 0
M  V30 10 C 9.3360 1.3337 0.0 0
M  V30 11 C 10.1060 2.6673 0.0 0
M  V30 12 C 10.6697 0.5637 0.0 0
M  V30 13 C 8.5660 0.0000 0.0 0
M  V30 14 C 4.0012 5.9538 0.0 0
M  V30 15 C 5.3348 6.7238 0.0 0
M  V30 16 C 4.0012 4.4137 0.0 0
M  V30 17 C 6.6685 5.9538 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 C 6.6685 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(2S)-2-[[3-chloro-4-(1-methylethoxy)benzoyl]amino]-3-(me...
C25H31ClN2O5
869566-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 4.0012 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 3 N 6.9302 5.3348 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 N 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 2.6673 0.0 0
M  V30 8 O 4.6201 4.0012 0.0 0
M  V30 9 C 6.9302 0.0000 0.0 0
M  V30 10 C 12.3203 9.3360 0.0 0
M  V30 11 O 13.8603 9.3360 0.0 0
M  V30 12 O 11.5503 10.6697 0.0 0
M  V30 13 C 14.6303 10.6697 0.0 0
M  V30 14 C 15.9640 9.8996 0.0 0
M  V30 15 C 15.4003 12.0033 0.0 0
M  V30 16 C 13.2967 11.4397 0.0 0
M  V30 17 Cl 5.3901 10.6697 0.0 0
M  V30 18 O 2.3101 10.6697 0.0 0
M  V30 19 C 0.7700 10.6697 0.0 0
M  V30 20 C 0.0000 12.0033 0.0 0
M  V30 21 C 0.0000 9.3360 0.0 0
M  V30 22 C 10.0102 5.3348 0.0 0
M  V30 23 C 11.5503 5.3348 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 12.3203 6.6685 0.0 0
M  V30 26 C 10.0102 8.0022 0.0 0
M  V30 27 C 11.5503 8.0022 0.0 0
M  V30 28 C 4.6201 6.6685 0.0 0
M  V30 29 C 5.3901 8.0022 0.0 0
M  V30 30 C 3.0801 6.6685 0.0 0
M  V30 31 C 4.6201 9.3360 0.0 0
M  V30 32 C 2.3101 8.0022 0.0 0
M  V30 33 C 3.0801 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 28
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 31
M  V30 19 1 18 19
M  V30 20 1 18 33
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 218962-77-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869566-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7990424
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of amino acid 64 (2.20 g, 8.27 mmol), pentafluorophenyl ester
28 (3.0 g, 7.88 mmol), diisopropylethylamine (5.5 mL, 31.5 mmol), and DMF
(30 mL) was stirred at 23°C. After 18 hours, H2NMe (2.0 M in THF, 3.94
mL), O-benzotriazole-N,N,N',N'-tetramethyluronium- hexafluorophosphate
(HBTU, 6.0 g, 15.76 mmol) was added. After 4 hours, the reaction solution
was dissolved in EtOAc (200 mL), washed with brine (3x200 mL), and
concentrated in vacuo. The resulting residue was purified by column
chromatography (silica gel, 2:1 EtOAc:hexanes) to give amide 30. Yield
3.5 g (93%) LRMS (M+H+) m/z 475.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino acid-related imidazopyridine benzamide derivatives
as anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew I.; Zhou, Han-Jie; Ashcraft, Luke W.;
Yao, Bing; Jiang, Hong; Huang, Jennifer Kuo Chen; Wang, Jianchao;
Morgans, David J., Jr.; Morgan, Bradley P.; Bergnes, Gustave; Dhanak,
Dashyant; Knight, Steven D.; Adams, Nicholas D.; Parrish, Cynthia A.;
Duffy, Kevin; Fitch, Duke; Tedesco, Rosanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7618981 B2 2009-11-17

$RFMT $RIREG SCHEME354 STEP1
$RXN



  3  1
$MOL
4-[(1,1-Dimethylethoxy)carbonyl]-L-phenylalanine
C14H19NO4
218962-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.7238 0.0 0
M  V30 2 C 2.6673 8.2638 0.0 0 CFG=2
M  V30 3 C 1.3337 9.0338 0.0 0
M  V30 4 N 4.0012 9.0338 0.0 0
M  V30 5 O 0.0000 8.2638 0.0 0
M  V30 6 O 1.3337 10.5739 0.0 0
M  V30 7 C 8.0023 3.6437 0.0 0
M  V30 8 O 8.0023 2.1037 0.0 0
M  V30 9 O 9.3360 4.4137 0.0 0
M  V30 10 C 9.3360 1.3337 0.0 0
M  V30 11 C 10.1060 2.6673 0.0 0
M  V30 12 C 10.6697 0.5637 0.0 0
M  V30 13 C 8.5660 0.0000 0.0 0
M  V30 14 C 4.0012 5.9538 0.0 0
M  V30 15 C 5.3348 6.7238 0.0 0
M  V30 16 C 4.0012 4.4137 0.0 0
M  V30 17 C 6.6685 5.9538 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 C 6.6685 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(2S)-2-[[3-chloro-4-(1-methylethoxy)benzoyl]amino]-3-(me...
C25H31ClN2O5
869566-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 4.0012 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 3 N 6.9302 5.3348 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 N 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 2.6673 0.0 0
M  V30 8 O 4.6201 4.0012 0.0 0
M  V30 9 C 6.9302 0.0000 0.0 0
M  V30 10 C 12.3203 9.3360 0.0 0
M  V30 11 O 13.8603 9.3360 0.0 0
M  V30 12 O 11.5503 10.6697 0.0 0
M  V30 13 C 14.6303 10.6697 0.0 0
M  V30 14 C 15.9640 9.8996 0.0 0
M  V30 15 C 15.4003 12.0033 0.0 0
M  V30 16 C 13.2967 11.4397 0.0 0
M  V30 17 Cl 5.3901 10.6697 0.0 0
M  V30 18 O 2.3101 10.6697 0.0 0
M  V30 19 C 0.7700 10.6697 0.0 0
M  V30 20 C 0.0000 12.0033 0.0 0
M  V30 21 C 0.0000 9.3360 0.0 0
M  V30 22 C 10.0102 5.3348 0.0 0
M  V30 23 C 11.5503 5.3348 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 12.3203 6.6685 0.0 0
M  V30 26 C 10.0102 8.0022 0.0 0
M  V30 27 C 11.5503 8.0022 0.0 0
M  V30 28 C 4.6201 6.6685 0.0 0
M  V30 29 C 5.3901 8.0022 0.0 0
M  V30 30 C 3.0801 6.6685 0.0 0
M  V30 31 C 4.6201 9.3360 0.0 0
M  V30 32 C 2.3101 8.0022 0.0 0
M  V30 33 C 3.0801 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 28
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 31
M  V30 19 1 18 19
M  V30 20 1 18 33
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 218962-77-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869566-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3893748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of amino acid 64 (2.20 g, 8.27 mmol), pentafluorophenyl ester
28 (3.0 g, 7.88 mmol), diisopropylethylamine (5.5 mL, 31.5 mmol), and DMF
(30 mL) was stirred at 23°C. After 18 hours, H2NMe (2.0 M in THF, 3.94
mL), O-benzotriazole-N,N,N',N'-tetramethyl-uroniumhexafluorophosphate
(HBTU, 6.0 g, 15.76 mmol) was added. After 4 hours, the reaction solution
was dissolved in EtOAc (200 mL), washed with brine (3x200 mL), and
concentrated in vacuo. The resulting residue was purified by column
chromatography (silica gel, 2:1 EtOAc:hexanes) to give 3.5 g (93%) of
amide 30. Example 39, compound 30, yield 3.5 g (93%) LRMS (M+H+) m/z
475.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-chloro-4-isopropoxybenzamide and
3-cyano-4-isopropoxybenzamide derivatives as inhibitors of mitotic
kinesins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; Ashcraft, Luke W.; Wang, Jianchao; Yao, Bing; Jiang,
Hong; Bergnes, Gustave; Morgan, Bradley P.; Morgans, David J.; Dhanak,
Dashyant; Knight, Steven D.; Adams, Nicholas D.; Parrish, Cynthia A.;
Duffy, Kevin J.; Fitch, Duke; Tedesco, Rosanna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070149516 A1 2007-06-28

$RFMT $RIREG SCHEME354 STEP1
$RXN



  3  1
$MOL
4-[(1,1-Dimethylethoxy)carbonyl]-L-phenylalanine
C14H19NO4
218962-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 6.7238 0.0 0
M  V30 2 C 2.6673 8.2638 0.0 0 CFG=2
M  V30 3 C 1.3337 9.0338 0.0 0
M  V30 4 N 4.0012 9.0338 0.0 0
M  V30 5 O 0.0000 8.2638 0.0 0
M  V30 6 O 1.3337 10.5739 0.0 0
M  V30 7 C 8.0023 3.6437 0.0 0
M  V30 8 O 8.0023 2.1037 0.0 0
M  V30 9 O 9.3360 4.4137 0.0 0
M  V30 10 C 9.3360 1.3337 0.0 0
M  V30 11 C 10.1060 2.6673 0.0 0
M  V30 12 C 10.6697 0.5637 0.0 0
M  V30 13 C 8.5660 0.0000 0.0 0
M  V30 14 C 4.0012 5.9538 0.0 0
M  V30 15 C 5.3348 6.7238 0.0 0
M  V30 16 C 4.0012 4.4137 0.0 0
M  V30 17 C 6.6685 5.9538 0.0 0
M  V30 18 C 5.3348 3.6437 0.0 0
M  V30 19 C 6.6685 4.4137 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[(2S)-2-[[3-chloro-4-(1-methylethoxy)benzoyl]amino]-3-(me...
C25H31ClN2O5
869566-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 4.0012 0.0 0
M  V30 2 C 7.7002 4.0012 0.0 0 CFG=1
M  V30 3 N 6.9302 5.3348 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 5.3901 5.3348 0.0 0
M  V30 6 N 7.7002 1.3337 0.0 0
M  V30 7 O 5.3901 2.6673 0.0 0
M  V30 8 O 4.6201 4.0012 0.0 0
M  V30 9 C 6.9302 0.0000 0.0 0
M  V30 10 C 12.3203 9.3360 0.0 0
M  V30 11 O 13.8603 9.3360 0.0 0
M  V30 12 O 11.5503 10.6697 0.0 0
M  V30 13 C 14.6303 10.6697 0.0 0
M  V30 14 C 15.9640 9.8996 0.0 0
M  V30 15 C 15.4003 12.0033 0.0 0
M  V30 16 C 13.2967 11.4397 0.0 0
M  V30 17 Cl 5.3901 10.6697 0.0 0
M  V30 18 O 2.3101 10.6697 0.0 0
M  V30 19 C 0.7700 10.6697 0.0 0
M  V30 20 C 0.0000 12.0033 0.0 0
M  V30 21 C 0.0000 9.3360 0.0 0
M  V30 22 C 10.0102 5.3348 0.0 0
M  V30 23 C 11.5503 5.3348 0.0 0
M  V30 24 C 9.2402 6.6685 0.0 0
M  V30 25 C 12.3203 6.6685 0.0 0
M  V30 26 C 10.0102 8.0022 0.0 0
M  V30 27 C 11.5503 8.0022 0.0 0
M  V30 28 C 4.6201 6.6685 0.0 0
M  V30 29 C 5.3901 8.0022 0.0 0
M  V30 30 C 3.0801 6.6685 0.0 0
M  V30 31 C 4.6201 9.3360 0.0 0
M  V30 32 C 2.3101 8.0022 0.0 0
M  V30 33 C 3.0801 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 28
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 27
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 31
M  V30 19 1 18 19
M  V30 20 1 18 33
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 218962-77-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869566-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15489700
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A solution of amino acid 64 (2.20 g, 8.27 mmol), pentafluorophenyl ester
28 (3.0 g, 7.88 mmol), diisopropylethylamine (5.5 mL, 31.5 mmol), and DMF
(30 mL) was stirred at 23°C. After 18 hours, H2NMe (2.0 M in THF, 3.94
mL), O-benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate
(HBTU, 6.0 g, 15.76 mmol) was added. After 4 hours, the reaction solution
was dissolved in EtOAc (200 mL), washed with brine (3 x 200 mL), and
concentrated in vacuo. The resulting residue was purified by column
chromatography (silica gel, 2:1 EtOAc:hexanes) to give 3.5 g (93%) of
amide 30. 30 yield 3.5 g (93%) LRMS (M+H+) m/z 475.2.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino acid-related compounds for treating cellular
proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew I.; Zhou, Han-Jie; Ashcraft, Luke W.;
Yao, Bing; Jiang, Hong; Huang, Jennifer Kuo Chen; Wang, Jianchao;
Morgans, David J., Jr.; Morgan, Bradley P.; Bergnes, Gustave; Dhanak,
Dashyant; Knight, Steven D.; Adams, Nicholas D.; Parrish, Cynthia A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005107762 A2 2005-11-17

$RFMT $RIREG SCHEME355 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)-2-propanone
C9H9BrO
21906-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 C 6.6685 0.7700 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(3-bromophenyl)-1-methylethyl]-N-methylcarbamate
C15H22BrNO2
2055845-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 5.3348 1.5400 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 O 2.6673 1.5400 0.0 0
M  V30 8 O 4.0010 3.8501 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 0.5637 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 Br 13.3370 1.5400 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21906-32-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055845-58-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17229329
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal
Nitric Oxide Synthase Leading to the Development of Potent and Selective
2-Aminoquinoline Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cinelli, Maris A.; Li, Huiying; Chreifi, Georges; Poulos, Thomas L.;
Silverman, Richard B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(9), 3958-3978

$RFMT $RIREG SCHEME355 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)-2-propanone
C9H9BrO
21906-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 2.3100 0.0 0
M  V30 3 C 6.6685 0.7700 0.0 0
M  V30 4 O 8.0021 3.0800 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3336 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-(3-bromophenyl)-1-methylethyl]-N-methylcarbamate
C15H22BrNO2
2055845-58-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 5.3348 1.5400 0.0 0
M  V30 4 C 6.6685 3.8501 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 O 2.6673 1.5400 0.0 0
M  V30 8 O 4.0010 3.8501 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 0.5637 0.9764 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 2.1037 3.6437 0.0 0
M  V30 13 Br 13.3370 1.5400 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6697 1.5400 0.0 0
M  V30 16 C 9.3360 3.8501 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21906-32-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2055845-58-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-17439165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-Aminoquinoline-Based Compounds for Potent and Selective
Neuronal Nitric Oxide Synthase Inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Silverman, Richard B.; Cinelli, Maris A.; Pensa, Anthony V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160368877 A1 2016-12-22

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-α-[(1E)-2-(4-methylphenyl)ethenyl]-2-(methylthio)-5-pyrimidineme...
C15H14Cl2N2OS
2200240-46-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0 CFG=3
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 Cl 4.0010 0.0000 0.0 0
M  V30 6 Cl 6.6685 4.6201 0.0 0
M  V30 7 S 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 C 14.6707 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 N 2.6673 2.3101 0.0 0
M  V30 14 N 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 12.0033 1.5400 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 2.3101 0.0 0
M  V30 21 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 4 16
M  V30 6 1 5 11
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-α-[(1E)-2-(4-methylphenyl)ethenyl]-2-(methylthio)-5-...
C16H18ClN3OS
2200240-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 0.7700 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0 CFG=3
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 Cl 5.3348 5.3901 0.0 0
M  V30 8 S 0.0000 5.3901 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 C 13.3370 5.3901 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 N 1.3337 3.0801 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 N 2.6673 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 12.0033 3.0801 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 6 17
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 1 8 15
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2200240-46-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2200240-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18498337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 7,8-dihydropyrido[2,3-d]pyrimidine derivatives from
4,6-dichloro-2-(methylsulfanyl)pyrimidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Nozawa, Ippei; Ueyama, Takuma; Utsumi, Hiroaki;
Hiyoshi, Hidetaka; Umezu, Kazuto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2017), 94(8), 1427-1438

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-α-[(1E)-2-(4-chlorophenyl)ethenyl]-2-(methylthio)-5-pyrimidineme...
C14H11Cl3N2OS
2200240-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0 CFG=3
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 Cl 4.0010 0.0000 0.0 0
M  V30 6 Cl 6.6685 4.6201 0.0 0
M  V30 7 S 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8501 0.0 0
M  V30 9 Cl 14.6707 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 N 2.6673 2.3101 0.0 0
M  V30 14 N 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 12.0033 1.5400 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 20 C 13.3370 2.3101 0.0 0
M  V30 21 C 13.3370 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 4 16
M  V30 6 1 5 11
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-α-[(1E)-2-(4-chlorophenyl)ethenyl]-6-(methylamino)-2-(methylthio)-5-...
C15H15Cl2N3OS
2200240-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6673 0.7700 0.0 0
M  V30 2 C 1.3337 0.0000 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0 CFG=3
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 Cl 5.3348 5.3901 0.0 0
M  V30 8 S 0.0000 5.3901 0.0 0
M  V30 9 C 0.0000 6.9302 0.0 0
M  V30 10 Cl 13.3370 5.3901 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 3.0801 0.0 0
M  V30 13 N 1.3337 3.0801 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 N 2.6673 5.3901 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 9.3360 4.6201 0.0 0
M  V30 19 C 10.6697 2.3101 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 12.0033 3.0801 0.0 0
M  V30 22 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 12
M  V30 6 2 4 6
M  V30 7 1 6 17
M  V30 8 1 7 14
M  V30 9 1 8 9
M  V30 10 1 8 15
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2200240-47-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2200240-54-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18498340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 7,8-dihydropyrido[2,3-d]pyrimidine derivatives from
4,6-dichloro-2-(methylsulfanyl)pyrimidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Nozawa, Ippei; Ueyama, Takuma; Utsumi, Hiroaki;
Hiyoshi, Hidetaka; Umezu, Kazuto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2017), 94(8), 1427-1438

$RFMT $RIREG SCHEME358 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-methoxy-β-oxobenzenepropanoate
C11H12O4
22027-50-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 O 10.6697 2.3101 0.0 0
M  V30 6 O 9.3360 0.0000 0.0 0
M  V30 7 C 12.0033 1.5400 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 C 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(4-methoxyphenyl)-3-(methylamino)-2-propenoate
C12H15NO3
2304416-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6675 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 O 1.5400 2.6675 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 O 10.7801 2.6675 0.0 0
M  V30 10 C 11.5501 4.0011 0.0 0
M  V30 11 C 6.1601 2.6675 0.0 0
M  V30 12 C 6.9301 4.0011 0.0 0
M  V30 13 C 6.9301 1.3338 0.0 0
M  V30 14 C 8.4701 4.0011 0.0 0
M  V30 15 C 8.4701 1.3338 0.0 0
M  V30 16 C 9.2401 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22027-50-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-12-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946804
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclohexylmethyl)-3-methyl-2-oxiranecarboxamide
C11H19NO2
2211036-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 10.8760 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 9.5424 2.3101 0.0 0
M  V30 8 O 8.7723 3.6437 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 9
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Cyclohexylmethyl)-2-hydroxy-3-(methylamino)butanamide
C12H24N2O2
2211040-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 C 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 N 10.6697 2.3101 0.0 0
M  V30 9 C 9.3360 4.6201 0.0 0
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 2.6673 0.7700 0.0 0
M  V30 13 C 1.3337 3.0801 0.0 0
M  V30 14 C 1.3337 0.0000 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2211036-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2211040-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-19112994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM β-Oxocarboxamides as antiviral agents and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fischl, Wolfgang; Whittaker, Mark; Yarnold, Christopher John; Pons,
Jean-Francois; Kerry, Mark Anthony; Amouzegh, Patricia Leonie; Morao,
Inaki; Ingram, Peter Neville; Chudyk, Ewa Iwona
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018050631 A1 2018-03-22

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-benzoyl-5-(1-hydroxyethylidene)-4-methyl-1,3-cyclopentadiene-1-carbox...
C18H18O4
2227466-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5803 3.8987 0.0 0
M  V30 2 O 3.4856 2.6529 0.0 0
M  V30 3 O 1.0488 3.7378 0.0 0
M  V30 4 C 2.8592 1.2459 0.0 0
M  V30 5 C 3.7645 0.0000 0.0 0
M  V30 6 C 0.9051 6.8003 0.0 0
M  V30 7 C 0.2787 8.2071 0.0 0
M  V30 8 O 0.0000 5.5544 0.0 0
M  V30 9 C 3.1471 9.2903 0.0 0
M  V30 10 C 6.2079 7.9275 0.0 0
M  V30 11 O 6.2079 9.4675 0.0 0
M  V30 12 C 3.2068 5.3056 0.0 0
M  V30 13 C 2.4368 6.6394 0.0 0
M  V30 14 C 4.7131 5.6259 0.0 0
M  V30 15 C 3.4672 7.7838 0.0 0
M  V30 16 C 4.8741 7.1575 0.0 0
M  V30 17 C 7.5415 7.1575 0.0 0
M  V30 18 C 7.5415 5.6174 0.0 0
M  V30 19 C 8.8752 7.9275 0.0 0
M  V30 20 C 8.8752 4.8474 0.0 0
M  V30 21 C 10.2089 7.1575 0.0 0
M  V30 22 C 10.2089 5.6174 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 13 CFG=2
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 16
M  V30 12 1 10 17
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (5Z)-3-benzoyl-4-methyl-5-[1-(methylamino)ethylidene]-1,3-cyclopentadie...
C19H21NO3
2227466-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6285 3.8987 0.0 0
M  V30 2 O 6.7233 2.6528 0.0 0
M  V30 3 O 9.1600 3.7378 0.0 0
M  V30 4 C 7.3497 1.2459 0.0 0
M  V30 5 C 6.4445 0.0000 0.0 0
M  V30 6 C 9.3037 6.8003 0.0 0
M  V30 7 N 10.2090 5.5544 0.0 0
M  V30 8 C 9.9301 8.2071 0.0 0
M  V30 9 C 11.7405 5.7153 0.0 0
M  V30 10 C 7.0619 9.2902 0.0 0
M  V30 11 C 4.0011 7.9274 0.0 0
M  V30 12 O 4.0011 9.4674 0.0 0
M  V30 13 C 7.0022 5.3055 0.0 0
M  V30 14 C 7.7722 6.6393 0.0 0
M  V30 15 C 5.4957 5.6258 0.0 0
M  V30 16 C 6.7416 7.7837 0.0 0
M  V30 17 C 5.3348 7.1574 0.0 0
M  V30 18 C 2.6673 7.1574 0.0 0
M  V30 19 C 1.3337 7.9274 0.0 0
M  V30 20 C 2.6673 5.6174 0.0 0
M  V30 21 C 0.0000 7.1574 0.0 0
M  V30 22 C 1.3337 4.8474 0.0 0
M  V30 23 C 0.0000 5.6174 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 14
M  V30 9 1 7 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 17
M  V30 13 1 11 18
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227466-92-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2227466-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22120899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ethyl 6-Hydroxyfulvene-1-Carboxylate: A Reagent Discriminating Primary
Amines from Secondary Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Sen; Lu, Dengfu; Zhu, Yuequan; Shi, Mei; Luo, Fan; Gong, Yuefa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2018), 83(12), 6681-6689

$RFMT $RIREG SCHEME361 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-N-[3-(2-Cyclopropyl-5-thiazolyl)phenyl]-N-[[trans-4-[6-(dimethylamino)-...
C33H42N4O2S
2244440-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.4700 6.6685 0.0 0
M  V30 2 C 9.2400 5.3347 0.0 0
M  V30 3 C 6.9300 6.6685 0.0 0
M  V30 4 O 10.7801 5.3347 0.0 0
M  V30 5 O 6.1600 0.0000 0.0 0
M  V30 6 N 1.5400 16.0042 0.0 0
M  V30 7 C 0.0000 16.0042 0.0 0
M  V30 8 C 2.3100 17.3380 0.0 0
M  V30 9 C 9.2400 8.0022 0.0 0
M  V30 10 C 10.7801 8.0022 0.0 0
M  V30 11 C 8.4700 9.3358 0.0 0
M  V30 12 C 11.5501 9.3358 0.0 0
M  V30 13 C 9.2400 10.6695 0.0 0
M  V30 14 C 10.7801 10.6695 0.0 0
M  V30 15 C 8.4700 4.0011 0.0 0 CFG=1
M  V30 16 C 9.2400 2.6674 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 8.4700 1.3338 0.0 0
M  V30 19 C 6.1600 2.6674 0.0 0
M  V30 20 C 6.9300 1.3338 0.0 0 CFG=1
M  V30 21 C 6.1600 8.0022 0.0 0 CFG=1
M  V30 22 C 4.6200 8.0022 0.0 0
M  V30 23 C 6.9300 9.3358 0.0 0
M  V30 24 C 3.8500 9.3358 0.0 0
M  V30 25 C 6.1600 10.6695 0.0 0
M  V30 26 C 4.6200 10.6695 0.0 0 CFG=1
M  V30 27 C 13.0901 9.3358 0.0 0
M  V30 28 S 13.9953 10.5817 0.0 0
M  V30 29 C 13.9953 8.0900 0.0 0
M  V30 30 C 15.4600 10.1058 0.0 0
M  V30 31 N 15.4600 8.5658 0.0 0
M  V30 32 C 3.8500 12.0033 0.0 0
M  V30 33 C 2.3100 12.0033 0.0 0
M  V30 34 C 4.6200 13.3369 0.0 0
M  V30 35 C 1.5400 13.3369 0.0 0
M  V30 36 N 3.8500 14.6706 0.0 0
M  V30 37 C 2.3100 14.6706 0.0 0
M  V30 38 C 16.7059 11.0111 0.0 0
M  V30 39 C 17.3322 12.4179 0.0 0
M  V30 40 C 18.2374 11.1720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 15 2 CFG=3
M  V30 6 1 21 3 CFG=3
M  V30 7 1 20 5 CFG=1
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 37
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 12 27
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 26 32 CFG=1
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 31
M  V30 36 1 30 38
M  V30 37 1 32 33
M  V30 38 2 32 34
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 37
M  V30 43 1 38 39
M  V30 44 1 38 40
M  V30 45 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 15 20 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-N-[3-(2-Cyclopropyl-5-thiazolyl)phenyl]-N-[[trans-4-[6-(dimethylamino)-...
C35H45N5O3S
2244433-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.6694 9.7673 0.0 0
M  V30 2 C 12.0031 8.9973 0.0 0
M  V30 3 C 10.6694 11.3073 0.0 0
M  V30 4 O 12.0031 7.4573 0.0 0
M  V30 5 O 17.3378 12.0773 0.0 0
M  V30 6 C 18.6716 11.3073 0.0 0
M  V30 7 N 20.0052 12.0773 0.0 0
M  V30 8 O 18.6716 9.7673 0.0 0
M  V30 9 C 21.3389 11.3073 0.0 0
M  V30 10 N 1.3336 16.6973 0.0 0
M  V30 11 C 0.0000 15.9273 0.0 0
M  V30 12 C 1.3336 18.2373 0.0 0
M  V30 13 C 9.3358 8.9973 0.0 0
M  V30 14 C 9.3358 7.4573 0.0 0
M  V30 15 C 8.0020 9.7673 0.0 0
M  V30 16 C 8.0020 6.6873 0.0 0
M  V30 17 C 6.6684 8.9973 0.0 0
M  V30 18 C 6.6684 7.4573 0.0 0
M  V30 19 C 13.3369 9.7673 0.0 0 CFG=1
M  V30 20 C 13.3369 11.3073 0.0 0
M  V30 21 C 14.6705 8.9973 0.0 0
M  V30 22 C 14.6705 12.0773 0.0 0
M  V30 23 C 16.0041 9.7673 0.0 0
M  V30 24 C 16.0041 11.3073 0.0 0 CFG=1
M  V30 25 C 9.3358 12.0773 0.0 0 CFG=1
M  V30 26 C 8.0020 11.3073 0.0 0
M  V30 27 C 9.3358 13.6173 0.0 0
M  V30 28 C 6.6684 12.0773 0.0 0
M  V30 29 C 8.0020 14.3873 0.0 0
M  V30 30 C 6.6684 13.6173 0.0 0 CFG=1
M  V30 31 C 8.0020 5.1473 0.0 0
M  V30 32 S 6.7561 4.2421 0.0 0
M  V30 33 C 9.2480 4.2421 0.0 0
M  V30 34 C 7.2320 2.7774 0.0 0
M  V30 35 N 8.7720 2.7774 0.0 0
M  V30 36 C 5.3347 14.3873 0.0 0
M  V30 37 C 4.0011 13.6173 0.0 0
M  V30 38 C 5.3347 15.9273 0.0 0
M  V30 39 C 2.6673 14.3873 0.0 0
M  V30 40 N 4.0011 16.6973 0.0 0
M  V30 41 C 2.6673 15.9273 0.0 0
M  V30 42 C 6.3269 1.5315 0.0 0
M  V30 43 C 6.1659 0.0000 0.0 0
M  V30 44 C 4.9200 0.9052 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 1 19 2 CFG=3
M  V30 6 1 25 3 CFG=3
M  V30 7 1 5 6
M  V30 8 1 24 5 CFG=1
M  V30 9 1 6 7
M  V30 10 2 6 8
M  V30 11 1 7 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 41
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 31
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 30 36 CFG=1
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 34 42
M  V30 41 1 36 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 41
M  V30 47 1 42 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 19 24 25 30)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244440-89-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2244433-55-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28910747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclohexanecarboxamides as farnesoid X receptor agonists and their
preparation and use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Nicholas D.; Govek, Steven P.; Nagasawa, Johnny Y.; Douglas,
Karensa L.; Lai, Andiliy G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018170182 A1 2018-09-20

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL

C24H33IO6
2252226-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 5.3900 0.0 0
M  V30 2 C 4.0011 4.6200 0.0 0 CFG=1
M  V30 3 C 4.0011 3.0800 0.0 0
M  V30 4 C 2.6674 5.3900 0.0 0
M  V30 5 O 2.6674 6.9300 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 I 8.0021 6.9300 0.0 0
M  V30 8 O 10.6696 5.3900 0.0 0
M  V30 9 C 12.0032 4.6200 0.0 0 CFG=1
M  V30 10 C 12.0032 3.0800 0.0 0
M  V30 11 C 13.3369 5.3900 0.0 0
M  V30 12 O 13.3369 6.9300 0.0 0
M  V30 13 O 14.6705 4.6200 0.0 0
M  V30 14 C 6.6685 4.6200 0.0 0
M  V30 15 C 8.0021 5.3900 0.0 0
M  V30 16 C 6.6685 3.0800 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 18 C 8.0021 2.3100 0.0 0
M  V30 19 C 9.3358 3.0800 0.0 0
M  V30 20 C 2.6674 2.3100 0.0 0
M  V30 21 C 2.6674 0.7700 0.0 0
M  V30 22 C 1.3338 3.0800 0.0 0
M  V30 23 C 1.3338 0.0000 0.0 0
M  V30 24 C 0.0000 2.3100 0.0 0
M  V30 25 C 0.0000 0.7700 0.0 0
M  V30 26 C 13.3369 2.3100 0.0 0
M  V30 27 C 14.6705 3.0800 0.0 0
M  V30 28 C 13.3369 0.7700 0.0 0
M  V30 29 C 16.0043 2.3100 0.0 0
M  V30 30 C 14.6705 0.0000 0.0 0
M  V30 31 C 16.0043 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3 CFG=3
M  V30 4 1 2 4
M  V30 5 1 3 20
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 1 8 17
M  V30 11 1 9 10 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 26
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H39IN2O4
2252226-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6684 0.0 0
M  V30 2 C 3.8500 8.0020 0.0 0 CFG=1
M  V30 3 C 4.6200 9.3358 0.0 0
M  V30 4 C 2.3100 8.0020 0.0 0
M  V30 5 N 1.5400 6.6684 0.0 0
M  V30 6 O 1.5400 9.3358 0.0 0
M  V30 7 C 0.0000 6.6684 0.0 0
M  V30 8 I 6.1600 4.0009 0.0 0
M  V30 9 O 9.2400 4.0009 0.0 0
M  V30 10 C 10.7800 4.0009 0.0 0 CFG=1
M  V30 11 C 11.5500 5.3347 0.0 0
M  V30 12 C 11.5500 2.6673 0.0 0
M  V30 13 N 10.7800 1.3336 0.0 0
M  V30 14 O 13.0900 2.6673 0.0 0
M  V30 15 C 11.5500 0.0000 0.0 0
M  V30 16 C 6.1600 6.6684 0.0 0
M  V30 17 C 6.9300 5.3347 0.0 0
M  V30 18 C 6.9300 8.0020 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 8.4700 8.0020 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 3.8500 10.6694 0.0 0
M  V30 23 C 4.6200 12.0031 0.0 0
M  V30 24 C 2.3100 10.6694 0.0 0
M  V30 25 C 3.8500 13.3367 0.0 0
M  V30 26 C 1.5400 12.0031 0.0 0
M  V30 27 C 2.3100 13.3367 0.0 0
M  V30 28 C 13.0900 5.3347 0.0 0
M  V30 29 C 13.8600 4.0009 0.0 0
M  V30 30 C 13.8600 6.6684 0.0 0
M  V30 31 C 15.4000 4.0009 0.0 0
M  V30 32 C 15.4000 6.6684 0.0 0
M  V30 33 C 16.1700 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 10 11 CFG=3
M  V30 13 1 10 12
M  V30 14 1 11 28
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 30 1 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2252226-47-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2252226-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19387619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective, Catalytic Vicinal Difluorination of Alkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Scheidt, Felix; Schaefer, Michael; Sarie, Jerome C.; Daniliuc, Constantin
G.; Molloy, John J.; Gilmour, Ryan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2018), 57(50), 16431-16435

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) (3S)-3-[(carboxymethoxy)methyl]-1-piperidinecarboxylate
C13H23NO5
231622-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 2.1037 4.4137 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 0.5637 1.7464 0.0 0
M  V30 8 C 9.3358 3.0801 0.0 0
M  V30 9 O 10.6697 2.3101 0.0 0
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 O 14.6707 3.0801 0.0 0
M  V30 13 O 13.3370 0.7700 0.0 0
M  V30 14 N 5.3348 2.3101 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0 CFG=1
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 17 8 CFG=1
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S)-3-[[2-(methylamino)-2-oxoethoxy]methyl]-1-piperidineca...
C14H26N2O4
934745-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 1.3338 3.0801 0.0 0
M  V30 5 C 0.5638 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1038 4.4137 0.0 0
M  V30 8 C 9.3360 3.0801 0.0 0
M  V30 9 O 10.6698 2.3101 0.0 0
M  V30 10 C 12.0035 3.0801 0.0 0
M  V30 11 C 13.3372 2.3101 0.0 0
M  V30 12 N 14.6708 3.0801 0.0 0
M  V30 13 O 13.3372 0.7700 0.0 0
M  V30 14 C 16.0046 2.3101 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 6.6687 3.0801 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 8.0023 2.3101 0.0 0 CFG=1
M  V30 19 C 6.6687 0.0000 0.0 0
M  V30 20 C 8.0023 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 18 8 CFG=1
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 231622-02-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 934745-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32532890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
3-amino-4-{(3S)-3-[(2-ethoxyethoxy)methyl]piperidin-1-yl}thieno[2,3-b]pyridine-2-carboxamide
(DS96432529): A potent and orally active bone anabolic agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saito, Keiji; Shinozuka, Tsuyoshi; Nakao, Akira; Kunikata, Tomonori;
Nakai, Daisuke; Nagai, Yoko; Naito, Satoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 54128440

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C23H31NO5
2319580-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2551 4.6200 0.0 0
M  V30 2 C 8.2551 3.0800 0.0 0
M  V30 3 C 9.7951 4.6200 0.0 0
M  V30 4 O 8.2551 6.1600 0.0 0
M  V30 5 O 9.5889 2.3100 0.0 0
M  V30 6 O 6.9214 2.3100 0.0 0
M  V30 7 O 10.5651 5.9537 0.0 0
M  V30 8 O 10.5651 3.2862 0.0 0
M  V30 9 C 9.5889 0.7700 0.0 0
M  V30 10 C 12.1051 5.9537 0.0 0
M  V30 11 C 10.9225 0.0000 0.0 0
M  V30 12 C 12.8751 7.2873 0.0 0
M  V30 13 C 6.2859 7.3304 0.0 0
M  V30 14 C 3.0994 2.9448 0.0 0
M  V30 15 C 1.5315 4.1372 0.0 0
M  V30 16 C 3.0631 3.9763 0.0 0
M  V30 17 C 1.3706 2.6057 0.0 0
M  V30 18 C 0.0000 4.2982 0.0 0
M  V30 19 C 6.7151 4.6200 0.0 0
M  V30 20 C 5.8098 5.8659 0.0 0
M  V30 21 C 5.8098 3.3740 0.0 0
M  V30 22 N 4.3453 5.3900 0.0 0
M  V30 23 C 4.3453 3.8500 0.0 0
M  V30 24 C 3.0994 6.2951 0.0 0
M  V30 25 C 1.6925 5.6688 0.0 0
M  V30 26 C 3.2604 7.8268 0.0 0
M  V30 27 C 0.4466 6.5740 0.0 0
M  V30 28 C 2.0145 8.7318 0.0 0
M  V30 29 C 0.6075 8.1055 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 3 7
M  V30 8 2 3 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 13 20
M  V30 14 1 14 23
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 25
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1-[2-(1,1-Dimethylethyl)phenyl]-2,5-dimethyl-1H-pyrrol-3-yl]-2-hydroxy-N1,...
C21H29N3O3
2307492-48-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9345 6.1793 0.0 0
M  V30 2 C 3.2239 1.4846 0.0 0
M  V30 3 C 1.5400 2.5065 0.0 0
M  V30 4 C 3.0800 2.5065 0.0 0
M  V30 5 C 1.5400 0.9665 0.0 0
M  V30 6 C 0.0000 2.5065 0.0 0
M  V30 7 C 8.1763 3.6896 0.0 0
M  V30 8 C 8.3374 2.1579 0.0 0
M  V30 9 C 9.7080 3.8505 0.0 0
M  V30 10 O 8.0154 5.2211 0.0 0
M  V30 11 N 9.7442 1.5316 0.0 0
M  V30 12 O 7.0913 1.2527 0.0 0
M  V30 13 N 10.3343 5.2573 0.0 0
M  V30 14 O 10.6131 2.6046 0.0 0
M  V30 15 C 9.9051 0.0000 0.0 0
M  V30 16 C 11.8659 5.4184 0.0 0
M  V30 17 N 4.2073 4.0466 0.0 0
M  V30 18 C 5.6143 4.6730 0.0 0
M  V30 19 C 4.3684 2.5150 0.0 0
M  V30 20 C 6.6447 3.5285 0.0 0
M  V30 21 C 5.8747 2.1948 0.0 0
M  V30 22 C 2.8737 4.8166 0.0 0
M  V30 23 C 1.5400 4.0466 0.0 0
M  V30 24 C 2.8737 6.3566 0.0 0
M  V30 25 C 0.2064 4.8166 0.0 0
M  V30 26 C 1.5400 7.1266 0.0 0
M  V30 27 C 0.2064 6.3566 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 23
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 20
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 9 14
M  V30 15 1 11 15
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2319580-50-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2307492-48-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20270413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM ee 96%, literature procedure used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphoric acid-catalyzed atroposelective construction of axially chiral
arylpyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Lei; Xiang, Shao-Hua; Wang, Jun; Xiao, Jian; Wang, Jun-Qi; Tan,
Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2019), 10(1), 1-10

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-Chloro-5-(trifluoromethyl)-2-pyrimidinyl]amino]-α,α,3-trimethyl-1H-pyra...
C13H14ClF3N6O
2357113-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6529 5.3915 0.0 0
M  V30 2 C 1.2460 4.7650 0.0 0
M  V30 3 C 2.0265 6.7983 0.0 0
M  V30 4 C 4.0597 6.0178 0.0 0
M  V30 5 N 1.0850 3.2335 0.0 0
M  V30 6 O 0.0000 5.6703 0.0 0
M  V30 7 N 6.2803 1.3628 0.0 0
M  V30 8 C 3.2196 0.0000 0.0 0
M  V30 9 Cl 11.6151 1.3628 0.0 0
M  V30 10 C 11.6151 4.4428 0.0 0
M  V30 11 F 12.3851 3.1092 0.0 0
M  V30 12 F 12.9489 5.2129 0.0 0
M  V30 13 F 10.8451 5.7765 0.0 0
M  V30 14 N 3.2792 3.9845 0.0 0
M  V30 15 C 4.7857 3.6644 0.0 0
M  V30 16 N 2.5092 2.6509 0.0 0
M  V30 17 C 4.9466 2.1328 0.0 0
M  V30 18 C 3.5398 1.5063 0.0 0
M  V30 19 C 7.6141 2.1328 0.0 0
M  V30 20 N 8.9477 1.3628 0.0 0
M  V30 21 N 7.6141 3.6728 0.0 0
M  V30 22 C 10.2814 2.1328 0.0 0
M  V30 23 C 8.9477 4.4428 0.0 0
M  V30 24 C 10.2814 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 14
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 17
M  V30 8 1 7 19
M  V30 9 1 8 18
M  V30 10 1 9 22
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α,α,3-Trimethyl-4-[[4-(methylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-...
C14H18F3N7O
1374829-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 F 0.9764 2.1037 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 3.6437 0.5636 0.0 0
M  V30 5 N 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 N 5.3900 6.6684 0.0 0
M  V30 8 C 7.3594 9.3790 0.0 0
M  V30 9 C 10.5458 4.9932 0.0 0
M  V30 10 C 11.4510 6.2392 0.0 0
M  V30 11 C 11.7917 4.0881 0.0 0
M  V30 12 C 9.6406 3.7473 0.0 0
M  V30 13 N 12.9826 6.0781 0.0 0
M  V30 14 O 10.8246 7.6460 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 4.6200 2.6673 0.0 0
M  V30 18 N 3.0800 5.3347 0.0 0
M  V30 19 N 5.3900 4.0011 0.0 0
M  V30 20 C 4.6200 5.3347 0.0 0
M  V30 21 C 6.9300 6.6684 0.0 0
M  V30 22 C 7.8353 5.4225 0.0 0
M  V30 23 C 7.8353 7.9143 0.0 0
M  V30 24 N 9.3000 5.8984 0.0 0
M  V30 25 N 9.3000 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 7 20
M  V30 8 1 7 21
M  V30 9 1 8 23
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 24
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2357113-93-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1374829-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20365895
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Remarchuk, Travis; Sudhakar, Anantha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019126383 A1 2019-06-27

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-[(6-bromohexyl)oxy]-2-fluorobenzene
C12H15Br2FO
2361126-31-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3358 2.3101 0.0 0
M  V30 5 C 10.6697 3.0801 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 Br 14.6707 2.3101 0.0 0
M  V30 9 F 0.0000 3.0801 0.0 0
M  V30 10 Br 0.0000 0.0000 0.0 0
M  V30 11 C 4.0010 2.3101 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 4.0010 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6673 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 14
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Bromo-3-fluorophenoxy)-N-methyl-1-hexanamine
C13H19BrFNO
1487613-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 6.6687 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6698 3.0801 0.0 0
M  V30 6 C 12.0035 2.3101 0.0 0
M  V30 7 C 13.3372 3.0801 0.0 0
M  V30 8 N 14.6708 2.3101 0.0 0
M  V30 9 C 16.0046 3.0801 0.0 0
M  V30 10 F 0.0000 3.0801 0.0 0
M  V30 11 Br 0.0000 0.0000 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 3.0801 0.0 0
M  V30 14 C 4.0012 0.7700 0.0 0
M  V30 15 C 1.3338 2.3101 0.0 0
M  V30 16 C 2.6675 0.0000 0.0 0
M  V30 17 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 15
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2361126-31-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1487613-61-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21547819
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of aryl-substituted 1H-indazole derivatives CFTR modulator
compounds useful for treatment of cystic fibrosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Lianhal; Hwang, Tzyh-Chang; Zou, Xiaoqin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019136314 A1 2019-07-11

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonate
C28H36O7
2376619-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 5.0131 0.0 0 CFG=2
M  V30 2 C 10.6379 4.0232 0.0 0
M  V30 3 O 13.2647 4.4862 0.0 0
M  V30 4 O 10.9054 2.5065 0.0 0
M  V30 5 O 9.1907 4.5498 0.0 0
M  V30 6 C 9.7256 1.5166 0.0 0
M  V30 7 C 9.9931 0.0000 0.0 0
M  V30 8 C 2.3100 9.1970 0.0 0
M  V30 9 C 1.5400 10.5307 0.0 0
M  V30 10 C 0.0000 10.5307 0.0 0
M  V30 11 C 20.0203 7.8634 0.0 0
M  V30 12 C 20.7903 9.1970 0.0 0
M  V30 13 C 22.3304 9.1970 0.0 0
M  V30 14 C 10.7802 7.8634 0.0 0 CFG=1
M  V30 15 C 11.5502 9.1970 0.0 0 CFG=2
M  V30 16 C 11.5502 6.5297 0.0 0 CFG=1
M  V30 17 O 9.2401 7.8634 0.0 0
M  V30 18 O 13.0902 9.1970 0.0 0
M  V30 19 C 10.7802 10.5307 0.0 0
M  V30 20 O 13.0902 6.5297 0.0 0
M  V30 21 C 8.4701 9.1970 0.0 0 CFG=3
M  V30 22 C 13.8602 7.8634 0.0 0 CFG=3
M  V30 23 O 9.2401 10.5307 0.0 0
M  V30 24 C 6.9301 9.1970 0.0 0
M  V30 25 C 6.1601 7.8634 0.0 0
M  V30 26 C 6.1601 10.5307 0.0 0
M  V30 27 C 4.6201 7.8634 0.0 0
M  V30 28 C 4.6201 10.5307 0.0 0
M  V30 29 C 3.8501 9.1970 0.0 0
M  V30 30 C 15.4002 7.8634 0.0 0
M  V30 31 C 16.1703 9.1970 0.0 0
M  V30 32 C 16.1703 6.5297 0.0 0
M  V30 33 C 17.7103 9.1970 0.0 0
M  V30 34 C 17.7103 6.5297 0.0 0
M  V30 35 C 18.4803 7.8634 0.0 0
M  V30 36 H 10.0102 6.5297 0.0 0
M  V30 37 H 12.3202 10.5307 0.0 0
M  V30 38 H 10.1030 6.0029 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 36 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 37 CFG=1
M  V30 21 1 16 20
M  V30 22 1 16 38 CFG=1
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 21 24
M  V30 29 1 22 30
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonamide
C27H35NO6
2376620-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 3.4963 0.0 0 CFG=2
M  V30 2 C 10.6378 2.5065 0.0 0
M  V30 3 O 13.2646 2.9696 0.0 0
M  V30 4 N 10.9053 0.9899 0.0 0
M  V30 5 O 9.1907 3.0332 0.0 0
M  V30 6 C 9.7255 0.0000 0.0 0
M  V30 7 C 2.3100 7.6804 0.0 0
M  V30 8 C 1.5400 9.0140 0.0 0
M  V30 9 C 0.0000 9.0140 0.0 0
M  V30 10 C 20.0202 6.3467 0.0 0
M  V30 11 C 20.7902 7.6804 0.0 0
M  V30 12 C 22.3302 7.6804 0.0 0
M  V30 13 C 10.7801 6.3467 0.0 0 CFG=2
M  V30 14 C 11.5501 5.0131 0.0 0 CFG=1
M  V30 15 C 11.5501 7.6804 0.0 0 CFG=2
M  V30 16 O 9.2401 6.3467 0.0 0
M  V30 17 O 13.0901 5.0131 0.0 0
M  V30 18 O 13.0901 7.6804 0.0 0
M  V30 19 C 10.7801 9.0140 0.0 0
M  V30 20 C 8.4701 7.6804 0.0 0 CFG=3
M  V30 21 C 13.8602 6.3467 0.0 0 CFG=3
M  V30 22 O 9.2401 9.0140 0.0 0
M  V30 23 C 6.9301 7.6804 0.0 0
M  V30 24 C 6.1601 9.0140 0.0 0
M  V30 25 C 6.1601 6.3467 0.0 0
M  V30 26 C 4.6201 9.0140 0.0 0
M  V30 27 C 4.6201 6.3467 0.0 0
M  V30 28 C 3.8500 7.6804 0.0 0
M  V30 29 C 15.4002 6.3467 0.0 0
M  V30 30 C 16.1702 7.6804 0.0 0
M  V30 31 C 16.1702 5.0131 0.0 0
M  V30 32 C 17.7102 7.6804 0.0 0
M  V30 33 C 17.7102 5.0131 0.0 0
M  V30 34 C 18.4802 6.3467 0.0 0
M  V30 35 H 10.0101 5.0131 0.0 0
M  V30 36 H 10.1030 4.4862 0.0 0
M  V30 37 H 12.3201 9.0140 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 35 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 36 CFG=1
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 15 37 CFG=1
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 21 29
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21725670
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nucleating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179773 A1 2019-09-26

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonate
C28H36O7
2376619-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 5.0131 0.0 0 CFG=2
M  V30 2 C 10.6379 4.0232 0.0 0
M  V30 3 O 13.2647 4.4862 0.0 0
M  V30 4 O 10.9054 2.5065 0.0 0
M  V30 5 O 9.1907 4.5498 0.0 0
M  V30 6 C 9.7256 1.5166 0.0 0
M  V30 7 C 9.9931 0.0000 0.0 0
M  V30 8 C 2.3100 9.1970 0.0 0
M  V30 9 C 1.5400 10.5307 0.0 0
M  V30 10 C 0.0000 10.5307 0.0 0
M  V30 11 C 20.0203 7.8634 0.0 0
M  V30 12 C 20.7903 9.1970 0.0 0
M  V30 13 C 22.3304 9.1970 0.0 0
M  V30 14 C 10.7802 7.8634 0.0 0 CFG=1
M  V30 15 C 11.5502 9.1970 0.0 0 CFG=2
M  V30 16 C 11.5502 6.5297 0.0 0 CFG=1
M  V30 17 O 9.2401 7.8634 0.0 0
M  V30 18 O 13.0902 9.1970 0.0 0
M  V30 19 C 10.7802 10.5307 0.0 0
M  V30 20 O 13.0902 6.5297 0.0 0
M  V30 21 C 8.4701 9.1970 0.0 0 CFG=3
M  V30 22 C 13.8602 7.8634 0.0 0 CFG=3
M  V30 23 O 9.2401 10.5307 0.0 0
M  V30 24 C 6.9301 9.1970 0.0 0
M  V30 25 C 6.1601 7.8634 0.0 0
M  V30 26 C 6.1601 10.5307 0.0 0
M  V30 27 C 4.6201 7.8634 0.0 0
M  V30 28 C 4.6201 10.5307 0.0 0
M  V30 29 C 3.8501 9.1970 0.0 0
M  V30 30 C 15.4002 7.8634 0.0 0
M  V30 31 C 16.1703 9.1970 0.0 0
M  V30 32 C 16.1703 6.5297 0.0 0
M  V30 33 C 17.7103 9.1970 0.0 0
M  V30 34 C 17.7103 6.5297 0.0 0
M  V30 35 C 18.4803 7.8634 0.0 0
M  V30 36 H 10.0102 6.5297 0.0 0
M  V30 37 H 12.3202 10.5307 0.0 0
M  V30 38 H 10.1030 6.0029 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 36 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 37 CFG=1
M  V30 21 1 16 20
M  V30 22 1 16 38 CFG=1
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 21 24
M  V30 29 1 22 30
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonamide
C27H35NO6
2376620-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 3.4963 0.0 0 CFG=2
M  V30 2 C 10.6378 2.5065 0.0 0
M  V30 3 O 13.2646 2.9696 0.0 0
M  V30 4 N 10.9053 0.9899 0.0 0
M  V30 5 O 9.1907 3.0332 0.0 0
M  V30 6 C 9.7255 0.0000 0.0 0
M  V30 7 C 2.3100 7.6804 0.0 0
M  V30 8 C 1.5400 9.0140 0.0 0
M  V30 9 C 0.0000 9.0140 0.0 0
M  V30 10 C 20.0202 6.3467 0.0 0
M  V30 11 C 20.7902 7.6804 0.0 0
M  V30 12 C 22.3302 7.6804 0.0 0
M  V30 13 C 10.7801 6.3467 0.0 0 CFG=2
M  V30 14 C 11.5501 5.0131 0.0 0 CFG=1
M  V30 15 C 11.5501 7.6804 0.0 0 CFG=2
M  V30 16 O 9.2401 6.3467 0.0 0
M  V30 17 O 13.0901 5.0131 0.0 0
M  V30 18 O 13.0901 7.6804 0.0 0
M  V30 19 C 10.7801 9.0140 0.0 0
M  V30 20 C 8.4701 7.6804 0.0 0 CFG=3
M  V30 21 C 13.8602 6.3467 0.0 0 CFG=3
M  V30 22 O 9.2401 9.0140 0.0 0
M  V30 23 C 6.9301 7.6804 0.0 0
M  V30 24 C 6.1601 9.0140 0.0 0
M  V30 25 C 6.1601 6.3467 0.0 0
M  V30 26 C 4.6201 9.0140 0.0 0
M  V30 27 C 4.6201 6.3467 0.0 0
M  V30 28 C 3.8500 7.6804 0.0 0
M  V30 29 C 15.4002 6.3467 0.0 0
M  V30 30 C 16.1702 7.6804 0.0 0
M  V30 31 C 16.1702 5.0131 0.0 0
M  V30 32 C 17.7102 7.6804 0.0 0
M  V30 33 C 17.7102 5.0131 0.0 0
M  V30 34 C 18.4802 6.3467 0.0 0
M  V30 35 H 10.0101 5.0131 0.0 0
M  V30 36 H 10.1030 4.4862 0.0 0
M  V30 37 H 12.3201 9.0140 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 35 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 36 CFG=1
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 15 37 CFG=1
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 21 29
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21780031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Budde, Felix; Muller, Thierry; Hauck, Stefan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019179774 A1 2019-09-26

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonate
C28H36O7
2376619-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 5.0131 0.0 0 CFG=2
M  V30 2 C 10.6379 4.0232 0.0 0
M  V30 3 O 13.2647 4.4862 0.0 0
M  V30 4 O 10.9054 2.5065 0.0 0
M  V30 5 O 9.1907 4.5498 0.0 0
M  V30 6 C 9.7256 1.5166 0.0 0
M  V30 7 C 9.9931 0.0000 0.0 0
M  V30 8 C 2.3100 9.1970 0.0 0
M  V30 9 C 1.5400 10.5307 0.0 0
M  V30 10 C 0.0000 10.5307 0.0 0
M  V30 11 C 20.0203 7.8634 0.0 0
M  V30 12 C 20.7903 9.1970 0.0 0
M  V30 13 C 22.3304 9.1970 0.0 0
M  V30 14 C 10.7802 7.8634 0.0 0 CFG=1
M  V30 15 C 11.5502 9.1970 0.0 0 CFG=2
M  V30 16 C 11.5502 6.5297 0.0 0 CFG=1
M  V30 17 O 9.2401 7.8634 0.0 0
M  V30 18 O 13.0902 9.1970 0.0 0
M  V30 19 C 10.7802 10.5307 0.0 0
M  V30 20 O 13.0902 6.5297 0.0 0
M  V30 21 C 8.4701 9.1970 0.0 0 CFG=3
M  V30 22 C 13.8602 7.8634 0.0 0 CFG=3
M  V30 23 O 9.2401 10.5307 0.0 0
M  V30 24 C 6.9301 9.1970 0.0 0
M  V30 25 C 6.1601 7.8634 0.0 0
M  V30 26 C 6.1601 10.5307 0.0 0
M  V30 27 C 4.6201 7.8634 0.0 0
M  V30 28 C 4.6201 10.5307 0.0 0
M  V30 29 C 3.8501 9.1970 0.0 0
M  V30 30 C 15.4002 7.8634 0.0 0
M  V30 31 C 16.1703 9.1970 0.0 0
M  V30 32 C 16.1703 6.5297 0.0 0
M  V30 33 C 17.7103 9.1970 0.0 0
M  V30 34 C 17.7103 6.5297 0.0 0
M  V30 35 C 18.4803 7.8634 0.0 0
M  V30 36 H 10.0102 6.5297 0.0 0
M  V30 37 H 12.3202 10.5307 0.0 0
M  V30 38 H 10.1030 6.0029 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 36 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 37 CFG=1
M  V30 21 1 16 20
M  V30 22 1 16 38 CFG=1
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 21 24
M  V30 29 1 22 30
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonamide
C27H35NO6
2376620-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 3.4963 0.0 0 CFG=2
M  V30 2 C 10.6378 2.5065 0.0 0
M  V30 3 O 13.2646 2.9696 0.0 0
M  V30 4 N 10.9053 0.9899 0.0 0
M  V30 5 O 9.1907 3.0332 0.0 0
M  V30 6 C 9.7255 0.0000 0.0 0
M  V30 7 C 2.3100 7.6804 0.0 0
M  V30 8 C 1.5400 9.0140 0.0 0
M  V30 9 C 0.0000 9.0140 0.0 0
M  V30 10 C 20.0202 6.3467 0.0 0
M  V30 11 C 20.7902 7.6804 0.0 0
M  V30 12 C 22.3302 7.6804 0.0 0
M  V30 13 C 10.7801 6.3467 0.0 0 CFG=2
M  V30 14 C 11.5501 5.0131 0.0 0 CFG=1
M  V30 15 C 11.5501 7.6804 0.0 0 CFG=2
M  V30 16 O 9.2401 6.3467 0.0 0
M  V30 17 O 13.0901 5.0131 0.0 0
M  V30 18 O 13.0901 7.6804 0.0 0
M  V30 19 C 10.7801 9.0140 0.0 0
M  V30 20 C 8.4701 7.6804 0.0 0 CFG=3
M  V30 21 C 13.8602 6.3467 0.0 0 CFG=3
M  V30 22 O 9.2401 9.0140 0.0 0
M  V30 23 C 6.9301 7.6804 0.0 0
M  V30 24 C 6.1601 9.0140 0.0 0
M  V30 25 C 6.1601 6.3467 0.0 0
M  V30 26 C 4.6201 9.0140 0.0 0
M  V30 27 C 4.6201 6.3467 0.0 0
M  V30 28 C 3.8500 7.6804 0.0 0
M  V30 29 C 15.4002 6.3467 0.0 0
M  V30 30 C 16.1702 7.6804 0.0 0
M  V30 31 C 16.1702 5.0131 0.0 0
M  V30 32 C 17.7102 7.6804 0.0 0
M  V30 33 C 17.7102 5.0131 0.0 0
M  V30 34 C 18.4802 6.3467 0.0 0
M  V30 35 H 10.0101 5.0131 0.0 0
M  V30 36 H 10.1030 4.4862 0.0 0
M  V30 37 H 12.3201 9.0140 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 35 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 36 CFG=1
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 15 37 CFG=1
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 21 29
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21831751
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of nuclating agents diacetal derivatives and their use as
clarifier
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543244 A1 2019-09-25

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonate
C28H36O7
2376619-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 5.0131 0.0 0 CFG=2
M  V30 2 C 10.6379 4.0232 0.0 0
M  V30 3 O 13.2647 4.4862 0.0 0
M  V30 4 O 10.9054 2.5065 0.0 0
M  V30 5 O 9.1907 4.5498 0.0 0
M  V30 6 C 9.7256 1.5166 0.0 0
M  V30 7 C 9.9931 0.0000 0.0 0
M  V30 8 C 2.3100 9.1970 0.0 0
M  V30 9 C 1.5400 10.5307 0.0 0
M  V30 10 C 0.0000 10.5307 0.0 0
M  V30 11 C 20.0203 7.8634 0.0 0
M  V30 12 C 20.7903 9.1970 0.0 0
M  V30 13 C 22.3304 9.1970 0.0 0
M  V30 14 C 10.7802 7.8634 0.0 0 CFG=1
M  V30 15 C 11.5502 9.1970 0.0 0 CFG=2
M  V30 16 C 11.5502 6.5297 0.0 0 CFG=1
M  V30 17 O 9.2401 7.8634 0.0 0
M  V30 18 O 13.0902 9.1970 0.0 0
M  V30 19 C 10.7802 10.5307 0.0 0
M  V30 20 O 13.0902 6.5297 0.0 0
M  V30 21 C 8.4701 9.1970 0.0 0 CFG=3
M  V30 22 C 13.8602 7.8634 0.0 0 CFG=3
M  V30 23 O 9.2401 10.5307 0.0 0
M  V30 24 C 6.9301 9.1970 0.0 0
M  V30 25 C 6.1601 7.8634 0.0 0
M  V30 26 C 6.1601 10.5307 0.0 0
M  V30 27 C 4.6201 7.8634 0.0 0
M  V30 28 C 4.6201 10.5307 0.0 0
M  V30 29 C 3.8501 9.1970 0.0 0
M  V30 30 C 15.4002 7.8634 0.0 0
M  V30 31 C 16.1703 9.1970 0.0 0
M  V30 32 C 16.1703 6.5297 0.0 0
M  V30 33 C 17.7103 9.1970 0.0 0
M  V30 34 C 17.7103 6.5297 0.0 0
M  V30 35 C 18.4803 7.8634 0.0 0
M  V30 36 H 10.0102 6.5297 0.0 0
M  V30 37 H 12.3202 10.5307 0.0 0
M  V30 38 H 10.1030 6.0029 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 29
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 35
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 36 CFG=1
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 37 CFG=1
M  V30 21 1 16 20
M  V30 22 1 16 38 CFG=1
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 21 24
M  V30 29 1 22 30
M  V30 30 2 24 25
M  V30 31 1 24 26
M  V30 32 1 25 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 28 29
M  V30 36 2 30 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 2 32 34
M  V30 40 2 33 35
M  V30 41 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,5:4,6-bis-O-[(4-propylphenyl)methylene]-L-gulonamide
C27H35NO6
2376620-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.8175 3.4963 0.0 0 CFG=2
M  V30 2 C 10.6378 2.5065 0.0 0
M  V30 3 O 13.2646 2.9696 0.0 0
M  V30 4 N 10.9053 0.9899 0.0 0
M  V30 5 O 9.1907 3.0332 0.0 0
M  V30 6 C 9.7255 0.0000 0.0 0
M  V30 7 C 2.3100 7.6804 0.0 0
M  V30 8 C 1.5400 9.0140 0.0 0
M  V30 9 C 0.0000 9.0140 0.0 0
M  V30 10 C 20.0202 6.3467 0.0 0
M  V30 11 C 20.7902 7.6804 0.0 0
M  V30 12 C 22.3302 7.6804 0.0 0
M  V30 13 C 10.7801 6.3467 0.0 0 CFG=2
M  V30 14 C 11.5501 5.0131 0.0 0 CFG=1
M  V30 15 C 11.5501 7.6804 0.0 0 CFG=2
M  V30 16 O 9.2401 6.3467 0.0 0
M  V30 17 O 13.0901 5.0131 0.0 0
M  V30 18 O 13.0901 7.6804 0.0 0
M  V30 19 C 10.7801 9.0140 0.0 0
M  V30 20 C 8.4701 7.6804 0.0 0 CFG=3
M  V30 21 C 13.8602 6.3467 0.0 0 CFG=3
M  V30 22 O 9.2401 9.0140 0.0 0
M  V30 23 C 6.9301 7.6804 0.0 0
M  V30 24 C 6.1601 9.0140 0.0 0
M  V30 25 C 6.1601 6.3467 0.0 0
M  V30 26 C 4.6201 9.0140 0.0 0
M  V30 27 C 4.6201 6.3467 0.0 0
M  V30 28 C 3.8500 7.6804 0.0 0
M  V30 29 C 15.4002 6.3467 0.0 0
M  V30 30 C 16.1702 7.6804 0.0 0
M  V30 31 C 16.1702 5.0131 0.0 0
M  V30 32 C 17.7102 7.6804 0.0 0
M  V30 33 C 17.7102 5.0131 0.0 0
M  V30 34 C 18.4802 6.3467 0.0 0
M  V30 35 H 10.0101 5.0131 0.0 0
M  V30 36 H 10.1030 4.4862 0.0 0
M  V30 37 H 12.3201 9.0140 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 28
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 34
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 13 35 CFG=1
M  V30 17 1 14 17
M  V30 18 1 14 36 CFG=1
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 15 37 CFG=1
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 1 20 22
M  V30 27 1 20 23
M  V30 28 1 21 29
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 2 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 2 31 33
M  V30 39 2 32 34
M  V30 40 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376619-94-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376620-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-21938144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed pressure flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer composition comprising gulonic acid diacetal derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauck, Stefan; Budde, Felix; Muller, Thierry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3543286 A1 2019-09-25

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(1R)-1-(4-Bromophenyl)ethyl]butylamino]-5-benzoxazoleacetic acid
C21H23BrN2O3
2378626-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.3347 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0 CFG=1
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 6.9300 8.0021 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 C 6.9300 0.0000 0.0 0
M  V30 8 C 14.8408 6.8747 0.0 0
M  V30 9 C 16.1746 6.1047 0.0 0
M  V30 10 O 17.5083 6.8747 0.0 0
M  V30 11 O 16.1746 4.5647 0.0 0
M  V30 12 Br 0.0000 6.6685 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 N 9.3752 6.5806 0.0 0
M  V30 15 O 9.3752 4.0889 0.0 0
M  V30 16 C 10.8399 6.1047 0.0 0
M  V30 17 C 10.8399 4.5647 0.0 0
M  V30 18 C 12.1735 6.8747 0.0 0
M  V30 19 C 12.1735 3.7947 0.0 0
M  V30 20 C 13.5072 6.1047 0.0 0
M  V30 21 C 13.5072 4.5647 0.0 0
M  V30 22 C 4.6200 6.6685 0.0 0
M  V30 23 C 3.8500 5.3347 0.0 0
M  V30 24 C 3.8500 8.0021 0.0 0
M  V30 25 C 2.3100 5.3347 0.0 0
M  V30 26 C 2.3100 8.0021 0.0 0
M  V30 27 C 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 22
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 20
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 12 27
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[(1R)-1-(4-Bromophenyl)ethyl]butylamino]-N-methyl-5-benzoxazoleacetamide
C22H26BrN3O2
2378630-22-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 5.3347 0.0 0
M  V30 2 C 6.1600 6.6685 0.0 0 CFG=1
M  V30 3 C 6.1600 4.0011 0.0 0
M  V30 4 C 6.9300 8.0022 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 6.1600 1.3336 0.0 0
M  V30 7 C 6.9300 0.0000 0.0 0
M  V30 8 C 14.8409 6.8747 0.0 0
M  V30 9 C 16.1745 6.1047 0.0 0
M  V30 10 N 17.5083 6.8747 0.0 0
M  V30 11 O 16.1745 4.5647 0.0 0
M  V30 12 C 18.8419 6.1047 0.0 0
M  V30 13 Br 0.0000 6.6685 0.0 0
M  V30 14 C 8.4700 5.3347 0.0 0
M  V30 15 N 9.3752 6.5806 0.0 0
M  V30 16 O 9.3752 4.0889 0.0 0
M  V30 17 C 10.8398 6.1047 0.0 0
M  V30 18 C 10.8398 4.5647 0.0 0
M  V30 19 C 12.1736 6.8747 0.0 0
M  V30 20 C 12.1736 3.7947 0.0 0
M  V30 21 C 13.5072 6.1047 0.0 0
M  V30 22 C 13.5072 4.5647 0.0 0
M  V30 23 C 4.6200 6.6685 0.0 0
M  V30 24 C 3.8500 5.3347 0.0 0
M  V30 25 C 3.8500 8.0022 0.0 0
M  V30 26 C 2.3100 5.3347 0.0 0
M  V30 27 C 2.3100 8.0022 0.0 0
M  V30 28 C 1.5400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 23
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 13 28
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378626-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378630-22-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22591985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery and optimization of a series of 2-aminobenzoxazole
derivatives as ChemR23 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imaizumi, Takamichi; Kobayashi, Atsuko; Otsubo, Shigeki; Komai, Masato;
Magara, Megumiko; Otsubo, Nobumasa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(21), 115091

$RFMT $RIREG SCHEME369 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-[[6-(3,5-dichlorophenyl)-4-[[4-(hydroxymethyl)-1-piper...
C31H38Cl2N6O4
2387630-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 3.8501 0.0 0
M  V30 2 C 6.6685 8.4702 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 Cl 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 11.5503 0.0 0
M  V30 6 O 1.3337 13.0903 0.0 0
M  V30 7 C 18.6718 9.2402 0.0 0
M  V30 8 O 20.0057 8.4702 0.0 0
M  V30 9 O 18.6718 10.7802 0.0 0
M  V30 10 C 21.3393 9.2402 0.0 0
M  V30 11 C 20.5693 10.5739 0.0 0
M  V30 12 C 22.6730 10.0102 0.0 0
M  V30 13 C 22.1093 7.9065 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 N 6.6685 3.8501 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 6.6685 6.9302 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 4.0012 3.8501 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 4.0012 2.3101 0.0 0
M  V30 23 C 1.3337 3.8501 0.0 0
M  V30 24 C 2.6673 1.5400 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 10.6697 4.6201 0.0 0
M  V30 27 C 12.0033 3.8501 0.0 0
M  V30 28 C 10.6697 6.1601 0.0 0
M  V30 29 N 13.3370 4.6201 0.0 0
M  V30 30 N 12.0033 6.9302 0.0 0
M  V30 31 C 13.3370 6.1601 0.0 0
M  V30 32 N 5.3348 9.2402 0.0 0
M  V30 33 C 4.0012 8.4702 0.0 0
M  V30 34 C 5.3348 10.7802 0.0 0
M  V30 35 C 2.6673 9.2402 0.0 0
M  V30 36 C 4.0012 11.5503 0.0 0
M  V30 37 C 2.6673 10.7802 0.0 0
M  V30 38 N 14.6708 6.9302 0.0 0
M  V30 39 C 14.6708 8.4702 0.0 0
M  V30 40 C 16.0045 6.1601 0.0 0
M  V30 41 C 16.0045 9.2402 0.0 0
M  V30 42 C 17.3382 6.9302 0.0 0
M  V30 43 N 17.3382 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 1 2 18
M  V30 4 1 2 32
M  V30 5 1 3 23
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 5 37
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 43
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 20
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 31 38
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-[[6-(3,5-dichlorophenyl)-4-[[4-[[[(methylamino)carbony...
C33H41Cl2N7O5
2387630-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.0336 6.6684 0.0 0
M  V30 2 C 13.6536 9.3358 0.0 0
M  V30 3 Cl 12.8836 0.0000 0.0 0
M  V30 4 Cl 17.5036 2.6674 0.0 0
M  V30 5 C 19.8136 9.3358 0.0 0
M  V30 6 O 20.5836 10.6694 0.0 0
M  V30 7 C 22.1236 10.6694 0.0 0
M  V30 8 N 22.8936 12.0032 0.0 0
M  V30 9 O 22.8936 9.3358 0.0 0
M  V30 10 C 24.4336 12.0032 0.0 0
M  V30 11 C 3.6436 16.0041 0.0 0
M  V30 12 O 2.1036 16.0041 0.0 0
M  V30 13 O 4.4136 17.3379 0.0 0
M  V30 14 C 1.3336 17.3379 0.0 0
M  V30 15 C 2.6673 18.1079 0.0 0
M  V30 16 C 0.5636 18.6716 0.0 0
M  V30 17 C 0.0000 16.5679 0.0 0
M  V30 18 C 12.8836 5.3347 0.0 0
M  V30 19 N 11.3436 5.3347 0.0 0
M  V30 20 C 13.6536 6.6684 0.0 0
M  V30 21 C 10.5736 6.6684 0.0 0
M  V30 22 C 12.8836 8.0021 0.0 0
M  V30 23 C 11.3436 8.0021 0.0 0
M  V30 24 C 13.6536 4.0011 0.0 0
M  V30 25 C 12.8836 2.6674 0.0 0
M  V30 26 C 15.1936 4.0011 0.0 0
M  V30 27 C 13.6536 1.3336 0.0 0
M  V30 28 C 15.9636 2.6674 0.0 0
M  V30 29 C 15.1936 1.3336 0.0 0
M  V30 30 C 8.2636 8.0021 0.0 0
M  V30 31 C 9.0336 9.3358 0.0 0
M  V30 32 C 6.7236 8.0021 0.0 0
M  V30 33 N 8.2636 10.6694 0.0 0
M  V30 34 N 5.9536 9.3358 0.0 0
M  V30 35 C 6.7236 10.6694 0.0 0
M  V30 36 N 15.1936 9.3358 0.0 0
M  V30 37 C 15.9636 10.6694 0.0 0
M  V30 38 C 15.9636 8.0021 0.0 0
M  V30 39 C 17.5036 10.6694 0.0 0
M  V30 40 C 17.5036 8.0021 0.0 0
M  V30 41 C 18.2736 9.3358 0.0 0
M  V30 42 N 5.9536 12.0032 0.0 0
M  V30 43 C 4.4136 12.0032 0.0 0
M  V30 44 C 6.7236 13.3369 0.0 0
M  V30 45 C 3.6436 13.3369 0.0 0
M  V30 46 C 5.9536 14.6705 0.0 0
M  V30 47 N 4.4136 14.6705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 1 30
M  V30 3 1 2 22
M  V30 4 1 2 36
M  V30 5 1 3 27
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 5 41
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 47
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 18 24
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 39 1 35 42
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 46 1 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2387630-01-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387630-02-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31254919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phenylpyridinylmethylpiperidines,
phenylpyridinylmethylpiperazines and their analogs as furin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axten, Jeffrey Michael; Cheung, Mui; Demartino, Michael P.; Guan, Huiping
Amy; Hu, Yan; Miller, Aaron Bayne; Qin, Donghui; Wu, Chengde; Zhang,
Zhiliu; Lin, Xiaojuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019215341 A1 2019-11-14

$RFMT $RIREG SCHEME370 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-[[6-(3,5-dichlorophenyl)-4-[[4-(hydroxymethyl)-1-piper...
C32H39Cl2N5O4
2387630-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 3.8501 0.0 0
M  V30 2 C 6.6685 8.4702 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 Cl 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 11.5503 0.0 0
M  V30 6 O 1.3337 13.0903 0.0 0
M  V30 7 C 18.6718 9.2402 0.0 0
M  V30 8 O 20.0057 8.4702 0.0 0
M  V30 9 O 18.6718 10.7802 0.0 0
M  V30 10 C 21.3393 9.2402 0.0 0
M  V30 11 C 22.1093 7.9065 0.0 0
M  V30 12 C 22.6730 10.0102 0.0 0
M  V30 13 C 20.5693 10.5739 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 N 6.6685 3.8501 0.0 0
M  V30 16 C 5.3348 6.1601 0.0 0
M  V30 17 C 8.0022 4.6201 0.0 0
M  V30 18 C 6.6685 6.9302 0.0 0
M  V30 19 C 8.0022 6.1601 0.0 0
M  V30 20 C 4.0012 3.8501 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 4.0012 2.3101 0.0 0
M  V30 23 C 1.3337 3.8501 0.0 0
M  V30 24 C 2.6673 1.5400 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 10.6697 4.6201 0.0 0
M  V30 27 C 12.0033 3.8501 0.0 0
M  V30 28 C 10.6697 6.1601 0.0 0
M  V30 29 C 13.3370 4.6201 0.0 0
M  V30 30 N 12.0033 6.9302 0.0 0
M  V30 31 C 13.3370 6.1601 0.0 0
M  V30 32 N 5.3348 9.2402 0.0 0
M  V30 33 C 5.3348 10.7802 0.0 0
M  V30 34 C 4.0012 8.4702 0.0 0
M  V30 35 C 4.0012 11.5503 0.0 0
M  V30 36 C 2.6673 9.2402 0.0 0
M  V30 37 C 2.6673 10.7802 0.0 0
M  V30 38 N 14.6708 6.9302 0.0 0
M  V30 39 C 16.0045 6.1601 0.0 0
M  V30 40 C 14.6708 8.4702 0.0 0
M  V30 41 C 17.3382 6.9302 0.0 0
M  V30 42 C 16.0045 9.2402 0.0 0
M  V30 43 N 17.3382 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 1 2 18
M  V30 4 1 2 32
M  V30 5 1 3 23
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 5 37
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 43
M  V30 12 1 8 10
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 20
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 31 38
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-[[6-(3,5-dichlorophenyl)-4-[[4-[[[(methylamino)carbony...
C34H42Cl2N6O5
2387630-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.0336 6.6684 0.0 0
M  V30 2 C 13.6536 9.3358 0.0 0
M  V30 3 Cl 12.8836 0.0000 0.0 0
M  V30 4 Cl 17.5036 2.6674 0.0 0
M  V30 5 C 19.8136 9.3358 0.0 0
M  V30 6 O 20.5836 10.6694 0.0 0
M  V30 7 C 22.1236 10.6694 0.0 0
M  V30 8 N 22.8936 12.0032 0.0 0
M  V30 9 O 22.8936 9.3358 0.0 0
M  V30 10 C 24.4336 12.0032 0.0 0
M  V30 11 C 3.6436 16.0041 0.0 0
M  V30 12 O 2.1036 16.0041 0.0 0
M  V30 13 O 4.4136 17.3379 0.0 0
M  V30 14 C 1.3336 17.3379 0.0 0
M  V30 15 C 2.6673 18.1079 0.0 0
M  V30 16 C 0.5636 18.6716 0.0 0
M  V30 17 C 0.0000 16.5679 0.0 0
M  V30 18 C 12.8836 5.3347 0.0 0
M  V30 19 N 11.3436 5.3347 0.0 0
M  V30 20 C 13.6536 6.6684 0.0 0
M  V30 21 C 10.5736 6.6684 0.0 0
M  V30 22 C 12.8836 8.0021 0.0 0
M  V30 23 C 11.3436 8.0021 0.0 0
M  V30 24 C 13.6536 4.0011 0.0 0
M  V30 25 C 12.8836 2.6674 0.0 0
M  V30 26 C 15.1936 4.0011 0.0 0
M  V30 27 C 13.6536 1.3336 0.0 0
M  V30 28 C 15.9636 2.6674 0.0 0
M  V30 29 C 15.1936 1.3336 0.0 0
M  V30 30 C 8.2636 8.0021 0.0 0
M  V30 31 C 9.0336 9.3358 0.0 0
M  V30 32 C 6.7236 8.0021 0.0 0
M  V30 33 C 8.2636 10.6694 0.0 0
M  V30 34 N 5.9536 9.3358 0.0 0
M  V30 35 C 6.7236 10.6694 0.0 0
M  V30 36 N 15.1936 9.3358 0.0 0
M  V30 37 C 15.9636 10.6694 0.0 0
M  V30 38 C 15.9636 8.0021 0.0 0
M  V30 39 C 17.5036 10.6694 0.0 0
M  V30 40 C 17.5036 8.0021 0.0 0
M  V30 41 C 18.2736 9.3358 0.0 0
M  V30 42 N 5.9536 12.0032 0.0 0
M  V30 43 C 4.4136 12.0032 0.0 0
M  V30 44 C 6.7236 13.3369 0.0 0
M  V30 45 C 3.6436 13.3369 0.0 0
M  V30 46 C 5.9536 14.6705 0.0 0
M  V30 47 N 4.4136 14.6705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 1 1 30
M  V30 3 1 2 22
M  V30 4 1 2 36
M  V30 5 1 3 27
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 5 41
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 47
M  V30 16 1 12 14
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 18 24
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 39 1 35 42
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 46 1 42 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2387630-06-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387630-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31254920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phenylpyridinylmethylpiperidines,
phenylpyridinylmethylpiperazines and their analogs as furin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axten, Jeffrey Michael; Cheung, Mui; Demartino, Michael P.; Guan, Huiping
Amy; Hu, Yan; Miller, Aaron Bayne; Qin, Donghui; Wu, Chengde; Zhang,
Zhiliu; Lin, Xiaojuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019215341 A1 2019-11-14

$RFMT $RIREG SCHEME371 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-4-bromo-2-butenoate
C5H7BrO2
6000-00-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 O 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6687 2.3101 0.0 0
M  V30 8 Br 8.0023 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-4-[[(1,1-dimethylethoxy)carbonyl]methylamino]-2-butenoate
C11H19NO4
915788-21-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 2.3101 0.0 0
M  V30 2 N 5.3348 1.5400 0.0 0
M  V30 3 O 2.6673 1.5400 0.0 0
M  V30 4 O 4.0010 3.8501 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 8.0022 1.5400 0.0 0
M  V30 9 C 2.1037 3.6437 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 0.5637 0.9764 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 10.6697 1.5400 0.0 0
M  V30 14 O 12.0033 2.3101 0.0 0
M  V30 15 O 10.6697 0.0000 0.0 0
M  V30 16 C 13.3370 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6000-00-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915788-21-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32718668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation methods and polyamide compounds for modulating myotonic
dystrophy 1
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ansari, Aseem; Jeffries, Sean J.; Shah, Pratik; Zhang, Chengzhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022126000 A1 2022-06-16

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetyl-7-methoxy-1(2H)-isoquinolinone
C12H11NO3
2445603-44-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 O 2.3101 6.6687 0.0 0
M  V30 4 O 4.6201 0.0000 0.0 0
M  V30 5 O 8.4702 4.0012 0.0 0
M  V30 6 C 9.2402 5.3348 0.0 0
M  V30 7 C 3.8501 4.0012 0.0 0
M  V30 8 C 4.6201 2.6675 0.0 0
M  V30 9 C 2.3101 4.0012 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 C 6.1601 2.6675 0.0 0
M  V30 12 C 3.8501 1.3338 0.0 0
M  V30 13 C 1.5400 2.6675 0.0 0
M  V30 14 C 6.1601 5.3348 0.0 0
M  V30 15 C 6.9302 4.0012 0.0 0
M  V30 16 N 2.3101 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 12
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 16
M  V30 17 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methoxy-4-[1-(methylamino)ethyl]-1(2H)-isoquinolinone
C13H16N2O2
2445603-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3348 0.0 0
M  V30 2 N 0.7700 5.3348 0.0 0
M  V30 3 C 3.0800 6.6686 0.0 0
M  V30 4 C 0.0000 6.6686 0.0 0
M  V30 5 O 5.3901 0.0000 0.0 0
M  V30 6 O 9.2401 4.0011 0.0 0
M  V30 7 C 10.0101 5.3348 0.0 0
M  V30 8 C 4.6201 4.0011 0.0 0
M  V30 9 C 5.3901 2.6675 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 5.3901 5.3348 0.0 0
M  V30 12 C 6.9301 2.6675 0.0 0
M  V30 13 C 4.6201 1.3338 0.0 0
M  V30 14 C 2.3100 2.6675 0.0 0
M  V30 15 C 6.9301 5.3348 0.0 0
M  V30 16 C 7.7001 4.0011 0.0 0
M  V30 17 N 3.0800 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445603-44-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445603-45-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-22813661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal in stage 1,reaction in a sealed tube in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted arylmethylureas and heteroarylmethylureas use in treating HBV
and preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cole, Andrew G.; Fan, Yi; Kultgen, Steven; Mesaros, Eugen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020123674 A1 2020-06-18

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3α)-3-[(O-2,3,4-Tri-O-acetyl-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[2,3,4-tri-O...
C64H93ClO23
2496395-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  91 98 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 21.7379 10.0627 0.0 0
M  V30 2 C 21.0945 9.6912 0.0 0
M  V30 3 C 25.3403 12.3202 0.0 0
M  V30 4 Cl 26.6741 13.0902 0.0 0
M  V30 5 O 25.3403 10.7802 0.0 0
M  V30 6 C 21.3393 16.1703 0.0 0
M  V30 7 C 24.0067 17.7103 0.0 0
M  V30 8 C 16.9397 12.2677 0.0 0
M  V30 9 C 15.0146 7.2905 0.0 0
M  V30 10 C 16.9943 7.2905 0.0 0
M  V30 11 O 13.3371 8.4701 0.0 0
M  V30 12 O 10.6696 6.9301 0.0 0
M  V30 13 O 8.0023 8.4701 0.0 0
M  V30 14 C 6.6686 9.2401 0.0 0
M  V30 15 C 5.3348 8.4701 0.0 0
M  V30 16 O 6.6686 10.7802 0.0 0
M  V30 17 C 10.6696 13.0902 0.0 0
M  V30 18 O 12.0034 13.8602 0.0 0
M  V30 19 C 12.0034 15.4002 0.0 0
M  V30 20 C 10.6696 16.1703 0.0 0
M  V30 21 O 13.3371 16.1703 0.0 0
M  V30 22 O 8.0023 11.5502 0.0 0
M  V30 23 O 10.6696 3.8501 0.0 0
M  V30 24 C 10.6696 2.3100 0.0 0
M  V30 25 C 12.0034 1.5400 0.0 0
M  V30 26 O 9.3359 1.5400 0.0 0
M  V30 27 O 8.0023 2.3100 0.0 0
M  V30 28 C 6.6686 1.5400 0.0 0
M  V30 29 C 5.3348 2.3100 0.0 0
M  V30 30 O 6.6686 0.0000 0.0 0
M  V30 31 C 5.3348 6.9301 0.0 0
M  V30 32 O 8.0023 14.6302 0.0 0
M  V30 33 C 8.0023 16.1703 0.0 0
M  V30 34 C 6.6686 16.9403 0.0 0
M  V30 35 O 9.3359 16.9403 0.0 0
M  V30 36 O 5.3348 3.8501 0.0 0
M  V30 37 C 4.0011 4.6201 0.0 0
M  V30 38 C 4.0011 6.1601 0.0 0
M  V30 39 O 2.6675 3.8501 0.0 0
M  V30 40 O 5.3348 16.1703 0.0 0
M  V30 41 C 5.3348 17.7103 0.0 0
M  V30 42 C 4.0011 18.4803 0.0 0
M  V30 43 O 6.6686 18.4803 0.0 0
M  V30 44 C 2.6675 11.5502 0.0 0
M  V30 45 O 2.6675 14.6302 0.0 0
M  V30 46 C 1.3338 13.8602 0.0 0
M  V30 47 C 0.0000 14.6302 0.0 0
M  V30 48 O 1.3338 12.3202 0.0 0
M  V30 49 C 21.3393 13.0902 0.0 0
M  V30 50 C 21.3393 11.5502 0.0 0 CFG=2
M  V30 51 C 22.6730 13.8602 0.0 0 CFG=2
M  V30 52 C 20.0055 13.8602 0.0 0
M  V30 53 C 20.0055 10.7802 0.0 0 CFG=1
M  V30 54 C 22.6730 10.7802 0.0 0
M  V30 55 C 24.0067 13.0902 0.0 0 CFG=1
M  V30 56 C 22.6730 15.4002 0.0 0 CFG=1
M  V30 57 C 18.6719 13.0902 0.0 0
M  V30 58 C 18.6719 11.5502 0.0 0 CFG=1
M  V30 59 C 20.0055 9.2401 0.0 0
M  V30 60 C 24.0067 11.5502 0.0 0
M  V30 61 C 25.3403 13.8602 0.0 0
M  V30 62 C 24.0067 16.1703 0.0 0 CFG=2
M  V30 63 C 17.3382 10.7802 0.0 0 CFG=2
M  V30 64 C 18.6719 8.4701 0.0 0
M  V30 65 C 25.3403 15.4002 0.0 0
M  V30 66 C 17.3382 9.2401 0.0 0 CFG=2
M  V30 67 C 16.0045 11.5502 0.0 0
M  V30 68 C 16.0045 8.4701 0.0 0
M  V30 69 C 14.6707 10.7802 0.0 0
M  V30 70 C 14.6707 9.2401 0.0 0 CFG=2
M  V30 71 C 12.0034 9.2401 0.0 0 CFG=2
M  V30 72 C 10.6696 8.4701 0.0 0 CFG=2
M  V30 73 O 12.0034 10.7802 0.0 0
M  V30 74 C 9.3359 9.2401 0.0 0 CFG=1
M  V30 75 C 10.6696 11.5502 0.0 0 CFG=2
M  V30 76 C 9.3359 10.7802 0.0 0 CFG=2
M  V30 77 C 9.3359 6.1601 0.0 0 CFG=2
M  V30 78 C 9.3359 4.6201 0.0 0 CFG=2
M  V30 79 O 8.0023 6.9301 0.0 0
M  V30 80 C 8.0023 3.8501 0.0 0 CFG=2
M  V30 81 C 6.6686 6.1601 0.0 0 CFG=1
M  V30 82 C 6.6686 4.6201 0.0 0 CFG=1
M  V30 83 C 6.6686 12.3202 0.0 0 CFG=2
M  V30 84 C 6.6686 13.8602 0.0 0 CFG=2
M  V30 85 O 5.3348 11.5502 0.0 0
M  V30 86 C 5.3348 14.6302 0.0 0 CFG=2
M  V30 87 C 4.0011 12.3202 0.0 0 CFG=1
M  V30 88 C 4.0011 13.8602 0.0 0 CFG=1
M  V30 89 H 21.3393 14.6302 0.0 0
M  V30 90 H 17.7885 12.8118 0.0 0
M  V30 91 H 17.3382 7.7001 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 50 1 CFG=3
M  V30 2 1 53 2 CFG=1
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 55 3 CFG=1
M  V30 6 1 56 6 CFG=1
M  V30 7 1 62 7 CFG=3
M  V30 8 1 63 8 CFG=1
M  V30 9 1 9 68
M  V30 10 1 10 68
M  V30 11 1 70 11 CFG=3
M  V30 12 1 71 11 CFG=1
M  V30 13 1 72 12 CFG=3
M  V30 14 1 77 12 CFG=1
M  V30 15 1 13 14
M  V30 16 1 74 13 CFG=1
M  V30 17 1 14 15
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 75 17 CFG=1
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 76 22 CFG=3
M  V30 25 1 83 22 CFG=3
M  V30 26 1 23 24
M  V30 27 1 78 23 CFG=3
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 1 27 28
M  V30 31 1 80 27 CFG=3
M  V30 32 1 28 29
M  V30 33 2 28 30
M  V30 34 1 81 31 CFG=3
M  V30 35 1 32 33
M  V30 36 1 84 32 CFG=1
M  V30 37 1 33 34
M  V30 38 2 33 35
M  V30 39 1 36 37
M  V30 40 1 82 36 CFG=1
M  V30 41 1 37 38
M  V30 42 2 37 39
M  V30 43 1 40 41
M  V30 44 1 86 40 CFG=1
M  V30 45 1 41 42
M  V30 46 2 41 43
M  V30 47 1 87 44 CFG=1
M  V30 48 1 45 46
M  V30 49 1 88 45 CFG=3
M  V30 50 1 46 47
M  V30 51 2 46 48
M  V30 52 1 49 50
M  V30 53 1 49 51
M  V30 54 2 49 52
M  V30 55 1 50 53
M  V30 56 1 50 54
M  V30 57 1 51 55
M  V30 58 1 51 56
M  V30 59 1 51 89 CFG=1
M  V30 60 1 52 57
M  V30 61 1 53 58
M  V30 62 1 53 59
M  V30 63 1 54 60
M  V30 64 1 55 60
M  V30 65 1 55 61
M  V30 66 1 56 62
M  V30 67 1 57 58
M  V30 68 1 58 63
M  V30 69 1 58 90 CFG=3
M  V30 70 1 59 64
M  V30 71 1 61 65
M  V30 72 1 62 65
M  V30 73 1 63 66
M  V30 74 1 63 67
M  V30 75 1 64 66
M  V30 76 1 66 68
M  V30 77 1 66 91 CFG=3
M  V30 78 1 67 69
M  V30 79 1 68 70
M  V30 80 1 69 70
M  V30 81 1 71 72
M  V30 82 1 71 73
M  V30 83 1 72 74
M  V30 84 1 73 75
M  V30 85 1 74 76
M  V30 86 1 75 76
M  V30 87 1 77 78
M  V30 88 1 77 79
M  V30 89 1 78 80
M  V30 90 1 79 81
M  V30 91 1 80 82
M  V30 92 1 81 82
M  V30 93 1 83 84
M  V30 94 1 83 85
M  V30 95 1 84 86
M  V30 96 1 85 87
M  V30 97 1 86 88
M  V30 98 1 87 88
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(25 50 51 53 55 56 58 62 63 66 70 71 72 74 75 76 77 78 80 81 82 83 84 86 87 88)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3α)-3-[(O-6-Deoxy-α-L-mannopyranosyl-(1→2)-O-[6-deoxy-α-L-mannopyranosyl-(1→...
C49H81NO15
2496395-05-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  68 75 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 13.3367 0.0 0
M  V30 2 N 0.7700 13.3367 0.0 0
M  V30 3 O 3.0800 14.6703 0.0 0
M  V30 4 C 0.0000 14.6703 0.0 0
M  V30 5 C 3.8500 8.0020 0.0 0
M  V30 6 C 6.2943 13.5372 0.0 0
M  V30 7 C 0.7700 8.0020 0.0 0
M  V30 8 C 7.5657 13.5372 0.0 0
M  V30 9 C 9.8757 9.1353 0.0 0
M  V30 10 C 13.7671 12.5297 0.0 0
M  V30 11 C 12.0527 13.5197 0.0 0
M  V30 12 O 14.6300 10.6694 0.0 0
M  V30 13 O 17.7100 10.6694 0.0 0
M  V30 14 O 19.2500 8.0020 0.0 0
M  V30 15 C 14.6300 5.3347 0.0 0
M  V30 16 O 13.0900 5.3347 0.0 0
M  V30 17 O 17.7100 5.3347 0.0 0
M  V30 18 O 19.2500 13.3367 0.0 0
M  V30 19 O 22.3300 13.3367 0.0 0
M  V30 20 C 22.3300 8.0020 0.0 0
M  V30 21 O 19.2500 2.6673 0.0 0
M  V30 22 O 23.8700 10.6694 0.0 0
M  V30 23 O 17.7100 0.0000 0.0 0
M  V30 24 C 13.0900 2.6673 0.0 0
M  V30 25 O 14.6300 0.0000 0.0 0
M  V30 26 C 3.0800 12.0031 0.0 0 CFG=1
M  V30 27 C 3.8500 10.6694 0.0 0 CFG=1
M  V30 28 C 3.8500 13.3367 0.0 0
M  V30 29 C 1.5400 12.0031 0.0 0
M  V30 30 C 5.3900 10.6694 0.0 0
M  V30 31 C 3.0800 9.3356 0.0 0 CFG=1
M  V30 32 C 5.3900 13.3367 0.0 0
M  V30 33 C 0.7700 10.6694 0.0 0
M  V30 34 C 6.1600 12.0031 0.0 0 CFG=1
M  V30 35 C 6.1600 9.3356 0.0 0
M  V30 36 C 1.5400 9.3356 0.0 0 CFG=2
M  V30 37 C 7.7000 12.0031 0.0 0 CFG=1
M  V30 38 C 7.7000 9.3356 0.0 0
M  V30 39 C 8.4700 10.6694 0.0 0 CFG=1
M  V30 40 C 8.4700 13.3367 0.0 0
M  V30 41 C 10.0100 10.6694 0.0 0 CFG=2
M  V30 42 C 10.0100 13.3367 0.0 0
M  V30 43 C 10.7800 12.0031 0.0 0 CFG=2
M  V30 44 C 10.7800 9.3356 0.0 0
M  V30 45 C 12.3200 12.0031 0.0 0
M  V30 46 C 12.3200 9.3356 0.0 0
M  V30 47 C 13.0900 10.6694 0.0 0 CFG=2
M  V30 48 C 15.4000 9.3356 0.0 0 CFG=2
M  V30 49 C 16.9400 9.3356 0.0 0 CFG=2
M  V30 50 O 14.6300 8.0020 0.0 0
M  V30 51 C 17.7100 8.0020 0.0 0 CFG=1
M  V30 52 C 15.4000 6.6684 0.0 0 CFG=2
M  V30 53 C 16.9400 6.6684 0.0 0 CFG=2
M  V30 54 C 19.2500 10.6694 0.0 0 CFG=2
M  V30 55 C 20.0200 12.0031 0.0 0 CFG=2
M  V30 56 O 20.0200 9.3356 0.0 0
M  V30 57 C 21.5600 12.0031 0.0 0 CFG=2
M  V30 58 C 21.5600 9.3356 0.0 0 CFG=1
M  V30 59 C 22.3300 10.6694 0.0 0 CFG=1
M  V30 60 C 16.9400 4.0009 0.0 0 CFG=2
M  V30 61 C 17.7100 2.6673 0.0 0 CFG=2
M  V30 62 O 15.4000 4.0009 0.0 0
M  V30 63 C 16.9400 1.3336 0.0 0 CFG=2
M  V30 64 C 14.6300 2.6673 0.0 0 CFG=1
M  V30 65 C 15.4000 1.3336 0.0 0 CFG=1
M  V30 66 H 4.6200 9.3356 0.0 0
M  V30 67 H 8.6043 9.1353 0.0 0
M  V30 68 H 11.5500 13.3367 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 26 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 31 5 CFG=1
M  V30 6 1 34 6 CFG=3
M  V30 7 1 36 7 CFG=3
M  V30 8 1 37 8 CFG=1
M  V30 9 1 41 9 CFG=1
M  V30 10 1 10 45
M  V30 11 1 11 45
M  V30 12 1 47 12 CFG=3
M  V30 13 1 48 12 CFG=1
M  V30 14 1 49 13 CFG=3
M  V30 15 1 54 13 CFG=1
M  V30 16 1 51 14 CFG=1
M  V30 17 1 15 16
M  V30 18 1 52 15 CFG=1
M  V30 19 1 53 17 CFG=3
M  V30 20 1 60 17 CFG=1
M  V30 21 1 55 18 CFG=3
M  V30 22 1 57 19 CFG=3
M  V30 23 1 58 20 CFG=3
M  V30 24 1 61 21 CFG=3
M  V30 25 1 59 22 CFG=1
M  V30 26 1 63 23 CFG=3
M  V30 27 1 64 24 CFG=3
M  V30 28 1 65 25 CFG=1
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 29
M  V30 32 1 27 30
M  V30 33 1 27 31
M  V30 34 1 27 66 CFG=1
M  V30 35 1 28 32
M  V30 36 1 29 33
M  V30 37 1 30 34
M  V30 38 2 30 35
M  V30 39 1 31 36
M  V30 40 1 32 34
M  V30 41 1 33 36
M  V30 42 1 34 37
M  V30 43 1 35 38
M  V30 44 1 37 39
M  V30 45 1 37 40
M  V30 46 1 38 39
M  V30 47 1 39 41
M  V30 48 1 39 67 CFG=3
M  V30 49 1 40 42
M  V30 50 1 41 43
M  V30 51 1 41 44
M  V30 52 1 42 43
M  V30 53 1 43 45
M  V30 54 1 43 68 CFG=3
M  V30 55 1 44 46
M  V30 56 1 45 47
M  V30 57 1 46 47
M  V30 58 1 48 49
M  V30 59 1 48 50
M  V30 60 1 49 51
M  V30 61 1 50 52
M  V30 62 1 51 53
M  V30 63 1 52 53
M  V30 64 1 54 55
M  V30 65 1 54 56
M  V30 66 1 55 57
M  V30 67 1 56 58
M  V30 68 1 57 59
M  V30 69 1 58 59
M  V30 70 1 60 61
M  V30 71 1 60 62
M  V30 72 1 61 63
M  V30 73 1 62 64
M  V30 74 1 63 65
M  V30 75 1 64 65
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(25 26 27 31 34 36 37 39 41 43 47 48 49 51 52 53 54 55 57 58 59 60 61 63 64 65)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2496395-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2496395-05-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-352-CAS-22883213
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 69011-20-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM dowex 50*8 resin in H+ form used in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-aided optimization of 3-O-β-chacotriosyl epiursolic acid
derivatives as novel H5N1 virus entry inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Sumei; Jia, Xiuhua; Li, Hui; Ye, Yilu; Zhang, Xuesha; Gao, Yongfeng;
Guo, Guoqing; Liu, Shuwen; Song, Gaopeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(22), 127518

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-iodophenoxy)thieno[2,3-c]pyridine-2-carboxylate
C15H10INO3S
251996-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 O 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 I 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Iodophenoxy)-N-methylthieno[2,3-c]pyridine-2-carboxamide
C15H11IN2O2S
251996-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 N 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 I 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 2.6673 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 2.6673 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251996-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251996-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17637605
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stewart, Andrew O.; Boyd, Steven A.; Arendsen, David L.; Bhatia, Pramila;
Condroski, Kevin R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Zhu,
Gui-dong; Lartey, Kraig; Mccarty, Catherine M.; Mort, Nicholas A.; Patel,
Meena V.; Staeger, Michael A.; Stout, David M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6232320 B1 2001-05-15

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-iodophenoxy)thieno[2,3-c]pyridine-2-carboxylate
C15H10INO3S
251996-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 O 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 I 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 2.6673 0.0 0
M  V30 18 C 3.8500 5.3347 0.0 0
M  V30 19 C 2.3100 2.6673 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Iodophenoxy)-N-methylthieno[2,3-c]pyridine-2-carboxamide
C15H11IN2O2S
251996-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0009 0.0 0
M  V30 2 C 12.2410 3.9553 0.0 0
M  V30 3 N 13.5748 3.1853 0.0 0
M  V30 4 O 12.2410 5.4953 0.0 0
M  V30 5 C 14.9084 3.9553 0.0 0
M  V30 6 I 0.0000 4.0009 0.0 0
M  V30 7 C 8.4700 2.6673 0.0 0
M  V30 8 C 9.2400 1.3336 0.0 0
M  V30 9 C 6.9300 2.6673 0.0 0
M  V30 10 C 9.5006 3.8118 0.0 0
M  V30 11 S 10.7464 1.6538 0.0 0
M  V30 12 C 8.4700 0.0000 0.0 0
M  V30 13 C 6.1600 1.3336 0.0 0
M  V30 14 C 10.9074 3.1853 0.0 0
M  V30 15 N 6.9300 0.0000 0.0 0
M  V30 16 C 4.6200 4.0009 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 2.6673 0.0 0
M  V30 19 C 2.3100 5.3347 0.0 0
M  V30 20 C 2.3100 2.6673 0.0 0
M  V30 21 C 1.5400 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 251996-52-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251996-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2472718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 190B.
N-Methyl-4-[4-(4-iodophenoxy)]thieno[2,3-c]pyridine-2-carboxamide. A
solution of Example 190A (1.4 g, 3.4 mmol) in methylamine/methanol (2.0 M
solution, 70 mL) was stirred at 45°C for 15 hours, and concentrated under
vacuum. The residue was flash chromatographed on silica gel with
EtOAc/hexane (1.5/1) to provide the designated compound. Yield: (1.3 g,
93%). MS (DCI/NH3) m/e: 411 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridines and thienopyrimidines as cell
adhesion-inhibiting antiinflammatory compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Arendsen, David L.; Bhatia, Pramila; Boyd, Steven A.; Condroski, Kevin
R.; Freeman, Jennifer C.; Gunawardana, Indrani W.; Lartey, Kraig;
McCarty, Catherine M.; Mort, Nicholas A.; Patel, Meena V.; Staeger,
Michael A.; Stewart, Andrew O.; Stout, David M.; Zhu, Gui-Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000075145 A1 2000-12-14

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C30H34N4O6S
254738-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 O 7.0497 13.1325 0.0 0
M  V30 9 O 4.7397 11.7987 0.0 0
M  V30 10 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 11 N 12.4397 9.1314 0.0 0
M  V30 12 O 10.3360 9.6951 0.0 0
M  V30 13 O 13.0033 11.2351 0.0 0
M  V30 14 C 14.4090 6.4209 0.0 0
M  V30 15 C 17.5954 7.4562 0.0 0
M  V30 16 C 2.3699 7.2340 0.0 0
M  V30 17 C 3.8344 7.7099 0.0 0
M  V30 18 N 2.3699 5.6940 0.0 0
M  V30 19 C 2.3699 8.7740 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 N 4.7397 6.4640 0.0 0
M  V30 22 C 3.8344 5.2181 0.0 0
M  V30 23 C 0.9052 9.2500 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 7.0497 7.7978 0.0 0
M  V30 26 C 6.2797 9.1314 0.0 0
M  V30 27 C 8.5897 7.7978 0.0 0
M  V30 28 C 7.0497 10.4651 0.0 0
M  V30 29 C 9.3597 9.1314 0.0 0
M  V30 30 C 8.5897 10.4651 0.0 0
M  V30 31 C 9.3597 11.7987 0.0 0
M  V30 32 C 10.8997 11.7987 0.0 0
M  V30 33 C 8.5897 13.1325 0.0 0
M  V30 34 C 11.6697 13.1325 0.0 0
M  V30 35 C 9.3597 14.4661 0.0 0
M  V30 36 C 10.8997 14.4661 0.0 0
M  V30 37 C 13.9797 9.1314 0.0 0
M  V30 38 C 14.8849 7.8856 0.0 0
M  V30 39 O 14.8849 10.3773 0.0 0
M  V30 40 C 16.3496 8.3614 0.0 0
M  V30 41 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 21
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 28
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 10 32
M  V30 15 1 11 37
M  V30 16 1 14 38
M  V30 17 1 15 40
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 30 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C31H37N5O5S
254739-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 N 4.7397 11.7987 0.0 0
M  V30 9 O 7.0497 13.1325 0.0 0
M  V30 10 C 3.9697 13.1325 0.0 0
M  V30 11 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 12 N 12.4397 9.1314 0.0 0
M  V30 13 O 10.3360 9.6951 0.0 0
M  V30 14 O 13.0033 11.2351 0.0 0
M  V30 15 C 14.4090 6.4209 0.0 0
M  V30 16 C 17.5954 7.4562 0.0 0
M  V30 17 C 2.3699 7.2340 0.0 0
M  V30 18 C 3.8344 7.7100 0.0 0
M  V30 19 N 2.3699 5.6940 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 C 2.3699 8.7740 0.0 0
M  V30 22 N 4.7397 6.4640 0.0 0
M  V30 23 C 3.8344 5.2181 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 0.9052 9.2500 0.0 0
M  V30 26 C 7.0497 7.7978 0.0 0
M  V30 27 C 6.2797 9.1314 0.0 0
M  V30 28 C 8.5897 7.7978 0.0 0
M  V30 29 C 7.0497 10.4651 0.0 0
M  V30 30 C 9.3597 9.1314 0.0 0
M  V30 31 C 8.5897 10.4651 0.0 0
M  V30 32 C 9.3597 11.7987 0.0 0
M  V30 33 C 10.8997 11.7987 0.0 0
M  V30 34 C 8.5897 13.1325 0.0 0
M  V30 35 C 11.6697 13.1325 0.0 0
M  V30 36 C 9.3597 14.4661 0.0 0
M  V30 37 C 10.8997 14.4661 0.0 0
M  V30 38 C 13.9797 9.1314 0.0 0
M  V30 39 C 14.8849 7.8856 0.0 0
M  V30 40 O 14.8849 10.3773 0.0 0
M  V30 41 C 16.3496 8.3614 0.0 0
M  V30 42 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 22
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 29
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 33
M  V30 16 1 12 38
M  V30 17 1 15 39
M  V30 18 1 16 41
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 254738-93-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 254739-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8348400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Method 12: Amide Formation using
1,1′-Carbonyldiimidazole 1,1′-Carbonyldiimidazole (2.0 eq) was added to a
0.1 M solution or suspension of an appropriate carboxylic acid (1.0 eq)
in THF. The mixture was heated at 50° C. for 1 h, and was then cooled to
RT. An appropriate amine (5-10 eq) was then added, and the mixture was
stirred at RT for 12 h. Ethyl acetate and aqueous sodium bicarbonate
solution were added and the aqueous layer was extracted with ethyl
acetate. The combined organic layers were dried over sodium sulfate and
concentrated. The residue was purified by reverse-phase preparative HPLC
or by silica gel chromatography.
2′-[(3,3-Dimethyl-2-oxopyrrolidin-1-yl)methyl]-4′-[(2-ethoxy-7-(N-methylcarbamoyl)benzimidazol-1-yl)methyl]-N-(3,4-dimethyl-5-isoxazolyl)-[1,1′-biphenyl]-2-sulfonamide
33 (80 mg) was subjected to amide formation according to General Method
12 using methylamine as the amine component. The product was purified by
reverse-phase preparative HPLC. * A. Linear gradient of 0 to 100% solvent
B over 4 min, with 1 min hold at 100% B; * UV visualization at 220 nm *
Column: YMC S5 ODS Ballistic 4.6×50 mm * Flowrate: 4 ml/min * Solvent A:
0.1% trifluoroacetic acid, 90% water, 10% methanol * Solvent B: 0.1%
trifluoroacetic acid, 90% methanol, 10% water. STARTING EXAMPLE 150 * A.
Linear gradient of 0 to 100% solvent B over 4 min, with 1 min hold at
100% B; * UV visualization at 220 nm * Column: YMC S5 ODS Ballistic
4.6×50 mm * Flowrate: 4 ml/min * Solvent A: 0.1% trifluoroacetic acid,
90% water, 10% methanol * Solvent B: 0.1% trifluoroacetic acid, 90%
methanol, 10% water.
N-Methyl-4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl-5-iso-xazolyl)amino]sulfonyl][1,1′-biphenyl]-2-carboxamide
(MH)-592; HPLC 3.17 (A)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as
dual angiotensin II and endothelin receptor antagonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Tellew, John E.; Macor, Jhon E.; Gu, Zhengxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020143024 A1 2002-10-03

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C30H34N4O6S
254738-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 O 7.0497 13.1325 0.0 0
M  V30 9 O 4.7397 11.7987 0.0 0
M  V30 10 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 11 N 12.4397 9.1314 0.0 0
M  V30 12 O 10.3360 9.6951 0.0 0
M  V30 13 O 13.0033 11.2351 0.0 0
M  V30 14 C 14.4090 6.4209 0.0 0
M  V30 15 C 17.5954 7.4562 0.0 0
M  V30 16 C 2.3699 7.2340 0.0 0
M  V30 17 C 3.8344 7.7099 0.0 0
M  V30 18 N 2.3699 5.6940 0.0 0
M  V30 19 C 2.3699 8.7740 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 N 4.7397 6.4640 0.0 0
M  V30 22 C 3.8344 5.2181 0.0 0
M  V30 23 C 0.9052 9.2500 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 7.0497 7.7978 0.0 0
M  V30 26 C 6.2797 9.1314 0.0 0
M  V30 27 C 8.5897 7.7978 0.0 0
M  V30 28 C 7.0497 10.4651 0.0 0
M  V30 29 C 9.3597 9.1314 0.0 0
M  V30 30 C 8.5897 10.4651 0.0 0
M  V30 31 C 9.3597 11.7987 0.0 0
M  V30 32 C 10.8997 11.7987 0.0 0
M  V30 33 C 8.5897 13.1325 0.0 0
M  V30 34 C 11.6697 13.1325 0.0 0
M  V30 35 C 9.3597 14.4661 0.0 0
M  V30 36 C 10.8997 14.4661 0.0 0
M  V30 37 C 13.9797 9.1314 0.0 0
M  V30 38 C 14.8849 7.8856 0.0 0
M  V30 39 O 14.8849 10.3773 0.0 0
M  V30 40 C 16.3496 8.3614 0.0 0
M  V30 41 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 21
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 28
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 10 32
M  V30 15 1 11 37
M  V30 16 1 14 38
M  V30 17 1 15 40
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 30 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C31H37N5O5S
254739-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 N 4.7397 11.7987 0.0 0
M  V30 9 O 7.0497 13.1325 0.0 0
M  V30 10 C 3.9697 13.1325 0.0 0
M  V30 11 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 12 N 12.4397 9.1314 0.0 0
M  V30 13 O 10.3360 9.6951 0.0 0
M  V30 14 O 13.0033 11.2351 0.0 0
M  V30 15 C 14.4090 6.4209 0.0 0
M  V30 16 C 17.5954 7.4562 0.0 0
M  V30 17 C 2.3699 7.2340 0.0 0
M  V30 18 C 3.8344 7.7100 0.0 0
M  V30 19 N 2.3699 5.6940 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 C 2.3699 8.7740 0.0 0
M  V30 22 N 4.7397 6.4640 0.0 0
M  V30 23 C 3.8344 5.2181 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 0.9052 9.2500 0.0 0
M  V30 26 C 7.0497 7.7978 0.0 0
M  V30 27 C 6.2797 9.1314 0.0 0
M  V30 28 C 8.5897 7.7978 0.0 0
M  V30 29 C 7.0497 10.4651 0.0 0
M  V30 30 C 9.3597 9.1314 0.0 0
M  V30 31 C 8.5897 10.4651 0.0 0
M  V30 32 C 9.3597 11.7987 0.0 0
M  V30 33 C 10.8997 11.7987 0.0 0
M  V30 34 C 8.5897 13.1325 0.0 0
M  V30 35 C 11.6697 13.1325 0.0 0
M  V30 36 C 9.3597 14.4661 0.0 0
M  V30 37 C 10.8997 14.4661 0.0 0
M  V30 38 C 13.9797 9.1314 0.0 0
M  V30 39 C 14.8849 7.8856 0.0 0
M  V30 40 O 14.8849 10.3773 0.0 0
M  V30 41 C 16.3496 8.3614 0.0 0
M  V30 42 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 22
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 29
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 33
M  V30 16 1 12 38
M  V30 17 1 15 39
M  V30 18 1 16 41
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 254738-93-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 254739-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8865401
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Method 12: Amide Formation using
1,1'-Carbonyldiimidazole 1,1'-Carbonyldiimidazole (2.0 eq) was added to a
0.1 M solution or suspension of an appropriate carboxylic acid (1.0 eq)
in THF. The mixture was heated at 50 °C for 1h, and was then cooled to
RT. An appropriate amine (5-10 eq) was then added, and the miture was
stirred at RT for 12 h. Ethyl acetate and aqueous sodium bicarbonate
solution were added and the aqueous layer was extracted with ethyl
acetate. The combined organic layers were dried over sodium sulfate and
concentrated. The residue was purified by reverse-phase preparative HPLC
or by silica gel chromatography. Example: 150,
N-Methy4-[(2-buty4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2'-[
[(3,4-dimethy5-isoxazolyl)amino]sulfonyl][1,1'-biphenyl]-2-carboxamide,
yield 93%. M/z (MH)- 592 HPLC % Purity: 99 HPLC ret time, (method) 3.17
(A).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as
dual angiotensin II and endothelin receptor antagonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Tellew, John E.; Macor, John E.; Gu, Zhengxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001044239 A2 2001-06-21

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C30H34N4O6S
254738-93-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 O 7.0497 13.1325 0.0 0
M  V30 9 O 4.7397 11.7987 0.0 0
M  V30 10 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 11 N 12.4397 9.1314 0.0 0
M  V30 12 O 10.3360 9.6951 0.0 0
M  V30 13 O 13.0033 11.2351 0.0 0
M  V30 14 C 14.4090 6.4209 0.0 0
M  V30 15 C 17.5954 7.4562 0.0 0
M  V30 16 C 2.3699 7.2340 0.0 0
M  V30 17 C 3.8344 7.7099 0.0 0
M  V30 18 N 2.3699 5.6940 0.0 0
M  V30 19 C 2.3699 8.7740 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 N 4.7397 6.4640 0.0 0
M  V30 22 C 3.8344 5.2181 0.0 0
M  V30 23 C 0.9052 9.2500 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 7.0497 7.7978 0.0 0
M  V30 26 C 6.2797 9.1314 0.0 0
M  V30 27 C 8.5897 7.7978 0.0 0
M  V30 28 C 7.0497 10.4651 0.0 0
M  V30 29 C 9.3597 9.1314 0.0 0
M  V30 30 C 8.5897 10.4651 0.0 0
M  V30 31 C 9.3597 11.7987 0.0 0
M  V30 32 C 10.8997 11.7987 0.0 0
M  V30 33 C 8.5897 13.1325 0.0 0
M  V30 34 C 11.6697 13.1325 0.0 0
M  V30 35 C 9.3597 14.4661 0.0 0
M  V30 36 C 10.8997 14.4661 0.0 0
M  V30 37 C 13.9797 9.1314 0.0 0
M  V30 38 C 14.8849 7.8856 0.0 0
M  V30 39 O 14.8849 10.3773 0.0 0
M  V30 40 C 16.3496 8.3614 0.0 0
M  V30 41 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 21
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 3 22
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 28
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 10 13
M  V30 14 1 10 32
M  V30 15 1 11 37
M  V30 16 1 14 38
M  V30 17 1 15 40
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 22
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 30 31
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl...
C31H37N5O5S
254739-35-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3103 9.1746 0.0 0
M  V30 2 C 6.2797 6.4640 0.0 0
M  V30 3 C 4.3103 3.7536 0.0 0
M  V30 4 C 3.2799 2.6091 0.0 0
M  V30 5 C 3.7558 1.1445 0.0 0
M  V30 6 C 2.7253 0.0000 0.0 0
M  V30 7 C 6.2797 11.7987 0.0 0
M  V30 8 N 4.7397 11.7987 0.0 0
M  V30 9 O 7.0497 13.1325 0.0 0
M  V30 10 C 3.9697 13.1325 0.0 0
M  V30 11 S 11.6697 10.4651 0.0 0 VAL=6
M  V30 12 N 12.4397 9.1314 0.0 0
M  V30 13 O 10.3360 9.6951 0.0 0
M  V30 14 O 13.0033 11.2351 0.0 0
M  V30 15 C 14.4090 6.4209 0.0 0
M  V30 16 C 17.5954 7.4562 0.0 0
M  V30 17 C 2.3699 7.2340 0.0 0
M  V30 18 C 3.8344 7.7100 0.0 0
M  V30 19 N 2.3699 5.6940 0.0 0
M  V30 20 C 0.9052 6.7581 0.0 0
M  V30 21 C 2.3699 8.7740 0.0 0
M  V30 22 N 4.7397 6.4640 0.0 0
M  V30 23 C 3.8344 5.2181 0.0 0
M  V30 24 C 0.0000 8.0040 0.0 0
M  V30 25 C 0.9052 9.2500 0.0 0
M  V30 26 C 7.0497 7.7978 0.0 0
M  V30 27 C 6.2797 9.1314 0.0 0
M  V30 28 C 8.5897 7.7978 0.0 0
M  V30 29 C 7.0497 10.4651 0.0 0
M  V30 30 C 9.3597 9.1314 0.0 0
M  V30 31 C 8.5897 10.4651 0.0 0
M  V30 32 C 9.3597 11.7987 0.0 0
M  V30 33 C 10.8997 11.7987 0.0 0
M  V30 34 C 8.5897 13.1325 0.0 0
M  V30 35 C 11.6697 13.1325 0.0 0
M  V30 36 C 9.3597 14.4661 0.0 0
M  V30 37 C 10.8997 14.4661 0.0 0
M  V30 38 C 13.9797 9.1314 0.0 0
M  V30 39 C 14.8849 7.8856 0.0 0
M  V30 40 O 14.8849 10.3773 0.0 0
M  V30 41 C 16.3496 8.3614 0.0 0
M  V30 42 N 16.3496 9.9014 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 22
M  V30 3 1 2 26
M  V30 4 1 3 4
M  V30 5 1 3 23
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 29
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 11 14
M  V30 15 1 11 33
M  V30 16 1 12 38
M  V30 17 1 15 39
M  V30 18 1 16 41
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 31 32
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 254738-93-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 254739-35-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15322952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Method 13: Benzylic Bromination Using
N-Bromosuccinimide To a 0.4 M solution of a methyl-substituted aromatic
compound in carbon tetrachloride was added N-bromosuccinimide (1.05 eq)
and benzoyl peroxide (0.03 eq), and the mixture was heated at reflux for
8-16 h. The mixture was cooled and filtered and the filtrate
concentrated. The residue was purified by trituration with 3:1
hexanes/ethyl acetate, or by silica gel chromatography using
hexanes/ethyl acetate as eluant, The mono-brominated product. A.
4-Bromo-3-(bromomethyl)benzonitrile The product was prepared according to
General Method 13 starting from 19.6 g 4-bromo-3-methylbenzonitrile.
After cooling the mixture was filtered and the filtrate was washed with
H2O and brine, dried and concentrated. The residue was chromatographed on
silica gel using 100:3 and then 100:10 hexane/EtOAc. Ex No 150
N-Methyl-4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2′-[[(3,4-dimethyl-5-iso-xazolyl)amino]sulfonyl][1,1′-biphenyl]-2-carboxamide
Yield 93%; HPLC Purity 99% A. Linear gradient of 0 to 100% solvent B over
4 min, with 1 min hold at 100% B; UV visualization at 220 nm Column: YMC
S5 ODS Ballistic 4.6×50 mm Flowrate: 4 ml/min Solvent A: 0.1%
trifluoroacetic acid, 90% water, 10% methanol Solvent B: 0.1%
trifluoroacetic acid, 90% methanol, 10% water. HPLC Retention Time 3.17
min; LRMS m/z 592 [MH+].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-isoxazolyl biphenylsulfonamides and related compounds as
dual angiotensin II and endothelin receptor antagonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Murugesan, Natesan; Tellew, John E.; Macor, John E.; Gu, Zhengxiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000001389 A1 2000-01-13

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl β-(acetyloxy)-2-fluoro-α-methylene-5-nitrobenzenepropanoate
C14H14FNO6
2565611-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.8500 0.0 0
M  V30 2 C 8.0021 4.6201 0.0 0
M  V30 3 O 6.6684 2.3100 0.0 0
M  V30 4 C 9.3359 3.8500 0.0 0
M  V30 5 C 8.0021 6.1601 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 O 10.6695 4.6201 0.0 0
M  V30 8 O 9.3359 2.3100 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 4.0010 2.3100 0.0 0
M  V30 11 C 12.0032 3.8500 0.0 0
M  V30 12 C 13.3369 4.6201 0.0 0
M  V30 13 F 6.6684 6.9301 0.0 0
M  V30 14 N 1.3337 3.8500 0.0 0 VAL=5
M  V30 15 O 1.3337 2.3100 0.0 0
M  V30 16 O 0.0000 4.6201 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 4.0010 3.8500 0.0 0
M  V30 19 C 5.3348 6.1601 0.0 0
M  V30 20 C 2.6673 4.6201 0.0 0
M  V30 21 C 4.0010 6.9301 0.0 0
M  V30 22 C 2.6673 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 2 14 16
M  V30 16 1 14 20
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1,2-dihydro-1-methyl-6-nitro-3-quinolinecarboxylate
C13H14N2O4
2633025-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 13.3370 3.8501 0.0 0
M  V30 7 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 N 6.6685 1.5400 0.0 0
M  V30 13 C 4.0010 1.5400 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 8.0022 2.3101 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 18 C 8.0022 3.8501 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2565611-21-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2633025-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23513445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydroquinolines, dihydronaphthyridines and quinolones by domino
reactions of Morita-Baylis-Hillman acetates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annor-Gyamfi, Joel K.; Ametsetor, Ebenezer; Meraz, Kevin; Bunce, Richard
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(4), 890

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-[[(6-bromo-8-quinolinyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-hyd...
C20H16BrFN2O5S
2596364-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.1838 0.0 0 VAL=6
M  V30 2 N 6.6685 5.9538 0.0 0
M  V30 3 O 4.5648 6.5174 0.0 0
M  V30 4 O 6.1048 3.8501 0.0 0
M  V30 5 Br 2.6673 0.5637 0.0 0
M  V30 6 O 9.3358 7.4938 0.0 0
M  V30 7 C 12.0033 5.9538 0.0 0
M  V30 8 O 13.3370 5.1838 0.0 0
M  V30 9 O 12.0033 7.4938 0.0 0
M  V30 10 C 14.6707 5.9538 0.0 0
M  V30 11 F 12.0033 2.8737 0.0 0
M  V30 12 C 2.6673 5.1838 0.0 0
M  V30 13 C 4.0010 4.4137 0.0 0
M  V30 14 C 1.3337 4.4137 0.0 0
M  V30 15 N 2.6673 6.7238 0.0 0
M  V30 16 C 4.0010 2.8737 0.0 0
M  V30 17 C 1.3337 2.8737 0.0 0
M  V30 18 C 0.0000 5.1838 0.0 0
M  V30 19 C 1.3337 7.4938 0.0 0
M  V30 20 C 2.6673 2.1037 0.0 0
M  V30 21 C 0.0000 6.7238 0.0 0
M  V30 22 C 8.0022 5.1838 0.0 0
M  V30 23 C 8.0022 3.6437 0.0 0
M  V30 24 C 9.3358 5.9538 0.0 0
M  V30 25 C 9.3358 2.8737 0.0 0
M  V30 26 C 10.6697 5.1838 0.0 0
M  V30 27 C 10.6697 3.6437 0.0 0
M  V30 28 C 9.3358 1.3337 0.0 0
M  V30 29 C 8.5658 0.0000 0.0 0
M  V30 30 C 10.1059 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 22
M  V30 6 1 5 20
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[[(6-Bromo-8-quinolinyl)sulfonyl]amino]-5-cyclopropyl-6-fluoro-2-hydroxy-N-...
C20H17BrFN3O4S
2596361-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 5.1838 0.0 0 VAL=6
M  V30 2 N 6.6685 5.9538 0.0 0
M  V30 3 O 6.1048 3.8501 0.0 0
M  V30 4 O 4.5648 6.5174 0.0 0
M  V30 5 Br 2.6673 0.5637 0.0 0
M  V30 6 O 9.3358 7.4938 0.0 0
M  V30 7 C 12.0033 5.9538 0.0 0
M  V30 8 N 13.3370 5.1838 0.0 0
M  V30 9 O 12.0033 7.4938 0.0 0
M  V30 10 C 14.6707 5.9538 0.0 0
M  V30 11 F 12.0033 2.8737 0.0 0
M  V30 12 C 2.6673 5.1838 0.0 0
M  V30 13 C 4.0010 4.4137 0.0 0
M  V30 14 C 1.3337 4.4137 0.0 0
M  V30 15 N 2.6673 6.7238 0.0 0
M  V30 16 C 4.0010 2.8737 0.0 0
M  V30 17 C 1.3337 2.8737 0.0 0
M  V30 18 C 0.0000 5.1838 0.0 0
M  V30 19 C 1.3337 7.4938 0.0 0
M  V30 20 C 2.6673 2.1037 0.0 0
M  V30 21 C 0.0000 6.7238 0.0 0
M  V30 22 C 8.0022 5.1838 0.0 0
M  V30 23 C 8.0022 3.6437 0.0 0
M  V30 24 C 9.3358 5.9538 0.0 0
M  V30 25 C 9.3358 2.8737 0.0 0
M  V30 26 C 10.6697 5.1838 0.0 0
M  V30 27 C 10.6697 3.6437 0.0 0
M  V30 28 C 9.3358 1.3337 0.0 0
M  V30 29 C 10.1059 0.0000 0.0 0
M  V30 30 C 8.5658 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 22
M  V30 6 1 5 20
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 26
M  V30 11 1 8 10
M  V30 12 1 11 27
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 2 17 20
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 25 28
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2596364-26-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2596361-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23483657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted N-phenyl sulfonamides as WDR5-MYC inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tansey, William P.; Fesik, Stephen W.; Stauffer, Shaun R.; Waterson, Alex
G.; Han, Changho; Alvarado, Joseph R.; Macdonald, Jonathan D.; Chacon
Simon, Selena; Nikhar, Sameer S.; Kuznetsov, Alexey
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021021951 A1 2021-02-04

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carbonyl azide, 5-bromo-
C9H5BrN4O
2638559-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 3.1885 0.0 0
M  V30 2 N 7.1955 2.7126 0.0 0
M  V30 3 O 5.4107 4.6948 0.0 0
M  V30 4 N 8.3400 3.7430 0.0 0 CHG=1 VAL=4
M  V30 5 N 9.4844 4.7735 0.0 0 CHG=-1
M  V30 6 Br 0.0000 5.1455 0.0 0
M  V30 7 C 3.0801 2.4782 0.0 0
M  V30 8 C 4.5864 2.1579 0.0 0
M  V30 9 C 2.3100 1.1444 0.0 0
M  V30 10 C 2.3100 3.8119 0.0 0
M  V30 11 C 4.7474 0.6263 0.0 0
M  V30 12 N 3.3405 0.0000 0.0 0
M  V30 13 C 0.7700 1.1444 0.0 0
M  V30 14 C 0.7700 3.8119 0.0 0
M  V30 15 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-1H-indol-3-yl)-N′-methylurea
C10H10BrN3O
2801650-79-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.7308 1.9570 0.0 0
M  V30 2 C 7.1954 2.4329 0.0 0
M  V30 3 N 8.3398 1.4025 0.0 0
M  V30 4 O 7.5156 3.9393 0.0 0
M  V30 5 C 9.8045 1.8783 0.0 0
M  V30 6 Br 0.0000 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 4.0010 0.0 0
M  V30 9 C 4.5864 2.9876 0.0 0
M  V30 10 C 2.3100 1.3336 0.0 0
M  V30 11 N 3.3405 5.1454 0.0 0
M  V30 12 C 0.7700 4.0010 0.0 0
M  V30 13 C 4.7473 4.5191 0.0 0
M  V30 14 C 0.7700 1.3336 0.0 0
M  V30 15 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2638559-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2801650-79-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34227431
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterobicyclic compounds having an urea or analogue and their
compositions for treating conditions associated with STING activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Venkatraman, Shankar; Katz, Jason; Roush, William R.; Seidel, Hans Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022150585 A1 2022-07-14

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4′-[(phenoxycarbonyl)amino]spiro[cycloheptane-1,2′(1′H)-naphthalene]-3′...
C26H29NO4
2639887-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6403 3.0800 0.0 0
M  V30 2 O 5.9740 2.3100 0.0 0
M  V30 3 O 3.3067 2.3100 0.0 0
M  V30 4 C 5.9740 0.7700 0.0 0
M  V30 5 C 7.3078 0.0000 0.0 0
M  V30 6 N 7.3078 4.6200 0.0 0
M  V30 7 C 8.6414 5.3900 0.0 0
M  V30 8 O 9.9750 4.6200 0.0 0
M  V30 9 O 8.6414 6.9300 0.0 0
M  V30 10 C 4.6403 4.6200 0.0 0
M  V30 11 C 3.3067 5.3900 0.0 0
M  V30 12 C 5.9740 5.3900 0.0 0
M  V30 13 C 3.3067 6.9300 0.0 0
M  V30 14 C 3.4217 3.8543 0.0 0
M  V30 15 C 2.0342 6.2575 0.0 0
M  V30 16 C 5.9740 6.9300 0.0 0
M  V30 17 C 4.6403 7.7000 0.0 0
M  V30 18 C 2.2929 2.8068 0.0 0
M  V30 19 C 0.5627 5.8036 0.0 0
M  V30 20 C 7.3078 7.7000 0.0 0
M  V30 21 C 4.6403 9.2400 0.0 0
M  V30 22 C 0.7700 3.0364 0.0 0
M  V30 23 C 0.0000 4.3701 0.0 0
M  V30 24 C 7.3078 9.2400 0.0 0
M  V30 25 C 5.9740 10.0100 0.0 0
M  V30 26 C 11.3087 5.3900 0.0 0
M  V30 27 C 11.3087 6.9300 0.0 0
M  V30 28 C 12.6425 4.6200 0.0 0
M  V30 29 C 12.6425 7.7000 0.0 0
M  V30 30 C 13.9761 5.3900 0.0 0
M  V30 31 C 13.9761 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 26
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 2 16 20
M  V30 22 2 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 25
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H22N2O2
2924010-81-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 3.3065 0.0 0
M  V30 2 C 0.0000 5.9740 0.0 0
M  V30 3 O 1.5400 8.6412 0.0 0
M  V30 4 C 3.8500 4.6403 0.0 0
M  V30 5 C 4.6200 3.3065 0.0 0
M  V30 6 C 4.6200 5.9740 0.0 0
M  V30 7 C 2.3100 4.6403 0.0 0
M  V30 8 C 6.1600 3.3065 0.0 0
M  V30 9 C 3.0843 3.4217 0.0 0
M  V30 10 C 5.4875 2.0342 0.0 0
M  V30 11 C 6.1600 5.9740 0.0 0
M  V30 12 N 3.8500 7.3076 0.0 0
M  V30 13 N 1.5400 5.9740 0.0 0
M  V30 14 C 6.9300 4.6403 0.0 0
M  V30 15 C 2.0368 2.2928 0.0 0
M  V30 16 C 5.0336 0.5626 0.0 0
M  V30 17 C 6.9300 7.3076 0.0 0
M  V30 18 C 2.3100 7.3076 0.0 0
M  V30 19 C 8.4700 4.6403 0.0 0
M  V30 20 C 2.2664 0.7700 0.0 0
M  V30 21 C 3.6001 0.0000 0.0 0
M  V30 22 C 8.4700 7.3076 0.0 0
M  V30 23 C 9.2400 5.9740 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 13
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 14
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 1 13 18
M  V30 20 2 14 19
M  V30 21 1 15 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 19 23
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2639887-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2924010-81-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36872056
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Activity of 3-Substituted 1H-Spiro[Benzo[h
]-Quinazoline-5,1'-Cycloheptane]-2,4(3H,6H)-Diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Markosyan, A. I.; Ayvazyan, A. S.; Gabrielyan, S. H.; Mamyan, S. S.;
Arsenyan, F. H.; Muradyan, R. E.; Avakimyan, J. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2020), 54(5), 449-454

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-phenyl-2-pyridineacetate
C14H13NO2
26483-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 O 6.6686 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 C 8.0022 5.3901 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 N 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-phenyl-2-pyridineacetamide
C14H14N2O
2414044-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6201 0.0 0
M  V30 2 C 5.3348 5.3901 0.0 0
M  V30 3 N 6.6686 4.6201 0.0 0
M  V30 4 O 5.3348 6.9301 0.0 0
M  V30 5 C 8.0022 5.3901 0.0 0
M  V30 6 C 4.0011 3.0800 0.0 0
M  V30 7 C 5.3348 2.3100 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 N 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 C 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26483-64-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414044-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22373227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 5807-14-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationship and cardiac safety of
2-aryl-2-(pyridin-2-yl)acetamides as a new class of broad-spectrum
anticonvulsants derived from Disopyramide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dawidowski, Maciej; Krol, Marek; Szulczyk, Bartlomiej; Chodkowski,
Andrzej; Podsadni, Piotr; Konopelski, Piotr; Ufnal, Marcin; Szuberski,
Piotr; Wrobel, Martyna Zofia; Zhang, Yihong; El Harchi, Aziza; Hancox,
Jules C.; Jarkovska, Dagmar; Mistrova, Eliska; Sviglerova, Jitka; Stengl,
Milan; Popowicz, Grzegorz M.; Turlo, Jadwiga
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic Chemistry (2020), 98103717

$RFMT $RIREG SCHEME381 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4′-Thiodiphenol
C12H10O2S
2664-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 0.0000 0.0 0
M  V30 2 O 10.6695 3.0800 0.0 0
M  V30 3 O 0.0000 3.0800 0.0 0
M  V30 4 C 6.6684 0.7700 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 C 8.0022 0.0000 0.0 0
M  V30 7 C 8.0022 3.0800 0.0 0
M  V30 8 C 9.3359 0.7700 0.0 0
M  V30 9 C 9.3359 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 2.6673 3.0800 0.0 0
M  V30 15 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 9
M  V30 4 1 3 15
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-1,3-Benzoxazine, 6,6′-thiobis[3,4-dihydro-3-methyl-
C18H20N2O2S
267420-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0023 3.0801 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 C 16.0046 3.0801 0.0 0
M  V30 4 C 4.0012 0.7700 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 6.6687 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 6.6687 2.3101 0.0 0
M  V30 13 N 1.3338 2.3101 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 C 10.6698 3.0801 0.0 0
M  V30 16 C 9.3360 0.7700 0.0 0
M  V30 17 C 12.0035 2.3101 0.0 0
M  V30 18 C 10.6698 0.0000 0.0 0
M  V30 19 C 12.0035 0.7700 0.0 0
M  V30 20 C 13.3372 3.0801 0.0 0
M  V30 21 O 13.3372 0.0000 0.0 0
M  V30 22 N 14.6708 2.3101 0.0 0
M  V30 23 C 14.6708 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 14
M  V30 3 1 2 13
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2664-63-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 267420-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-11677776
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):NOTES
$DATUM paraformaldehyde used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Systematic examination of thermal, mechanical and dielectrical properties
of aromatic polybenzoxazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hamerton, Ian; Howlin, Brendan J.; Mitchell, Amy L.; McNamara, Lisa T.;
Takeda, Shinji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Reactive & Functional Polymers (2012), 72(10), 736-744

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl N-(2-chloroacetyl)-N-(phenylmethyl)-L-glutamate
C16H20ClNO5
269717-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0 CFG=2
M  V30 3 C 4.0010 3.8501 0.0 0
M  V30 4 C 5.3348 6.1601 0.0 0
M  V30 5 C 8.0022 4.6201 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 6.6685 6.9302 0.0 0
M  V30 8 O 4.0010 6.9302 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 O 8.0022 1.5400 0.0 0
M  V30 11 O 5.3348 1.5400 0.0 0
M  V30 12 Cl 6.6685 8.4702 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 8.0022 0.0000 0.0 0
M  V30 15 O 12.0033 3.8501 0.0 0
M  V30 16 O 10.6697 6.1601 0.0 0
M  V30 17 C 13.3370 4.6201 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 1.3337 3.8501 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 23 C 0.0000 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5 CFG=1
M  V30 5 1 2 6
M  V30 6 1 3 18
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 1 7 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 15 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-4-methyl-3,6-dioxo-1-(phenylmethyl)-2-piperazinepropanoate
C16H20N2O4
269717-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.3347 0.0 0
M  V30 2 C 7.7000 5.3347 0.0 0
M  V30 3 C 9.2400 5.3347 0.0 0
M  V30 4 C 10.0100 6.6685 0.0 0
M  V30 5 O 11.5500 6.6685 0.0 0
M  V30 6 O 9.2400 8.0021 0.0 0
M  V30 7 C 12.3200 8.0021 0.0 0
M  V30 8 O 3.0800 2.6674 0.0 0
M  V30 9 O 9.2400 2.6674 0.0 0
M  V30 10 C 7.7000 0.0000 0.0 0
M  V30 11 N 5.3900 4.0011 0.0 0
M  V30 12 C 6.9300 4.0011 0.0 0 CFG=1
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 5.3900 1.3336 0.0 0
M  V30 16 N 6.9300 1.3336 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 2.3100 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.7700 6.6685 0.0 0
M  V30 22 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 12 2 CFG=1
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 2 8 13
M  V30 10 2 9 14
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 269717-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 269717-63-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3791592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chiral non-racemic 3-(dioxopiperazin-2-yl)propionic acid
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weigl, Manuela; Wunsch, Bernhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2002), 58(6), 1173-1183

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[3,5-dichloro-4-[[3-(1-methylethyl)-4-(phenylmethoxy)phenyl]methyl]ph...
C27H27Cl2FO4
2756022-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 7.7002 0.0 0
M  V30 2 Cl 9.3360 4.6201 0.0 0
M  V30 3 Cl 12.0033 9.2402 0.0 0
M  V30 4 O 14.6708 4.6201 0.0 0
M  V30 5 C 16.0045 5.3901 0.0 0
M  V30 6 C 17.3382 4.6201 0.0 0
M  V30 7 F 16.0045 6.9302 0.0 0
M  V30 8 O 18.6720 5.3901 0.0 0
M  V30 9 O 17.3382 3.0801 0.0 0
M  V30 10 C 20.0057 4.6201 0.0 0
M  V30 11 C 21.3393 5.3901 0.0 0
M  V30 12 C 4.0012 7.7002 0.0 0
M  V30 13 C 2.6673 6.9302 0.0 0
M  V30 14 C 4.0012 9.2402 0.0 0
M  V30 15 O 4.0012 4.6201 0.0 0
M  V30 16 C 4.0012 3.0801 0.0 0
M  V30 17 C 10.6697 6.9302 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 12.0033 7.7002 0.0 0
M  V30 20 C 12.0033 4.6201 0.0 0
M  V30 21 C 13.3372 6.9302 0.0 0
M  V30 22 C 13.3372 5.3901 0.0 0
M  V30 23 C 8.0022 6.9302 0.0 0
M  V30 24 C 6.6685 7.7002 0.0 0
M  V30 25 C 8.0022 5.3901 0.0 0
M  V30 26 C 5.3348 6.9302 0.0 0
M  V30 27 C 6.6685 4.6201 0.0 0
M  V30 28 C 5.3348 5.3901 0.0 0
M  V30 29 C 2.6673 2.3101 0.0 0
M  V30 30 C 1.3337 3.0801 0.0 0
M  V30 31 C 2.6673 0.7700 0.0 0
M  V30 32 C 0.0000 2.3101 0.0 0
M  V30 33 C 1.3337 0.0000 0.0 0
M  V30 34 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 18
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 26
M  V30 16 1 15 16
M  V30 17 1 15 28
M  V30 18 1 16 29
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3,5-Dichloro-4-[[3-(1-methylethyl)-4-(phenylmethoxy)phenyl]methyl]phenoxy]...
C26H26Cl2FNO3
2756022-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3358 7.7000 0.0 0
M  V30 2 Cl 9.3358 4.6200 0.0 0
M  V30 3 Cl 12.0031 9.2400 0.0 0
M  V30 4 O 14.6705 4.6200 0.0 0
M  V30 5 C 16.0041 5.3900 0.0 0
M  V30 6 C 17.3378 4.6200 0.0 0
M  V30 7 F 16.0041 6.9300 0.0 0
M  V30 8 N 18.6716 5.3900 0.0 0
M  V30 9 O 17.3378 3.0800 0.0 0
M  V30 10 C 20.0052 4.6200 0.0 0
M  V30 11 C 4.0011 7.7000 0.0 0
M  V30 12 C 4.0011 9.2400 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 14 O 4.0011 4.6200 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 10.6694 6.9300 0.0 0
M  V30 17 C 10.6694 5.3900 0.0 0
M  V30 18 C 12.0031 7.7000 0.0 0
M  V30 19 C 12.0031 4.6200 0.0 0
M  V30 20 C 13.3369 6.9300 0.0 0
M  V30 21 C 13.3369 5.3900 0.0 0
M  V30 22 C 8.0021 6.9300 0.0 0
M  V30 23 C 6.6684 7.7000 0.0 0
M  V30 24 C 8.0021 5.3900 0.0 0
M  V30 25 C 5.3347 6.9300 0.0 0
M  V30 26 C 6.6684 4.6200 0.0 0
M  V30 27 C 5.3347 5.3900 0.0 0
M  V30 28 C 2.6674 2.3100 0.0 0
M  V30 29 C 1.3336 3.0800 0.0 0
M  V30 30 C 2.6674 0.7700 0.0 0
M  V30 31 C 0.0000 2.3100 0.0 0
M  V30 32 C 1.3336 0.0000 0.0 0
M  V30 33 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 22
M  V30 3 1 2 17
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 25
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 1 15 28
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2756022-01-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2756022-02-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31075019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzylphenols as thyromimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Von Geldern, Thomas; Backes, Bradley; Stearns, Brian Andrew; Baccei, Jill
Melissa; Harris, Jason Randall
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021257851 A1 2021-12-23

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (2R,5S)-2-[4-(chlorosulfonyl)phenyl]-5-methyl-1-piperid...
C17H24ClNO4S
2760488-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 3.8500 2.6674 0.0 0
M  V30 3 O 6.1600 4.0011 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.2864 0.5638 0.0 0
M  V30 6 C 5.3900 0.0000 0.0 0
M  V30 7 C 5.9536 2.1038 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 S 10.7800 6.6685 0.0 0 VAL=6
M  V30 10 Cl 12.3200 6.6685 0.0 0
M  V30 11 O 10.7800 5.1285 0.0 0
M  V30 12 O 10.7800 8.2085 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0 CFG=2
M  V30 14 N 3.8500 5.3347 0.0 0
M  V30 15 C 3.8500 8.0021 0.0 0
M  V30 16 C 2.3100 5.3347 0.0 0
M  V30 17 C 2.3100 8.0021 0.0 0
M  V30 18 C 1.5400 6.6685 0.0 0 CFG=2
M  V30 19 C 6.1600 6.6685 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 8.4700 5.3347 0.0 0
M  V30 23 C 8.4700 8.0021 0.0 0
M  V30 24 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 18 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19 CFG=1
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (2R,5S)-5-methyl-2-[4-[(methylamino)sulfonyl]phenyl]-1-...
C18H28N2O4S
2760488-55-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 3.8500 2.6674 0.0 0
M  V30 3 O 6.1600 4.0011 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 3.2864 0.5638 0.0 0
M  V30 6 C 5.3900 0.0000 0.0 0
M  V30 7 C 5.9536 2.1038 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 S 10.7800 6.6685 0.0 0 VAL=6
M  V30 10 N 12.3200 6.6685 0.0 0
M  V30 11 O 10.7800 8.2085 0.0 0
M  V30 12 O 10.7800 5.1285 0.0 0
M  V30 13 C 13.0900 8.0021 0.0 0
M  V30 14 C 4.6200 6.6685 0.0 0 CFG=2
M  V30 15 N 3.8500 5.3347 0.0 0
M  V30 16 C 3.8500 8.0021 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 1.5400 6.6685 0.0 0 CFG=2
M  V30 20 C 6.1600 6.6685 0.0 0
M  V30 21 C 6.9300 8.0021 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 8.4700 8.0021 0.0 0
M  V30 24 C 8.4700 5.3347 0.0 0
M  V30 25 C 9.2400 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 19 8 CFG=3
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 9 12
M  V30 12 1 9 25
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20 CFG=1
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2760488-52-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2760488-55-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31746038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the
treatment of MTAP-deficient and/or MT-A accumulating cancers and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cottrell, Kevin M.; Maxwell, John P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022026892 A1 2022-02-03

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(E)-(2-Benzothiazolylimino)hydroxymethyl]-L-phenylalanine methyl ester
C18H17N3O3S
2770660-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0 CFG=2
M  V30 6 C 4.0010 4.6201 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 O 2.6673 0.7700 0.0 0
M  V30 9 O 1.3337 3.0801 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 11.7733 3.5981 0.0 0
M  V30 12 C 11.0032 4.9318 0.0 0
M  V30 13 N 10.7428 2.4537 0.0 0
M  V30 14 C 13.3133 3.5981 0.0 0
M  V30 15 S 9.4969 4.6116 0.0 0
M  V30 16 C 11.7733 6.2656 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 14.0833 4.9318 0.0 0
M  V30 19 C 13.3133 6.2656 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 5.3901 0.0 0
M  V30 25 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C18H18N4O2S
2770660-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 N 5.3348 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0 CFG=2
M  V30 6 C 4.0010 4.6201 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 N 2.6673 0.7700 0.0 0
M  V30 9 O 1.3337 3.0801 0.0 0
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 11.7733 3.5981 0.0 0
M  V30 12 C 11.0032 4.9318 0.0 0
M  V30 13 N 10.7428 2.4537 0.0 0
M  V30 14 C 13.3133 3.5981 0.0 0
M  V30 15 S 9.4969 4.6116 0.0 0
M  V30 16 C 11.7733 6.2656 0.0 0
M  V30 17 C 9.3360 3.0801 0.0 0
M  V30 18 C 14.0833 4.9318 0.0 0
M  V30 19 C 13.3133 6.2656 0.0 0
M  V30 20 C 2.6673 5.3901 0.0 0
M  V30 21 C 2.6673 6.9302 0.0 0
M  V30 22 C 1.3337 4.6201 0.0 0
M  V30 23 C 1.3337 7.7002 0.0 0
M  V30 24 C 0.0000 5.3901 0.0 0
M  V30 25 C 0.0000 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3 CFG=3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2770660-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2770660-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32438672
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isothioureas, ureas, and their N-methyl amides from 2-aminobenzothiazole
and chiral amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Padilla-Martinez, Itzia I.; Gonzalez-Encarnacion, Jose Miguel;
Garcia-Baez, Efren V.; Cruz, Alejandro; Ramos-Organillo, Angel Andres
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(18), 3391

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S,6R,9S)-6,9,13,13-tetramethyl-4,8,11-trioxo-2-(phenylmethyl)-6-(tri...
C23H32F3N3O6
2781122-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.0800 0.0 0 CFG=2
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 N 9.5421 3.0800 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 C 6.4621 3.0800 0.0 0
M  V30 6 C 6.6685 5.3900 0.0 0
M  V30 7 C 10.3121 4.4136 0.0 0
M  V30 8 F 6.4621 1.5400 0.0 0
M  V30 9 F 8.0021 0.0000 0.0 0
M  V30 10 F 9.5421 1.5400 0.0 0
M  V30 11 N 6.6685 6.9300 0.0 0
M  V30 12 O 5.3347 4.6200 0.0 0
M  V30 13 C 11.8521 4.4136 0.0 0 CFG=2
M  V30 14 O 9.5421 5.7474 0.0 0
M  V30 15 C 5.3347 7.7000 0.0 0 CFG=2
M  V30 16 N 12.6221 5.7474 0.0 0
M  V30 17 C 12.6221 3.0800 0.0 0
M  V30 18 C 4.0011 6.9300 0.0 0
M  V30 19 C 5.3347 9.2400 0.0 0
M  V30 20 C 14.1621 5.7474 0.0 0
M  V30 21 O 6.6685 10.0100 0.0 0
M  V30 22 O 4.0011 10.0100 0.0 0
M  V30 23 O 14.9321 7.0811 0.0 0
M  V30 24 O 14.9321 4.4136 0.0 0
M  V30 25 C 6.6685 11.5500 0.0 0
M  V30 26 C 16.4721 7.0811 0.0 0
M  V30 27 C 16.4721 8.6211 0.0 0
M  V30 28 C 18.0121 7.0811 0.0 0
M  V30 29 C 16.4721 5.5411 0.0 0
M  V30 30 C 2.6674 7.7000 0.0 0
M  V30 31 C 2.6674 9.2400 0.0 0
M  V30 32 C 1.3336 6.9300 0.0 0
M  V30 33 C 1.3338 10.0100 0.0 0
M  V30 34 C 0.0000 7.7000 0.0 0
M  V30 35 C 0.0000 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17 CFG=1
M  V30 17 1 15 18 CFG=1
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 18 30
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 23 26
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 2 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 2 32 34
M  V30 34 2 33 35
M  V30 35 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (3S,6R,10S)-3,6-dimethyl-4,8,11-trioxo-10-(phenylmethyl)-6-...
C23H33F3N4O5
2781122-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0021 3.0800 0.0 0 CFG=2
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 N 9.5421 3.0800 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 C 6.4621 3.0800 0.0 0
M  V30 6 C 6.6685 5.3900 0.0 0
M  V30 7 C 10.3121 4.4136 0.0 0
M  V30 8 F 6.4621 1.5400 0.0 0
M  V30 9 F 8.0021 0.0000 0.0 0
M  V30 10 F 9.5421 1.5400 0.0 0
M  V30 11 N 6.6685 6.9300 0.0 0
M  V30 12 O 5.3347 4.6200 0.0 0
M  V30 13 C 11.8521 4.4136 0.0 0 CFG=2
M  V30 14 O 9.5421 5.7474 0.0 0
M  V30 15 C 5.3347 7.7000 0.0 0 CFG=2
M  V30 16 N 12.6221 5.7474 0.0 0
M  V30 17 C 12.6221 3.0800 0.0 0
M  V30 18 C 4.0011 6.9300 0.0 0
M  V30 19 C 5.3347 9.2400 0.0 0
M  V30 20 C 14.1621 5.7474 0.0 0
M  V30 21 N 6.6685 10.0100 0.0 0
M  V30 22 O 4.0011 10.0100 0.0 0
M  V30 23 O 14.9321 7.0811 0.0 0
M  V30 24 O 14.9321 4.4136 0.0 0
M  V30 25 C 6.6685 11.5500 0.0 0
M  V30 26 C 16.4721 7.0811 0.0 0
M  V30 27 C 16.4721 8.6211 0.0 0
M  V30 28 C 18.0121 7.0811 0.0 0
M  V30 29 C 16.4721 5.5411 0.0 0
M  V30 30 C 2.6674 7.7000 0.0 0
M  V30 31 C 2.6674 9.2400 0.0 0
M  V30 32 C 1.3336 6.9300 0.0 0
M  V30 33 C 1.3338 10.0100 0.0 0
M  V30 34 C 0.0000 7.7000 0.0 0
M  V30 35 C 0.0000 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 1 7 13
M  V30 13 2 7 14
M  V30 14 1 11 15
M  V30 15 1 13 16
M  V30 16 1 13 17 CFG=1
M  V30 17 1 15 18 CFG=1
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 18 30
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 2 20 24
M  V30 25 1 21 25
M  V30 26 1 23 26
M  V30 27 1 26 27
M  V30 28 1 26 28
M  V30 29 1 26 29
M  V30 30 2 30 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 2 32 34
M  V30 34 2 33 35
M  V30 35 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2781122-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2781122-23-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32911929
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantiopure β3-Trifluoromethyl-β3-homoalanine derivatives: Coupling with
Boc-protected amino acids and conformational studies of peptides in solid
state
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saraiva Rosa, Nathalie; Grellepois, Fabienne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2022), 54(13), 3025-3046

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[2,3-dihydro-5-[(1E)-1-(methoxyimino)propyl]-2,2-dimethyl-7-b...
C25H30N2O6
2795115-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2538 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2001 0.0 0
M  V30 4 C 1.0304 9.9850 0.0 0
M  V30 5 C 6.2538 4.0010 0.0 0
M  V30 6 N 5.4838 2.6673 0.0 0
M  V30 7 C 7.7938 4.0010 0.0 0
M  V30 8 O 6.2538 1.3337 0.0 0
M  V30 9 C 8.5638 2.6673 0.0 0
M  V30 10 C 5.4838 0.0000 0.0 0
M  V30 11 C 10.8739 9.3360 0.0 0
M  V30 12 C 10.1039 8.0022 0.0 0
M  V30 13 N 12.4139 9.3360 0.0 0
M  V30 14 O 10.8739 6.6685 0.0 0
M  V30 15 O 8.5638 8.0022 0.0 0
M  V30 16 O 13.1839 10.6697 0.0 0
M  V30 17 C 12.4139 6.6685 0.0 0
M  V30 18 C 14.7240 10.6697 0.0 0
M  V30 19 C 3.9437 8.0022 0.0 0
M  V30 20 C 3.1737 6.6685 0.0 0
M  V30 21 C 5.4838 8.0022 0.0 0
M  V30 22 O 2.9133 9.1467 0.0 0
M  V30 23 C 3.9437 5.3348 0.0 0
M  V30 24 C 1.6674 6.9887 0.0 0
M  V30 25 C 6.2538 6.6685 0.0 0
M  V30 26 C 1.5063 8.5202 0.0 0
M  V30 27 C 5.4838 5.3348 0.0 0
M  V30 28 C 8.5638 10.6697 0.0 0
M  V30 29 C 10.1039 10.6697 0.0 0
M  V30 30 C 7.7938 12.0033 0.0 0
M  V30 31 C 10.8739 12.0033 0.0 0
M  V30 32 C 8.5638 13.3370 0.0 0
M  V30 33 C 10.1039 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 28
M  V30 4 1 3 26
M  V30 5 1 4 26
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 29
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[2,3-Dihydro-5-[(1E)-1-(methoxyimino)propyl]-2,2-dimethyl-7-benzofur...
C25H31N3O5
2795115-46-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2538 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2001 0.0 0
M  V30 4 C 1.0304 9.9850 0.0 0
M  V30 5 C 6.2538 4.0010 0.0 0
M  V30 6 N 5.4838 2.6673 0.0 0
M  V30 7 C 7.7938 4.0010 0.0 0
M  V30 8 O 6.2538 1.3337 0.0 0
M  V30 9 C 8.5638 2.6673 0.0 0
M  V30 10 C 5.4838 0.0000 0.0 0
M  V30 11 C 10.8739 9.3360 0.0 0
M  V30 12 C 10.1039 8.0022 0.0 0
M  V30 13 N 12.4139 9.3360 0.0 0
M  V30 14 N 10.8739 6.6685 0.0 0
M  V30 15 O 8.5638 8.0022 0.0 0
M  V30 16 O 13.1839 10.6697 0.0 0
M  V30 17 C 12.4139 6.6685 0.0 0
M  V30 18 C 14.7240 10.6697 0.0 0
M  V30 19 C 3.9437 8.0022 0.0 0
M  V30 20 C 3.1737 6.6685 0.0 0
M  V30 21 C 5.4838 8.0022 0.0 0
M  V30 22 O 2.9133 9.1467 0.0 0
M  V30 23 C 3.9437 5.3348 0.0 0
M  V30 24 C 1.6674 6.9887 0.0 0
M  V30 25 C 6.2538 6.6685 0.0 0
M  V30 26 C 1.5063 8.5202 0.0 0
M  V30 27 C 5.4838 5.3348 0.0 0
M  V30 28 C 8.5638 10.6697 0.0 0
M  V30 29 C 10.1039 10.6697 0.0 0
M  V30 30 C 7.7938 12.0033 0.0 0
M  V30 31 C 10.8739 12.0033 0.0 0
M  V30 32 C 8.5638 13.3370 0.0 0
M  V30 33 C 10.1039 13.3370 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 28
M  V30 4 1 3 26
M  V30 5 1 4 26
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 27
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 29
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2795115-45-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2795115-46-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471943
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 4-[4-carboxy-3-[[1-[4-[[(3S)-1-[(1,1-dimethylethoxy)car...
C47H68N4O9
2803961-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  60 65 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.2710 7.7002 0.0 0
M  V30 2 C 14.6060 10.7802 0.0 0
M  V30 3 O 15.9397 10.0102 0.0 0
M  V30 4 C 11.9385 1.5400 0.0 0
M  V30 5 C 13.2722 0.7700 0.0 0
M  V30 6 C 11.9385 0.0000 0.0 0
M  V30 7 C 10.6048 0.7700 0.0 0
M  V30 8 C 3.9684 8.8273 0.0 0
M  V30 9 O 3.0631 10.0732 0.0 0
M  V30 10 O 3.3420 7.4203 0.0 0
M  V30 11 C 1.5316 9.9123 0.0 0
M  V30 12 C 1.3706 11.4438 0.0 0
M  V30 13 C 0.0000 9.7512 0.0 0
M  V30 14 C 1.6925 8.3806 0.0 0
M  V30 15 O 14.6060 16.9404 0.0 0
M  V30 16 C 14.6060 20.0204 0.0 0
M  V30 17 O 14.6058 21.5605 0.0 0
M  V30 18 O 13.2722 19.2504 0.0 0
M  V30 19 C 23.9418 14.6303 0.0 0
M  V30 20 O 25.2756 15.4003 0.0 0
M  V30 21 O 23.9418 13.0903 0.0 0
M  V30 22 C 26.6093 14.6303 0.0 0
M  V30 23 C 27.3793 15.9640 0.0 0
M  V30 24 C 27.9430 13.8603 0.0 0
M  V30 25 C 25.8393 13.2967 0.0 0
M  V30 26 C 11.9385 7.7002 0.0 0
M  V30 27 C 10.6048 8.4702 0.0 0
M  V30 28 C 13.2722 8.4702 0.0 0
M  V30 29 C 10.6048 10.0102 0.0 0
M  V30 30 C 13.2722 10.0102 0.0 0
M  V30 31 C 11.9385 10.7802 0.0 0
M  V30 32 C 11.9385 6.1601 0.0 0 CFG=3
M  V30 33 C 10.6048 5.3901 0.0 0
M  V30 34 C 13.2722 5.3901 0.0 0
M  V30 35 C 10.6048 3.8501 0.0 0
M  V30 36 C 13.2722 3.8501 0.0 0
M  V30 37 C 11.9385 3.0801 0.0 0 CFG=3
M  V30 38 C 7.9373 8.4702 0.0 0 CFG=1
M  V30 39 C 6.5305 7.8439 0.0 0
M  V30 40 C 7.7764 10.0017 0.0 0
M  V30 41 N 5.4999 8.9883 0.0 0
M  V30 42 C 6.2699 10.3219 0.0 0
M  V30 43 N 14.6060 12.3203 0.0 0
M  V30 44 C 13.2722 13.0903 0.0 0
M  V30 45 C 15.9397 13.0903 0.0 0
M  V30 46 C 13.2722 14.6303 0.0 0
M  V30 47 C 15.9397 14.6303 0.0 0
M  V30 48 C 14.6058 15.4003 0.0 0
M  V30 49 C 15.9397 17.7104 0.0 0
M  V30 50 C 15.9397 19.2504 0.0 0
M  V30 51 C 17.2733 16.9404 0.0 0
M  V30 52 C 17.2733 20.0204 0.0 0
M  V30 53 C 18.6070 17.7104 0.0 0
M  V30 54 C 18.6070 19.2504 0.0 0
M  V30 55 N 19.9408 16.9404 0.0 0
M  V30 56 C 19.9408 15.4003 0.0 0
M  V30 57 C 21.2745 17.7104 0.0 0
M  V30 58 C 21.2745 14.6303 0.0 0
M  V30 59 C 22.6082 16.9404 0.0 0
M  V30 60 N 22.6082 15.4003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 1 38 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 30
M  V30 5 1 2 43
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 37
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 41
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 48
M  V30 18 1 15 49
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 16 50
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 1 19 60
M  V30 25 1 20 22
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 22 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 26 32
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 47 1 43 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 1 47 48
M  V30 53 2 49 50
M  V30 54 1 49 51
M  V30 55 1 50 52
M  V30 56 2 51 53
M  V30 57 2 52 54
M  V30 58 1 53 54
M  V30 59 1 53 55
M  V30 60 1 55 56
M  V30 61 1 55 57
M  V30 62 1 56 58
M  V30 63 1 57 59
M  V30 64 1 58 60
M  V30 65 1 59 60
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[[1-[4-[[(3S)-1-[(1,1-dimethylethoxy)carbonyl]-3-pyrro...
C48H71N5O8
2803961-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  61 66 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 9.2710 7.7001 0.0 0
M  V30 2 C 14.6058 10.7802 0.0 0
M  V30 3 O 15.9396 10.0102 0.0 0
M  V30 4 C 11.9384 1.5400 0.0 0
M  V30 5 C 13.4785 1.5400 0.0 0
M  V30 6 C 11.9384 0.0000 0.0 0
M  V30 7 C 10.3984 1.5400 0.0 0
M  V30 8 C 3.9683 8.8273 0.0 0
M  V30 9 O 3.0631 10.0732 0.0 0
M  V30 10 O 3.3420 7.4203 0.0 0
M  V30 11 C 1.5316 9.9122 0.0 0
M  V30 12 C 1.3706 11.4438 0.0 0
M  V30 13 C 0.0000 9.7511 0.0 0
M  V30 14 C 1.6925 8.3805 0.0 0
M  V30 15 O 14.6058 16.9403 0.0 0
M  V30 16 C 14.6058 20.0204 0.0 0
M  V30 17 N 14.6058 21.5604 0.0 0
M  V30 18 O 13.2721 19.2503 0.0 0
M  V30 19 C 13.2721 22.3304 0.0 0
M  V30 20 C 23.9417 14.6303 0.0 0
M  V30 21 O 25.2756 15.4003 0.0 0
M  V30 22 O 23.9417 13.0902 0.0 0
M  V30 23 C 26.6092 14.6303 0.0 0
M  V30 24 C 25.8392 13.2966 0.0 0
M  V30 25 C 27.9429 13.8602 0.0 0
M  V30 26 C 27.3792 15.9639 0.0 0
M  V30 27 C 11.9384 7.7001 0.0 0
M  V30 28 C 10.6048 8.4702 0.0 0
M  V30 29 C 13.2721 8.4702 0.0 0
M  V30 30 C 10.6048 10.0102 0.0 0
M  V30 31 C 13.2721 10.0102 0.0 0
M  V30 32 C 11.9384 10.7802 0.0 0
M  V30 33 C 11.9384 6.1601 0.0 0 CFG=3
M  V30 34 C 13.2721 5.3901 0.0 0
M  V30 35 C 10.6048 5.3901 0.0 0
M  V30 36 C 13.2721 3.8501 0.0 0
M  V30 37 C 10.6048 3.8501 0.0 0
M  V30 38 C 11.9384 3.0801 0.0 0 CFG=3
M  V30 39 C 7.9373 8.4702 0.0 0 CFG=1
M  V30 40 C 6.5305 7.8438 0.0 0
M  V30 41 C 7.7764 10.0017 0.0 0
M  V30 42 N 5.4999 8.9882 0.0 0
M  V30 43 C 6.2699 10.3219 0.0 0
M  V30 44 N 14.6059 12.3202 0.0 0
M  V30 45 C 13.2721 13.0902 0.0 0
M  V30 46 C 15.9396 13.0902 0.0 0
M  V30 47 C 13.2721 14.6303 0.0 0
M  V30 48 C 15.9396 14.6303 0.0 0
M  V30 49 C 14.6058 15.4003 0.0 0
M  V30 50 C 15.9396 17.7103 0.0 0
M  V30 51 C 15.9396 19.2503 0.0 0
M  V30 52 C 17.2733 16.9403 0.0 0
M  V30 53 C 17.2733 20.0204 0.0 0
M  V30 54 C 18.6069 17.7103 0.0 0
M  V30 55 C 18.6069 19.2503 0.0 0
M  V30 56 N 19.9407 16.9403 0.0 0
M  V30 57 C 19.9407 15.4003 0.0 0
M  V30 58 C 21.2744 17.7103 0.0 0
M  V30 59 C 21.2744 14.6303 0.0 0
M  V30 60 C 22.6081 16.9403 0.0 0
M  V30 61 N 22.6081 15.4003 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 28
M  V30 2 1 39 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 31
M  V30 5 1 2 44
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 38
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 8 42
M  V30 13 1 9 11
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 11 14
M  V30 17 1 15 49
M  V30 18 1 15 50
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 16 51
M  V30 22 1 17 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 20 61
M  V30 26 1 21 23
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 23 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 27 33
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 48 1 44 45
M  V30 49 1 44 46
M  V30 50 1 45 47
M  V30 51 1 46 48
M  V30 52 1 47 49
M  V30 53 1 48 49
M  V30 54 2 50 51
M  V30 55 1 50 52
M  V30 56 1 51 53
M  V30 57 2 52 54
M  V30 58 2 53 55
M  V30 59 1 54 55
M  V30 60 1 54 56
M  V30 61 1 56 57
M  V30 62 1 56 58
M  V30 63 1 57 59
M  V30 64 1 58 60
M  V30 65 1 59 61
M  V30 66 1 60 61
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2803961-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2803961-72-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33735539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors
of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Zilu; Zhang, Min; Teuscher, Kevin B.; Ji, Haitao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(15), 11195-11218

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-4-Methyl-5-[2-(phenylmethoxy)ethylidene]-2(5H)-furanone
C14H14O3
2808477-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.7106 0.0 0
M  V30 2 C 6.9300 4.0442 0.0 0
M  V30 3 O 5.3900 4.0442 0.0 0
M  V30 4 C 4.6200 5.3778 0.0 0
M  V30 5 C 9.6692 0.0000 0.0 0
M  V30 6 O 12.8556 4.3858 0.0 0
M  V30 7 C 9.2400 2.7106 0.0 0
M  V30 8 C 10.1452 1.4647 0.0 0
M  V30 9 O 10.1452 3.9564 0.0 0
M  V30 10 C 11.6098 1.9406 0.0 0
M  V30 11 C 11.6098 3.4806 0.0 0
M  V30 12 C 3.0800 5.3778 0.0 0
M  V30 13 C 2.3100 4.0442 0.0 0
M  V30 14 C 2.3100 6.7116 0.0 0
M  V30 15 C 0.7700 4.0442 0.0 0
M  V30 16 C 0.7700 6.7116 0.0 0
M  V30 17 C 0.0000 5.3778 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 12
M  V30 6 1 5 8
M  V30 7 2 6 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dihydro-5-hydroxy-1,4-dimethyl-5-[2-(phenylmethoxy)ethyl]-2H-pyrrol-2-one
C15H19NO3
2808477-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2187 3.3320 0.0 0
M  V30 2 C 6.5524 2.5620 0.0 0
M  V30 3 O 7.8861 3.3320 0.0 0
M  V30 4 C 9.2199 2.5620 0.0 0
M  V30 5 O 4.7903 1.3161 0.0 0
M  V30 6 C 4.0286 5.3026 0.0 0
M  V30 7 C 2.9016 0.0000 0.0 0
M  V30 8 O 0.0000 1.6752 0.0 0
M  V30 9 C 3.8850 2.5620 0.0 0
M  V30 10 C 3.2586 3.9690 0.0 0
M  V30 11 N 2.7405 1.5316 0.0 0
M  V30 12 C 1.7270 3.8079 0.0 0
M  V30 13 C 1.4068 2.3016 0.0 0
M  V30 14 C 10.5535 3.3320 0.0 0
M  V30 15 C 10.5535 4.8721 0.0 0
M  V30 16 C 11.8872 2.5620 0.0 0
M  V30 17 C 11.8872 5.6421 0.0 0
M  V30 18 C 13.2209 3.3320 0.0 0
M  V30 19 C 13.2209 4.8721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 14
M  V30 6 1 5 9
M  V30 7 1 6 10
M  V30 8 1 7 11
M  V30 9 2 8 13
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2808477-06-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808477-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33445180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Construction of Tetrasubstituted Carbon Stereocenters
via Chiral Phosphoric Acid-Catalyzed Friedel-Craft Alkylation of Indoles
with 5-Substituted Hydroxybutyrolactams
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saidah, Milane; Mardjan, Muhammad Idham Darussalam; Masson, Geraldine;
Parrain, Jean-Luc; Commeiras, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(29), 5298-5303

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[Imino(methylthio)methyl]amino]benzoic acid
C9H10N2O2S
285556-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 S 9.3359 4.6201 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[Imino(methylamino)methyl]amino]benzoic acid
C9H11N3O2
738523-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 N 9.3359 4.6201 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 285556-33-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 738523-12-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27385477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel series of guanidinebenzoates as gut-restricted
enteropeptidase and trypsin dual inhibitors for the treatment of
metabolic syndrome
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xuqing; Zhu, Bin; Sun, Weimei; Wang, Mina; Albarazanji, Kamal;
Ghosh, Brahma; Cummings, Maxwell; Lenhard, James; Leonard, James;
Macielag, Mark; Lanter, James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 40127939

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H19O2.ClO4
2904546-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.0033 7.7001 0.0 0
M  V30 2 C 13.3370 6.9301 0.0 0
M  V30 3 C 6.6685 7.7001 0.0 0
M  V30 4 C 8.0022 6.9301 0.0 0
M  V30 5 C 6.6685 9.2401 0.0 0
M  V30 6 O 5.3348 6.9301 0.0 0 CHG=1 VAL=3
M  V30 7 C 9.3360 7.7001 0.0 0
M  V30 8 C 8.0022 5.3900 0.0 0
M  V30 9 C 5.3348 10.0101 0.0 0
M  V30 10 C 8.0022 10.0101 0.0 0
M  V30 11 C 4.0010 7.7001 0.0 0
M  V30 12 C 10.6697 6.9301 0.0 0
M  V30 13 C 9.3360 9.2401 0.0 0
M  V30 14 C 9.3360 4.6200 0.0 0
M  V30 15 C 4.0010 9.2401 0.0 0
M  V30 16 C 2.6673 6.9301 0.0 0
M  V30 17 C 10.6697 5.3900 0.0 0
M  V30 18 C 2.6673 10.0101 0.0 0
M  V30 19 C 1.3337 7.7001 0.0 0
M  V30 20 C 2.6673 5.3900 0.0 0
M  V30 21 C 1.3337 9.2401 0.0 0
M  V30 22 C 0.0000 6.9301 0.0 0
M  V30 23 C 1.3337 4.6200 0.0 0
M  V30 24 C 0.0000 5.3900 0.0 0
M  V30 25 Cl 6.6685 1.5400 0.0 0 VAL=7
M  V30 26 O 5.1285 1.5400 0.0 0
M  V30 27 O 8.2085 1.5400 0.0 0
M  V30 28 O 6.6685 0.0000 0.0 0
M  V30 29 O 6.6685 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 13
M  V30 16 2 11 15
M  V30 17 1 11 16
M  V30 18 1 12 17
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 1 18 21
M  V30 24 1 19 21
M  V30 25 2 19 22
M  V30 26 1 20 23
M  V30 27 1 22 24
M  V30 28 2 23 24
M  V30 29 2 25 26
M  V30 30 2 25 27
M  V30 31 2 25 28
M  V30 32 1 25 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dibenz[c,h]acridinium, 5,6,8,9-tetrahydro-4-methoxy-14-methyl-, perchlorate (...
C23H22NO.ClO4
2904546-58-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 5.3900 0.0 0
M  V30 2 O 12.0033 7.7001 0.0 0
M  V30 3 C 13.3370 6.9301 0.0 0
M  V30 4 C 6.6685 7.7001 0.0 0
M  V30 5 C 8.0022 6.9301 0.0 0
M  V30 6 C 6.6685 9.2401 0.0 0
M  V30 7 N 5.3348 6.9301 0.0 0 CHG=1 VAL=4
M  V30 8 C 9.3360 7.7001 0.0 0
M  V30 9 C 8.0022 5.3900 0.0 0
M  V30 10 C 5.3348 10.0101 0.0 0
M  V30 11 C 8.0022 10.0101 0.0 0
M  V30 12 C 4.0010 7.7001 0.0 0
M  V30 13 C 10.6697 6.9301 0.0 0
M  V30 14 C 9.3360 9.2401 0.0 0
M  V30 15 C 9.3360 4.6200 0.0 0
M  V30 16 C 4.0010 9.2401 0.0 0
M  V30 17 C 2.6673 6.9301 0.0 0
M  V30 18 C 10.6697 5.3900 0.0 0
M  V30 19 C 2.6673 10.0101 0.0 0
M  V30 20 C 1.3337 7.7001 0.0 0
M  V30 21 C 2.6673 5.3900 0.0 0
M  V30 22 C 1.3337 9.2401 0.0 0
M  V30 23 C 0.0000 6.9301 0.0 0
M  V30 24 C 1.3337 4.6200 0.0 0
M  V30 25 C 0.0000 5.3900 0.0 0
M  V30 26 Cl 6.6685 1.5400 0.0 0 VAL=7
M  V30 27 O 5.1285 1.5400 0.0 0
M  V30 28 O 8.2085 1.5400 0.0 0
M  V30 29 O 6.6685 0.0000 0.0 0
M  V30 30 O 6.6685 3.0800 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 14
M  V30 17 2 12 16
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 2 17 21
M  V30 24 1 19 22
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 1 21 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 2 26 28
M  V30 32 2 26 29
M  V30 33 1 26 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2904546-45-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2904546-58-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35001829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM IndiFluors: A New Full-Visible Color-Tunable Donor-Acceptor-Donor
(D1-A-D2) Fluorophore Family for Ratiometric pH Imaging during Mitophagy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munan, Subrata; Kottarathil, Shamna; Joseph, Manu M.; Jana, Anal; Ali,
Mudassar; Mapa, Koyeli; Maiti, Kaustabh Kumar; Samanta, Animesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sensors (2024), 9(7), 3502-3510

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-8-carboxylic acid, 3-[6-(methoxycarbonyl)-3-pyr...
C18H25N3O4
2917537-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9086 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0390 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5164 3.0797 0.0 0
M  V30 6 C 0.0000 1.5164 0.0 0
M  V30 7 C 1.5634 0.0000 0.0 0
M  V30 8 C 15.1031 4.4283 0.0 0
M  V30 9 O 15.8731 5.7621 0.0 0
M  V30 10 O 15.8731 3.0946 0.0 0
M  V30 11 C 17.4131 5.7621 0.0 0
M  V30 12 C 6.6202 3.4360 0.0 0
M  V30 13 N 5.3691 2.9322 0.0 0
M  V30 14 C 7.4721 4.9739 0.0 0
M  V30 15 C 7.4793 2.2412 0.0 0
M  V30 16 C 6.8345 2.3933 0.0 0
M  V30 17 N 8.9431 4.4283 0.0 0
M  V30 18 C 7.5115 0.8678 0.0 0
M  V30 19 C 7.7522 3.9868 0.0 0
M  V30 20 C 10.4831 4.4283 0.0 0
M  V30 21 C 11.2531 5.7621 0.0 0
M  V30 22 C 11.2531 3.0946 0.0 0
M  V30 23 C 12.7931 5.7621 0.0 0
M  V30 24 N 12.7931 3.0946 0.0 0
M  V30 25 C 13.5631 4.4283 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,8-Diazabicyclo[3.2.1]octane-8-carboxylic acid, 3-[6-[(methylamino)carbonyl]...
C18H26N4O3
2917537-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8292 2.9086 0.0 0
M  V30 2 O 3.0797 1.5634 0.0 0
M  V30 3 O 3.0390 4.2304 0.0 0
M  V30 4 C 1.5398 1.5398 0.0 0
M  V30 5 C 1.5634 0.0000 0.0 0
M  V30 6 C 0.0000 1.5164 0.0 0
M  V30 7 C 1.5164 3.0797 0.0 0
M  V30 8 C 15.1031 4.4283 0.0 0
M  V30 9 N 15.8731 5.7621 0.0 0
M  V30 10 O 15.8731 3.0946 0.0 0
M  V30 11 C 17.4131 5.7621 0.0 0
M  V30 12 C 6.6202 3.4360 0.0 0
M  V30 13 N 5.3691 2.9322 0.0 0
M  V30 14 C 7.4721 4.9739 0.0 0
M  V30 15 C 7.4793 2.2412 0.0 0
M  V30 16 C 6.8345 2.3933 0.0 0
M  V30 17 N 8.9431 4.4283 0.0 0
M  V30 18 C 7.5115 0.8678 0.0 0
M  V30 19 C 7.7522 3.9868 0.0 0
M  V30 20 C 10.4831 4.4283 0.0 0
M  V30 21 C 11.2531 5.7621 0.0 0
M  V30 22 C 11.2531 3.0946 0.0 0
M  V30 23 C 12.7931 5.7621 0.0 0
M  V30 24 N 12.7931 3.0946 0.0 0
M  V30 25 C 13.5631 4.4283 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 25
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2917537-07-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2917537-08-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41162513
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kankanala, Jayakanth; Pettigrew, Jeremy D.; Conte, Aurelia; Chen, Jiyun;
Pham, Son Minh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20240132522 A1 2024-04-25

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrolo[3,2-b]pyridine-5-carboxylic acid, 1-[(2R,3S)-1-[(1,1-dimethylethox...
C18H23N3O4
2921728-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5765 8.4725 0.0 0
M  V30 2 C 12.2055 5.8436 0.0 0
M  V30 3 O 12.9755 4.5099 0.0 0
M  V30 4 O 12.9755 7.1772 0.0 0
M  V30 5 C 14.5155 4.5099 0.0 0
M  V30 6 C 14.5155 6.0499 0.0 0
M  V30 7 C 16.0555 4.5099 0.0 0
M  V30 8 C 14.5155 2.9699 0.0 0
M  V30 9 C 2.6091 1.5063 0.0 0
M  V30 10 O 1.1444 1.9821 0.0 0
M  V30 11 O 2.9292 0.0000 0.0 0
M  V30 12 C 0.0000 0.9517 0.0 0
M  V30 13 N 6.9476 5.8436 0.0 0
M  V30 14 C 6.0424 4.5977 0.0 0
M  V30 15 C 6.0424 7.0894 0.0 0
M  V30 16 C 4.5778 5.0736 0.0 0
M  V30 17 C 6.3625 3.0914 0.0 0
M  V30 18 C 4.5778 6.6136 0.0 0
M  V30 19 N 3.4333 4.0431 0.0 0
M  V30 20 C 5.2182 2.0608 0.0 0
M  V30 21 C 3.7535 2.5367 0.0 0
M  V30 22 C 8.4876 5.8436 0.0 0 CFG=1
M  V30 23 C 9.5765 6.9325 0.0 0 CFG=1
M  V30 24 C 9.5765 4.7546 0.0 0
M  V30 25 N 10.6655 5.8436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 23 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 22 13 CFG=3
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Azetidinecarboxylic acid, 2-methyl-3-[5-[(methylamino)carbonyl]-1H-pyrrolo[...
C18H24N4O3
2921728-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.5765 8.4725 0.0 0
M  V30 2 C 12.2054 5.8435 0.0 0
M  V30 3 O 12.9754 4.5099 0.0 0
M  V30 4 O 12.9754 7.1773 0.0 0
M  V30 5 C 14.5154 4.5099 0.0 0
M  V30 6 C 14.5154 6.0499 0.0 0
M  V30 7 C 16.0554 4.5099 0.0 0
M  V30 8 C 14.5154 2.9699 0.0 0
M  V30 9 C 2.6091 1.5063 0.0 0
M  V30 10 N 1.1444 1.9821 0.0 0
M  V30 11 O 2.9292 0.0000 0.0 0
M  V30 12 C 0.0000 0.9517 0.0 0
M  V30 13 N 6.9476 5.8435 0.0 0
M  V30 14 C 6.0423 4.5977 0.0 0
M  V30 15 C 6.0423 7.0894 0.0 0
M  V30 16 C 4.5778 5.0735 0.0 0
M  V30 17 C 6.3625 3.0914 0.0 0
M  V30 18 C 4.5778 6.6135 0.0 0
M  V30 19 N 3.4333 4.0431 0.0 0
M  V30 20 C 5.2181 2.0608 0.0 0
M  V30 21 C 3.7534 2.5367 0.0 0
M  V30 22 C 8.4876 5.8435 0.0 0 CFG=1
M  V30 23 C 9.5765 6.9325 0.0 0 CFG=1
M  V30 24 C 9.5765 4.7546 0.0 0
M  V30 25 N 10.6654 5.8435 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 23 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 25
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 21
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 22 13 CFG=3
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2921728-08-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921728-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36115968
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine for treating cancer and pharmaceutical composition thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Dong, Qing; Trzoss, Lynnie; Va, Porino Jinjo; Kaldor,
Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023056039 A1 2023-04-06

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 4-(2-bromophenyl)-3-(methylthio)-4-oxo-, methyl ester, (2E)-
C12H11BrO3S
2922561-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0
M  V30 3 O 5.3901 5.3348 0.0 0
M  V30 4 C 6.9302 2.6675 0.0 0
M  V30 5 S 4.6201 1.3338 0.0 0
M  V30 6 C 7.7002 4.0012 0.0 0
M  V30 7 C 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 Br 3.0801 6.6687 0.0 0
M  V30 12 C 3.0801 4.0012 0.0 0
M  V30 13 C 2.3101 5.3348 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 0.7700 5.3348 0.0 0
M  V30 16 C 0.7700 2.6675 0.0 0
M  V30 17 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 2 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 8 10
M  V30 11 1 11 13
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Pyrrol-2-one, 5-(2-bromophenyl)-1,5-dihydro-5-hydroxy-1-methyl-4-(methylth...
C12H12BrNO2S
2922561-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.4592 5.1959 0.0 0
M  V30 2 S 6.7529 5.3914 0.0 0
M  V30 3 C 8.2845 5.5524 0.0 0
M  V30 4 C 3.1253 1.3628 0.0 0
M  V30 5 Br 3.0801 6.3317 0.0 0
M  V30 6 O 6.1862 0.0000 0.0 0
M  V30 7 C 4.6201 3.6644 0.0 0
M  V30 8 C 6.1264 3.9845 0.0 0
M  V30 9 N 4.4592 2.1328 0.0 0
M  V30 10 C 6.8964 2.6509 0.0 0
M  V30 11 C 5.8660 1.5063 0.0 0
M  V30 12 C 3.0801 3.6644 0.0 0
M  V30 13 C 2.3101 4.9980 0.0 0
M  V30 14 C 2.3101 2.3307 0.0 0
M  V30 15 C 0.7700 4.9980 0.0 0
M  V30 16 C 0.7700 2.3307 0.0 0
M  V30 17 C 0.0000 3.6644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 8
M  V30 4 1 4 9
M  V30 5 1 5 13
M  V30 6 2 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922561-76-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922561-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36150637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM I2-DMSO Promoted Deaminative Coupling Reactions of Glycine Esters: Access
to 5-(Methylthio)pyridazin-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhat, Showkat Ahmad; Bhat, Mohammad Yaqoob; Rather, Suhail Ahmad; Jameel,
Salman; Bhat, Khursheed Ahmad; Ahmed, Qazi Naveed
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(14), 2382-2387

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Propanone, 1-(1,3-benzodioxol-5-yl)-3-cyclopropyl-
C13H14O3
2933196-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7046 2.3100 0.0 0
M  V30 3 C 9.0384 3.0800 0.0 0
M  V30 4 O 7.7046 0.7700 0.0 0
M  V30 5 C 2.3698 2.3100 0.0 0
M  V30 6 C 2.3698 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 O 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0373 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0373 0.7700 0.0 0
M  V30 14 C 10.3720 2.3100 0.0 0
M  V30 15 C 11.1421 0.9764 0.0 0
M  V30 16 C 11.9121 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 14
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-ethanamine, α-(cyclopropylmethyl)-N-methyl-
C14H19NO2
2933194-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2874 4.0011 0.0 0
M  V30 2 C 7.0574 2.6673 0.0 0
M  V30 3 C 8.5974 2.6673 0.0 0
M  V30 4 N 6.2874 1.3336 0.0 0
M  V30 5 C 7.0574 0.0000 0.0 0
M  V30 6 C 1.6674 4.0011 0.0 0
M  V30 7 C 2.4374 5.3347 0.0 0
M  V30 8 C 2.4374 2.6673 0.0 0
M  V30 9 O 0.1611 4.3212 0.0 0
M  V30 10 C 3.9774 5.3347 0.0 0
M  V30 11 O 1.4069 6.4791 0.0 0
M  V30 12 C 3.9774 2.6673 0.0 0
M  V30 13 C 0.0000 5.8528 0.0 0
M  V30 14 C 4.7474 4.0011 0.0 0
M  V30 15 C 9.3674 4.0011 0.0 0
M  V30 16 C 10.7012 4.7711 0.0 0
M  V30 17 C 9.3674 5.5411 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2933196-40-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2933194-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36957470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel in stage 1,molecular sieves used in stage
1,product is further converted to HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analogues of 3,4-methylenedioxymethamphetamine for modulating SERT, DAT,
and or NET activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pullella, Glenn; Gandy, Michael; Scaffidi, Adrian; King, Jasmine;
Piggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023092195 A1 2023-06-01

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4-Oxadiazole-5-carboxylic acid, 3-[3-[1-[[3,5-bis(trifluoromethyl)benzoyl...
C23H19F6N5O4
2938217-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3357 6.1600 0.0 0
M  V30 2 N 8.0020 5.3900 0.0 0
M  V30 3 C 10.6695 5.3900 0.0 0
M  V30 4 C 6.6684 6.1600 0.0 0
M  V30 5 C 8.0020 3.8500 0.0 0
M  V30 6 O 6.6684 7.7000 0.0 0
M  V30 7 C 15.9720 7.3429 0.0 0
M  V30 8 O 16.5984 8.7499 0.0 0
M  V30 9 O 16.8773 6.0970 0.0 0
M  V30 10 C 18.1299 8.9108 0.0 0
M  V30 11 C 4.0009 1.5400 0.0 0
M  V30 12 F 2.4609 1.5400 0.0 0
M  V30 13 F 4.0009 0.0000 0.0 0
M  V30 14 F 5.5409 1.5400 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 F 0.5636 4.8264 0.0 0
M  V30 17 F 0.0000 6.9300 0.0 0
M  V30 18 F 2.1037 7.4937 0.0 0
M  V30 19 C 10.6695 8.4700 0.0 0
M  V30 20 C 9.3357 7.7000 0.0 0
M  V30 21 N 10.6695 10.0101 0.0 0
M  V30 22 N 8.0020 8.4700 0.0 0
M  V30 23 C 9.3357 10.7801 0.0 0
M  V30 24 C 8.0020 10.0101 0.0 0
M  V30 25 C 12.0031 7.7000 0.0 0
M  V30 26 N 13.4099 8.3264 0.0 0
M  V30 27 N 12.1641 6.1685 0.0 0
M  V30 28 C 14.4405 7.1820 0.0 0
M  V30 29 O 13.6705 5.8483 0.0 0
M  V30 30 C 5.3347 5.3900 0.0 0
M  V30 31 C 5.3347 3.8500 0.0 0
M  V30 32 C 4.0009 6.1600 0.0 0
M  V30 33 C 4.0009 3.0800 0.0 0
M  V30 34 C 2.6673 5.3900 0.0 0
M  V30 35 C 2.6673 3.8500 0.0 0
M  V30 36 C 9.3357 3.0800 0.0 0
M  V30 37 C 10.1057 1.7464 0.0 0
M  V30 38 C 10.8757 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 1 4 30
M  V30 8 1 5 36
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 28
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 34
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 25
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4-Oxadiazole-5-carboxamide, 3-[3-[1-[[3,5-bis(trifluoromethyl)benzoyl](cy...
C23H20F6N6O3
2938217-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3357 6.1600 0.0 0
M  V30 2 N 8.0020 5.3900 0.0 0
M  V30 3 C 10.6695 5.3900 0.0 0
M  V30 4 C 6.6684 6.1600 0.0 0
M  V30 5 C 8.0020 3.8500 0.0 0
M  V30 6 O 6.6684 7.7000 0.0 0
M  V30 7 C 15.9720 7.3429 0.0 0
M  V30 8 N 16.5984 8.7499 0.0 0
M  V30 9 O 16.8773 6.0970 0.0 0
M  V30 10 C 18.1299 8.9108 0.0 0
M  V30 11 C 4.0009 1.5400 0.0 0
M  V30 12 F 5.5409 1.5400 0.0 0
M  V30 13 F 4.0009 0.0000 0.0 0
M  V30 14 F 2.4609 1.5400 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 F 2.1037 7.4937 0.0 0
M  V30 17 F 0.0000 6.9300 0.0 0
M  V30 18 F 0.5636 4.8264 0.0 0
M  V30 19 C 10.6695 8.4700 0.0 0
M  V30 20 C 9.3357 7.7000 0.0 0
M  V30 21 N 10.6695 10.0101 0.0 0
M  V30 22 N 8.0020 8.4700 0.0 0
M  V30 23 C 9.3357 10.7801 0.0 0
M  V30 24 C 8.0020 10.0101 0.0 0
M  V30 25 C 12.0031 7.7000 0.0 0
M  V30 26 N 13.4099 8.3264 0.0 0
M  V30 27 N 12.1641 6.1685 0.0 0
M  V30 28 C 14.4405 7.1820 0.0 0
M  V30 29 O 13.6705 5.8483 0.0 0
M  V30 30 C 5.3347 5.3900 0.0 0
M  V30 31 C 5.3347 3.8500 0.0 0
M  V30 32 C 4.0009 6.1600 0.0 0
M  V30 33 C 4.0009 3.0800 0.0 0
M  V30 34 C 2.6673 5.3900 0.0 0
M  V30 35 C 2.6673 3.8500 0.0 0
M  V30 36 C 9.3357 3.0800 0.0 0
M  V30 37 C 10.1057 1.7464 0.0 0
M  V30 38 C 10.8757 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 1 4 30
M  V30 8 1 5 36
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 28
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 34
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 25
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2938217-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2938217-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37128885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazine compounds for the control of invertebrate pests
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pedroni, Julia; Gilberg, Erik; Koerber, Karsten; Huwyler, Nikolas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023104564 A1 2023-06-15

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4-Oxadiazole-5-carboxylic acid, 3-[3-[1-[[3,5-bis(trifluoromethyl)benzoyl...
C23H19F6N5O4
2938217-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3357 6.1600 0.0 0
M  V30 2 N 8.0020 5.3900 0.0 0
M  V30 3 C 10.6695 5.3900 0.0 0
M  V30 4 C 6.6684 6.1600 0.0 0
M  V30 5 C 8.0020 3.8500 0.0 0
M  V30 6 O 6.6684 7.7000 0.0 0
M  V30 7 C 15.9720 7.3429 0.0 0
M  V30 8 O 16.5984 8.7499 0.0 0
M  V30 9 O 16.8773 6.0970 0.0 0
M  V30 10 C 18.1299 8.9108 0.0 0
M  V30 11 C 4.0009 1.5400 0.0 0
M  V30 12 F 2.4609 1.5400 0.0 0
M  V30 13 F 4.0009 0.0000 0.0 0
M  V30 14 F 5.5409 1.5400 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 F 0.5636 4.8264 0.0 0
M  V30 17 F 0.0000 6.9300 0.0 0
M  V30 18 F 2.1037 7.4937 0.0 0
M  V30 19 C 10.6695 8.4700 0.0 0
M  V30 20 C 9.3357 7.7000 0.0 0
M  V30 21 N 10.6695 10.0101 0.0 0
M  V30 22 N 8.0020 8.4700 0.0 0
M  V30 23 C 9.3357 10.7801 0.0 0
M  V30 24 C 8.0020 10.0101 0.0 0
M  V30 25 C 12.0031 7.7000 0.0 0
M  V30 26 N 13.4099 8.3264 0.0 0
M  V30 27 N 12.1641 6.1685 0.0 0
M  V30 28 C 14.4405 7.1820 0.0 0
M  V30 29 O 13.6705 5.8483 0.0 0
M  V30 30 C 5.3347 5.3900 0.0 0
M  V30 31 C 5.3347 3.8500 0.0 0
M  V30 32 C 4.0009 6.1600 0.0 0
M  V30 33 C 4.0009 3.0800 0.0 0
M  V30 34 C 2.6673 5.3900 0.0 0
M  V30 35 C 2.6673 3.8500 0.0 0
M  V30 36 C 9.3357 3.0800 0.0 0
M  V30 37 C 10.1057 1.7464 0.0 0
M  V30 38 C 10.8757 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 1 4 30
M  V30 8 1 5 36
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 28
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 34
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 25
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,4-Oxadiazole-5-carboxamide, 3-[3-[1-[[3,5-bis(trifluoromethyl)benzoyl](cy...
C23H20F6N6O3
2938217-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3357 6.1600 0.0 0
M  V30 2 N 8.0020 5.3900 0.0 0
M  V30 3 C 10.6695 5.3900 0.0 0
M  V30 4 C 6.6684 6.1600 0.0 0
M  V30 5 C 8.0020 3.8500 0.0 0
M  V30 6 O 6.6684 7.7000 0.0 0
M  V30 7 C 15.9720 7.3429 0.0 0
M  V30 8 N 16.5984 8.7499 0.0 0
M  V30 9 O 16.8773 6.0970 0.0 0
M  V30 10 C 18.1299 8.9108 0.0 0
M  V30 11 C 4.0009 1.5400 0.0 0
M  V30 12 F 5.5409 1.5400 0.0 0
M  V30 13 F 4.0009 0.0000 0.0 0
M  V30 14 F 2.4609 1.5400 0.0 0
M  V30 15 C 1.3336 6.1600 0.0 0
M  V30 16 F 2.1037 7.4937 0.0 0
M  V30 17 F 0.0000 6.9300 0.0 0
M  V30 18 F 0.5636 4.8264 0.0 0
M  V30 19 C 10.6695 8.4700 0.0 0
M  V30 20 C 9.3357 7.7000 0.0 0
M  V30 21 N 10.6695 10.0101 0.0 0
M  V30 22 N 8.0020 8.4700 0.0 0
M  V30 23 C 9.3357 10.7801 0.0 0
M  V30 24 C 8.0020 10.0101 0.0 0
M  V30 25 C 12.0031 7.7000 0.0 0
M  V30 26 N 13.4099 8.3264 0.0 0
M  V30 27 N 12.1641 6.1685 0.0 0
M  V30 28 C 14.4405 7.1820 0.0 0
M  V30 29 O 13.6705 5.8483 0.0 0
M  V30 30 C 5.3347 5.3900 0.0 0
M  V30 31 C 5.3347 3.8500 0.0 0
M  V30 32 C 4.0009 6.1600 0.0 0
M  V30 33 C 4.0009 3.0800 0.0 0
M  V30 34 C 2.6673 5.3900 0.0 0
M  V30 35 C 2.6673 3.8500 0.0 0
M  V30 36 C 9.3357 3.0800 0.0 0
M  V30 37 C 10.1057 1.7464 0.0 0
M  V30 38 C 10.8757 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 4 6
M  V30 7 1 4 30
M  V30 8 1 5 36
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 7 28
M  V30 12 1 8 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 33
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 15 34
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 25
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 39 1 36 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2938217-23-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2938217-16-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37129516
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazine compounds for the control of invertebrate pests
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pedroni, Julia; Gilberg, Erik; Koerber, Karsten; Huwyler, Nikolas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4194453 A1 2023-06-14

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrano[2,3-b]pyridin-4-one, 3-bromo-7-methyl-2,5-diphenyl-
C21H14BrNO2
2943939-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 6.6685 0.0 0
M  V30 2 Br 7.7000 6.6685 0.0 0
M  V30 3 C 2.3100 0.0000 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 O 6.9300 2.6674 0.0 0
M  V30 10 N 4.6200 1.3336 0.0 0
M  V30 11 C 6.9300 5.3347 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 3.0800 6.6685 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 2.3100 8.0021 0.0 0
M  V30 19 C 0.7700 8.0021 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 5.3347 0.0 0
M  V30 22 C 10.0100 2.6674 0.0 0
M  V30 23 C 11.5500 5.3347 0.0 0
M  V30 24 C 11.5500 2.6674 0.0 0
M  V30 25 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 11
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 1 13 20
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-b]pyridin-3(2H)-one, 6-methyl-2-[(methylamino)phenylmethylene]-4-phe...
C22H18N2O2
2943939-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6245 7.2708 0.0 0
M  V30 2 C 7.9566 7.6210 0.0 0
M  V30 3 N 7.1866 8.9548 0.0 0
M  V30 4 C 7.9566 10.2884 0.0 0
M  V30 5 C 5.3347 0.0000 0.0 0
M  V30 6 C 5.3347 4.6200 0.0 0
M  V30 7 C 6.6685 3.8500 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 5.6549 6.1264 0.0 0
M  V30 10 O 7.8129 4.8806 0.0 0
M  V30 11 N 6.6685 2.3100 0.0 0
M  V30 12 C 4.0011 2.3100 0.0 0
M  V30 13 C 7.1866 6.2874 0.0 0
M  V30 14 C 5.3347 1.5400 0.0 0
M  V30 15 C 2.6674 4.6200 0.0 0
M  V30 16 C 2.6674 6.1600 0.0 0
M  V30 17 C 1.3338 3.8500 0.0 0
M  V30 18 C 1.3338 6.9300 0.0 0
M  V30 19 C 0.0000 4.6200 0.0 0
M  V30 20 C 0.0000 6.1600 0.0 0
M  V30 21 C 9.4966 7.6210 0.0 0
M  V30 22 C 10.2666 8.9548 0.0 0
M  V30 23 C 10.2666 6.2874 0.0 0
M  V30 24 C 11.8066 8.9548 0.0 0
M  V30 25 C 11.8066 6.2874 0.0 0
M  V30 26 C 12.5766 7.6210 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 2 2 13
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 8 15
M  V30 14 1 9 13
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 2 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2943939-95-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943939-99-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36892444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Accessing 7-Azaaurones of Controllable E and Z Configurations from
8-Azaflavones via a Rearrangement-Acylation-Photoisomerization Sequence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Mehiaoui, Nawel; Leleu, Stephane; Jean, Ludovic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(20), e202301218

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4H-Pyrano[2,3-b]pyridin-4-one, 3-bromo-5-methyl-2,7-diphenyl-
C21H14BrNO2
2943939-96-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.0000 0.0 0
M  V30 2 C 8.0022 0.0000 0.0 0
M  V30 3 Br 2.6673 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 O 5.3348 4.6201 0.0 0
M  V30 9 N 8.0022 4.6201 0.0 0
M  V30 10 C 4.0010 2.3101 0.0 0
M  V30 11 C 9.3360 2.3101 0.0 0
M  V30 12 C 4.0010 3.8501 0.0 0
M  V30 13 C 9.3360 3.8501 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 2.6673 6.1601 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 C 1.3337 6.9302 0.0 0
M  V30 19 C 0.0000 6.1601 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 10.6697 6.1601 0.0 0
M  V30 22 C 12.0033 3.8501 0.0 0
M  V30 23 C 12.0033 6.9302 0.0 0
M  V30 24 C 13.3370 4.6201 0.0 0
M  V30 25 C 13.3370 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 7
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 20
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-b]pyridin-3(2H)-one, 4-methyl-2-[(methylamino)phenylmethylene]-6-phe...
C22H18N2O2
2943940-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0494 0.3694 0.0 0
M  V30 2 C 8.3235 0.0000 0.0 0
M  V30 3 C 3.0800 3.0800 0.0 0
M  V30 4 N 2.3100 1.7462 0.0 0
M  V30 5 C 0.7700 1.7462 0.0 0
M  V30 6 C 6.9899 2.3100 0.0 0
M  V30 7 C 6.9899 3.8500 0.0 0
M  V30 8 C 5.5252 1.8340 0.0 0
M  V30 9 C 8.3235 1.5400 0.0 0
M  V30 10 O 5.5252 4.3259 0.0 0
M  V30 11 N 8.3235 4.6200 0.0 0
M  V30 12 C 4.6200 3.0800 0.0 0
M  V30 13 C 9.6572 2.3100 0.0 0
M  V30 14 C 9.6572 3.8500 0.0 0
M  V30 15 C 10.9908 4.6200 0.0 0
M  V30 16 C 10.9908 6.1600 0.0 0
M  V30 17 C 12.3246 3.8500 0.0 0
M  V30 18 C 12.3246 6.9300 0.0 0
M  V30 19 C 13.6583 4.6200 0.0 0
M  V30 20 C 13.6583 6.1600 0.0 0
M  V30 21 C 2.3100 4.4136 0.0 0
M  V30 22 C 0.7700 4.4136 0.0 0
M  V30 23 C 3.0800 5.7473 0.0 0
M  V30 24 C 0.0000 5.7473 0.0 0
M  V30 25 C 2.3100 7.0809 0.0 0
M  V30 26 C 0.7700 7.0809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 12
M  V30 5 1 3 21
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 14 15
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2943939-96-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2943940-00-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36892442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Accessing 7-Azaaurones of Controllable E and Z Configurations from
8-Azaflavones via a Rearrangement-Acylation-Photoisomerization Sequence
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Mehiaoui, Nawel; Leleu, Stephane; Jean, Ludovic
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2023), 8(20), e202301218

$RFMT $RIREG SCHEME400 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-iodoaniline
C6H5FIN
29632-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 I 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-4-iodophenyl)-N′-methylurea
C8H8FIN2O
871700-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 F 2.6674 0.0000 0.0 0
M  V30 7 I 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29632-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871700-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9467511
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted pyridinone compounds as MEK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Gil Nam; Jeon, Hye Sun; Jeon, Ki Joon; Rhim, Chul Yun; Kim, Jin
Sung; Seo, Jeong Beob; Cho, Suk Young; Kim, Choung Soo; Lee, Jung Shin;
Choi, Eun Kyung; Hwang, Jung Jin; Kim, Bong Cheol
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014204263 A1 2014-12-24

$RFMT $RIREG SCHEME400 STEP1
$RXN



  3  1
$MOL
1,1′-Carbonyldiimidazole
C7H6N4O
530-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-4-iodoaniline
C6H5FIN
29632-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 0.0000 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 I 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Fluoro-4-iodophenyl)-N′-methylurea
C8H8FIN2O
871700-37-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 1.5400 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0021 1.5400 0.0 0
M  V30 4 O 6.6684 3.8500 0.0 0
M  V30 5 C 9.3358 2.3100 0.0 0
M  V30 6 F 2.6674 0.0000 0.0 0
M  V30 7 I 0.0000 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 1.3336 2.3100 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29632-74-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871700-37-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9203632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A: 1-(2-fluoro-4-iodophenyl)-3-methylurea. To
N,N'-carbonyldiimidazole (51.3 g, 316 mmol) in dry DMF (52 mL) was added
TEA (3.55 mL, 25.5 mmol) after addition of a solution of
2-fluoro-4-iodoaniline (50.0 g, 211 mmol) in dry DMF (52 mL) at 0°C.
under a N2 atmosphere. The reaction mixture was stirred at room
temperature for 16 h followed by the addition of a solution of 40%
methylamine (24.5 g, 316 mmol) at 0°C. After stirring for 1 h at room
temperature, the reaction mixture was added to water/toluene (v/v=2/1)
while stirring. The resulting solid was collected by filtration, rinsed
with water and dried in vacuo. 1-(2-fluoro-4-iodophenyl)-3-methylurea
(57.6 g, 93%) as a white solid, which was used for the next reaction
without further purification. 1H NMR (DMSO-d6, Varian 400 MHz) δ 2.64
(3H, d, J=2.4 Hz), 6.45-6.49 (1H, m), 7.40-7.42 (1H, m), 7.55 (1H, dd,
J=5.4, 2.0 Hz), 7.95 (1H, t, J=8.8 Hz), 8.36 (1H, brs).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as MEK inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Gilnam; Cho, Han Won; Song, Eun Jin; Jeon, Hye Sun; Kim, Min Jeong;
Seo, Jeongbeob; Gyorkos, Albert Charles; Cho, Suk Young
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20120238599 A1 2012-09-20

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Norcantharidin
C8H8O4
29745-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6460 2.7105 0.0 0
M  V30 2 O 1.9512 0.0000 0.0 0
M  V30 3 C 3.9952 3.4208 0.0 0 CFG=2
M  V30 4 C 2.6614 2.6508 0.0 0 CFG=1
M  V30 5 C 3.9998 4.9527 0.0 0 CFG=1
M  V30 6 C 5.1395 2.3904 0.0 0
M  V30 7 C 1.3324 3.4128 0.0 0 CFG=2
M  V30 8 C 2.9817 1.1445 0.0 0
M  V30 9 O 2.4301 4.5916 0.0 0
M  V30 10 C 2.6657 5.7235 0.0 0
M  V30 11 O 4.5132 0.9834 0.0 0
M  V30 12 C 1.3319 4.9535 0.0 0
M  V30 13 H 5.4029 4.0451 0.0 0
M  V30 14 H 1.4169 1.7437 0.0 0
M  V30 15 H 5.3347 5.7206 0.0 0
M  V30 16 H 0.0000 2.6406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 13 CFG=3
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 14 CFG=3
M  V30 10 1 5 9 CFG=1
M  V30 11 1 5 10
M  V30 12 1 5 15
M  V30 13 1 6 11
M  V30 14 1 7 9 CFG=1
M  V30 15 1 7 12
M  V30 16 1 7 16
M  V30 17 1 8 11
M  V30 18 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 3 4 5 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(3aR,4S,7R,7aS)-Hexahydro-2-methyl-4,7-epoxy-1H-isoindole-1,3(2H)-dione
C9H11NO3
89104-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0608 0.0 0
M  V30 2 O 4.6949 0.3502 0.0 0
M  V30 3 C 1.3628 0.0000 0.0 0
M  V30 4 C 2.6508 3.7710 0.0 0 CFG=2
M  V30 5 C 3.9846 3.0010 0.0 0 CFG=1
M  V30 6 C 2.6462 5.3031 0.0 0 CFG=1
M  V30 7 C 1.5064 2.7406 0.0 0
M  V30 8 C 5.3137 3.7630 0.0 0 CFG=2
M  V30 9 C 3.6643 1.4947 0.0 0
M  V30 10 O 4.2160 4.9419 0.0 0
M  V30 11 C 3.9803 6.0738 0.0 0
M  V30 12 N 2.1328 1.3337 0.0 0
M  V30 13 C 5.3141 5.3038 0.0 0
M  V30 14 H 1.2431 4.3954 0.0 0
M  V30 15 H 5.2291 2.0940 0.0 0
M  V30 16 H 1.3113 6.0709 0.0 0
M  V30 17 H 6.6461 2.9909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 14 CFG=1
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 15 CFG=1
M  V30 11 1 6 10 CFG=3
M  V30 12 1 6 11
M  V30 13 1 6 16
M  V30 14 1 7 12
M  V30 15 1 8 10 CFG=3
M  V30 16 1 8 13
M  V30 17 1 8 17
M  V30 18 1 9 12
M  V30 19 1 11 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 4 5 6 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29745-04-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 89104-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-13701131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cantharidin and its anhydride-modified derivatives: relation of structure
to insecticidal activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Wenbo; Liu, Zhongyi; Zhang, Yalin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2013), 141-16

$RFMT $RIREG SCHEME402 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glyoxylic acid
C2H2O3
298-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 O 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methylindole
C9H9N
603-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 3.1885 0.0 0
M  V30 2 C 3.0801 2.4782 0.0 0
M  V30 3 C 2.3101 1.1444 0.0 0
M  V30 4 N 4.5864 2.1580 0.0 0
M  V30 5 C 2.3101 3.8119 0.0 0
M  V30 6 C 0.7700 1.1444 0.0 0
M  V30 7 C 3.3405 0.0000 0.0 0
M  V30 8 C 4.7473 0.6263 0.0 0
M  V30 9 C 0.7700 3.8119 0.0 0
M  V30 10 C 0.0000 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 8
M  V30 11 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-α-(methylamino)-1H-indole-3-acetic acid
C12H14N2O2
1185731-68-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.0287 0.0 0
M  V30 2 C 7.0871 3.2587 0.0 0
M  V30 3 N 5.7534 5.5688 0.0 0
M  V30 4 O 7.0871 1.7187 0.0 0
M  V30 5 O 8.4209 4.0287 0.0 0
M  V30 6 C 7.0871 6.3388 0.0 0
M  V30 7 C 2.1260 0.0000 0.0 0
M  V30 8 C 3.0128 3.8850 0.0 0
M  V30 9 C 4.4197 3.2587 0.0 0
M  V30 10 C 1.9823 2.7406 0.0 0
M  V30 11 C 2.5369 5.3498 0.0 0
M  V30 12 C 4.2588 1.7271 0.0 0
M  V30 13 N 2.7523 1.4070 0.0 0
M  V30 14 C 0.4760 3.0608 0.0 0
M  V30 15 C 1.0306 5.6699 0.0 0
M  V30 16 C 0.0000 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 298-12-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 603-76-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1185731-68-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-8858232
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, uncatalyzed Friedel-Crafts reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient one-pot synthesis of indol-3-yl-glycines via uncatalyzed
Friedel-Crafts reaction in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghandi, Mehdi; Taheri, Abuzar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2009), 14(3), 1056-1061

$RFMT $RIREG SCHEME403 STEP1
$RXN



  5  1
$MOL
Quinoline
C9H7N
91-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzyl isothiocyanate
C9H9NOS
3694-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 C 9.2401 2.6673 0.0 0
M  V30 4 S 10.7801 2.6673 0.0 0
M  V30 5 O 0.7700 1.3337 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 C 5.3901 1.3337 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-carboxaldehyde, 6-amino-2-(1-methylethenyl)-
C12H12N2O
2991873-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2891 0.0 0
M  V30 2 C 8.3912 6.8291 0.0 0
M  V30 3 C 9.7250 4.5191 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 N 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 5.6507 5.1455 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 N 6.8966 2.9875 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 7.0575 4.5191 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
15cH-Indolizino[3,2-f]quino[1,2-c]quinazoline-13,14-dicarboxylic acid, 6-[[(4...
C37H33N5O5
2991873-04-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 53 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5128 7.4720 0.0 0
M  V30 2 O 5.2718 8.9930 0.0 0
M  V30 3 O 6.9505 6.9200 0.0 0
M  V30 4 C 3.8342 9.5448 0.0 0
M  V30 5 C 10.4080 2.3100 0.0 0
M  V30 6 N 10.4080 0.7700 0.0 0
M  V30 7 C 11.7416 0.0000 0.0 0
M  V30 8 C 1.6004 2.7651 0.0 0
M  V30 9 C 2.1580 8.0706 0.0 0
M  V30 10 O 0.6265 8.2316 0.0 0
M  V30 11 O 3.0632 9.3166 0.0 0
M  V30 12 C 0.0000 9.6384 0.0 0
M  V30 13 N 11.7416 7.7000 0.0 0
M  V30 14 C 13.0754 6.9300 0.0 0
M  V30 15 O 18.4102 10.0101 0.0 0
M  V30 16 C 19.7438 9.2400 0.0 0
M  V30 17 C 6.4069 4.6200 0.0 0
M  V30 18 C 7.7407 5.3900 0.0 0
M  V30 19 N 4.9423 5.0959 0.0 0
M  V30 20 C 6.4069 3.0800 0.0 0
M  V30 21 C 7.7407 6.9300 0.0 0
M  V30 22 C 9.0743 4.6200 0.0 0
M  V30 23 C 4.0371 3.8500 0.0 0
M  V30 24 C 4.3159 6.5028 0.0 0
M  V30 25 C 4.9423 2.6042 0.0 0
M  V30 26 C 7.7407 2.3100 0.0 0
M  V30 27 N 9.0743 7.7000 0.0 0
M  V30 28 C 6.4069 7.7000 0.0 0
M  V30 29 C 9.0743 3.0800 0.0 0
M  V30 30 N 10.4080 5.3900 0.0 0
M  V30 31 C 2.5056 4.0110 0.0 0
M  V30 32 C 2.7843 6.6638 0.0 0
M  V30 33 C 10.4080 6.9300 0.0 0
M  V30 34 C 9.0743 9.2400 0.0 0
M  V30 35 C 6.4069 9.2400 0.0 0
M  V30 36 C 1.8791 5.4179 0.0 0
M  V30 37 C 7.7407 10.0101 0.0 0
M  V30 38 C 10.4080 10.0101 0.0 0
M  V30 39 C 7.7407 11.5501 0.0 0
M  V30 40 C 10.4080 11.5501 0.0 0
M  V30 41 C 9.0743 12.3201 0.0 0
M  V30 42 C 14.4091 7.7000 0.0 0
M  V30 43 C 15.7427 6.9300 0.0 0
M  V30 44 C 14.4091 9.2400 0.0 0
M  V30 45 C 17.0764 7.7000 0.0 0
M  V30 46 C 15.7427 10.0101 0.0 0
M  V30 47 C 17.0764 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 2 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 29
M  V30 7 1 6 7
M  V30 8 1 8 31
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 32
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 33
M  V30 15 1 14 42
M  V30 16 1 15 16
M  V30 17 1 15 47
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 20 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 21 28
M  V30 29 1 22 29
M  V30 30 1 22 30
M  V30 31 2 23 25
M  V30 32 1 23 31
M  V30 33 2 24 32
M  V30 34 2 26 29
M  V30 35 1 27 33
M  V30 36 1 27 34
M  V30 37 2 28 35
M  V30 38 2 30 33
M  V30 39 2 31 36
M  V30 40 1 32 36
M  V30 41 1 34 37
M  V30 42 2 34 38
M  V30 43 1 35 37
M  V30 44 2 37 39
M  V30 45 1 38 40
M  V30 46 1 39 41
M  V30 47 2 40 41
M  V30 48 2 42 43
M  V30 49 1 42 44
M  V30 50 1 43 45
M  V30 51 2 44 46
M  V30 52 2 45 47
M  V30 53 1 46 47
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-22-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3694-57-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2991873-09-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2991873-04-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37936692
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable and reusable catalyst used, catalyst prepared
and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of new quinolinoquinazoline derivatives via one-pot
multicomponent reactions using ZnO/TiO2@MWCNTs as a new nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasani, Leila; Ezzatzadeh, Elham; Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2023), 60(12), 2023-2035

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3R)-2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-1H-pyrido[3,4-b]indole-...
C20H20N2O3
303984-26-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 O 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=2
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=2
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 7.5823 8.4701 0.0 0
M  V30 22 C 8.9160 6.1601 0.0 0
M  V30 23 C 8.9160 9.2401 0.0 0
M  V30 24 C 10.2498 6.9301 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3R)-2,3,4,9-Tetrahydro-1-(4-methoxyphenyl)-N-methyl-1H-pyrido[3,4-b]indol...
C20H21N3O2
2254177-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 N 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=2
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=2
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 8.9160 6.1601 0.0 0
M  V30 22 C 7.5823 8.4701 0.0 0
M  V30 23 C 10.2498 6.9301 0.0 0
M  V30 24 C 8.9160 9.2401 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 303984-26-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254177-53-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19425562
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of all stereoisomers of
1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Onda, Momoko; Higashida, Ayaka; Hirano, Takako; Nishio, Toshiyuki;
Hakamata, Wataru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molbank (2018), (1), M973/1-M973/6

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′(1′H)-pyridin]-2′(3′H)-one, 5-chloro-2-methoxy-1′-methyl-...
C14H13ClN2O2
3054153-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 1.3338 4.3755 0.0 0
M  V30 2 C 0.0000 5.1455 0.0 0
M  V30 3 O 2.1057 0.9517 0.0 0
M  V30 4 Cl 8.9549 6.9973 0.0 0
M  V30 5 C 5.0350 0.0000 0.0 0
M  V30 6 C 4.0743 4.5190 0.0 0 CFG=2
M  V30 7 C 5.1049 5.6636 0.0 0
M  V30 8 C 2.6675 5.1455 0.0 0
M  V30 9 C 2.9299 3.4886 0.0 0
M  V30 10 C 5.5390 4.0432 0.0 0
M  V30 11 C 4.3349 6.9973 0.0 0
M  V30 12 C 6.6449 5.6636 0.0 0
M  V30 13 N 2.8284 6.6771 0.0 0
M  V30 14 C 3.2501 1.9822 0.0 0
M  V30 15 C 5.8592 2.5369 0.0 0
M  V30 16 C 5.1049 8.3309 0.0 0
M  V30 17 C 7.4149 6.9973 0.0 0
M  V30 18 N 4.7148 1.5063 0.0 0
M  V30 19 C 6.6449 8.3309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 14
M  V30 4 1 4 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 11 13
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,4′(1′H)-pyridin]-2′(3′H)-one, 5-chloro-1′-methyl-2-(methyla...
C14H14ClN3O
3054153-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 4.3755 0.0 0
M  V30 2 C 0.0000 5.1455 0.0 0
M  V30 3 O 2.1057 0.9517 0.0 0
M  V30 4 Cl 8.9549 6.9973 0.0 0
M  V30 5 C 5.0350 0.0000 0.0 0
M  V30 6 C 4.0743 4.5190 0.0 0 CFG=2
M  V30 7 C 5.1049 5.6636 0.0 0
M  V30 8 C 2.6675 5.1455 0.0 0
M  V30 9 C 2.9299 3.4886 0.0 0
M  V30 10 C 5.5390 4.0432 0.0 0
M  V30 11 C 4.3349 6.9973 0.0 0
M  V30 12 C 6.6449 5.6636 0.0 0
M  V30 13 N 2.8284 6.6771 0.0 0
M  V30 14 C 3.2501 1.9822 0.0 0
M  V30 15 C 5.8592 2.5369 0.0 0
M  V30 16 C 5.1049 8.3309 0.0 0
M  V30 17 C 7.4149 6.9973 0.0 0
M  V30 18 N 4.7148 1.5063 0.0 0
M  V30 19 C 6.6449 8.3309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 14
M  V30 4 1 4 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 1 9 14
M  V30 14 2 10 15
M  V30 15 1 11 13
M  V30 16 2 11 16
M  V30 17 1 12 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3054153-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3054153-13-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42872390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 304-59-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Synthesis of (-)-Caulamidine A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Zhouyang; Maimone, Thomas J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(26), 14215-14220

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butanone, 1-(7-fluoro-5-benzofuranyl)-
C12H11FO2
3057895-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 4.6200 0.0 0
M  V30 3 C 7.7045 3.8500 0.0 0
M  V30 4 C 9.0383 4.6200 0.0 0
M  V30 5 O 7.7045 2.3100 0.0 0
M  V30 6 C 10.3720 3.8500 0.0 0
M  V30 7 C 2.3698 3.8500 0.0 0
M  V30 8 C 2.3698 2.3100 0.0 0
M  V30 9 C 3.7036 4.6200 0.0 0
M  V30 10 C 0.9052 4.3259 0.0 0
M  V30 11 C 3.7036 1.5400 0.0 0
M  V30 12 O 0.9052 1.8341 0.0 0
M  V30 13 C 5.0372 3.8500 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Benzofuranethanamine, α-ethyl-7-fluoro-N-methyl-
C13H16FNO
3057895-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.6672 1.3337 0.0 0
M  V30 2 C 6.2873 4.0012 0.0 0
M  V30 3 C 7.0574 2.6673 0.0 0
M  V30 4 C 8.5974 2.6673 0.0 0
M  V30 5 N 6.2873 1.3337 0.0 0
M  V30 6 C 9.3674 4.0012 0.0 0
M  V30 7 C 7.0574 0.0000 0.0 0
M  V30 8 C 2.4373 5.3348 0.0 0
M  V30 9 C 1.6672 4.0012 0.0 0
M  V30 10 C 3.9773 5.3348 0.0 0
M  V30 11 C 1.4068 6.4792 0.0 0
M  V30 12 C 2.4373 2.6673 0.0 0
M  V30 13 O 0.1609 4.3213 0.0 0
M  V30 14 C 4.7473 4.0012 0.0 0
M  V30 15 C 0.0000 5.8529 0.0 0
M  V30 16 C 3.9773 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3057895-60-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3057895-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-43117092
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of advantageous fluorobenzofurans for the treatment of mental
disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024206712 A1 2024-10-03

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinazoline, 2,4-dichloro-7-(cyclopentyloxy)-6-methoxy-
C14H14Cl2N2O2
3058007-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 O 6.6684 6.9300 0.0 0
M  V30 3 Cl 2.6673 0.0000 0.0 0
M  V30 4 O 4.0011 8.4701 0.0 0
M  V30 5 C 2.6673 9.2401 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6673 4.6200 0.0 0
M  V30 8 C 5.3348 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 2.6673 6.1600 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 12 C 5.3348 6.1600 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 4.0011 6.9300 0.0 0
M  V30 15 N 1.3336 2.3100 0.0 0
M  V30 16 C 8.0021 6.1600 0.0 0
M  V30 17 C 9.4090 6.7864 0.0 0
M  V30 18 C 8.1631 4.6285 0.0 0
M  V30 19 C 10.4394 5.6420 0.0 0
M  V30 20 C 9.6694 4.3083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 2 16
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinazolinamine, 2-chloro-7-(cyclopentyloxy)-6-methoxy-N-methyl-
C15H18ClN3O2
3058007-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 5.3348 8.4702 0.0 0
M  V30 4 C 4.0010 9.2402 0.0 0
M  V30 5 O 8.0022 6.9302 0.0 0
M  V30 6 Cl 4.0010 0.0000 0.0 0
M  V30 7 C 4.0010 4.6201 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 4.0010 6.1601 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 N 5.3348 2.3101 0.0 0
M  V30 13 N 2.6673 2.3101 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 6.6685 6.1601 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 C 9.3360 6.1601 0.0 0
M  V30 18 C 10.7428 6.7865 0.0 0
M  V30 19 C 9.4969 4.6286 0.0 0
M  V30 20 C 11.7732 5.6421 0.0 0
M  V30 21 C 11.0032 4.3084 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 15
M  V30 6 1 5 17
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 16
M  V30 18 1 14 15
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3058007-51-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3058007-80-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39793341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents
against Leishmania donovani
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Nirmal; Roy, Jayasree; Patra, Binita; Saunders, Eleanor; Sarkar,
Dipika; Goon, Sunny; Sinha, Bishnu Prasad; Roy, Shreya; Roy, Swarnali;
Sarif, Jafar; Bandopadhyay, Purbita; Barik, Subhasis; Mukherjee, Suravi;
McNamara, Nicole; Varghese, Swapna; Simpson, Kaylene; Baell, Jonathan;
McConville, Malcolm; Ganguly, Dipyaman; Talukdar, Arindam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2024), 269116256

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Isothiocyanato-3-methoxybenzene
C8H7NOS
3125-64-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 S 9.3360 1.5400 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxy-N-methyl-2-benzothiazolamine
C9H10N2OS
50450-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.5400 0.0 0
M  V30 2 C 0.0000 0.2064 0.0 0
M  V30 3 O 8.6809 3.0800 0.0 0
M  V30 4 C 10.0147 2.3100 0.0 0
M  V30 5 C 4.6799 2.3100 0.0 0
M  V30 6 C 4.6799 0.7700 0.0 0
M  V30 7 N 3.2152 2.7859 0.0 0
M  V30 8 C 6.0136 3.0800 0.0 0
M  V30 9 S 3.2152 0.2941 0.0 0
M  V30 10 C 6.0136 0.0000 0.0 0
M  V30 11 C 2.3100 1.5400 0.0 0
M  V30 12 C 7.3472 2.3100 0.0 0
M  V30 13 C 7.3472 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3125-64-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50450-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28613393
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 111865-47-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Xin; McCorvy, John D.; Fischer, Matthew G.; Butler, Kyle V.; Shen,
Yudao; Roth, Bryan L.; Jin, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(23), 10601-10618

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Thieno[2,3-c]pyridine-2-carboxylic acid, 7-bromo-4-(4-chlorophenoxy)-, methyl...
C15H9BrClNO3S
313216-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.7484 5.3347 0.0 0
M  V30 2 Br 5.6684 0.0000 0.0 0
M  V30 3 C 2.6674 5.2890 0.0 0
M  V30 4 O 1.3336 4.5190 0.0 0
M  V30 5 O 2.6674 6.8290 0.0 0
M  V30 6 C 0.0000 5.2890 0.0 0
M  V30 7 Cl 14.9084 5.3347 0.0 0
M  V30 8 C 6.4384 4.0009 0.0 0
M  V30 9 C 5.6684 2.6673 0.0 0
M  V30 10 C 7.9784 4.0009 0.0 0
M  V30 11 C 5.4079 5.1454 0.0 0
M  V30 12 S 4.1620 2.9874 0.0 0
M  V30 13 C 6.4384 1.3336 0.0 0
M  V30 14 C 8.7484 2.6673 0.0 0
M  V30 15 C 4.0011 4.5190 0.0 0
M  V30 16 N 7.9784 1.3336 0.0 0
M  V30 17 C 10.2884 5.3347 0.0 0
M  V30 18 C 11.0584 4.0009 0.0 0
M  V30 19 C 11.0584 6.6684 0.0 0
M  V30 20 C 12.5984 4.0009 0.0 0
M  V30 21 C 12.5984 6.6684 0.0 0
M  V30 22 C 13.3684 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 17
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-4-(4-chlorophenoxy)-N-methylthieno[2,3-c]pyridine-2-carboxamide
C15H10BrClN2O2S
251995-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.7484 5.3347 0.0 0
M  V30 2 Br 5.6684 0.0000 0.0 0
M  V30 3 C 2.6674 5.2890 0.0 0
M  V30 4 N 1.3336 4.5190 0.0 0
M  V30 5 O 2.6674 6.8290 0.0 0
M  V30 6 C 0.0000 5.2890 0.0 0
M  V30 7 Cl 14.9084 5.3347 0.0 0
M  V30 8 C 6.4384 4.0009 0.0 0
M  V30 9 C 5.6684 2.6673 0.0 0
M  V30 10 C 7.9784 4.0009 0.0 0
M  V30 11 C 5.4079 5.1454 0.0 0
M  V30 12 S 4.1620 2.9874 0.0 0
M  V30 13 C 6.4384 1.3336 0.0 0
M  V30 14 C 8.7484 2.6673 0.0 0
M  V30 15 C 4.0011 4.5190 0.0 0
M  V30 16 N 7.9784 1.3336 0.0 0
M  V30 17 C 10.2884 5.3347 0.0 0
M  V30 18 C 11.0584 6.6684 0.0 0
M  V30 19 C 11.0584 4.0009 0.0 0
M  V30 20 C 12.5984 6.6684 0.0 0
M  V30 21 C 12.5984 4.0009 0.0 0
M  V30 22 C 13.3684 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 17
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 7 22
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 313216-28-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 251995-72-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5767366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile and general synthesis of 2,4-Di- and 2,4,7-trisubstituted
thieno[2,3-c]pyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Gui-Dong; Gunawardana, Indrani W.; Boyd, Steven A.; Melcher, Laura
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2008), 45(1), 91-96

$RFMT $RIREG SCHEME410 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-3-quinolinecarbonitrile
C10H7N3
31407-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 N 8.4700 2.6674 0.0 0
M  V30 3 N 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylpyrimido[4,5-b]quinolin-4-amine
C12H10N4
2316741-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7000 4.0011 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 N 5.3900 0.0000 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 N 7.7000 1.3338 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 0.7700 2.6674 0.0 0
M  V30 15 C 0.7700 5.3349 0.0 0
M  V30 16 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 11
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 31407-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2316741-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26840477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, microwave irradiation (200W), pressure vial used,
optimization study, optimized on catalyst, optimized on solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-free, one-pot, three-component synthesis of
pyrimido[4,5-b]quinoline-4-amines under microwave irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Jiao; Zhang, Li Hong; Liu, Xiu Bo; Ma, Wei; Ma, Ling; Ma, Yan; Yang,
Jian Nan; Wang, Dao Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2018), 42(10), 525-528

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[ethoxy(3-methylphenyl)methylene]-, (OC-6-21)-
C15H12CrO6
332847-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 5.1227 7.2148 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1227 3.0189 0.0 0 CHG=-2 VAL=4
M  V30 3 C 3.7501 9.6941 0.0 0
M  V30 4 C 6.4992 4.7317 0.0 0
M  V30 5 C 7.6059 8.5874 0.0 0
M  V30 6 C 5.1227 10.0499 0.0 0
M  V30 7 C 2.6435 5.8383 0.0 0
M  V30 8 O 6.3506 2.3111 0.0 0
M  V30 9 O 2.5223 10.4018 0.0 0 VAL=3
M  V30 10 O 7.7271 4.0239 0.0 0 VAL=3
M  V30 11 O 8.8337 7.8796 0.0 0 VAL=3
M  V30 12 O 3.8987 10.7577 0.0 0 VAL=3
M  V30 13 O 1.4156 6.5461 0.0 0 VAL=3
M  V30 14 C 7.5785 3.0189 0.0 0
M  V30 15 C 8.8181 2.3306 0.0 0
M  V30 16 C 0.0000 3.0189 0.0 0
M  V30 17 C 3.8987 2.3111 0.0 0
M  V30 18 C 2.5653 3.0814 0.0 0
M  V30 19 C 3.8987 0.7704 0.0 0
M  V30 20 C 1.2318 2.3111 0.0 0
M  V30 21 C 2.5653 0.0000 0.0 0
M  V30 22 C 1.2318 0.7704 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 17
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 14 15
M  V30 16 1 16 20
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[(methylamino)(3-methylphenyl)methylene]-, (OC-6-21)-
C14H11CrNO5
332847-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 5.1164 7.2114 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1203 3.0175 0.0 0 CHG=-2 VAL=4
M  V30 3 C 3.7484 9.6895 0.0 0
M  V30 4 C 6.4922 4.7294 0.0 0
M  V30 5 C 7.5984 8.5834 0.0 0
M  V30 6 C 5.1164 10.0452 0.0 0
M  V30 7 C 2.6422 5.8356 0.0 0
M  V30 8 N 6.3476 2.3100 0.0 0
M  V30 9 O 2.5211 10.3970 0.0 0 VAL=3
M  V30 10 O 7.7195 4.0220 0.0 0 VAL=3
M  V30 11 O 8.8257 7.8759 0.0 0 VAL=3
M  V30 12 O 3.8930 10.7526 0.0 0 VAL=3
M  V30 13 O 1.4149 6.5430 0.0 0 VAL=3
M  V30 14 C 7.7430 3.1152 0.0 0
M  V30 15 C 0.0000 3.0175 0.0 0
M  V30 16 C 3.8930 2.3100 0.0 0
M  V30 17 C 2.5641 3.0800 0.0 0
M  V30 18 C 3.8930 0.7700 0.0 0
M  V30 19 C 1.2273 2.3100 0.0 0
M  V30 20 C 2.5641 0.0000 0.0 0
M  V30 21 C 1.2273 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 16
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 19
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-8585871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 25:75 syn:anti
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-4-chloro-6-methylpyrimidine
C5H4BrClN2
3438-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 2.6674 0.0000 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 Cl 5.3349 1.5400 0.0 0
M  V30 4 C 2.6674 1.5400 0.0 0
M  V30 5 C 1.3338 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 N 1.3338 3.8500 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 2.6674 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 6
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N,6-dimethyl-4-pyrimidinamine
C6H8BrN3
1315326-21-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 1.5400 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 Br 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 1.5400 0.0 0
M  V30 7 N 4.0011 3.8500 0.0 0
M  V30 8 C 1.3338 2.3100 0.0 0
M  V30 9 C 2.6675 4.6201 0.0 0
M  V30 10 N 1.3338 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3438-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315326-21-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3426684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Bromo-N,6-dimethylpyrimidin-4-amine (3).
5-Bromo-4-chloro-6-methylpyrimidine (6; 90 mg, 0.43 mmol) was added to a
solution of MeNH2 (2.0 mL, 4.0 mmol, 2 M in THF). After 3 h at r.t., the
precipitate was filtered and the filtrate was concentrated under reduced
pressure. The residue was purified by preparative TLC eluting with
PE-EtOAc (1:1). 80 mg (93%) of 3 as a white solid. mp 128.4-129.1 °C.
IR(KBr): 3243 (br), 1590, 1405, 1029 cm-1. 1H NMR (400 MHz, CDCl3): δ =
8.41 (s, 1 H), 5.48 (br, 1 H), 3.07 (d, J= 5.2 Hz, 3 H), 2.50 (s, 3.H).
13C NMR (100 MHz, CDCl3): δ = 162.2, 159.0, 155.9, 104.8, 28.4, 24.4.
HRMS (+ESI): m/z[M + H] calcd for C6H9BrN3 : 201.9980 and 203.9959;
found: 201.9970 and 203.9948.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Scalable synthesis of 4-substituted 5-bromo-6-methylpyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Zhihan; Chi, Yushi; Harris, Anthony R.; Gray, David; Davoren,
Jennifer E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2011), (10), 1529-1531

$RFMT $RIREG SCHEME413 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Chloroadenosine
C10H12ClN5O4
34408-14-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 5.2478 6.9159 0.0 0
M  V30 2 O 2.9016 6.4171 0.0 0
M  V30 3 N 10.5368 3.9147 0.0 0
M  V30 4 C 0.6966 1.4647 0.0 0
M  V30 5 O 1.1724 0.0000 0.0 0
M  V30 6 O 0.0000 4.7419 0.0 0
M  V30 7 N 5.3913 4.1753 0.0 0
M  V30 8 C 6.5359 3.1447 0.0 0
M  V30 9 C 6.0178 5.5821 0.0 0
M  V30 10 C 7.8695 3.9147 0.0 0
M  V30 11 N 6.5359 1.6047 0.0 0
M  V30 12 N 7.5493 5.4212 0.0 0
M  V30 13 C 9.2032 3.1447 0.0 0
M  V30 14 C 7.8695 0.8347 0.0 0
M  V30 15 N 9.2032 1.6047 0.0 0
M  V30 16 C 3.8850 3.8551 0.0 0 CFG=1
M  V30 17 O 3.2585 2.4482 0.0 0
M  V30 18 C 2.7405 4.8856 0.0 0 CFG=2
M  V30 19 C 1.7270 2.6093 0.0 0 CFG=2
M  V30 20 C 1.4068 4.1156 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 18 2 CFG=1
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
8-(Methylamino)adenosine
C11H16N6O4
13389-13-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.2478 1.3338 0.0 0
M  V30 2 C 6.0178 0.0000 0.0 0
M  V30 3 O 2.9016 1.8325 0.0 0
M  V30 4 N 10.5369 4.3349 0.0 0
M  V30 5 C 0.6966 6.7849 0.0 0
M  V30 6 O 1.1724 8.2497 0.0 0
M  V30 7 O 0.0000 3.5077 0.0 0
M  V30 8 N 5.3914 4.0743 0.0 0
M  V30 9 C 6.5359 5.1049 0.0 0
M  V30 10 C 6.0178 2.6675 0.0 0
M  V30 11 C 7.8696 4.3349 0.0 0
M  V30 12 N 6.5359 6.6449 0.0 0
M  V30 13 N 7.5494 2.8284 0.0 0
M  V30 14 C 9.2032 5.1049 0.0 0
M  V30 15 C 7.8696 7.4150 0.0 0
M  V30 16 N 9.2032 6.6449 0.0 0
M  V30 17 C 3.8850 4.3945 0.0 0 CFG=1
M  V30 18 O 3.2586 5.8015 0.0 0
M  V30 19 C 2.7405 3.3640 0.0 0 CFG=2
M  V30 20 C 1.7270 5.6405 0.0 0 CFG=2
M  V30 21 C 1.4068 4.1341 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 19 3 CFG=3
M  V30 4 1 4 14
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=1
M  V30 7 1 21 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=1
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34408-14-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 13389-13-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8394951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of
Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne;
Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert;
Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(15), 6248-6263

$RFMT $RIREG SCHEME414 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,6-dimethylbenzenesulfonyl chloride
C8H8BrClO2S
351003-50-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 2.6674 0.0 0 VAL=6
M  V30 2 Cl 0.0000 2.6674 0.0 0
M  V30 3 O 1.5400 4.2074 0.0 0
M  V30 4 O 1.5400 1.1274 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 5.3349 0.0 0
M  V30 7 Br 7.7000 2.6674 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N,2,6-trimethylbenzenesulfonamide
C9H12BrNO2S
937014-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 2.6674 0.0 0 VAL=6
M  V30 2 N 0.7700 2.6674 0.0 0
M  V30 3 O 2.3100 4.2074 0.0 0
M  V30 4 O 2.3100 1.1274 0.0 0
M  V30 5 C 0.0000 4.0011 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 5.3349 0.0 0
M  V30 8 Br 8.4700 2.6674 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351003-50-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 937014-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-962802
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 219. 4-Bromo-2,6-N-trimethyl-benzenesulfonamide (Intermediate
121) A vigorously stirring solution of methylamine in water (40 wt.%) was
treated with intermediate 120 (2.6 g, 9.19 mmol). After 3 h, white
precipitate was filtered off and dried (2.37 g, 93%).
4-Bromo-2,6-N-trimethyl-benzenesulfonamide, yield (2.37 g, 93%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of six membered heteroaromatic, particularly pyrimidine and
triazine, inhibitors targeting resistant kinase mutations for treating
angiogenic and hematological associated disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Jianguo; Hood, John; Lohse, Dan; Mak, Chi Ching; Mc Pherson, Andrew;
Noronha, Glenn; Pathak, Ved; Renick, Joel; Soll, Richard M.; Zeng, Binqi;
Chow, Chun; Palanki, Moorthy; Dneprovskaia, Elena
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007056075 A2 2007-05-18

$RFMT $RIREG SCHEME415 STEP1
$RXN



  2  1
$MOL
3-(Phenylmethoxy)-N-[(phenylmethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosine
C31H29NO6
35591-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 5.3347 0.0 0
M  V30 2 C 7.7000 4.0009 0.0 0
M  V30 3 O 5.3900 8.0020 0.0 0
M  V30 4 C 4.6200 9.3358 0.0 0
M  V30 5 C 10.0100 10.6694 0.0 0
M  V30 6 C 11.5500 10.6694 0.0 0 CFG=1
M  V30 7 N 12.3200 9.3358 0.0 0
M  V30 8 C 12.3200 12.0031 0.0 0
M  V30 9 C 13.8600 9.3358 0.0 0
M  V30 10 O 13.8600 12.0031 0.0 0
M  V30 11 O 11.5500 13.3367 0.0 0
M  V30 12 O 14.6300 8.0020 0.0 0
M  V30 13 O 14.6300 10.6694 0.0 0
M  V30 14 C 16.1700 8.0020 0.0 0
M  V30 15 C 7.7000 6.6684 0.0 0
M  V30 16 C 6.9300 8.0020 0.0 0
M  V30 17 C 9.2400 6.6684 0.0 0
M  V30 18 C 7.7000 9.3358 0.0 0
M  V30 19 C 10.0100 8.0020 0.0 0
M  V30 20 C 9.2400 9.3358 0.0 0
M  V30 21 C 6.9300 2.6673 0.0 0
M  V30 22 C 7.7000 1.3336 0.0 0
M  V30 23 C 5.3900 2.6673 0.0 0
M  V30 24 C 6.9300 0.0000 0.0 0
M  V30 25 C 4.6200 1.3336 0.0 0
M  V30 26 C 5.3900 0.0000 0.0 0
M  V30 27 C 3.0800 9.3358 0.0 0
M  V30 28 C 2.3100 10.6694 0.0 0
M  V30 29 C 2.3100 8.0020 0.0 0
M  V30 30 C 0.7700 10.6694 0.0 0
M  V30 31 C 0.7700 8.0020 0.0 0
M  V30 32 C 0.0000 9.3358 0.0 0
M  V30 33 C 16.9400 6.6684 0.0 0
M  V30 34 C 16.1700 5.3347 0.0 0
M  V30 35 C 18.4800 6.6684 0.0 0
M  V30 36 C 16.9400 4.0009 0.0 0
M  V30 37 C 19.2500 5.3347 0.0 0
M  V30 38 C 18.4800 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 21
M  V30 4 1 3 4
M  V30 5 1 3 16
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 5 20
M  V30 9 1 6 7 CFG=1
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 2 9 13
M  V30 16 1 12 14
M  V30 17 1 14 33
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 2 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-[[3,4-bis(phenylmethoxy)phenyl]methyl]-2-(methylamino)...
C32H32N2O5
1246370-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 8.0020 0.0 0
M  V30 2 C 4.6200 9.3358 0.0 0
M  V30 3 O 6.9300 5.3347 0.0 0
M  V30 4 C 7.7000 4.0009 0.0 0
M  V30 5 C 11.5500 8.0020 0.0 0
M  V30 6 C 12.3200 9.3358 0.0 0 CFG=1
M  V30 7 N 13.8600 9.3358 0.0 0
M  V30 8 C 11.5500 10.6694 0.0 0
M  V30 9 C 14.6300 8.0020 0.0 0
M  V30 10 N 12.3200 12.0031 0.0 0
M  V30 11 O 10.0100 10.6694 0.0 0
M  V30 12 O 13.8600 6.6684 0.0 0
M  V30 13 O 16.1700 8.0020 0.0 0
M  V30 14 C 11.5500 13.3367 0.0 0
M  V30 15 C 14.6300 5.3347 0.0 0
M  V30 16 C 6.9300 8.0020 0.0 0
M  V30 17 C 7.7000 6.6684 0.0 0
M  V30 18 C 7.7000 9.3358 0.0 0
M  V30 19 C 9.2400 6.6684 0.0 0
M  V30 20 C 9.2400 9.3358 0.0 0
M  V30 21 C 10.0100 8.0020 0.0 0
M  V30 22 C 3.0800 9.3358 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 2.3100 8.0020 0.0 0
M  V30 25 C 0.7700 10.6694 0.0 0
M  V30 26 C 0.7700 8.0020 0.0 0
M  V30 27 C 0.0000 9.3358 0.0 0
M  V30 28 C 6.9300 2.6673 0.0 0
M  V30 29 C 5.3900 2.6673 0.0 0
M  V30 30 C 7.7000 1.3336 0.0 0
M  V30 31 C 4.6200 1.3336 0.0 0
M  V30 32 C 6.9300 0.0000 0.0 0
M  V30 33 C 5.3900 0.0000 0.0 0
M  V30 34 C 16.1700 5.3347 0.0 0
M  V30 35 C 16.9400 6.6684 0.0 0
M  V30 36 C 16.9400 4.0009 0.0 0
M  V30 37 C 18.4800 6.6684 0.0 0
M  V30 38 C 18.4800 4.0009 0.0 0
M  V30 39 C 19.2500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 22
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 28
M  V30 7 1 5 6
M  V30 8 1 5 21
M  V30 9 1 6 7 CFG=1
M  V30 10 1 6 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 2 9 13
M  V30 16 1 10 14
M  V30 17 1 12 15
M  V30 18 1 15 34
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35591-10-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1246370-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8502339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6066-82-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological evaluation of L-dopa amide derivatives
as potential prodrugs for the treatment of Parkinson's disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Tao; Hider, Robert C.; Jenner, Peter; Campbell, Bruce; Hobbs,
Christopher J.; Rose, Sarah; Jairaj, Mark; Tayarani-Binazir, Kayhan A.;
Syme, Alexander
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2010), 45(9), 4035-4042

$RFMT $RIREG SCHEME416 STEP1
$RXN



  2  1
$MOL
1,1-Dimethylethyl 4-iodo-3-methylbenzoate
C12H15IO2
360059-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.6673 0.0 0
M  V30 2 O 3.0800 4.0009 0.0 0
M  V30 3 O 3.0800 1.3336 0.0 0
M  V30 4 C 1.5400 4.0009 0.0 0
M  V30 5 C 1.5400 5.5409 0.0 0
M  V30 6 C 0.0000 4.0009 0.0 0
M  V30 7 C 1.5400 2.4609 0.0 0
M  V30 8 C 8.4700 0.0000 0.0 0
M  V30 9 I 10.0100 2.6673 0.0 0
M  V30 10 C 5.3900 2.6673 0.0 0
M  V30 11 C 6.1600 1.3336 0.0 0
M  V30 12 C 6.1600 4.0009 0.0 0
M  V30 13 C 7.7000 1.3336 0.0 0
M  V30 14 C 7.7000 4.0009 0.0 0
M  V30 15 C 8.4700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-iodo-3-[(methylamino)methyl]benzoate
C13H18INO2
360059-34-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 2.3101 0.0 0
M  V30 2 O 8.0023 3.0801 0.0 0
M  V30 3 O 6.6685 0.7700 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 8.5660 0.9764 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 C 10.1060 3.6437 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 N 1.3337 0.7700 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 I 1.3337 5.3901 0.0 0
M  V30 12 C 5.3348 3.0801 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 2.6673 3.0801 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 360059-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 360059-34-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1064239
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 93-97-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128-08-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 56-23-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-Butyl 4-iodo-3-methylaminomethylbenzoate 9: A solution of t-butyl
4-iodo-3-methylbenzoate 8 (18.0 g, 56.6 mmol), NBS (12.1 g, 67.9 mmol)
and (PhCO)2O (1.37 g, 5.7 mmol) in 100 mL of CCl4 was refluxed for 2 days
under nitrogen atmosphere. After it was cooled to room temperature, the
mixture was washed with water, and dried over anhydrous Na2SO4. The
solvent was evaporated and the residue was dissolved in 50 mL THF. To
this stirring solution was added dropwise to a solution of 28% CH3NH2 (22
mL, 198 mmol) in 100 mL of THF and 50 mL of H2O. The reaction mixture was
stirred for 1 h at room temperature before the solvent was removed under
reduced pressure. The residue was dissolved with CHCl3 and washed with
water. After it was dried over anhydrous Na2SO4, the solution was
concentrated and the residual oil was purified by chromatography eluting
with triethylamine/ethyl acetate/petroleum ether (0.05/1/2) to give 18.3
g (93%) of 9. tert-Butyl 4-iodo-3-methylaminomethylbenzoate 9, yield 18.3
g, 93% 1H NMR (300 MHz, CDCl3) δ 7.92 (d, J = 2.1 Hz, 1H), 7.89 (d, J =
8.2 Hz, 1H), 7.55 (dd, J = 8.2, 2.1 Hz, 1H), 3.81 (s, 2H), 2.48 (s, 3H),
1.59 (s, 9H); MS m/z 347 (M+), 290, 246, 164.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CuI-catalyzed coupling reaction of β-amino acids or esters with aryl
halides at temperature lower than that employed in the normal Ullmann
reaction. Facile synthesis of SB-214857
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Dawei; Xia, Chengfeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2001), 3(16), 2583-2586

$RFMT $RIREG SCHEME417 STEP1
$RXN



  2  1
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methan-d3-amine
CH2D3N
5581-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3337 0.0 0
M  V30 2 N 0.7700 0.0000 0.0 0
M  V30 3 H 0.0000 1.3337 0.0 0 MASS=2
M  V30 4 H 0.7700 2.6673 0.0 0 MASS=2
M  V30 5 H 3.0800 1.3337 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C7H4BrD3N2O2
2796969-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 1.3338 0.0 0 VAL=5
M  V30 2 O 4.6200 0.0000 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 N 2.3100 4.0011 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 Br 8.4700 4.0011 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 C 6.1600 2.6674 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 H 0.0000 5.3347 0.0 0 MASS=2
M  V30 14 H 0.7700 6.6685 0.0 0 MASS=2
M  V30 15 H 2.3100 6.6685 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 13
M  V30 7 1 5 14
M  V30 8 1 5 15
M  V30 9 1 6 11
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5581-55-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2796969-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33547478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lactam (hetero)aryl fused pyrimidine derivatives as inhibitors of ERBB2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lyssikatos, Joseph P.; Kintz, Samuel; Ren, Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022140769 A1 2022-06-30

$RFMT $RIREG SCHEME418 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2R,3S)-3-phenyl-2-oxiranecarboperoxoate
C13H16O4
370084-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8749 2.3101 0.0 0
M  V30 2 O 8.2085 3.0801 0.0 0
M  V30 3 O 6.8749 0.7700 0.0 0
M  V30 4 O 9.5424 2.3101 0.0 0
M  V30 5 C 10.8760 3.0801 0.0 0
M  V30 6 C 11.6460 1.7464 0.0 0
M  V30 7 C 12.2097 3.8501 0.0 0
M  V30 8 C 10.1060 4.4137 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0 CFG=2
M  V30 10 C 5.5412 3.0801 0.0 0 CFG=2
M  V30 11 O 4.7712 4.4137 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12 CFG=3
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R,3S)-N-Methyl-3-phenyl-2-oxiranecarboxamide
C10H11NO2
486413-41-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.8748 2.1037 0.0 0
M  V30 2 N 8.2086 1.3337 0.0 0
M  V30 3 O 6.8748 3.6437 0.0 0
M  V30 4 C 9.5423 2.1037 0.0 0
M  V30 5 C 4.0011 1.3337 0.0 0 CFG=2
M  V30 6 C 5.5411 1.3337 0.0 0 CFG=2
M  V30 7 O 4.7711 0.0000 0.0 0
M  V30 8 C 2.6675 2.1037 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 C 2.6675 3.6437 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 1.3337 4.4137 0.0 0
M  V30 13 C 0.0000 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8 CFG=1
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 370084-23-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 486413-41-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27507863
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unique reactivity of α,β-unsaturated carboxylic acid imidazolides:
catalytic asymmetric synthesis of α,β-epoxy esters and α,β-epoxy
carboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nemoto, Tetsuhiro; Tosaki, Shin-Ya; Ohshima, Takashi; Shibasaki,
Masakatsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chirality (2003), 15(4), 306-311

$RFMT $RIREG SCHEME419 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Chlorosulfonyl)-2-fluorobenzoic acid
C7H4ClFO4S
37098-75-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 F 6.6687 0.0000 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 Cl 0.0000 3.8501 0.0 0
M  V30 7 O 2.1037 4.4137 0.0 0
M  V30 8 O 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-[(methylamino)sulfonyl]benzoic acid
C8H8FNO4S
716358-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 F 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 37098-75-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 716358-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23075701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown,alternate reaction conditions gave 79%
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfamides as TEAD inhibitors and their preparation, pharmaceutical
compositions and use in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Alfredo C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020243415 A2 2020-12-03

$RFMT $RIREG SCHEME420 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-1H-imidazole-5-carboxaldehyde
C5H6N2O
39021-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7709 1.3627 0.0 0
M  V30 2 O 5.1046 2.1327 0.0 0
M  V30 3 C 0.7104 0.0000 0.0 0
M  V30 4 C 2.4373 2.1327 0.0 0
M  V30 5 N 1.0305 1.5064 0.0 0
M  V30 6 C 2.2764 3.6642 0.0 0
M  V30 7 C 0.0000 2.6507 0.0 0
M  V30 8 N 0.7700 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-1H-imidazole-5-methanamine
C6H11N3
384821-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7709 1.3627 0.0 0
M  V30 2 N 5.1047 2.1327 0.0 0
M  V30 3 C 6.4383 1.3627 0.0 0
M  V30 4 C 0.7102 0.0000 0.0 0
M  V30 5 C 2.4373 2.1327 0.0 0
M  V30 6 N 1.0306 1.5064 0.0 0
M  V30 7 C 2.2764 3.6642 0.0 0
M  V30 8 C 0.0000 2.6508 0.0 0
M  V30 9 N 0.7700 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39021-62-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 384821-19-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-15141156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-5-aminomethyl-1-methyl-1H-imidazole (22). A solution of compound
21 (15.4 g, 0.14 mol) in CH3NH2 (36.0 mL, 0.42 mol, 40% in water) and
CH3OH (270 mL) was stirred at room temperature overnight, and then NaBH4
(15.9 g, 0.42 mol) was cautiously added to the solution. The resulting
mixture was stirred at room temperature for several hours and then
refluxed overnight. The reaction mixture was cooled to room temperature
and evaporated to dryness in vacuo. The resulting solid was extracted
with hot CHCl3, and the extract was dried over anhydrous Na2SO4. The
solvent was removed, and the residue was purified by silica gel column
chromatography using 1/19 (v/v) CH3OH/CHCl3 (saturated with NH3 gas) as
the eluent to give 16.3 g of compound 22 as a pale yellow liquid in 93%
yield. N-Methyl-5-aminomethyl-1-methyl-1H-imidazole (22), yield 16.3 g
93%. 1H NMR (400 MHz, CDCl3): δ 7.37 (s, 1H), 6.88 (s, 1H), 3.67 (s, 2H),
3.63 (s, 3H), 2.40 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 138.01, 129.63,
127.70, 44.63, 35.56, 30.98. MS (m/z): 125 (M+), 95 (100), 83, 68. HRMS:
calcd for C6H11N3 (M+), 125.095; found, 125.095.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New imidazole-based tripodal ligands as CuB site mimics of cytochrome c
oxidase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collman, James P.; Zhong, Min; Costanzo, Simona; Zhang, Chi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2001), 66(24), 8252-8256

$RFMT $RIREG SCHEME421 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-(aminomethyl)-4-hydroxy-1-piperidinecarboxylate
C11H22N2O3
392331-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6498 3.8636 0.0 0
M  V30 2 N 11.0969 3.3369 0.0 0
M  V30 3 O 9.6498 1.8837 0.0 0
M  V30 4 C 3.8500 2.8736 0.0 0
M  V30 5 O 3.0800 1.5400 0.0 0
M  V30 6 O 3.0800 4.2073 0.0 0
M  V30 7 C 1.5400 1.5400 0.0 0
M  V30 8 C 1.5400 3.0800 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 C 8.4700 2.8736 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 7.7000 1.5400 0.0 0
M  V30 14 C 6.1600 4.2073 0.0 0
M  V30 15 C 6.1600 1.5400 0.0 0
M  V30 16 N 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 11
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-hydroxy-4-[(methylamino)methyl]-, 1,1-dimethyl...
C12H24N2O3
1073559-55-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6498 3.8636 0.0 0
M  V30 2 N 11.0968 3.3369 0.0 0
M  V30 3 C 12.2766 4.3268 0.0 0
M  V30 4 O 9.6498 1.8837 0.0 0
M  V30 5 C 3.8500 2.8736 0.0 0
M  V30 6 O 3.0800 1.5400 0.0 0
M  V30 7 O 3.0800 4.2074 0.0 0
M  V30 8 C 1.5400 1.5400 0.0 0
M  V30 9 C 1.5400 0.0000 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 1.5400 3.0800 0.0 0
M  V30 12 C 8.4700 2.8736 0.0 0
M  V30 13 C 7.7000 4.2074 0.0 0
M  V30 14 C 7.7000 1.5400 0.0 0
M  V30 15 C 6.1600 4.2074 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 17 N 5.3900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 392331-66-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1073559-55-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-14885300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alkyl derivatives of 1-oxa-4,9-diazaspiroundecane
compounds having multimodal activity against pain
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Virgili-Bernardo, Marina; Alonso-Xalma, Monica; Alegret-Molina, Carlos;
Almansa-Rosales, Carmen; Garcia Lopez, Monica
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015185209 A1 2015-12-10

$RFMT $RIREG SCHEME422 STEP1
$RXN



  2  1
$MOL
2,4-Dimethoxy-6-methyl-1,3,5-triazine
C6H9N3O2
4000-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 N 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,6-dimethyl-1,3,5-triazin-2-amine
C6H10N4O
5248-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0
M  V30 2 C 0.0000 3.8501 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 N 2.6675 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4000-78-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5248-39-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14311556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine (Crude
Product) 5000 g of a 40% by weight strength methanolic solution of
2,4-dimethoxy-6-methyl-1,3,5-triazine are initially charged and then, at
from 5 to 10°C , admixed with a 40% by weight strength aqueous
methylamine solution to neutralize the acetic acid, establishing a pH of
from 7.2 to 7.5 (glass electrode). At from 13 to 15°C , 1500 g of a 40%
by weight strength aqueous methylamine solution are then introduced over
a period of 8 hours. After the addition of the methylamine solution has
ended, stirring is continued at 14°C. for another 4 hours and then with
water-cooling for 12 hours. The reaction product is subsequently filtered
off with suction using a nutsch filter and washed with 5x900 ml of a 2%
by weight strength methylamine solution and finally with 4x900 ml of
water. The yield of 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine,
based on the dried product, is 1850 g (yield: about 93%).
2-methoxy-4-methyl-6-methylamino-1,3,5-triazine (Crude Product), yield
93%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for preparing 2-methoxy-4-methyl-6-methylamino-1,3,5-triazine.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Stefan; Krommer, Helmut
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6342600 B1 2002-01-29

$RFMT $RIREG SCHEME423 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-4-(trifluoromethyl)benzene
C7H4BrF3
402-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 Br 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethyl)benzenamine
C8H8F3N
22864-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 N 7.7000 1.5400 0.0 0
M  V30 6 C 8.4700 2.8736 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 3.8500 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 5.3900 0.2064 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22864-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39679142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4271-96-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1134-35-6
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7758-94-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical (12 W purple LED used), sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Light-Promoted Efficient Generation of Fe(I) to Initiate Amination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Song, Geyang; Li, Qi; Song, Jiameng; Nong, Ding-Zhan; Dong, Jianyang; Li,
Gang; Fan, Juan; Wang, Chao; Xue, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2024), 14(7), 4968-4974

$RFMT $RIREG SCHEME424 STEP1
$RXN



  2  1
$MOL
Butanoic acid, 2-[(6-chloro-3-pyridinyl)oxy]-
C9H10ClNO3
402943-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 1.3336 1.5400 0.0 0
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 O 0.0000 2.3100 0.0 0
M  V30 6 O 1.3336 0.0000 0.0 0
M  V30 7 C 1.3336 4.6200 0.0 0
M  V30 8 Cl 9.3358 4.6200 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 6.6684 1.5400 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 8.0021 2.3100 0.0 0
M  V30 13 N 6.6684 4.6200 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, 2-[(6-chloro-3-pyridinyl)oxy]-N-methyl-
C10H13ClN2O2
402943-89-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.8500 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 4.6200 1.3338 0.0 0
M  V30 5 N 1.5400 4.0011 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 C 0.0000 4.0011 0.0 0
M  V30 9 Cl 10.7800 4.0011 0.0 0
M  V30 10 C 6.1600 4.0011 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 8.4700 2.6674 0.0 0
M  V30 14 N 8.4700 5.3349 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 9 15
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 402943-88-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402943-89-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10287038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7697-37-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 2-[(6-Chloro-3-pyridinyl)oxy]-N-methylbutyranamide
(Compound 39) To a slurry of 19.7 g (0.0912 mol) of compound 38 in 150 mL
of benzene was added 7.32 mL (0.100 mol) of thionyl chloride and four
drops of DMF. The slurry was heated under nitrogen for 1 hr with the
starting material dissolving. The solvent was removed in vacuo leaving
23.3 g of desired acid chloride which was dissolved in 50 mL of methylene
chloride. This solution was then added dropwise to a solution of 137 mL
(0.274 mol) of 2 M methylamine in tetrahydroforan at 0°C. An additional
300 mL of methylene chloride was added and the slurry was allowed to warm
to room temperature. The reaction mixture was washed with water, 0.50 M
NaOH and dried over Na2SO4. The solvent was removed in vacuo leaving 19.4
g (93.0%) of desired product Off-white crystalline, Yield 18.5 g (88.7%)
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (methylamine) (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel heterocyclic nitroalkenes as potential acaricides
and insecticides and processes for using and making them
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Markley, Lowell Dean; Sparks, Thomas Clarence; Dripps, James Edwin;
Gifford, James Michael; Schoonover, Joe Raymond; Neese, Paul Allen;
Dintenfass, Leonard Paul; Karr, Laura Lee; Benko, Zoltan Laszlo; De
Amicis, Carl Vincent; Erickson, William Randal; Samaritoni, Jack Geno;
Demeter, David Anthony; Watson, Gerald Bryan; Rau, Carrie Lynn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002018339 A2 2002-03-07

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
412284-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.4211 0.0 0
M  V30 2 O 0.0000 5.7412 0.0 0
M  V30 3 C 1.5063 0.0000 0.0 0
M  V30 4 Cl 7.4479 4.2505 0.0 0
M  V30 5 C 3.4469 3.4805 0.0 0
M  V30 6 C 3.4469 1.9404 0.0 0
M  V30 7 C 1.9822 3.9565 0.0 0
M  V30 8 C 4.7806 4.2505 0.0 0
M  V30 9 N 1.9822 1.4646 0.0 0
M  V30 10 C 4.7806 1.1704 0.0 0
M  V30 11 C 1.0769 2.7105 0.0 0
M  V30 12 C 6.1142 3.4805 0.0 0
M  V30 13 C 6.1142 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 0.0000 6.6519 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 412284-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9677693
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole c)
5-Chloro-1-methyl-3-(methylaminomethyl)-1H-indole [0764] According to the
procedure of Preparation 13 (c), except substituting
5-chloro-1-methyl-1H-indole-3-carboxaldehyde for
the,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (2.1 g,
93%) was obtained as an amber oil. MS (ES) m/e 209.0 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
412284-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.4211 0.0 0
M  V30 2 O 0.0000 5.7412 0.0 0
M  V30 3 C 1.5063 0.0000 0.0 0
M  V30 4 Cl 7.4479 4.2505 0.0 0
M  V30 5 C 3.4469 3.4805 0.0 0
M  V30 6 C 3.4469 1.9404 0.0 0
M  V30 7 C 1.9822 3.9565 0.0 0
M  V30 8 C 4.7806 4.2505 0.0 0
M  V30 9 N 1.9822 1.4646 0.0 0
M  V30 10 C 4.7806 1.1704 0.0 0
M  V30 11 C 1.0769 2.7105 0.0 0
M  V30 12 C 6.1142 3.4805 0.0 0
M  V30 13 C 6.1142 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 0.0000 6.6519 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 412284-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2843334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME425 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-1-methyl-1H-indole-3-carboxaldehyde
C10H8ClNO
412284-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 5.4211 0.0 0
M  V30 2 O 0.0000 5.7412 0.0 0
M  V30 3 C 1.5063 0.0000 0.0 0
M  V30 4 Cl 7.4479 4.2505 0.0 0
M  V30 5 C 3.4469 3.4805 0.0 0
M  V30 6 C 3.4469 1.9404 0.0 0
M  V30 7 C 1.9822 3.9565 0.0 0
M  V30 8 C 4.7806 4.2505 0.0 0
M  V30 9 N 1.9822 1.4646 0.0 0
M  V30 10 C 4.7806 1.1704 0.0 0
M  V30 11 C 1.0769 2.7105 0.0 0
M  V30 12 C 6.1142 3.4805 0.0 0
M  V30 13 C 6.1142 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N,1-dimethyl-1H-indole-3-methanamine
C11H13ClN2
620175-83-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7306 4.6948 0.0 0
M  V30 2 N 7.1953 4.2188 0.0 0
M  V30 3 C 8.3397 5.2494 0.0 0
M  V30 4 C 3.0202 0.0000 0.0 0
M  V30 5 Cl 0.0000 6.6519 0.0 0
M  V30 6 C 3.0800 3.9844 0.0 0
M  V30 7 C 2.3100 2.6508 0.0 0
M  V30 8 C 4.5863 3.6643 0.0 0
M  V30 9 C 2.3100 5.3182 0.0 0
M  V30 10 N 3.3404 1.5064 0.0 0
M  V30 11 C 0.7700 2.6508 0.0 0
M  V30 12 C 4.7472 2.1327 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 412284-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-83-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-230308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME426 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2-(methylthio)-5-nitroso-4(3H)-pyrimidinone
C5H6N4O2S
43005-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 N 1.3337 4.6201 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 S 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 N 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2-(methylamino)-5-nitroso-4(3H)-pyrimidinone
C5H7N5O2
100516-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 N 1.3337 4.6201 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 N 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 N 4.0011 4.6201 0.0 0
M  V30 11 N 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 43005-49-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100516-80-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24550453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Wet-dry cycles enable the parallel origin of canonical and non-canonical
nucleosides by continuous synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Becker, Sidney; Schneider, Christina; Okamura, Hidenori; Crisp, Antony;
Amatov, Tynchtyk; Dejmek, Milan; Carell, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-9

$RFMT $RIREG SCHEME427 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Adenosine, N-benzoyl-5′-O-[(4-methoxyphenyl)diphenylmethyl]-1-methyl-
C38H35N5O6
434329-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 55 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 O 5.9537 4.7711 0.0 0
M  V30 3 C 7.2875 4.0011 0.0 0
M  V30 4 O 1.5400 9.3358 0.0 0
M  V30 5 C 0.0000 9.3358 0.0 0
M  V30 6 O 7.6377 7.3331 0.0 0
M  V30 7 O 10.9148 8.0298 0.0 0
M  V30 8 N 17.6801 5.9250 0.0 0
M  V30 9 C 18.9259 6.8302 0.0 0
M  V30 10 O 18.7650 8.3618 0.0 0
M  V30 11 C 17.3582 8.9883 0.0 0
M  V30 12 C 3.8500 5.3347 0.0 0
M  V30 13 C 4.6200 6.6684 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 3.8500 8.0022 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 C 2.3100 8.0022 0.0 0
M  V30 18 C 5.3900 2.6674 0.0 0
M  V30 19 C 6.9300 2.6674 0.0 0
M  V30 20 C 4.6200 1.3336 0.0 0
M  V30 21 C 7.7000 1.3336 0.0 0
M  V30 22 C 5.3900 0.0000 0.0 0
M  V30 23 C 6.9300 0.0000 0.0 0
M  V30 24 C 3.2864 3.2311 0.0 0
M  V30 25 C 3.2864 1.6911 0.0 0
M  V30 26 C 1.9527 4.0011 0.0 0
M  V30 27 C 1.9527 0.9211 0.0 0
M  V30 28 C 0.6189 3.2311 0.0 0
M  V30 29 C 0.6189 1.6911 0.0 0
M  V30 30 C 8.6211 4.7711 0.0 0 CFG=2
M  V30 31 O 10.0279 4.1448 0.0 0
M  V30 32 C 8.7820 6.3026 0.0 0 CFG=1
M  V30 33 C 11.0585 5.2892 0.0 0 CFG=1
M  V30 34 C 10.2885 6.6228 0.0 0 CFG=1
M  V30 35 N 12.5900 5.1282 0.0 0
M  V30 36 C 13.6204 6.2726 0.0 0
M  V30 37 C 13.3600 3.7944 0.0 0
M  V30 38 C 15.0274 5.6463 0.0 0
M  V30 39 N 13.4595 7.8041 0.0 0
M  V30 40 N 14.8663 4.1147 0.0 0
M  V30 41 C 16.2733 6.5515 0.0 0
M  V30 42 C 14.7054 8.7094 0.0 0
M  V30 43 N 16.1123 8.0830 0.0 0
M  V30 44 C 20.3329 6.2039 0.0 0
M  V30 45 C 20.4938 4.6722 0.0 0
M  V30 46 C 21.5787 7.1091 0.0 0
M  V30 47 C 21.9008 4.0459 0.0 0
M  V30 48 C 22.9857 6.4827 0.0 0
M  V30 49 C 23.1466 4.9511 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 3
M  V30 6 1 30 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 17
M  V30 9 1 32 6 CFG=1
M  V30 10 1 34 7 CFG=1
M  V30 11 1 8 9
M  V30 12 2 8 41 CFG=2
M  V30 13 2 9 10
M  V30 14 1 9 44
M  V30 15 1 11 43
M  V30 16 2 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 2 14 16
M  V30 20 2 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 1 33 35 CFG=3
M  V30 40 1 35 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 1 36 39
M  V30 44 2 37 40
M  V30 45 1 38 40
M  V30 46 1 38 41
M  V30 47 2 39 42
M  V30 48 1 41 43
M  V30 49 1 42 43
M  V30 50 2 44 45
M  V30 51 1 44 46
M  V30 52 1 45 47
M  V30 53 2 46 48
M  V30 54 2 47 49
M  V30 55 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 30 32 33 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Adenosine, 5′-O-[(4-methoxyphenyl)diphenylmethyl]-N,1-dimethyl-
C32H33N5O5
434329-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 6.9300 0.0 0
M  V30 2 O 6.1600 6.9300 0.0 0
M  V30 3 C 6.9300 8.2636 0.0 0
M  V30 4 O 4.6200 0.7700 0.0 0
M  V30 5 C 3.2864 0.0000 0.0 0
M  V30 6 O 8.8994 10.9742 0.0 0
M  V30 7 O 12.0858 9.9389 0.0 0
M  V30 8 N 16.8923 4.7337 0.0 0
M  V30 9 C 18.4239 4.8946 0.0 0
M  V30 10 C 18.1451 7.5472 0.0 0
M  V30 11 C 4.6200 5.3900 0.0 0
M  V30 12 C 3.2864 4.6200 0.0 0
M  V30 13 C 5.9538 4.6200 0.0 0
M  V30 14 C 3.2864 3.0800 0.0 0
M  V30 15 C 5.9538 3.0800 0.0 0
M  V30 16 C 4.6200 2.3100 0.0 0
M  V30 17 C 3.0800 6.9300 0.0 0
M  V30 18 C 2.3100 5.5964 0.0 0
M  V30 19 C 2.3100 8.2636 0.0 0
M  V30 20 C 0.7700 5.5964 0.0 0
M  V30 21 C 0.7700 8.2636 0.0 0
M  V30 22 C 0.0000 6.9300 0.0 0
M  V30 23 C 4.6200 8.4700 0.0 0
M  V30 24 C 3.2864 9.2400 0.0 0
M  V30 25 C 5.9538 9.2400 0.0 0
M  V30 26 C 3.2864 10.7800 0.0 0
M  V30 27 C 5.9538 10.7800 0.0 0
M  V30 28 C 4.6200 11.5500 0.0 0
M  V30 29 C 8.4700 8.2636 0.0 0 CFG=2
M  V30 30 O 9.3752 7.0178 0.0 0
M  V30 31 C 9.3752 9.5095 0.0 0 CFG=1
M  V30 32 C 10.8399 7.4936 0.0 0 CFG=1
M  V30 33 C 10.8399 9.0336 0.0 0 CFG=1
M  V30 34 N 12.0858 6.5884 0.0 0
M  V30 35 C 13.5505 7.0644 0.0 0
M  V30 36 C 12.0858 5.0484 0.0 0
M  V30 37 C 14.4555 5.8184 0.0 0
M  V30 38 N 14.1768 8.4712 0.0 0
M  V30 39 N 13.5505 4.5726 0.0 0
M  V30 40 C 15.9872 5.9795 0.0 0
M  V30 41 C 15.7083 8.6322 0.0 0
M  V30 42 N 16.6135 7.3863 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 1 23
M  V30 5 1 2 3
M  V30 6 1 29 3 CFG=3
M  V30 7 1 4 5
M  V30 8 1 4 16
M  V30 9 1 31 6 CFG=1
M  V30 10 1 33 7 CFG=1
M  V30 11 1 8 9
M  V30 12 2 8 40 CFG=2
M  V30 13 1 10 42
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 37 1 32 34 CFG=3
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 1 35 38
M  V30 42 2 36 39
M  V30 43 1 37 39
M  V30 44 1 37 40
M  V30 45 2 38 41
M  V30 46 1 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 29 31 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 434329-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 434329-11-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25682708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemical incorporation of 1-methyladenosine into oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mikhailov, Sergey N.; Rozenski, Jef; Efimtseva, Ekaterina V.; Busson,
Roger; Van Aerschot, Arthur; Herdewijn, Piet
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleic Acids Research (2002), 30(5), 1124-1131

$RFMT $RIREG SCHEME428 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl chloride
C31H40ClNO3
443104-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6839 7.1955 0.0 0
M  V30 2 O 6.6685 1.9497 0.0 0
M  V30 3 C 5.5795 7.6587 0.0 0
M  V30 4 C 1.3337 5.0298 0.0 0
M  V30 5 Cl 0.0000 4.2597 0.0 0
M  V30 6 O 1.3337 6.5698 0.0 0
M  V30 7 C 1.6774 0.0000 0.0 0
M  V30 8 C 3.6573 0.0000 0.0 0
M  V30 9 C 9.3358 5.0298 0.0 0
M  V30 10 C 11.6596 10.0595 0.0 0
M  V30 11 C 9.6797 10.0595 0.0 0
M  V30 12 C 13.3370 5.7998 0.0 0
M  V30 13 N 14.6707 5.0298 0.0 0
M  V30 14 O 13.3370 8.8798 0.0 0
M  V30 15 C 5.3348 4.2597 0.0 0 CFG=2
M  V30 16 C 5.3348 5.7998 0.0 0 CFG=2
M  V30 17 C 4.0010 3.4897 0.0 0 CFG=2
M  V30 18 C 6.6685 3.4897 0.0 0
M  V30 19 C 6.6685 6.5698 0.0 0 CFG=1
M  V30 20 C 4.0010 6.5698 0.0 0
M  V30 21 C 2.6673 4.2597 0.0 0 CFG=1
M  V30 22 C 4.0010 1.9497 0.0 0
M  V30 23 C 8.0022 4.2597 0.0 0
M  V30 24 C 8.0022 5.7998 0.0 0
M  V30 25 C 6.6685 8.1098 0.0 0
M  V30 26 C 2.6673 5.7998 0.0 0
M  V30 27 C 1.3337 3.4897 0.0 0
M  V30 28 C 2.6673 1.1797 0.0 0
M  V30 29 C 9.3358 6.5698 0.0 0 CFG=2
M  V30 30 C 8.0022 8.8798 0.0 0
M  V30 31 C 1.3337 1.9497 0.0 0
M  V30 32 C 9.3358 8.1098 0.0 0 CFG=2
M  V30 33 C 10.6697 5.7998 0.0 0
M  V30 34 C 10.6697 8.8798 0.0 0
M  V30 35 C 12.0033 6.5698 0.0 0
M  V30 36 C 12.0033 8.1098 0.0 0
M  V30 37 H 5.7334 2.7722 0.0 0
M  V30 38 H 4.8844 2.2281 0.0 0
M  V30 39 H 9.3358 9.6499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=3
M  V30 2 2 2 18
M  V30 3 1 19 3 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 21 4 CFG=1
M  V30 7 1 7 28
M  V30 8 1 8 28
M  V30 9 1 29 9 CFG=1
M  V30 10 1 10 34
M  V30 11 1 11 34
M  V30 12 3 12 13
M  V30 13 1 12 35
M  V30 14 2 14 36
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 37 CFG=1
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 17 38 CFG=1
M  V30 24 1 18 23
M  V30 25 1 19 24
M  V30 26 1 19 25
M  V30 27 1 20 26
M  V30 28 1 21 26
M  V30 29 1 21 27
M  V30 30 1 22 28
M  V30 31 2 23 24
M  V30 32 1 24 29
M  V30 33 1 25 30
M  V30 34 1 27 31
M  V30 35 1 28 31
M  V30 36 1 29 32
M  V30 37 1 29 33
M  V30 38 1 30 32
M  V30 39 1 32 34
M  V30 40 1 32 39 CFG=3
M  V30 41 2 33 35
M  V30 42 1 34 36
M  V30 43 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 17 19 21 29 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Cyano-N-methyl-3,12-dioxooleana-1,9(11)-dien-28-amide
C32H44N2O3
443103-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.0297 0.0 0
M  V30 2 N 1.3338 4.2597 0.0 0
M  V30 3 O 2.6675 6.5698 0.0 0
M  V30 4 C 0.0000 5.0297 0.0 0
M  V30 5 C 6.0178 7.1955 0.0 0
M  V30 6 O 8.0023 1.9497 0.0 0
M  V30 7 C 3.0112 0.0000 0.0 0
M  V30 8 C 4.9911 0.0000 0.0 0
M  V30 9 C 6.9134 7.6587 0.0 0
M  V30 10 C 10.6697 5.0297 0.0 0
M  V30 11 C 12.9934 10.0595 0.0 0
M  V30 12 C 11.0136 10.0595 0.0 0
M  V30 13 C 14.6708 5.7998 0.0 0
M  V30 14 N 16.0046 5.0297 0.0 0
M  V30 15 O 14.6708 8.8798 0.0 0
M  V30 16 C 4.0012 4.2597 0.0 0 CFG=1
M  V30 17 C 5.3348 3.4897 0.0 0 CFG=1
M  V30 18 C 4.0012 5.7998 0.0 0
M  V30 19 C 2.6675 3.4897 0.0 0
M  V30 20 C 6.6687 4.2597 0.0 0 CFG=1
M  V30 21 C 5.3348 1.9497 0.0 0
M  V30 22 C 5.3348 6.5698 0.0 0
M  V30 23 C 2.6675 1.9497 0.0 0
M  V30 24 C 6.6687 5.7998 0.0 0 CFG=1
M  V30 25 C 8.0023 3.4897 0.0 0
M  V30 26 C 4.0012 1.1797 0.0 0
M  V30 27 C 8.0023 6.5698 0.0 0 CFG=1
M  V30 28 C 9.3360 4.2597 0.0 0
M  V30 29 C 9.3360 5.7998 0.0 0
M  V30 30 C 8.0023 8.1098 0.0 0
M  V30 31 C 10.6697 6.5698 0.0 0 CFG=2
M  V30 32 C 9.3360 8.8798 0.0 0
M  V30 33 C 10.6697 8.1098 0.0 0 CFG=2
M  V30 34 C 12.0035 5.7998 0.0 0
M  V30 35 C 12.0035 8.8798 0.0 0
M  V30 36 C 13.3372 6.5698 0.0 0
M  V30 37 C 13.3372 8.1098 0.0 0
M  V30 38 H 6.4239 2.4008 0.0 0
M  V30 39 H 7.0672 2.7722 0.0 0
M  V30 40 H 10.6697 9.6499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 24 5 CFG=3
M  V30 6 2 6 25
M  V30 7 1 7 26
M  V30 8 1 8 26
M  V30 9 1 27 9 CFG=1
M  V30 10 1 31 10 CFG=1
M  V30 11 1 11 35
M  V30 12 1 12 35
M  V30 13 3 13 14
M  V30 14 1 13 36
M  V30 15 2 15 37
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 17 38 CFG=1
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 20 25
M  V30 26 1 20 39 CFG=1
M  V30 27 1 21 26
M  V30 28 1 22 24
M  V30 29 1 23 26
M  V30 30 1 24 27
M  V30 31 1 25 28
M  V30 32 1 27 29
M  V30 33 1 27 30
M  V30 34 2 28 29
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 31 34
M  V30 39 1 32 33
M  V30 40 1 33 35
M  V30 41 1 33 40 CFG=3
M  V30 42 2 34 36
M  V30 43 1 35 37
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 16 17 20 24 27 31 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443104-14-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 443103-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11691004
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 93
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel dicyanotriterpenoid,
2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar
concentrations for inhibition of nitric oxide production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Honda, Tadashi; Honda, Yukiko; Favaloro, Frank G.; Gribble, Gordon W.;
Suh, Nanjoo; Place, Andrew E.; Rendi, Mara H.; Sporn, Michael B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2002), 12(7), 1027-1030

